Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.8353691222913687,2.0611303089291564,0.0,0.17613967444874665,0.1,11/47,4.41%,ZAP70;PDGFB;RELN;PTPN6;FGFR1;FLT1;FGFR3;SRC;EGFR;PDGFRA;EPHA3
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.869437700496405,-2.041314098235676,0.0,0.0,0.0,64/88,8.41%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;SRP14;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;RPS11;RPL37;RPS3A;RPL13;SEC62;RPS20;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19;RPL32;RPL6;SRP54
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8726023627620877,-2.0249135684024733,0.0,0.0,0.0,64/85,8.41%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;SRP14;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;SEC61B;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;RPS11;RPL37;RPS3A;RPL13;RPS20;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19;RPL32;RPL6;SRP54
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.8290597248057864,-1.9873391800033129,0.0,0.0,0.0,78/142,11.60%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;MRPL51;RPS5;RPS7;RPL18;RPL10A;RPL41;MRPL35;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;MRPL36;RPS11;RPL37;RPS3A;RPL13;MRPS12;RPS20;RPL15;RPS24;RPL3;MRPL34;RPL28;RPS9;RPS4X;RPS28;RPL36;RPS19;MRPL27;COPS5;RPL32;RPL6;MRPS21;MRPS18B;RPL31;RPL39;PCSK1;MRPS18A;RPL8;RPLP0;RPS26;MRPL52;ABCF1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8414718926853532,-1.9806918912223859,0.0,0.0,0.0,59/105,6.72%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;RPS11;RPL37;RPS3A;RPL13;RPS20;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8679353257434388,-1.9756160829889173,0.0,0.0,0.0,60/87,6.72%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;TMA7;RPS11;RPL37;RPS3A;RPL13;RPS20;RPL22L1;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8215316403999098,-1.962129079212151,0.0,0.0,0.0,65/97,8.41%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;SRP14;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;RPS11;RPL37;RPS3A;RPL13;SEC62;RPS20;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19;RPL32;RPL6;GET3;SRP54
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.799250452121568,-1.960717159265793,0.0,0.0,0.0,86/192,11.60%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;NARS1;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;EEF1B2;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;MRPL51;RPS5;RPS7;RPL18;RPL10A;RPL41;MRPL35;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;TMA7;MRPL36;RPS11;RPL37;RPS3A;RPL13;MRPS12;RPS20;RPL22L1;RPL15;RPS24;RPL3;MRPL34;MRPS34;RPL28;RPS9;UBA52;RPS4X;AIMP1;TRMT112;RPS28;RPL36;RPS19;MRPL27;COPS5;RPL32;RPL6;MRPS21;MRPS18B;MRPL2;RPL31;RPL39;MRPS18A;RPL8;RPLP0;RPS26;MRPL52;ABCF1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.9708981841543187,1.955398310199277,0.0,0.6435872720242667,0.36,1/11,0.02%,GABRE
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7616114357178212,1.9238051776586267,0.0,0.6232634634340265,0.48,4/43,4.52%,GABRE;GABRR2;ANO4;GLRB
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.8288239963929465,1.9065109008015677,0.0,0.6097142577071999,0.56,2/31,2.13%,GABRE;CHRNA4
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.771031603542372,-1.9056870280355478,0.0,0.0,0.0,60/161,6.72%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;POLR2G;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;RPS5;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;RPS3;RPS11;RPL37;RPS3A;RPL13;RPS20;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.7192832722846503,-1.9009399741512853,0.0,0.0,0.0,91/320,11.66%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;NOX4;RPL35A;RPS27A;POLR2G;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;MRPL51;RPS5;RPS7;RPL18;RPL10A;RPL41;PTMA;MRPL35;RPLP2;RPS6;RPL24;POLR2J;RPL21;RPL11;RPL13A;RPS3;RBMS2;MRPL36;RPS11;RPL37;RPS3A;POLR2L;RPL13;MRPS12;RPS20;RPL15;RPS24;RPL3;MRPL34;RPL28;POLR2I;RPS9;RPS4X;RBM3;RPS28;RPL36;RPS19;MRPL27;COPS5;FIP1L1;PAX8;RPL32;RPL6;MRPS21;MRPS18B;DHX38;RPL31;RPL39;TFIP11;MRPS18A;RPL8;RPLP0;RPS26;MRPL52;ABCF1;UPF2;SRSF7
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.7233880965042365,-1.8869813337893553,0.0,0.0,0.0,102/278,12.90%,RPS12;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;MCM2;RPS21;RPL35A;RPS27A;POLR2G;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;EEF1B2;RPL18A;RPL30;TYMS;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;MRPL51;RPS5;RPS7;RPL18;RPL10A;RPL41;PTMA;RMI1;MRPL35;RPLP2;RPS6;RPL24;POLR2J;RPL21;RPL11;RPL13A;RPS3;MRPL36;RPS11;RPL37;RPS3A;POLR2L;RPL13;MRPS12;RPS20;RPL15;RPS24;RPL3;MRPL34;RPL28;POLR2I;GCNT1;RPS9;POLE3;RPS4X;ORC6;MCM4;RPS28;RPL36;RPS19;MRPL27;COPS5;MCM3;GRWD1;PAX8;RPL32;RPL6;MRPS21;FAM111A;MRPS18B;RPA3;RPL31;RFC2;RPL39;MRPS18A;RPL8;RPLP0;RPS26;MRPL52;ABCF1;CLSPN;THAP1;BRCA1;EEF2;RPS29;RPL14
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.6637993775057414,1.883633469657314,0.0,0.6259733045793919,0.66,3/89,1.27%,KLRF2;NOS2;KAT2A
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.9668808494326471,1.8813670517945793,0.0,0.5419682290730665,0.66,1/9,0.07%,F2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.7516546892300587,1.8810834758016182,0.0,0.4664797971664609,0.66,11/54,4.41%,ZAP70;PDGFB;RELN;PTPN6;FGFR1;FLT1;FGFR3;SRC;EGFR;PDGFRA;EPHA3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8399064341336744,1.8624460833244947,0.0,0.508095214756,0.71,6/14,12.19%,RELN;NLGN1;CACNG5;CACNG4;NRXN1;NLGN3
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7517139445627069,-1.8364869490324929,0.0,0.0014866984232502745,0.02,61/151,12.94%,RPS27;RPL19;RPL38;RPL23;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPS15;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;SBDS;RPL37;RPL13;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS28;RPL36;NOP53;RPS19;RPL32;RPL6;NIFK;RPL31;IMP3;RPL39;RPL8;RPLP0;EXOSC4;NOC4L;EXOSC10;NOB1;RPL14;WDR74
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.739874203815004,-1.8081260235354686,0.0,0.011583858547825059,0.14,62/164,12.94%,RPS27;RPL19;RPL38;RPL23;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPS15;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;SBDS;RPL37;RPL13;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS28;RPL36;NOP53;RPS19;RPL32;NHP2;RPL6;TSR3;RPL31;IMP3;RPL39;RPL8;RPLP0;EXOSC4;NOC4L;EXOSC10;NOB1;RPL14;WDR74
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7487014170780082,1.804981530177705,0.0,0.8114468763066193,0.87,11/29,14.64%,PBX3;ADAMTS18;PBX1;FREM2;MEIS1;SMG9;MEIS3;TGFB2;C3;MEIS2;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7919527661023295,1.7887640315160034,0.0,0.8414056756359359,0.91,8/22,10.72%,PDGFB;PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;NFKB1;SLC4A4
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8902354099303348,1.7812620215558412,0.02857142857142857,0.8289650412867586,0.93,4/12,6.61%,PDGFB;NFATC4;RELA;NFIB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8403133225679252,1.777098262042236,0.0,0.7926285350193598,0.95,3/12,6.71%,PDGFB;IGF1;DOCK7
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.8594986115543185,1.776496381730694,0.0,0.7368683422204964,0.95,2/8,5.54%,SLC39A8;SLC40A1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.9731930946750436,1.775436830675939,0.0,0.6948806937043961,0.95,2/10,0.01%,KLRF2;CLEC2A
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6730890884030187,1.7731927177789244,0.0,0.6612012394691412,0.95,7/59,5.96%,GABRE;SLC26A7;GABRR2;ANO4;CLIC5;GLRB;SLC26A6
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.715687135936815,-1.7721985429149067,0.0,0.02704647516143769,0.31,74/190,16.01%,RPS27;RPL19;RPL38;RPL23;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPS15;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;SBDS;RPL37;RPL13;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPS28;RPL36;NOP53;RPS19;TRPT1;RPL32;RPL6;RPL31;IMP3;RPL39;RPL8;RPLP0;EXOSC4;NOC4L;EXOSC10;NOB1;SSB;INTS5;RPL14;WDR74;WDR12;SARS1;INTS12;POP7;EBNA1BP2;RPL7;IMP4;MRTO4;UTP11;METTL3;SNU13
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.8242632877637098,1.7685116626253787,0.0,0.6452809227401199,0.96,2/16,0.27%,VDR;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.790783068416941,1.7631295175069672,0.0,0.6415947417703215,0.96,5/26,4.38%,F2;NLRP7;NOS2;TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.7180523383172479,-1.7607653312572442,0.0,0.03387548550120269,0.36,72/182,15.31%,RPS27;RPL19;RPL38;RPL23;RPL34;RPL12;RPL35A;RPLP1;RPL27A;RPS16;RPS14;RPL29;RPL7A;RPL18A;RPL30;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPS15;RPS7;RPL18;RPL10A;RPL41;RPLP2;RPS6;RPL24;RPL21;RPL11;RPL13A;SBDS;MRPL36;RBIS;RPL37;RPL13;NOP16;RPL15;RPS24;RPL3;RPL28;RPS9;UBA52;RPF2;RPS28;RPL36;NOP53;RPS19;RPL32;RPL6;ZNF622;RPL31;IMP3;RPL39;RPL8;RPLP0;EXOSC4;NOC4L;EXOSC10;NOB1;RPL14;WDR74;SURF6;WDR12;EBNA1BP2;RPL7;IMP4;MRTO4;RPL26L1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.6624083117820532,1.760296240906331,0.0,0.6194997951765747,0.97,15/66,11.23%,MFNG;TP63;YJEFN3;SRC;EGFR;MAML2;RFNG;LLGL2;NOTCH4;NOTCH3;DLL1;TGFB2;ARRB1;FBXW7;LFNG
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7996974226504262,-1.7503400749944,0.0,0.04306469766014963,0.46,17/63,5.68%,CD44;GBP3;HLA-F;B2M;GBP2;HLA-C;GAPDH;IRF4;IFNGR2;MT2A;HLA-DPA1;PTAFR;RPL13A;HLA-E;HLA-A;IRF9;IRF1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.7774705163129744,1.7479005631475675,0.02857142857142857,0.6639110806145065,0.99,3/19,5.72%,PDGFB;EGFR;PKD1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6793763500302382,1.747278988462443,0.0,0.6361352088745119,0.99,13/40,12.19%,GRM2;RELN;HOMER1;GRM8;NLGN1;CACNG5;CACNG4;GRM3;GRM1;UNC13A;NRXN1;CDH2;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7987381648472922,1.7426127940982707,0.0,0.6303606664337928,0.99,5/21,3.97%,PDGFB;PDGFC;IGF1;CDK6;PDGFRA
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.698279015194529,1.7387934691720703,0.0,0.630653939285023,0.99,12/39,14.64%,PBX3;ADAMTS18;PBX1;FREM2;MEIS1;SMG9;MEIS3;TGFB2;COL5A1;MEIS2;CEP290;HIPK2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.7733206970516449,1.7357129046677218,0.06060606060606061,0.6173725044223628,0.99,3/31,2.01%,PDGFB;IGF1;TAFA5
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8136562135941003,-1.7284449201724192,0.0,0.059282099627104706,0.53,19/30,15.40%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFB9;NDUFC1;NDUFA2;NDUFS6;NDUFB11;NDUFB4;NDUFB2;NDUFA3;NDUFS8;NDUFB7;NDUFB10;NDUFAB1;NDUFB1;NDUFAF1;NDUFS7
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.879625282197708,1.7236068902549202,0.03125,0.6672983820462133,1.0,2/17,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7823875268481947,1.7229788820787213,0.02702702702702703,0.6438582561388031,1.0,5/24,12.19%,RELN;NLGN1;CACNG5;CACNG4;NLGN3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7821307192781126,-1.722149072581269,0.0,0.06397175862397506,0.6,29/53,12.32%,NDUFS5;COX7C;NDUFA1;NDUFB3;NDUFA12;COX6C;COX4I1;COX6A1;NDUFB9;NDUFC1;UQCR10;UQCC3;NDUFA2;NDUFS6;NDUFB11;NDUFB4;UQCRQ;NDUFB2;NDUFA3;CYC1;COX7B;NDUFS8;NDUFB7;UQCRH;COX6B1;NDUFB10;NDUFAB1;UQCRB;NDUFB1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6748202781109317,1.719169275014424,0.0,0.6399394089439672,1.0,6/57,7.66%,GABRE;GABRR2;ANO4;GLRB;SLC37A3;LRRC8A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.8035487579946317,-1.7172001740329157,0.0,0.06859461336163072,0.64,14/45,5.68%,CD44;HLA-F;B2M;GBP2;HLA-C;IRF4;IFNGR2;MT2A;HLA-DPA1;PTAFR;HLA-E;HLA-A;IRF9;IRF1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8842815303777679,-1.715550394384225,0.0,0.06928797125200623,0.66,4/18,2.43%,SLC28A2;B2M;ACTG1;PRDX1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7959233956289149,-1.7125004490817306,0.0,0.07113851955252565,0.71,19/44,8.15%,RPS27;MPV17L2;RPS14;RPL23A;RPL5;RPL10;RPSA;RPS15;RPS5;RPL24;RPL11;SBDS;RPL3;RPF2;RPS28;NOP53;RPS19;RPL6;MRPL20
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7803117204802011,-1.7122316887557052,0.0,0.06814034439897092,0.72,29/54,12.32%,NDUFS5;COX7C;NDUFA1;NDUFB3;NDUFA12;COX6C;COX4I1;COX6A1;NDUFB9;NDUFC1;UQCR10;UQCC3;NDUFA2;NDUFS6;NDUFB11;NDUFB4;UQCRQ;NDUFB2;NDUFA3;CYC1;COX7B;NDUFS8;NDUFB7;UQCRH;COX6B1;NDUFB10;NDUFAB1;UQCRB;NDUFB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.8587830219927057,1.705220266046896,0.02857142857142857,0.7075696324009481,1.0,1/9,0.32%,RELN
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.8138504824618777,1.7048655071480543,0.029411764705882353,0.6847187894092761,1.0,9/31,6.83%,F2;CREB3L1;RAB27A;RUNX1;ADGRB1;SCX;CYBA;SORBS1;SERPINF2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.8532466524821483,1.6987137539433164,0.0,0.7078291957290482,1.0,2/7,4.38%,TICAM1;CLEC7A
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.9530882452455137,1.6981404035619394,0.0,0.6892029313045831,1.0,2/7,2.36%,F2;TMEM98
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.8813167097130681,1.695271085802164,0.047619047619047616,0.6862017093908988,1.0,3/8,5.28%,CPNE1;CPNE7;HDHD5
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.9307105782402156,1.6942305185853634,0.0,0.6702622707989566,1.0,1/7,0.13%,MDGA2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.9516089664558443,1.6907140557345914,0.0,0.6745862123992791,1.0,1/6,2.46%,ALK
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.6479189151988007,1.690710602766488,0.03571428571428571,0.654745441446359,1.0,10/53,11.65%,PDGFB;EPB41L4B;VIT;ADAM8;TGFB2;FRMD5;NPNT;MEGF10;CHRD;AFDN
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.8610320810517968,1.6863218422635715,0.05128205128205128,0.6615883596327649,1.0,3/13,4.20%,DACT2;COL22A1;GRHL2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.78631184420385,1.6802835345883576,0.04878048780487805,0.6804712209472947,1.0,6/21,13.03%,PNLDC1;CNOT2;SAMD4A;CNOT11;CNOT4;CNOT6L
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7085880982939163,1.6767147740068695,0.0,0.6785588705894543,1.0,10/37,13.86%,KCNN4;KCNJ2;KCNIP2;KCNMB4;ATP1B3;KCNN2;AKAP6;NOS1AP;KCNN1;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.8716356673194826,1.6747887685052076,0.0,0.6728250317505767,1.0,5/14,7.24%,RAB27A;CACNA1I;NLGN1;STX1A;UNC13D
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.8582799681457992,1.6719672510771386,0.05405405405405406,0.6722490533694768,1.0,1/8,0.30%,LEPR
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.8639631141872377,1.666367837572521,0.0,0.6906707619249893,1.0,2/13,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.740796980671678,-1.6639896665692822,0.0,0.1791794795325983,0.94,24/50,16.08%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFB9;NDUFC1;NDUFA2;NDUFS6;NDUFB11;DMAC1;NDUFB4;NDUFB2;NDUFA3;TMEM126B;NDUFAF3;NDUFS8;NDUFB7;NDUFB10;NDUFAB1;NDUFB1;TMEM126A;NDUFAF1;NDUFS7;ECSIT
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.740796980671678,-1.6639896665692822,0.0,0.1791794795325983,0.94,24/50,16.08%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFB9;NDUFC1;NDUFA2;NDUFS6;NDUFB11;DMAC1;NDUFB4;NDUFB2;NDUFA3;TMEM126B;NDUFAF3;NDUFS8;NDUFB7;NDUFB10;NDUFAB1;NDUFB1;TMEM126A;NDUFAF1;NDUFS7;ECSIT
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.8531944922183531,1.6638218081421265,0.0,0.6863829340150972,1.0,1/13,1.70%,ITGA11
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.6987653799068788,-1.661570799400745,0.0,0.18193471954525237,0.94,77/180,19.77%,GPX4;SLC25A4;PDHX;COX7C;NDUFA1;NDUFB3;MRPS22;COX6C;COX4I1;ATP6V1F;SLC25A6;LDHA;COX6A1;NDUFC1;IDH3B;UQCR10;MRPL35;ATP5F1E;NDUFA2;NDUFS6;SLC25A5;SLC25A11;MRPS12;MRPL34;TIMM8B;CYB5R3;ATP5MC3;RETSAT;HCCS;NDUFB4;TIMM10;ETFB;UQCRQ;NDUFB2;ISCU;NDUFA3;CYC1;COX7B;ATP5PB;ATP5PD;SURF1;COX17;NDUFS8;NDUFB7;PHB2;UQCRH;COX6B1;ATP5F1B;COX7A2;TIMM50;AFG3L2;NDUFAB1;ATP5PF;PMPCA;UQCRB;MGST3;NDUFB1;IDH3G;DECR1;ATP5ME;MDH2;MDH1;NDUFS7;ATP6V1E1;SLC25A3;NQO2;TIMM13;PDHB;COX5A;UQCRC1;BAX;GRPEL1;NDUFS3;ATP6V1D;ATP5MC1;ATP6AP1;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.9060865395081553,1.6536381709486592,0.0,0.735528310884876,1.0,3/9,3.97%,F2;PDGFB;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.8801669491168219,1.6533765524567994,0.02702702702702703,0.7225192728282219,1.0,3/7,9.23%,NFKBIZ;CLEC7A;MALT1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.8138507676804065,-1.6523080762095586,0.03125,0.2047481068500278,0.98,6/14,12.09%,ENTPD2;NUDT1;ADPRM;NUDT18;NUDT15;ENTPD3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.7129531352266053,1.6497155100874132,0.023255813953488372,0.7273459983355587,1.0,9/30,13.86%,KCNN4;KCNJ2;KCNMB4;KCNN2;AKAP6;NOS1AP;DLG1;KCNN1;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.8314287605909486,1.6484032100123758,0.030303030303030304,0.7169035296794286,1.0,1/16,0.07%,F2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.882123625479269,1.6483783553700093,0.05128205128205128,0.7016132182891547,1.0,2/5,10.41%,ABHD2;MGLL
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.7296100175876546,1.6480888722306128,0.03125,0.6887032442848703,1.0,3/25,2.16%,B3GNT6;ST8SIA6;GAL3ST2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6793115220622599,1.643067696041775,0.0,0.7087928245846198,1.0,15/35,24.05%,MEMO1;EPHA3;CAMSAP3;DIAPH1;CLASP1;TRIM36;GSK3B;MAPT;MARK4;MARK2;MACF1;BICD2;PHLDB2;EFNA5;CYLD
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.9093312396274825,1.6412060156646338,0.0,0.7034526401846334,1.0,2/9,1.53%,CLEC2A;KLRD1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.628908235351509,-1.6401599770249942,0.0,0.24216030086403512,0.98,107/332,13.48%,RPS12;AFP;RPS27;RPL19;RPL38;RPL23;RPS13;RPL34;RPL12;RPS18;RPS21;RPL35A;RPS27A;RPLP1;RPL27A;RPS16;RPS14;RPS8;RPL29;RPS23;RPL7A;MEPE;RPL18A;RPL30;UBL5;RPL35;RPS25;RPS2;RPL23A;RPL5;RPL27;RPL10;RPL9;RPSA;RPS15;MRPL51;RPS5;RPS7;RPL18;RPL10A;TIMP1;RPL41;MRPL35;RPLP2;RPS6;MSRB1;RPL24;RPL21;RPL11;RPL13A;RPS3;PIGH;USP6;TMEM208;MRPL36;RPS11;RPL37;RPS3A;RPL13;MRPS12;RPS20;RPL15;RPS24;RPL3;MRPL34;RPL28;F5;RPS9;UBA52;RPS4X;RPS28;RPL36;RPS19;MRPL27;SEC11C;GPC3;FUCA2;COPS5;VWA1;RPL32;RPL6;MRPS21;APH1A;MRPS18B;B4GALT7;ATP23;SPARCL1;RPL31;RPL39;MRPS18A;AFG3L2;RPL8;RPLP0;RPS26;MRPL52;ABCF1;RNF5;SCG3;TTF1;SPCS2;CHGB;RPS29;NUCB1;RPL14;WARS1;ARAF;STOML2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.7680887414061272,-1.640080095655565,0.0,0.23349424680714037,0.98,8/47,4.91%,H1-4;TINF2;POLR2G;H1-2;MAGEF1;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.8574643327506,1.6395616817350853,0.02702702702702703,0.6991390155042558,1.0,4/8,11.34%,HDAC4;HDAC10;SIRT1;HDAC9
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7475041504249704,-1.6365330186284222,0.0,0.24034072903008458,0.98,27/51,16.78%,RPL35A;RPL7A;RPL23A;RPL5;RPL10;RPL10A;RPL24;RPL11;NOP16;RPL3;RPF2;NOP53;NHP2;RPL6;MRPL20;ZNF622;RPLP0;RPL14;WDR74;SURF6;WDR12;EBNA1BP2;RPL7;MRTO4;RPL26L1;SNU13;NIP7
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.9488302345402304,1.6364721013859544,0.027777777777777776,0.7034960149928826,1.0,1/5,4.54%,HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated immunity (GO:0002705),0.9179528511792833,1.6360722127309486,0.0,0.6917911770139383,1.0,2/5,4.38%,NOS2;CLEC7A
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.7373870676844326,1.6359556646754605,0.030303030303030304,0.6795054494699109,1.0,4/20,7.73%,SPIRE2;ELMO1;DOCK1;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.8397158443315232,1.6330620470431714,0.0,0.6847367116390735,1.0,5/14,6.83%,F2;CREB3L1;RUNX1;SCX;SERPINF2
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.9291640886173711,1.631772924091933,0.024390243902439025,0.6826336194370307,1.0,2/6,4.38%,ZBTB1;CLEC7A
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.8691649030877953,1.6288667038698166,0.0,0.6864124401251294,1.0,1/10,0.07%,F2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.5840993995005529,1.6286593068434738,0.06896551724137931,0.676034054159562,1.0,31/100,14.26%,EPB41L4B;MCF2L;ZBTB7C;FGFR3;MYO5B;HAMP;SOWAHA;MYH14;NDRG2;CAMSAP3;SORBS1;AGAP1;COBL;DSCAML1;TOX3;USP54;ZNF704;SLC22A23;PLEKHA7;SH3BGRL2;HDC;ZDHHC11B;CHDH;NEO1;SHANK2;ZSWIM5;DLG3;RALGPS1;EBF4;ARFGEF3;PRKCZ
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.8901511670548978,1.6275619813996982,0.0,0.6581698917472072,1.0,2/8,8.82%,CACNG5;CACNG4
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.8901511670548978,1.6275619813996982,0.0,0.6581698917472072,1.0,2/8,8.82%,CACNG5;CACNG4
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.7853516476096868,1.625725493796172,0.0,0.6584913983237759,1.0,1/15,0.02%,CPA1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.7832702787472987,1.6255545484533194,0.02857142857142857,0.6485849298743255,1.0,3/16,5.72%,PDGFB;EGFR;PKD1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.8998927204583368,1.6245612802954021,0.0,0.6435872720242666,1.0,3/8,8.48%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5788050415380538,1.6178422725787427,0.0,0.673589084705097,1.0,11/79,7.47%,F2;PDGFB;NFKBIZ;FEM1A;SNCA;CYBA;SASH1;BMP6;SERPINF2;OPTN;ADAM8
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.946929216264919,1.617603247066305,0.0,0.6636993742750249,1.0,1/9,0.45%,REP15
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.9613427864932136,-1.6130227709835758,0.0,0.355269657693945,0.99,1/7,0.32%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7332095049338464,1.6118304102087206,0.02702702702702703,0.6872574043284234,1.0,5/23,11.25%,PDGFB;IGF1;ESPL1;DMRT1;NSMCE2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7735510636879601,1.6108364485536404,0.037037037037037035,0.6821819792461364,1.0,5/25,7.77%,MDGA2;SPOCK1;CHD5;NPY;NTRK2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.8473019587471978,1.6106008930187647,0.05714285714285714,0.6732135203672532,1.0,4/15,7.47%,NLRP7;RUNX1;BAG2;ADAM8
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.9171391173245831,1.6102814389720368,0.0,0.6663021169192407,1.0,1/7,2.48%,SLC15A2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7657366419157934,1.608569233487839,0.0,0.6690165784246151,1.0,8/18,18.54%,CGNL1;SPRY2;TGFB2;SYNGAP1;SLIT2;SPRY4;CYRIB;FBP1
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.9047139126619625,1.6083614463058176,0.075,0.6606205592237059,1.0,2/5,5.53%,TICAM1;SARM1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6098084864928013,1.6068890072843836,0.0,0.6610485723623601,1.0,15/93,8.25%,F2;RELN;FGFR1;LCP2;FLT1;FGFR3;ALK;EGFR;PDGFRA;MMD2;EPHA3;IGF1R;DRD4;NTRK2;CD4
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.7909847905630174,1.6014308266466561,0.03225806451612903,0.6814121380116577,1.0,5/9,16.76%,RELA;NFKB1;PID1;CHI3L1;ST3GAL6
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.9664977945753203,-1.600046658197502,0.0,0.42219757389602386,1.0,2/6,2.04%,TYRP1;TPH1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8312184088420752,1.5985292056075284,0.0,0.6805729417110097,1.0,1/9,0.49%,CA12
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8312184088420752,1.5985292056075284,0.0,0.6805729417110097,1.0,1/9,0.49%,CA12
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.9093300466393246,1.5981812279715775,0.0,0.6745697891196102,1.0,1/7,5.73%,ALDH1A1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.724269316810043,1.5973663734565107,0.05555555555555555,0.6612716249534364,1.0,6/19,10.72%,PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.724269316810043,1.5973663734565107,0.05555555555555555,0.6612716249534364,1.0,6/19,10.72%,PFKFB3;IGF1;ARNT;P2RX7;MLXIPL;SLC4A4
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.807287658568768,1.5965725537509448,0.0,0.6562679389224505,1.0,1/11,0.18%,VAPB
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.892178171633179,-1.5930321422409188,0.04918032786885246,0.45183642563395043,1.0,3/10,6.10%,TYRP1;LRMDA;SLC24A5
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.7597247276022709,1.5927036772726377,0.07407407407407407,0.6695708754117885,1.0,4/20,6.15%,RAB27A;ADGRB1;SNCA;CYBA
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.8985929147326724,-1.5919445479760261,0.0,0.44436022091178917,1.0,1/10,0.04%,TYRP1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.966247006041113,1.5916639697819377,0.0,0.6679758423325547,1.0,1/5,0.02%,GABRE
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.678884456363257,1.58836855772089,0.038461538461538464,0.682645784829378,1.0,7/33,6.11%,NUPR1;ADGRB1;ALK;HDAC4;EGFR;BANP;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.7985720411001946,1.5877231900399227,0.05714285714285714,0.6782864574222374,1.0,2/15,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.825490566505407,-1.5871991944196686,0.0,0.4650888234067942,1.0,1/21,0.04%,TYRP1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.822174294467583,-1.5869913352713692,0.0,0.45213122636493647,1.0,11/20,11.34%,RPL23A;RPL5;RPL10;RPL24;RPL11;RPL3;RPF2;NOP53;RPL6;MRPL20;RPLP0
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.8402169224467632,1.5825014037668368,0.025,0.7040689674675109,1.0,5/13,6.83%,F2;CREB3L1;RUNX1;SCX;SERPINF2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6627450459064884,1.5811408378574594,0.034482758620689655,0.7045586977949866,1.0,13/35,14.64%,PBX3;ADAMTS18;ASCL1;PBX1;CHD7;FREM2;MEIS1;SMG9;MEIS3;TGFB2;MAFB;MEIS2;HIPK2
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.8082239628300032,1.5776648201976207,0.08333333333333333,0.7165138793186572,1.0,1/8,0.12%,ZAP70
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.6717301296795735,1.5769299547217048,0.05714285714285714,0.7133814364078038,1.0,5/27,11.99%,KCNJ14;KCNJ2;ATP12A;ATP1B3;SLC12A2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7750402433994888,1.5765032273360409,0.06451612903225806,0.7076734577321881,1.0,3/13,3.97%,F2;PDGFB;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7490897856690096,1.5751520419220943,0.0,0.7074840944860059,1.0,4/12,10.24%,F2;KLK14;NECAB2;C3
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6653120897625368,-1.5750911629295599,0.0,0.5186453642253102,1.0,24/70,20.13%,RPS27A;POLR2G;POLR2J;POLR2L;PCNA;PPIE;COPS6;COPS7A;POLR2I;UBA52;COPS5;ZNF830;RPA3;RBX1;RFC2;RFC4;UBB;POLR2A;XPA;POLD2;GTF2H2;ERCC8;POLD4;UVSSA
prerank,GO_Biological_Process_2021__natural killer cell activation involved in immune response (GO:0002323),0.9760012489537363,1.5749405731109403,0.0,0.7015139324631153,1.0,1/5,0.01%,KLRF2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.9121720325652397,1.573839130917853,0.0,0.699289562234554,1.0,1/7,2.48%,PLK1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.8103784450629585,-1.573208752467991,0.03389830508474576,0.5025442480970591,1.0,5/20,4.91%,TINF2;POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.8103784450629585,-1.573208752467991,0.03389830508474576,0.5025442480970591,1.0,5/20,4.91%,TINF2;POLR2G;POLR2J;POLR2L;POLR2I
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.8304077712396818,1.5731919268215948,0.0,0.6956251555575184,1.0,3/11,5.00%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9297174981140557,1.573172913075564,0.022222222222222223,0.688064012562328,1.0,1/5,0.54%,BTLA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.8492341708952047,1.572840028399179,0.0,0.6819766882502755,1.0,1/6,0.21%,PDGFB
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.822275281387798,1.5709718498941232,0.07692307692307693,0.6852438726099358,1.0,3/7,8.05%,HSPA1A;CPNE1;HSPA1B
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.8332835666512709,1.570211385624975,0.02702702702702703,0.6805979971412299,1.0,5/14,6.83%,F2;CREB3L1;RUNX1;SCX;SERPINF2
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.8255399952180136,1.5694582072862262,0.07317073170731707,0.67830711169926,1.0,6/11,10.23%,RELN;VIT;PKD1;GLI2;DLL1;SOX12
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.916418851011252,1.5685287707617104,0.022727272727272728,0.6771809212748008,1.0,1/5,4.44%,CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.9460537053929815,-1.5683458920299735,0.015873015873015872,0.523748205053985,1.0,3/5,4.54%,RPS3;PCNA;DDX11
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.8188420891566808,1.5680262415739852,0.023255813953488372,0.6723447698934497,1.0,4/13,7.51%,NFATC4;KAT2A;CPEB3;SGK1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.923363805865595,1.5677656137487503,0.0,0.6671957365482828,1.0,1/7,0.21%,PDGFB
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8927632138439289,1.5660209746785756,0.0,0.671769619936066,1.0,1/7,2.40%,SRC
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7804389428491,1.565611139257221,0.0,0.6671306938565249,1.0,2/16,2.74%,PDGFB;PLPP4
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.8526155667770234,1.5645846855774015,0.029411764705882353,0.6684274825234487,1.0,4/8,13.39%,ADSS2;HPRT1;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.8795363726165603,-1.5638551964278262,0.0,0.5430261292102606,1.0,1/13,0.08%,CD44
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7177059761500904,-1.5630010978451723,0.016129032258064516,0.5374228962746836,1.0,16/60,11.11%,PSMB8;HLA-F;B2M;HLA-C;PSME1;HLA-E;HLA-A;PSMB6;PSMC5;PSMD8;PSMD7;VAMP8;CALR;PDIA3;PSMD3;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.7644533404256192,1.5626147963339363,0.058823529411764705,0.6736454614279549,1.0,6/24,3.97%,F2;PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8932936986567837,1.5625351369843046,0.03225806451612903,0.6674286628705097,1.0,1/6,0.18%,VAPB
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5700250289328932,1.5621037448063673,0.0,0.6628787601781769,1.0,35/122,13.95%,KCNQ2;CELF3;CTNNA2;MMD2;EPHA3;SCRT1;NPAS3;ASCL1;CTNND2;ADGRB3;AMER2;PCDH8;HIVEP2;OLFM3;CAMKV;NOTCH3;ROBO1;EFR3B;SOX5;NXPH1;ADGRL3;SNAP91;GRM3;NCAN;UNC13A;ZNF536;UNC79;LRRC4C;NRXN1;GPM6B;SLC8A2;ROBO2;CADM2;ABI2;STIM2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6645260837587416,-1.561705755930934,0.0,0.5318935566206501,1.0,26/78,14.86%,PSMB8;B2M;GBP2;HLA-C;IL7;PSME1;IFIT2;IRF9;CNP;IFIT3;IRF1;IFITM3;DDX60;TRIM25;PARP14;IFI44;PROCR;LAP3;SP110;PARP12;WARS1;HELZ2;NMI;PARP9;LGALS3BP;ISG20
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6658190512304265,-1.5616324941601731,0.0,0.5198134844150067,1.0,30/76,16.32%,NDUFS5;NDUFA1;NDUFB3;NDUFA12;NDUFB9;NDUFC1;UQCC3;NDUFA2;NDUFS6;NDUFB11;DMAC1;NDUFB4;NDUFB2;NDUFA3;SURF1;TMEM126B;NDUFAF3;COX17;NDUFS8;NDUFB7;NDUFB10;NDUFAB1;NDUFB1;SMIM20;TMEM126A;SDHAF1;NDUFAF1;NDUFS7;ECSIT;COA5
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.9386574325989228,1.560569719043035,0.04878048780487805,0.6651893075698676,1.0,1/7,0.04%,MFNG
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5494275445452677,1.558114770376747,0.1,0.6703691132506576,1.0,25/146,10.33%,CREB3L1;VDR;PDGFB;ABCC2;IGF1;NOS2;RUNX1;IFNA2;ATOH8;CPNE1;MTMR2;SLC24A3;SIRT1;SFMBT2;CCDC3;PICALM;OPTN;ROBO1;TCEAL1;SLC7A5;TGFB2;NFKB1;PTPN22;FBXW7;DICER1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.7427035781720925,1.5571786514223378,0.0,0.669682038609266,1.0,5/23,4.62%,PDGFB;ZSWIM6;ZSWIM4;PDGFRA;ADGRA2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.9118668338678568,1.5560517878328741,0.10526315789473684,0.667764524445072,1.0,2/5,7.82%,JCAD;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.871657980029005,1.5558259229201756,0.02631578947368421,0.6568313154599486,1.0,2/8,3.12%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.871657980029005,1.5558259229201756,0.02631578947368421,0.6568313154599486,1.0,2/8,3.12%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7207280976773212,1.5554305224956355,0.06896551724137931,0.6527813759103275,1.0,4/18,6.49%,RELN;IL1RAPL1;PTPRD;OBSL1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.8150879249179739,1.554519547966589,0.05714285714285714,0.6518007285931837,1.0,2/7,5.48%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.5374874668468671,1.5523726393216415,0.06666666666666667,0.6580872992056074,1.0,24/228,7.22%,KLRF2;VDR;PDGFB;LEPR;PDGFC;KAT2A;IL4R;SNAI1;OXTR;PPARGC1A;RFX3;TBXA2R;PLAC8;ZNF516;NLGN1;LEF1;ZBTB16;SIRT1;SCX;IGF1R;TRIM16;HAP1;ITGAX;PAXIP1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.6145712764792945,1.5514017104895135,0.0,0.6566062914400435,1.0,11/65,12.26%,NUPR1;PFKFB3;IGF1;HDAC4;ARNT;P2RX7;MLXIPL;OGT;SLC4A4;NDC1;NUP42
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7664972604072215,1.5507966763518102,0.045454545454545456,0.6552676217887723,1.0,5/16,13.09%,RELN;CRTC1;PRKD1;LRP8;ADCY8
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7367356345886572,-1.547800124264147,0.030303030303030304,0.6144040541946281,1.0,6/28,9.71%,GATA1;COL9A3;MEA1;FSHR;AR;SOX15
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.8337678580820509,1.5473858946097827,0.0,0.6694697291178201,1.0,2/14,1.01%,F2;NLRP7
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9463778601870974,-1.5467237628518995,0.0,0.6102897027442378,1.0,5/7,4.05%,HLA-F;B2M;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7595644415692429,1.5464701623139738,0.09375,0.6694226219271141,1.0,4/20,4.85%,LEPR;ACSM1;PPARGC1A;ACADVL
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6087146525748637,1.5460854306377094,0.07407407407407407,0.6658466814326246,1.0,13/72,6.69%,F2;CORIN;CGNL1;FRZB;SLC7A9;COL22A1;C6;PPARGC1A;EYA4;SPTSSB;SORBS1;RNF128;NPY1R
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),0.8859221226940227,1.5445872519605597,0.0,0.6682016624280017,1.0,2/5,9.23%,NFKBIZ;MALT1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.9569926910805386,-1.5421920614674438,0.0,0.6348863022133452,1.0,1/7,0.93%,NLRP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8693258189296783,1.5409576269922518,0.07692307692307693,0.6803716859189985,1.0,6/8,8.21%,SPRY2;SPRED3;SPRED2;SPRED1;NOTCH4;DLL1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.7512668510434259,-1.5408149193725529,0.028169014084507043,0.6203960888342052,1.0,12/41,5.83%,PSMB8;HLA-F;GBP2;HLA-C;IFIT2;IRF4;HLA-E;HLA-A;IRF9;IFIT3;IRF1;IFITM3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.7512668510434259,-1.5408149193725529,0.028169014084507043,0.6203960888342052,1.0,12/41,5.83%,PSMB8;HLA-F;GBP2;HLA-C;IFIT2;IRF4;HLA-E;HLA-A;IRF9;IFIT3;IRF1;IFITM3
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.7979820342411903,-1.5407174629028424,0.03571428571428571,0.6081525737608156,1.0,2/14,1.34%,CD44;RHOC
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7878098229061559,1.5400756225870995,0.05405405405405406,0.679126172291353,1.0,3/13,6.02%,HNRNPU;SIRT1;FTO
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9184268543054697,1.5385995198925315,0.03125,0.6817563759620344,1.0,2/5,5.51%,SRC;NPY
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5859991159572131,1.537972596764295,0.041666666666666664,0.6792085709512464,1.0,27/103,13.89%,EPB41L4B;CGNL1;FRZB;EFNB3;FGFR3;TMEM98;EGFR;MYH14;RNF128;OBSL1;TMEM47;EPB41L1;AGAP1;SLC13A4;COBL;BCAM;NOTCH3;TOX3;AQP1;TEAD1;CDC42EP4;CHRD;NEO1;SHANK2;MPDZ;SHROOM3;GYG2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8118534883466817,-1.5379315549141892,0.028169014084507043,0.6226080611083115,1.0,7/17,6.72%,RPS27;RPS14;RPSA;RPS15;RPS5;RPS28;RPS19
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.701176492812427,-1.5363760393327013,0.014285714285714285,0.6220940882248449,1.0,26/56,19.91%,PSMB8;MCM2;RPS27A;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;ORC6;MCM4;MCM3;PSMD3;PSMC3;UBB;PSMA4;MCM5;PSMA7;PSMD2;PSMD6;PSMB2;ORC2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.8163575277814576,1.53587060627825,0.03571428571428571,0.6841806923818393,1.0,1/14,0.07%,F2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.8673663859703593,1.533172243293642,0.08,0.6954183605983177,1.0,4/9,4.59%,TNNC2;TCAP;MYH3;MYH14
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7056776649276281,1.5326801850819234,0.0,0.6927164786164214,1.0,9/15,24.84%,ABHD2;GDPD3;MGLL;PNPLA6;GPCPD1;PLA2G4C;SMPD4;PRDX6;PLA2G4A
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.7265697144287333,1.5320619294696847,0.10714285714285714,0.6920680237655683,1.0,8/14,20.99%,HDAC4;SIRT1;HDAC9;SMARCAD1;SFPQ;HDAC1;HDAC3;PER1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7501424492028931,1.531884173927502,0.0,0.6876484487870866,1.0,8/12,23.10%,IRS1;AKT2;PRKCE;GPLD1;SLC45A3;IRS2;PPM1K;PPARA
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6937778142630269,-1.5315909775028933,0.029411764705882353,0.6490167391224337,1.0,19/50,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;RBX1;PSMD3;PSMC3;PSMA4;AVEN;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.869961467140025,1.5289118776677733,0.05263157894736842,0.6936986474032552,1.0,4/8,12.07%,IGF1;AKAP6;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.869961467140025,1.5289118776677733,0.05263157894736842,0.6936986474032552,1.0,4/8,12.07%,IGF1;AKAP6;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7130374840209406,-1.5287346214747513,0.016666666666666666,0.6612234189177063,1.0,16/62,11.11%,PSMB8;HLA-F;B2M;HLA-C;PSME1;HLA-E;HLA-A;PSMB6;PSMC5;PSMD8;PSMD7;VAMP8;CALR;PDIA3;PSMD3;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.7575566066922378,1.5287146181010112,0.02702702702702703,0.6897777460929939,1.0,1/13,0.32%,RELN
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.7844147369747427,1.52824726424015,0.07407407407407407,0.6870364167046543,1.0,3/7,13.31%,TICAM1;CLEC7A;IL17D
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8506417961324584,1.5280491491677244,0.04878048780487805,0.6831226409734399,1.0,2/6,7.73%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.8864610524822161,1.5279823326505497,0.024390243902439025,0.6784639312099872,1.0,3/6,10.87%,VDR;CASK;PTPRK
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8674502530032693,1.527878836440685,0.030303030303030304,0.6741726114223238,1.0,2/8,5.48%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.7626335506495204,-1.5274881233495001,0.03225806451612903,0.6564615066059349,1.0,6/24,9.71%,GATA1;COL9A3;MEA1;FSHR;AR;SOX15
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.687481906806973,-1.52667823316149,0.0,0.6521788073919284,1.0,18/43,22.77%,MIS12;CENPE;CHMP2A;RAB11A;CHAMP1;NUF2;DCTN2;ANKRD53;SPDL1;KIF18A;CHMP3;CHMP7;CDC23;ZW10;CHMP4B;KIF22;KPNB1;VPS4B
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.6334610874591098,-1.5258935217389555,0.0,0.6476058331678196,1.0,73/188,19.95%,HSPE1;RPL34;MCM2;EEF1B2;TYMS;H2AZ1;LDHA;RPS2;RPS5;RPL18;DDX18;RPS6;RPS3;APEX1;USP1;NOP16;PCNA;PSMD8;PSMD7;EIF2S2;POLE3;LSM2;MCM4;LSM7;CYC1;SF3A1;COPS5;RACK1;NHP2;CCT7;RPL6;PHB2;MRPS18B;SNRPB2;RANBP1;SNRPD1;CDK4;PSMD3;PPM1G;VBP1;RPLP0;EIF3D;NDUFAB1;SRSF7;KPNA2;SSB;RPL14;PPIA;C1QBP;IMPDH2;EIF3J;RFC4;SNRPD2;CANX;PSMA4;CCT2;MCM5;TUFM;SRSF3;PSMA7;IFRD1;SLC25A3;PRPS2;COX5A;POLD2;PSMB2;MRPL9;TFDP1;ORC2;NCBP1;PSMB3;RAN;ILF2
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.9251523339585456,-1.5245907052431271,0.0,0.6480146752342134,1.0,2/7,2.01%,F8;SERPING1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5760403244308678,1.5233550024798181,0.03571428571428571,0.6950643638550205,1.0,21/97,12.60%,KCNN4;KCNJ14;KCNH4;KCNJ2;KCNQ2;ABCC8;KCNIP2;KCNH3;ATP12A;SLC24A3;PKD2L1;SLC9C2;ATP1B3;KCNN2;KCND2;SLC9A2;KCNH7;KCNC2;KCNN1;SLC12A2;LRRC38
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7840754518589615,-1.5229721145976873,0.0,0.6529996793770856,1.0,9/27,9.66%,HLA-F;B2M;HLA-C;HLA-E;HLA-A;ERAP1;CALR;ERAP2;PDIA3
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6573685994020418,-1.5228979900358643,0.013157894736842105,0.6424459643298839,1.0,36/93,22.87%,MRPS22;EEF1B2;MRPL51;MRPL35;MRPL36;MRPS12;MRPL34;MRPS34;MRPL40;MRPL27;RACK1;MRPL20;MRPS21;MRPL14;MRPS18B;MRPL2;GADD45GIP1;MRPL54;MRPS18A;MRPL52;EEF2;MRPL4;MRPL16;MRPS26;EEF1A1;TUFM;MRPL45;MRPL9;AURKAIP1;MRPL57;ERAL1;LTN1;TSFM;MRPL24;MTRES1;MRPL58
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.9356699907973204,-1.5223720008914297,0.0,0.625800922960149,1.0,1/7,0.04%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.9356699907973204,-1.5223720008914297,0.0,0.625800922960149,1.0,1/7,0.04%,TYRP1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6066993853843761,1.5211884699781923,0.10526315789473684,0.7007295744374051,1.0,17/46,16.82%,RELN;FGFR1;SPOCK1;NTRK2;ADGRL3;SH3RF1;CELSR1;AUTS2;DCDC2;NAV1;FGF13;DCX;MARK1;NR4A2;ASTN2;GPM6A;ELP3
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.6538906049364805,1.5202865352850348,0.06896551724137931,0.7009520746878457,1.0,8/31,11.23%,ZAP70;LEPR;CHD7;CD4;NHEJ1;GPR89B;PTPN22;LFNG
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8663990363239633,1.5196231840691372,0.05555555555555555,0.7003003759951267,1.0,2/7,5.09%,NPAS2;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8537838031812153,-1.517745765808669,0.034482758620689655,0.6526727938595203,1.0,4/12,10.37%,GATA1;DDIT3;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7697147513982158,1.5157563534570038,0.045454545454545456,0.717723528891265,1.0,8/16,13.75%,KAT2A;ZBTB16;SCX;SOX5;SCIN;TRPS1;PTHLH;BMPR2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6810972739192501,-1.5157539284745174,0.0136986301369863,0.6607415331074407,1.0,13/40,13.83%,SLC28A2;ADH4;TPH1;GLOD5;SLC3A1;GBA3;VIL1;CDH17;ACSM3;CYP3A5;SLC2A2;ESM1;CYP3A4
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.8397394053073891,1.5149179924769012,0.0625,0.717058317162693,1.0,2/6,8.21%,CDK6;DLL1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8810306292002829,1.5138847898884318,0.025,0.717065656927442,1.0,1/7,1.07%,IGF1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.6126648427584818,1.513753414474793,0.034482758620689655,0.7130269513742533,1.0,1/39,0.02%,CPA1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8889354824562795,-1.5130738391170822,0.013888888888888888,0.6620686212665012,1.0,1/7,0.41%,CACNA2D4
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8889354824562795,-1.5130738391170822,0.013888888888888888,0.6620686212665012,1.0,1/7,0.41%,CACNA2D4
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6456730581536283,-1.5130317945871783,0.012987012987012988,0.6525119379645455,1.0,32/94,21.53%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPL34;MRPS34;MRPL40;MRPL27;MRPL20;MRPS21;MRPL14;MRPS18B;MRPL2;GADD45GIP1;MRPL54;MTIF3;MRPS18A;MRPL52;MRPL4;MRPL16;MRPS26;TUFM;MRPL45;MTRF1L;MRPL9;AURKAIP1;FASTKD2;MRPL57;ERAL1;TSFM;MRPL24
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8509702036150602,-1.5129706845405975,0.01694915254237288,0.6334000968907327,1.0,1/10,0.08%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8509702036150602,-1.5129706845405975,0.01694915254237288,0.6334000968907327,1.0,1/10,0.08%,CD44
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.770754731688706,-1.5127157868600285,0.03278688524590164,0.6260093522488988,1.0,6/21,13.63%,TINF2;PARP2;MPG;EXOSC4;PARP1;MBD4
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6199933388432163,-1.5126802376589783,0.0,0.6172922677812861,1.0,29/98,20.13%,RPS27A;POLR2G;POLR2J;RAD23A;POLR2L;PCNA;PPIE;COPS6;COPS7A;POLR2I;PNKP;UBA52;COPS5;ZNF830;CETN2;RPA3;RBX1;RFC2;PARP1;RFC4;UBB;POLR2A;RNF111;XPA;POLD2;GTF2H2;ERCC8;POLD4;UVSSA
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7082207446691312,-1.5108658127739092,0.015384615384615385,0.6271637298481284,1.0,19/44,20.70%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;OAZ3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.809975779860711,-1.510823994540407,0.03333333333333333,0.6183304378784364,1.0,2/11,3.17%,TIMP1;CD63
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8200160588264144,1.51061749892131,0.05714285714285714,0.7260505413616771,1.0,8/11,16.48%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;NLGN3;PTEN;CEL
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.7784614922436189,1.5088407915726318,0.09375,0.7313787009117874,1.0,4/13,5.00%,F2;PDGFB;PDGFRA;ADAMTS18
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7946292972007624,-1.5083018143897138,0.04411764705882353,0.6317745598191254,1.0,4/16,8.64%,FTH1;SFRP1;GSTP1;B4GALT7
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.8337542344239999,-1.5065863821759178,0.016129032258064516,0.638913738824762,1.0,1/11,0.46%,GATA1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8768438030541238,-1.5065381174744656,0.015151515151515152,0.6306112629485304,1.0,4/10,8.07%,MIS12;CENPE;CHAMP1;NUF2
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.880528129107501,1.5056810970614618,0.0,0.7453906579105255,1.0,4/5,5.72%,ERRFI1;GRHL2;ASCL1;PKD1
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.8110085117408659,1.5053612951095148,0.05128205128205128,0.7428260491045375,1.0,3/11,7.73%,SPIRE2;COBL;SPIRE1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.7050235533848859,1.5046038412232743,0.08571428571428572,0.7420236156436617,1.0,2/13,1.34%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6275126104822325,-1.5040982823592137,0.0,0.6410643601055184,1.0,41/116,19.91%,PSMB8;MCM2;RPS27A;PSME1;PSMB6;PSMC5;PSMD8;PNKP;PSMD7;POLE3;UBA52;ORC6;MCM4;MCM3;WDHD1;TEFM;RPA3;RFC2;PSMD3;PSMC3;GINS2;RFC4;UBB;MGME1;GINS4;PSMA4;CDC34;MCM5;PSMA7;PSMD2;POLD2;PSMD6;PSMB2;ORC2;PSMB4;RECQL;MCMBP;POLD4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.7361455771860708,-1.5040851776309796,0.0,0.6328444827706532,1.0,8/28,16.89%,DTX3L;PNKP;USP51;TFIP11;CYREN;KDM4D;PARP9;MRNIP
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7851759874663191,1.5036432652713227,0.06976744186046512,0.7417738495246704,1.0,3/12,5.36%,IRS1;PLIN5;AKT2
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.704409090519331,1.503291159394109,0.05405405405405406,0.7394636052634341,1.0,4/26,2.86%,CPA1;GIPC2;LGALS4;ANXA4
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.8846497099509147,1.5026687174771718,0.0425531914893617,0.7383425726006925,1.0,5/5,11.56%,SLC7A2;SLC7A1;SLC47A1;SLC22A2;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8304994901038647,1.5024448395867722,0.030303030303030304,0.7346680438546014,1.0,2/8,6.71%,PDGFB;DOCK7
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7376497827352733,-1.5020402393038295,0.013333333333333334,0.6397050929756897,1.0,6/33,5.83%,GBP3;GBP2;GAPDH;HLA-DPA1;RPL13A;IFITM3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.7359301215094458,1.5014959905570602,0.06451612903225806,0.7364081294385662,1.0,5/22,11.34%,JCAD;STARD13;TBXA2R;RHOJ;HDAC9
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.7249936721398063,1.5012963893871725,0.05405405405405406,0.7328809084755791,1.0,5/21,12.03%,KCNJ2;SCN9A;CACNA1I;SCN7A;CACNA1G
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7412342794007571,-1.5004512168558957,0.013157894736842105,0.6471236091920731,1.0,11/25,16.01%,RPL7A;RPL35;RPL10A;DDX18;RPF2;NHP2;FTSJ3;NIFK;WDR12;RPL7;SNU13
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7051870222369176,-1.4999921860238832,0.0,0.6433828568870935,1.0,25/57,15.31%,RPL38;RPL35A;RPS16;RPS25;RPL5;RPS15;RPS7;RPS6;RPL11;MRPL36;RBIS;NOP16;RPS24;RPF2;RPS28;RPS19;ZNF622;RPL14;WDR74;SURF6;WDR12;EBNA1BP2;RPL7;MRTO4;RPL26L1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.8092672251365194,1.4999586348430218,0.10344827586206896,0.7356523878603964,1.0,1/8,0.21%,PDGFB
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.8155869641299742,-1.498821169870035,0.014705882352941176,0.6443350966366691,1.0,1/11,2.08%,STMN1
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.8943128733376586,1.4988027063516605,0.14634146341463414,0.7369214503272159,1.0,1/5,2.33%,COL22A1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.6165788556929988,1.4984586678302176,0.0967741935483871,0.7349157789804083,1.0,8/37,5.92%,CREB3L1;REP15;BACE2;LGALS4;PDIA5;DMBT1;PLA2G10;FCGBP
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8132635305190842,1.4975488343928938,0.03225806451612903,0.735491790114723,1.0,2/11,6.71%,PDGFB;DOCK7
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8818025837798872,-1.4968160815334695,0.0,0.6525321276962193,1.0,4/8,10.37%,DDIT3;LAMTOR5;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.7746366737140891,1.4964857519156252,0.10810810810810811,0.7365686963246146,1.0,3/12,5.36%,IRS1;PLIN5;AKT2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.7172807549734661,-1.496389446783187,0.1,0.6476656637141212,1.0,5/25,4.91%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.8424923481583568,1.4960808499444873,0.0967741935483871,0.7334243969521389,1.0,1/7,0.07%,F2
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.8992977411416512,1.4960656840667936,0.06976744186046512,0.7289807229322297,1.0,4/5,9.95%,HSPA1A;ERBIN;HSPA1B;PTPN22
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.6627054996691616,-1.4943877406927588,0.02702702702702703,0.6544428547118514,1.0,27/79,20.50%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPL34;MRPS34;MRPL40;MRPL27;MRPL20;MRPS21;MRPL14;MRPS18B;MRPL2;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPS26;MRPL45;MTRF1L;MRPL9;AURKAIP1;MRPL57;ERAL1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.8324179052557517,1.4939752033371754,0.0,0.7358133073243537,1.0,1/7,0.21%,PDGFB
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6964381584301769,-1.4935515964619852,0.015151515151515152,0.6528818426912829,1.0,20/47,20.70%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;BHMT;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;OAZ3
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.6708658488506124,1.493543764552299,0.10526315789473684,0.7340530053832617,1.0,3/21,11.23%,CGNL1;NLGN1;TJP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9524673007681337,-1.4927016720735364,0.0,0.6444491920970581,1.0,4/6,4.05%,HLA-F;HLA-C;HLA-E;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9524673007681337,-1.4927016720735364,0.0,0.6444491920970581,1.0,4/6,4.05%,HLA-F;HLA-C;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7158280581330709,1.4926891033810241,0.06666666666666667,0.7296981879387372,1.0,4/16,5.94%,IL1RAPL2;IL1RAPL1;PTPRD;SNCA
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7158280581330709,1.4926891033810241,0.06666666666666667,0.7296981879387372,1.0,4/16,5.94%,IL1RAPL2;IL1RAPL1;PTPRD;SNCA
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.822740555312023,1.4925353940129502,0.08163265306122448,0.7263834663010726,1.0,1/7,0.19%,VDR
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.8567935654184704,1.4922759463556554,0.02702702702702703,0.7235114558057262,1.0,1/10,0.04%,MFNG
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8229177674187351,1.4919655152481945,0.05555555555555555,0.7206734336002656,1.0,8/10,16.48%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;NLGN3;PTEN;CEL
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.7678794657137796,1.4918732189478703,0.06666666666666667,0.7165935805288149,1.0,4/13,8.53%,ZMYND10;ODAD3;DNAAF1;DNAI2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.5820619524597201,1.4913153820546756,0.06666666666666667,0.7153346742794804,1.0,21/88,12.60%,KCNN4;KCNJ14;KCNH4;KCNJ2;KCNQ2;ABCC8;KCNIP2;KCNH3;SLC24A3;KCNMB4;PKD2L1;SLC9C2;ATP1B3;KCNN2;KCND2;AQP1;SLC9A2;KCNH7;KCNC2;KCNN1;LRRC38
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.798459073919085,1.4912641318526842,0.07692307692307693,0.7113333006583998,1.0,5/8,19.37%,RUNX1;PTPN22;CBFB;ELF1;ELF2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.8602414855029161,-1.4909706024879743,0.029411764705882353,0.6493539854517105,1.0,1/12,1.46%,ACTG1
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8223543961925155,-1.4907692953539804,0.03125,0.6429041494042906,1.0,4/13,12.52%,XBP1;SFRP1;SLAMF8;CD27
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.7410151500614311,1.4907657866439583,0.03125,0.7101193544805628,1.0,9/23,12.54%,SLC38A1;SLC7A2;SLC7A1;SLC47A1;SLC7A5;SLC25A18;SLC22A2;SLC25A29;SLC1A2
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.9919145827120789,-1.4903911101304896,0.0,0.6400904891159063,1.0,1/5,0.32%,BMP5
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8848474345597512,1.4895580969695008,0.030303030303030304,0.7132800256191509,1.0,1/8,0.99%,JCAD
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.6630827056565253,-1.4895307953480923,0.027777777777777776,0.639792407010071,1.0,29/79,21.53%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPL34;MRPS34;MRPL40;MRPL27;MRPL20;MRPS21;MRPL14;MRPS18B;MRPL2;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPS26;TUFM;MRPL45;MRPL9;AURKAIP1;MRPL57;ERAL1;TSFM;MRPL24
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.6738189192413812,1.4894593234046456,0.06666666666666667,0.7095912599220935,1.0,8/20,12.97%,GNLY;RELA;ADORA2B;CX3CR1;RAB23;CLEC5A;DCDC2;VEZF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.6775378825140704,-1.4884617039802068,0.02702702702702703,0.6403994301513835,1.0,13/34,19.32%,RPS27A;PCNA;UBA52;RPA3;RBX1;RFC2;PARP1;RFC4;UBB;XPA;POLD2;GTF2H2;POLD4
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.6409468498297034,1.486617990389638,0.07692307692307693,0.7213412367066242,1.0,5/19,10.91%,VDR;EGFR;SNCA;GDNF;NOS1AP
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7422903010881712,-1.483746338991899,0.0,0.673256228898528,1.0,16/39,13.43%,RPS27;RPS16;RPS14;RPS25;RPSA;RPS15;RPS5;RPS7;RPS6;RPS24;RPS28;RPS19;TSR3;NOB1;SURF6;RPS27L
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.8488407595321127,1.4833873827113848,0.0975609756097561,0.736862453821658,1.0,3/9,4.16%,NUPR1;IGF1;CD200R1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7258433503851217,1.4819210082516998,0.07407407407407407,0.7401824521778791,1.0,9/27,13.33%,SPRY2;FLT1;VEGFD;HSPB1;RELA;GAB1;PRKD1;PIK3CA;EGR3
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.8094442823081376,1.4817014654929324,0.0851063829787234,0.7365772118868731,1.0,3/8,7.56%,GPR35;CBARP;DRD4
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7462449304128498,1.4815603507413881,0.023809523809523808,0.7333883966470678,1.0,7/16,14.09%,SCN9A;MYH14;CACNA1I;KCNMB4;SCN7A;CACNA1G;GPER1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.8257212933547216,-1.4809224369350376,0.031746031746031744,0.6899319774177094,1.0,2/10,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.8354276167480628,1.4807289868199256,0.02631578947368421,0.7340525489351508,1.0,2/11,5.48%,CDK6;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.951481861527445,1.4804195528834345,0.02702702702702703,0.7270666679641412,1.0,1/5,0.07%,F2
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.951481861527445,1.4804195528834345,0.02702702702702703,0.7270666679641412,1.0,1/5,0.07%,F2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8854522599497967,-1.4803430603634389,0.01694915254237288,0.6866806961942253,1.0,5/10,8.07%,CENPF;MIS12;CENPE;CENPH;NUF2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7525027202357847,1.4800604543186096,0.09302325581395349,0.724735232409935,1.0,3/10,17.84%,LGI2;FGF13;WNT5A
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.8598405742862751,1.4794695886973661,0.05405405405405406,0.7234543468626691,1.0,3/5,10.34%,FBLN5;TNXB;LTBP3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.6225025119268448,1.4790425642972778,0.0625,0.7220415438941177,1.0,15/56,9.69%,PDGFB;PTPN6;PDGFC;FGFR1;IGF1;FLT1;SRC;PIK3R5;PDGFRA;SIRT1;IGF1R;HCLS1;NTRK2;TGFB2;GAB1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7923456430333687,1.478391968014253,0.05405405405405406,0.7222378753208994,1.0,3/11,11.84%,GPR35;CXCL13;ACKR3
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7440571669679397,-1.478276818927009,0.05263157894736842,0.6952036568974588,1.0,2/16,5.46%,BMP5;CXCL17
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.81429772209527,1.4767209496774558,0.05263157894736842,0.7257473493039602,1.0,1/9,0.07%,F2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.7973796933386055,1.4766242807806185,0.13953488372093023,0.722695994349945,1.0,4/11,5.36%,IRS1;PLIN5;PPARGC1A;AKT2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.8081214033867687,-1.4765735340352208,0.046875,0.7037194067803723,1.0,1/14,0.08%,CD44
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.8541261005491934,1.4753097257830885,0.11627906976744186,0.7253816876488466,1.0,1/6,1.19%,ZBTB1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6541044684823673,1.4748257258172628,0.03225806451612903,0.7243504695111366,1.0,4/16,11.91%,SPIRE2;SPIRE1;SCIN;JMY
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.8047711743721337,1.4747331275486761,0.0,0.7212129298342109,1.0,3/11,6.74%,IGF1;IRS1;IGF1R
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7532562009929952,-1.4735413651650398,0.06666666666666667,0.7198149288529643,1.0,4/18,7.91%,CD44;RHOC;PLET1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.8015179110086061,-1.4734822994739705,0.08064516129032258,0.7128870643405807,1.0,3/14,4.05%,HLA-F;B2M;HLA-A
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.6613859044505195,-1.4731892444356227,0.02702702702702703,0.7081640156082141,1.0,28/85,20.50%,MRPS22;MRPL51;MRPL35;MRPL36;MRPS12;MRPL34;MRPS34;MRPL40;TRMT112;MRPL27;MRPL20;MRPS21;MRPL14;MRPS18B;MRPL2;GADD45GIP1;MRPL54;MRPS18A;MRPL52;MRPL4;MRPL16;MRPS26;MRPL45;MTRF1L;MRPL9;AURKAIP1;MRPL57;ERAL1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8644373964252463,-1.473056590244834,0.0,0.7025542068911498,1.0,1/7,0.43%,CYP1A2
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.8377949315655309,1.4727990291349138,0.05128205128205128,0.7261812644471244,1.0,3/6,9.57%,NGB;CA2;AQP1
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.848549547731001,1.4726928366173047,0.15789473684210525,0.722857109652866,1.0,2/7,10.17%,LYPD1;CHRM3
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.9041893042384748,-1.4724884950554484,0.016129032258064516,0.7018320541718959,1.0,2/7,4.90%,DDIT3;MESP1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.9099507271694438,-1.470893453186124,0.06060606060606061,0.7113050304141989,1.0,1/6,1.54%,NDUFA12
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.8299898553732934,1.4706552224558729,0.12121212121212122,0.729850548485063,1.0,2/5,8.21%,CDK6;DLL1
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.932665995091461,1.470402029312974,0.027777777777777776,0.72716375020658,1.0,1/5,0.32%,RELN
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7596601862675371,1.4693593809296317,0.13043478260869565,0.7279431137702205,1.0,1/7,7.77%,PHF14
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8080688058556564,-1.4680549630239201,0.015384615384615385,0.7268656232819158,1.0,4/16,9.64%,CD44;HYAL2;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.6112715676603248,-1.4677952239851981,0.011904761904761904,0.722077988030941,1.0,27/123,14.87%,RPS27;RPL38;RPS14;EIF2S3B;RPL23A;RPL5;RPL10;RPSA;RPS15;RPS5;RPL24;RPL11;RPL3;EIF2S2;RPF2;RPS28;NOP53;RPS19;RPL6;MRPL20;SNRPD1;SNRNP200;RPLP0;PRPF6;RPS27L;SNRPD2;PRPF18
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8384808276732285,-1.4674660484568935,0.06060606060606061,0.7176930445496184,1.0,2/9,2.74%,SEMA3E;TGFBR2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.5644605548423107,1.46726885172661,0.04,0.7352839168421844,1.0,25/97,13.25%,ZNF423;KCNQ2;EFNB3;CELF3;CASKIN1;LRP4;MMD2;SCRT1;CTNND2;PCDH8;SEMA5B;CACNG5;CAMKV;EFR3B;ADGRL3;SNAP91;NCAN;MEGF10;UNC13A;ZNF536;LRRC4C;SLC8A2;SRRM3;LGR5;CADM2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6994117968002224,1.467171329425892,0.125,0.7319294550923952,1.0,5/19,11.16%,IGF1;IRS1;AKT2;SORBS1;RHOQ
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.8433112454910283,-1.4669346205103366,0.07692307692307693,0.7154736161891946,1.0,3/11,3.91%,NOX4;CPS1;TST
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.8498092625747631,1.4664574156209944,0.075,0.7318603473345423,1.0,1/7,5.00%,SPRED1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.8999164183378955,-1.4664090346347582,0.016666666666666666,0.7136013487823445,1.0,1/6,1.48%,SFRP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6061411498309461,-1.466227839601344,0.04878048780487805,0.7083567357741911,1.0,23/79,21.77%,HLA-F;HLA-DPA1;DCTN3;HLA-E;HLA-A;CENPE;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;DYNLL1;CANX;KIF4A;DCTN1;CTSS;HLA-DRA;HLA-DRB1;AP1S1;AP2A2;HLA-DPB1;KIF22
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7896672233388322,1.4659419828194853,0.025,0.7308482014440533,1.0,2/9,2.42%,ZSWIM6;ZSWIM4
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8534888601734985,-1.465869246651328,0.05172413793103448,0.704708692055706,1.0,1/9,0.32%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.6560347374976975,-1.4649946241966394,0.04285714285714286,0.7051410621476053,1.0,19/55,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;RBX1;PSMD3;PSMC3;PSMA4;AVEN;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.882193522639594,1.4646906079734585,0.05,0.7342059697319044,1.0,2/5,10.32%,GNGT1;PDE6B
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.8323181993295949,-1.4642002971530377,0.046153846153846156,0.7058603027361507,1.0,3/10,7.08%,COPS6;COPS7A;COPS5
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.9141729650159737,1.4636499789642774,0.06666666666666667,0.7361957594428479,1.0,4/5,5.00%,SPRY2;SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6487257691707906,1.4631742021852119,0.037037037037037035,0.7348451576549521,1.0,7/34,10.17%,PDGFB;NFATC4;ATOH8;RELA;NFIB;TGFB2;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6762645140908461,1.4630963612962669,0.0625,0.7313927345027507,1.0,6/32,6.15%,F2;PDGFB;RAB27A;ADGRB1;CLEC7A;CYBA
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.8440397367985782,1.4616702858252717,0.05555555555555555,0.7355377070053524,1.0,2/8,8.54%,AMER2;VAX2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6641249278728033,-1.4616277164683023,0.03125,0.7205841420191175,1.0,21/53,20.70%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;AZIN1;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PDK2;PSMD6;PSMB2;PSMB4;PSMA3;CAV1;PSMB3;PSMC1;OAZ3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.6032708011227378,1.4614917475340161,0.045454545454545456,0.7325080255503247,1.0,7/44,5.48%,VDR;NFKBIZ;GCM1;TRIM29;ANXA4;ADAM19;SIRT1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.8470336726312595,1.4607155697843577,0.045454545454545456,0.731982811309381,1.0,1/6,0.67%,NUPR1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6441038446169479,1.4602687945851733,0.08823529411764706,0.7310088218932894,1.0,9/28,12.58%,NUPR1;PFKFB3;IGF1;PPARGC1A;ARNT;P2RX7;MLXIPL;SLC4A4;PID1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7307364815240536,-1.4597946297168525,0.058823529411764705,0.7293308295899765,1.0,4/30,8.94%,CD44;ZMYM6;SPARC;VIL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8764817642221756,-1.4593651591478451,0.0,0.726878158041233,1.0,6/12,7.77%,HLA-F;B2M;HLA-E;HLA-A;ERAP1;ERAP2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.8353928659986294,1.4593228921352417,0.03333333333333333,0.7330765498485932,1.0,6/11,13.39%,AK3;ADSS2;NT5E;AMPD1;AK4;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.8078519081055392,1.4571571531912142,0.12,0.7405186750794553,1.0,2/8,2.46%,PLIN5;ALK
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.6099053247984936,-1.4564045794528624,0.012658227848101266,0.7454435172300639,1.0,40/132,19.91%,CENPF;PSMB8;PSME1;DCTN3;PSMB6;PSMC5;SSNA1;TUBB4B;PSMD8;PSMD7;RAB11A;CETN2;TPX2;DCTN2;CEP131;RBX1;HAUS6;CDK4;PSMD3;PSMC3;TUBA1A;CEP72;DYNLL1;PSMA4;DCTN1;AVEN;PLK4;PSMA7;PSMD2;CEP135;PSMD6;PSMB2;PSMB4;PRKACA;CEP41;TUBB;PSMA3;TUBA4A;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.6278868757127176,1.4563242590970538,0.06896551724137931,0.7414994568049196,1.0,2/31,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.8006759515946822,1.4558431502843177,0.07142857142857142,0.7410715808334771,1.0,1/7,0.07%,F2
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.912864615398976,-1.4545015974767832,0.05357142857142857,0.7541726324737137,1.0,3/7,4.85%,CENPF;MIS12;CENPE
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7589347138345026,1.4537845683375297,0.05405405405405406,0.7484353312935421,1.0,4/12,5.48%,IRS1;PPARGC1A;AKT2;SIRT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.6667487463985607,-1.4535607265076715,0.043478260869565216,0.7554143411368992,1.0,13/36,19.32%,RPS27A;PCNA;UBA52;RPA3;RBX1;RFC2;PARP1;RFC4;UBB;XPA;POLD2;GTF2H2;POLD4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7328441098415963,-1.4529182999279404,0.06493506493506493,0.7537938980054295,1.0,5/23,4.05%,HLA-F;B2M;LACC1;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.670440005265471,1.4526320911658739,0.125,0.7511931733198784,1.0,7/14,10.29%,PLIN5;PLA2G10;SIRT1;FTO;NFKB1;C3;FBXW7
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.8873759074327909,-1.452089048348185,0.017857142857142856,0.7540559389253515,1.0,2/6,7.87%,NOP10;NHP2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7708665037052566,1.4517169766358524,0.075,0.752357284664625,1.0,2/11,1.34%,SLC38A1;SLC29A2
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.882400701574254,1.4516976216032382,0.023255813953488372,0.748952639139566,1.0,1/6,4.44%,CX3CR1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.6651867013057267,1.4516750566691146,0.1111111111111111,0.7455170765747057,1.0,3/14,5.69%,IGF1;MAPK12;MBNL1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.614064454676894,-1.4513607517286393,0.013157894736842105,0.752337542509038,1.0,36/111,20.06%,PSMB8;MCM2;RPS27A;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;ORC6;MCM4;MCM3;GRWD1;CETN2;RPA3;RBX1;PSMD3;PSMC3;CHAF1A;PARP1;UBB;PSMA4;MCM5;XPA;PSMA7;PSMD2;GTF2H2;PSMD6;PSMB2;ORC2;PSMB4;NAP1L2;PSMA3;PSMB3;PSMC1;CHAF1B
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.8199972574231706,1.4510198485825319,0.027777777777777776,0.7453919205333683,1.0,1/6,12.49%,SLC6A13
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.803325772672236,1.4508773745386467,0.10810810810810811,0.7428044103238928,1.0,1/6,2.36%,TMEM98
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.7045277514359489,1.4506931877419063,0.0,0.740546859612395,1.0,4/19,8.70%,ZMYND10;HAP1;CCP110;ARHGAP35
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.7993477995186716,1.4500401199941626,0.15789473684210525,0.7396523612766321,1.0,1/7,1.07%,IGF1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.8500748880301199,-1.4497198183461912,0.07017543859649122,0.7584189274608106,1.0,1/8,0.32%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.9666047335576213,-1.4496616192442546,0.0,0.7529396350603667,1.0,1/6,0.57%,DDIT3
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8273639919154907,1.4495206618503111,0.125,0.7382190564167891,1.0,4/7,10.24%,PLIN5;PLA2G10;NFKB1;C3
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7788232801363166,1.4494038499540884,0.17142857142857143,0.7356492859360084,1.0,2/6,6.60%,SASH1;BMP6
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.8487087890523096,-1.448450483372076,0.03076923076923077,0.7554603646340542,1.0,3/8,11.10%,B2M;ADAM15;BDNF
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.7592528634883822,1.4484486700092645,0.1,0.7384618214581129,1.0,3/8,12.60%,KCNIP2;ATP1B3;LRRC38
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7927437509287992,1.4481012277914838,0.07894736842105263,0.7367530494556324,1.0,3/6,18.82%,RELA;NFKB1;SLC30A10
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5327292161775649,1.4480284575812141,0.0,0.7337461938320713,1.0,19/96,9.49%,MFNG;EPB41L4B;ONECUT1;EFNB3;FGFR3;ABCC8;SLC7A2;HNF4G;LRP4;CXXC4;SOWAHA;MYH14;CAMSAP3;EPB41L1;COBL;CACNG4;TOX3;NPNT;CD276
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.627078357855807,-1.4477732693966114,0.013157894736842105,0.7553686887969793,1.0,25/71,22.36%,PSMB8;RPS27A;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;PSMD3;PSMC3;ANAPC15;UBB;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;CDC23;PSMA3;PSMB3;PSMC1;CDC20;PSMD10;UBC
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.6589073124128902,-1.4468443724399587,0.06944444444444445,0.7569138480388728,1.0,9/42,15.83%,SLC8A3;MPZ;DEGS1;PMP22;KLK6;TNFRSF21;MYRF;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.9414237688085716,1.4467326824038254,0.0,0.7336687817146317,1.0,1/5,0.21%,PDGFB
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.9414237688085716,1.4467326824038254,0.0,0.7336687817146317,1.0,1/5,0.21%,PDGFB
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.9533960746039922,-1.446051021330202,0.0,0.7575259430182739,1.0,1/5,0.32%,BMP5
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.923728659370455,1.4452970700030914,0.0,0.736841153178904,1.0,1/5,2.48%,SLC15A2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7097225939627758,1.4451097657326941,0.09090909090909091,0.734648492331186,1.0,6/13,13.97%,FGFR1;CAMSAP3;TGFB2;RICTOR;UBR3;SCEL
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.9002736582995601,-1.444680493679345,0.03508771929824561,0.7622490116592915,1.0,1/5,1.48%,SFRP1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.6696016697810023,-1.4440887758131815,0.06451612903225806,0.7615961118042482,1.0,12/33,20.18%,APEX1;PCNA;PNKP;MPG;RPA3;RFC2;PARP1;MBD4;RFC4;POLD2;POLD4;PARG
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.8495714462553521,1.4426828136806598,0.17391304347826086,0.7433958607619682,1.0,2/6,7.56%,NOS2;DRD4
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8347119839550206,1.4425177739165165,0.0,0.7407868315624245,1.0,3/8,5.00%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.7333605234544596,-1.4416758444019013,0.05084745762711865,0.7751518806093166,1.0,9/15,21.56%,EMC6;GET3;EMC3;EMC7;CAMLG;MMGT1;EMC10;EMC4;UBL4A
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6571364360023554,1.4415335581507733,0.0,0.742484893312386,1.0,4/22,9.28%,HDAC4;HDAC10;SIRT1;ABHD17C
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7777477309764004,1.4411681879130205,0.075,0.7411127251601274,1.0,2/8,5.48%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.809291526486132,-1.4408479310119828,0.015873015873015872,0.7757935456771453,1.0,2/15,1.25%,DDIT3;XBP1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6938105437340425,-1.4400538198037496,0.07692307692307693,0.7763005770595433,1.0,4/21,12.33%,SLC25A4;CDC37;FLOT1;YBX3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.7270747545841468,-1.4396807671030907,0.031746031746031744,0.7741362581399451,1.0,8/22,14.32%,RPS27A;PCNA;UBA52;RPA3;RFC2;SPRTN;RFC4;UBB
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.9483570780738324,1.438822966094811,0.0,0.7492251471825762,1.0,3/5,4.83%,NOS2;ICAM1;AGER
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.7138400861618871,1.4381620514133677,0.18604651162790697,0.7482934757739841,1.0,1/8,0.86%,RAB39A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.8969108740770121,1.4373940708088482,0.11428571428571428,0.7491913754833567,1.0,3/6,9.17%,IGF1;SIRT1;CDKN2A
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5413898187048086,1.437301678030205,0.045454545454545456,0.7465102134345336,1.0,34/165,12.67%,CPA1;CREB3L1;SLCO2B1;TIAM2;STARD13;STK32B;POSTN;PDGFRA;ADAMTS9;HPGDS;SPRED1;DUSP1;ALDH1A1;RNF128;COBL;OPTN;LTC4S;MRC1;HS2ST1;SLC7A5;RAB27B;IL2RA;AQP1;MITF;SLC4A4;SGCD;CD55;CDH9;HDC;MEIS2;NEO1;PID1;GP1BA;PLSCR4
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.8107868424633494,-1.4372506046353444,0.03389830508474576,0.7879892879653628,1.0,1/12,0.32%,BMP5
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7838268439336835,1.436548785676892,0.0967741935483871,0.7438570164798489,1.0,5/14,12.41%,FHDC1;SRC;SORBS1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7838268439336835,1.436548785676892,0.0967741935483871,0.7438570164798489,1.0,5/14,12.41%,FHDC1;SRC;SORBS1;ARRB1;FAM171A1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.7094180891771757,-1.4330970738985314,0.03225806451612903,0.8160975814852274,1.0,4/19,8.50%,XBP1;LACC1;HLA-E;PHB2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.667090484970738,1.4330356262785453,0.07692307692307693,0.7582516246215434,1.0,10/22,25.42%,TAL1;PPP1R10;EIF4EBP1;EIF4E;MEIS2;CDC25B;PRKCA;APP;RPS6KB1;HES1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8748593845515433,1.4328839126951884,0.07142857142857142,0.7556888280480732,1.0,2/6,10.32%,DIAPH1;GABRB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8225933249271358,1.43282542014871,0.0625,0.752702801750555,1.0,3/8,5.36%,IRS1;PLIN5;AKT2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6761536696139038,1.431346100871386,0.07692307692307693,0.7565987083621045,1.0,5/17,13.86%,KCNJ2;ATP12A;ATP1B3;SLC12A2;KCNMA1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.7412669600530546,-1.4311426368676348,0.08064516129032258,0.8271329272109751,1.0,3/15,13.63%,TINF2;MPG;MBD4
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6892665594984183,-1.4310329953673013,0.014492753623188406,0.8216523057850028,1.0,4/29,10.84%,LIX1;ATG14;VAMP8;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.8282735467928426,1.4305831425862354,0.06521739130434782,0.7572133346846057,1.0,3/8,6.15%,RAB27A;ADGRB1;CYBA
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.9188855462426233,-1.430545271929507,0.0,0.8194149970103402,1.0,4/7,7.77%,B2M;HLA-A;ERAP1;ERAP2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.8623218870376157,1.4303015395090626,0.08823529411764706,0.755738491087008,1.0,4/6,13.39%,HPRT1;NT5E;PRTFDC1;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.8554555772710117,-1.4301663455774953,0.0,0.8164990833198429,1.0,2/8,4.04%,IRF4;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.8716807489081847,-1.4300447696987597,0.0625,0.8113897297510843,1.0,2/9,3.94%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7435373129218541,-1.4299328726171252,0.057971014492753624,0.8068790210329572,1.0,2/20,3.28%,CD44;HLA-DPA1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.6007001792415264,1.4297585453049917,0.08333333333333333,0.7560784598933638,1.0,11/49,11.55%,B3GNT6;ST8SIA6;GAL3ST2;ADAMTS9;GANC;ST8SIA1;ST8SIA4;MAN2A1;ENGASE;FUT8;FBXO2
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.8113141069583435,-1.42911458656458,0.031746031746031744,0.8077675379857583,1.0,7/11,16.44%,MCM2;MCM4;MCM3;GINS2;MUS81;GINS4;MCM5
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8612458702341217,1.4289720126149372,0.15789473684210525,0.7566877704307293,1.0,3/5,11.37%,TMEM108;LLPH;AUTS2
prerank,GO_Biological_Process_2021__detection of molecule of bacterial origin (GO:0032490),0.9105396770954898,1.4286896070596014,0.06666666666666667,0.755015939921689,1.0,2/5,5.68%,DMBT1;SSC5D
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.8282357089721493,1.4281249860076584,0.175,0.7544370487574878,1.0,3/7,10.54%,GLI2;CLEC5A;PTHLH
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7522940135399466,-1.4275693788887898,0.043478260869565216,0.8154959639815996,1.0,10/23,16.90%,RPS27A;COPS6;COPS7A;UBA52;COPS5;CETN2;RBX1;PARP1;UBB;XPA
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8739158700970375,1.4275664841836395,0.05,0.754884319066057,1.0,1/5,2.22%,SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6984131152059544,1.4259075971395514,0.05405405405405406,0.7612725668254587,1.0,4/14,10.24%,PLIN5;PLA2G10;NFKB1;C3
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5985926668043766,1.425610380564059,0.12,0.7595023273171577,1.0,11/35,15.43%,TP63;SRC;MAML2;NOTCH4;ROBO1;DLL1;TGFB2;ROBO2;TSPAN14;KAT2B;CREBBP
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.826355949144556,1.4253397516648614,0.13513513513513514,0.7583835817215568,1.0,1/8,0.67%,NUPR1
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.8785351141854865,1.425143262007538,0.02631578947368421,0.7566913838923469,1.0,2/5,6.46%,FBLN5;DHFR
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.808393079859169,-1.4246621252412364,0.017241379310344827,0.8327798398545001,1.0,4/14,9.64%,CD44;HYAL2;CEMIP;TGFB1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.7956910332562305,1.4237179211608184,0.21875,0.760758905206649,1.0,1/6,5.48%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8176047204141871,-1.4233421194816973,0.02857142857142857,0.8395458266156542,1.0,1/15,0.30%,IL26
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7657274302966476,-1.4229966508662462,0.08,0.8365754558555037,1.0,8/14,14.37%,ATP5F1E;ATP5MC3;ATP5PB;ATP5PD;ATP5F1B;ATP5PF;STOML2;ATP5ME
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.8825601590022367,1.4225581559747251,0.06666666666666667,0.7639546345277034,1.0,2/5,7.56%,HPRT1;DRD4
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.7821302747079693,1.4220300466932907,0.11627906976744186,0.7635160524441512,1.0,3/8,8.48%,ACSM1;KYAT1;KYNU
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7702563274857331,1.421940194503658,0.08823529411764706,0.7611526878693472,1.0,5/14,11.24%,DSE;VCAN;CSPG4;NCAN;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6846088298433386,1.42175077789762,0.1,0.7594822980209736,1.0,3/15,2.95%,LIFR;RUNX1;IRAK2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.8761824512146029,1.4215693621851404,0.06896551724137931,0.7574626575604204,1.0,3/7,10.16%,CPEB3;CPEB2;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6803660988774558,1.4214838803142786,0.06976744186046512,0.7550462324424776,1.0,3/23,6.55%,PDGFB;CRACR2A;P2RX7
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.7616050978058844,1.4211033840582041,0.05128205128205128,0.7537772140526637,1.0,5/10,13.07%,BCO1;RDH10;BCO2;ALDH1A3;ALDH8A1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.8538602480344705,1.4206846127218415,0.1388888888888889,0.7523643859254883,1.0,1/7,1.01%,NLRP7
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6425575039312723,-1.4206148580205995,0.05405405405405406,0.8525197170749059,1.0,14/46,19.12%,MCM2;RPS27A;DDX11;UBA52;MCM4;CETN2;RBX1;PARP1;UBB;RAD50;XPA;GTF2H2;DDX1;RECQL
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.7076375230404596,-1.4195403522013155,0.07462686567164178,0.8577895926339026,1.0,9/21,14.88%,CYP1A2;GPX4;ASAH2B;GSTM4;GSTP1;ACSBG2;ASAH2;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.8712904333512823,1.4191102901933146,0.10256410256410256,0.7575839728386954,1.0,1/5,2.22%,VEGFD
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8568288023232963,1.4181087977219304,0.15151515151515152,0.7591107433243448,1.0,1/5,2.87%,AK3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7654395927084368,1.4180726782041355,0.1111111111111111,0.7565310242396799,1.0,3/11,11.53%,VEGFD;GAB1;PIK3CA
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.8503413547015617,1.4175441157556636,0.05128205128205128,0.7562370809761173,1.0,4/9,10.92%,MYH3;MBNL1;TGFB2;MEGF8
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6900075981977632,1.4171105622860327,0.11538461538461539,0.7549416702014087,1.0,3/24,3.64%,PDGFB;IGF1;PRR5
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6279843999358672,1.4169255680061748,0.08108108108108109,0.7530058577554849,1.0,7/25,12.89%,IL1RAPL1;PTPRD;AGRN;NLGN1;NRXN1;NLGN3;CLSTN2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7797084575988664,1.4167023175226268,0.12121212121212122,0.7510842792246046,1.0,6/8,19.61%,GALNT3;EOGT;GALNT2;GALNT16;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7244787088159967,-1.4161322040914872,0.057971014492753624,0.8796181809535266,1.0,10/25,14.37%,MICOS13;ATP5F1E;UQCC3;ATP5MC3;ATP5PB;ATP5PD;ATP5F1B;AFG3L2;ATP5PF;ATP5ME
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7419651179484013,1.4161221592035975,0.06666666666666667,0.7512116405906535,1.0,6/13,14.39%,FHDC1;OPTN;VAMP4;TRIP11;VTI1A;GOLPH3
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.834000100327902,-1.4153116569549582,0.03076923076923077,0.8801354444059295,1.0,3/7,9.01%,DEGS1;DECR2;SCD
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.6622882620686628,-1.4153102202125458,0.06349206349206349,0.8743223870520757,1.0,7/46,7.32%,PKMYT1;CCNB2;CNPPD1;SERTAD1;CDKN1C;CDC37;CCNJL
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.6196981272534391,1.4147471188815155,0.14285714285714285,0.7540578033882475,1.0,6/29,11.96%,IGF1;ICAM1;AGER;IGF1R;CACNA2D1;GRIN1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.623675257099129,1.4144731849642538,0.0,0.7526460606654696,1.0,3/44,1.91%,F2;PDGFB;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.8828530438989959,-1.4133529351170575,0.05555555555555555,0.8877558723788578,1.0,1/5,2.49%,CLU
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5673219541563969,1.4127515505652783,0.12,0.7581173334760296,1.0,17/80,9.69%,PDGFB;PTPN6;PDGFC;FGFR1;IGF1;FLT1;SRC;PIK3R5;EGFR;PDGFRA;SIRT1;IGF1R;HCLS1;PIP4K2A;NTRK2;TGFB2;GAB1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.6305939631531159,-1.4127378414127314,0.013888888888888888,0.8877790291706977,1.0,7/41,9.98%,GPX4;FTL;SELENOS;PRDX1;NDUFB4;LAMTOR5;TXNRD2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6783865166165581,-1.4125742086074577,0.014285714285714285,0.8832591936327784,1.0,11/45,20.55%,LIX1;RPL23;VAMP8;PPP1CA;GABARAPL2;PYM1;HSPA8;CHMP3;MAP1LC3B;CAV1;WNT8B
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.8660317426123235,1.4121615182682425,0.13333333333333333,0.7586087784020028,1.0,1/6,0.07%,F2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.8789640241959785,1.411973772871287,0.16666666666666666,0.7569522091487229,1.0,3/5,9.30%,NUPR1;PPP1R10;BAG3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.848903496040752,-1.411579834941758,0.01694915254237288,0.8860722602571637,1.0,3/9,3.57%,COPS9;RPL5;RPL11
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5542198846797042,1.4108026237675366,0.05128205128205128,0.7603095514666603,1.0,11/44,12.72%,RAB27A;IL1RAPL1;SYTL4;SNCA;HAP1;STXBP5;UNC13D;RAB27B;CADPS;RAB3B;CLASP1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.7908103622902797,-1.4103588492400332,0.09090909090909091,0.891592227628651,1.0,4/12,18.41%,MAGT1;MMGT1;SLC41A1;CNNM4
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.8415412144427641,1.4096762017043787,0.07692307692307693,0.7634977427066826,1.0,7/9,14.67%,ERRFI1;PDGFRA;NOTCH4;FBXW7;PIK3CA;BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.7979905682077101,1.4096352296260393,0.06666666666666667,0.7608288867031956,1.0,4/7,17.83%,FGFR3;SCX;BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6307181225631591,1.4091767044955916,0.1282051282051282,0.7576543485054134,1.0,7/18,18.44%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;PPM1D;MTRR
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6307181225631591,1.4091767044955916,0.1282051282051282,0.7576543485054134,1.0,7/18,18.44%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;PPM1D;MTRR
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.698032489720185,-1.408637142200942,0.07246376811594203,0.9007105216553203,1.0,3/32,5.48%,CD44;XBP1;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.8841182771753855,1.4086222873822527,0.025,0.7575628089305656,1.0,1/5,4.44%,CX3CR1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.838808600892365,1.4084642326654082,0.08888888888888889,0.7533074135044433,1.0,1/5,2.22%,SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.838808600892365,1.4084642326654082,0.08888888888888889,0.7533074135044433,1.0,1/5,2.22%,SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.7910689416689923,1.4074636321121654,0.05714285714285714,0.755592465706832,1.0,4/9,14.26%,NFKBIZ;MALT1;CD80;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.827060551223572,1.4069397505384065,0.08571428571428572,0.7556504943898955,1.0,2/6,5.48%,PPARGC1A;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.7973139291520321,1.4066609810483444,0.0625,0.7545829279352081,1.0,2/10,3.86%,STARD13;TBXA2R
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6250455609969006,1.40603826091989,0.125,0.7552514157729415,1.0,7/21,20.91%,LIMK1;L1CAM;MEGF8;RUFY3;MAPT;ZFYVE27;MACF1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7161389514883933,1.405680657634819,0.075,0.7546581663931498,1.0,6/15,13.75%,OXTR;TBXA2R;KCNMB4;ADRA1A;CHRM3;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8293256575069987,-1.4055905291793054,0.04,0.9210144079118994,1.0,3/8,9.49%,CD44;LCK;FLOT1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6485831049044398,-1.4047825648060488,0.014084507042253521,0.9236208049279245,1.0,9/37,15.06%,POLR2G;PTMA;POLR2J;POLR2L;POLR2I;PAX8;THAP1;HOXD3;POLR2A
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.5701698835977239,-1.40474105998827,0.04819277108433735,0.9182232824480197,1.0,32/134,15.39%,GPX4;POLR2G;TYMS;EDF1;EIF1B;NPR2;POLR2J;GTF2F1;PCNA;POLR2I;ADRM1;MRPL40;MPG;SURF1;COX17;DAD1;CETN2;RPA3;VPS28;RBX1;POLR3GL;RFC2;BRF2;GMPR2;NT5C;IMPDH2;GTF2A2;TK2;APRT;RFC4;POLR2A;SUPT5H
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6683236840381599,1.4043545631803847,0.18181818181818182,0.7578274929127845,1.0,3/15,3.97%,PDGFB;PDGFC;PDGFRA
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6541469444096633,1.404349919872077,0.05128205128205128,0.7552410509574508,1.0,10/22,24.69%,IL1RAPL1;CTNNA2;PDLIM5;ABHD17C;ABL1;WNT5A;ARHGAP22;MDGA1;CAMK2B;SETD5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6282948539021166,-1.404259301542323,0.05555555555555555,0.91641949182176,1.0,22/65,19.91%,PSMB8;RPS27A;PSME1;PSMB6;PSMC5;ELOB;PSMD8;PSMD7;UBA52;RBX1;PSMD3;PSMC3;UBB;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6399529375305824,-1.4024554267542448,0.06557377049180328,0.9269795522757893,1.0,1/32,0.08%,CD44
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.6479544248392568,-1.4022261846569497,0.10294117647058823,0.923427852429017,1.0,10/38,15.39%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I;IFITM3;TRIM13;HEXIM1;POLR2A;SUPT5H
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5648775658862845,1.4018938842594035,0.041666666666666664,0.764470151689118,1.0,12/53,11.34%,ZAP70;LEPR;IFNA2;HDAC4;PBX1;CHD7;CD4;NHEJ1;GPR89B;PTPN22;LFNG;HDAC9
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7509438343372677,-1.4015586790394017,0.10344827586206896,0.9236820820257068,1.0,6/10,19.11%,EMC6;EMC3;EMC7;MMGT1;EMC10;EMC4
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6449779040295274,1.4014937769364204,0.1111111111111111,0.7640374144602088,1.0,6/34,10.41%,PDGFB;SPOCK1;VIT;NPNT;TBCD;CORO2B
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6859705513649181,1.4009157156508552,0.04,0.7638364728498532,1.0,12/25,13.63%,DSE;CHST7;VCAN;CSPG4;CHST3;NCAN;CHSY3;CHST11;CSGALNACT1;HEXB;UGDH;CHST15
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.7337036824133513,1.4008366577658764,0.10869565217391304,0.7616752148656498,1.0,2/10,5.40%,ZMYND10;DNAAF1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.8036844000952506,-1.400695448534928,0.04918032786885246,0.9263762919021071,1.0,2/9,9.88%,TGFB1;FADD
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6518306651271529,1.4006665632383104,0.12903225806451613,0.7599376661683922,1.0,3/21,5.94%,KCNJ14;KCNJ2;SNCA
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.7069777274814472,1.4005445801049132,0.03125,0.7578492193158833,1.0,2/14,3.12%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6069764926316085,-1.3992991019684853,0.038461538461538464,0.9337952796434975,1.0,18/59,14.88%,CYP1A2;GPX4;XBP1;ASAH2B;GSTM4;DEGS1;ELOVL2;DECR2;ABHD1;SCD;ACSM6;OXSM;NDUFAB1;ACSBG2;ACSM3;ASAH2;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7142760902430089,-1.3992057313282515,0.08695652173913043,0.9288596199985987,1.0,4/24,4.59%,CD44;CLU;RPS3;DDIAS
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.848864357509503,1.398916828730757,0.09302325581395349,0.7628654464394307,1.0,2/5,12.17%,JAM2;GPLD1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5333009147832936,1.3988208984978308,0.03125,0.7607811494654402,1.0,23/86,11.69%,VDR;TRHDE;ZBTB7C;MYO5B;COBLL1;PPARGC1A;STON2;PLD1;GRHL2;MYH14;ALDH1L1;PDZD2;FRK;PROM2;LARP1B;TSC22D2;CLMN;COBL;SCIN;CPEB4;SLC22A2;THRB;LPP
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7527691341710112,1.3980895678765701,0.11363636363636363,0.761178226362057,1.0,3/10,6.55%,CHRNA4;SCN9A;P2RX7
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.72840975958066,-1.3980326550917246,0.08064516129032258,0.9333350262992938,1.0,2/15,3.24%,SELENOS;SEC61B
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.697738479992392,-1.3978869907654756,0.07246376811594203,0.9292396109036807,1.0,9/23,19.22%,PSME1;EFNA1;RHBDF1;PINK1;ATP5IF1;NUDT15;UBB;APOE;PRKACA
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6023738284629188,1.397722290352157,0.10344827586206896,0.7604994778750531,1.0,8/37,11.42%,PDGFB;FGFR1;JCAD;HSPB1;SIRT1;RHOJ;HDAC9;PRKD1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.7298574641477661,-1.3974280510941965,0.06153846153846154,0.9278053804932542,1.0,2/19,1.28%,TRPM1;JPH3
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8117023787406988,-1.3973295526008684,0.03225806451612903,0.9233096831171618,1.0,1/9,0.43%,CYP1A2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.7006554953411961,-1.3970005408641448,0.09836065573770492,0.9210661851319143,1.0,3/23,4.17%,SELENOS;SEC61B;TMED9
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8000266960608203,1.3966105463069751,0.13513513513513514,0.7608878547183184,1.0,5/9,14.35%,IRS1;SIRT1;SORBS1;PRKCZ;GKAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8000266960608203,1.3966105463069751,0.13513513513513514,0.7608878547183184,1.0,5/9,14.35%,IRS1;SIRT1;SORBS1;PRKCZ;GKAP1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.7216580902826139,1.3965750908713301,0.06451612903225806,0.7584898500017672,1.0,7/18,12.85%,GPR35;CBARP;PDE4B;CACNB4;DRD4;NOS1AP;DMD
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.821163586605786,-1.3963401075405757,0.07017543859649122,0.9220339392684008,1.0,2/8,6.33%,TINF2;MPG
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.84208936284015,-1.3963082503183226,0.03636363636363636,0.9065079920121839,1.0,2/8,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.84208936284015,-1.3963082503183226,0.03636363636363636,0.9065079920121839,1.0,2/8,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.84208936284015,-1.3963082503183226,0.03636363636363636,0.9065079920121839,1.0,2/8,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7657870898909881,1.3961367255342259,0.10344827586206896,0.7580052389519477,1.0,1/16,0.07%,F2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.6920945056637093,1.3961187301864137,0.17073170731707318,0.7555881739090091,1.0,1/9,0.86%,RAB39A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.743582040032724,1.3960880581915072,0.11428571428571428,0.7533182989866735,1.0,7/15,16.56%,LEPR;PHKA1;GFPT2;PID1;GFPT1;GSK3B;PHKG2
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.8573443645577825,1.3957001597830516,0.07142857142857142,0.7529424743743321,1.0,2/6,9.31%,UBA7;UBE2E2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7838713264157465,-1.3949802627451289,0.09230769230769231,0.9110209181723324,1.0,2/9,12.33%,SLC25A4;YBX3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.6808444633509732,-1.3947804185919337,0.0684931506849315,0.9077679779252736,1.0,2/24,1.23%,DDIT3;SELENOK
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.824148552440129,-1.3942521268124133,0.1,0.9070322023534928,1.0,1/6,0.28%,APIP
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.7750678384280876,-1.3941146130313833,0.05405405405405406,0.9030156389355467,1.0,7/14,14.73%,RPL35;DDX18;RPF2;FTSJ3;NIFK;WDR12;RPL7
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.8064354588991873,1.3940762885776585,0.10810810810810811,0.7584505546569948,1.0,3/7,18.64%,AGER;ADCY8;MAPT
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6605596261302205,-1.394075757819658,0.07575757575757576,0.8981805929709689,1.0,18/42,22.28%,TOMM7;SLC25A6;DNAJC19;ROMO1;TIMM8B;TIMM10;TSPO;TOMM20;PINK1;TIMM50;TIMM44;TIMM13;GRPEL1;FIS1;TIMM21;BCAP31;TOMM70;TOMM22
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5977377538053832,-1.3936518002040734,0.07792207792207792,0.8968775186869191,1.0,26/74,19.91%,PSMB8;DDIT3;RPS27A;PSME1;PSMB6;PSMC5;ELOB;PSMD8;PSMD7;UBA52;RBX1;PSMD3;PSMC3;ATF3;UBB;MAPK7;PSMA4;PSMA7;PSMD2;IMPACT;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.6455147234268082,1.3936450497997102,0.12195121951219512,0.7574961394007613,1.0,5/26,7.85%,F2;CYP2C8;DAO;SLC39A11;SERPINC1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.5503006944744363,1.3934288927417502,0.05263157894736842,0.7559850760808335,1.0,14/47,17.89%,KCNN4;KCNJ2;KCNIP2;KCNMB4;KCNN2;AKAP6;NOS1AP;DLG1;KCNN1;KCNMA1;KCNIP3;NEDD4L;KCNN3;KCNMB2
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.7325642809599086,-1.392270036378894,0.09230769230769231,0.9039453160267878,1.0,3/13,15.59%,POLR1G;NIFK;SNAPC2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8080774809524633,1.391564887939972,0.1,0.7619917959555162,1.0,5/8,16.33%,PKD1;NPNT;SLIT2;ROBO2;PKD2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.7854298937775374,1.390787416938118,0.17391304347826086,0.7630568558536667,1.0,1/8,5.21%,PBX1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6131823712031663,1.3907263859240044,0.08695652173913043,0.7609851368345558,1.0,9/44,10.98%,EPB41L4B;IGF1;PDGFRA;SYTL4;MYOF;DYSF;AHNAK2;TGFB2;FGF1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7459477855186799,-1.3898342069170067,0.1388888888888889,0.917816927409352,1.0,10/15,20.61%,ATP5F1E;ATP5MC3;ATP5PB;ATP5PD;ATP5F1B;ATP5PF;STOML2;ATP5ME;ATP5MC1;VPS9D1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.7255617921965937,1.3897845878835786,0.18181818181818182,0.7629014921707544,1.0,4/19,8.90%,F2;SNCA;P2RX7;AKAP6
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7336753259805944,1.3895264233184585,0.034482758620689655,0.7618658729603384,1.0,1/9,0.91%,RIDA
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.7264941018025965,-1.389417589421147,0.11940298507462686,0.9167838945331109,1.0,8/16,21.46%,DNAJC19;ROMO1;TOMM20;TIMM50;TIMM44;GRPEL1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7124493238264937,1.3891220642554911,0.05263157894736842,0.7610491166560507,1.0,5/13,15.56%,PLIN5;C3;FBXW7;GPLD1;NR1H3
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7758113006149101,-1.389038307405614,0.02702702702702703,0.9157620295798563,1.0,4/16,9.88%,HLA-F;HLA-E;HLA-A;FADD
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.5432624128008948,-1.3890177616461674,0.011494252873563218,0.9110583853704989,1.0,58/233,18.37%,CSTF2T;POLR2G;SNRNP27;UBL5;FRG1;POLR2J;GTF2F1;SNRNP25;POLR2L;PPIE;POLR2I;LSM2;SF3B5;PHF5A;LSM7;ZMAT2;IK;SF3B6;PRPF3;DHX16;RNPC3;SF3A1;FIP1L1;RBM22;SNRPB2;DHX38;SNRPN;SNRPD1;PNN;TFIP11;SNRNP200;PPWD1;SRSF7;PRPF6;ESS2;PRPF4;DDX41;SNRPD2;RBM4B;EIF4A3;PPIL1;CPSF3;POLR2A;BUD13;PQBP1;DNAJC8;METTL3;SNU13;CRNKL1;SRSF3;HSPA8;ZCRB1;MAGOHB;SYF2;HNRNPH2;SNW1;PRPF8;DDX5
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.8418022677736614,1.3886093366162833,0.05555555555555555,0.760999607900799,1.0,2/8,6.06%,CDK12;CCNH
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.8342183037697082,-1.3885787353671672,0.04838709677419355,0.9106902370892197,1.0,4/8,11.82%,DDIT3;SELENOS;ATG10;TMCO1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7180922950844375,-1.3884522444253062,0.07462686567164178,0.9068899921678358,1.0,8/20,17.99%,RPS27A;UBA52;CETN2;RBX1;PARP1;UBB;XPA;GTF2H2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.7605988831152343,1.3879720611459545,0.08823529411764706,0.7621322697930912,1.0,1/11,0.24%,RAB27A
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7412362165304852,1.3877562817060904,0.04878048780487805,0.7582521446381386,1.0,3/7,20.25%,AQP1;KCNC2;MTR
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7412362165304852,1.3877562817060904,0.04878048780487805,0.7582521446381386,1.0,3/7,20.25%,AQP1;KCNC2;MTR
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.7470589245928972,-1.3875658657506909,0.1044776119402985,0.9085811890303419,1.0,3/14,5.30%,DDX4;BTBD18;ZSCAN21
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.8082781929228856,-1.3875513507100488,0.06896551724137931,0.8991528712533526,1.0,4/8,14.23%,PCNA;DSCC1;RFC2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.8082781929228856,-1.3875513507100488,0.06896551724137931,0.8991528712533526,1.0,4/8,14.23%,PCNA;DSCC1;RFC2;RFC4
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5918112390433053,1.387151904949118,0.13793103448275862,0.7596755284985592,1.0,8/29,11.44%,ICAM1;IL1RAPL1;PTPRD;HMCN1;NLGN1;ALCAM;CADM1;CRTAM
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.8394671333812689,-1.3870610519593907,0.047619047619047616,0.8984304409004317,1.0,1/7,2.49%,CLU
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8246846990394057,1.3867155202859927,0.11538461538461539,0.7587972105660682,1.0,2/6,4.83%,ZBTB1;AGER
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7614361841808011,1.3865071994828537,0.13513513513513514,0.7575086612795792,1.0,2/7,6.74%,MTMR2;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7982960951415979,1.3861076081528314,0.1282051282051282,0.7570981255063512,1.0,3/6,15.02%,ROBO1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7086396541356647,-1.3860144325852979,0.08333333333333333,0.9030961126684751,1.0,7/21,14.32%,RPS27A;PCNA;UBA52;RPA3;RFC2;RFC4;UBB
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.7215665734017314,-1.385893533731918,0.10294117647058823,0.8995789920663319,1.0,8/19,21.02%,XBP1;DDX60;RPS19;CD81;APPL2;HLA-DRA;HLA-DRB1;CD46
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.802076119201739,1.3856232011233953,0.05,0.7567727101081235,1.0,8/10,16.30%,IRS1;AKT2;SNCA;PRKCE;PTH1R;GPLD1;SLC45A3;PTH
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.8571406356267363,1.3855645838554294,0.12903225806451613,0.7546372210892759,1.0,2/7,6.92%,ARNT;SESN2
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.8011276601793835,1.3854408228932809,0.06060606060606061,0.7527610236231517,1.0,1/5,0.32%,RELN
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6063158205015361,1.384573102096827,0.03125,0.7545802367623043,1.0,2/14,5.48%,TICAM1;SIRT1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7014452416296723,1.3844165649251643,0.08333333333333333,0.7529195676332083,1.0,2/15,1.43%,CREB3L1;SPRY2
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.806740254475084,1.384146310862047,0.11428571428571428,0.7514316257148195,1.0,2/8,8.21%,ASCL1;DLL1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.840394758667354,1.3841232226039437,0.13513513513513514,0.7492223969124602,1.0,4/6,11.04%,DUSP1;DUSP10;PTPN22;DLG1
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.8391521172528971,1.3838595860987912,0.1891891891891892,0.7455289151118195,1.0,2/5,11.99%,DLG2;SLC12A2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.8391521172528971,1.3838595860987912,0.1891891891891892,0.7455289151118195,1.0,2/5,11.99%,DLG2;SLC12A2
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.6318702044243636,-1.3828712936392948,0.08,0.9201252782440732,1.0,9/38,14.08%,CENPX;PCNA;DDX11;EME1;FAM111A;ZNF830;FANCM;BOD1L1;GEN1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.9218821288433289,1.382706830834904,0.047619047619047616,0.7481011007687351,1.0,1/5,1.24%,FLI1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7174926864193167,-1.3824445537620702,0.058823529411764705,0.9185179363053935,1.0,2/14,7.88%,TINF2;TPP1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.609537368425596,-1.3822117273782693,0.06172839506172839,0.9161382831923368,1.0,9/62,12.62%,GBP3;GBP2;SFRP1;RPS3;HYAL2;TNFRSF21;SELE;YBX3;BRCA1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7056627892639422,-1.3819860199267149,0.09722222222222222,0.9134109923735994,1.0,9/24,17.99%,RPS27A;UBA52;CETN2;RBX1;PARP1;UBB;RNF111;XPA;GTF2H2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8725591460571835,1.3817369693808503,0.13636363636363635,0.7502972887248955,1.0,2/5,1.65%,CORIN;OXTR
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.5713789388580541,-1.381211614870982,0.05263157894736842,0.9156418701025133,1.0,36/144,14.86%,VAMP5;PSMB8;B2M;IL7;APOL6;TNFAIP2;PSME1;SERPING1;IFIT2;IRF4;MT2A;P2RY14;HLA-A;IRF9;IFIT3;IRF1;IFITM3;DDX60;VAMP8;BTG1;TRIM25;PARP14;IFI44;ST3GAL5;SRI;LAP3;SP110;SELP;PARP12;STAT1;WARS1;HELZ2;NMI;LGALS3BP;ISOC1;ISG20
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.8888688972895463,-1.3802560700510829,0.03225806451612903,0.9186681231869258,1.0,1/5,3.96%,SBDS
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6069268008673412,1.3800811460662403,0.12903225806451613,0.7551983545970201,1.0,12/30,17.93%,GLRB;NPY;CYSLTR1;GPR149;PNOC;SORT1;SORCS2;NMU;SORCS3;NXPH2;ADCYAP1;GLRA3
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4951256779557809,1.3796702827174467,0.04,0.7548501614045608,1.0,30/86,16.04%,ZNF423;DACT2;NOS2;MCF2L;ZBTB7C;FRZB;MYO5B;CLIC5;MYH14;NDRG2;PBX1;COBL;ASXL3;TOX3;NPNT;TNFRSF19;ZNF704;CDS1;SH3BGRL2;SLC12A2;LRRN1;NEO1;LGR5;ARHGAP32;DLG3;RALGPS1;PCDH19;RIMBP2;AHCYL2;GPC4
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.7997070785664764,1.379656513229065,0.10526315789473684,0.750515068096504,1.0,1/6,3.56%,RELA
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.7997070785664764,1.379656513229065,0.10526315789473684,0.750515068096504,1.0,1/6,3.56%,RELA
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5902028867962882,1.3795995566257275,0.15151515151515152,0.7488010022091144,1.0,6/14,26.70%,ACACB;HMGCS1;MVD;MLYCD;ACSS1;ACACA
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.5718834686110815,1.3794151034231439,0.06896551724137931,0.747451386854621,1.0,9/42,10.10%,DACT2;CERS3;COL5A3;TP63;ERRFI1;PKD1;DLL1;COL5A1;ACER1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.8641403566295128,1.3791293701247629,0.0967741935483871,0.7465415990181103,1.0,3/6,11.48%,HELLS;UHRF2;UHRF1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.5854389279835525,1.3789454855119396,0.041666666666666664,0.745323793637838,1.0,9/32,14.38%,SLC38A1;SLC29A2;SLC7A1;SLC47A1;LRRC8A;SLC7A5;SLC22A2;SLC6A13;LRSAM1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.7026370783778662,-1.3787087762361623,0.0967741935483871,0.925610302155096,1.0,7/19,14.70%,PPIB;PPIE;NKTR;PPWD1;PPIF;PPIA;PPIL1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.6295237856966428,1.378653555971895,0.14285714285714285,0.7441130073087485,1.0,6/25,11.96%,IGF1;ICAM1;AGER;IGF1R;CACNA2D1;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8235220323273673,1.3786483731870591,0.16666666666666666,0.74197475154062,1.0,1/6,4.05%,TICAM1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.5005665141987214,1.3786456717703024,0.04,0.7398487493872085,1.0,23/105,10.92%,LIFR;EFNB3;FGFR3;GFAP;EGFR;MTCL1;LRP4;LEF1;OBSL1;DOCK1;EPB41L1;AGAP1;SLC13A4;ALCAM;ADGRB2;CHST3;MEIS3;NUAK1;SHC3;FMNL2;TNFRSF19;TEAD1;MEGF8
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.8346042718989005,-1.378273122348535,0.09230769230769231,0.9246712200627879,1.0,2/8,9.64%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.8255745971522481,-1.3778846684869035,0.08771929824561403,0.919373576164233,1.0,1/9,0.70%,TINF2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.8255745971522481,-1.3778846684869035,0.08771929824561403,0.919373576164233,1.0,1/9,0.70%,TINF2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5687478239871112,-1.3775397000197536,0.043478260869565216,0.9179202413581569,1.0,13/107,6.89%,GBP3;PSMB8;GBP2;RPS27A;SFRP1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;HYAL2;UBA52;TNIP2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.47374196798160867,1.377482733211035,0.058823529411764705,0.74214806568284,1.0,27/125,13.25%,KCNN4;OXTR;KCNQ2;GFAP;CELF3;CTNNA2;MMD2;SCRT1;AGER;PSD2;ADGRB3;AMER2;NGB;CDH20;OLFM3;NXPH1;SNAP91;GRM3;NCAN;KCND2;GRM1;KCNC2;NRXN1;SLC8A2;SLC32A1;ADCY8;CADM2
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.8825471929359702,-1.37747542973546,0.05,0.9136627848789395,1.0,2/5,1.96%,SLC28A2;AQP9
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.8239116232157506,-1.3774368552066445,0.017857142857142856,0.9095254665427859,1.0,4/9,11.67%,DDIT3;XBP1;CALR;HSPA5
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.7662794098786616,1.3768879092074773,0.10810810810810811,0.7427744062552669,1.0,3/8,5.94%,FGFR1;FGFR3;SNCA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.7476098202027519,1.3766467126179849,0.15,0.7418959976672078,1.0,5/14,20.04%,RUNX1;ZFPM2;FGF2;ERBB4;TP73
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6723291278450798,1.3759937740229642,0.075,0.7428649508130405,1.0,2/22,6.81%,BICDL1;HAP1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.8486479409828416,1.3758470798319282,0.11627906976744186,0.7414554049154976,1.0,1/7,0.98%,ABCC2
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.8500890170711249,-1.3757931228124223,0.06349206349206349,0.9199339611232606,1.0,2/6,9.51%,PLN;SRI
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.645963679404745,1.3754882708959426,0.1111111111111111,0.740855302432204,1.0,2/19,1.46%,GPR35;CBARP
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8124164379992269,-1.3749934688729741,0.014492753623188406,0.9184150304791584,1.0,2/11,4.97%,SYCE2;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8124164379992269,-1.3749934688729741,0.014492753623188406,0.9184150304791584,1.0,2/11,4.97%,SYCE2;STAG3
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6637899394302826,-1.3749922603053815,0.04477611940298507,0.914062352609589,1.0,8/25,10.66%,CENPF;P2RY10;TYMS;STMN1;H2AZ1;PCNA;LCK;HOPX
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5910307626517693,-1.3749397527950569,0.07042253521126761,0.9101750078076881,1.0,12/62,9.41%,TAGLN2;ACTL8;EDF1;TST;PCNA;DNPH1;MESP1;OVOL2;CBR1;TPP1;VIL1;GSTK1
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.7855061441842586,1.3748506923880153,0.1388888888888889,0.7418570731104083,1.0,2/7,7.47%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4847088197829018,1.37378099647305,0.125,0.7449026913177225,1.0,32/194,10.98%,F2;LEPR;FGFR1;PFKFB3;IGF1;FLT1;FGFR3;VEGFD;ALK;FGF17;IFNA2;EGFR;ARNT;PDGFRA;EPHA3;AGER;LIMCH1;PROM2;AKT2;SIRT1;P2RX7;IGF1R;TNIK;DRD4;NTRK2;CD4;WDFY2;MLXIPL;ARRB1;C3;SLC4A4;FGF1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.8623327297773811,-1.3736456936430008,0.08196721311475409,0.91680434080914,1.0,2/6,4.70%,NPR2;NPPC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7733656889025766,-1.3728314362908487,0.13043478260869565,0.9197036016915311,1.0,4/11,6.91%,TGFBR2;HLA-E;HLA-A;CD81
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8392378345721937,1.3725863871582098,0.09523809523809523,0.7474014376909859,1.0,1/7,2.40%,SRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.672499926538437,-1.372465798381252,0.03333333333333333,0.918848774332542,1.0,11/24,23.09%,RPS27A;PCNA;UBA52;RPA3;RFC2;RFC4;UBB;POLD2;POLD4;UBC;RFC1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.769427187827322,1.3722840146924569,0.08888888888888889,0.7468292003410754,1.0,2/5,13.86%,P2RX7;KCNMA1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7618742128470073,-1.3721997827979042,0.05263157894736842,0.9168661896350421,1.0,5/14,14.60%,CD44;LCK;FLOT1;MYADM;MAPK7
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.7099421880717576,-1.3718222141441285,0.07936507936507936,0.9154670970541927,1.0,2/17,3.24%,SELENOS;SEC61B
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6671175292429093,1.3716665451434418,0.11538461538461539,0.74806670285113,1.0,5/15,11.99%,GPR35;DUSP1;CXCL13;ACKR3;SLC12A2
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.7812550524433532,1.371540447533958,0.17647058823529413,0.7465574823055656,1.0,2/7,10.24%,CX3CR1;C3
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.774939858605278,1.3715172286931916,0.1388888888888889,0.7445700263087371,1.0,3/8,13.64%,PIP4K2A;ATP13A2;RUBCNL
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6153635586163447,1.3714531366273304,0.0967741935483871,0.7428547999319677,1.0,6/28,11.18%,CHRNA4;SCN9A;OR3A2;P2RX7;PCDH15;PNOC
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6372744629146141,1.3713802834872786,0.0625,0.7411117747832936,1.0,5/16,12.20%,CDK6;ZBTB16;MEIS1;MAFB;MEIS2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.881605934799527,-1.3713434873250059,0.03508771929824561,0.9146809753284247,1.0,2/6,7.95%,B2M;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7053816195984728,-1.3709532122446488,0.1095890410958904,0.9136780097464205,1.0,3/20,4.59%,CD44;CLU;DDIAS
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.817166142133967,1.3709314144085134,0.18604651162790697,0.7402692071352803,1.0,2/5,7.77%,TMEM108;NTRK2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7036726968750298,1.370917585927331,0.125,0.7382836333609404,1.0,4/22,8.92%,PDGFB;DACH1;HMBOX1;TNKS
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.522960244567269,1.3703755979398344,0.041666666666666664,0.7385609279704836,1.0,17/91,9.16%,RELN;COLEC11;ADAM33;TPM2;FRZB;PCDH18;GFAP;POSTN;PDGFRA;ADAMTS2;TMEM47;CDH11;COL14A1;HTRA1;RGS5;COL6A1;COL5A1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7524795416301382,1.370101260655671,0.10256410256410256,0.7376217052479495,1.0,4/8,17.41%,RUNX1;CBFB;HMGB1;CD274
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.8443740145091516,-1.3698819676868315,0.078125,0.918519453344601,1.0,3/7,9.71%,CENPF;TGFB1;SOX15
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6228469871884591,1.3696579690447497,0.07142857142857142,0.7373485100282013,1.0,5/25,10.17%,PDGFB;ATOH8;RELA;TGFB2;TEAD1
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.8957981557722141,-1.3694205882641113,0.05172413793103448,0.9141855935040315,1.0,3/6,7.20%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.8957981557722141,-1.3694205882641113,0.05172413793103448,0.9141855935040315,1.0,3/6,7.20%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),-0.9040219084979508,-1.3691819859060548,0.06153846153846154,0.9116994743332806,1.0,2/5,7.91%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.5188828007424781,1.3691500348952148,0.02631578947368421,0.7378091810381179,1.0,19/51,17.33%,EFNB3;TIAM2;LRP4;PLXNA1;NTRK2;ROBO1;KIF13B;ARHGAP35;LRRC4C;PLXNB2;CDH2;SLIT2;ROBO2;PTEN;CHODL;RUFY3;MCF2;GSK3B;PLXNA4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.6732413923169076,1.3691196465017657,0.13636363636363635,0.7361126432073268,1.0,6/12,23.82%,EPHA3;ARHGAP35;MEGF8;NRCAM;EPHB3;CNTN4
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4417269221536429,1.3688305617958108,0.09090909090909091,0.7353357914486655,1.0,13/220,4.83%,KLRF2;NOS2;KAT2A;RUNX1;HSPA1A;AFAP1L2;MAPK11;PDE4B;RELA;ARNT;TICAM1;CLEC7A;AGER
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.680989629675282,-1.3687793998229745,0.08771929824561403,0.9104766803566783,1.0,6/24,9.71%,GATA1;COL9A3;MEA1;FSHR;AR;SOX15
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7935781100558967,1.3684938273720264,0.10526315789473684,0.7343088304766784,1.0,4/11,9.27%,DSE;VCAN;CSPG4;NCAN
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.770501690087887,-1.3675947832835684,0.05,0.9146796416947728,1.0,6/14,13.94%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5756003261236761,-1.3670384533733684,0.02702702702702703,0.9143951808824028,1.0,21/81,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;RBX1;PSMD3;PSMC3;FBXO48;PSMA4;PSMA7;FBXL16;PSMD2;FBXL13;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.756044266412285,1.3669414685315893,0.06818181818181818,0.7381781173524602,1.0,4/8,14.74%,NFIB;NCAM1;GDNF;RYK
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7631762402283652,-1.3667094478275759,0.06329113924050633,0.91335677845655,1.0,2/13,9.64%,DDIT3;TGFB1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.6482824169049528,1.366233474612443,0.13793103448275862,0.7388833523029475,1.0,4/25,8.53%,ZMYND10;ODAD3;DNAAF1;DNAI2
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.534316984590799,1.3658729388639301,0.07407407407407407,0.7383596418688255,1.0,13/56,14.02%,CDKL1;ODAD3;CDK10;EVI5L;CCP110;ARHGAP35;TBC1D5;IFT88;TBC1D22B;DCDC2;IFT140;CEP97;TESK1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.9274760602538452,-1.3658640628956225,0.06153846153846154,0.9169179922360472,1.0,2/5,3.94%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7484173625368127,-1.3655643442186964,0.04411764705882353,0.9152349210311386,1.0,2/15,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6879291642381521,-1.3651354506761275,0.05714285714285714,0.9143841693607995,1.0,1/26,0.14%,VAMP5
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.5342364800368891,1.3648859325614715,0.08333333333333333,0.7401388401545578,1.0,26/70,21.40%,IGF1;SPRY2;EPS8L2;STARD13;MMD2;DENND1A;ARHGAP44;ERBIN;TGFB2;RAPGEF1;DENND4B;OGT;SYNGAP1;KANK1;RALGPS1;KIF14;KBTBD7;SPRY4;FBP1;ARHGAP17;BCR;DENND4A;ARHGEF28;DENND4C;RAF1;IRS2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.5969957359278609,-1.364534654976432,0.09333333333333334,0.9149920843475323,1.0,2/64,0.62%,SLC28A2;RIMS1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7242077160203969,1.3644527942430966,0.10810810810810811,0.7400447127938183,1.0,3/11,8.21%,APOLD1;PRKX;DLL1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7165641676959928,1.3641993049804537,0.1388888888888889,0.7392360844836986,1.0,6/15,21.51%,KCNJ2;CACNA2D1;CACNA1G;SCN3B;ATP1A2;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),0.8523131183295208,1.3636093172530508,0.11764705882352941,0.7396440094665587,1.0,1/5,4.38%,CLEC7A
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.7831741863878833,1.3633359493126653,0.13333333333333333,0.7388406776392409,1.0,1/7,1.24%,NOS2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.7684029905785921,-1.3631795110760865,0.15151515151515152,0.9221150847466946,1.0,6/12,13.83%,CYP1A2;ADH4;RDH12;RETSAT;LRAT;CYP3A4
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7974545415430061,-1.362972067186647,0.06896551724137931,0.9198771025163051,1.0,2/10,5.19%,EIF2S3B;EIF2S2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7843295166228225,1.3628564701103048,0.10526315789473684,0.738821872486386,1.0,3/8,11.72%,EPB41L4B;MAPRE2;MAP4K4
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.8132932933488999,-1.3610185267283574,0.05263157894736842,0.9311115983871687,1.0,3/9,7.20%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6677037030603747,1.3605823126198402,0.11428571428571428,0.7464444930444978,1.0,6/24,9.13%,RELN;IGF1;SRC;MMD2;ERBIN;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7947210475071884,-1.3605524865213285,0.10526315789473684,0.9311160592935124,1.0,1/8,2.49%,CLU
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.799214258400791,-1.3605448688317774,0.07936507936507936,0.9272399475280982,1.0,2/7,11.84%,TFIP11;CYREN
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6815388441467293,1.3601811365872771,0.08823529411764706,0.7462295622829612,1.0,5/21,3.97%,PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5898094327992679,-1.360136511040855,0.08108108108108109,0.9265706780651964,1.0,13/51,15.78%,TOMM7;SLC25A4;SLC25A6;SLC25A5;DNAJC19;TIMM8B;TIMM10;TSPO;TOMM20;TMEM14C;PPIF;KIFBP;TIMM44
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.8259639526883757,1.3598230776587596,0.1111111111111111,0.7455934351390902,1.0,3/7,14.83%,MLLT3;ESRRB;PRDM15
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.747101359037173,-1.359753971681898,0.07352941176470588,0.9250824772874072,1.0,1/15,0.08%,CD44
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.810243636648577,-1.3594967687568225,0.03389830508474576,0.915500869502456,1.0,1/8,1.62%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.810243636648577,-1.3594967687568225,0.03389830508474576,0.915500869502456,1.0,1/8,1.62%,DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.810243636648577,-1.3594967687568225,0.03389830508474576,0.915500869502456,1.0,1/8,1.62%,DTX3L
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.8188930669200359,-1.359348297605533,0.03278688524590164,0.9129341976772539,1.0,1/7,1.48%,SFRP1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6114685701958288,-1.3589905150494819,0.1267605633802817,0.9118692310457843,1.0,6/39,10.12%,GATA1;RPS14;ZFPM1;SLC25A5;RPS19;ATP5IF1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5372602854411397,-1.3589282759071872,0.011764705882352941,0.9087017600274568,1.0,72/256,22.51%,CSTF2T;POLR2G;SNRNP27;UBL5;FRG1;POLR2J;GTF2F1;SNRNP25;POLR2L;PPIE;POLR2I;SCNM1;LSM2;SF3B5;PHF5A;LSM7;ZMAT2;IK;SF3B6;PRPF3;DHX16;RNPC3;SF3A1;FIP1L1;RBM22;SNRPB2;DHX38;SNRPN;SNRPD1;PNN;TFIP11;SNRNP200;PPWD1;SRSF7;PRPF6;ESS2;PRPF4;DDX41;SNRPD2;RBM4B;EIF4A3;PPIL1;CPSF3;POLR2A;BUD13;PQBP1;DNAJC8;METTL3;SNU13;CRNKL1;SRSF3;HSPA8;ZCRB1;MAGOHB;SYF2;HNRNPH2;SNW1;PRPF8;DDX5;DDX1;NCBP1;CLP1;GEMIN6;DDX20;SMN1;LSM3;PDCD7;WDR83;RBM15B;SRSF9;GPATCH1;CWF19L1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.7229157911228735,-1.3586609015068885,0.13043478260869565,0.9068283906927864,1.0,3/16,12.30%,SLC25A4;SLC25A5;PPIF
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6054801024783186,-1.3583853174273925,0.0821917808219178,0.90540236150418,1.0,4/68,0.46%,CD44;VAMP5;DPEP2;GATA1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.7232159366717407,1.357318564004317,0.08333333333333333,0.753946605716347,1.0,2/9,15.69%,NAF1;SHQ1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.6691159323962937,1.3572380571286107,0.13513513513513514,0.7522084884777025,1.0,3/9,6.46%,FBLN5;AIFM2;DHFR
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.6803788899034575,-1.356852913017177,0.07575757575757576,0.914018579201095,1.0,8/18,17.99%,PCNA;POLE3;MCM4;MCM3;GINS2;RFC4;GINS4;POLD2
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.8152702868080144,-1.3567872862866517,0.14285714285714285,0.9109594719673393,1.0,3/7,14.98%,EDF1;MESP1;FSTL1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.7492461829658581,-1.3560914645746753,0.09090909090909091,0.9117999048587115,1.0,4/13,10.07%,COX7A1;NOP53;COX7A2;PINK1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.9079056116374992,-1.3559521649499378,0.037037037037037035,0.9093301703904909,1.0,2/5,7.91%,CELA2A;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.8192752121553621,-1.3556068277218942,0.16666666666666666,0.908639276163871,1.0,1/6,3.17%,CD63
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.8649449526269113,-1.3555390305240238,0.06779661016949153,0.9055527292792764,1.0,1/7,0.32%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7959764810957197,-1.3554929783756278,0.09090909090909091,0.9023289843200962,1.0,5/9,16.74%,DBI;PRELID1;TRIAP1;ABCA12;APOE
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5937984459552309,1.3553489255176605,0.15625,0.7586507588023436,1.0,5/33,5.19%,FGFR1;CPNE1;DLX1;MMD2;ASCL1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6876890182732533,-1.3550430052034574,0.09523809523809523,0.902446428914812,1.0,6/29,8.12%,RPS21;RPS16;RPS14;RPS8;RPS19;NOP9
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8111399998108262,1.354783509875727,0.11363636363636363,0.7590689984697521,1.0,3/8,10.32%,DIAPH1;DRD4;GABRB1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.6299188141558194,1.354292166723589,0.15625,0.7595198348714989,1.0,5/21,11.54%,SLC38A1;SLC7A9;LLGL2;SLC7A5;SLC38A2
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6906338808777842,1.354138179924143,0.07407407407407407,0.758235730201264,1.0,6/19,16.05%,IGF1;CLEC7A;AKAP6;CAMTA1;SPPL3;GSK3B
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.6010210037031427,-1.3537174148401998,0.1111111111111111,0.9089120291712146,1.0,7/40,13.61%,SFRP1;JUP;CFTR;ADAM15;MAP4K1;BRCA1;AHR
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.6900218411513712,-1.3535752961913314,0.13432835820895522,0.9061601112181898,1.0,3/17,8.84%,SDF2L1;RXYLT1;DPM3
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.4769304126184642,1.3534644815656347,0.045454545454545456,0.7589974708045579,1.0,21/110,10.17%,ZNF423;LIFR;RUNX1;EGFR;ERRFI1;CSPG4;FOXK1;LIMCH1;RND3;OBSL1;TMEM47;DOCK1;EPB41L1;NCAM1;NOTCH3;CHST3;HTRA1;NUAK1;COL6A1;CD276;TEAD1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.7030188306577569,-1.3527541845764934,0.11267605633802817,0.9093474785682434,1.0,2/20,4.29%,GPAT3;DGAT2L6
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.854535861874445,1.352507139783399,0.11904761904761904,0.7616515341400882,1.0,2/5,8.82%,COLGALT1;AEBP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.8253479974423603,-1.3524027705776434,0.037037037037037035,0.907978012412148,1.0,1/8,0.37%,HLA-F
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.49590506727233497,1.3519383878158142,0.0625,0.7622631830985783,1.0,45/155,17.35%,RELN;DACH1;KCNQ2;EFNB3;CELF3;CNTNAP2;SCRT1;GNL3L;NLGN1;ADGRB3;CNR1;PCDH8;CDH4;OLFM3;CAMKV;ZDBF2;TCEAL1;FSD1;ADGRL3;SNAP91;NCAN;MEGF10;NBEA;ZNF536;KCNH7;PNOC;ATP13A2;GPM6B;TRIM44;KIF5C;RGMB;CLSTN2;CADM2;ABI2;GDF5;PCDH19;LINGO2;NOL4;KIF1B;SLC25A46;RAB11FIP2;MAPK8;ADAM12;GRIA2;EDIL3
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7694292667787614,-1.3516967997597555,0.043478260869565216,0.9085765118724252,1.0,7/13,19.14%,COL9A3;ZNF830;FSHR;CEBPB;EIF2B2;EIF2B4;SOD1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.8203263937162645,1.3506015895794439,0.02564102564102564,0.7664391209119367,1.0,1/5,12.49%,SLC6A13
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.739024430961003,-1.3505613258646227,0.08695652173913043,0.9146740506921556,1.0,1/15,0.16%,GPAT3
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7129215291448827,1.350294818396572,0.16216216216216217,0.7660775662213359,1.0,9/13,26.58%,NPY;NTRK2;ARHGAP35;PTEN;MAPT;MAP2;B4GALT5;B4GALT6;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.871636142335964,-1.3498471487972643,0.061224489795918366,0.9169653977993012,1.0,3/5,10.34%,DBI;PRELID1;TRIAP1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.8099953910196478,-1.3493646408234208,0.125,0.9170858107620278,1.0,3/7,11.67%,SEC61B;SEC62;HSPA5
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8032423532040369,1.3491156684372678,0.1111111111111111,0.7686187964077162,1.0,3/6,10.34%,PDGFRA;SOX5;LTBP3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.6137775972734218,-1.3487058751729175,0.07692307692307693,0.9185422060486069,1.0,16/32,23.40%,SEC61B;EMC6;GET3;EMC3;EMC7;CAMLG;MMGT1;CCDC47;EMC10;EMC4;EMD;TRAM1L1;SERP1;UBL4A;TRAM2;CYB5A
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6304379132093251,-1.3484752972240512,0.07462686567164178,0.9169212525396069,1.0,16/48,18.71%,RPS27A;CENPX;USP1;EME1;UBA52;RNF8;RPA3;FANCM;RAD51AP1;MUS81;UBB;FANCD2;FANCF;XRCC3;XPA;FANCI
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5736881656270522,1.348438800776147,0.16216216216216217,0.7693770086087502,1.0,9/32,20.40%,CDK6;NRP2;L1CAM;CELSR1;TLE3;UNC5C;SLIT1;NRCAM;RTN1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7962834148577281,-1.348012347334876,0.109375,0.9160839327672669,1.0,4/10,8.35%,MCM2;MCM4;MCM3;ZNF830
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6603233081753705,-1.3479596796669473,0.05555555555555555,0.9130396282728879,1.0,7/33,10.90%,TOMM7;UBL5;ARIH2;HAX1;PINK1;ATP5IF1;ABLIM3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.790099600306116,1.3477894002711304,0.0625,0.770165378156463,1.0,4/12,9.27%,DSE;VCAN;CSPG4;NCAN
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.8808232281379555,1.3475868860230515,0.058823529411764705,0.7694593932264863,1.0,2/5,9.44%,HSD3B7;CXCL13
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.4833984848647818,1.3472076878922974,0.125,0.7692975461057096,1.0,21/111,9.13%,ZAP70;FGFR1;LIFR;LCP2;CASS4;FLT1;FGFR3;SRC;ALK;EGFR;PTPRD;CNKSR1;GUCA1B;PDGFRA;EPHA3;FRK;IGF1R;NTRK2;CD4;SHC3;RAPGEF1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7730662823516614,-1.3469123875124702,0.13432835820895522,0.9177049709031744,1.0,2/11,6.91%,CD9;CD81
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.7911909129950558,1.3468176140644186,0.14285714285714285,0.7690353907189155,1.0,1/6,8.81%,NUAK1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.7192750689554142,1.3467011052715174,0.2391304347826087,0.7675305646097419,1.0,3/6,24.08%,SIRT1;MAPKAPK5;TP53
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8696773627242745,-1.3462212452118132,0.05357142857142857,0.9194369903565621,1.0,3/6,10.12%,TOMM7;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.630731662801672,1.3454526454287723,0.1891891891891892,0.7711309091013008,1.0,3/22,5.96%,SLC26A7;ABCC2;SLC26A6
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7941533527965258,1.345426258401185,0.1282051282051282,0.7694276111389788,1.0,2/7,7.34%,AK3;AK4
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6191729519914606,1.3451539384663338,0.2692307692307692,0.7689341112113625,1.0,7/15,24.84%,GDPD3;PNPLA6;GPCPD1;PLA2G4C;SMPD4;PRDX6;PLA2G4A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8157584773086954,-1.3450221212447795,0.04285714285714286,0.9214391638591509,1.0,3/7,5.49%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8157584773086954,-1.3450221212447795,0.04285714285714286,0.9214391638591509,1.0,3/7,5.49%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.7673821669454176,-1.3448498260795831,0.12903225806451613,0.9193062788846551,1.0,6/13,16.90%,ORMDL2;RACK1;ORMDL1;SMPD2;TNFRSF1A;ORMDL3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7163857479463908,1.3446141638338565,0.18604651162790697,0.7693418780023691,1.0,2/11,1.43%,CREB3L1;SPRY2
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.8772244007274455,-1.344480307860864,0.05555555555555555,0.9186621108035967,1.0,2/5,11.89%,NUDT18;NUDT15
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.8539531559154553,-1.3444532262309297,0.04838709677419355,0.9155366625245469,1.0,3/5,13.83%,CYP1A2;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7623230859984742,1.3444189509388804,0.1282051282051282,0.7681868305709667,1.0,4/9,14.30%,EPB41L4B;MAPRE2;MAP4K4;PTEN
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7242091909114297,1.344364550487335,0.13793103448275862,0.7665405166578049,1.0,2/13,5.09%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7969543368049113,-1.3435972134710137,0.07936507936507936,0.9184622100293991,1.0,6/9,18.17%,XBP1;COPS5;RACK1;HSPA5;FICD;BAX
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.8334112827499023,-1.343210586131493,0.08064516129032258,0.9179173404831846,1.0,1/6,3.81%,CPTP
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.7384327808029741,1.342720123308848,0.15151515151515152,0.7718090237805775,1.0,4/12,13.18%,AK3;DCTPP1;AK4;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.6872086858172997,1.342664924790125,0.1891891891891892,0.7700630086932946,1.0,4/14,9.29%,PDGFB;TMEM106A;SLCO1C1;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.7561403242673821,1.3422412736662666,0.17857142857142858,0.7698382448040907,1.0,3/5,17.68%,ACVR2B;ACVR2A;SMAD2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.752186607623542,-1.342072247818412,0.07936507936507936,0.9233905453161416,1.0,2/16,4.54%,CPS1;DDX11
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7399584803049286,1.3417931331932753,0.14893617021276595,0.7696801829469259,1.0,2/7,6.15%,MFHAS1;CYBA
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.777981084341873,1.3413931277865931,0.1875,0.7690974265227696,1.0,2/6,13.03%,CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.7544941640636326,-1.3411318723706767,0.125,0.9273777875688393,1.0,1/11,1.25%,XBP1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.6973238501184198,1.341115186820923,0.10256410256410256,0.7662792383054109,1.0,7/11,27.78%,TNIK;MAP4K4;RAP1A;RAP2C;RAP2A;RAPGEF2;MINK1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.6973238501184198,1.341115186820923,0.10256410256410256,0.7662792383054109,1.0,7/11,27.78%,TNIK;MAP4K4;RAP1A;RAP2C;RAP2A;RAPGEF2;MINK1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6239818309798878,1.3410422805639428,0.12195121951219512,0.764604098713873,1.0,17/35,18.46%,KCNJ2;CHRNA4;SCN9A;MYH14;CACNA1I;KCNMB4;SCN7A;AKAP6;KCND2;CACNA1G;DMD;GPER1;GNAQ;KCNE4;GNA14;KCNMB2;SCN3B
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.777489799412591,-1.34074164941493,0.11666666666666667,0.9274244025513463,1.0,2/9,1.59%,H1-4;H1-2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6302220911243571,1.3406759439643716,0.0967741935483871,0.7640066482806328,1.0,5/18,10.91%,VDR;NPR3;DHFR;GDNF;NOS1AP
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5920070768689982,-1.3402667411024918,0.0547945205479452,0.9271776066261695,1.0,18/64,18.96%,CYP1A2;GPX4;ACOT2;ASAH2B;GSTM4;GSTP1;ELOVL2;ACOT1;AWAT1;FAAH2;ACSBG2;ASAH2;CYP3A4;CYP2E1;ELOVL1;GLYATL2;EPHX1;HPGD
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.7500515889218706,-1.340252883991934,0.028169014084507043,0.9240414760595307,1.0,4/15,14.20%,DTX3L;PNKP;KDM4D;PARP9
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.6967693159350539,-1.340025379660095,0.0625,0.9223244225209035,1.0,6/19,15.83%,SLC8A3;EIF2B1;CDK5;MYRF;EIF2B2;EIF2B4
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.7560690557419121,-1.3396444213153935,0.13432835820895522,0.9217503864250581,1.0,1/11,0.08%,CD44
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.718919800303095,1.3395666927431351,0.15151515151515152,0.7667427613097543,1.0,6/10,26.69%,TCOF1;CDH2;KBTBD8;NRG1;NOLC1;TAPT1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8083477406922326,-1.3392872699828808,0.10909090909090909,0.9211515136891556,1.0,2/9,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.6247217976074467,-1.3392066159572156,0.07692307692307693,0.9184838563401005,1.0,7/39,4.27%,RPL23;RPL5;MAGEF1;CLU;RPS7;RPL11;RAD23A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6105838808579407,1.3387683433584965,0.08333333333333333,0.7682399647110719,1.0,1/18,0.07%,F2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6572837195889739,1.3383674338506064,0.14705882352941177,0.768474903432701,1.0,5/24,10.17%,KCNJ14;KCNJ2;P2RX7;AKAP6;CHRM3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.7499166596200856,1.3382701057358002,0.13157894736842105,0.7671996939396284,1.0,5/9,13.86%,KCNJ2;ATP12A;ATP1B3;SLC12A2;KCNMA1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.812281051281827,-1.3382574615869223,0.13793103448275862,0.9225772271550775,1.0,2/8,3.54%,SELENOS;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.7107686015740886,1.3379413028871618,0.2,0.7664750445324711,1.0,3/10,7.47%,ICAM1;AGER;ADAM8
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.8583100653650753,1.3375046763164713,0.13513513513513514,0.7662331483911551,1.0,2/6,9.23%,NFKBIZ;MALT1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.7281122915912815,-1.337306418972034,0.16666666666666666,0.9270708283137193,1.0,3/14,14.18%,DDX11;NOP53;NCL
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.8218674573988165,-1.3369624141606302,0.1016949152542373,0.9263762919021071,1.0,2/8,11.67%,DDIT3;HSPA5
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.8182506291696318,-1.33682303816405,0.1016949152542373,0.9241534209110432,1.0,2/5,5.74%,XBP1;USF1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7858591311645033,1.3359012327863569,0.18604651162790697,0.7709976265825319,1.0,2/8,5.94%,IL1RAPL1;SNCA
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5873063644832649,-1.3358748141526804,0.125,0.9282553989099397,1.0,22/62,19.32%,RPS27A;RNASE1;PCNA;UBA52;IHO1;RPA3;RBX1;RFC2;PARP1;EDC4;MUS81;RFC4;UBB;ISG20;RAD50;REXO4;XPA;PNRC2;POLD2;GTF2H2;DDX1;POLD4
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7835700969082365,-1.3353035998292204,0.06557377049180328,0.9292557229062971,1.0,4/12,17.85%,SIGIRR;IL6R;CEBPB;APOL2
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.7673179897645555,1.3350910204933832,0.1388888888888889,0.7725273659598424,1.0,3/7,8.80%,DAO;SNCA;TGFB2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6047189418117543,1.334933349126534,0.125,0.7713527916005373,1.0,3/22,5.02%,MAIP1;MCUB;CACNA1I
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8956665028405546,1.3346317176027453,0.15384615384615385,0.7703736480428197,1.0,2/5,5.19%,CHD5;ASCL1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6916905250683927,-1.3345039350483388,0.0967741935483871,0.9316260282671674,1.0,4/19,12.08%,NLRP1;GAPDH;TNFRSF21;CDK5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6473644895334342,1.3340250358609704,0.14814814814814814,0.7707887313827616,1.0,8/24,16.30%,IGF1;IRS1;AKT2;SORBS1;C3;RHOQ;C2CD5;PTH
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6956648191741779,1.3335286526214067,0.10810810810810811,0.7711073547602376,1.0,4/12,11.16%,AK3;RAB23;AK4;RHOQ
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.8022078016947884,1.3334378213297853,0.09302325581395349,0.7696326092904187,1.0,3/5,17.84%,RYK;NR4A2;WNT5A
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4721069823566702,1.333348931046143,0.07142857142857142,0.7682587830523591,1.0,33/161,12.47%,MFNG;LIFR;RUNX1;KCTD8;YJEFN3;SRC;HOMER1;IRAK2;TMEM108;SIRT1;RFNG;GSKIP;LLGL2;NCAM1;DLL1;ZDHHC3;RGS5;GRK5;DOK5;FBXL17;OGT;ACVR1;GDNF;AMFR;MGLL;LFNG;GNG7;PRKD1;CD55;SLC8A2;RIC8B;CD80;DCDC2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5361055681823983,1.3329150517391357,0.13043478260869565,0.7688626649280784,1.0,11/65,13.47%,CDKL1;ODAD3;C10ORF90;TRAPPC12;TBC1D12;TBC1D5;IFT88;TBC1D22B;DCDC2;IFT140;HCK
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7638705756062744,-1.3324670810323673,0.14,0.9433050581193431,1.0,2/7,9.64%,ACMSD;TGFB1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5775982350384287,1.332459567352357,0.14705882352941177,0.7692764477298061,1.0,15/33,27.90%,CTNNA2;LRP4;CTNND2;CELSR2;DCDC2;PTEN;MAP2;EPHB3;PHACTR1;BTBD3;PAK3;WASL;SDC2;MINK1;SHANK1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7803552781468212,1.3323472755478545,0.17073170731707318,0.7679440625170377,1.0,3/8,16.20%,DOCK7;PCM1;KIF14
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.775745714608033,1.33226936144007,0.0975609756097561,0.766493484523348,1.0,1/7,1.46%,CBARP
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.5754886546990813,1.3320497502293231,0.1111111111111111,0.7655456260894216,1.0,8/31,13.86%,KCNN4;KCNJ2;KCNMB4;KCNN2;AKAP6;NOS1AP;KCNN1;KCNMA1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.776800748200994,-1.3317240336962275,0.057971014492753624,0.9456949558967622,1.0,3/10,5.49%,B2M;RPS27A;UBA52
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5653950403582169,-1.3316572864457636,0.08,0.9432292407945714,1.0,8/67,5.48%,CD44;POLR2G;SFRP1;POLR2J;GTF2F1;POLR2L;POLR2I;HYAL2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.8088472745948293,1.3313227529527571,0.17073170731707318,0.7665818883938164,1.0,1/5,0.21%,PDGFB
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.6864653782799567,1.3309722469101035,0.13513513513513514,0.766101103761484,1.0,8/13,17.84%,ICAM1;CD59;CYBA;TGFB2;CD55;CFH;MAPK8;WNT5A
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.691709152466333,1.3309141212355862,0.2,0.7646063140843319,1.0,2/10,3.18%,MAIP1;MCUB
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.7918375532893529,1.3308224101234996,0.125,0.7634255417237845,1.0,1/6,0.12%,ZAP70
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6090821038364247,1.3303391954751553,0.17647058823529413,0.7632617045073691,1.0,5/20,15.50%,MAPK11;CLEC7A;AGER;HMGB1;SYK
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.6180757198987819,-1.329951035619803,0.07042253521126761,0.9500881884785704,1.0,4/51,4.91%,POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.6180757198987819,-1.329951035619803,0.07042253521126761,0.9500881884785704,1.0,4/51,4.91%,POLR2G;POLR2J;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.7854710662449969,-1.329517269631718,0.05970149253731343,0.9498075722909487,1.0,1/9,5.63%,LCLAT1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7911414755833591,-1.3284429239402824,0.16393442622950818,0.9541386023296977,1.0,3/7,8.77%,AQP9;CFTR;AQP11
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.7682425017592908,-1.328438059575503,0.1111111111111111,0.9510021979160725,1.0,3/11,11.67%,DDIT3;EIF2AK1;HSPA5
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5445594305818532,1.3279468671435761,0.17391304347826086,0.7716318539099548,1.0,18/97,14.14%,F2;GPR35;TBXA2R;PDGFRA;LPAR2;CX3CR1;CYSLTR1;TRPC5;ADRA1A;CXCL13;CD55;ACKR3;SPPL3;SLC8A2;ADCY8;P2RY1;GPER1;HMGB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6997680370457819,1.3277750664843557,0.15555555555555556,0.7706873662860527,1.0,2/15,1.77%,FGFR1;FLT1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5541134126499452,1.327308448970814,0.06666666666666667,0.7705692101899534,1.0,2/37,4.65%,RAB27A;ALS2CL
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5573302346835823,-1.3271757405140936,0.05405405405405406,0.9578079370096948,1.0,23/94,19.32%,MCM2;RMI1;PNKP;POLE3;ORC6;MCM4;MCM3;GRWD1;WDHD1;FAM111A;RPA3;RFC2;CLSPN;BRCA1;KAT5;RFC4;RAD50;KIN;MCM5;POLD2;ORC2;MCMBP;POLD4
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.729646765331204,-1.327099197832154,0.12857142857142856,0.9551963281421724,1.0,6/17,20.89%,VPS35;WDR91;PTTG1IP;ATRAID;DACT1;MSN
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.688463914037942,-1.3267669842309178,0.14705882352941177,0.9546056115792785,1.0,5/20,12.49%,NFE2L1;PGRMC1;TSPO;ATP5IF1;UROD
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7199041514944732,1.32636689326,0.05555555555555555,0.7723654851991953,1.0,1/8,2.39%,MAPK12
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7382509925256407,-1.3260709370836585,0.109375,0.9566634490865423,1.0,6/11,20.76%,SEC61B;SEC62;GET3;HSPA5;CHMP4B;SGTB
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.75131011696448,1.3254571764598735,0.12195121951219512,0.7746387059391101,1.0,5/9,19.04%,HDAC4;HDAC9;SMARCAD1;HDAC1;HDAC3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5728286548392072,1.3252179333849268,0.07407407407407407,0.7738774020938408,1.0,8/28,11.04%,MFHAS1;PHLPP1;AGER;DUSP1;SASH1;DUSP10;PTPN22;DLG1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.8185758253573191,-1.324809872989038,0.06779661016949153,0.9632803239317155,1.0,5/7,14.12%,PM20D1;TST;CYP3A5;CYP3A4;NIT1
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7137765843949118,-1.3247173831465915,0.1038961038961039,0.9608190699992337,1.0,8/20,17.56%,NOP10;BUD23;TRMT112;NHP2;FTSJ3;TSR3;DIMT1;GAR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.6428199329890043,1.3246956828363894,0.1956521739130435,0.7743265455464861,1.0,4/18,3.97%,FGFR1;FLT1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.803544769297817,-1.3234337919346482,0.15625,0.9664973006142664,1.0,2/6,7.51%,CPS1;MTHFD1
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.822592917277474,-1.3233280373022072,0.057971014492753624,0.96390842884642,1.0,3/8,8.94%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.8417932206861624,-1.3232899483344909,0.13559322033898305,0.9578547752270099,1.0,2/5,12.62%,JUP;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.8417932206861624,-1.3232899483344909,0.13559322033898305,0.9578547752270099,1.0,2/5,12.62%,JUP;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5301786725247264,1.3232680304193287,0.1282051282051282,0.7783265956410429,1.0,20/60,17.83%,CREB3L1;SPRY2;DLX1;CASK;CHRD;SMAD4;SMURF2;SLIT2;LEMD3;BMPR2;HIPK2;ACVR2B;CRIM1;ACVR2A;TRIM33;SMAD9;UBE2D3;SPRY4;FGF2;BMPR1B
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.5115800359492293,-1.3232555971921742,0.011363636363636364,0.9549495594659394,1.0,67/276,19.34%,CSTF2T;POLR2G;SNRNP27;UBL5;FRG1;POLR2J;GTF2F1;SNRNP25;POLR2L;PPIE;POLR2I;LSM2;SF3B5;PHF5A;LSM7;ZMAT2;IK;SF3B6;PRPF3;DHX16;RNPC3;SF3A1;FIP1L1;RBM22;SNRPB2;DHX38;SNRPN;SNRPD1;PNN;TFIP11;SNRNP200;PPWD1;SRSF7;PRPF6;ESS2;PRPF4;DDX41;SNRPD2;RBM4B;EIF4A3;PPIL1;CPSF3;PRPF18;POLR2A;SUPT5H;PRMT9;BUD13;PQBP1;DNAJC8;METTL3;SNU13;KIN;CRNKL1;SRSF3;HSPA8;ZCRB1;MAGOHB;SYF2;HNRNPH2;SNW1;GTF2H2;PRPF8;DDX5;AURKAIP1;NCBP1;PRKACA;CLP1
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.8594632086521767,1.3231191882518598,0.13157894736842105,0.7771716251602638,1.0,2/6,12.95%,GDNF;ARX
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6933038998471357,1.323115733704884,0.14814814814814814,0.775482195028774,1.0,8/19,17.83%,ZNF423;SMAD4;BMPR2;GDF5;ACVR2B;ACVR2A;SMAD2;BMPR1B
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.519772707964111,1.3227455390658838,0.043478260869565216,0.7751162613923024,1.0,16/75,12.22%,VDR;FGFR1;STARD13;ABCC8;SPRED2;SOWAHA;CTNND2;CAMSAP3;EPB41L1;NTRK2;KIRREL2;NPNT;CD276;LGI2;SLC8A2;GALNT18
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4645372999271741,1.3227329056201598,0.0,0.7734686449827459,1.0,100/420,17.11%,ZAP70;PDGFB;RELN;PTPN6;CDKL1;FGFR1;CDK6;FLT1;FGFR3;PASK;MAPK12;SRC;STK32B;ALK;PLK1;CDK10;EGFR;MAP4K5;PDGFRA;LIMK1;PRKX;EPHA3;CDK12;FRK;AKT2;PKD1;NEK4;CCNH;IRAK3;FNIP2;IGF1R;MATK;TNIK;SGK1;CAMKV;NTRK2;NLK;PNCK;AURKC;MAP3K1;MYO3A;TGFB2;NUAK1;TNKS;MAPK10;GRK5;MEX3B;VRK2;RICTOR;ACVR1;PRKG2;USP15;MAP4K2;SGK3;TSSK6;ULK3;MKNK2;PXK;PRKD1;MAPKAPK3;PRKCE;MAP4K4;ATP13A2;MERTK;DYRK3;ABI2;RPS6KA1;HCK;CDK17;BMPR2;SIK3;SMG1;PRKCZ;RPS6KA6;HIPK2;ACVR2B;UHMK1;DYRK1A;RYK;CDKL4;MAST4;ACVR1C;MARK1;PDK4;HIPK3;ACVR2A;SYK;CDC25B;GSK3B;LMTK3;SBK1;LTK;TTBK2;FLT3;CDK18;CAMK2D;FER;MAPK8;ABL1;PRKACB
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6672785240925391,1.3225712096323643,0.18421052631578946,0.7726322896444938,1.0,4/14,13.63%,RUNX1;SNAI1;NPHP4;CBFB
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5582992085625961,-1.322386536545817,0.08695652173913043,0.9583731293968704,1.0,22/82,19.91%,PSMB8;RPS27A;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;TNIP2;RBX1;PSMD3;PSMC3;UBB;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.884488318168764,1.3223794054430376,0.18604651162790697,0.7718590288723163,1.0,1/5,2.35%,LHFPL2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.5954257339899011,-1.3222364405447637,0.04,0.9563235258147881,1.0,6/62,9.64%,POLR2G;DND1;POLR2J;POLR2L;POLR2I;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7918909703974233,-1.322088700809651,0.16071428571428573,0.9543653910223152,1.0,4/8,16.74%,DBI;PRELID1;TRIAP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5032244725190035,1.3216102030742445,0.08,0.7729569857857724,1.0,8/73,6.74%,LEPR;PDGFC;IL4R;OXTR;PPARGC1A;PLAC8;ZNF516;IGF1R
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.8230733068641751,1.3213361094448257,0.17777777777777778,0.7723934766849725,1.0,2/5,11.54%,SLC38A1;SLC38A2
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7566260669718292,-1.3211712318752666,0.12903225806451613,0.9575237440319085,1.0,1/10,0.62%,RIMS1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5676857309707798,1.3200089495462461,0.1875,0.776024116236484,1.0,12/32,14.35%,IRS1;GRB14;SIRT1;SORBS1;PIP4K2A;OGT;PTPRE;PID1;ENPP1;KANK1;PRKCZ;GKAP1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6667721480732549,-1.3197875994165726,0.14516129032258066,0.9645038615193005,1.0,4/22,9.84%,XBP1;HLA-E;PHB2;C17ORF99
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6634748670311363,1.319658848133632,0.1891891891891892,0.7758393018361182,1.0,4/15,5.00%,SPRY2;SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.7084476185449908,-1.3196510200722515,0.1267605633802817,0.9622020404338228,1.0,5/12,16.76%,CLU;VBP1;PFDN2;APOE;PFDN6
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.8139284467044826,1.319503918725912,0.20588235294117646,0.7745384349654296,1.0,1/5,4.44%,CX3CR1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.7007549876334486,-1.3192407324961597,0.15942028985507245,0.962029886954203,1.0,5/18,12.49%,NFE2L1;PGRMC1;TSPO;ATP5IF1;UROD
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5588744197687392,1.3190225246261242,0.11428571428571428,0.7744749455282219,1.0,14/34,25.11%,BICDL1;MYO5B;HAP1;MYO1D;MYO1B;NDE1;TRAK1;MYO7A;FBXW11;PPFIA2;TANC2;MYO5A;TRAK2;WASL
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6254074404652814,-1.3189210761240469,0.1232876712328767,0.9617816761883428,1.0,9/35,14.08%,CENPX;PCNA;DDX11;EME1;FAM111A;FANCM;ZGRF1;BOD1L1;GEN1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6039335351694193,1.318879543166081,0.1388888888888889,0.7735923399323171,1.0,7/26,13.75%,RUNX1;FGFR3;SCX;NFIB;SOX5;GPLD1;BMPR2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6929235761413084,1.318853985339997,0.15625,0.7719835168105961,1.0,4/20,8.90%,F2;SNCA;HAP1;AKAP6
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.6231374272234143,-1.3181956167793192,0.12307692307692308,0.9634062109976134,1.0,7/27,12.91%,GATA1;ACTG1;TLN1;MYL12A;PIK3CB;ILK;PPIA
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.7349361437275761,-1.3179548335747373,0.1206896551724138,0.9623375664036166,1.0,4/10,19.14%,CLU;DEGS1;MYRF;SOD1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.4871316332905969,1.3178996844860673,0.038461538461538464,0.7739073206548737,1.0,26/100,13.47%,STAB1;IL4R;CTSK;LCP2;C1ORF162;SAMSN1;SLCO2B1;PIK3R5;NRP2;HPGDS;CD200R1;CLEC7A;CX3CR1;CSF3R;MARCHF1;ITGAX;ADAM8;MRC1;CD83;CLEC5A;CPM;LAIR1;CD80;EGLN3;ADGRE1;HCK
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7652279175931735,1.3177993542572068,0.1794871794871795,0.7727408596606702,1.0,5/8,17.83%,ZBTB16;SOX5;LOXL2;GDF5;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5537582576605569,1.317774581001761,0.13333333333333333,0.7712312347548317,1.0,12/51,8.73%,PDGFB;PDGFC;FGFR1;FLT1;PIK3R5;EGFR;TRAF2;SASH1;TPD52L1;ADAM8;ROBO1;DIRAS2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7644313813357209,-1.3169067838378758,0.19117647058823528,0.9671089029724599,1.0,4/12,14.20%,IFNGR2;CDC37;STAT1;PARP9
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8011303305662074,1.3168273655130402,0.1,0.7734917294949316,1.0,1/6,2.20%,ZSWIM6
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.5567815020072282,-1.3157598689856147,0.03614457831325301,0.9728917545143009,1.0,37/135,20.54%,PSMB8;SFRP1;PSME1;RSPO4;JUP;TMEM198;PSMB6;PSMC5;ATP6AP2;PSMD8;PSMD7;SFRP4;RSPO2;GPC3;BAMBI;TGFB1;DEPDC1B;PSMD3;PSMC3;ILK;PPM1N;PLEKHA4;PSMA4;DACT1;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;TMEM9;PSMA3;ATP6V1C2;CAV1;PSMB3;PSMC1;PTK7;USP8
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6185114261438569,1.3154388031056705,0.06818181818181818,0.7774470689011351,1.0,5/20,13.62%,DAO;SULT2A1;SULT2B1;ENPP1;PPA2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.44600884016827314,1.3149621663785316,0.14285714285714285,0.7774937839415216,1.0,31/187,12.54%,GABRE;GABRR2;KCNQ2;CHRNA4;HOMER1;KCNIP2;GLRB;NLGN4X;NLGN1;KCNMB4;NPY;SNCA;CACNB4;HAP1;DRD4;GRM3;DLG2;KCND2;GRM1;CHRNA5;CHRM3;GABRB1;DLG1;PNOC;NRXN1;CHRNB3;HTR4;KCNN1;GRIN1;NLGN3;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6728061901349356,1.314854268116113,0.15151515151515152,0.7763033242975464,1.0,4/12,27.51%,PNPT1;PRR5L;CNOT7;NUDT21
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.6637838455363562,-1.3147664130853416,0.12121212121212122,0.976638890365783,1.0,3/22,4.51%,IL7;SIGIRR;IL6R
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5305965809636364,1.3146041696142565,0.16216216216216217,0.7756059100278171,1.0,9/35,12.49%,SLC38A1;SLC7A9;SLC7A1;SLC47A1;SLC7A5;SLC25A18;SLC22A2;SLC38A2;SLC6A13
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.7363019166800383,-1.3134832151506144,0.19117647058823528,0.9823818689164231,1.0,6/14,14.19%,CENPX;RMI1;EME1;FANCM;MEIOB;MUS81
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.69167190709043,-1.3134019791689386,0.14516129032258066,0.9801139408269457,1.0,4/17,4.04%,DDIT3;IRF4;ZFPM1;HLA-E
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7207919852102289,1.3132130357540601,0.1111111111111111,0.7794373949829885,1.0,2/11,2.63%,ICAM1;IFNA2
prerank,GO_Biological_Process_2021__regulation of dendritic cell cytokine production (GO:0002730),0.8176276221921762,1.3131061961924073,0.18181818181818182,0.7780788605152358,1.0,1/5,4.38%,CLEC7A
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7756828054784167,1.3126372679592395,0.125,0.776517504680318,1.0,1/5,7.81%,GDPD3
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7756828054784167,1.3126372679592395,0.125,0.776517504680318,1.0,1/5,7.81%,GDPD3
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5692078854719916,1.3124953835184139,0.08571428571428572,0.775599711469606,1.0,15/32,19.15%,RELN;CX3CR1;NLGN4X;NLGN1;GRID1;LRRC4C;PXK;NLGN3;LRP8;GRIK2;CEL;BTBD9;NRG3;EIF4EBP2;BCR
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6444194956306055,1.3121157076401362,0.12121212121212122,0.7749408689659293,1.0,4/16,10.91%,CBARP;DIAPH1;CACNA2D1;NOS1AP
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.8317290435615263,1.3116969611135194,0.17073170731707318,0.7746807875586678,1.0,4/5,15.51%,CD59;TGFB2;CD55;CFH
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6304537546297918,-1.3116758984583983,0.18181818181818182,0.9897238710327585,1.0,8/31,9.26%,CENPF;CENPX;MIS12;CENPE;CENPH;CENPQ;CENPK;MIS18BP1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.8121024277712567,1.3115534248304381,0.20408163265306123,0.77357496446601,1.0,2/5,7.73%,SPIRE2;SPIRE1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7677905121514189,-1.3113845308516885,0.1774193548387097,0.9883475641722296,1.0,3/9,14.32%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6130437746053832,1.3113227742550964,0.1951219512195122,0.7727835964859932,1.0,5/18,10.80%,ABCC2;SLC15A2;SLC47A1;SLC7A5;SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.7289957609113266,-1.3109691758060045,0.1016949152542373,0.9885751306614116,1.0,1/13,0.45%,B2M
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.7855023202681017,1.3105630811057372,0.1590909090909091,0.7744692260991731,1.0,4/5,20.46%,OGT;ZNF304;PHF1;PHF19
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7991705284263975,-1.3104009475248102,0.09375,0.9897954586099758,1.0,3/8,7.44%,CPS1;NIT2;GLYATL1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.7885175368840678,-1.310110425659987,0.1044776119402985,0.9890013477601911,1.0,4/9,11.63%,PDXDC1;FUCA1;SMPD2;SGPL1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7455127068532778,1.3094594758743434,0.15151515151515152,0.7774663286107681,1.0,3/12,11.34%,JCAD;RHOJ;HDAC9
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8064971283094409,-1.308511524467904,0.10294117647058823,0.9980687109633438,1.0,2/6,3.41%,TIMP1;SVBP
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5328265490710462,-1.308453543931705,0.012658227848101266,0.9954072864682443,1.0,46/167,20.29%,CENPF;PSMB8;RPS27A;PSME1;DCTN3;PSMB6;PSMC5;SSNA1;TUBB4B;PSMD8;CENPE;PSMD7;UBA52;MAD2L1BP;CETN2;TPX2;DCTN2;CEP131;NEK6;HAUS6;PSMD3;PSMC3;TUBA1A;CEP72;ANAPC15;DYNLL1;UBB;APPL2;PSMA4;DCTN1;PLK4;PSMA7;PSMD2;CEP135;PSMD6;PSMB2;PSMB4;PRKACA;CEP41;TUBB;CDC23;PSMA3;TUBA4A;PSMB3;PSMC1;ZW10
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.7628629593628166,-1.3082162381567202,0.1527777777777778,0.9941614860112201,1.0,3/11,6.91%,MADCAM1;RHOG;CD81
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7319745422906382,-1.3081645860990798,0.14705882352941177,0.9915766595897675,1.0,1/10,0.98%,IL7
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.751836518001965,1.3079452377154053,0.17777777777777778,0.7821586942304484,1.0,1/9,0.98%,ABCC2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.6780283165786226,-1.3077704218841992,0.15,0.9918874657937844,1.0,7/24,14.70%,PPIB;PPIE;NKTR;PPWD1;PPIF;PPIA;PPIL1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.47672572618466963,1.3072959401609563,0.034482758620689655,0.7829485354640086,1.0,42/105,21.34%,CELF3;CTNNA2;MMD2;SCRT1;PSD2;AMER2;OLFM3;NXPH1;GLS;DIRAS2;SNAP91;GRM3;DLG2;NCAN;GRM1;UNC13A;CADPS;UNC79;KCNC2;NRXN1;GRIN1;KCTD16;SLC8A2;MEIS2;SLC1A2;MAGI2;TMEM132B;NOL4;GRIA2;CA10;ADGRA1;FUT9;SCN3B;GRIN2B;SPHKAP;ADCYAP1R1;SLC6A1;TMEM196;TNR;GABRG1;GRM5;ST8SIA3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.6038040120958799,1.3072606434410186,0.13333333333333333,0.7815605624400385,1.0,5/28,3.97%,PDGFB;FLT1;IRS1;FGFR3;PDGFRA
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.6450360010134736,-1.3071268365604218,0.140625,0.9934375496624254,1.0,2/28,0.74%,LRTM1;SEMA3E
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7848069536045368,1.3060469065411182,0.21739130434782608,0.7852418530471372,1.0,2/7,6.23%,ABCC8;PKD2L1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.7097776342538878,1.3058297474794633,0.18421052631578946,0.7846878119909327,1.0,4/7,24.84%,PLA2G10;PLA2G4C;CHPT1;PLA2G4A
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.6172105589510253,1.3056651029342732,0.1111111111111111,0.7836095851950611,1.0,4/26,5.39%,VDR;SRPRB;ABCC8;LMO2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7108457491643816,1.3052271376170705,0.3055555555555556,0.7835865140547225,1.0,2/8,15.18%,PIWIL2;SFPQ
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7210911437563661,-1.3051742005932054,0.16071428571428573,1.0,1.0,5/10,14.47%,SELENOS;GSTP1;AR;TGFB1;EDN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.7320574569423061,-1.3051424045287963,0.12307692307692308,1.0,1.0,4/11,19.03%,RIC3;TMEM35A;MAP1A;RANGRF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7551558276747711,1.305007634417698,0.14285714285714285,0.7831496100353172,1.0,4/8,16.77%,NUPR1;PPP1R10;LTK;CAMK2D
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.6919441752382535,1.3049864739920183,0.09375,0.7817230767514263,1.0,3/10,8.05%,HSPA1A;ARHGEF7;HSPA1B
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.8228668621651815,1.3047907795216012,0.18604651162790697,0.779243894544276,1.0,3/5,16.31%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.8228668621651815,1.3047907795216012,0.18604651162790697,0.779243894544276,1.0,3/5,16.31%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),0.8116274900424292,1.3045116290108427,0.16216216216216217,0.7786550612344204,1.0,2/5,13.13%,GRHL2;KDM1B
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7100514753860694,1.3044915438938416,0.2647058823529412,0.7771398260534109,1.0,4/9,14.12%,GALNT3;POGLUT2;GALNT2;GALNT16
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6575670052387868,1.3038962028180106,0.20512820512820512,0.778384148717012,1.0,5/13,8.80%,RELN;GCM1;CDK6;NFIB;TGFB2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7884628135762682,1.3038867993190275,0.17777777777777778,0.7768211283380622,1.0,1/6,0.21%,PDGFB
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.6362179197297411,-1.303713853678075,0.19718309859154928,1.0,1.0,3/21,8.84%,SDF2L1;RXYLT1;DPM3
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6755762217745361,1.303484939438383,0.1875,0.7766491611311084,1.0,5/12,21.11%,CAMSAP3;PCM1;CLASP1;SAXO2;BICD2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.6251185241114261,-1.30335047672126,0.13333333333333333,1.0,1.0,13/33,23.72%,CENPX;RNF8;CENPH;CENPQ;CENPK;MIS18BP1;ITGB3BP;CENPU;CENPN;ACTR6;SMARCA5;MIS18A;ZNHIT1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5515429849290281,-1.303312483332164,0.11842105263157894,1.0,1.0,24/84,22.08%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;ANAPC15;PSMA4;PSMA7;PSMD2;GTSE1;PSMD6;PSMB2;PSMB4;CDC23;TCIM;PSMA3;PSMB3;PSMC1;DBF4;CDC20;PSMD10
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.8485183655057327,-1.3032879663367805,0.16923076923076924,1.0,1.0,1/5,1.48%,SFRP1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7899483830458482,-1.3032202737077465,0.109375,1.0,1.0,6/12,9.17%,COX7C;COX6C;COX4I1;COX6A1;COX7B;COX6B1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.703418413884068,-1.30320949540944,0.13846153846153847,0.9988344460427293,1.0,3/17,9.02%,GOLGB1;DCTN2;CEP131
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.7834959745790938,-1.3031309924647125,0.1320754716981132,0.9963184895650578,1.0,1/7,6.09%,ITGB4
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.7624664188609249,1.3027232133915283,0.14634146341463414,0.7780495896572944,1.0,1/5,4.38%,CLEC7A
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.7155784530654832,1.3025804146937283,0.17142857142857143,0.7768752169836782,1.0,4/11,13.82%,TRAF2;MALT1;TNFRSF10A;CHI3L1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.5577473315076926,-1.3024598527922209,0.08860759493670886,0.9981418217462206,1.0,27/105,19.91%,PSMB8;SLC8A3;RPS27A;SFRP1;PSME1;PSMB6;PSMC5;ELOB;PSMD8;PSMD7;UBA52;NOP53;RBX1;PINK1;PSMD3;PSMC3;UBB;PSMA4;PSMA7;PSMD2;HYOU1;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.749030737617328,-1.3023448741566939,0.12698412698412698,0.9963492940209644,1.0,2/11,13.05%,DEGS2;ASAH2
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.7743830650525945,1.3016851871445305,0.175,0.7787284534470177,1.0,4/6,16.30%,SNCA;PTH1R;GPER1;PTH
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4932355847677024,1.3015935365616103,0.047619047619047616,0.7774227166639053,1.0,9/84,6.74%,LEPR;PDGFC;IL4R;OXTR;PPARGC1A;CLEC7A;PLAC8;ZNF516;IGF1R
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.7798552625346624,-1.301384565444777,0.11666666666666667,1.0,1.0,1/11,2.64%,NEURL1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6862346973352096,1.3013696216597586,0.21428571428571427,0.7766060615804934,1.0,4/13,6.44%,IGF1;IRS1;AKT2;SORBS1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.6078861266781878,-1.301245884765306,0.14084507042253522,0.9981603756204097,1.0,15/40,21.46%,SEC61B;DNAJC19;ROMO1;SEC62;PEX10;SRP54;TOMM20;TIMM50;HSPA5;TIMM44;ZFAND2B;GRPEL1;PEX1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6707210206940064,-1.301095476202514,0.11475409836065574,0.996289709792268,1.0,7/23,15.17%,SYCE2;RNF212;STAG3;RNF212B;IHO1;MEIOB;FANCD2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.5140163841253279,1.3009998904557267,0.15151515151515152,0.7764633935333934,1.0,12/43,20.99%,HDAC4;HDAC10;SIRT1;TBL1XR1;HDAC9;SMARCAD1;MIER2;SFPQ;HDAC1;HDAC3;MIER1;PER1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5405324076306111,-1.3009129188710982,0.0641025641025641,0.9950353949788872,1.0,19/90,11.01%,TAGLN2;F8;TTN;SERPING1;TPH1;TLN1;CLU;CD9;TIMP1;ANXA5;CD63;F5;MANF;SPARC;CFD;TMSB4X;TGFB1;TEX264;SELP
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.7786662078886886,1.3008697857893798,0.16216216216216217,0.7754108684534518,1.0,1/5,10.24%,C3
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.769412994050138,1.3003739840927813,0.2,0.7754849147555348,1.0,2/7,3.45%,ACSM1;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.6949736195922601,1.3002752581420172,0.12903225806451613,0.774171742966281,1.0,2/13,5.48%,CDK6;SIRT1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.7340945270354062,-1.2995532334467852,0.11594202898550725,1.0,1.0,1/11,0.41%,CACNA2D4
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7131414845717157,1.2994678460257412,0.15,0.7757119923093435,1.0,2/9,2.08%,RUNX1;YJEFN3
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7837185082965861,1.2987235942455717,0.2391304347826087,0.7770867990385881,1.0,3/5,15.22%,KANK1;TESK1;ANLN
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7169375531579989,1.2987184796343578,0.11428571428571428,0.7756721415510514,1.0,7/14,17.83%,ZBTB16;SCX;SOX5;LOXL2;BMPR2;GDF5;BMPR1B
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.6816004804648439,-1.298050135963944,0.15384615384615385,1.0,1.0,1/17,0.46%,GATA1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),-0.8231533821348522,-1.2980498396981295,0.11475409836065574,1.0,1.0,2/5,9.64%,DND1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),-0.8231533821348522,-1.2980498396981295,0.11475409836065574,1.0,1.0,2/5,9.64%,DND1;TGFB1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7983093314453029,-1.2979208201952774,0.1746031746031746,1.0,1.0,4/8,14.32%,RPS7;PTTG1IP;EIF5A;UBB
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.8113279406521314,-1.2975751571338987,0.0847457627118644,1.0,1.0,3/8,7.20%,MCM2;MCM4;MCM3
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4435468679947583,1.297435645312424,0.05,0.7792116457547092,1.0,19/123,9.16%,PDGFB;PTPN6;FGFR1;JCAD;IGF1;FLT1;FGFR3;EGFR;PHLPP1;SPRED1;DUSP1;TMEM106A;P2RX7;IGF1R;TNIK;NTRK2;CD4;ADRA1A;VRK2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7319524602280587,-1.297011522139433,0.18309859154929578,1.0,1.0,5/9,16.76%,CLU;VBP1;PFDN2;APOE;PFDN6
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6474794468762681,-1.2963750898719277,0.11290322580645161,1.0,1.0,5/30,4.91%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6474794468762681,-1.2963750898719277,0.11290322580645161,1.0,1.0,5/30,4.91%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.6070390774417652,-1.2963129112747462,0.14473684210526316,0.9999302971203227,1.0,10/37,17.21%,CD44;TIMP1;MMP19;ADAM15;FLOT1;CAPNS1;TIMP2;TLL2;SCUBE3;LCP1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7625670997160463,-1.2962233070766664,0.06666666666666667,0.9980264011903198,1.0,2/14,7.00%,EHHADH;DECR2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.607589900140591,1.2960959651589183,0.12195121951219512,0.7826845273075661,1.0,2/18,6.02%,RIDA;FTO
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6270849959808611,1.2957909412268773,0.1111111111111111,0.7824270902406014,1.0,3/17,4.19%,PPP1R36;ENSA;MFHAS1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6963072111907468,1.2957459818392016,0.11764705882352941,0.7810656691612233,1.0,6/17,13.23%,KAT2A;CNOT2;ZNF706;LOXL2;ESRRB;ZC3H13
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7022262623337482,-1.2955124053157567,0.2054794520547945,1.0,1.0,6/19,14.20%,IFNGR2;CDC37;PARP14;IRGM;STAT1;PARP9
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5229471643869161,1.295266514138329,0.07692307692307693,0.7814425628495378,1.0,14/66,11.26%,ZNF423;KCNQ2;EFNB3;CNTNAP2;NLGN4X;IGLON5;LEF1;SEMA5B;CAMKV;MYO3A;TOX3;MEX3A;IGDCC3;VASH2
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7154225150632297,1.29497853014593,0.17142857142857143,0.781162814505846,1.0,3/10,2.84%,CLDN15;CLDN9;CLDN12
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5376167405375049,1.2944039406560108,0.08823529411764706,0.7816688493059615,1.0,2/25,1.47%,ZAP70;GNLY
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.593484522252331,1.294401569512629,0.1891891891891892,0.7801888499927069,1.0,7/23,12.54%,SLC7A9;SLC7A2;SLC7A1;SLC7A5;SLC25A18;SLC38A2;SLC1A2
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.8241088227674905,-1.2943616083383584,0.09230769230769231,1.0,1.0,1/5,6.89%,TNIP2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.7371538343584408,-1.294184572060315,0.14492753623188406,1.0,1.0,1/12,0.27%,IGSF1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6953240732388764,-1.294110843870762,0.12698412698412698,1.0,1.0,6/12,25.81%,GSTP1;ELOVL2;ELOVL1;ALOX5;FADS2;ALOX12
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.6280728184059365,-1.2937822483566668,0.12857142857142856,1.0,1.0,10/28,21.46%,DNAJC19;ROMO1;PEX10;TOMM20;TIMM50;TIMM44;GRPEL1;PEX1;TIMM21;TOMM70
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.6213257230884891,-1.2937310260430697,0.0684931506849315,0.9995077539452965,1.0,17/38,22.60%,CNP;ATP5PB;COX6B1;ATP5PF;HSPA5;DYNLL1;CKB;ACTB;CALM3;NDUFS3;INA;S100A1;RHOA;G6PD;CALM1;MAOB;PLP1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7205573086974133,1.2936878663847824,0.15384615384615385,0.7783265956410428,1.0,4/8,12.31%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7205573086974133,1.2936878663847824,0.15384615384615385,0.7783265956410428,1.0,4/8,12.31%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7205573086974133,1.2936878663847824,0.15384615384615385,0.7783265956410428,1.0,4/8,12.31%,HSPB1;RAB27B;DLG2;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6301504469789503,1.2936420543305192,0.125,0.776967932989022,1.0,3/8,20.10%,SIRT1;WNT5A;LILRB1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.5358821174028432,1.2935917554616885,0.1111111111111111,0.7757695996493389,1.0,7/52,4.44%,VAPB;CERS3;ST8SIA6;ACER2;SGMS1;PPM1L;SPTSSB
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7091017368063571,1.293290799871191,0.24390243902439024,0.7751952236508428,1.0,4/12,6.44%,IGF1;IRS1;AKT2;SORBS1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.6012365538742357,-1.2931222212415558,0.14102564102564102,1.0,1.0,10/37,17.21%,CD44;TIMP1;MMP19;ADAM15;FLOT1;CAPNS1;TIMP2;TLL2;SCUBE3;LCP1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.6829465601163922,1.2926571172817622,0.0975609756097561,0.7763231220439202,1.0,5/11,25.12%,CX3CR1;SMARCD3;DRD2;KDM1A;FZD3
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.8255901270018648,1.2923134856402059,0.14285714285714285,0.7759555560557032,1.0,3/5,12.84%,PLIN5;HDAC9;SORT1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.7602798957600656,1.2921087251320833,0.2857142857142857,0.7753840913670351,1.0,3/5,18.28%,CAMSAP3;PLEKHA7;TJP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7553254300578903,-1.2920657182599808,0.12121212121212122,1.0,1.0,2/8,12.09%,ENTPD2;ENTPD3
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.8152392482429348,-1.291815049508588,0.11475409836065574,1.0,1.0,1/5,8.39%,APH1A
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.7638048064026013,1.2915793403567297,0.23809523809523808,0.7758905275666543,1.0,3/6,17.74%,DNAAF1;MEGF8;SETDB2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6378391622023482,-1.2914395309238667,0.17142857142857143,1.0,1.0,10/25,22.30%,CENPX;CENPH;CENPQ;CENPK;MIS18BP1;ITGB3BP;CENPU;CENPN;SMARCA5;MIS18A
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6378391622023482,-1.2914395309238667,0.17142857142857143,1.0,1.0,10/25,22.30%,CENPX;CENPH;CENPQ;CENPK;MIS18BP1;ITGB3BP;CENPU;CENPN;SMARCA5;MIS18A
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7738891436836302,-1.2913356672512963,0.15,1.0,1.0,2/7,6.31%,ATG14;VAMP8
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.8668267455646594,-1.2913000226378206,0.07575757575757576,0.9980325451152954,1.0,1/5,1.37%,TMEM107
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.7374231006893309,-1.290997735710182,0.15714285714285714,0.9975311481640841,1.0,1/10,0.32%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7134467210393662,1.2909124509409673,0.1875,0.7769063434684195,1.0,7/10,25.52%,XPO5;FXR1;DHX9;PUM2;PUM1;WTIP;ZFP36
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7725169403087311,-1.29074590791347,0.13793103448275862,0.9963600448806132,1.0,3/9,11.44%,SLC25A4;SLC25A5;CR1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6306808537848207,-1.2907312741932457,0.07246376811594203,0.9938323310228322,1.0,11/35,19.91%,MRPL51;MRPS12;MRPS34;TEFM;MRPS21;MRPS18B;MRPL2;MRPS18A;MRPL16;FASTKD2;MRPL57
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.7105798248496232,-1.29070708967616,0.1,0.991404255141376,1.0,5/13,18.17%,COPS5;HSPA5;UFL1;FICD;BAX
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7525044657153772,-1.2906891771974016,0.15151515151515152,0.9888598505856977,1.0,5/15,3.57%,RPL23;DTX3L;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7370950643036909,1.2904987907063088,0.18421052631578946,0.7769231939179252,1.0,4/10,12.73%,VCAN;CSPG4;NCAN;HEXB
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5014094321328196,1.2903098155308184,0.11428571428571428,0.7763796755198947,1.0,12/42,24.42%,HDAC4;HDAC10;SIRT1;TBL1XR1;HDAC9;MIER2;HDAC1;HDAC3;MIER1;TBL1X;BAZ2A;FLNA
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.6425815614907179,-1.2901844604397803,0.14864864864864866,0.9900845694984964,1.0,11/32,20.72%,GAPDH;LDHA;ENO4;PFKL;ENOSF1;GCK;TPI1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.7722521672337442,-1.290081311213752,0.15942028985507245,0.9883275334835452,1.0,3/10,5.86%,ROMO1;TIMM8B;TIMM10
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.7864070086564272,1.289605807304971,0.21951219512195122,0.7775668006982628,1.0,2/5,6.15%,MFHAS1;CYBA
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.8092114652650717,-1.289325698562013,0.2,0.9911057570861914,1.0,3/7,13.29%,TINF2;PNKP;WARS1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.8520773633902188,-1.2889872776212457,0.109375,0.990781901418662,1.0,3/6,13.43%,FAM111A;TEX264;SPRTN
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.767116114127379,-1.2887034168967888,0.19117647058823528,0.9900561956890687,1.0,2/10,14.31%,STAT1;CANX
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.7406006102986471,1.2886515889181211,0.24242424242424243,0.7794852980034493,1.0,1/5,5.48%,SIRT1
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),-0.8140837027927209,-1.2883069915326506,0.0967741935483871,0.9902451417433041,1.0,1/7,0.32%,BMP5
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6918573618246899,-1.2880212654978316,0.16417910447761194,0.9897147325074717,1.0,10/22,20.72%,GAPDH;LDHA;ENO4;PFKL;GCK;TPI1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5967076212771232,1.2879149263733736,0.12121212121212122,0.7809660878470166,1.0,9/33,11.74%,CLDN15;CLDN9;GRHL2;FRMPD2;TBCD;DLG1;PARD6B;AFDN;ESAM
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7075017976829481,-1.2878905414899573,0.12857142857142856,0.9880068946739861,1.0,8/18,19.84%,PSMB8;PSMB6;PSMA4;PSMA7;PSMB2;PSMB4;PSMA3;PSMB3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.6642841584973671,-1.2878032544716926,0.11764705882352941,0.9858664141869826,1.0,7/23,10.84%,RPL23;RPL5;RPS7;RPL11;EFNA1;PDCL3;GABARAPL2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.72317406355934,1.2876325380504394,0.15555555555555556,0.7788396319845168,1.0,1/10,0.11%,B3GNT6
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.72317406355934,1.2876325380504394,0.15555555555555556,0.7788396319845168,1.0,1/10,0.11%,B3GNT6
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6690743417096477,1.287067471717413,0.15384615384615385,0.7797089392240772,1.0,10/19,13.63%,CHST7;VCAN;CSPG4;CHST3;NCAN;CHSY3;CHST11;CSGALNACT1;UGDH;CHST15
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5713292638372504,1.2859974237779257,0.25,0.7822843825952613,1.0,8/24,18.95%,CBARP;CACNA1I;STX1A;SYT3;CACNA1G;DOC2A;SYT5;STXBP3
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7130468128740299,-1.2856859643249885,0.208955223880597,0.9971553168046331,1.0,4/11,16.07%,MT1E;MT2A;MT1G;MT1M
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5968684853442371,1.2854687770728364,0.18181818181818182,0.7831942732540139,1.0,1/16,0.07%,F2
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6796761825128366,1.2836567762766375,0.21428571428571427,0.7879827352738399,1.0,5/9,19.24%,UNC13D;ADGRE2;SYK;FER;GAB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5334792145253461,-1.2833230438436907,0.12987012987012986,1.0,1.0,22/75,23.94%,HLA-DPA1;DCTN3;CENPE;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;DYNLL1;CANX;KIF4A;DCTN1;CTSS;HLA-DRA;HLA-DRB1;AP1S1;AP2A2;HLA-DPB1;KIF22;CTSL;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6405494452980723,-1.2831598318080495,0.11428571428571428,1.0,1.0,5/26,10.90%,TOMM7;UBL5;ARIH2;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5869105093558744,-1.2830727442442047,0.16666666666666666,1.0,1.0,14/44,20.18%,APEX1;PCNA;PNKP;MPG;RPA3;RFC2;PARP1;MBD4;RFC4;XPA;POLD2;POLQ;POLD4;PARG
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.808760691946029,1.2830046388397855,0.14285714285714285,0.7888787548366588,1.0,3/7,9.51%,RELA;NFKB1;CA2
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6466779587481408,-1.2829016212211426,0.12857142857142856,1.0,1.0,16/35,24.18%,RPS16;RPS14;RPS8;RPS28;RPS19;TSR3;NOB1;NGDN;SNU13;TSR2;DDX52;RIOK3;DHX37;NOP14;RIOK2;UTP3
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.689181148669412,-1.2826359753423242,0.15625,1.0,1.0,1/16,1.05%,POLR2G
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6135098487000081,1.2825624159474895,0.13333333333333333,0.7886735642869436,1.0,6/29,12.18%,PTPN6;DUSP6;DUSP1;DUSP10;PTPN22;DUSP18
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.8351863930488552,-1.2824738037573098,0.16981132075471697,1.0,1.0,1/6,7.24%,CARTPT
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.8298184059010305,-1.282323952561854,0.12903225806451613,1.0,1.0,1/6,9.22%,EIF2AK1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.7431706065260818,-1.282312239516863,0.10344827586206896,0.9939768318166686,1.0,4/9,13.83%,CYP1A2;MGST3;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.7431706065260818,-1.282312239516863,0.10344827586206896,0.9939768318166686,1.0,4/9,13.83%,CYP1A2;MGST3;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.7431706065260818,-1.282312239516863,0.10344827586206896,0.9939768318166686,1.0,4/9,13.83%,CYP1A2;MGST3;CYP3A5;CYP3A4
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6797888188302006,1.2822558742840444,0.15625,0.7881702485761577,1.0,2/18,0.33%,PRNT;GCNA
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5366291383583361,1.28177085436683,0.041666666666666664,0.7885389123733728,1.0,10/34,15.95%,TP63;IGF1;BMP6;NPNT;ACVR1;PRKD1;BMPR2;ACVR2B;ACVR2A;DNAI3
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5991612579571592,-1.2815599424407762,0.1527777777777778,0.9962492188430492,1.0,8/46,8.39%,PSMB8;GAPDH;PSME1;SERPING1;TIMP1;PRELID1;SERPINB8;APH1A
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.6050441632904835,-1.2815546589900646,0.1044776119402985,0.9937913273566932,1.0,5/35,9.99%,GPAT3;CPS1;FABP3;FABP6;SLC27A5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5836781866527665,1.281432356924306,0.16666666666666666,0.7881617639006259,1.0,2/33,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6487321961716205,-1.2811703837364865,0.12121212121212122,0.9943282533844079,1.0,7/34,13.74%,H1-4;TTN;H1-2;NCAPD3;NCAPH;SMC4;SMC2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5949710787723891,-1.2810016571041112,0.14754098360655737,0.9928992698555397,1.0,7/32,14.86%,ENTPD2;NUDT1;ADPRM;NUDT18;NUDT15;ENTPD3;ISG20
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6588071413445782,1.279996815628961,0.2,0.7920464393437102,1.0,6/10,17.84%,NOS2;CLEC7A;CYBA;SYK;MAPK8;WNT5A
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.8354006323042077,1.2794171757269301,0.14705882352941177,0.7927521591592033,1.0,1/5,6.23%,PKD2L1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.7028156716303192,-1.2786078316544027,0.14545454545454545,1.0,1.0,4/14,11.44%,XBP1;HLA-E;PHB2;CR1
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8344794986253771,-1.2785064879705372,0.15517241379310345,1.0,1.0,1/5,0.45%,B2M
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.541205453053309,1.278114696490591,0.18518518518518517,0.7951582136842047,1.0,15/56,9.16%,GLT8D2;TPM2;PCDH18;FBLN5;POSTN;PDGFRA;ADGRA2;ADAMTS2;EHD2;GLI2;CDH11;LOX;MSRB3;COL6A1;COL5A1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.6317799134617109,1.2779036577136857,0.23684210526315788,0.7945746936601222,1.0,4/13,9.44%,SRC;RASIP1;FBLIM1;CXCL13
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5315290586396406,1.27784121768853,0.15789473684210525,0.7933047657951996,1.0,7/42,12.30%,FGFR1;SNAI1;LEF1;NOTCH4;TGFB2;FBXL17;LOXL2
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.6710270042037056,1.2775149985256804,0.16216216216216217,0.7927512633321029,1.0,5/13,20.77%,MTERF1;TOP1MT;HMGB1;ABL1;TOP2B
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.8394581867123194,-1.2773760258330291,0.1111111111111111,1.0,1.0,1/6,7.03%,METAP2
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8121778991782763,-1.2771180883434246,0.1694915254237288,1.0,1.0,2/6,11.37%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8121778991782763,-1.2771180883434246,0.1694915254237288,1.0,1.0,2/6,11.37%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.7180061481778556,-1.2768533512349483,0.2222222222222222,1.0,1.0,1/10,2.18%,CELA2A
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.6031351021747855,-1.2766255266753985,0.1388888888888889,1.0,1.0,4/33,10.81%,VAMP5;GORASP2;NECTIN3;AMN
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5626164877873878,-1.2765927114792515,0.13846153846153847,1.0,1.0,8/56,8.84%,SELENOK;ZDHHC12;PIGH;PGAP4;PIGC;PGAP2;ATG10;DPM3
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.7422313883993341,1.2763510876260893,0.2708333333333333,0.7957524477321455,1.0,2/5,13.18%,DCTPP1;ENPP1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.6021505805844052,-1.2760921743245839,0.08450704225352113,1.0,1.0,6/35,12.37%,DTX3L;NEURL1;TRIM25;RBX1;ATXN7L3;PAF1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.48356839877944885,1.27597062597418,0.06451612903225806,0.7957345803755098,1.0,14/42,18.73%,TIAM2;LIMK1;L1CAM;PLXNA1;NTRK2;ROBO1;PLXNB2;SLIT2;ROBO2;CHODL;RUFY3;PLXNA4;MAPT;ZFYVE27
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6394886849185397,-1.2759303216676416,0.15492957746478872,1.0,1.0,9/26,17.99%,RPS27A;UBA52;CETN2;RPA3;RBX1;PARP1;UBB;XPA;GTF2H2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5894820226918344,1.2754895281615761,0.19047619047619047,0.7960585591718269,1.0,13/30,18.76%,IL1RAPL1;PTPRD;SARM1;NSMF;ADGRB3;OBSL1;TNIK;SS18L1;GSK3B;NEDD4L;CUL7;LZTS1;CUX1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.5553217713100309,1.2754751734062306,0.125,0.7946267991733164,1.0,7/58,5.48%,PDGFB;FGFR1;JCAD;VEGFD;NRP2;ARNT;SIRT1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5262751457664631,1.274533084301647,0.14285714285714285,0.7969219547873758,1.0,5/41,5.48%,PDGFB;FGFR1;VASH1;HSPB1;SIRT1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.48156730344734383,1.2744541619566043,0.07407407407407407,0.7957851600094809,1.0,19/83,14.30%,PDGFB;KAT2A;PDLIM7;ALPK3;NXN;PKD1;GLI2;PDLIM5;NOTCH4;SMG9;TGFB2;ACVR1;RBM20;FBXW7;HDAC9;PIK3CA;ZFPM2;KAT2B;PTEN
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5741133279709517,1.2744215288488925,0.13157894736842105,0.7945797175971945,1.0,7/26,10.72%,SLC26A7;CA12;SLC39A8;SLC26A6;CA2;AQP1;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.549886528500432,-1.2743802532745667,0.05,1.0,1.0,33/115,20.54%,PSMB8;SFRP1;PSME1;JUP;TMEM198;PSMB6;PSMC5;ATP6AP2;PSMD8;PSMD7;SFRP4;GPC3;BAMBI;TGFB1;PSMD3;PSMC3;ILK;PPM1N;PLEKHA4;PSMA4;DACT1;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;TMEM9;PSMA3;CAV1;PSMB3;PSMC1;PTK7;USP8
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7389918991160972,-1.2739309038773194,0.29850746268656714,1.0,1.0,3/7,18.42%,TGFB1;TNFRSF1A;CST3
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6716278817564051,-1.2738378897133238,0.2153846153846154,1.0,1.0,3/12,16.75%,ACTG1;FUZ;ACTB
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7455656085860504,-1.273780003357181,0.203125,1.0,1.0,4/9,14.20%,PARP2;PARP14;PARP1;PARP9
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6727552396294695,1.2734639626181816,0.15151515151515152,0.7968868568192198,1.0,5/12,26.40%,GRAMD1B;GPLD1;OSBPL7;SMO;GRAMD1A
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.7621110820595095,1.273282274934707,0.28125,0.796142633830863,1.0,4/10,10.33%,NOS2;DAO;GLS;ARG1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.6563097023146255,1.272921455127905,0.1794871794871795,0.7961484354394964,1.0,1/10,1.19%,ZBTB1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.6409548797025091,1.2728992453434533,0.21428571428571427,0.7933732608660471,1.0,2/9,1.96%,ABCC2;SLCO2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.6409548797025091,1.2728992453434533,0.21428571428571427,0.7933732608660471,1.0,2/9,1.96%,ABCC2;SLCO2B1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5875601289123288,-1.2728185085835888,0.15789473684210525,1.0,1.0,17/40,25.81%,GPX4;GSTP1;DEGS1;ELOVL2;DECR2;SCD;AWAT1;FAAH2;ELOVL1;EPHX1;DAGLA;ALOX5;PTGR1;CYP4F12;FADS2;ACOT8;ALOX12
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.8178950659266526,-1.272212550204455,0.14705882352941177,1.0,1.0,3/5,14.88%,CYP1A2;CYP3A4;CYP2E1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.6990991710578982,-1.2714530438002818,0.2028985507246377,1.0,1.0,4/10,21.68%,MUS81;ISG20;REXO4;DNASE1L1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.747012097336886,-1.2713748746307543,0.16129032258064516,1.0,1.0,5/9,19.14%,ZNF830;CEBPB;EIF2B2;EIF2B4;SOD1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.4766156789781061,1.2712223810228263,0.19047619047619047,0.798276035813462,1.0,22/105,9.16%,VDR;TNC;FRZB;PCDH18;PBX3;NRP2;POSTN;PDGFRA;HMCN1;CSPG4;AGER;LTBP2;ADAMTS2;TMEM47;COL9A1;CDH11;RHOJ;COL14A1;HTRA1;AEBP1;COL6A1;COL5A1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.7306225115825781,1.2712095226215623,0.23076923076923078,0.7969135311767839,1.0,1/6,0.21%,PDGFB
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.7501646908580589,-1.2710789344554472,0.12307692307692308,1.0,1.0,3/12,14.43%,SLC25A4;PARP1;MGME1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.6077024187574911,-1.271047762622393,0.16216216216216217,1.0,1.0,6/27,15.22%,OST4;DAD1;DPM3;MCFD2;DDOST;MAGT1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.5768240420558725,-1.2708686576085246,0.15942028985507245,1.0,1.0,7/33,12.91%,GATA1;ACTG1;TLN1;MYL12A;PIK3CB;ILK;PPIA
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.542408611807358,-1.2708145302023994,0.10526315789473684,1.0,1.0,20/72,20.79%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;AP2S1;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;AP2A2;RHOA
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5498628863780523,1.2705880545983326,0.08571428571428572,0.797921566886189,1.0,5/37,7.94%,F2;PLK1;MFHAS1;SESN2;OTUD7B
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.8376397667273756,-1.270519721426508,0.12727272727272726,1.0,1.0,4/6,14.65%,COX7A1;COX7A2;RAB5IF;HIGD1B
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.6777466730791208,1.2703343891459506,0.25806451612903225,0.7976617786960508,1.0,2/8,9.80%,IWS1;ARRB1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.76629453112708,1.2701563133119333,0.16666666666666666,0.7967599712119863,1.0,2/5,15.93%,SIRT1;CTBP2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.7905840104707055,1.2700943746464206,0.10256410256410256,0.7956236226010795,1.0,3/6,15.50%,FBLN5;DHFR;SYK
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6877278844661809,-1.2698859491674168,0.16666666666666666,1.0,1.0,8/19,18.05%,UQCR10;SURF1;NDUFS8;UQCRH;UQCRB;MDH2;NDUFS7;UQCRC1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7745231304007805,1.2698257802263213,0.225,0.7952031213965239,1.0,2/6,9.29%,SNCA;NFKB1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7389158536739241,-1.2698088068476276,0.19402985074626866,1.0,1.0,1/8,0.55%,GPX4
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.7673433077642035,1.2694645583562332,0.1951219512195122,0.7950683395470927,1.0,1/6,2.48%,PLK1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.5311266093500059,1.2693183713640412,0.1111111111111111,0.7943665221413874,1.0,5/39,8.80%,FGFR1;SNAI1;LEF1;NOTCH4;TGFB2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7130026620417559,1.2692451455416591,0.17647058823529413,0.793289471884083,1.0,7/10,17.84%,LRP4;NLGN4X;NLGN1;NRXN1;NLGN3;CEL;WNT5A
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8072736334624044,1.268926037395,0.2682926829268293,0.7929466468059898,1.0,3/5,17.84%,WNT3;RYK;WNT5A
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.7246749401445329,-1.2688328338057255,0.11864406779661017,1.0,1.0,8/12,17.54%,CYP1A2;CYP2A6;CYP2U1;NUDT15;CYP3A5;CYP3A4;CYP2E1;CYP2R1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6102645966842608,-1.2688028444566213,0.16455696202531644,1.0,1.0,12/44,11.59%,MICOS13;ATP5F1E;UQCC3;ROMO1;TIMM8B;ATP5MC3;TIMM10;ATP5PB;ATP5PD;ATP5F1B;AFG3L2;ATP5PF
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5901120475810491,1.2687725379057209,0.17857142857142858,0.7923933057532692,1.0,9/26,11.62%,KCNN4;IL4R;LGALS4;TM4SF20;DMBT1;DLL1;WNT3;KLF15;SLC26A3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.7107809263531546,1.2686184416750101,0.20512820512820512,0.7901671741174277,1.0,6/10,19.17%,SESN2;RRAGD;SESN1;UBR1;RPTOR;KLHL22
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.7107809263531546,1.2686184416750101,0.20512820512820512,0.7901671741174277,1.0,6/10,19.17%,SESN2;RRAGD;SESN1;UBR1;RPTOR;KLHL22
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6868201089448387,1.2685938063704596,0.2564102564102564,0.7888726671106282,1.0,3/11,15.50%,TGFB2;CXCL13;SYK
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7575586177867271,-1.2685341866979134,0.19117647058823528,1.0,1.0,4/8,11.44%,CR2;C4BPB;C4BPA;CR1
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.7575586177867271,-1.2685341866979134,0.19117647058823528,1.0,1.0,4/8,11.44%,CR2;C4BPB;C4BPA;CR1
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.7575586177867271,-1.2685341866979134,0.19117647058823528,1.0,1.0,4/8,11.44%,CR2;C4BPB;C4BPA;CR1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.8014345351102836,-1.268307811828496,0.1864406779661017,1.0,1.0,1/5,3.91%,TST
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.7464576649097416,-1.2680624293257297,0.1791044776119403,1.0,1.0,2/10,4.19%,CD9;PMP22
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.7225681927292606,1.2680444535838555,0.1388888888888889,0.7894514798834144,1.0,2/10,6.74%,MTMR2;IGF1R
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.6124769247619885,1.2675909396187257,0.20512820512820512,0.7897251337921828,1.0,8/21,21.47%,CHRNA4;DRD4;ARRB2;GRIN1;NLGN3;GSK3B;GRIN2B;DRD2
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.8337236377034354,-1.2675261201179868,0.16129032258064516,1.0,1.0,2/5,2.82%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7881120030494742,-1.2674393477584232,0.22580645161290322,1.0,1.0,2/7,1.30%,NOX4;DUOX1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6775223994486528,-1.2674066596003735,0.18181818181818182,0.9991392312299586,1.0,6/18,16.34%,RPS27A;UBA52;TRIM13;RNF5;UBB;MAN1B1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6652461623538651,-1.267326612629719,0.17647058823529413,0.9973144697768656,1.0,5/20,16.07%,MT1E;MT2A;HAAO;MT1G;MT1M
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7491825258461859,-1.267318161969532,0.22033898305084745,0.9950715273087272,1.0,6/8,24.79%,VIL1;STMN2;KATNB1;CFL2;WDR1;NES
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7068960996026309,1.267061221696419,0.21212121212121213,0.789974566887301,1.0,1/8,5.48%,SIRT1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.7754495836668874,1.2668792916651967,0.2,0.7893167651804701,1.0,3/7,15.30%,HS2ST1;CSGALNACT1;EXT2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.6152892058390883,-1.266408645368984,0.175,0.9987771186667985,1.0,2/38,1.47%,CD44;BEX3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.6939871005283385,1.266311313421061,0.1891891891891892,0.7898676523455715,1.0,2/11,7.32%,DPYSL3;DPYSL4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.7016354369735891,-1.2658293713560633,0.17391304347826086,1.0,1.0,3/15,6.30%,FBXO43;PKMYT1;KIF20B
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8030565466892755,-1.2654796291713988,0.2361111111111111,1.0,1.0,2/6,6.01%,BUD23;TRMT112
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.64432026023671,-1.2653094750993386,0.15714285714285714,0.9989527613258574,1.0,5/23,11.44%,PSME1;EFNA1;PRELID1;APH1A;CR1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5797181242616045,1.2652414226585291,0.15625,0.7925011493244923,1.0,6/17,25.71%,PDE4DIP;CAMSAP3;CAMSAP2;ARMH3;MYO5A;RBSN
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.8022239831733078,1.2651717079390965,0.21951219512195122,0.7914955809568779,1.0,1/5,1.57%,SNAI1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5145070030291587,-1.2651182154939542,0.07792207792207792,0.9980146513997439,1.0,24/137,12.12%,TAGLN2;RIMS1;F8;TTN;SERPING1;TPH1;TLN1;CLU;CD9;TIMP1;ANXA5;CD63;F5;MANF;SPARC;CFD;TMSB4X;TGFB1;SYT11;TEX264;SELP;ABCA12;CDK5;SCG3
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5826375374344424,-1.2645901559275032,0.15714285714285714,0.9998795234490606,1.0,6/59,4.15%,CACNA2D4;BEST1;TRPM1;GPR179;RDH12;DNAJC19
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.7480596741468098,-1.2642124124983332,0.12698412698412698,0.9998378748684715,1.0,2/8,9.64%,DND1;TGFB1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6149971917638272,1.263514861442437,0.11627906976744186,0.7959639016761341,1.0,6/17,18.46%,KCNJ2;CACNA2D1;PIK3CA;CACNA1G;CAMK2D;SCN3B
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6413607621847863,1.2633392039830418,0.17142857142857143,0.7951632503764193,1.0,1/20,0.11%,B3GNT6
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7499044470705338,-1.2626794039438891,0.14285714285714285,1.0,1.0,6/12,13.94%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.7292397837439056,-1.2622288368462637,0.2413793103448276,1.0,1.0,3/10,8.94%,CD44;CORO1B;VIL1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.8063772764820707,1.2621020969790728,0.21428571428571427,0.7981609356599403,1.0,3/6,16.31%,HNRNPU;UHRF1;DHX9
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7461221542096681,1.261404291742223,0.17647058823529413,0.7990357017952661,1.0,3/9,6.11%,IFNA2;TICAM1;IRAK3
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.6156731250781183,-1.261381188646692,0.16176470588235295,1.0,1.0,4/20,12.37%,DTX3L;RNF8;ATXN7L3;PAF1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5687506305008162,1.2612732894210175,0.17391304347826086,0.7981192875939368,1.0,11/44,11.61%,FGFR1;IGF1;IRS1;PLCL2;PDGFRA;PLCL1;IGF1R;OGT;PLCD3;PIK3CA;PI4KA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7096952805760997,1.2612683975046928,0.2391304347826087,0.7967940002934857,1.0,6/9,9.95%,ANXA4;MAPKBP1;SSC5D;OTUD7B;ARRB1;PTPN22
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.8510336942636464,-1.2612643885303882,0.12307692307692308,1.0,1.0,3/6,8.94%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.8510336942636464,-1.2612643885303882,0.12307692307692308,1.0,1.0,3/6,8.94%,GBA3;FUCA2;FUCA1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6471370972050178,1.2611961584472389,0.1282051282051282,0.7957930628324551,1.0,8/13,32.11%,CTNND2;PTEN;EPHB3;PAK3;WASL;SHANK1;EPHB2;EPHB1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.8022475821527173,-1.2608732438824357,0.15625,1.0,1.0,4/9,3.57%,RPL23;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6034095617369334,-1.2607605272397135,0.15151515151515152,1.0,1.0,7/44,9.64%,CD44;HYAL2;GPC3;CEMIP;SGSH;FUCA1;TGFB1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5540386318983359,-1.260544899485826,0.1,1.0,1.0,19/59,19.91%,PSMB8;GATA1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;PSMA4;METTL3;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.5463692512075521,-1.2605297852146682,0.14666666666666667,1.0,1.0,21/74,20.79%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;AP2S1;PSMA4;DACT1;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;AP2A2;RHOA
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.5895524430122027,1.2601999113735303,0.18518518518518517,0.7978748604691412,1.0,4/29,2.40%,PDGFB;RELN;CASS4;SRC
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7987498496160186,-1.260183171761764,0.125,1.0,1.0,2/6,2.48%,GBP2;IRF4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.7019397694580415,-1.2598737764889614,0.11475409836065574,1.0,1.0,3/10,10.09%,HLA-F;TGFB1;CUEDC2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7384203746037965,1.2589448185526868,0.24444444444444444,0.8009288467629369,1.0,3/7,7.63%,APOLD1;ATOH8;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.47356314666724936,1.2588951193669482,0.05555555555555555,0.799698674249298,1.0,19/112,7.47%,PDGFB;FGFR1;SPRY2;CASS4;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;CPNE1;PDGFRA;MFHAS1;CX3CR1;AKT2;NRG2;IGF1R;HCLS1;ADAM8
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.534566253175027,-1.258650010270367,0.1375,1.0,1.0,11/88,9.50%,FBXO43;PKMYT1;SFRP1;BUB1;RAB11A;USP51;KIF20B;IHO1;ANKK1;CETN2;USP19
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.5801533281526483,-1.2582187482244909,0.16176470588235295,1.0,1.0,2/45,4.20%,ARHGEF16;RHOG
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.5578162755005883,1.2580914239331211,0.20833333333333334,0.8012641678151012,1.0,14/38,23.31%,PLPP4;MTMR2;PLPPR4;MTMR11;PTEN;SYNJ2;INPP5B;MTMR3;MTMR12;MTM1;PIP4P2;PLPPR3;PLPPR2;MTMR9
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.8320596666719088,-1.2577593626563355,0.20967741935483872,1.0,1.0,2/5,15.86%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.8320596666719088,-1.2577593626563355,0.20967741935483872,1.0,1.0,2/5,15.86%,UFC1;UFL1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.8320596666719088,-1.2577593626563355,0.20967741935483872,1.0,1.0,2/5,15.86%,UFC1;UFL1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6192042172847938,-1.2576873092075598,0.14864864864864866,1.0,1.0,2/42,1.47%,CD44;BEX3
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.719991255173859,-1.2575215833182378,0.24242424242424243,1.0,1.0,5/9,20.35%,ADH4;SNX17;APOE;SCARF1;AKR1D1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6091967952315315,1.2573011465122113,0.1951219512195122,0.8028923982204509,1.0,8/27,12.03%,CHRNA4;SCN9A;CACNA1I;CACNB4;P2RX7;SCN7A;CACNG4;CACNA1G
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.626269148938952,1.2568997832620123,0.30303030303030304,0.8028639533689242,1.0,2/11,14.10%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.7491295122204242,-1.2567350956699406,0.19402985074626866,1.0,1.0,2/8,11.32%,RHOG;SLAMF8
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.7667724641409839,-1.256644161127148,0.15254237288135594,1.0,1.0,3/9,13.27%,RACK1;SMPD2;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.7667724641409839,-1.256644161127148,0.15254237288135594,1.0,1.0,3/9,13.27%,RACK1;SMPD2;TNFRSF1A
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7850511425772145,-1.256635355604686,0.11864406779661017,1.0,1.0,6/10,13.94%,MIS12;IK;CHAMP1;MTBP;SPDL1;ZWILCH
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.7619892456314661,-1.2564014982831837,0.1694915254237288,0.99977943785792,1.0,3/8,14.47%,ACTA2;HTR2B;EDN1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.7488385622019476,-1.2561856179245647,0.18461538461538463,0.9989432234943713,1.0,2/7,10.33%,PNKD;SYT11
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5881953610326628,-1.2561436405263995,0.14492753623188406,0.9971424622267336,1.0,19/48,22.28%,TOMM7;SLC25A6;DNAJC19;ROMO1;TIMM8B;TIMM10;TSPO;TOMM20;TIMM50;PMPCA;TIMM44;IMMP1L;TIMM13;GRPEL1;FIS1;TIMM21;BCAP31;TOMM70;TOMM22
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.551454834433997,-1.256060374256767,0.09090909090909091,0.9957805671104297,1.0,21/76,19.81%,CENPF;DCTN3;SSNA1;TUBB4B;ATAD5;CETN2;TPX2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;PLK4;GTSE1;CEP135;PRKACA;CEP41;TUBB;TUBA4A
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6795714573317775,-1.2559083380411231,0.16129032258064516,0.9948375519564452,1.0,4/15,5.87%,CLU;GSAP;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.7376609239921788,-1.255831807535154,0.15517241379310345,0.993108300099153,1.0,2/7,11.37%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.5475705330197674,-1.2556858515788043,0.11904761904761904,0.991746285498884,1.0,13/68,15.59%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I;PHAX;TAF11;INTS5;GTF2A2;INTS12;POLR2A;SNAPC1;SNAPC2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.6023240180551444,-1.2555859691589164,0.17567567567567569,0.9903899697044737,1.0,6/28,15.22%,OST4;DAD1;DPM3;MCFD2;DDOST;MAGT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4750252603730131,1.2555232567137393,0.2,0.8059293386411948,1.0,9/60,14.63%,CDKL1;ODAD3;PLD1;TBC1D5;IFT88;TBC1D22B;DCDC2;IFT140;FXR1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.7441736575512714,-1.2554866690873385,0.20689655172413793,0.9888515398745359,1.0,3/7,24.49%,TOM1L1;AURKAIP1;NME6
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6111623973695341,-1.2552405490849208,0.12857142857142856,0.9883756955070734,1.0,2/28,5.00%,CYP1A2;CYB5R3
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7279409695379799,1.2551788370842134,0.175,0.8061213796574727,1.0,1/5,2.40%,SRC
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.529587938377186,-1.2548825820720064,0.09859154929577464,0.9884118198060791,1.0,32/115,23.72%,PSMB8;PSME1;EDF1;PSMB6;PSMC5;PSMD8;PSMD7;AZIN1;SCD;PSMD3;GPS2;PSMC3;C1QTNF2;HELZ2;PSMA4;APOE;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;FASN;OAZ3;OPA3;NR1D1;PSMD10;CERS2;LACTB;SREBF1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.4191393211701546,1.25455618037463,0.07692307692307693,0.8067404154026163,1.0,38/261,10.42%,CREB3L1;VDR;PDGFB;RIDA;HELLS;ABCC2;IGF1;NOS2;RUNX1;HSPA1A;IFNA2;AEBP2;ATOH8;CPEB3;CPNE1;SLC24A3;IGF2BP2;SIRT1;EIF4E2;SAMD4A;SFMBT2;CCDC3;SYNCRIP;DHFR;PICALM;ZC3H12D;NANOS3;ROBO1;TCEAL1;HSPA1B;SLC7A5;PUS7;TGFB2;NFKB1;PTPN22;FBXW7;DICER1;DNMT3A
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.5457853234743877,-1.2545266319877206,0.12195121951219512,0.9884817230139181,1.0,13/69,15.59%,POLR2G;POLR2J;GTF2F1;POLR2L;POLR2I;PHAX;TAF11;INTS5;GTF2A2;INTS12;POLR2A;SNAPC1;SNAPC2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.6841282088759355,1.2543374520808659,0.23076923076923078,0.8061215665930903,1.0,5/9,26.40%,GRAMD1B;GPLD1;OSBPL7;SMO;GRAMD1A
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6449898338134479,1.2543219480494427,0.22580645161290322,0.8049215229966795,1.0,6/10,21.51%,ATP12A;ATP1B3;SLC12A2;NEDD4L;ATP1A2;SLC8A1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.684837727229021,1.2531820521866686,0.175,0.8075998474629691,1.0,3/8,11.77%,GFAP;SNCA;ATP13A2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6591947062352987,1.2530602907691626,0.125,0.8066025508267306,1.0,3/17,6.13%,KAT2A;DUSP6;SCX
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.5409525261187832,-1.2530259329799094,0.11538461538461539,0.9956954921305529,1.0,15/75,11.40%,TAGLN2;ACTL8;TST;PCNA;ALDH1A2;DNPH1;CBR1;MTHFD1;PAX8;TPP1;VIL1;GSTK1;TGFB1;STAT1;IFT122
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6638375047979714,-1.2530049754906574,0.1774193548387097,0.9937565301412234,1.0,6/17,19.95%,CLU;TIMM50;IFI6;DNM1L;BAX;FIS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.558710959046167,1.2528775149112925,0.24242424242424243,0.805898720858896,1.0,2/22,1.59%,NUPR1;ICAM1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.6128143610330004,-1.2528608059949589,0.203125,0.992449364137688,1.0,3/23,8.94%,ACTG1;SYNPO2L;VIL1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.7222143371886839,1.252756559668454,0.19148936170212766,0.8049297875871367,1.0,4/8,18.20%,IRS1;PID1;PDK4;LPL
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.620685117856326,1.2522245076312013,0.11764705882352941,0.8056104094719106,1.0,2/13,10.33%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7589338507885202,1.2520170711563006,0.22727272727272727,0.8053559036775102,1.0,2/5,9.27%,TMEM108;DOK5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.729388824444928,1.2519242841020497,0.2558139534883721,0.8043704408006279,1.0,3/5,19.75%,PTPN22;HMGB1;RSAD2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.714496435438179,1.2518640229776503,0.275,0.803321780715532,1.0,3/6,25.34%,PRKD1;RNF112;SP1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8384807467022527,1.2517616818705013,0.24489795918367346,0.8024754700133261,1.0,2/6,9.30%,IGF1;BAG3
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7201110198788802,1.2512939575536044,0.19230769230769232,0.8027573386490234,1.0,3/8,16.77%,CACNA2D1;NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.7817938420348058,1.2506288192239179,0.32558139534883723,0.8040076647070119,1.0,5/5,21.84%,TTBK2;ABL1;MAP2;MARK2;PPP2CB
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.5781374743762934,1.250490653700177,0.125,0.803054384880587,1.0,12/33,16.92%,STON2;NLGN4X;NLGN1;STX1A;SNCA;PICALM;SNAP91;DNAJC6;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6073309638836515,1.2503877935606793,0.2,0.8021700745465985,1.0,1/23,0.32%,RELN
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.49596137739944823,-1.2497177199579066,0.08641975308641975,1.0,1.0,26/137,15.19%,CENPF;RPL38;GPX4;COX7A1;CLU;BBS12;MIS12;CENPE;CHMP2A;ADRM1;CCDC39;VAMP8;TBCC;SRP54;TMEM35A;TGFB1;COX7A2;RAB5IF;HOPX;VBP1;AP2S1;TESPA1;CLTA;HIGD1B;CCT2;NDUFAF1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.7411346402249778,-1.2496130578512796,0.18181818181818182,1.0,1.0,1/10,4.09%,VPS35
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.8004939537100013,-1.2494399535995957,0.22580645161290322,1.0,1.0,2/5,9.00%,CD63;RAB32
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.8004939537100013,-1.2494399535995957,0.22580645161290322,1.0,1.0,2/5,9.00%,CD63;RAB32
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5605161719622725,-1.249238318970026,0.1,1.0,1.0,20/63,24.64%,H1-4;H1-2;POLE3;GRWD1;RNF8;CHAF1A;PAF1;MCM3AP;H1-10;SMARCD1;NAP1L2;ACTR6;CHAF1B;H1-0;H2BC11;SMARCA5;SET;ZNHIT1;SART3;PADI4
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5717261708146059,1.248983068178956,0.21212121212121213,0.8054761637506227,1.0,2/25,4.83%,RELN;AGER
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.851335283721891,-1.248873227963299,0.16923076923076924,1.0,1.0,1/5,5.48%,HYAL2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.6592300731780335,-1.24886264593451,0.1935483870967742,1.0,1.0,4/16,10.15%,GATA1;SRP54;JAGN1;CDK4
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.667026901606153,1.2487398917976225,0.2,0.8048972423051213,1.0,2/12,9.57%,HNRNPU;AQP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6790810586363566,1.2484881301642994,0.20588235294117646,0.8042109205600342,1.0,3/9,12.03%,CACNA1I;STX1A;CACNA1G
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7033703669916104,-1.2482370017671995,0.16923076923076924,1.0,1.0,8/13,21.87%,TMEM50A;VPS25;VPS28;SNF8;TMEM50B;CHMP7;CHMP4B;VPS36
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.8072801885314137,-1.2481521812473988,0.1896551724137931,1.0,1.0,2/5,7.57%,TIMP1;CALR
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.7284798415478468,-1.2479283886600065,0.22033898305084745,1.0,1.0,2/9,10.53%,APEX1;TFIP11
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6364331693511627,1.247554044953085,0.25,0.8057959193287639,1.0,2/9,15.44%,CX3CR1;UBAP2L
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.6730957969580784,1.2475436410910088,0.28888888888888886,0.8045439940749454,1.0,4/8,29.17%,KDM1B;KDM1A;KDM5B;KDM5A
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.5053555103840601,1.2474822519304678,0.16666666666666666,0.8033830811380047,1.0,7/56,5.58%,LEPR;NUPR1;DAPL1;PLIN5;MTMR2;FOXK1;RASIP1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.6870062104124018,-1.24729073235909,0.2,1.0,1.0,3/13,9.69%,CPS1;FABP3;FABP6
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.8089183904768877,-1.2472838543144624,0.14285714285714285,1.0,1.0,1/5,4.29%,DGAT2L6
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5884962550408401,-1.247128675812923,0.2191780821917808,1.0,1.0,11/33,22.30%,CENPX;CENPH;CENPQ;CENPK;MIS18BP1;ITGB3BP;CENPU;CENPN;ASF1B;SMARCA5;MIS18A
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.8227718953575744,-1.2471133711514737,0.18333333333333332,0.9991641281909224,1.0,1/5,3.93%,FABP3
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.7570448278019354,-1.247031975532483,0.21052631578947367,0.99759099568359,1.0,4/7,20.98%,CALR;SLAMF8;C1QBP;CCR7
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.7665906572361678,-1.2469318269864882,0.1864406779661017,0.9962036745926676,1.0,2/9,0.93%,APIP;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.44856591123843764,1.2467171291417063,0.125,0.8043320957353208,1.0,34/338,8.16%,KLRF2;VDR;PDGFB;RAB27A;EPB41L4B;IGF1;KAT2A;SPRY2;MYOM1;HSPA1A;PASK;FGF17;MAPK11;ADAM19;EGFR;PPARGC1A;PIWIL2;CPEB3;TICAM1;PLD1;CLEC7A;SLC24A3;LEF1;ZNF804A;SAMD4A;SCX;P2RX7;BMP6;ITGAX;NTRK2;ROBO1;TESC;HSPA1B;PRR16
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.7955048344688137,1.246587762583738,0.13953488372093023,0.8032619516737733,1.0,3/5,15.54%,MTHFS;DHFR;QDPR
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.5605737767687394,1.2463775078961192,0.125,0.8026064644763361,1.0,7/25,12.60%,RELN;KCNIP2;HAP1;AKAP6;ATPSCKMT;NLGN3;LRRC38
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.5180402791882306,1.2460284999419307,0.09375,0.8023852597173858,1.0,6/29,13.83%,RELN;NLGN1;DLG2;DLG1;GRIN1;DLG3
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.6216478554986232,1.2457432622035793,0.18181818181818182,0.8018411319068679,1.0,6/27,11.70%,MAPK12;MAPK11;CTNNA2;MEGF10;HDAC9;CDH2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6330504381785385,-1.2454558020466615,0.24,1.0,1.0,4/25,4.05%,HLA-F;B2M;HLA-E;HLA-A
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),-0.8111106408304304,-1.2452136701596352,0.21153846153846154,1.0,1.0,2/5,13.02%,SBDS;C1QBP
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.6339451166804843,1.2449653676375345,0.15625,0.8033666575230531,1.0,7/18,20.16%,SRC;ARHGEF7;SORBS1;PTPRK;WHAMM;BCR;PEAK1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.6373027464470289,-1.244766107490923,0.17142857142857143,1.0,1.0,3/21,6.72%,DUOX1;PHPT1;RPS19
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5765353140600864,-1.2447125837835664,0.16,1.0,1.0,1/33,0.15%,EPN1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5228718794306054,1.2446570684299532,0.11538461538461539,0.8029947527341701,1.0,4/30,6.11%,MAPK11;CLEC7A;AGER;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5554310280687572,-1.2445879627809362,0.1,1.0,1.0,21/78,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;RBX1;CDK4;PSMD3;PSMC3;PSMA4;AVEN;DACT1;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.8595244968768088,-1.2444321216576697,0.10909090909090909,0.9988648733741694,1.0,1/5,4.14%,POLR3H
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6470483942181839,-1.2442113865551814,0.19718309859154928,0.9983472569295527,1.0,3/18,2.43%,NOX4;DUOX1;PRDX1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.7045808871468482,-1.24412413641727,0.18461538461538463,0.9969802547138392,1.0,2/13,11.92%,CPTP;ABCA12
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5576932623253552,-1.244061127383096,0.2028985507246377,0.9954903491134365,1.0,13/54,15.86%,RPS27A;CFTR;UFC1;ATG14;UBA52;PHB2;TEX264;ARL13B;LGALS8;ACBD5;DYNLL1;UBB;UFL1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.746029797141839,-1.2439816099044634,0.20689655172413793,0.9941342880175812,1.0,3/5,9.64%,FLOT1;USP19;TGFB1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.6384916208032323,-1.2436094953997323,0.20967741935483872,0.9941569778521735,1.0,4/20,19.07%,CPTP;AQP11;ABCA12;SLC14A2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6117711429797934,1.243448613475635,0.3076923076923077,0.8060166963041085,1.0,5/19,10.72%,KCNIP2;ATP12A;SLC40A1;ATP1B3;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7692436096015792,-1.2432250127994782,0.24561403508771928,0.9944505466787827,1.0,4/5,23.10%,TGFB1;GREM1;MYOCD;EFNB2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5569170934070724,1.2431258057804777,0.21052631578947367,0.8061777407461865,1.0,5/26,7.73%,SPIRE2;PSTPIP1;DIAPH1;COBL;SPIRE1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5834579317359734,-1.242514963276903,0.14285714285714285,0.9967951376720123,1.0,6/26,16.75%,PDZK1;VAMP8;GPC3;AR;CDK5;ACTB
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.8049572530357572,-1.2424579228732666,0.14035087719298245,0.9952089150924808,1.0,2/5,16.74%,ABCA12;APOE
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.7190258277633815,1.2423412963040055,0.28205128205128205,0.8079436324878346,1.0,3/8,5.07%,KCNIP2;CNTNAP2;AGRN
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.8313515627913516,1.2419026511424833,0.18421052631578946,0.8077164518066463,1.0,2/5,4.71%,PPARGC1A;ZNF516
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6020627842269997,1.241870227854183,0.2857142857142857,0.8065938187173255,1.0,2/12,14.10%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5561747620879935,-1.2412992932579714,0.1267605633802817,1.0,1.0,20/63,19.91%,PSMB8;GATA1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;PDCD2;PSMA4;METTL3;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.777627207341519,-1.2412039249589708,0.1896551724137931,0.9989822607208203,1.0,1/6,2.43%,PRDX1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.8138666740519545,-1.240955802501265,0.208955223880597,0.9983007707675026,1.0,3/5,15.12%,PRPS1;DCK;DCTD
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.6743805472351264,1.2407231858554586,0.21951219512195122,0.8091389665261063,1.0,3/10,15.56%,PLIN5;GPLD1;NR1H3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.578656225719445,-1.2399388473260862,0.16666666666666666,1.0,1.0,9/41,16.72%,P2RY10;IRF4;CD9;PPIB;CD27;TMEM156;SSR4;ST6GALNAC4;ARHGAP30
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6215558720755245,1.2398395383343672,0.2571428571428571,0.8103786326316627,1.0,4/19,12.39%,PRKRA;XPO5;DICER1;TENT4B
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8113032609629097,-1.2391608480128251,0.22033898305084745,1.0,1.0,2/6,10.22%,CPS1;DDAH2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6811483590993622,1.2390947343101757,0.21951219512195122,0.8112533836438536,1.0,2/12,8.25%,CDK6;CD4
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.7685796293783898,-1.238487189951272,0.1694915254237288,1.0,1.0,4/7,21.35%,TST;TXN2;GLYATL2;MPST
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7308121460538608,1.2380918403533892,0.2564102564102564,0.8133552151413834,1.0,4/7,16.87%,UNC13D;ADGRE2;SYK;FER
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.8193115793357306,-1.23782433798326,0.15873015873015872,1.0,1.0,1/5,4.37%,GBA3
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.7075295179209687,-1.2373179220384614,0.2,1.0,1.0,3/11,14.78%,KDELR1;HSPA5;KDELR3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5114345173237201,1.237220630716784,0.1935483870967742,0.8150270657365203,1.0,7/28,22.58%,SIRT1;SESN2;SESN1;UBR1;KPTN;MINAR1;MAPKAPK5
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7012263066087698,-1.2370116490591225,0.22727272727272727,1.0,1.0,1/13,1.01%,GJC3
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.7428181743426123,-1.2368401937702056,0.18840579710144928,1.0,1.0,2/8,2.13%,PLAAT4;PLAAT5
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5975355625691043,1.2365405573241521,0.13333333333333333,0.8162286726075065,1.0,2/22,0.21%,F2;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.4984591350085282,1.2363051842120814,0.18518518518518517,0.8156115335186033,1.0,7/52,5.94%,LEPR;NUPR1;DAPL1;FOXK1;RASIP1;USP36;SNCA
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6368949787040665,-1.2360067030137576,0.2,1.0,1.0,10/27,22.77%,CHMP2A;RAB11A;VPS25;VPS28;SNF8;CHMP3;CHMP7;CHMP4B;VPS36;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.7010506705325288,1.2359862531315158,0.19047619047619047,0.8153545356047138,1.0,3/9,16.22%,MLXIPL;NR1H3;SLC45A3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5623499067775347,1.235719354753468,0.18181818181818182,0.8149089835670452,1.0,7/21,16.30%,SRC;IFNA2;EGFR;SNCA;PTH1R;PTGES3;PTH
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.7263261519993416,-1.2356613359453115,0.2033898305084746,1.0,1.0,3/10,11.06%,IL31RA;SYT11;GRN
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.7421258335323402,-1.2354903634754844,0.21875,1.0,1.0,1/7,14.62%,APPL2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.7421258335323402,-1.2354903634754844,0.21875,1.0,1.0,1/7,14.62%,APPL2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6901527781049832,-1.2351588922702108,0.16393442622950818,1.0,1.0,2/14,9.49%,RIMS1;FLOT1
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.7502443193290814,-1.2344829944200426,0.2413793103448276,1.0,1.0,3/7,21.54%,SYT11;GRN;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.6591839785792395,-1.2338621815037114,0.19718309859154928,1.0,1.0,4/14,18.71%,ATAD5;PHB2;PAF1;EZH2
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.7640078520877187,-1.2334263953330298,0.25757575757575757,1.0,1.0,2/6,16.23%,FSTL1;GREM1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.44219663302487194,1.2333687374118893,0.2,0.8215860235378569,1.0,29/193,13.08%,CPA1;BACE2;ADAM33;TRHDE;CTSK;VASH1;ADAM19;CPNE1;ADAMTS9;KLK14;OLR1;ATG4C;HTRA1;AEBP1;CPA4;LVRN;MALT1;OGT;CPM;CASP7;CPA2;VASH2;FBXO2;ATG4B;SPPL3;NAPSA;DESI2;MMP16;LRP8
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7386640206651801,1.2332967783260547,0.2619047619047619,0.820482010569245,1.0,4/6,16.87%,UNC13D;ADGRE2;SYK;FER
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6114012172258021,-1.23278002982937,0.19444444444444445,1.0,1.0,9/26,24.12%,TINF2;NOP10;NHP2;PPIA;RAD50;GAR1;TERF2IP;RFC1;TERF1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.4578997751129209,1.232678121748489,0.045454545454545456,0.8214336856797155,1.0,29/98,19.27%,ZNF423;KCNQ2;PTPRD;CPT1C;CTNNA2;ADGRB3;SEMA5B;EFR3B;ASXL3;ADGRL3;SNAP91;NCAN;UNC13A;CADPS;NRXN1;GPM6B;ROBO2;MAGI2;ABI2;DCX;TMEM132B;FMN2;NFASC;GRIA2;GUCY1A2;SCN3B;NTM;ADCYAP1R1;KCNIP1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.6086854877600736,-1.2325307293610535,0.17391304347826086,1.0,1.0,7/42,11.63%,SEMA3E;PDXDC1;FAT2;GPC3;HTR2B;SEMA3A;SGPL1
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),-0.8139871612275102,-1.2322638853491688,0.2222222222222222,1.0,1.0,2/5,8.20%,SFRP1;GPIHBP1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5253694481376601,1.2317537862169556,0.18181818181818182,0.8229678830280412,1.0,9/38,13.97%,CERS3;COL7A1;GRHL2;KLK14;DLL1;ACER1;PTHLH;ATP2C1;SCEL
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),0.8263586935612535,1.2317057275941545,0.2571428571428571,0.8219294752930136,1.0,3/5,16.31%,HNRNPU;SYNCRIP;DHX9
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.622842432169843,1.2316655644120789,0.1794871794871795,0.820790037999272,1.0,7/15,16.48%,NLGN4X;NLGN1;NCAM2;NRXN1;NLGN3;ASTN2;CEL
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.6838645458437387,-1.2315104953723994,0.15384615384615385,1.0,1.0,5/18,19.28%,DDIT3;CR1;C1QBP;PDCD1LG2;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5717268633485209,1.2314722981453325,0.1875,0.8201119853454345,1.0,2/20,1.46%,GPR35;CBARP
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.5429327894730149,1.2314313832461625,0.2,0.8189580498290062,1.0,2/23,1.47%,ZAP70;GNLY
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5484422536409191,-1.2309619030509527,0.1527777777777778,1.0,1.0,16/65,19.86%,POLR2G;DDX24;DNASE2;POLR2J;GTF2F1;POLR2L;POLR2I;KPNA2;WDR74;POLR2A;METTL3;RAD50;HNRNPH2;DDX1;NCBP1;RAN
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.7772571213964414,-1.2308213613691072,0.20689655172413793,1.0,1.0,1/6,1.73%,SELENOS
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.7372120885802173,1.2308012020640038,0.2857142857142857,0.8201730535528398,1.0,2/8,7.32%,DPYSL3;DPYSL4
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.45044605763610174,1.2304358938026743,0.058823529411764705,0.8200584255122016,1.0,26/147,7.82%,PDGFB;GRM2;FGFR1;SPRY2;CASS4;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;CPNE1;PDGFRA;MFHAS1;CX3CR1;PHLPP1;AKT2;SIRT1;NRG2;IGF1R;PLEKHA1;PHLPP2;HCLS1;ADAM8;NTRK2;ARRB2
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.7524029769570167,1.230197887403587,0.2978723404255319,0.8195511170857185,1.0,3/5,17.46%,PGAP1;PIGT;PIGK
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.7105988539679363,-1.2300194772505415,0.19402985074626866,1.0,1.0,2/9,9.51%,PLN;SRI
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.6743535737473415,-1.2297487517147958,0.22950819672131148,1.0,1.0,3/10,12.22%,SPAG17;SPEF2;SPA17
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6295072147395702,1.2295523427016526,0.1794871794871795,0.8203052662296462,1.0,9/15,29.66%,ARRB2;GRIN1;GSK3B;GRIN2B;DRD2;MPP2;RAB3GAP1;GRIN2A;LRRK2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.6007853119698305,1.228801157466363,0.175,0.8213870850742454,1.0,5/17,16.14%,COL7A1;DUSP1;COL6A1;COL12A1;COL4A2
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6612719846252993,-1.2286798445767821,0.21666666666666667,1.0,1.0,3/15,7.91%,CELA2A;CD9;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6320967743812761,-1.2282162996762542,0.20833333333333334,1.0,1.0,10/19,25.12%,HRK;PINK1;PPIF;CIDEB;DNM1L;BAX;MOAP1;PDCD5;BNIP3;PLAUR
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7213745980648343,1.2281082453272845,0.23529411764705882,0.8223214752292141,1.0,6/9,16.48%,LRP4;NLGN4X;NLGN1;NRXN1;NLGN3;CEL
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.814725524514039,-1.2278388808206118,0.18461538461538463,1.0,1.0,4/6,17.85%,SIGIRR;IL6R;CEBPB;APOL2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.5987653335324769,1.2277157635795275,0.19444444444444445,0.822430619542934,1.0,3/29,2.83%,F2;NLRP7;TM4SF20
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.4862618519112782,1.227712914034171,0.19230769230769232,0.8212255707427986,1.0,10/63,9.57%,CREB3L1;ADAM33;FRZB;POSTN;PDGFRA;ADAMTS2;FBLIM1;CDH11;COL14A1;AQP1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.7581005964474841,1.2276951267919562,0.24242424242424243,0.819983171997348,1.0,1/7,4.82%,PLA2G10
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6381076607333163,1.2275517594628356,0.2222222222222222,0.819297137832132,1.0,9/15,17.84%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;NLGN3;PTEN;CEL;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6477946352966096,1.2266837066520901,0.28205128205128205,0.8213311887800357,1.0,6/13,23.10%,PPARGC1A;MLXIPL;NR1H3;SLC45A3;MLYCD;PPARA
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7486359578467379,1.226224367182508,0.20512820512820512,0.8215838406313585,1.0,7/9,24.39%,SNCA;BMP6;FGF1;PTH1R;PTH;WNT4;SCAP
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.720466776289135,-1.2261364370984815,0.2153846153846154,1.0,1.0,3/12,8.21%,BTN3A1;RASGRP1;DOCK8
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6686813177734836,1.2258983419934093,0.2682926829268293,0.8201541736806159,1.0,1/10,0.30%,GRM2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6686813177734836,1.2258983419934093,0.2682926829268293,0.8201541736806159,1.0,1/10,0.30%,GRM2
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.6390472299734683,-1.225690423965656,0.21212121212121213,1.0,1.0,2/16,5.63%,MCM2;MCM4
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6869198599487497,-1.2256902526818951,0.2413793103448276,1.0,1.0,3/12,15.86%,UFC1;TEX264;UFL1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.5729363287349012,1.2255297040582145,0.15789473684210525,0.8202449445930043,1.0,6/23,6.77%,VDR;RUNX1;CTSK;ERRFI1;GRHL2;TRIM16
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.5906862152792902,1.2254325142200608,0.2,0.8193415648729987,1.0,3/16,6.21%,MFHAS1;AGER;SASH1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.6974424460149502,1.225382003747729,0.25,0.8182788624528815,1.0,4/8,21.83%,RARG;ALDH1A3;KDM2B;FBN1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.637464697640582,-1.2249405526863617,0.21875,1.0,1.0,2/15,11.32%,CXCL17;SLAMF8
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.7333473845888697,-1.224884633763804,0.2318840579710145,1.0,1.0,2/7,15.98%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7108654188086045,1.2246224650978053,0.22727272727272727,0.819686501082784,1.0,3/5,14.14%,RUNX1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5064975045077397,1.2243341962968401,0.16666666666666666,0.8195956948527087,1.0,9/49,13.09%,LEPR;BACE2;IRS1;VGF;IGF1R;MLXIPL;TENT4B;ADIPOR2;ADCY8
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5620243396873451,1.2241797747172973,0.20588235294117646,0.8189204461321306,1.0,1/28,0.07%,F2
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.7439644904498872,-1.2240345716335201,0.23809523809523808,1.0,1.0,2/7,17.02%,ALG10B;GOLGA2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6667627959307183,-1.2236932928758362,0.22033898305084745,1.0,1.0,3/18,11.50%,EIF2S3B;EIF2S2;EIF3D
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.7638912199241045,1.2235243706423917,0.275,0.8197974103958124,1.0,1/6,8.14%,NECAB2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.5679683434362601,-1.223340832965823,0.1527777777777778,1.0,1.0,12/46,21.91%,H1-4;H1-2;POLE3;GRWD1;CHAF1A;PAF1;H1-10;NAP1L2;CHAF1B;H1-0;H2BC11;SMARCA5
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.791244518789064,1.2232299585540547,0.2857142857142857,0.8196867411147734,1.0,2/5,17.31%,BMP6;PTPN23
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.45920024549388594,1.223068960549084,0.17391304347826086,0.8189742128215228,1.0,15/96,11.12%,EPB41L4B;DACT2;SRC;PRKX;DUSP1;ADAM8;PLXNA1;TESC;DLL1;NUAK1;FRMD5;CELSR2;CHRD;PKP4;PLXNB2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.7574824004323721,-1.2230305230150083,0.23333333333333334,1.0,1.0,3/6,20.43%,GSTP1;PPIA;FOXM1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.44970515431712127,1.2224348951998545,0.14814814814814814,0.8199674649178681,1.0,16/82,12.87%,B3GNT6;GALNT3;ST8SIA6;EOGT;POGLUT2;GALNT14;TMTC1;OGT;GCNT3;C1GALT1;TMTC2;GALNT2;MUCL1;GALNT18;GXYLT2;POMK
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.7189606608736966,-1.2224224723199653,0.1864406779661017,1.0,1.0,7/11,17.54%,CYP1A2;CYP2A6;CYP2U1;NUDT15;CYP3A4;CYP2E1;CYP2R1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.7423264702251615,1.222413900993814,0.29545454545454547,0.8189163957611426,1.0,3/6,13.39%,HPRT1;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5903332224375812,-1.22114927590635,0.17333333333333334,1.0,1.0,8/36,15.83%,XBP1;SELENOS;PFKL;RACK1;EIF2B1;EIF2B2;GCK;EIF2B4
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.6182616257591803,1.221120897542714,0.25,0.8219052111105118,1.0,6/9,26.89%,ADCY10;ADCY8;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.7527375587649319,-1.221017746259984,0.2545454545454545,1.0,1.0,3/6,21.54%,SYT11;GRN;NR1D1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6341886357146362,1.2210012317853411,0.18181818181818182,0.8212135677199183,1.0,3/14,3.97%,FGFR1;FLT1;PDGFRA
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5395250085903315,1.2206088325609623,0.275,0.8214604477939456,1.0,3/16,11.02%,PLIN5;AUP1;CDS1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5685843150514283,1.2204994061703147,0.25,0.8206123204155151,1.0,9/23,16.92%,STON2;NLGN4X;NLGN1;STX1A;SNCA;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6741993600258263,1.2203604031828834,0.27906976744186046,0.8199852157903867,1.0,3/9,20.77%,TOP1MT;HMGB1;TOP2B
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6979924720713965,1.2201157953480983,0.1956521739130435,0.8197567031473766,1.0,4/10,24.06%,ZFPM2;FGF2;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.5597731800375432,-1.2197954238307671,0.24,1.0,1.0,1/44,0.14%,VAMP5
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7305106797094045,-1.219666943826813,0.22727272727272727,1.0,1.0,2/9,4.54%,BUB1;DDX11
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.7424092733829991,1.2192235579342314,0.21951219512195122,0.8214305015790178,1.0,1/6,2.07%,PIWIL4
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6313677430191719,1.2192129406735803,0.2857142857142857,0.8202313329635739,1.0,4/7,30.70%,PRMT6;PRDM4;PRMT5;CARM1
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.8483127259824188,-1.2190421557971924,0.14035087719298245,1.0,1.0,2/5,11.10%,B2M;BDNF
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.6658281340972343,1.2188104356301084,0.21428571428571427,0.8205762407095344,1.0,2/10,2.85%,KCNJ2;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.694722224289064,1.218356151649655,0.2391304347826087,0.8209201443572535,1.0,2/6,17.54%,PTEN;RGCC
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.4526799492261664,1.2176971287870502,0.06896551724137931,0.8217160013834921,1.0,17/77,12.66%,STAB1;ZNF521;PCDH18;EGFR;CSPG4;EHD2;RND3;GLI2;NOTCH3;CHST3;COL14A1;LOX;COL6A1;COL5A1;TEAD1;TEAD2;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.7188091984849646,1.2174058357274486,0.3142857142857143,0.8214279715751476,1.0,1/5,10.92%,MEGF8
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.646087914095361,1.217167948630474,0.24390243902439024,0.8209836843955015,1.0,2/8,5.48%,PLIN5;SIRT1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.7775502485424427,-1.2170278925186073,0.19298245614035087,1.0,1.0,1/7,2.43%,PRDX1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7014116899154411,1.2164518962541186,0.25,0.8218740347900719,1.0,3/8,17.77%,OTUD7B;YOD1;OTUD7A
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7826784960978871,-1.216027619647243,0.24561403508771928,1.0,1.0,1/6,0.80%,MPV17L2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.7390139357110875,1.2159442582353983,0.24390243902439024,0.8223310568222444,1.0,4/6,8.02%,RUNX1;LEF1;HCLS1;TESC
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.7569468891222206,1.21583623291242,0.35294117647058826,0.8213986017250242,1.0,2/7,7.32%,DPYSL3;DPYSL4
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.5340360227575586,1.2155815376715058,0.17647058823529413,0.8209959643004539,1.0,8/22,14.26%,IRS1;GRB14;PIP4K2A;PTPRE;PID1;ENPP1;KANK1;PRKCZ
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5948628950588646,1.2155279003770396,0.23076923076923078,0.8200096277435729,1.0,3/15,12.51%,IRAK3;IGF1R;CLEC16A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.660897457381153,-1.2154108492987081,0.1791044776119403,1.0,1.0,2/13,4.90%,DNASE2;ENDOG
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.7856429831490932,1.215374171088941,0.2765957446808511,0.8195712084761533,1.0,2/5,11.77%,LETM2;ATP13A2
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.6059349985979504,-1.2153022667888822,0.20634920634920634,1.0,1.0,3/24,3.71%,H1-4;H1-2;RPS3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7710028045342789,1.2152982679197317,0.3404255319148936,0.8186286249183996,1.0,4/5,22.04%,TANK;ITCH;OTUD4;TNIP1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.625706206718746,-1.2151401939863136,0.2714285714285714,1.0,1.0,4/25,6.23%,SBDS;PPIB;RPL13;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4952340567792405,1.2147563585050947,0.19230769230769232,0.8192610712044691,1.0,20/59,14.39%,RAB27A;IGF1;MYOM1;PLA2G10;SYTL4;STX1A;SNCA;BMP6;STXBP5;UNC13D;ADAM8;RAB27B;TGFB2;NMB;CADPS;ATP13A2;SLC12A2;CLASP1;GPER1;GOLPH3
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.5029498695430092,1.2141383681741174,0.12,0.8199692427127633,1.0,6/46,4.12%,ZAP70;IL4R;LCP2;GNLY;KLRD1;HPGDS
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5776828289689308,1.214022627209723,0.17647058823529413,0.8191075542112154,1.0,4/13,14.50%,UBA7;DESI2;UBA3;UBA2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6942278387192617,-1.2134141399315936,0.27692307692307694,1.0,1.0,3/13,9.35%,SLC25A4;SLC25A5;SLC35B2
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),-0.8090053359920952,-1.2128102689574398,0.15384615384615385,1.0,1.0,3/5,18.71%,CALR;PRAME;EZH2
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6158407998440013,1.212730714541439,0.25,0.822056018213502,1.0,1/13,5.48%,SIRT1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.5001735567759177,1.2126326307218889,0.21212121212121213,0.821155210324559,1.0,5/38,3.97%,PDGFB;PDGFC;IGF1;CDK6;PDGFRA
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.5399075704019647,1.2126072115796254,0.21428571428571427,0.8201605981499032,1.0,4/41,4.64%,F2;PLK1;TM4SF20;CLN6
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5106780766524864,-1.2117874451645545,0.14634146341463414,1.0,1.0,12/86,7.43%,HLA-F;B2M;HLA-C;IRF4;MADCAM1;FGL1;HLA-E;HLA-A;IRF1;COLEC12;CD81;ERAP1
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.8167833558607365,-1.211689579344827,0.15625,1.0,1.0,1/5,2.99%,DBI
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7465432572680272,1.2116813750869622,0.28205128205128205,0.8218825019295538,1.0,2/5,9.29%,PLA2G10;NFKB1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.7282919159226094,-1.211621420783383,0.2878787878787879,1.0,1.0,2/6,17.39%,SEMA3A;PTN
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.6544893624396365,1.2115921994814285,0.21875,0.8210626483141684,1.0,4/13,8.80%,DAO;SNCA;DRD4;TGFB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.655197912069196,-1.2113783940750962,0.1774193548387097,1.0,1.0,2/17,14.25%,BEX3;NLRP12
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.5918986354954265,-1.2112054648829151,0.25333333333333335,1.0,1.0,7/25,13.05%,PM20D1;CPS1;ASAH2B;CYB5R3;DDAH2;ARG2;ASAH2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5262438177902958,-1.2109877064319519,0.13333333333333333,1.0,1.0,29/93,20.70%,CLGN;PARP2;BUB1;CCNB2;GSG1;DDX4;CFTR;MEP1B;PEBP1;PCSK1N;HSPA2;NCAPH;TALDO1;TSN;ART3;ZC2HC1C;SCG3;RFC4;GSTM3;SEPTIN4;NEFH;LDHC;SCG5;EZH2;GAPDHS;NPHP1;RPL39L;CCT6B;OAZ3
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6442760624206881,1.2102903405308352,0.2903225806451613,0.8246591644217306,1.0,2/13,7.47%,BAG2;ADAM8
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6062048314730307,-1.2100165597185233,0.25,1.0,1.0,3/25,7.87%,TINF2;NOP10;NHP2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.5967547713011326,-1.209769161358383,0.21052631578947367,1.0,1.0,4/28,9.99%,ACOT2;ELOVL2;ACOT1;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.7030235618129037,1.2096398904747698,0.30303030303030304,0.8254091805578846,1.0,4/7,15.94%,IRAK3;UBQLN4;CLEC16A;TMEM39A
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5653841832298203,1.209612001413254,0.15625,0.8242816229744041,1.0,3/26,3.83%,RUNX1;ZNF366;CNOT2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.7194731770478453,-1.2095614914321051,0.26666666666666666,1.0,1.0,1/6,5.49%,DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.7194731770478453,-1.2095614914321051,0.26666666666666666,1.0,1.0,1/6,5.49%,DPH6
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5706044717393811,-1.2091298793955594,0.22058823529411764,1.0,1.0,9/34,14.88%,CYP1A2;GPX4;CYP2A6;CBR1;CYP2U1;AWAT1;FAAH2;PTGES2;CYP2E1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8351736776118244,1.2090654332181228,0.13513513513513514,0.8248198425607415,1.0,3/5,15.48%,CHRM3;DOCK5;DOCK4
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7606773727053436,-1.209057937963471,0.23636363636363636,1.0,1.0,1/5,7.04%,SF3A1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5858557736310824,-1.2087792955256997,0.1506849315068493,1.0,1.0,16/36,27.97%,LSM2;PRPF3;SNRPD1;PRPF6;SNRPD2;PRPF8;GEMIN6;DDX20;SMN1;SART3;USP4;SRSF10;SNUPN;SNRPG;SNRPE;GEMIN2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7082150389943431,-1.2083283302392742,0.19402985074626866,1.0,1.0,6/11,12.17%,UQCR10;UQCC3;UQCRQ;CYC1;UQCRH;UQCRB
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.548195321477269,1.208209489132,0.21052631578947367,0.8263297988412979,1.0,4/18,15.37%,ATP6V0A4;SCNN1B;SLC12A2;PDK4
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.672361296335338,1.2081004003943654,0.34285714285714286,0.8255296653813377,1.0,1/8,1.62%,CASS4
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.6859585686346463,1.2080355422792575,0.3235294117647059,0.8246937199206279,1.0,3/8,10.72%,ATP12A;ATP1B3;SLC4A4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.7236684180074036,-1.2079779989912536,0.25757575757575757,1.0,1.0,2/8,15.98%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.7162504721263112,-1.2079174715524013,0.2727272727272727,1.0,1.0,5/8,19.46%,LIMA1;VIL1;PLEKHH2;CFL2;WDR1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6886652046993819,-1.2075292789574399,0.31746031746031744,1.0,1.0,2/9,10.29%,FBXO43;TOM1L1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5109196456758534,1.207340789150993,0.21739130434782608,0.8253043544405079,1.0,13/56,11.63%,FLT1;VEGFD;SRC;NRP2;HSPB1;MAPK11;ELMO1;CYBA;DOCK1;ELMO2;PRKD1;PIK3CA;MAPKAPK3
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7982457233467595,1.2073083629429766,0.23809523809523808,0.8242243719033464,1.0,3/6,9.03%,OXTR;TBXA2R;ADRA1A
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),-0.7474542069611133,-1.2067261021151947,0.3064516129032258,1.0,1.0,2/5,10.81%,TCN2;AMN
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6069846009916076,-1.2065128704362167,0.25675675675675674,1.0,1.0,15/43,20.72%,PDHX;GAPDH;LDHA;ENO4;PFKL;SLC16A1;SLC16A8;GCK;TPI1;PDHB;LDHC;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.7314999876728392,1.2061817916145041,0.2972972972972973,0.8266152489649035,1.0,1/5,15.50%,SYK
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.5162131364962027,1.2058958376193105,0.21428571428571427,0.8262744676762004,1.0,11/30,26.74%,PRKRA;NOTCH4;XPO5;DICER1;TNRC6B;PUM2;PUM1;WTIP;ZFP36;CNOT7;TNRC6A
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5443095000706378,1.2055945477091163,0.16666666666666666,0.8260858135958545,1.0,9/28,16.92%,STON2;NLGN4X;NLGN1;STX1A;SNCA;NLGN3;SYNJ2;CEL;SYT5
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6327063180192585,1.2054962657648305,0.2702702702702703,0.8251994668919265,1.0,4/15,17.57%,MTHFS;GLS;GAD1;ALDH18A1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.7055923108320848,-1.2053398612750177,0.2857142857142857,1.0,1.0,3/10,12.37%,DTX3L;RNF8;PAF1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7912925715451631,-1.205306598143939,0.25,1.0,1.0,1/5,1.36%,SLC6A12
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.49868353015464983,1.205032298749966,0.18181818181818182,0.8255404791110188,1.0,19/69,11.40%,ADAM33;ZNF521;ITGA11;PCDH18;CPED1;POSTN;PDGFRA;ADGRA2;ADAMTS2;SSC5D;CDH11;COL14A1;MSRB3;AEBP1;COL5A1;AQP1;SGCD;ZCCHC24;VSTM4
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6893770977216191,1.204978220612997,0.2571428571428571,0.8245068051599771,1.0,2/6,6.31%,MYOF;DYSF
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.503929473653845,-1.203930911878472,0.17721518987341772,1.0,1.0,19/91,14.12%,PLAAT4;PM20D1;PLAAT5;ACOT2;DBI;ORMDL2;MTHFD1;ORMDL1;ACSM6;PDZD11;OXSM;ACOT1;DHFR2;SMPD2;SGPL1;ABCA12;ACSM3;ASAH2;NIT1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5006988073101437,-1.203776157440144,0.1566265060240964,1.0,1.0,17/114,11.31%,CENPF;RPS27;BUB1;STMN1;SBDS;MIS12;CENPE;ERCC6L;CENPH;NUF2;CENPQ;CENPK;DCTN2;NEK6;SPDL1;DCTN6;KIF18A
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.8134853668872439,-1.203689775365759,0.2413793103448276,1.0,1.0,1/6,14.54%,CAV2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.632280394638662,1.2035469774895629,0.2972972972972973,0.8276854605164405,1.0,1/11,4.54%,HNRNPU
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7623014803674707,1.2033383504881001,0.32432432432432434,0.8271583667885581,1.0,5/7,21.94%,PICALM;SNAP91;AP3D1;DNM2;DNM3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.6139348459537571,-1.2033189044810413,0.25,1.0,1.0,4/21,5.16%,CYP1A2;ADH4;RDH12;RETSAT
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.7851019185200911,1.2033007096140205,0.325,0.8261829649694058,1.0,4/6,12.69%,SNCA;DRD4;GDNF;RAB3B
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.639287106911121,1.2027197197634478,0.2564102564102564,0.8259035154284838,1.0,1/13,0.24%,RAB27A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.639287106911121,1.2027197197634478,0.2564102564102564,0.8259035154284838,1.0,1/13,0.24%,RAB27A
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.46822852788997704,1.2026957616801202,0.21052631578947367,0.8248965470051495,1.0,12/55,18.76%,RELN;NLGN1;CACNG5;CACNG4;DLG2;DLG1;GRIN1;DLG3;GRIA2;SHISA9;NPTX2;GRIN2B
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.6414028477625586,-1.2021812926845599,0.19444444444444445,1.0,1.0,7/17,17.99%,MCM4;MCM3;GINS2;RFC4;GINS4;RAD50;POLD2
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.7450665782713592,-1.2017839268376895,0.3137254901960784,1.0,1.0,3/5,23.92%,VAMP8;SNX6;VAMP3
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6441262261776795,1.2015608119443468,0.23076923076923078,0.8275265924106706,1.0,4/8,21.12%,DAO;CBS;GLDC;DLD
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6328809127346563,1.2014250842505971,0.29545454545454547,0.8267993340776754,1.0,6/16,11.11%,OXTR;GLI2;NOTCH4;ARHGAP35;WNT3;GPAT4
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.6623273871901711,1.2012570324732932,0.22857142857142856,0.8262971031594786,1.0,2/7,9.95%,TICAM1;PTPN22
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.4926124465953029,1.2012436399403275,0.15384615384615385,0.8252023104311144,1.0,9/61,8.92%,LEPR;BACE2;IRS1;PPARGC1A;FOXK1;SIRT1;IGF1R;LRRC8A;MLXIPL
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.5233595543580657,1.2012119235603982,0.1,0.8241475833619984,1.0,3/34,3.71%,PDGFB;PDGFC;ERRFI1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.7717544504942824,1.201170361842893,0.3076923076923077,0.8232623266558328,1.0,2/6,11.24%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.5091328349953697,-1.2008076740845186,0.2,1.0,1.0,33/129,19.91%,PSMB8;DDIT3;SFRP1;PSME1;PSMB6;PSMC5;KREMEN1;PSMD8;MESP1;PSMD7;SFRP4;RBX1;FUZ;PSMD3;PSMC3;ANKRD6;PSMA4;GREM1;DACT1;APOE;PSMA7;DKK3;PSMD2;GLI3;TPBG;PSMD6;PSMB2;PSMB4;EMD;PSMA3;CAV1;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.7590196083406109,-1.2007414627349835,0.23636363636363636,1.0,1.0,1/6,1.76%,RPS23
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.7106681739387567,-1.200699010778399,0.2033898305084746,1.0,1.0,5/14,15.35%,IRF1;IFITM3;IRGM;STAT1;CDC34
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.7789052776972087,1.2004571870475516,0.24444444444444444,0.824154006188668,1.0,2/5,15.04%,AKT2;C2CD5
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.7256679913615194,-1.2004167576601161,0.26865671641791045,1.0,1.0,4/11,25.44%,IFITM3;IFNAR1;RO60;KLHL20
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7690410836649053,-1.2003031093801881,0.30303030303030304,1.0,1.0,2/5,19.86%,RPF2;RAN
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5808825394985526,1.1999861797803724,0.21212121212121213,0.8247663649517921,1.0,4/14,11.16%,AK3;RAB23;AK4;RHOQ
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4750413765800422,1.199831246389929,0.12121212121212122,0.8241235254741671,1.0,4/36,6.88%,RIDA;CPEB3;FTO;ZC3H12D
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.6629974699525166,-1.1996710763661182,0.3125,1.0,1.0,1/10,5.27%,ADRM1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.8035418426789185,-1.199334159285678,0.22807017543859648,1.0,1.0,1/5,5.63%,LCLAT1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.4249536985235374,1.199258016507762,0.15384615384615385,0.8247342616329274,1.0,19/121,10.54%,GCM1;FGFR1;RUNX1;CDK6;ALK;DLX1;EPHA3;NLGN1;SERPINF2;NOTCH4;HEMGN;DLL1;SCIN;MOSMO;MAFB;MEGF10;TRPS1;GDNF;PTHLH
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7902886930746496,-1.1990213313235276,0.23333333333333334,1.0,1.0,3/5,16.29%,SEC61B;SRP54;ZFAND2B
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.4381857806917173,1.198938756345483,0.15789473684210525,0.8245160483615319,1.0,28/133,12.59%,RELN;FGFR1;RUNX1;CDK6;IL1RAPL1;SPOCK1;CTF1;ATOH8;PTPRD;TAFA1;CX3CR1;NLGN4X;ASCL1;DOCK7;NTRK2;DLL1;VAX2;ADGRL3;TGFB2;SH3RF1;WNT3;CELSR1;SNPH;PLXNB2;ACSL4;AUTS2;DCDC2;NAV1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.7474011276004717,-1.1984844435570223,0.27586206896551724,1.0,1.0,2/7,16.37%,GEN1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.7474011276004717,-1.1984844435570223,0.27586206896551724,1.0,1.0,2/7,16.37%,GEN1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6596753624401135,-1.1984534363445771,0.25806451612903225,1.0,1.0,1/13,0.80%,MPV17L2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5074591822786065,1.198374857703753,0.25,0.825087878820213,1.0,11/37,14.57%,SPRY2;SPRED3;SPRED2;DUSP6;SPRED1;DUSP10;SMAD4;DLG1;GPER1;PTEN;RPS6KA6
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.7372627307131756,1.1982695097641152,0.28888888888888886,0.8243380767034556,1.0,2/6,12.17%,PLIN5;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.7332893541062568,-1.1980829249720215,0.25396825396825395,1.0,1.0,3/8,13.17%,SIGIRR;GSTP1;APOD
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6423873329170479,1.19779713204624,0.2857142857142857,0.8235942298889698,1.0,3/9,12.61%,NFATC4;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6423873329170479,1.19779713204624,0.2857142857142857,0.8235942298889698,1.0,3/9,12.61%,NFATC4;ADGRB2;NFAT5
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7450461172697764,-1.1977447480058967,0.2857142857142857,1.0,1.0,3/5,19.83%,FLOT1;CAV2;CAV1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5451047628745939,1.1975936547324175,0.21621621621621623,0.8229590346315688,1.0,9/21,17.83%,ZBTB16;SOX5;SCIN;TRPS1;PTHLH;LOXL2;GDF5;ADAMTS7;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6936941867832506,-1.197557751300535,0.31746031746031744,1.0,1.0,2/10,14.18%,DDX11;NCL
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5134060439874558,1.197303998862281,0.20588235294117646,0.8226902653567405,1.0,7/30,11.99%,LETM2;SNCA;CNNM2;SCNN1B;TMTC2;GRIN1;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6716964415864153,-1.1971888729964935,0.22857142857142856,1.0,1.0,3/17,5.92%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5842245101995792,-1.1971054972715927,0.17142857142857143,1.0,1.0,5/37,9.28%,B2M;RPS27A;UBA52;APH1A;ITM2B
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.713352498990533,1.197082464616277,0.28888888888888886,0.8222036830037235,1.0,3/5,14.30%,MTMR2;NLGN4X;PTEN
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6503964294511875,-1.1964581981880031,0.296875,1.0,1.0,1/16,1.48%,SFRP1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.6077476652191957,-1.1964520819057782,0.26666666666666666,1.0,1.0,4/21,13.12%,TGFBR2;MESP1;TGFB1;MYH6
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.6204462912705686,-1.196366522322877,0.2571428571428571,1.0,1.0,7/20,22.15%,DNASE2;ENDOG;MUS81;REXO4;H1-0;DNASE1L1;KPNB1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5038352435444101,1.1962003277269124,0.19444444444444445,0.8239917635776318,1.0,11/42,17.86%,ISYNA1;IP6K2;PLCD3;INPP1;NUDT3;IPMK;PTEN;FGF2;INPP5B;ITPKC;INPP5D
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.6331529985363997,-1.196048069518441,0.30158730158730157,1.0,1.0,2/14,4.70%,NPR2;NPPC
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.6884247949224687,1.196011893087126,0.2222222222222222,0.8234502536767658,1.0,3/7,11.90%,PHYH;HMGCR;MVD
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.5994543122446611,1.1959790879941252,0.20512820512820512,0.822456739594683,1.0,4/17,6.46%,MTHFD2L;MTHFS;ALDH1L1;DHFR
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6462049996801889,1.1955770069893272,0.2571428571428571,0.8226795140311319,1.0,3/11,19.51%,HNRNPU;ESRRB;N4BP2L2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7411327179238711,-1.1953374199661968,0.22857142857142856,1.0,1.0,2/8,3.65%,ZFPM1;EFNA1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5939229718098963,-1.1951057094124329,0.21428571428571427,1.0,1.0,7/31,19.77%,TRMO;TRMT112;TRMT10A;DALRD3;TRMT5;WDR6;HSD17B10
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.49268798343788506,1.1946552070473013,0.21428571428571427,0.8241679745183215,1.0,8/47,6.65%,ARAP1;CDK6;ZSWIM6;ZSWIM4;EGFR;MEMO1;NRG2;DIAPH1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.684175120202162,1.1945503166969025,0.3181818181818182,0.8233039367848956,1.0,3/5,15.94%,UBQLN4;CLEC16A;TMEM39A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.464277026897809,1.1944369256043605,0.11764705882352941,0.8226226156063763,1.0,20/89,13.57%,LIFR;EFNB3;NXN;EYA4;LRP4;GLRB;GLI2;OBSL1;EPB41L1;ZFHX4;CHST3;MEIS3;CACNA2D1;MEX3A;CD276;TEAD1;CDH2;SLIT2;FIGN;MPDZ
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.641191589904474,-1.194435194154884,0.22058823529411764,1.0,1.0,3/16,3.41%,PSMB8;CSTB;SVBP
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6717059316439333,-1.1941397769778155,0.2608695652173913,1.0,1.0,3/16,5.92%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6717059316439333,-1.1941397769778155,0.2608695652173913,1.0,1.0,3/16,5.92%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6717059316439333,-1.1941397769778155,0.2608695652173913,1.0,1.0,3/16,5.92%,CENPF;BUB1;IK
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7131524573032437,-1.1939445240013802,0.29310344827586204,1.0,1.0,2/6,7.91%,XBP1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5034736684977631,1.1934028963872678,0.2,0.8248979864246081,1.0,14/71,8.73%,PDGFB;PDGFC;FGFR1;SPRY2;FLT1;PIK3R5;EGFR;CDK12;DUSP1;IRAK3;TPD52L1;ADAM8;ROBO1;DIRAS2
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5317518367872539,1.1933739944018513,0.3225806451612903,0.8239284598026467,1.0,8/30,12.19%,NRP2;CPNE1;TMEM108;SEMA5B;ALCAM;LLPH;AUTS2;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.6903531667451448,1.1918790617387467,0.3142857142857143,0.8281547680723259,1.0,2/7,8.05%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.7223181503475649,-1.1918668993705472,0.30303030303030304,1.0,1.0,3/7,22.84%,MDH2;MDH1;MDH1B
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.7434919002594216,-1.1918458706426067,0.22413793103448276,1.0,1.0,2/6,11.50%,LARP6;EIF3D
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5682889090900187,1.1918043705375436,0.28125,0.8273091178896812,1.0,9/21,21.81%,HELLS;DNMT3A;TEX15;ATRX;EHMT1;PPM1D;MTRR;FOS;PICK1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.44992741412051385,1.1916768220777236,0.18181818181818182,0.8267166160939952,1.0,32/108,12.66%,ZNF423;EFNB3;GFAP;PTPRD;LRP4;NLGN1;NPAS3;DPYSL3;ADGRB3;PLPPR4;TMEM47;SEMA5B;CDH4;NTRK2;NOTCH3;ASXL3;ADGRL3;SNAP91;CACNA2D1;MAPK10;SHC3;NCAN;DOK5;MEGF10;ZNF536;RCAN2;CORO2B;LRRC4C;SEMA6D;GPM6B;FBXL7;SLIT2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.42410201428108857,1.1916087547530172,0.1,0.8258750999302986,1.0,27/122,12.16%,KCNN4;KCNH4;KCNJ2;ABCC8;KCNIP2;SCN9A;PIEZO2;KCNH3;SLC7A1;SLC47A1;KCNMB4;PKD2L1;PANX2;SCNN1D;SLC22A16;SGK1;KCNN2;SCN7A;AQP1;SLC4A4;SLC22A2;SLC25A29;SCNN1B;KCNN1;GRIN1;SLC12A2;SLC8A2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.5390447557960791,-1.1915431169252277,0.24615384615384617,1.0,1.0,10/53,19.10%,XBP1;SFRP1;ATG14;RRAGA;CARTPT;HSPA8;PDK2;MAP1LC3B;RRAGC;WDR45B
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.6523338218096612,1.1911168443248141,0.3103448275862069,0.826126175562992,1.0,3/7,8.50%,PATL1;DCP1B;DCP1A
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7136506736970408,1.1910661694421796,0.2926829268292683,0.8240591267251434,1.0,3/6,25.80%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7136506736970408,1.1910661694421796,0.2926829268292683,0.8240591267251434,1.0,3/6,25.80%,CNTNAP1;PARD3;NF1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6104591435962861,-1.1910655843037106,0.2608695652173913,1.0,1.0,4/19,5.87%,CLU;GSAP;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5203720771429944,-1.1909342584384777,0.21428571428571427,1.0,1.0,17/64,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.7056563708142706,1.1903548198743106,0.22727272727272727,0.8252552360632625,1.0,3/7,16.87%,UNC13D;ADGRE2;FER
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.584766327821046,-1.1902021946014174,0.21333333333333335,1.0,1.0,6/30,8.81%,MCM2;POLE3;ORC6;MCM4;MCM3;RPA3
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.6545616148866714,1.1900659570746592,0.36585365853658536,0.8250612794363308,1.0,4/10,16.33%,ADAMTS9;ROBO1;ROBO2;PKD2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.6729177888519243,-1.189924336250342,0.27692307692307694,1.0,1.0,4/10,12.25%,DNPH1;HINT1;NUDT15;NT5C
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.5548835704249656,1.189820785601181,0.26666666666666666,0.8248500734090413,1.0,8/19,24.84%,PLA2G10;GDPD3;PNPLA6;GPCPD1;PLA2G4C;SMPD4;PRDX6;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.8005045847529803,-1.1892638252017842,0.21052631578947367,1.0,1.0,2/5,12.52%,XBP1;CD27
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.7658114697334715,-1.1889585078322324,0.22388059701492538,1.0,1.0,2/5,11.01%,SELE;SELP
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.6278192335003772,1.1887229032651527,0.2631578947368421,0.8266434258361839,1.0,2/7,26.39%,H6PD;EGR1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5418450696363241,1.1886707427537742,0.1794871794871795,0.8257399599949186,1.0,5/26,11.90%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.7112346311801334,1.1885027682178766,0.3125,0.8252279947511374,1.0,2/7,10.80%,SLC29A2;SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.648915152593676,1.1884645092994668,0.25,0.8242404041825363,1.0,3/10,17.09%,SESN2;SESN1;KPTN
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.7472397561124176,-1.1883420090556946,0.25,1.0,1.0,2/7,8.50%,IRGM;PHB2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4558855115263927,-1.1882675429071745,0.12359550561797752,1.0,1.0,61/280,19.91%,PSMB8;AFP;FBXW10;BTBD6;PSME1;MEPE;TIMP1;PSMB6;PSMC5;ASB18;ELOB;PSMD8;COPS6;COPS7A;F5;PSMD7;RAB11A;GPC3;FUCA2;COPS5;VWA1;DDA1;DSCC1;SPARCL1;RBX1;PSMD3;PSMC3;SCG3;CHGB;NUCB1;RAB8A;LGALS1;ASB13;PSMA4;FSTL1;FBXW8;RABGGTB;PRSS23;CKAP4;APOE;RCN1;MFGE8;PSMA7;FBXL16;PSMD2;HSP90B1;FBXL13;SPSB3;RBBP5;SHISA5;CP;PSMD6;PSMB2;CST3;ERCC8;PSMB4;IGFBP7;ASB6;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),-0.7259104785442578,-1.1882450388750472,0.2727272727272727,1.0,1.0,4/5,23.48%,GPR62;GPR61;CGAS;SCTR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.6537841651869959,1.187998503312198,0.2727272727272727,0.8245079813063074,1.0,2/12,3.00%,FGFR1;HSPB1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6886389651112164,-1.1879943668844413,0.2698412698412698,1.0,1.0,2/16,4.23%,FABP3;SLC22A9
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.7337625333364003,-1.1879723518969678,0.3055555555555556,1.0,1.0,2/7,6.91%,TGFBR2;CD81
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5617519382846264,1.1878208418996357,0.2413793103448276,0.8241581886580548,1.0,2/17,4.03%,SRC;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.4533741447350847,1.187703726888417,0.19444444444444445,0.8235277626249541,1.0,7/68,6.21%,PDGFB;FGFR1;NRP2;HSPB1;ATOH8;SIRT1;SASH1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5085161772708474,1.187655099786261,0.25806451612903225,0.822617795165702,1.0,12/38,21.06%,KAT2A;SUPT3H;LEF1;TRIM16;PHF14;TAF12;KAT2B;JADE2;JADE3;TAF5L;PER1;DR1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.6830234766693438,-1.1875827138016555,0.19642857142857142,1.0,1.0,1/11,1.25%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7565202402009892,-1.187408896148104,0.2037037037037037,1.0,1.0,2/7,10.07%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6852205994370895,1.1873095873293995,0.2857142857142857,0.8224122165199103,1.0,5/9,25.15%,KDM4C;PHF8;KDM2B;KDM7A;KDM2A
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6334032226201455,1.186545781406601,0.24242424242424243,0.8238372811986806,1.0,3/12,6.91%,SLC26A7;SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.45721387507846395,1.1862181722228755,0.16129032258064516,0.8240332831768884,1.0,12/57,11.52%,AFF2;IGF2BP2;MBNL1;USP36;OAS3;CLK1;AHNAK2;RBM20;MBNL2;MITF;RBM12B;PTBP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.7159132959874834,-1.1860224490155966,0.25806451612903225,1.0,1.0,1/7,6.89%,TNIP2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.7243380287385217,1.1859782948957365,0.30612244897959184,0.8237217768066646,1.0,3/6,12.19%,CHRNA4;DRD4;NLGN3
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.571341873771954,-1.185381700678563,0.2702702702702703,1.0,1.0,6/29,10.80%,B2M;CLU;ARF1;FLOT1;LRPAP1;PIK3CB
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6146089580773179,-1.1850474441124106,0.2537313432835821,1.0,1.0,11/20,31.29%,CLU;GNPTAB;HSPA8;NAGPA;AP3M1;M6PR;HGS;NEDD4;AP4M1;NCOA4;ZFYVE16
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.665364081853839,-1.1850379709146233,0.171875,1.0,1.0,6/18,21.45%,SELENOK;TMCO1;CCDC47;BAX;FIS1;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.7530484102185929,-1.1848267051253694,0.25,1.0,1.0,2/6,15.46%,TIMP1;TIMP2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6343964822080423,-1.1848135270587992,0.2727272727272727,1.0,1.0,4/15,13.02%,DDX60;NOP53;GPATCH3;C1QBP
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.5602120556588956,-1.1847607676870957,0.25,1.0,1.0,9/24,15.94%,STMN1;VIL1;STMN2;KIF18A;STMN3;DSTN;KATNB1;CFL1;CFL2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7606315993723485,-1.1847035607738785,0.3,1.0,1.0,2/5,16.74%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7681954177989476,1.184570345612666,0.30952380952380953,0.8272174223194162,1.0,3/6,21.76%,NLGN1;BTRC;FBXW11
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.7575112250344638,-1.1845044188646485,0.3333333333333333,1.0,1.0,2/5,10.07%,LANCL1;PINK1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6136844468900722,-1.184409273787298,0.28169014084507044,1.0,1.0,5/19,16.07%,MT1E;MT2A;HAAO;MT1G;MT1M
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6689181403312022,1.1842501751328258,0.2972972972972973,0.8271641874543407,1.0,4/7,17.84%,NLGN1;PLXNB2;PTEN;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.549644568543108,1.1842501183345686,0.25806451612903225,0.8261009944113404,1.0,5/23,8.25%,RUNX1;LEF1;HCLS1;TESC;CD4
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7590943669464014,1.1839922580396216,0.34146341463414637,0.8259623639994155,1.0,4/6,21.94%,PICALM;SNAP91;DNM2;DNM3
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6275763431333202,-1.183758103159895,0.23880597014925373,1.0,1.0,1/18,0.62%,RIMS1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5595460648859563,1.183548069565374,0.1935483870967742,0.8264146954535623,1.0,7/23,15.37%,CX3CR1;SIRT1;MITF;C3;NOS1AP;ADIPOR2;PDK4
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),-0.7452497318407695,-1.1833950648747427,0.2786885245901639,1.0,1.0,3/6,20.98%,CALR;C1QBP;CCR7
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.7314681414177696,-1.1829270966274308,0.2835820895522388,1.0,1.0,1/6,1.62%,DTX3L
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5562870260029997,1.1829259854562875,0.23529411764705882,0.8271434451263018,1.0,3/17,4.82%,SLC29A2;SLC15A2;PLA2G10
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.764671581420338,-1.182510656248966,0.22641509433962265,1.0,1.0,2/5,17.02%,ALG10B;GOLGA2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5750658340012587,-1.1822049120677558,0.1917808219178082,1.0,1.0,7/31,11.92%,ARHGEF16;HR;ITGB4;TMEM54;KRT86;S100A16;ABCA12
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.4230320413669007,1.18218432176458,0.11764705882352941,0.8283554687900971,1.0,9/78,8.84%,DACT2;CHRNA4;ABCC8;CELF3;TMEM74B;CAMSAP3;SEMA5B;CACNG4;TOX3
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.4614346068886269,-1.182025494793524,0.14444444444444443,1.0,1.0,52/265,19.32%,RPS27A;PARP2;DTX3L;NUDT1;CENPX;ALKBH2;APEX1;USP1;RAD23A;PCNA;EME1;PNKP;UBA52;MPG;NOP53;ABRAXAS1;UBXN1;RNF8;WDHD1;FAM111A;CETN2;RPA3;FANCM;RAD51AP1;RFC2;TEX264;PARP1;BRCA1;KPNA2;SPRTN;MBD4;KAT5;MUS81;PARP9;RFC4;UBB;MGME1;FANCD2;RAD50;XRCC2;FANCF;XRCC3;REXO4;XPA;POLD2;GTF2H2;DDX1;FANCI;ERCC8;RECQL;POLQ;POLD4
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7554846281872336,1.1817562038746485,0.26666666666666666,0.8285780559612276,1.0,2/5,16.25%,CNTNAP2;CNTNAP1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6919464586353181,1.1815670696428153,0.25,0.828108789301471,1.0,2/8,4.85%,PLIN5;ACADVL
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.49397419699482775,-1.1815281909579551,0.1566265060240964,1.0,1.0,32/133,20.81%,EHHADH;PSME1;H2AZ1;LDHA;ACOT2;IDH3B;APEX1;RETSAT;HCCS;CA6;CBR3;CBR1;BPHL;TP53INP2;UROD;ACSM3;IDH3G;DECR1;LGALS1;MDH2;MDH1;HMGCL;PDHB;GSTZ1;EPHX1;HPGD;GAPDHS;GPD1;HSD17B10;FASN;PTS;ECHS1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.518718582275005,1.1814643711398232,0.2647058823529412,0.8273990763399871,1.0,8/26,18.99%,ARHGEF7;ARHGEF6;SPEF1;GOLPH3;CYFIP1;PTPRO;WHAMM;SNX1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.771194573838344,-1.1813387697092175,0.22727272727272727,1.0,1.0,3/6,17.52%,FABP3;HTR2B;HTR2A
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.4962755963452987,1.1810424621414157,0.16129032258064516,0.8277771743030743,1.0,10/41,17.86%,ISYNA1;IP6K2;PLCD3;INPP1;NUDT3;IPMK;PTEN;INPP5B;ITPKC;INPP5D
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.626125145918391,-1.180943490326851,0.25,1.0,1.0,6/17,18.42%,DUOX1;ACTG1;HRAS;GRN;PTN;SCARF1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.656805472166292,1.1805673093938345,0.24324324324324326,0.8280682300494395,1.0,6/7,34.10%,PHYH;HACL1;SLC27A2;PECR;SLC25A17;PEX13
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.681073111735021,-1.1804171361765285,0.29310344827586204,1.0,1.0,2/9,11.37%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.6948849098857122,-1.180366123652767,0.2222222222222222,1.0,1.0,4/8,23.10%,TGFB1;GREM1;MYOCD;EFNB2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.7455431905593802,1.180290638963088,0.36,0.8276363812881659,1.0,2/5,19.43%,SLC38A2;SFXN1
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.56093389892726,1.179926264631692,0.20689655172413793,0.8275490798172078,1.0,7/18,20.71%,CDH8;UNC13A;GRID1;NAPB;GRIK2;GRIA2;GRIK1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5798803816531731,-1.1798204865564954,0.2698412698412698,1.0,1.0,10/33,22.36%,RPS27A;UBA52;MAD2L1BP;PHB2;ANAPC15;UBB;CDC23;ZW10;CDC20;UBC
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6089198391112506,1.1796867428839293,0.23076923076923078,0.8273762448960065,1.0,5/17,11.16%,LLGL2;STRIP1;FMNL2;DLG1;RHOQ
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6712172006613841,-1.1796690077629255,0.22413793103448276,1.0,1.0,8/13,24.81%,LSM2;PRPF3;PRPF6;PRPF8;DDX20;SART3;USP4;SRSF10
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.6541761671342003,-1.179658624837063,0.30434782608695654,1.0,1.0,4/10,23.86%,ACMSD;GCK;PGP;BCKDK
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4896647759063684,1.1796237807690602,0.17857142857142858,0.8265015493364265,1.0,10/46,20.99%,CHD5;LEF1;TRIM16;MSL2;OGT;KANSL2;JADE2;JADE3;ZZZ3;PER1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.7483884616563704,-1.1795623276890697,0.2878787878787879,1.0,1.0,1/6,3.81%,CPTP
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.7592493864709741,-1.179511524315432,0.25925925925925924,1.0,1.0,2/5,10.46%,ATG14;GPS2
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.757443714483043,1.179452810643442,0.1875,0.8259712142637857,1.0,2/7,12.69%,PICALM;RAB3B
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.47728156746333505,1.1793708399659761,0.2,0.8252030125958983,1.0,15/84,9.34%,PDGFB;PDGFC;FGFR1;FLT1;SRC;PIK3R5;EGFR;SIRT1;PKD1;SNCA;TPD52L1;ADAM8;ROBO1;DIRAS2;PARP16
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5597372143711438,1.1791638405204066,0.21621621621621623,0.8248633582158028,1.0,6/18,10.27%,ST8SIA6;GANC;ST8SIA1;ST8SIA4;MAN2A1;FUT8
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.673284771555136,-1.1790803456656778,0.2698412698412698,1.0,1.0,3/11,13.02%,TIMP1;CALR;C1QBP
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5454229310759336,-1.1784487044608707,0.22077922077922077,1.0,1.0,7/49,6.09%,ARHGEF16;TMC4;CFTR;EFNA1;TMEM125;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7148344024834019,1.1784021054822669,0.2765957446808511,0.8259732155282106,1.0,1/6,1.91%,PLIN5
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6768467200665841,-1.178250955634797,0.2898550724637681,1.0,1.0,2/11,2.82%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6439400069695513,-1.1781406868379158,0.27941176470588236,1.0,1.0,4/18,13.02%,RPS13;RPS26;SRSF7;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7104292214596637,-1.177895337618313,0.30666666666666664,1.0,1.0,3/10,13.76%,BUD23;TRMT112;DIMT1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.7379563430036995,1.1772357458556086,0.3148148148148148,0.8283569053970097,1.0,4/6,24.93%,PDGFRA;NIPBL;EPHB3;BBS7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.5527404343541678,-1.1767290978402625,0.25,1.0,1.0,3/45,7.22%,ARHGEF16;RHOG;RACK1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4517747036353807,1.1765410934021205,0.14814814814814814,0.8295275952829451,1.0,24/92,12.81%,KCNN4;SLC26A7;CHRNA4;SLC15A2;PIEZO2;GLRB;SLC24A3;SLC26A6;PKD2L1;PANX2;LRRC8A;P2RX1;KCNN2;GABRB1;SLC25A18;SLC9A2;SLC26A3;KCNN1;GRIN1;SLC12A2;SLC8A2;SLC32A1;SLC1A2;SLC26A9
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.5660959995069123,1.176515248914406,0.3235294117647059,0.8285390238818139,1.0,5/18,10.13%,RUNX1;CTSK;ERRFI1;DLL1;SULT2B1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7582735850878932,1.1764327273090913,0.35714285714285715,0.8278242502709604,1.0,4/5,22.75%,HS2ST1;HS3ST5;HS6ST3;HS6ST1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6810509146404171,-1.176324857582521,0.19718309859154928,1.0,1.0,3/14,11.40%,RPS13;TGFB1;RPS26
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6613113270100127,1.1755355669103835,0.3170731707317073,0.8296009301464381,1.0,5/13,17.73%,IGF1;AKAP6;ZFPM2;FGF2;ERBB4
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7027896259170439,1.1749105979152565,0.3111111111111111,0.8302398445494462,1.0,3/6,21.57%,AKT2;ERBB4;ZNF703
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.6929520200987505,-1.1749010283187318,0.31666666666666665,1.0,1.0,3/9,12.22%,SPAG17;SPEF2;SPA17
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6397707103082256,1.174831795444946,0.25,0.8283913513805168,1.0,1/12,0.24%,RAB27A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6397707103082256,1.174831795444946,0.25,0.8283913513805168,1.0,1/12,0.24%,RAB27A
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5579133750437024,1.174572482646508,0.21212121212121213,0.8282373306671021,1.0,5/25,12.51%,RAB27A;CLEC7A;CYBA;C3;MERTK
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5448811601907104,1.174500216884958,0.2222222222222222,0.8274104401553689,1.0,4/20,9.56%,HELLS;SIRT1;CDKN2A;BAHD1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.48803234269369966,1.1744124740078996,0.25,0.826551980623251,1.0,13/62,11.61%,FGFR1;IGF1;IRS1;PIK3R5;PLCL2;PDGFRA;PLCL1;IGF1R;PLEKHA1;OGT;PLCD3;PIK3CA;PI4KA
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.49567588502259635,-1.1744075926535982,0.189873417721519,1.0,1.0,9/78,11.10%,CD44;RACK1;IRGM;CAMK1;HAX1;TGFB1;PINK1;MTCP1;BDNF
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.6463859565167389,-1.1742230800915199,0.2727272727272727,1.0,1.0,6/17,21.21%,SLC8A3;SRI;C12ORF57;CALM3;PRKACA;CALM1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5273103035962022,1.1742192507269162,0.29411764705882354,0.8261489677747619,1.0,4/19,15.28%,HSPA1A;HSPA1B;DCUN1D1;ITCH
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6721543844893693,-1.1736203071700224,0.27692307692307694,1.0,1.0,3/10,13.34%,FLII;MYH6;LMOD1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.6650202529112688,1.1736076071058914,0.36363636363636365,0.8269878450865231,1.0,2/6,10.33%,NOS2;ARG1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.5487846061209704,1.173598797486458,0.36363636363636365,0.8259656104201615,1.0,6/22,10.92%,FGFR1;FGFR3;PDGFRA;WWOX;DSCAML1;MEGF8
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.6633127212223568,1.1733908407530176,0.30303030303030304,0.8255480867112053,1.0,1/7,3.09%,TAL1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5155315543160377,-1.1732912707920433,0.2028985507246377,1.0,1.0,25/75,27.36%,COPE;TMED9;CENPE;ARF5;KDELR1;USE1;KIF18A;ARCN1;KDELR3;KIF4A;TMEM115;LMAN2;COPZ1;ZW10;NAPA;BNIP1;TMED2;KIF22;TAPBP;ARF4;SURF4;RER1;RAB1B;KIF3A;RAB6C
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5155851383263562,1.1731579751356382,0.2727272727272727,0.8251315926538129,1.0,9/32,12.72%,RAB27A;SYTL4;SNCA;STXBP5;UNC13D;RAB27B;CADPS;ATP13A2;CLASP1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.4994927991118278,1.172805756385271,0.22857142857142856,0.8254169454297224,1.0,10/24,23.31%,MTMR2;MTMR11;PTEN;SYNJ2;INPP5B;MTMR3;MTMR12;MTM1;PIP4P2;MTMR9
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.6826974224145519,-1.1727868188743849,0.28169014084507044,1.0,1.0,6/14,25.32%,EME1;MUS81;FANCD2;MDC1;RAD9A;HUS1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6923602645280803,1.172587133138549,0.4146341463414634,0.8250349686427481,1.0,4/5,30.19%,PER1;CRY1;LMO3;CLOCK
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.6092100929502777,-1.1724824832117562,0.2702702702702703,1.0,1.0,5/18,15.01%,NOP10;NHP2;CCT7;EXOSC10;CCT2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5622601537332819,-1.172354072010285,0.30666666666666664,1.0,1.0,6/48,11.10%,B2M;DTX3L;RPL11;BAMBI;FLOT1;BDNF
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.40829577266209194,1.172260619929403,0.0,0.8248869633960061,1.0,41/139,20.45%,FGFR1;FLT1;FGFR3;PASK;SRC;ALK;EGFR;PDGFRA;PRKX;CDK12;IGF1R;TNIK;NTRK2;MYO3A;GRK5;MEX3B;VRK2;ULK3;MKNK2;PRKD1;MAPKAPK3;ATP13A2;HCK;SMG1;UHMK1;DYRK1A;GSK3B;FLT3;CAMK2D;FER;ABL1;ERBB4;PIM3;MKNK1;SIK2;PIKFYVE;PEAK1;MAPKAPK2;MAP3K10;CSF1R;MARK2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7406241489301493,1.1722181980112027,0.2564102564102564,0.8239745809063928,1.0,1/7,1.27%,KAT2A
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.7214265810783199,1.172197874325618,0.32653061224489793,0.8229648081356741,1.0,3/5,19.75%,HMGB1;RAD51;APLF
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.49313092988190554,-1.1719113073742993,0.2361111111111111,1.0,1.0,12/72,9.64%,RHOC;CLU;RPS3;HRK;CHMP2A;SYNPO2L;RACK1;TRABD2B;BRK1;VIL1;FLOT1;TGFB1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.5809351344959952,1.171800826892962,0.1794871794871795,0.8231018098333672,1.0,1/15,1.07%,IGF1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.7400472992506457,1.1717204526488385,0.27906976744186046,0.8223440302197598,1.0,3/6,21.76%,MTCL1;MAP2;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5805076112205717,-1.171404947292399,0.31746031746031744,1.0,1.0,2/17,7.57%,B2M;CALR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7388422302540916,1.1711990212920798,0.35294117647058826,0.8228123272642869,1.0,2/5,17.84%,ADRA1A;WNT5A
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5230488251501426,-1.1711296080964193,0.22972972972972974,1.0,1.0,11/64,14.51%,HSPE1;NLRP1;BEX3;KHDC1;RACK1;LCK;FADD;PDCD2;RPS27L;NLRP12;MTCH1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.6716497391575296,-1.1706955336157623,0.2857142857142857,1.0,1.0,2/10,6.33%,ALKBH2;MPG
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.6716497391575296,-1.1706955336157623,0.2857142857142857,1.0,1.0,2/10,6.33%,ALKBH2;MPG
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.6872263071161442,-1.1705428049871003,0.3442622950819672,1.0,1.0,1/8,1.48%,CPS1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.7530521971704995,-1.1704580710324202,0.2857142857142857,1.0,1.0,2/6,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.599304352606191,1.170406865606213,0.2682926829268293,0.8242213171531314,1.0,3/13,15.56%,PLIN5;GPLD1;NR1H3
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.7259638700584407,1.1703575080883366,0.36363636363636365,0.8234154330502919,1.0,3/6,14.14%,TMEM98;LEF1;HMGB1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.756199599321681,-1.1703259859316655,0.3225806451612903,1.0,1.0,2/6,14.47%,ACTA2;EDN1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.4606359032022335,1.170119396146195,0.23076923076923078,0.8230235902021682,1.0,16/47,24.42%,CASS4;TNIK;MKLN1;RICTOR;GAB1;AUTS2;ATP2C1;THSD7B;FER;WHAMM;THSD7A;PHACTR1;RAP2A;RALA;MCU;FLNA
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6467514781526551,1.1700774734386457,0.2619047619047619,0.8221388038715309,1.0,2/10,2.85%,KCNJ2;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5673705062119093,-1.169466384103502,0.21428571428571427,1.0,1.0,9/34,12.44%,RPL23;RPL5;RPS7;RPL11;NOP53;UBXN1;PDCL3;GIPC1;CAMLG
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6421223326050788,1.1692406062943859,0.25,0.823804862759728,1.0,4/8,18.42%,CLEC16A;SMG1;LARP1;RPTOR
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7852436970734084,-1.1691479557208682,0.3114754098360656,1.0,1.0,2/6,9.20%,GALK1;GALE
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5204586411310551,1.168991101863759,0.25,0.8235782055553658,1.0,7/23,18.15%,ARHGEF7;ARHGEF6;SPEF1;GOLPH3;CYFIP1;PTPRO;WHAMM
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5643111820860747,-1.1686524082134186,0.25,1.0,1.0,11/34,22.88%,B2M;CLU;CD63;SFRP4;SELE;GREM1;SERPINE1;ANGPT1;DGKD;ATAD1;PPT1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6807669831202877,-1.168568640585128,0.22727272727272727,1.0,1.0,4/10,19.28%,TGFBR2;CD81;HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5341982698727779,1.1684111481754946,0.20512820512820512,0.8244511247409625,1.0,6/27,14.57%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD;SC5D
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.59890985992665,-1.16816107302359,0.3142857142857143,1.0,1.0,2/18,2.84%,MT1E;MT2A
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7246255022520555,-1.1680957497739075,0.2711864406779661,1.0,1.0,4/8,16.74%,PPIB;CAV2;CFL1;APOE
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.5543638372734837,-1.167822308604082,0.1917808219178082,1.0,1.0,7/30,19.24%,TAX1BP3;RIC3;TMEM35A;BDNF;MAP1A;RANGRF;GOPC
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.5830662782891324,1.1677384672687403,0.30303030303030304,0.825174480819047,1.0,2/15,1.47%,ZAP70;GNLY
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.599787581463374,-1.167251783891804,0.3181818181818182,1.0,1.0,4/22,7.51%,NOX4;CPS1;TST;MTHFD1
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7620797349689497,-1.1669299735649556,0.2727272727272727,1.0,1.0,4/5,21.87%,VPS25;VPS28;SNF8;VPS36
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7620797349689497,-1.1669299735649556,0.2727272727272727,1.0,1.0,4/5,21.87%,VPS25;VPS28;SNF8;VPS36
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5999864131706774,-1.1663144963235912,0.24324324324324326,1.0,1.0,1/22,0.08%,CD44
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7205283648262755,-1.1660351105682958,0.40350877192982454,1.0,1.0,2/5,23.79%,CALR;TAPBP
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6910259204204456,1.1659124814321449,0.2553191489361702,0.829348846192064,1.0,1/7,0.92%,ISYNA1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.6960725085512303,1.165352257973686,0.4117647058823529,0.8298847647591686,1.0,1/8,2.40%,SRC
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.6330171203956565,-1.1652106275206668,0.3157894736842105,1.0,1.0,1/10,5.46%,CXCL17
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6406912233785418,-1.1648609653473705,0.29508196721311475,1.0,1.0,1/13,0.70%,TINF2
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.7462109204351938,-1.164741193737551,0.3220338983050847,1.0,1.0,4/5,22.92%,FUCA2;CAV1;ITGAV;EXOC7
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5654736480666909,1.1646545746061883,0.21621621621621623,0.8301374974436255,1.0,3/13,15.53%,CPEB3;NANOS3;TNRC6B
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5654736480666909,1.1646545746061883,0.21621621621621623,0.8301374974436255,1.0,3/13,15.53%,CPEB3;NANOS3;TNRC6B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.45943435172300506,1.1644733068650235,0.1875,0.8297097146347258,1.0,9/51,11.01%,PNLDC1;CNOT2;EXOSC7;SAMD4A;PATL1;DCP1B;DCP1A;CNOT11;CNOT4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.6039440665325221,-1.1643675977196122,0.3548387096774194,1.0,1.0,7/19,23.58%,CYP1A2;CYP3A4;GLYATL2;LIPH;LIPI;PPT1;CYP4F12
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.8038587194791706,-1.1642803199885805,0.22413793103448276,1.0,1.0,3/5,10.12%,HAX1;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.589261137083089,1.1642348794521444,0.2894736842105263,0.829624535530365,1.0,4/16,10.24%,PSTPIP1;NT5E;P2RX7;C3
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7154307404066533,1.1640485524089086,0.37209302325581395,0.8292146396917983,1.0,2/6,10.80%,ABCC2;SLC22A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.4816449767915525,-1.163887607870581,0.21794871794871795,1.0,1.0,21/77,22.82%,HLA-DPA1;DCTN3;CENPE;ARF1;DCTN2;DCTN6;KIF18A;AP2S1;CLTA;DYNLL1;CANX;KIF4A;DCTN1;CTSS;HLA-DRA;HLA-DRB1;AP1S1;AP2A2;HLA-DPB1;KIF22;CTSL
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.5698547067857096,1.1638527414087567,0.32142857142857145,0.8287570458586169,1.0,2/9,4.44%,CD200R1;CX3CR1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.526033281201853,1.1636320979572115,0.24242424242424243,0.8283815826669432,1.0,1/17,1.07%,IGF1
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7036117608126378,-1.163468441454175,0.25806451612903225,1.0,1.0,5/9,20.61%,ATP5MC3;ATP5PB;ATP5PD;ATP5MC1;VPS9D1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.7088239689349976,-1.1632696247058427,0.26153846153846155,1.0,1.0,1/10,0.93%,NLRP1
prerank,GO_Biological_Process_2021__cellular response to salt stress (GO:0071472),0.6764722327193822,1.1630155332338006,0.35714285714285715,0.8292372909945314,1.0,1/5,9.57%,AQP1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5419284667576564,-1.1627129660841016,0.2441860465116279,1.0,1.0,15/53,21.04%,DDIT3;BTN3A1;ZFPM1;HLA-DPA1;HLA-A;RASGRP1;FADD;CR1;C1QBP;ZP3;PDCD1LG2;HLA-DRB1;CD226;CCR7;HLA-DPB1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5226060933203416,-1.1624504902061614,0.23943661971830985,1.0,1.0,2/35,6.19%,EPN1;VPS25
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6319494615085058,-1.1624074448946529,0.27419354838709675,1.0,1.0,5/18,15.83%,SELENOS;PFKL;EIF2B1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5862366404226225,-1.1622289577830136,0.31343283582089554,1.0,1.0,1/20,0.80%,MPV17L2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6353848488816686,-1.1622039626090142,0.2857142857142857,1.0,1.0,6/12,24.79%,COLEC12;FLOT1;PQBP1;CGAS;CAV1;IFIT1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7211277523407607,1.1620139082277379,0.29545454545454547,0.831675470377697,1.0,2/7,16.05%,RFX3;GSK3B
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.47369712453174573,-1.1619219472352647,0.15384615384615385,1.0,1.0,14/107,14.25%,LIX1;TOMM7;ATG14;CHMP2A;VPS25;VAMP8;ATG10;TOMM20;VPS28;PINK1;GABARAPL2;ACBD5;SNF8;DYNLL1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.7532224539605308,-1.161812834698389,0.3442622950819672,1.0,1.0,1/5,0.79%,GLYCTK
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.7532224539605308,-1.161812834698389,0.3442622950819672,1.0,1.0,1/5,0.79%,GLYCTK
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5955131332581481,1.161696380356617,0.25,0.8318146466953371,1.0,7/20,18.28%,RUNX1;SNAI1;PDLIM5;RAPGEF1;CBFB;RAP1A;TJP1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6439996725179334,-1.1614818747679603,0.2753623188405797,1.0,1.0,7/15,17.93%,GSTM4;GSTP1;GSTK1;AKR1A1;MGST3;GSTM3;GSTZ1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6439996725179334,-1.1614818747679603,0.2753623188405797,1.0,1.0,7/15,17.93%,GSTM4;GSTP1;GSTK1;AKR1A1;MGST3;GSTM3;GSTZ1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.49565595559575176,-1.161413764942809,0.18055555555555555,1.0,1.0,21/88,16.44%,MCM2;RMI1;AP5S1;MCM4;MCM3;RPA3;FANCM;RAD51AP1;GINS2;PARP1;BRCA1;KDM4D;SFR1;MEIOB;GEN1;MUS81;GINS4;RAD50;XRCC2;XRCC3;MCM5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.6861759560951839,-1.1613363367029452,0.3709677419354839,1.0,1.0,2/8,10.07%,LANCL1;PINK1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6131008698188851,-1.1610658132600218,0.2727272727272727,1.0,1.0,4/20,3.57%,RPL23;RPL5;RPS7;RPL11
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.4560027182429518,1.161031508269207,0.25,0.832759991981675,1.0,8/50,8.21%,ZNF423;SNAI1;ASCL1;PBX1;MAML2;NOTCH4;NOTCH3;DLL1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.665147616835517,-1.1607606521453306,0.2463768115942029,1.0,1.0,2/13,9.20%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.665147616835517,-1.1607606521453306,0.2463768115942029,1.0,1.0,2/13,9.20%,SLC8A3;SLC24A1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.7871782597032253,-1.1606771071239859,0.23728813559322035,1.0,1.0,1/5,11.89%,NUDT15
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.41275204681403604,1.1604527494492112,0.05263157894736842,0.8334130942315618,1.0,52/128,21.34%,GFAP;EGFR;CTNNA2;DAO;MMD2;ALDH1L1;NPAS3;PSD2;ADGRB3;PLPPR4;P2RX7;AMER2;CDH20;NTRK2;ZEB2;AKAP6;MAPK10;GRM3;DLG2;SLCO1C1;NCAN;CDC42EP4;LRRC4C;SLC4A4;NRXN1;GPM6B;SLC1A2;ADCY8;MAGI2;CADM2;P2RY1;GRIN3A;RUFY3;NFASC;RAPGEF4;KIF1B;GRIA2;CA10;FABP7;RFTN2;ADGRA1;GRIN2B;SPHKAP;ADCYAP1R1;KCNIP1;SLC6A1;TNR;BICD2;ATP1A2;GABRG1;GRM5;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4859092832429391,-1.1603677992820698,0.20987654320987653,1.0,1.0,38/152,19.91%,PSMB8;DDIT3;SFRP1;TAX1BP3;PSME1;PSMB6;PSMC5;KREMEN1;PSMD8;PSMD7;SHISA2;SFRP4;RACK1;TRABD2B;NFATC1;RBX1;FUZ;PSMD3;PSMC3;ANKRD6;PSMA4;GREM1;RNF213;DACT1;APOE;PSMA7;DKK3;PSMD2;GLI3;TPBG;PSMD6;PSMB2;PSMB4;EMD;PSMA3;CAV1;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.5987471490139874,-1.1602084670666248,0.25,1.0,1.0,5/24,8.84%,PIGH;PGAP4;PIGC;PGAP2;DPM3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6549237870918346,-1.1601887853567903,0.3382352941176471,1.0,1.0,2/12,7.53%,CSTF2T;FIP1L1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.44617895470336677,1.1601104619140852,0.23529411764705882,0.8333083355863644,1.0,28/116,13.57%,ZNF423;LIFR;FRZB;EFNB3;ABCC8;LRP4;LIMCH1;DPYSL3;PLPPR4;OBSL1;TMEM47;EPB41L1;CHST3;MEIS3;GFRA1;HTRA1;NUAK1;CACNA2D1;COL6A1;CBS;TEAD1;SEMA6D;PTH1R;SRRM3;FBXL7;SLIT2;FIGN;MPDZ
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6212077827090277,-1.160039607845001,0.3194444444444444,1.0,1.0,5/18,9.88%,HLA-F;HLA-E;HLA-A;CEACAM1;FADD
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.46461381189484774,1.1600317983807287,0.2222222222222222,0.8325287760832356,1.0,9/61,10.09%,FGFR1;ALK;CPNE1;MMD2;NLGN1;ASCL1;DLL1;MOSMO;BRINP3
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5050669693604878,1.1599596215024228,0.24,0.8317992245613706,1.0,4/30,6.31%,RAB27A;CLEC7A;CYBA;DYSF
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4983016176073585,-1.1599420475361666,0.20253164556962025,1.0,1.0,19/84,15.99%,MPV17L2;POLR2G;EIF2S3B;RPL5;RPS9;RPS4X;RBM3;LARP6;JMJD4;EIF3D;YBX3;EEF2;C1QBP;RPS27L;EIF5A;PYM1;EIF4A3;CIRBP;METTL3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5471618952436529,-1.1597370456405505,0.2676056338028169,1.0,1.0,6/29,13.17%,GALK1;FUCA2;FUCA1;PMM1;AKR1A1;APOD
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.7555435902024786,-1.1593776927420592,0.2711864406779661,1.0,1.0,2/8,2.92%,CYP1A2;CYP2A6
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6187385587134706,1.159246088063659,0.2619047619047619,0.8330917547254512,1.0,4/10,17.04%,TGFB2;ACVR1;BMPR2;MDM4
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6211996022937988,-1.1592113935327326,0.2833333333333333,1.0,1.0,2/14,7.22%,KIF20B;RACK1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.46274996537826824,1.1591967852434748,0.20588235294117646,0.8322671687946508,1.0,12/36,19.19%,ZNF207;PLK1;MTCL1;NCKAP5;SPEF1;NAV1;CLASP1;JHY;DCX;CFAP74;CDK5RAP2;MARK4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.4633500834593842,1.1591224902165864,0.21428571428571427,0.8316044969478287,1.0,17/96,14.29%,IGF1;RRAS2;TIAM2;MAPK11;ARHGAP31;CNKSR1;PLD1;SHC3;CDKN2A;MRAS;ZNF304;SIAH2;RUNDC3A;PRKD1;ARHGAP32;G3BP1;RASGRP2
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.783832973530117,-1.1590983677327882,0.22058823529411764,1.0,1.0,1/6,5.17%,CHMP2A
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4079439124670086,1.1590729380809837,0.11764705882352941,0.8308475209846541,1.0,37/325,6.81%,ZAP70;PDGFB;SH2B2;PDGFC;NFATC4;FGFR1;IGF1;GALNT3;ATP6V0A4;LCP2;CASS4;FLT1;IRS1;EFNB3;FGFR3;VEGFD;SRC;ALK;FGF17;NRP2;SPRED2;ARHGEF7;MAPK11;EGFR;CNKSR1;PDGFRA;EPHA3;GRB14;SPRED1;FRK;AKT2;ELMO1;CYBA;SORBS1;DOCK1;IGF1R;HAP1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6946344093948301,1.1587909940184826,0.4146341463414634,0.8307785659851774,1.0,3/6,21.15%,NLGN3;TSHZ3;ATP1A2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7453478508515791,1.1587870661500024,0.3333333333333333,0.8298011794369596,1.0,4/5,25.43%,ALDH1A1;GAD1;ABAT;GAD2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.5675586318920843,1.158735321186246,0.25,0.8290012265386731,1.0,7/15,25.80%,TAFA1;CX3CR1;SMARCD3;DRD2;KDM1A;FZD3;NF1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.5689446973356913,-1.158653907116397,0.2647058823529412,1.0,1.0,8/29,19.43%,POLR1G;POLR2L;POLR1F;POLR1H;TTF1;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.59423150553265,1.1585809166618104,0.25,0.8284416938184368,1.0,2/11,14.09%,HNRNPU;GPER1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.751394251835816,-1.1581267194042681,0.23728813559322035,1.0,1.0,3/7,12.49%,CPS1;SLC25A15;ARG2
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.6414741237276788,-1.1580127187765787,0.3064516129032258,1.0,1.0,1/10,6.91%,CD81
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5383319591616197,1.1576605669735525,0.2727272727272727,0.8302661000483351,1.0,12/59,9.80%,FHDC1;EPB41L4B;TCAP;SRC;MYH3;MYH14;SORBS1;OBSCN;EPB41L1;FRMD3;FRMD5;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5978856878788088,1.1570679066076583,0.2857142857142857,0.8312770890598162,1.0,2/20,0.50%,PDGFB;PDGFC
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),-0.7255078927519693,-1.1568605673065668,0.3076923076923077,1.0,1.0,4/5,21.25%,SLAMF8;PTN;NINJ1;ALOX5
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5366994119812984,1.1568501075246431,0.27586206896551724,0.8310654923180945,1.0,5/19,7.34%,AK3;ADSS2;HPRT1;AMPD1;AK4
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5783523731647737,1.15683026104785,0.3142857142857143,0.8301421069499431,1.0,2/12,14.10%,GFPT2;GFPT1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.5911462516295187,-1.1567305475140304,0.27692307692307694,1.0,1.0,7/26,14.32%,RPS27A;CFTR;UBA52;ARL13B;ACBD5;DYNLL1;UBB
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.6010957236791357,-1.1563878299926822,0.3220338983050847,1.0,1.0,1/16,1.25%,XBP1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.48248649422240963,1.1563089602380747,0.3076923076923077,0.8303750095500467,1.0,8/52,9.23%,ZAP70;CHRNA4;IFNA2;HDAC4;CD22;NHEJ1;LAT2;MALT1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6762448288619448,-1.1561911558549345,0.30434782608695654,1.0,1.0,4/10,7.91%,HLA-F;HLA-E;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7181811293899024,-1.1559724574828631,0.29508196721311475,1.0,1.0,3/8,11.62%,MANF;LMX1B;CDNF
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.6745818669881098,-1.1558613291311346,0.27941176470588236,1.0,1.0,2/8,7.08%,SLC3A1;SLC7A7
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6758446111364474,-1.1555526814274428,0.29508196721311475,1.0,1.0,3/9,18.68%,CLU;APOE;ABCA5
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.564425798543591,-1.1550203820224425,0.26666666666666666,1.0,1.0,4/24,5.80%,MMP21;TGFBR2;MESP1;CCDC39
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.6557360431297935,-1.154892772092959,0.38333333333333336,1.0,1.0,4/11,22.40%,RAG2;FADD;GLI3;ADAM17
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.6222457621855543,-1.154798371819345,0.2028985507246377,1.0,1.0,4/12,25.79%,ELOVL2;ELOVL1;FADS2;ACOT8
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.39820122987969514,1.1544673178822693,0.21428571428571427,0.8349026885516617,1.0,41/240,13.37%,GABRE;GABRR2;TSPOAP1;KCNQ2;CHRNA4;HOMER1;KCNIP2;GLRB;NLGN4X;NLGN1;KCNMB4;STX1A;NPY;SNCA;CACNB4;HAP1;DRD4;CDH8;GRM3;DLG2;KCND2;GRM1;UNC13A;SNPH;CHRNA5;CHRM3;GABRB1;GRID1;DLG1;PNOC;NRXN1;CHRNB3;HTR4;KCNN1;GRIN1;SLC32A1;NLGN3;SLC1A2;NAPB;GRIK2;RPS6KA1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.7502198350498219,-1.1541365308645715,0.3548387096774194,1.0,1.0,2/7,11.29%,BEX4;FNTA
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.6279541293653987,1.1539300507749066,0.35294117647058826,0.8354291982786662,1.0,3/10,9.44%,SRC;RASIP1;CXCL13
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6519373380093268,1.1536137971219795,0.32432432432432434,0.8353557977300041,1.0,1/12,0.46%,SH2B2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.5352526411878625,1.153373131071436,0.19047619047619047,0.8350150456177426,1.0,5/15,9.55%,GRM2;HOMER1;GRM8;GRM3;GRM1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6578579857494752,-1.1533650407744171,0.24,1.0,1.0,4/10,23.18%,GRN;PTN;SCARF1;CERS2
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.6222621330571914,-1.1532392301042256,0.22388059701492538,1.0,1.0,5/17,11.06%,PSME1;PRELID1;APH1A;PINK1;GRN
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6523647860269517,-1.15322371398645,0.3484848484848485,1.0,1.0,1/11,0.32%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.5882043332485373,-1.1531745481746647,0.2714285714285714,1.0,1.0,5/22,14.20%,TIMP1;PHPT1;PLN;ATP5IF1;PARP9
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5361393880608222,1.1531569911834392,0.23809523809523808,0.8348322674747307,1.0,5/26,12.85%,KCNJ2;KCNIP2;CACNA2D1;CACNA1G;DMD
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7542888312854253,-1.1529639253644892,0.23636363636363636,1.0,1.0,3/5,22.79%,RACK1;LTN1;MTRES1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.46016794993754523,1.1527950901179345,0.2,0.834854014512176,1.0,12/32,17.84%,ZBTB16;P2RX7;BMP6;TGFB2;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;WNT5A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.49032239049087756,-1.1522055011183474,0.18571428571428572,1.0,1.0,20/76,19.91%,PSMB8;GATA1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;PSMD3;PSMC3;PSMA4;METTL3;PSMA7;PSMD2;PTN;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.5811840641104384,1.1521279144048873,0.2727272727272727,0.8355500351053836,1.0,6/18,11.96%,TMC8;SNCA;CNNM2;ATP13A2;TMTC2;GRIN1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.42944297816442734,1.1515191314330229,0.2,0.8360251528993291,1.0,30/112,12.66%,ZNF423;LIFR;FRZB;PCDH18;EFNB3;PTPRD;VCAN;LRP4;DPYSL3;PBX1;CCDC3;PLPPR4;TMEM47;SEMA5B;CDH11;ASXL3;SCN7A;GFRA1;ADGRL3;TGFB2;CACNA2D1;MAPK10;DOK5;MEGF10;COL23A1;RCAN2;COL25A1;SEMA6D;FBXL7;SLIT2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6375825768705542,1.1513690305075077,0.225,0.8355134921755167,1.0,3/11,8.71%,KCNJ2;KCNIP2;KCNN2
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5905534056210527,1.1512808742629337,0.3333333333333333,0.8348154794940642,1.0,8/14,22.48%,SLC39A8;TRPC5;ATP2C1;TMEM165;TRPC7;SLC30A10;SLC39A14;TRPC3
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.4174509433548504,1.1507206482423566,0.17391304347826086,0.8353210208060776,1.0,38/111,21.38%,GFAP;ABCC8;CELF3;DLX1;MMD2;SCRT1;PSD2;CTNND2;ADGRB3;PLPPR4;OLFM3;NTRK2;NXPH1;SNAP91;NCAN;ZNF536;KCNC2;KCTD16;SLC8A2;SLC32A1;CADM2;PVALB;NKAIN2;SEMA3C;GAD1;TNFAIP8L3;GRIA2;CA10;ADGRA1;SPHKAP;MAP2;ADCYAP1R1;KCNIP1;SLC6A1;TMEM196;GRM5;ST8SIA3;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.58383879902812,-1.1507065483461496,0.24615384615384617,1.0,1.0,5/20,5.93%,BMP5;SFRP1;EFNA1;IL17RD;OVOL2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6181335135150975,1.1505519725757674,0.32142857142857145,0.8348275284597009,1.0,1/9,0.32%,RELN
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.7150748836571951,1.1501718738123405,0.34210526315789475,0.8351450081621608,1.0,5/7,20.61%,PIK3CA;EPDR1;CAMK2D;CCDC88C;PDPN
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6380157851639654,1.1499563685922618,0.27906976744186046,0.8348239661720778,1.0,3/11,8.80%,PDGFRA;GLI2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7281450744651506,-1.1499009542468965,0.31343283582089554,1.0,1.0,3/9,22.29%,EFNA1;ATRAID;FURIN
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6123623302674007,-1.149895243328334,0.26229508196721313,1.0,1.0,6/23,16.34%,RPS27A;UBA52;TRIM13;RNF5;UBB;MAN1B1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4680778863528019,1.149661211633025,0.20588235294117646,0.834736731716264,1.0,7/38,13.47%,SPIRE2;SPIRE1;SCIN;CDC42EP4;BAIAP2L1;PRKCE;HCK
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6394909993580483,1.1494227383676385,0.2894736842105263,0.8346652173917654,1.0,5/8,23.68%,OAS3;HMGB1;LPL;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.46051967987446374,1.149171077240118,0.32,0.8346868818578963,1.0,7/56,7.47%,NFKBIZ;NPAS2;FEM1A;SNCA;CYBA;OPTN;ADAM8
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5237520787311434,1.1489900529133903,0.2,0.8343833158678035,1.0,6/29,14.57%,HSD17B7;DHCR7;HMGCR;HMGCS1;MVD;SC5D
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.5407268382991124,1.1486444529638682,0.27906976744186046,0.834343384157775,1.0,6/11,24.05%,TICAM1;IPMK;PGAM5;TRPM7;MLKL;CYLD
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6019114885012865,-1.1484331300321649,0.31343283582089554,1.0,1.0,1/18,1.87%,BUB1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6899149646447631,-1.1481781457153113,0.27941176470588236,1.0,1.0,2/7,11.06%,IL31RA;GRN
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.7012935764534438,1.1480573649934012,0.375,0.834844275781679,1.0,3/7,25.77%,CTBS;CHI3L1;CHIT1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.5344239822185742,-1.147983483673997,0.2597402597402597,1.0,1.0,10/45,20.13%,TRPM1;USP1;USF1;SLC24A1;OPN4;SPRTN;CIRBP;GTF2H2;ERCC8;UVSSA
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6406065237716279,1.147830465969288,0.35555555555555557,0.8344335444885779,1.0,2/9,1.77%,PDGFB;FLT1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6891064083150649,-1.1473763057905693,0.27692307692307694,1.0,1.0,5/13,16.52%,SFRP1;SFRP4;GPC3;RNF213;DACT1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.67257025846205,-1.1471819484819565,0.3392857142857143,1.0,1.0,3/7,26.87%,CXCL17;LGALS3;SFTPD
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.6605915283131439,-1.1465848356288162,0.27586206896551724,1.0,1.0,3/11,14.59%,PTK6;NLRP12;OPRM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.49119730546708806,1.1463584717081408,0.2608695652173913,0.8380160620530812,1.0,8/56,8.91%,PDGFB;NUPR1;TAL1;EGFR;PKD1;EIF4EBP1;TGFB2;EIF4E
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5179637704231048,-1.1461132979431268,0.2987012987012987,1.0,1.0,13/47,20.72%,GAPDH;SLC25A11;G6PC3;AKR1A1;APOD;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7303726715194657,1.1450969888061429,0.4117647058823529,0.8406358344014571,1.0,7/11,21.73%,AKT2;WNT3;ERBB4;SCRIB;CSF1R;ZNF703;WNT4
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.6338981033887064,-1.1448379864804998,0.2676056338028169,1.0,1.0,7/24,15.02%,GBP2;HLA-E;HLA-A;ROMO1;RPL39;PPP1R11;PGLYRP1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.6541193079169024,-1.1444197720480558,0.23333333333333334,1.0,1.0,2/15,6.54%,PIGH;PIGC
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.5221784263611792,-1.1443975738594379,0.23684210526315788,1.0,1.0,11/54,16.74%,NLRP1;LACC1;IRF1;ERAP1;TMSB4X;SELE;GRN;APPL2;RNF135;UFL1;APOE
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6976388120632764,1.144317336228097,0.4473684210526316,0.8420808290200535,1.0,2/6,10.59%,TGFB2;SMAD4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5938047365436345,-1.144066158151611,0.2535211267605634,1.0,1.0,7/28,15.98%,POLR3H;POLR2L;POLR3K;POLR3GL;SNAPC1;SNAPC2;GTF3C6
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.5826457611554053,1.1438238703889507,0.27586206896551724,0.8424164893965086,1.0,2/12,5.51%,HNRNPU;MLLT3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.5351969124923702,-1.143755814061019,0.2676056338028169,1.0,1.0,7/59,6.09%,ARHGEF16;ENTPD2;TMC4;EFNA1;TMEM125;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6642040630007935,1.143613890103722,0.3611111111111111,0.8421989870018215,1.0,1/10,2.22%,VEGFD
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7772062533992374,-1.1434488373332778,0.30612244897959184,1.0,1.0,2/5,15.86%,HSPA5;UFL1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.5862606472191327,1.1434149664718631,0.3103448275862069,0.841981976694,1.0,7/18,12.54%,SLC7A2;SLC7A1;SLC47A1;SLC7A5;SLC22A2;SLC6A13;SLC1A2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7224714750251735,1.143394985480168,0.40540540540540543,0.8411071338148363,1.0,1/8,1.57%,SNAI1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.46336509485869054,1.143209026069294,0.25,0.8406624573534035,1.0,4/49,5.49%,SNX31;DENND1B;DENND1A;EHD2
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6180944357300863,1.1431843173192235,0.4,0.8397757993664292,1.0,1/10,0.32%,RELN
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5467049329404373,-1.1426754383322637,0.23376623376623376,1.0,1.0,6/54,6.09%,ARHGEF16;BTN3A1;TMEM125;SGMS2;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.6375291893729435,1.1426659375498203,0.375,0.8405390147290848,1.0,3/8,15.54%,KYAT1;KYNU;QDPR
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4651134906644487,1.1425039439907403,0.28,0.8400050322092818,1.0,16/61,16.87%,SH2B2;ATP6V0A4;IRS1;GRB14;AKT2;SORBS1;IGF1R;GAB1;RHOQ;PIK3CA;GPLD1;ATP6V0D2;C2CD5;PDK4;GSK3B;FER
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5910923840092881,1.142395641457795,0.2857142857142857,0.839350459036923,1.0,4/14,12.58%,NUPR1;HDAC4;MLXIPL;PID1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5925065345982514,-1.1420028952428165,0.2777777777777778,1.0,1.0,4/11,26.70%,PPIB;TBC1D20;FBXL2;NUCKS1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.650520419314776,-1.1418916016982905,0.2903225806451613,1.0,1.0,5/11,20.90%,PPIB;CAV2;CFL1;APOE;TBC1D20
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.49458466153005753,1.1418093733076322,0.2571428571428571,0.8400507550632532,1.0,4/34,8.21%,KAT2A;LEF1;NOTCH4;DLL1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.5780036721344565,-1.141735105739934,0.23333333333333334,1.0,1.0,5/25,13.00%,HSPE1;SDF2L1;HSPA2;HSPA5;DNAJC7
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.7759189286709897,-1.141705319928204,0.2807017543859649,1.0,1.0,1/5,4.37%,GBA3
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.4595978786320854,-1.1416342382998055,0.19230769230769232,1.0,1.0,24/112,20.09%,PSMB8;RPS27A;PSME1;APEX1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;PSMD3;PSMC3;EXOSC4;UBB;PSMA4;HSPA8;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;YWHAB
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.4486114526673578,1.1416104632657624,0.2222222222222222,0.839716581827838,1.0,7/64,6.45%,VAPB;CERS3;ACER2;SGMS1;PPM1L;SPTSSB;ST8SIA1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5518832022054704,1.141560219159727,0.3225806451612903,0.8388824584888237,1.0,4/13,20.98%,SLC8A2;GRIK2;SHISA9;SLC4A10
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7066040427855944,1.141418851674606,0.3611111111111111,0.8383684711307277,1.0,2/6,9.51%,SRC;CA2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5253144200363512,-1.1414006092397477,0.22950819672131148,1.0,1.0,5/32,17.02%,UFC1;TEX264;MTIF3;UFL1;GOLGA2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.45515870092510197,1.1413668662094674,0.1935483870967742,0.8375679955781141,1.0,7/30,12.81%,SLC26A7;SLCO2B1;SLC13A4;LRRC8A;SLCO1A2;SLC26A3;SLC26A9
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.6155540726924076,-1.141290990411189,0.22727272727272727,1.0,1.0,4/22,5.72%,DDIT3;HES6;ATP6AP2;BHLHE41
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5683653915445619,-1.1412133898353731,0.29411764705882354,1.0,1.0,13/25,33.23%,PRPF3;PRPF6;PRPF4;PRPF8;WDR83;SRSF10;SF3B4;MPHOSPH10;GEMIN2;SLU7;DDX23;SMNDC1;SF3A3
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7121332957109275,1.141108871106298,0.3333333333333333,0.8373439382941661,1.0,4/6,25.10%,UNC13A;SNPH;UNC13B;STX1B
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.4818406075939527,-1.1410663934736929,0.21794871794871795,1.0,1.0,16/72,16.88%,NLRP1;IFIT2;RNASE1;IFIT3;IRF1;IFITM3;FADD;STAT1;IFI6;EXOSC4;IFNLR1;IFIT5;AGBL5;ISG20;PQBP1;NLRP9
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6913511396480652,-1.1409438233837441,0.3684210526315789,1.0,1.0,2/7,8.12%,RPS21;NOP9
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.6109513885544252,-1.1408955772249827,0.2711864406779661,1.0,1.0,6/10,33.03%,COX17;CUTC;ATOX1;SLC31A2;STEAP4;STEAP2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.6548078093421796,1.1405614437760883,0.36363636363636365,0.8381022070824722,1.0,2/10,6.83%,NLRP7;SERPINF2
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6675654490763886,1.1403081779710273,0.3076923076923077,0.8379384067316766,1.0,1/12,0.53%,BACE2
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.6122485969585927,-1.1402368091813158,0.3114754098360656,1.0,1.0,3/16,16.03%,TINF2;TFIP11;RAD50
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7958009620891289,-1.1400541892672698,0.23214285714285715,1.0,1.0,1/5,0.58%,RPL23
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.6849330514747474,-1.1400190901885052,0.36666666666666664,1.0,1.0,3/10,14.98%,EDF1;MESP1;FSTL1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.4788652696344771,1.1397811582569515,0.28,0.8383778275485949,1.0,10/32,14.30%,IL1RAPL1;PTPRD;LRP4;NLGN4X;NLGN1;PICALM;NSFL1C;NRXN1;NLGN3;PTEN
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.585838602849738,1.1388909088500199,0.2702702702702703,0.8400357003902235,1.0,4/12,8.28%,SYTL4;MYOF;DYSF;AHNAK2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5990782557201084,1.138798285658978,0.2619047619047619,0.8392537429616752,1.0,3/10,18.20%,PLA2G10;NFKB1;LPL
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6198713226913077,-1.1385886195060466,0.3684210526315789,1.0,1.0,1/13,5.46%,CXCL17
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.677194913036254,-1.1385726432219248,0.375,1.0,1.0,1/5,10.46%,GPS2
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.6864447256471413,-1.1383796100589303,0.32727272727272727,1.0,1.0,4/8,23.82%,ATG14;PHB2;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.591872735883717,1.1378264700771272,0.2962962962962963,0.8410271390679581,1.0,8/12,26.89%,ADCY10;PTHLH;ADCY8;PTH;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.781212579463643,-1.1376262601220921,0.3076923076923077,1.0,1.0,1/6,1.04%,FBXO43
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.7502688769321645,-1.137567397722987,0.3050847457627119,1.0,1.0,3/6,21.02%,HLA-DRA;HLA-DRB1;CD46
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.7502688769321645,-1.137567397722987,0.3050847457627119,1.0,1.0,3/6,21.02%,HLA-DRA;HLA-DRB1;CD46
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.47250653276736865,-1.1373834465318025,0.25675675675675674,1.0,1.0,11/119,7.09%,CD44;GPX4;DDIT3;CLU;TIMP1;BCL2L2;RETSAT;IRF1;IFITM3;BTG3;TSPO
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4829892377712597,-1.1373540296109574,0.24691358024691357,1.0,1.0,13/71,15.25%,CD44;GATA1;RHOG;FAM78A;TALDO1;GMFG;PTPN7;USE1;STAT5A;ADGRE5;NMI;DOCK2;EPOR
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.6929426059940914,-1.13694293431144,0.3389830508474576,1.0,1.0,2/7,14.78%,KDELR1;KDELR3
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6668322237787369,1.136864774467425,0.30952380952380953,0.8427665980716205,1.0,4/9,15.43%,KAT2A;SIRT1;KAT2B;CREBBP
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.6789601045758533,1.1364207393052557,0.34210526315789475,0.8433631161977984,1.0,2/6,8.29%,LLGL2;SLC7A5
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6863381526179705,1.1363443673561144,0.36363636363636365,0.8426707672203744,1.0,2/6,18.49%,MEGF10;AKIRIN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6649625655497043,1.1363428614586006,0.3953488372093023,0.8417556220090129,1.0,4/6,33.12%,GSK3B;MARK4;APC;BICD1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.702009631717681,1.1361662275310045,0.46808510638297873,0.8414101571813803,1.0,1/5,3.37%,EGFR
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5639784080128428,1.1361520817511177,0.3333333333333333,0.840498416045417,1.0,1/17,0.30%,GRM2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5913656287516307,1.1361182244071675,0.29411764705882354,0.8396333977911398,1.0,6/16,14.21%,CLEC7A;CD22;ITPR1;SLC8A2;SLA2;GPR143
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.5814467499313721,-1.135915562783932,0.30303030303030304,1.0,1.0,1/17,0.62%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.592981332413048,1.135666284028109,0.3333333333333333,0.8402145366709401,1.0,2/15,2.90%,RUNX1;COLGALT1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6012764301233177,1.135551289545964,0.3157894736842105,0.8396194411597648,1.0,4/10,17.68%,TGFB2;ACVR1;MDM4;SMAD2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.46459082622380393,-1.1352979880387062,0.21686746987951808,1.0,1.0,20/139,11.31%,CENPF;RPS27;BUB1;STMN1;SBDS;MIS12;CENPE;RAB11A;ERCC6L;ABRAXAS1;CENPH;NUF2;CENPQ;TPX2;CENPK;DCTN2;NEK6;SPDL1;DCTN6;KIF18A
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.46483355424713857,-1.1350467266459137,0.21333333333333335,1.0,1.0,34/125,19.91%,GBP3;PSMB8;GBP2;SFRP1;PSME1;RPS3;PSMB6;PSMC5;PSMD8;PSMD7;HYAL2;TMSB4X;TNFRSF21;PSMD3;PSMC3;TXNDC17;STAT1;ILK;YBX3;CD27;BRCA1;TNFRSF1A;EIF5A;PSMA4;TNFSF9;PSMA7;PSMD2;PSMD6;PSMB2;PLVAP;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.4582225496159535,1.1350131079343602,0.1951219512195122,0.8402290340859747,1.0,6/42,6.52%,CASS4;IL1RAPL1;ARHGEF7;PTPRD;OBSL1;DOCK1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.634289219137458,1.1348897231599693,0.2894736842105263,0.8396649069264541,1.0,3/9,11.02%,SIRT1;DIP2B;KLF15
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3616599408558209,1.1347469460524267,0.18181818181818182,0.8391464864097123,1.0,34/363,7.57%,CREB3L1;VDR;PDGFB;ZNF423;TP63;DACH1;SPINDOC;ATXN1;IFNA2;GMNN;HDAC4;ATOH8;RELA;RFX3;HDAC10;HIC2;ID1;SAMD13;FOXK1;ZNF706;ASCL1;LEF1;YAF2;ZBTB16;SIRT1;SFMBT2;SMARCA2;HMX1;FOXN3;ZNF93;HMBOX1;ZHX2;PHF10;ARID5A
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.4035093962950611,1.1343875937459602,0.17647058823529413,0.839058627430797,1.0,30/146,13.86%,ADGRB1;KCNQ2;CHRNA4;CELF3;CTNNA2;CNTNAP2;NRIP3;MMD2;SCRT1;SLC24A3;PSD2;CTNND2;ADGRB3;AMER2;PCDH8;HIVEP2;OLFM3;NXPH1;SNAP91;GRM3;NCAN;CADPS;PKP4;NRXN1;GRIN1;SLC8A2;SLC32A1;CADM2;SHANK2;KCNMA1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.41774565711748407,1.1343499042599914,0.20833333333333334,0.838201791399658,1.0,19/103,13.28%,SGSM1;CELF3;CTNNA2;KCNT1;CACNB4;PKD2L1;P2RX7;AMER2;C4ORF50;ST18;CADPS;FAM135B;KCNC2;RUNDC3A;GNG7;NRXN1;SLC1A2;NAPB;FGF13
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.694542144985056,-1.1343377518427777,0.421875,1.0,1.0,2/7,17.82%,MTHFD1;MEOX1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.49846531131666466,-1.134321040273279,0.2564102564102564,1.0,1.0,8/62,11.10%,CD44;IRGM;CAMK1;HAX1;TGFB1;PINK1;MTCP1;BDNF
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.5306473116640658,-1.134275149707412,0.21428571428571427,1.0,1.0,3/42,4.50%,APIP;B2M;ALDH1A2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.5785149289179997,1.134138794013486,0.38461538461538464,0.8378639694061427,1.0,2/18,3.18%,BACE2;ADAM19
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.7184155833248345,1.1341231867203336,0.45,0.8369807825238416,1.0,1/5,12.03%,CACNA1G
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.6656827123211984,1.1340114162668562,0.3939393939393939,0.836335412470043,1.0,3/8,10.33%,NOS2;SLC39A8;ARG1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.5296755402536752,-1.1337003419306269,0.2631578947368421,1.0,1.0,6/47,9.09%,XBP1;RBP1;FABP3;ORMDL2;USF1;ORMDL1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.43919840180275943,1.1336948283690327,0.2,0.8361627221155551,1.0,17/74,9.16%,TNC;PCDH18;POSTN;PDGFRA;CSPG4;LTBP2;ADAMTS2;EHD2;SSC5D;TMEM47;CDH11;COL14A1;LOX;HTRA1;RGS5;COL6A1;COL5A1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.7118495875946482,-1.1336733396057452,0.32075471698113206,1.0,1.0,1/5,1.25%,XBP1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4555308425676017,1.1333425104296762,0.21052631578947367,0.8364464603802212,1.0,46/146,20.45%,PDGFB;MAPK12;STK32B;PLK1;PRKX;AKT2;PKD1;SGK1;CAMKV;NLK;PNCK;TNKS;VRK2;RICTOR;SGK3;ULK3;MKNK2;PRKD1;MAPKAPK3;PRKCE;DYRK3;RPS6KA1;SMG1;PRKCZ;RPS6KA6;HIPK2;UHMK1;DYRK1A;MAST4;MARK1;HIPK3;GSK3B;SBK1;TTBK2;CAMK2D;MAPK8;DMPK;MKNK1;WNK1;PIKFYVE;SRPK2;MAST3;MAPKAPK2;MAP3K10;TLK2;MARK2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4923729502268765,1.1330546003241069,0.3076923076923077,0.8362152423791948,1.0,20/106,11.75%,LEPR;DACT2;ETV1;FRZB;ABCC8;PTPRD;PPARGC1A;CELF3;RXRG;SOWAHA;PLPPR4;SORBS1;ASXL3;TOX3;SNAP91;MAPK10;CADPS;RCAN2;NRXN1;SEMA6D
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5790719742041991,-1.1330517197945755,0.30158730158730157,1.0,1.0,2/19,4.90%,DNASE2;ENDOG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6057352044779537,1.1327290965625012,0.3448275862068966,0.8363074750412156,1.0,4/14,4.44%,NLRP7;IGF1;CARD18;CX3CR1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5600535489994598,1.1326837197168278,0.3333333333333333,0.835534353154311,1.0,6/12,26.36%,KAT2B;CREBBP;NAA16;NAA30;NAA25;NAA50
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.7367929289500508,-1.1326468210428182,0.3088235294117647,1.0,1.0,5/7,25.79%,PEX11A;PEX11G;DNM1L;FIS1;ACOT8
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.729271540018062,1.1322709353232565,0.35,0.8357443048106186,1.0,3/5,26.44%,DICER1;HES1;RNF10
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6317059876243012,-1.1321509780378873,0.3055555555555556,1.0,1.0,7/15,24.79%,COLEC12;FLOT1;PQBP1;CGAS;CAV1;RIOK3;IFIT1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.6594634481351381,-1.1318868161957818,0.40298507462686567,1.0,1.0,2/10,2.82%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6591051246339628,-1.131836596129847,0.3968253968253968,1.0,1.0,1/12,0.46%,GATA1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.66232613808681,-1.1316097652354271,0.32857142857142857,1.0,1.0,4/10,16.07%,MT1E;MT2A;MT1G;MT1M
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.4325802250646386,-1.1313323857519728,0.1411764705882353,1.0,1.0,34/283,12.52%,CD44;APIP;GATA1;GPX4;IL7;RPS27A;XBP1;SFRP1;RPL10;PRDX5;ANXA5;PTMA;IL31RA;GSTP1;BCL2L2;PSMC5;RPS3A;PRELID1;UBA52;IFIT3;COPS5;MYDGF;HTR2B;ZNF830;PHB2;NAA38;HAX1;DDAH2;TRIAP1;TM7SF3;IFI6;HSPA5;PPIF;CD27
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5647779782627923,1.13101620056397,0.3103448275862069,0.8381924946665934,1.0,8/16,19.57%,ADAM19;BMP6;SERPINF2;NOTCH4;AFDN;RGCC;TJP1;PTPRU
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.6411051361332007,1.1308499391954665,0.3783783783783784,0.837829094577301,1.0,1/8,0.94%,TNNC2
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6614220476110453,1.1308489466037654,0.38235294117647056,0.8369262615012479,1.0,2/9,3.83%,ZNF366;CNOT2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4210999618112473,1.1308216151394472,0.10714285714285714,0.8361712193007819,1.0,29/108,18.76%,RELN;IL1RAPL1;TIAM2;PTPRD;EPHA3;DPYSL3;PROM2;ZNF804A;OBSL1;PLXNA1;NTRK2;ROBO1;ARHGAP35;RAPGEF1;PLXNB2;PRKD1;SLIT2;SS18L1;ROBO2;MAGI2;CHODL;ROR1;LTK;RAP1A;CUL7;PLXNA4;WNT5A;FUT9;CUX1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.6852058236713747,-1.1304166587153515,0.42857142857142855,1.0,1.0,3/5,26.87%,CXCL17;LGALS3;SFTPD
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6302539437586092,1.130002486406344,0.34375,0.8372243616105604,1.0,5/14,16.04%,PTPRD;LRRC4C;NTNG1;GPC6;GPC4
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.598651171691497,1.129964769139014,0.3333333333333333,0.8364560678296054,1.0,6/10,30.66%,ARHGAP35;NRCAM;EPHB3;CNTN4;RTN4;EPHB2
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.6490157787428686,-1.129910905527418,0.4126984126984127,1.0,1.0,1/13,0.46%,GATA1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.654838054220676,1.1296406574936035,0.2777777777777778,0.8365180758876966,1.0,5/8,26.89%,ADRA1A;DRD2;ADRB1;RAPGEF2;ADCY9
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.6827087156213553,-1.1295456630026257,0.29577464788732394,1.0,1.0,2/12,12.73%,IDH3B;IDH3G
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.6965544007353046,-1.1291175441680918,0.3384615384615385,1.0,1.0,2/7,15.15%,MYADM;DCTN1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.5832765022723456,-1.1287578847601836,0.3188405797101449,1.0,1.0,4/17,19.43%,POLR1G;NIFK;GTF3C6;POLR1E
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.71004543156927,-1.1287414931213164,0.3148148148148148,1.0,1.0,3/7,21.62%,PPP1R3D;PPP1R3E;INPP5K
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.42830155862087055,-1.1283361542399526,0.2558139534883721,1.0,1.0,27/233,12.62%,PSMB8;RPS27A;PSME1;CFTR;USP6;PSMB6;PSMC5;USP1;RAD23A;PSMD8;COPS6;COPS7A;PSMD7;ADRM1;UBA52;USP51;JOSD2;TNIP2;COPS5;ABRAXAS1;TOMM20;AR;USP19;PSMD3;PSMC3;CLSPN;BRCA1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5238062798321479,-1.128056840831429,0.25,1.0,1.0,18/52,22.86%,H1-4;H1-2;POLR1G;POLR2L;SERTAD1;POLR1F;POLR1H;MYBBP1A;TAF1D;ACTB;H1-10;SMARCD1;POLR1E;H1-0;DDX21;SMARCA5;POLR1B;ELOF1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.42563065828138674,1.128016163427881,0.25925925925925924,0.8406897315391165,1.0,20/82,9.57%,COL5A3;ADAM33;TNC;ICAM1;PCDH18;FBLN5;POSTN;PDGFRA;ADGRA2;LTBP2;ADAMTS2;SSC5D;CDH11;RHOJ;COL14A1;HTRA1;AEBP1;COL6A1;COL5A1;AQP1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4174503289971496,1.127801562488399,0.13636363636363635,0.8404424344579259,1.0,40/155,17.31%,PDGFB;GALNT3;MAPK12;STK32B;PLK1;POGLUT2;PRKX;AKT2;PKD1;SGK1;CAMKV;PNCK;TNKS;VRK2;RICTOR;SGK3;ULK3;MKNK2;PRKD1;MAPKAPK3;PRKCE;GALNT2;DYRK3;RPS6KA1;SMG1;GALNT16;PRKCZ;RPS6KA6;HIPK2;UHMK1;DYRK1A;MAST4;MARK1;HIPK3;GSK3B;SBK1;TTBK2;CAMK2D;MAPK8;DMPK
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.692458105418881,1.1277007917294208,0.42857142857142855,0.8397754236099808,1.0,3/6,20.46%,OGT;PHF1;PHF19
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.5694658135822773,-1.127650500338243,0.3492063492063492,1.0,1.0,5/27,8.84%,PIGH;PGAP4;PIGC;PGAP2;DPM3
prerank,GO_Biological_Process_2021__negative regulation of meiotic cell cycle (GO:0051447),-0.7414565637523038,-1.1276099797960781,0.26865671641791045,1.0,1.0,2/5,4.70%,FBXO43;NPPC
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6257560505665388,1.1275484852651654,0.3409090909090909,0.839355924000339,1.0,1/11,0.70%,FGFR1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.6786276085648238,1.1274451598185324,0.4090909090909091,0.838807178016821,1.0,2/5,24.77%,DYRK3;KLC1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5161445606876209,-1.1274226414714654,0.2753623188405797,1.0,1.0,12/50,13.83%,CYP1A2;ADH4;RBP1;RDH12;ALDH1A2;RETSAT;GPC3;GPIHBP1;RBP2;CYP3A5;LRAT;CYP3A4
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.731753983295432,1.1272845116457966,0.4090909090909091,0.8384040498896304,1.0,1/5,5.36%,AKT2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.4673867521736155,-1.1270724658381561,0.24,1.0,1.0,24/182,14.96%,DDIT3;HSPE1;MCM2;XBP1;GAPDH;SDF2L1;BUB1;LDHA;PRDX1;CD9;EIF2S2;PFKL;MCM4;COPS5;CALR;SCD;PNO1;HSPA5;PPIA;WARS1;TPI1;CANX;NMT1;PSMA4
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.7417954901707116,-1.127025197827585,0.3389830508474576,1.0,1.0,1/5,6.23%,SFRP4
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4998237687196072,1.126973077429658,0.1724137931034483,0.8383913741701915,1.0,9/21,15.32%,CDK10;EVI5L;ARHGAP44;CCP110;SLIT2;CEP97;KANK1;TESK1;ARHGAP24
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.44452345997219816,-1.1268933361723246,0.2558139534883721,1.0,1.0,48/180,22.24%,MCM2;STMN1;CCNB2;H2AZ1;USP1;PCNA;CENPE;ORC6;MCM4;PHF5A;MCM3;DSCC1;NAA38;RPA3;RANBP1;PRPS1;RAD51AP1;TCF19;CDK4;RFC2;PNN;SMC4;PSMC3IP;BRCA1;KPNA2;DCK;DIAPH3;POP7;ILF3;GINS4;KIF4A;PLK4;RAD50;MCM5;PAICS;CSE1L;POLD2;ASF1B;EZH2;ORC2;TUBB;RAN;ZW10;CDC20;KIF22;SPC25;SSRP1;SMC1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5551117766530949,1.1268607828446606,0.3157894736842105,0.8377445072799636,1.0,7/17,26.31%,PAXIP1;MITF;BCLAF1;MED13;MED14;MED30;MED4
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.7303184622567302,-1.1264499358179219,0.4074074074074074,1.0,1.0,2/6,8.77%,UBXN1;AQP11
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5459542534434254,1.12620470065433,0.29545454545454547,0.8384956921318002,1.0,2/15,1.19%,ZAP70;ZBTB1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.7305034736811937,-1.1259532566347994,0.3157894736842105,1.0,1.0,1/5,6.01%,TRMT112
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7165437463706137,-1.1259442009446752,0.36538461538461536,1.0,1.0,2/6,17.96%,PLN;TRDN
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),-0.7064161055535674,-1.12579410747329,0.375,1.0,1.0,1/6,0.32%,BMP5
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.7112468384238763,-1.1256432577218711,0.31666666666666665,1.0,1.0,1/5,23.50%,CTR9
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.5567315250910615,-1.1254321313388262,0.30434782608695654,1.0,1.0,4/30,4.90%,BMP5;TTN;ZFPM1;MESP1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6900919244181412,-1.1250325709200282,0.3333333333333333,1.0,1.0,2/7,4.54%,RPS3;DDX11
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.713508473834896,-1.1246549611464483,0.375,1.0,1.0,4/5,27.07%,RTF1;PAF1;CTR9;LEO1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.43669434451613287,1.1246421574623942,0.19047619047619047,0.8420212871063268,1.0,8/60,8.95%,RAB27A;CLEC7A;AKT2;SNCA;CYBA;SGK1;DLL1;SCIN
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.46570903409793657,-1.1242566210678695,0.3125,1.0,1.0,5/75,4.20%,ARHGEF16;TAX1BP3;ARHGAP42;USP6;RHOG
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5266738121158323,-1.1238522753541804,0.28378378378378377,1.0,1.0,2/62,1.47%,CD44;BEX3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6271866733817733,-1.1237054046241806,0.3064516129032258,1.0,1.0,3/12,11.10%,XBP1;BHLHE41;BDNF
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.6433755871891456,-1.1233915975849433,0.38461538461538464,1.0,1.0,2/12,9.35%,SLC25A4;SLC35B2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.6460259836928564,-1.12324857951479,0.28125,1.0,1.0,7/17,20.89%,VPS35;CD81;ATP5IF1;PTTG1IP;DACT1;APOE;MSN
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3963358165743329,1.1231768506922546,0.19047619047619047,0.8452233044393482,1.0,11/133,4.93%,B3GNT6;VAPB;CERS3;GAL3ST2;CHKA;ACER2;HPGDS;SGMS1;PPM1L;SPTSSB;LPIN3
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.6027864852013114,-1.123173035000934,0.35384615384615387,1.0,1.0,5/14,13.53%,STMN1;STMN2;KIF18A;STMN3;KATNB1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7297667931132201,-1.1229144057122693,0.3333333333333333,1.0,1.0,3/5,20.76%,PDCL3;PDCD5;SGTB
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.6308117845463621,-1.1226317229578078,0.26865671641791045,1.0,1.0,3/11,13.12%,ZFPM1;MESP1;MYH6
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6838194052722855,1.1225660919505658,0.35294117647058826,0.8453700728671185,1.0,2/7,15.53%,EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6838194052722855,1.1225660919505658,0.35294117647058826,0.8453700728671185,1.0,2/7,15.53%,EIF4E2;TNRC6B
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6258695014951843,1.1223129715939746,0.34375,0.8451782557505725,1.0,1/9,3.11%,GMNN
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.7220938093730539,-1.1221070736442864,0.4,1.0,1.0,2/6,11.35%,ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5544317008932134,-1.122068598605921,0.27941176470588236,1.0,1.0,8/30,19.95%,IFIT2;CLU;VPS35;TIMM50;IFI6;DNM1L;BAX;FIS1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.744648976370398,-1.1219778120685662,0.29850746268656714,1.0,1.0,1/6,0.32%,BMP5
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.6554606105087921,-1.1218581431361379,0.39705882352941174,1.0,1.0,2/11,7.53%,CSTF2T;FIP1L1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.46774652881594936,-1.1216799392483918,0.3333333333333333,1.0,1.0,27/104,22.50%,PSMB8;SFRP1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;FZD8;SFRP4;NFATC1;PSMD3;PSMC3;AP2S1;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;AP2A2;RHOA;CALM1;PSMD10;PLCB3
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7713724273659698,-1.1215515636142237,0.38235294117647056,1.0,1.0,2/5,12.73%,IDH3B;IDH3G
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.5040767022807457,-1.1212605963721105,0.273972602739726,1.0,1.0,25/64,27.07%,POLR2G;POLR2J;GTF2F1;POLR2L;ELOB;POLR2I;ADRM1;RTF1;PAF1;TCEA2;POLR2A;SUPT5H;GTF2H2;NCBP1;POLR1E;NELFE;SSRP1;NELFCD;ELOF1;CTR9;POLR2K;POLR2C;ELOC;NCBP2;LEO1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.5936459203890402,1.1212073205824342,0.3181818181818182,0.8472760442840004,1.0,1/11,1.91%,PLIN5
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5745434691093702,1.120738456514041,0.3076923076923077,0.8479258735816936,1.0,6/15,17.83%,MYH3;MBNL1;TGFB2;MEGF8;PCSK5;BMPR1B
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.754848655263919,-1.1201315296899454,0.28125,1.0,1.0,4/5,19.28%,CALR;TAPBPL;HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.5773720875519318,1.1200854124914317,0.3103448275862069,0.8487171068822036,1.0,1/18,2.23%,MTHFS
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6095017313538991,-1.1200074624025254,0.3181818181818182,1.0,1.0,2/13,2.01%,DUOX1;TYMS
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6353370608269457,1.1198909425833716,0.43333333333333335,0.8483086393957087,1.0,3/9,17.54%,BMP6;NOTCH4;RGCC
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.4766173029309228,1.1196078357960224,0.3076923076923077,0.8483569453248095,1.0,9/27,23.77%,NSMF;SLC8A2;GRIK2;ZDHHC2;SHISA9;SLC4A10;DRD2;APP;CAMK2B
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.7313190901601824,-1.1193467125373362,0.3559322033898305,1.0,1.0,1/6,11.37%,STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.7313190901601824,-1.1193467125373362,0.3559322033898305,1.0,1.0,1/6,11.37%,STAT1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5579823065201834,-1.1191156529761852,0.3548387096774194,1.0,1.0,1/18,0.68%,SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6472327491755937,-1.1190960151833307,0.29850746268656714,1.0,1.0,1/10,0.32%,BMP5
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.6999802244611092,-1.1189435418564924,0.3684210526315789,1.0,1.0,1/5,4.90%,MESP1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5901824483573789,-1.1185962262595852,0.34375,1.0,1.0,4/14,13.12%,TTN;ZFPM1;TGFB1;MYH6
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.7047940753633725,1.1184929398082206,0.3783783783783784,0.8505969330502055,1.0,2/7,7.47%,ICAM1;ADAM8
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7024388532467924,-1.1184795399395793,0.31666666666666665,1.0,1.0,1/6,1.63%,ZDHHC12
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6108022207256456,-1.1184107659351457,0.3384615384615385,1.0,1.0,2/15,9.02%,DCTN2;CEP131
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.6789990457978037,-1.1178044343607183,0.3387096774193548,1.0,1.0,1/7,0.57%,DDIT3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.7253739321539742,-1.1177716269809037,0.39655172413793105,1.0,1.0,2/5,22.44%,GREM1;MYOCD
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.444526460993159,-1.117743779567557,0.27631578947368424,1.0,1.0,22/127,13.34%,GFRA3;STMN1;PCDHB4;MPZ;TST;PMP22;CNP;HSPB8;TCEAL6;ITGB4;TNS2;TCEAL7;SPARCL1;GPR62;ART3;CMTM5;MAG;CADM4;NACAD;OLIG1;APOD;LMOD1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.705444981305644,-1.117396253196528,0.36065573770491804,1.0,1.0,2/6,13.02%,GPATCH3;C1QBP
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.5331365326267588,-1.1173303424785532,0.3787878787878788,1.0,1.0,6/32,13.61%,SFRP1;CFTR;ADAM15;MAP4K1;AR;AHR
prerank,MSigDB_Hallmark_2020__Apical Surface,0.4625772782555526,1.1173141780414826,0.26666666666666666,0.8529601766791595,1.0,3/33,3.00%,ATP6V0A4;AFAP1L2;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.6634115453407271,1.1173079385303188,0.3783783783783784,0.8520944934870991,1.0,3/8,11.42%,HSPB1;GAB1;PRKD1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.47562006342057817,1.1170505297011688,0.25925925925925924,0.8518406921930888,1.0,8/36,14.09%,IL1RAPL1;PTPRD;CX3CR1;NLGN1;NRXN1;NLGN3;CLSTN2;GPER1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.4644288286628847,1.1169551183874855,0.3181818181818182,0.8511622375839981,1.0,18/77,11.40%,ADAM33;ITGA11;PCDH18;POSTN;PDGFRA;HMCN1;ADGRA2;ADAMTS2;SSC5D;CDH11;RHOJ;COL14A1;MSRB3;CACNA2D1;COL5A1;AQP1;SGCD;VSTM4
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6410091247429132,-1.1168279900331877,0.3620689655172414,1.0,1.0,5/10,29.00%,ZNF830;CLSPN;TOPBP1;HUS1;STK33
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5535137699347623,1.1168278721450613,0.2608695652173913,0.8506126228503093,1.0,5/17,21.13%,RYBP;PCGF5;RNF168;RNF2;KDM2B
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5034142711851455,-1.1167987723445065,0.24285714285714285,1.0,1.0,3/26,7.85%,SEMA3E;TGFBR2;PAX8
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.41213560062914467,1.116659373818853,0.23809523809523808,0.8502197309688779,1.0,12/82,9.29%,F2;RIDA;TM4SF20;CPEB3;IGF2BP2;EIF4E2;SAMD4A;SYNCRIP;DHFR;NANOS3;PUS7;NFKB1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7114678654439499,-1.1165319461275105,0.4090909090909091,1.0,1.0,2/7,5.45%,ADH4;ADH5
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.7338044868373462,-1.1161306828149828,0.3484848484848485,1.0,1.0,1/5,3.98%,SLC25A11
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.7338044868373462,-1.1161306828149828,0.3484848484848485,1.0,1.0,1/5,3.98%,SLC25A11
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5933380241260273,-1.115948241929724,0.34328358208955223,1.0,1.0,7/19,16.07%,MT1E;MT2A;LCK;SLC39A7;SLC39A6;MT1G;MT1M
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.4787884733486121,-1.1153626892385993,0.24324324324324326,1.0,1.0,7/83,5.83%,CD44;DPEP2;RHOC;AQP9;PTAFR;IFIT3;IFITM3
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.41339184823973374,1.1152899387441608,0.21428571428571427,0.8530348218650818,1.0,32/121,16.63%,PDGFB;ADAM33;TPM2;PCDH18;POSTN;PDGFRA;HMCN1;LTBP2;LEF1;EHD2;TMEM47;MRC1;CDH11;RHOJ;COL14A1;HTRA1;COL6A1;COL5A1;OGT;FGF1;ECM1;FBXL7;PLSCR4;MIB1;PAWR;COL12A1;DYRK1A;CRIM1;NR4A2;COL4A2;SERPINE2;NCOA2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.707530466433524,-1.1150715739119081,0.2857142857142857,1.0,1.0,2/7,10.23%,TRMT10A;TRMT10B
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.6647817887061209,-1.1149984674122215,0.36764705882352944,1.0,1.0,1/10,9.99%,SLC27A5
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5612379434023751,-1.1146320766039002,0.2876712328767123,1.0,1.0,4/21,18.80%,TRIM13;HRAS;FANCD2;TMEM109
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7350662983998524,-1.114599669981837,0.38095238095238093,1.0,1.0,1/6,9.94%,PMM1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5675565648163187,1.1143840490003216,0.3,0.854460899903972,1.0,7/14,21.51%,ATP12A;ATP1B3;SCNN1B;SLC12A2;NEDD4L;ATP1A2;SLC8A1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.4970101631284558,-1.114351269984357,0.3026315789473684,1.0,1.0,5/52,2.73%,RHOC;ACTG1;TLN1;JUP;CD9
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5460328161681469,1.1143115517103077,0.2857142857142857,0.853783248692732,1.0,4/17,8.05%,HSPA1A;PLK1;HNRNPU;HSPA1B
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.6983313617338416,1.1143037881494935,0.4375,0.8529239089450822,1.0,3/5,21.44%,FTO;ALKBH5;ALKBH1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.7115260410022507,-1.114193559013303,0.3492063492063492,1.0,1.0,1/5,3.71%,RPS3
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.716038866178668,-1.11394477871596,0.33962264150943394,1.0,1.0,1/8,6.09%,ITGB4
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.6395453719110186,-1.1138259868407605,0.359375,1.0,1.0,2/7,22.82%,TFIP11;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6759843118918655,-1.1136021247032473,0.34545454545454546,1.0,1.0,1/11,0.32%,BMP5
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.40011690141664136,1.1133997032539882,0.21739130434782608,0.8545285667900493,1.0,12/119,6.11%,F2;PTPN6;NLRP7;UBA7;IFNA2;ANXA4;MAPKBP1;CD200R1;AGER;LEF1;SSC5D;IRAK3
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.6365573620679194,1.1133623101334196,0.40540540540540543,0.8537264575240441,1.0,3/12,7.80%,KCNJ2;KCNIP2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4756642906986089,1.1132722065076388,0.2647058823529412,0.8531085388207131,1.0,9/33,19.60%,NUPR1;TBC1D12;PIP4K2A;IFT88;LRSAM1;SCFD1;TMEM39A;MTMR3;PIKFYVE
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6400105470132268,-1.1131903006987693,0.35,1.0,1.0,3/8,30.08%,TGFB1;HEY2;HEY1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4637276208078912,-1.1131420604054234,0.2948717948717949,1.0,1.0,17/129,10.40%,SLC28A2;BEST1;SELENOS;AQP9;IFNGR2;TIMP1;PTAFR;RHOG;ADRM1;SGMS2;IRF1;GPC3;RASGRP1;LCK;GPR183;SRI;SELE
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),0.6659418735662055,1.1129295264766137,0.40476190476190477,0.8530669692604532,1.0,3/6,20.61%,BMPR2;ACVR2B;PDPN
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.695893807615085,-1.1127851764592398,0.3548387096774194,1.0,1.0,3/8,20.73%,PDZD11;WDR1;CRB2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.695893807615085,-1.1127851764592398,0.3548387096774194,1.0,1.0,3/8,20.73%,PDZD11;WDR1;CRB2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.6711036607860105,1.1127776515490369,0.38095238095238093,0.8526331612087449,1.0,2/5,14.67%,BMPR2;ACVR2B
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5477054566077864,-1.1127277554652941,0.3225806451612903,1.0,1.0,5/25,15.15%,RPS3;ANKRD53;STMN2;KATNB1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.7015359264148858,1.1126517179561302,0.4318181818181818,0.8520742754344764,1.0,3/6,24.11%,PTPN22;MARCHF7;DDX3X
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7228354181840095,-1.1125300599940013,0.391304347826087,1.0,1.0,4/7,12.06%,HLA-E;HLA-A;IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6012901550448218,1.1123396397714305,0.24390243902439024,0.851991953918475,1.0,3/11,8.96%,KCNJ2;AKAP6;CACNA2D1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.4215349343378654,1.1123106159955427,0.2857142857142857,0.8511834529645737,1.0,17/108,9.67%,KCNQ2;CHRNA4;ABCC8;CELF3;CHD5;MYT1;LONRF2;CASKIN1;SCRT1;CTNND2;PCDH8;OLFM3;CAMKV;NXPH1;SNAP91;NCAN;UNC13A
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5291398305999306,-1.1121906048487256,0.2753623188405797,1.0,1.0,9/38,20.89%,CNN2;ARF1;TALDO1;RPLP0;PPIA;CFL1;LCP1;SOD1;MSN
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.6410196811424163,-1.1121860680129678,0.3684210526315789,1.0,1.0,1/9,1.73%,SELENOS
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.726422252505968,-1.1112266018083194,0.3548387096774194,1.0,1.0,2/5,15.42%,FNTA;RABGGTB
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7410961045573893,-1.1109452792440262,0.39655172413793105,1.0,1.0,1/6,6.01%,TRMT112
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.7280031758159087,-1.1108671176371545,0.375,1.0,1.0,2/7,22.13%,IFNAR1;RO60
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.41748914592675623,1.1108590244532757,0.25925925925925924,0.8545767315427861,1.0,6/61,8.14%,F2;PLK1;GNL3L;TRAPPC12;SESN2;NECAB2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.7146645147616962,-1.1105351442864795,0.3050847457627119,1.0,1.0,2/5,18.32%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.7146645147616962,-1.1105351442864795,0.3050847457627119,1.0,1.0,2/5,18.32%,DPM3;DPY19L2
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.6532609778219189,1.110484721191251,0.3783783783783784,0.854938153948285,1.0,3/6,20.01%,SLC7A5;SLCO1C1;SLC16A2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.6205519325586623,-1.1103499624014472,0.36363636363636365,1.0,1.0,5/11,11.44%,SERPING1;CR2;C4BPB;C4BPA;CR1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.6699740327925563,-1.1101913671894146,0.36764705882352944,1.0,1.0,1/7,0.79%,GLYCTK
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.6638711052890568,-1.1101116079174258,0.3283582089552239,1.0,1.0,4/9,12.06%,HLA-E;HLA-A;IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5005153859509973,1.1100578580572256,0.25925925925925924,0.8551874319646515,1.0,3/24,6.91%,SLC26A7;SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.5072947434834164,1.1098849223817933,0.3235294117647059,0.8546710992304964,1.0,9/23,16.95%,NRP2;SEMA5B;ALCAM;AUTS2;NLGN3;SLIT2;SLIT3;CYFIP1;SLIT1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6562798960234619,-1.1094544768459549,0.3880597014925373,1.0,1.0,2/10,16.23%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.4881999796695789,1.1093985759307465,0.26666666666666666,0.8551980722347826,1.0,4/23,3.49%,F2;NOS2;ADGRB1;DMBT1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5600800053454271,1.1091761361385808,0.40476190476190477,0.8549049047842618,1.0,6/16,13.63%,KAT2A;RUNX1;DUSP10;IL2RA;SOX12;CBFB
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.6819725587725582,-1.1090381861378074,0.32142857142857145,1.0,1.0,4/7,25.32%,ZNF830;CLSPN;TOPBP1;HUS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5103388056353179,1.1086718813080445,0.43478260869565216,0.8552502734630507,1.0,1/33,0.07%,F2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.5799076077472822,1.1085805996975215,0.3695652173913043,0.8546390103090084,1.0,2/12,6.61%,GLI2;NFIB
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.4690190997875396,1.108474115256163,0.24242424242424243,0.8540013162201903,1.0,6/27,6.31%,IGF1;TCAP;SGCZ;ALPK3;MYOF;DYSF
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.6426109828159565,1.1083247056949301,0.36363636363636365,0.8537243922712445,1.0,3/8,19.42%,ATP1B3;DLG1;WNK1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.74700497342909,1.1080396308482054,0.375,0.8524685607192043,1.0,1/5,12.31%,KIF5C
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.74700497342909,1.1080396308482054,0.375,0.8524685607192043,1.0,1/5,12.31%,KIF5C
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.661983267017742,1.1078245114054568,0.39473684210526316,0.8522905258520854,1.0,3/5,31.20%,GSK3B;APC;AXIN1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5890375474458172,-1.1078092937192485,0.4230769230769231,1.0,1.0,5/18,4.44%,RPL23;RPS15;RPS7;RPL37;RPS20
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.583626027291182,-1.1072886118335374,0.3424657534246575,1.0,1.0,4/15,15.01%,NOP10;NHP2;CCT7;CCT2
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.7174483229427957,-1.107230344917398,0.4126984126984127,1.0,1.0,2/5,19.28%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3713515325582557,1.107225030684714,0.23529411764705882,0.8531593362135979,1.0,56/217,15.49%,IL1RAPL2;RELN;PDGFC;NPAS2;PCDH18;PBX3;SPOCK1;ATXN1;VIT;TBX6;KLHL17;AFF2;VCAN;CNTNAP2;GRHL2;CX3CR1;ADGRA2;PBX1;ZBTB16;PKD1;NFIB;HAP1;CHD7;UGT8;DSCAML1;DLL1;MEIS1;NHEJ1;SMG9;MEIS3;VAX2;ADGRL3;SCIN;NPAS1;NCAN;CELSR1;SOX12;C3;PLXNB2;PITPNM1;CDH2;GRIN1;MEIS2;CHST8;POMK;ROBO2;JRKL;PTEN;RPS6KA6;JHY;DCX;PSPN;SYNJ2;SLC23A1;TBC1D23;NR4A2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5194531384182621,-1.1065667296631798,0.3333333333333333,1.0,1.0,3/52,0.59%,CD44;DPEP2;P2RY10
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.60738154004126,-1.1062705413268343,0.4,1.0,1.0,4/11,24.67%,CCT7;CCT2;TERF1;CCT6A
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.668958283019154,-1.1059310416725332,0.3787878787878788,1.0,1.0,4/8,17.09%,PROCR;EDN1;APOE;SERPINE1
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.619112463155218,-1.1058958220286008,0.35,1.0,1.0,2/11,12.21%,CLU;MYRF
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5510379050122494,-1.1058930933931461,0.3384615384615385,1.0,1.0,3/18,11.10%,XBP1;BHLHE41;BDNF
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.6916940681018144,-1.1057447135115186,0.4117647058823529,1.0,1.0,2/6,10.12%,OPALIN;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5160723970031948,1.1056238097083084,0.3783783783783784,0.8568737790266125,1.0,5/22,10.49%,TICAM1;MFHAS1;SARM1;IRAK3;BPIFB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.7145513082197179,-1.1054545645263223,0.33962264150943394,1.0,1.0,1/5,1.25%,XBP1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5349087233992543,1.1054543299348478,0.34285714285714286,0.8565681437890602,1.0,4/24,6.36%,CHRNA4;STX1A;SNCA;SYT3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.6128522291647447,-1.1052849567184984,0.38095238095238093,1.0,1.0,4/11,22.44%,CLU;LRPAP1;APOE;MYOCD
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6312985186641444,-1.1051218297408525,0.43478260869565216,1.0,1.0,4/12,20.57%,NEFL;UXT;UBB;MAP1S
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.6166212457434862,1.1049644372164238,0.43243243243243246,0.8571142431265212,1.0,3/8,8.95%,MTURN;TESC;SCIN
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.6890348040262879,-1.1049614208035305,0.4576271186440678,1.0,1.0,3/5,26.27%,MAOB;COMT;LRTOMT
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6089096159104042,-1.1048077769624651,0.40298507462686567,1.0,1.0,3/16,12.21%,RIMS1;CARTPT;MYRF
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.48176632391501345,1.1047733933131287,0.26666666666666666,0.8568638382829795,1.0,10/44,6.77%,NLRP7;IGF1;CARD18;HSPB1;CLEC7A;CX3CR1;AGER;TMEM106A;P2RX7;TRIM16
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.7398615362741956,-1.1047104811115225,0.36507936507936506,1.0,1.0,2/5,10.33%,RAB11A;SYT11
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.7062044877488967,1.104451009938719,0.4666666666666667,0.8569564374362605,1.0,2/5,24.39%,FGF1;SCAP
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.7471561190457165,-1.1042822792288045,0.3787878787878788,1.0,1.0,1/5,9.35%,SLC35B2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.7471561190457165,-1.1042822792288045,0.3787878787878788,1.0,1.0,1/5,9.35%,SLC35B2
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.5357112395730326,1.1042052142675445,0.37142857142857144,0.8568298724582931,1.0,6/13,16.56%,MGAM;PHKA1;PYGB;PHKA2;PGM2;PHKG2
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6998014632691314,-1.1041203034792966,0.46551724137931033,1.0,1.0,3/5,25.02%,GDI1;INPP5K;KCNE1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5456280824608011,1.1038678364151757,0.3125,0.85693599126167,1.0,5/25,2.63%,ZAP70;ZBTB1;KAT2A;RUNX1;IFNA2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.7238607900654789,1.1035817267157502,0.47058823529411764,0.8567277512250026,1.0,1/6,2.22%,VEGFD
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.4123754436589631,1.1035530207601387,0.2608695652173913,0.8559741418539952,1.0,21/95,12.27%,KCNQ2;EFNB3;CELF3;CASKIN1;MMD2;SCRT1;PSD2;NGB;PCDH8;ADGRB2;CAMKV;PNCK;NXPH1;SNAP91;NCAN;B4GALNT4;CELSR2;GRIN1;SLC8A2;SLC32A1;SRRM3
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.44480848033525644,-1.103019754261031,0.2857142857142857,1.0,1.0,26/155,14.05%,RPL23;GAPDH;RPL5;CLU;RPS7;RPL11;EFNA1;PPIB;GBA3;NOP53;TNIP2;CDC37;CALR;CCT7;IRGM;GPIHBP1;PHB2;FLOT1;USP19;PDCL3;PINK1;GRN;GLMP;CAMLG;LAMP1;PER3
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6152985745364079,-1.1030153518484296,0.3472222222222222,1.0,1.0,2/13,2.84%,MT1E;MT2A
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6549838917335564,-1.1030020954262147,0.3333333333333333,1.0,1.0,2/10,2.82%,TTN;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6410207310092166,1.102887239065786,0.3829787234042553,0.8569259227592406,1.0,3/7,19.42%,ADA;CXCL13;WNK1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6457497687240332,1.102849485976299,0.425,0.8561191598448166,1.0,4/6,25.11%,ATP10A;ASAP1;DNM2;WASL
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5004456491386304,-1.1027272877877208,0.3088235294117647,1.0,1.0,10/44,14.32%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;BRCA1;SPRTN;RFC4;UBB
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.4433941927889231,1.1024830862192896,0.2857142857142857,0.8562662703507807,1.0,3/63,4.20%,RELN;DACT2;GRHL2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7007851014226008,-1.1024736070880605,0.46153846153846156,1.0,1.0,2/7,16.23%,GSTP1;GREM1
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.5289329972985034,1.1022739557546015,0.36,0.8560053864808004,1.0,10/30,21.76%,BICDL1;HAP1;ARHGAP21;RHOT1;BORCS5;MAPT;NDE1;TRAK1;BICD2;FBXW11
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.642874562175205,1.1019468845702418,0.37142857142857144,0.8561251634606107,1.0,1/11,0.29%,KCNN4
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.6748171161458749,-1.1019219205252873,0.3137254901960784,1.0,1.0,2/6,14.62%,SELENOS;APPL2
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.47476824883176505,-1.1018483342897463,0.32894736842105265,1.0,1.0,11/75,13.29%,TINF2;DBI;ATG14;PNKP;FBLN1;BEX4;TGFB1;CADM4;PPIA;MYADM;WARS1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.5241109444111445,1.1015073090471732,0.35714285714285715,0.8566380209330321,1.0,7/24,17.70%,MYH3;MBNL1;TGFB2;RARG;MEGF8;CREBBP;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.7062779651432143,-1.1014945410495953,0.39285714285714285,1.0,1.0,3/7,25.84%,APPL2;PPT1;ANKFY1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.751211290542682,-1.1013979055684204,0.32727272727272727,1.0,1.0,2/5,16.20%,STMN1;PBXIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4855316481361287,1.1012444052291845,0.2857142857142857,0.856567236844255,1.0,8/23,14.26%,IRS1;GRB14;PIP4K2A;PTPRE;PID1;ENPP1;KANK1;PRKCZ
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.713252393617066,-1.1011910398520022,0.3225806451612903,1.0,1.0,2/6,12.79%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5391064264291877,1.1007529460238559,0.36,0.8569026642839317,1.0,4/18,9.80%,PPARGC1A;PAXIP1;DIP2B;ARRB1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5485151079090004,-1.1007049710496895,0.3333333333333333,1.0,1.0,3/25,5.80%,SPAG17;RSPH6A;CCDC39
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.5115803622132683,-1.1005060493914187,0.3235294117647059,1.0,1.0,6/51,12.38%,ATG16L2;ATG14;EMC6;IRGM;GABARAPL2;TP53INP2
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.7305028155917941,-1.1003851782755842,0.4090909090909091,1.0,1.0,4/5,21.21%,RACK1;MAPK7;CALM3;CALM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.48353348531336626,-1.1002808773507868,0.3055555555555556,1.0,1.0,15/71,20.76%,SELENOS;SEC61B;TRIM13;TRIM25;USP19;RNF5;HSPA5;FAM8A1;SEL1L2;MAN1B1;UBXN8;HSP90B1;RNF175;FOXRED2;SGTB
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.519609441077267,-1.1000153348224413,0.352112676056338,1.0,1.0,1/39,0.08%,CD44
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.6736079036069809,-1.0997689181215098,0.4716981132075472,1.0,1.0,2/5,20.89%,AR;MSN
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.6736079036069809,-1.0997689181215098,0.4716981132075472,1.0,1.0,2/5,20.89%,AR;MSN
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5095178042979184,1.0996056046384761,0.2894736842105263,0.8588600815762432,1.0,7/20,15.56%,MTMR2;EPHA3;PROM2;PICALM;PRKD1;LRSAM1;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.684005340400791,-1.0993879583366846,0.45901639344262296,1.0,1.0,2/8,7.24%,SFRP1;CARTPT
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.67119790762576,1.099337538043198,0.43902439024390244,0.8588548371886199,1.0,3/8,10.87%,HOMER1;GRAMD2A;STIM1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.7096642254513931,-1.0992109896327869,0.4339622641509434,1.0,1.0,1/5,1.25%,XBP1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.48065251315607876,-1.099117083605376,0.2972972972972973,1.0,1.0,16/86,17.07%,RPS27A;COPS6;COPS7A;POLE3;UBA52;COPS5;CENPH;NUF2;CETN2;SOX15;RBX1;PARP1;HMGN2;UBB;XPA;GATAD1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.6922968570396936,-1.098713019144989,0.3492063492063492,1.0,1.0,4/7,24.55%,TRMT10A;TRMT10B;HSD17B10;TRNT1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6318975409345046,-1.0985507895843416,0.4107142857142857,1.0,1.0,1/10,2.04%,TPH1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.5961339057008008,-1.098483765095709,0.3392857142857143,1.0,1.0,1/14,5.46%,CXCL17
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.39902866984218704,1.0981988715594697,0.2222222222222222,0.8613327246162468,1.0,34/131,15.75%,RUNX1;IRS1;FBLN5;ATXN1;ANXA4;ADORA2B;SLC7A1;ID1;DUSP1;RND3;NFIB;IGF1R;PDLIM5;RASA2;GRK5;NFKB1;SPOP;MGLL;DLG1;PRKCE;BCKDHB;SCAF8;APBB2;ATP2C1;MMP16;MAGI2;KCNMA1;CELF2;ATRX;PTEN;DYRK1A;SYNJ2;ACVR2A;TENT4A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),0.6352690921735239,1.098189491368963,0.4418604651162791,0.8604891589258097,1.0,2/5,11.42%,HSPB1;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.6196212008786801,-1.0979066037467744,0.3870967741935484,1.0,1.0,1/8,1.73%,SELENOS
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.4780953581174068,-1.0974252945904417,0.35135135135135137,1.0,1.0,24/67,26.78%,ARHGEF16;MBNL3;KDELR1;TMEM54;TEAD3;PSMD3;GIPC1;RPL8;EIF5A;SLC25A1;LRRC42;POLD2;FASN;LRRC59;CDC20;SSRP1;PDIA4;REEP6;PES1;SLC25A10;LAS1L;TUBG1;LDOC1;PACSIN3
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.6309714316928865,1.0973900995933905,0.38636363636363635,0.8619638343053475,1.0,1/6,4.80%,MOGAT1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.6806591619172668,-1.0973421887366839,0.43333333333333335,1.0,1.0,2/6,17.86%,GCK;PGP
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.44615399397719135,-1.09719455240337,0.2727272727272727,1.0,1.0,26/155,14.65%,TOMM7;SLC25A4;COX7A1;SLC25A6;IFIT2;DNAJC19;TIMM8B;TIMM10;CHCHD2;TSPO;PHB2;ATP23;TOMM20;RAB32;HAX1;ATP5F1B;COX7A2;RAB5IF;PINK1;TIMM50;AFG3L2;PARP1;STOML2;MGME1;CAV2;HIGD1B
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5480470602654179,1.0971773431402536,0.38636363636363635,0.8617940683249732,1.0,8/18,20.35%,ID1;ROBO1;GPLD1;SLIT2;EGR3;FGF2;MIA3;PIK3R3
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.6656435483207391,-1.096946486598759,0.3387096774193548,1.0,1.0,5/8,24.68%,SNX17;APOE;SCARF1;AKR1D1;CYP27A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.6656435483207391,-1.096946486598759,0.3387096774193548,1.0,1.0,5/8,24.68%,SNX17;APOE;SCARF1;AKR1D1;CYP27A1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.7188036787043203,-1.0968492504728498,0.3103448275862069,1.0,1.0,3/8,9.84%,RNF8;GPR183;C17ORF99
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6207467985071866,1.0968400832026832,0.42857142857142855,0.8619606809905622,1.0,1/10,2.74%,BDH2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4191668588089052,-1.096732906316463,0.28888888888888886,1.0,1.0,97/350,23.53%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;CSTB;TRAPPC1;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;TUBB4B;PPIE;ATP6AP2;CYB5R3;PSMD7;NIT2;PFKL;PGRMC1;VAMP8;CNN2;FUCA2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;CR1;DDOST;ADGRE5;LRRC7;EEF2;PPIA;PRSS3;COMMD9;GGH;IMPDH2;PTGES2;LAMP1;APRT;PYGL;DYNLL1;CLEC12A;DOCK2;CCT2;PGLYRP1;MAGT1;TIMP2;ARPC5;LAMTOR1;EEF1A1;AGA;CKAP4;ORMDL3;HSPA8;PSMD2;CYSTM1;LILRB3;PSMD6;CST3;TMEM179B;CTSZ;VAT1;ATP6V1D;ARL8A;CTSS;AGL;TUBB;FRMPD3;ILF2;PGAM1;STK10;ITGAV;AP2A2;RHOA;LAMTOR2;ALOX5;C6ORF120;DNASE1L1;HGSNAT;LGALS3;ADGRE3;KPNB1;SVIP;BRI3;RAB31;NPC2;HVCN1;RAB37;CREG1;GLIPR1;TMBIM1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.6958547309842076,-1.0967276356647022,0.4166666666666667,1.0,1.0,2/6,14.54%,VPS35;CAV2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6084224407255712,1.0964396432513606,0.3888888888888889,0.8621941051559562,1.0,1/8,3.18%,ADAM19
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5941993735866825,-1.0964390090283365,0.3561643835616438,1.0,1.0,3/16,6.91%,B2M;HLA-A;CD81
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.48057137894383967,1.0961905800216565,0.2857142857142857,0.8618770498331016,1.0,10/42,13.11%,IL1RAPL2;IL1RAPL1;PTPRD;NLGN1;SNCA;PDLIM5;NRXN1;NLGN3;CLSTN2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5213789943381562,-1.0961225838481354,0.2777777777777778,1.0,1.0,9/40,20.89%,CNN2;ARF1;TALDO1;RPLP0;PPIA;CFL1;LCP1;SOD1;MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.4755534468988898,-1.095749569237503,0.3,1.0,1.0,6/66,12.08%,ARHGEF16;RHOG;VAMP8;AR;TGFB1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.4154288202348111,1.0956752262276517,0.2692307692307692,0.8623379253142055,1.0,2/78,0.21%,F2;PDGFB
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.5670305350887547,1.0953497215966401,0.37142857142857144,0.862369456591534,1.0,3/10,12.17%,SGK1;SCIN;GPLD1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6754358999567225,-1.095347884805101,0.4727272727272727,1.0,1.0,4/10,15.35%,IRF1;IRGM;STAT1;CDC34
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5050402848441983,1.095228776885403,0.36666666666666664,0.8618257865768502,1.0,1/27,0.18%,VAPB
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6436928391126884,-1.0948220112155342,0.36507936507936506,1.0,1.0,1/9,2.51%,JUP
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.5826413363131014,1.0947023521586023,0.36363636363636365,0.86241897043476,1.0,8/12,32.11%,ARHGAP35;PTEN;B4GALT5;B4GALT6;SPTBN4;EPHB2;MYCBP2;EPHB1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.49170227650197185,1.0942461216958108,0.32142857142857145,0.8627707039766118,1.0,4/25,15.43%,KAT2A;CPA4;KAT2B;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.7223338897781051,1.094233915627451,0.4722222222222222,0.8619481918776719,1.0,4/5,27.75%,ATP1A2;DRD2;SLC8A1;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.5333454632384205,1.0940401781089888,0.41379310344827586,0.8616202379263136,1.0,4/21,8.46%,RELN;CPEB3;NLGN1;LLPH
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5247625242036719,1.094011335004737,0.3,0.8608137815208657,1.0,3/25,7.71%,PTPN6;TTLL12;OAS3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4502102574402005,1.0936759870032333,0.34615384615384615,0.8609130747741375,1.0,12/53,10.70%,FGFR1;IGF1;SRC;RELA;WWOX;TRAF2;TMC8;SH3RF1;ACVR1;SIAH2;TNFRSF10A;FEM1B
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.4197083066892359,-1.0936552203736687,0.29213483146067415,1.0,1.0,98/353,23.53%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;CSTB;TRAPPC1;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;TUBB4B;PPIE;ATP6AP2;CYB5R3;PSMD7;NIT2;PFKL;PGRMC1;VAMP8;CNN2;FUCA2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;CR1;DDOST;ADGRE5;LRRC7;EEF2;PPIA;PRSS3;COMMD9;GGH;IMPDH2;PTGES2;LAMP1;APRT;PYGL;DYNLL1;CLEC12A;DOCK2;CCT2;PGLYRP1;MAGT1;TIMP2;ARPC5;LAMTOR1;EEF1A1;AGA;CKAP4;ORMDL3;HSPA8;PSMD2;CYSTM1;LILRB3;PSMD6;CST3;TMEM179B;CTSZ;VAT1;ATP6V1D;ARL8A;CTSS;AGL;TUBB;FRMPD3;ILF2;PGAM1;STK10;ITGAV;AP2A2;RHOA;LAMTOR2;ALOX5;C6ORF120;DNASE1L1;HGSNAT;LGALS3;ADGRE3;KPNB1;SVIP;BRI3;ADAM17;RAB31;NPC2;HVCN1;RAB37;CREG1;GLIPR1;TMBIM1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.3663680151518527,1.0936028023118805,0.2,0.8602948624433354,1.0,26/140,12.42%,KCNN4;RELN;CSF2RA;GALNT3;ETV1;SPRY2;DUSP6;ANKH;ADGRA2;AKT2;ETV5;CAB39L;ADAM8;MAP3K1;SNAP91;LAT2;MAFB;WDR33;CA2;PRKG2;ALDH1A3;ARG1;HDAC9;PTBP2;KIF5C;GFPT2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.547268529819497,-1.093412721947574,0.29411764705882354,1.0,1.0,1/26,0.32%,BMP5
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.41797685417932967,-1.0932126463242338,0.32222222222222224,1.0,1.0,97/352,23.53%,CD44;B2M;HLA-C;FTH1;FTL;SRP14;CSTB;TRAPPC1;JUP;CD63;PTAFR;GSTP1;DEGS1;RHOG;TUBB4B;PPIE;ATP6AP2;CYB5R3;PSMD7;NIT2;PFKL;PGRMC1;VAMP8;CNN2;FUCA2;CEACAM1;CFD;FUCA1;GMFG;PSMD3;GRN;PSMC3;CR1;DDOST;ADGRE5;LRRC7;EEF2;PPIA;PRSS3;COMMD9;GGH;IMPDH2;PTGES2;LAMP1;APRT;PYGL;DYNLL1;CLEC12A;DOCK2;CCT2;PGLYRP1;MAGT1;TIMP2;ARPC5;LAMTOR1;EEF1A1;AGA;CKAP4;ORMDL3;HSPA8;PSMD2;CYSTM1;LILRB3;PSMD6;CST3;TMEM179B;CTSZ;VAT1;ATP6V1D;ARL8A;CTSS;AGL;TUBB;FRMPD3;ILF2;PGAM1;STK10;ITGAV;AP2A2;RHOA;LAMTOR2;ALOX5;C6ORF120;DNASE1L1;HGSNAT;LGALS3;ADGRE3;KPNB1;SVIP;BRI3;RAB31;NPC2;HVCN1;RAB37;CREG1;GLIPR1;TMBIM1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6174689713142849,-1.09316144427557,0.38095238095238093,1.0,1.0,2/13,12.09%,ENTPD2;ENTPD3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.5318904689864887,-1.093051119001063,0.38571428571428573,1.0,1.0,10/32,20.95%,H1-4;H1-2;USP51;RAD51AP1;KPNA2;FIGNL1;RAD50;H1-10;PPP4C;H1-0
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5157324104519483,1.093014702586759,0.325,0.8612172419724488,1.0,7/18,18.73%,HAP1;NTRK2;RAPGEF1;SORT1;MAGI2;RAP1A;ZFYVE27
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4741591112529424,1.092972092062483,0.28,0.860467366432444,1.0,6/42,2.49%,ZAP70;LCP2;GNLY;C1ORF162;PSTPIP1;PIK3R5
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6137960678746914,1.0928407614304223,0.3333333333333333,0.8599573593715821,1.0,2/9,9.90%,RXRG;RARG
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4320569744014622,1.0927580999949267,0.2608695652173913,0.859249873724997,1.0,7/47,5.48%,NPAS2;SPRED3;SPRED2;EGFR;EYA4;SPRED1;SIRT1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.4272389737256128,1.092602457764122,0.3181818181818182,0.8588213620213935,1.0,28/142,11.12%,TNNC2;IGF1;TCAP;PDLIM7;TPM2;MYOM1;MAPK12;CTF1;MYH4;MYH3;VIPR1;GNAO1;PDE4DIP;AGRN;PTP4A3;AKT2;CKM;SORBS1;TPD52L1;SMTN;REEP1;NCAM1;AEBP1;MRAS;SGCG;ENO3;SGCD;PLXNB2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5403397514010797,-1.0925839282216199,0.36619718309859156,1.0,1.0,5/27,15.15%,TMEM107;FUZ;ARL13B;IFT122;DCTN1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.43114561584384686,1.0923288148464712,0.3,0.8587238319616284,1.0,13/76,9.57%,ADAM33;TPM2;PCDH18;GFAP;POSTN;PDGFRA;TMEM47;CDH11;COL14A1;HTRA1;COL6A1;COL5A1;AQP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6840309762463447,1.0923087267835132,0.375,0.8570663431890638,1.0,2/5,22.32%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6840309762463447,1.0923087267835132,0.375,0.8570663431890638,1.0,2/5,22.32%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6854579550587574,-1.0922997020555587,0.373134328358209,1.0,1.0,2/7,8.77%,AQP9;AQP11
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5246981858528174,-1.0921689085065558,0.37142857142857144,1.0,1.0,8/38,17.09%,B2M;CLU;GPC3;VPS28;FLOT1;APPL2;APOE;SERPINE1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7314505552190119,-1.0920198229633724,0.3870967741935484,1.0,1.0,2/5,15.56%,GSTM4;GSTM3
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5687854697436449,-1.0919578764554922,0.359375,1.0,1.0,7/22,20.78%,CPS1;FABP3;FABP6;LIPH;LIPI;DAGLA;ABHD12B
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5102005898126137,1.0917793499775557,0.34210526315789475,0.8575633338938455,1.0,9/23,16.99%,IL1RAPL1;HOMER1;CTNNA2;ZNF804A;NTNG1;PTEN;MARK1;GSK3B;NCS1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.5747622699136341,-1.0917225487610838,0.3888888888888889,1.0,1.0,6/23,20.07%,PEX11A;PEX10;PEX11G;DNM1L;FIS1;PEX1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5587957545384759,-1.091691411750795,0.3076923076923077,1.0,1.0,2/21,10.33%,RIMS1;SYT11
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.41641837895016165,1.0915308614299437,0.22727272727272727,0.8572437763107895,1.0,18/101,9.92%,IGF1;LIFR;FRZB;VIT;TACC2;EGFR;POSTN;PDGFRA;ALDH1A1;SASH1;TMEM47;CDH11;COL14A1;HTRA1;DHCR7;MAFB;AQP1;ALDH1A3
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.6870923985124974,1.0915253049047045,0.47368421052631576,0.8564254498601747,1.0,2/6,17.29%,DLG1;PARD3
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.5214236297453221,1.0914367661612592,0.3055555555555556,0.8558712908198677,1.0,13/22,26.48%,SLC4A4;AP3D1;CAMK2D;KLHL3;NEDD4L;SLC4A7;WNK1;SLC4A10;FHL1;SLC30A3;SLC30A8;SLC4A3;WNK2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.5483731497707535,-1.0913482361163123,0.3492063492063492,1.0,1.0,7/30,17.11%,HSPE1;SDF2L1;HSPA2;HSPA5;DNAJC7;CCT2;HSPA8
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5389074928359712,-1.0911350733449876,0.38571428571428573,1.0,1.0,3/30,7.87%,TINF2;NOP10;NHP2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.6861646127260146,-1.0909324040833972,0.3770491803278688,1.0,1.0,2/6,4.04%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5822711704207348,1.0906122753155063,0.4,0.8573643577345129,1.0,2/9,5.40%,ZMYND10;DNAAF1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.5871830093501784,-1.09052998837788,0.3333333333333333,1.0,1.0,8/19,25.82%,BUD23;TRMT112;FTSJ3;DIMT1;MRM3;EMG1;METTL5;NSUN4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.5691294306197854,1.0904669970109753,0.3157894736842105,0.8568496735756244,1.0,7/17,20.54%,DPYSL3;NT5E;DPYSL4;NT5M;UPP1;DPYD;TET2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.4832357650483569,1.0903184680472386,0.35135135135135137,0.8564276211156785,1.0,6/25,18.46%,KCNJ2;CACNA2D1;CACNA1G;NEDD4L;KCNE4;SCN3B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5421677161514766,-1.0901460137471821,0.3492063492063492,1.0,1.0,2/23,5.49%,RPS27A;UBA52
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.5836348624727761,-1.0900850043276027,0.4117647058823529,1.0,1.0,3/18,12.62%,BMP5;CEACAM1;BRCA1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.5182633084654001,1.090044876505176,0.30303030303030304,0.856241794339133,1.0,8/18,25.11%,MYO5B;SYNE2;MYO1D;MYO1B;SUN2;MYO7A;MYO5A;WASL
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4196826355763106,1.0899967143285332,0.2413793103448276,0.8554553004363762,1.0,27/99,14.46%,GRM2;RELN;HOMER1;GRM8;TMEM108;CX3CR1;NLGN4X;AGER;NLGN1;KCNMB4;CACNG5;USP46;GRM3;GRM1;UNC13A;GRID1;LRRC4C;PXK;CDH2;SLC12A2;SLC8A2;NLGN3;CLSTN2;LRP8;GRIK2;PTEN;NMU
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.4700006879359754,-1.0894939382862003,0.3108108108108108,1.0,1.0,9/61,11.65%,OST4;ALG10B;TMEM258;DAD1;B4GALT7;DPM3;PMM1;MCFD2;DDOST
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.549390461243239,-1.0893098636498701,0.3492063492063492,1.0,1.0,6/21,20.71%,ISCU;ISCA2;CIAO2B;GLRX5;NUBP2;NUBP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.44374995765786535,-1.0892172202798767,0.27848101265822783,1.0,1.0,31/150,19.91%,PSMB8;FBXO43;PKMYT1;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;BTG3;KIF20B;CDKN1C;BTG1;DYNLT3;TGFB1;NEK6;PSMD3;PSMC3;THAP1;ASAH2;ANAPC15;CAV2;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;CDC23;PSMA3;PSMB3;PSMC1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.46776707211915103,-1.089179703753223,0.3116883116883117,1.0,1.0,11/95,9.69%,SLC25A4;EHHADH;PRDX1;PRDX5;RETSAT;PEX11A;TSPO;HRAS;SLC35B2;GSTK1;FABP6
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.46458183796749075,-1.0889447044254372,0.26666666666666666,1.0,1.0,23/96,18.17%,DDIT3;SELENOK;SELENOS;CFTR;UFC1;RASGRF2;TTC23L;ATG10;FLOT1;USP19;PDIA3;GORASP2;RNF5;HSPA5;CEBPB;TMCO1;ATF3;UFL1;CCDC47;HSP90B1;HYOU1;FICD;BAX
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.6440274089674464,1.0888958682156815,0.4375,0.8578291926354478,1.0,3/6,15.95%,TEKT5;CFAP54;DNAI3
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.6715062144729107,-1.088873565221725,0.453125,1.0,1.0,5/6,31.37%,RTF1;PAF1;CTR9;LEO1;POU5F1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.6505187610912848,1.0887081123094728,0.4594594594594595,0.8575773503441532,1.0,2/6,7.77%,SRC;NTRK2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5816287228926742,-1.0879122728354063,0.36764705882352944,1.0,1.0,8/21,20.72%,GAPDH;PFKL;GCK;TPI1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.580615050808973,1.0878691876529982,0.3076923076923077,0.8586939410200696,1.0,9/16,18.76%,PKD1;TMEM120B;CPSF6;KCNC2;CPSF7;GRIN1;PKD2;CBR4;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4871265036987738,1.087778661686344,0.35,0.8581293782664831,1.0,11/32,15.94%,NUPR1;KAT2A;CDK10;EVI5L;CCP110;SMAD4;CEP97;KAT2B;TESK1;SCFD1;TMEM39A
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.7170605242423986,1.0877710634657831,0.3488372093023256,0.8573058375963617,1.0,1/5,9.33%,MAFB
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.5038267033852268,1.0876583080040167,0.37142857142857144,0.8568476131694726,1.0,7/29,14.30%,RELN;NLGN1;ARHGAP44;PDLIM5;LRP8;ABI2;PTEN
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.6897505286787662,1.0876472599340175,0.4418604651162791,0.856026877907816,1.0,3/6,24.11%,OAS3;ADCYAP1;DDX3X
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5415745756475694,-1.0876103965614201,0.37142857142857144,1.0,1.0,6/22,22.77%,VPS25;VPS28;TOM1L1;SNF8;VPS36;VPS4B
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5616626795795128,1.0874591083276859,0.3611111111111111,0.8556744803272017,1.0,4/16,10.70%,SPTSSB;FEM1A;HMBOX1;FEM1B
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.5870608014476483,-1.0874115168504892,0.35714285714285715,1.0,1.0,2/17,7.73%,DTX3L;RNF8
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4203379193973086,1.0874016757687854,0.34615384615384615,0.8549730160549399,1.0,24/60,25.42%,CPNE1;ACP6;CPNE7;PLA2G10;HDHD5;PIGP;GDPD3;GPLD1;LCAT;PNPLA6;GPCPD1;ABHD3;PLAAT1;PLA2G4C;CPNE6;PIGX;CSF1R;SMPD4;PRDX6;PLCB1;PIGZ;PLA2G4A;IP6K3;DGKH
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5510904395411524,-1.0873613235181776,0.3939393939393939,1.0,1.0,6/21,28.17%,TGFB1;AP2S1;CLTA;AP2A2;AP2A1;NEDD4
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.42261727932821425,-1.0871420973840304,0.32941176470588235,1.0,1.0,16/143,11.83%,CD44;TNFAIP2;IFIT2;IFNGR2;EFNA1;SNN;IRF1;BTG3;TNIP2;BTG1;SERPINB8;GPR183;EIF1;STAT5A;CEBPB;CEBPD
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.5657771457134297,-1.0870311825325056,0.3387096774193548,1.0,1.0,4/13,14.85%,MAGEF1;ISCA2;CIAO2B;GLRX5
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.6364282720992666,1.086978248398186,0.4186046511627907,0.8546083940407406,1.0,2/6,27.04%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.6364282720992666,1.086978248398186,0.4186046511627907,0.8546083940407406,1.0,2/6,27.04%,MAGI2;IQGAP1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5007850508247171,-1.0867761983243438,0.3384615384615385,1.0,1.0,9/42,14.32%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;SPRTN;RFC4;UBB
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5583896168190616,-1.0865807050773109,0.453125,1.0,1.0,4/23,14.32%,RPS27A;UBA52;FADD;UBB
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5583896168190616,-1.0865807050773109,0.453125,1.0,1.0,4/23,14.32%,RPS27A;UBA52;FADD;UBB
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.6937699900562875,-1.086557303499976,0.42028985507246375,1.0,1.0,1/6,4.18%,USP1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.542470333177167,-1.0864456361662924,0.31746031746031744,1.0,1.0,6/22,20.71%,ISCU;ISCA2;CIAO2B;GLRX5;NUBP2;NUBP1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.7363108796804863,-1.0861127175643208,0.39655172413793105,1.0,1.0,1/5,0.78%,PDHX
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6196684592168794,-1.0860499783611888,0.37735849056603776,1.0,1.0,4/16,14.64%,TCN2;AMN;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6196684592168794,-1.0860499783611888,0.37735849056603776,1.0,1.0,4/16,14.64%,TCN2;AMN;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.709045082592881,-1.0859449049777268,0.390625,1.0,1.0,3/5,13.48%,HLA-E;HLA-A;STOML2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.6227049666619364,1.0858143814946928,0.40425531914893614,0.857268191892481,1.0,2/5,25.10%,STK39;CAB39
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.5211509305450017,1.0857924075263037,0.3611111111111111,0.8565033620172571,1.0,6/14,16.56%,MGAM;PHKA1;PYGB;PHKA2;PGM2;PHKG2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.47059136783741856,-1.0857269711045254,0.32432432432432434,1.0,1.0,5/65,1.48%,IL26;BMP5;B2M;TINF2;SFRP1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.45838477263328087,1.0857186558986416,0.3333333333333333,0.8559591469442275,1.0,14/64,15.95%,TP63;IGF1;CDK6;BMP6;HEMGN;NPNT;ACVR1;CHRD;PRKD1;BMPR2;ACVR2B;CRIM1;ACVR2A;DNAI3
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.701991908467744,1.0852214728892022,0.41304347826086957,0.8565622396086827,1.0,4/5,21.55%,OTUD7B;ZRANB1;OTUD7A;USP9X
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.46202208796323674,1.0851134201900392,0.41935483870967744,0.8561219402036202,1.0,9/37,10.79%,ZNF423;PLCL2;ID1;PLCL1;ALDH1A1;NPR3;DOCK7;TLE3;ARRDC3
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.479591736490343,-1.0850484264676006,0.3870967741935484,1.0,1.0,6/45,11.67%,DDIT3;HSPE1;HSPB8;HSPA2;TM7SF3;HSPA5
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3951977408128277,1.0849861747326806,0.3333333333333333,0.8557981715863677,1.0,4/64,2.15%,VAPB;BET1;CD59;COL7A1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.3869342090424851,1.0849148361407202,0.29411764705882354,0.8551924740698207,1.0,9/116,1.59%,F2;ZAP70;PTPN6;STAB1;NOS2;IL4R;LCP2;KLRD1;ICAM1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5439658358759175,-1.0848658952144483,0.38235294117647056,1.0,1.0,6/26,14.20%,PARP2;PARP14;ART3;PARP12;PARP1;PARP9
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.6248702546612859,1.084614368357555,0.45,0.8551653046335201,1.0,5/11,15.43%,RUNX1;MAFB;IL17D;CBFB;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5628982220031117,-1.0845866413858738,0.3424657534246575,1.0,1.0,3/21,10.15%,RAB11A;ATAD5;CDK4
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.7095463941181623,-1.084586201086375,0.4745762711864407,1.0,1.0,1/5,3.06%,NPR2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.7095463941181623,-1.084586201086375,0.4745762711864407,1.0,1.0,1/5,3.06%,NPR2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.5375281444808937,-1.0845451986719916,0.38461538461538464,1.0,1.0,7/31,19.43%,POLR1G;POLR2L;POLR1F;POLR1H;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.6881884426808975,1.0845050003206782,0.4,0.854676718861086,1.0,3/6,28.73%,TENT4B;SND1;LIN28B
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.6565842745160193,1.0842543675327003,0.425,0.8543683467481229,1.0,3/6,22.53%,MITF;RALY;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4818414259886778,-1.0840661594257262,0.3717948717948718,1.0,1.0,16/75,19.86%,B2M;DTX3L;STMN1;EDF1;RPL11;DDX11;BAMBI;FLOT1;KDM4D;PARP9;DACT1;APOE;TXN;NCBP1;CAV1;RAN
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.5909127933811278,1.0840642437266748,0.34285714285714286,0.8540989400378101,1.0,2/10,6.89%,HDAC10;SMS
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.411205255883963,-1.0840147290356337,0.2840909090909091,1.0,1.0,69/391,14.96%,CD44;IL26;PSMB8;HLA-F;B2M;GBP2;HLA-C;IL7;RPS27A;DUOX1;PSME1;NDN;IFIT2;IRF4;IFNGR2;MT2A;TIMP1;HLA-DPA1;IL31RA;PTAFR;HLA-E;HLA-A;PSMB6;PSMC5;IL6R;PSMD8;IRF9;PSMD7;UBA52;IFIT3;IRF1;IFITM3;TNIP2;CNN2;ARF1;CEACAM1;TRIM25;LCK;TALDO1;IL5;TMSB4X;JAGN1;TGFB1;RBX1;PSMD3;STAT5A;PIK3CB;PSMC3;TXNDC17;RPLP0;STAT1;IFI6;ILK;CEBPD;CD27;PPIA;IL3RA;IFNLR1;TNFRSF1A;EIF5A;OSMR;CANX;UBB;OPRM1;APPL2;IFIT5;CFL1;ISG20;PSMA4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.39439219170659573,1.0839355264287287,0.2,0.8537022189465088,1.0,34/123,20.04%,PTPN6;PPP4R2;PPM1M;DUSP6;PTPRD;EYA4;MTMR2;PPM1L;DUSP1;DUSP10;PTPN22;PTPRK;PTPRE;PPP2R2C;PTPN4;DUSP18;PTEN;PPP2R2A;PPM1E;PTPRN2;CDC14B;RPRD1B;BTRC;PTPRO;MTMR3;PPM1D;PTPN14;PPP3CA;PTPRR;SSH2;PTPRU;PPP1R15B;SSH1;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6091533577993133,-1.083926460451131,0.4,1.0,1.0,1/13,1.05%,POLR2G
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.37648284348284267,1.0839025532953093,0.3076923076923077,0.8530253007922409,1.0,91/348,20.45%,ZAP70;PDGFB;CDKL1;FGFR1;CDK6;PASK;ALK;PLK1;CDK10;MAP4K5;LIMK1;CDK12;FRK;NEK4;IRAK3;FNIP2;MATK;TNIK;SGK1;NLK;AURKC;MAP3K1;TGFB2;NUAK1;MAPK10;GRK5;MEX3B;VRK2;ACVR1;PRKG2;MAP4K2;SGK3;TSSK6;MKNK2;PXK;PRKD1;PIK3CA;PI4KA;PRKCE;MAP4K4;MERTK;POMK;DYRK3;HCK;CDK17;BMPR2;SIK3;PRKCZ;HIPK2;ACVR2B;DYRK1A;RYK;CDKL4;ACVR1C;MARK1;PDK4;HIPK3;ACVR2A;SYK;CDC25B;DGKI;GSK3B;DGKE;LMTK3;LTK;CDK18;CAMK2D;FER;MAPK8;ABL1;PRKACB;DMPK;PANK3;BMPR1B;GRK4;PIM3;MKNK1;COPS2;BCR;MARK4;TRIB2;WNK1;SIK2;DGKB;DGKK;SRPK2;PDK1;PEAK1;MAPKAPK2;TLK2;MARK2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4096906009377189,-1.0836561473678559,0.3048780487804878,1.0,1.0,46/225,22.36%,PSMB8;RPS27A;PSME1;CFTR;USP6;PSMB6;PSMC5;USP1;RAD23A;PSMD8;PSMD7;ADRM1;UBA52;USP51;JOSD2;TNIP2;COPS5;ABRAXAS1;TOMM20;AR;USP19;PSMD3;PSMC3;CLSPN;ATXN7L3;BRCA1;UBB;PSMA4;ACTB;PSMA7;MBD6;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;USP16;USP8;RHOA;CDC20;MCRS1;PSMD10;ENY2;UBC
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.5332558902000566,-1.08319004592967,0.3142857142857143,1.0,1.0,5/31,12.30%,SLC25A4;MICOS13;SLC25A5;TIMM50;PPIF
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6579389202262566,-1.082837788103995,0.4,1.0,1.0,2/7,5.35%,VPS35;RAB11A
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6603486325207446,-1.0823515917868138,0.4153846153846154,1.0,1.0,1/7,9.85%,PRPS1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.5072771468525669,1.082344845324382,0.4074074074074074,0.857095706900391,1.0,4/22,8.05%,HSPA1A;PLK1;HNRNPU;HSPA1B
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.403951873441977,1.0822565901867076,0.23076923076923078,0.8565953167127557,1.0,40/217,10.02%,CREB3L1;PDGFB;COL20A1;ADAMTSL3;COL5A3;TNC;ADAMTSL2;CTSK;ICAM1;ITGA11;COL7A1;SLC39A8;COL22A1;FBLN5;VIT;COLGALT1;JAM2;ADAM19;POSTN;VCAN;ADAMTS9;ADAMTS18;AGRN;ADAMTS2;SCX;ITGA10;SERPINF2;COL9A1;ITGAX;ADAM8;COL14A1;LOX;HTRA1;TGFB2;COL6A1;COL5A1;NCAN;NPNT;COL23A1;ADAMTS10
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.677590213174495,-1.0821523055294366,0.3548387096774194,1.0,1.0,3/7,25.70%,MCM3AP;POLQ;POLL
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.6456768449829506,-1.0819864337977627,0.3870967741935484,1.0,1.0,3/10,21.02%,FSTL1;GREM1;CD46
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5952218014291225,1.0819568264093173,0.4411764705882353,0.8566689068240697,1.0,5/9,32.58%,ACACB;CPT1A;ACACA;PRKAG2;MID1IP1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.703256892430707,-1.0815856214885908,0.32786885245901637,1.0,1.0,4/6,20.99%,PRPS1;PRPSAP1;PRPS2;G6PD
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6187792806284091,-1.0815196738343025,0.35294117647058826,1.0,1.0,3/12,12.58%,PARP2;PARP12;PARP1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.6995546260312189,1.0814941801725368,0.47619047619047616,0.8562945495462593,1.0,4/5,25.66%,SLC8A1;RYR3;RYR2;CASQ2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.6995546260312189,1.0814941801725368,0.47619047619047616,0.8562945495462593,1.0,4/5,25.66%,SLC8A1;RYR3;RYR2;CASQ2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6684504540329038,-1.0813980680136859,0.417910447761194,1.0,1.0,3/6,20.74%,DDX60;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.4926568822703168,1.081158337448683,0.3055555555555556,0.8564190082796351,1.0,3/33,1.62%,PDGFB;RELN;CASS4
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6762349095761957,-1.0810941436190702,0.39344262295081966,1.0,1.0,2/7,12.83%,NOP53;PIK3IP1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5388188276302199,-1.0809900626109419,0.37142857142857144,1.0,1.0,2/28,1.38%,B2M;FTL
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.43883098012940613,-1.0808989688659403,0.32558139534883723,1.0,1.0,45/206,20.54%,PSMB8;DDIT3;SFRP1;PSME1;JUP;TMEM198;PSMB6;PSMC5;KREMEN1;ATP6AP2;PSMD8;PSMD7;SFRP4;GPC3;BAMBI;TGFB1;RBX1;FUZ;PPP1CA;PSMD3;PSMC3;ILK;PPM1N;PLEKHA4;ANKRD6;PSMA4;GREM1;DACT1;APOE;PSMA7;DKK3;PSMD2;GLI3;TPBG;PSMD6;PSMB2;PSMB4;TMEM9;EMD;PSMA3;CAV1;PSMB3;PSMC1;PTK7;USP8
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5857137203296524,1.0807559581221011,0.425,0.8566827856885995,1.0,2/10,4.16%,IGF1;CD200R1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.6936659712874312,-1.0807004566110463,0.38596491228070173,1.0,1.0,2/7,11.11%,PSMC5;PSMC3
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.6669630404632574,1.0806095352551404,0.47619047619047616,0.8563376861754817,1.0,4/5,32.83%,CRACD;CARMIL1;WASHC2C;CARMIL2
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4461293221125279,-1.0804577236339346,0.3026315789473684,1.0,1.0,29/136,15.69%,HLA-F;SLC25A4;PARP2;SLC6A12;ATP6V1F;TST;CNP;POLE3;HYAL2;IRF1;BTG3;C4BPB;CDKN1C;PRPF3;HSPA2;BTG1;RASGRP1;PDLIM3;PSMC3;OLFM1;PPIF;UROD;AP2S1;CCK;GGH;ATF3;RFC4;CDC34;SELENOW
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.48874098958531004,-1.0803134973689925,0.323943661971831,1.0,1.0,5/59,4.15%,BEST1;TRPM1;GPR179;RDH12;DNAJC19
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.5381460420118797,1.0802852063212955,0.4,0.8564490928354407,1.0,5/21,5.23%,NUPR1;TP63;TRIM29;POSTN;PROM2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4229689685776487,-1.0802045093108998,0.26506024096385544,1.0,1.0,40/244,16.90%,TINF2;MCM2;RPS27A;PARP2;TYMS;DNASE2;NUDT1;APEX1;PCNA;ENDOG;PNKP;POLE3;UBA52;ORC6;MCM4;MPG;NOP53;MCM3;WDHD1;RPA3;TSN;RAD51AP1;RFC2;NUDT15;PARP1;BRCA1;KPNA2;MBD4;KAT5;GEN1;MUS81;RFC4;UBB;CDC34;RAD50;XRCC2;XRCC3;MCM5;REXO4;XPA
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.5998936814853144,-1.0801410838682466,0.39436619718309857,1.0,1.0,5/15,22.44%,MESP1;MYEF2;MTLN;CBY1;MYOCD
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.49536235576216986,-1.079948789224789,0.32857142857142857,1.0,1.0,23/62,27.07%,POLR2G;POLR2J;GTF2F1;POLR2L;ELOB;POLR2I;ADRM1;RTF1;PAF1;POLR2A;SUPT5H;GTF2H2;NCBP1;NELFE;SSRP1;NELFCD;ELOF1;CTR9;POLR2K;POLR2C;ELOC;NCBP2;LEO1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6639929109622507,-1.0798834201901013,0.37735849056603776,1.0,1.0,4/6,22.82%,CAV2;TPCN2;CAV1;CTSL
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.5464647495292314,1.079857224704201,0.325,0.8568259621536101,1.0,4/18,6.46%,MTHFD2L;MTHFS;ALDH1L1;DHFR
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5584648013310258,1.0790235677273543,0.30303030303030304,0.8582385414820065,1.0,8/13,30.56%,PAXIP1;TFRC;SHLD1;KMT5B;HMCES;KMT5C;TP53BP1;PARP3
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.49119002433274195,1.0788814087133716,0.2926829268292683,0.8579311607568101,1.0,9/16,16.62%,NRP2;ROBO1;TGFB2;ACVR1;SMAD4;ZFPM2;ROBO2;BMPR2;SEMA3C
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5000471876132362,1.0788024457064465,0.358974358974359,0.8572837299448596,1.0,6/26,11.23%,KAT2A;MAML2;NOTCH3;DLL1;ARRB1;LFNG
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5119124575980326,-1.0786615185184483,0.38571428571428573,1.0,1.0,7/29,18.01%,TPP1;GRN;GNPTAB;SNAPIN;LAMTOR1;TPCN2;NAGPA
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.46933998168740426,1.0785966055336615,0.25,0.8561184005162558,1.0,1/22,0.84%,TP63
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.46933998168740426,1.0785966055336615,0.25,0.8561184005162558,1.0,1/22,0.84%,TP63
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.6362413579679405,-1.0783543820646826,0.40298507462686567,1.0,1.0,3/9,15.42%,AIPL1;FNTA;RABGGTB
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4338371732772107,-1.0782738174356765,0.2911392405063291,1.0,1.0,21/149,12.30%,CD44;IGSF1;HR;XBP1;COX6C;CD9;PDZK1;TST;BLVRB;HSPB8;OVOL2;BTG3;SLC16A1;ETFB;DYNLT3;GALE;PDLIM3;MEST;OLFM1;GINS2;PPIF
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.4165366082500509,1.0780319475003564,0.25,0.8566947654407757,1.0,16/92,6.55%,CDKL1;TP63;TRIM29;ICAM1;NRP2;LGALS4;TM4SF20;MYO5B;GRHL2;SPTSSB;FZD6;AGER;SEC23B;RNF128;P2RX7;SCNN1D
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5237637624507342,1.077920971276002,0.43243243243243246,0.8561388657592996,1.0,5/20,16.95%,SRC;ROBO2;PTEN;CORO1C;SLIT1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6023660539575636,1.077852571454956,0.325,0.8556593396030544,1.0,6/8,24.39%,PRKCE;CAMK2D;NEDD4L;ATP1A2;STK39;HECW2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.510622836243459,-1.0770384670286237,0.30158730158730157,1.0,1.0,4/32,11.37%,CENPF;HYAL2;PAX8;STAT1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.6576183464810397,-1.0769172065644461,0.42857142857142855,1.0,1.0,1/5,1.73%,SELENOS
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.52068292740745,-1.076656158529475,0.2916666666666667,1.0,1.0,10/42,13.05%,PM20D1;CPS1;DEGS1;DEGS2;SGMS2;SLC25A15;PCSK1;SMPD2;ARG2;ASAH2
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.4588782658570213,1.0766134301953167,0.3142857142857143,0.8581665449424548,1.0,6/29,7.47%,ZAP70;ZBTB1;LEF1;DUSP10;GLI2;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6705628313874847,-1.0765320020639566,0.4626865671641791,1.0,1.0,1/10,1.48%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4783260758253658,1.0763828363492918,0.25,0.8579868451604677,1.0,7/31,9.03%,FGFR1;FLT1;EGFR;PDGFRA;LPAR2;NTRK2;ADRA1A
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5951828203111755,-1.0762435231711251,0.4090909090909091,1.0,1.0,1/11,9.88%,FADD
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6807168601832421,-1.0761780185924803,0.423728813559322,1.0,1.0,2/8,26.90%,JMJD4;GLE1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.611494851463048,1.076109934158977,0.45454545454545453,0.8580328802238106,1.0,4/6,33.66%,ARFIP1;USP7;LRRK2;PRKN
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.698402767086166,-1.075905231906496,0.5,1.0,1.0,3/7,28.44%,GARS1;AARS2;DARS2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5275563318451963,1.075871821127083,0.3235294117647059,0.8578536357181695,1.0,7/24,10.92%,DNAAF1;NPY;PKD1;GLI2;COBL;TGFB2;MEGF8
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4348525694592206,-1.075795385115433,0.3614457831325301,1.0,1.0,16/127,10.90%,TOMM7;UBL5;JUP;PDZK1;HYAL2;KIF20B;CD81;RBM22;CEMIP;HRAS;CEP131;ARIH2;CAMK1;TGFB1;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.41183738380531765,1.0754867590288655,0.2727272727272727,0.8581371948111483,1.0,7/44,7.73%,SPIRE2;NPAS2;EGFR;HDAC10;EYA4;SIRT1;SPIRE1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6886799784027273,-1.0754019997632258,0.38235294117647056,1.0,1.0,3/6,22.24%,EME1;MUS81;SMC1A
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6023584321247576,-1.075267525803402,0.4074074074074074,1.0,1.0,3/13,15.86%,RACK1;HSPA5;UFL1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5048367706811923,1.075032159834926,0.275,0.858295353742418,1.0,1/20,0.11%,TNFSF13B
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.5915442096398214,-1.0748284571386755,0.4266666666666667,1.0,1.0,3/10,24.67%,CCT7;CCT2;CCT6A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.46010175922570845,1.0747905762014067,0.34146341463414637,0.8579541714702479,1.0,8/31,18.88%,GNAO1;FZD6;LEF1;NLK;PDE6B;TNRC6B;WNT5A;PPP3CA
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.668533659951861,-1.0746859391461343,0.43037974683544306,1.0,1.0,2/6,11.01%,SOX15;SELP
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.5760502150084205,-1.0746425160291002,0.423728813559322,1.0,1.0,3/11,17.95%,CHMP2A;CAV2;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.6603855201281352,-1.074404779757296,0.417910447761194,1.0,1.0,1/7,1.40%,SIGIRR
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5600096886940138,-1.0743854725124644,0.3888888888888889,1.0,1.0,7/19,16.76%,CLU;BBS12;TMEM35A;HOPX;CCT2;NDUFAF1;PFDN6
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6294989247327967,-1.0743259794892202,0.4411764705882353,1.0,1.0,3/13,8.45%,CD9;FBLN1;SPINT2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.671566202074907,1.0740404399985017,0.42857142857142855,0.859371149613926,1.0,4/6,25.80%,BCL2L1;DFFA;FZD3;PAK2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3523579720478305,1.073921559608608,0.2727272727272727,0.8589299792193831,1.0,65/393,13.02%,PDGFB;ZNF423;GCM1;TP63;NPAS2;IGF1;FLI1;KAT2A;MYRFL;RUNX1;SNAI1;IFNA2;AFAP1L2;TAL1;HDAC4;ATOH8;EGFR;PPARGC1A;RELA;RFX3;ZXDC;SUPT3H;ZNF516;CREB5;FOXK1;ARID1B;NPAS3;LEF1;YAF2;ZBTB16;HIVEP3;MLLT3;TBL1XR1;NEK4;SMARCA2;SCX;GLI2;NFIB;RYBP;PICALM;TRIM16;NOTCH4;TESC;CD4;MLXIPL;NFKB1;MAFB;ACVR1;RNF14;TEAD1;WAC;MITF;SMAD4;ARID1A;ZNF318;TRIM44;TEAD2;RGMB;CD80;ESRRB;ZNF281;ESRRG;FOXO3;TCF4;SS18L1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4354700854286444,-1.073879940859124,0.325,1.0,1.0,21/149,14.58%,CD44;HR;XBP1;PDZK1;BLVRB;PEX11A;HSPB8;OVOL2;ELOVL2;SLC16A1;RASGRP1;DYNLT3;AR;SH3BP5;PDLIM3;OLFM1;THSD4;PPIF;MYBBP1A;ASB13;SLC39A6
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.453577028741946,1.0736854338353357,0.26666666666666666,0.8587011309902626,1.0,5/53,2.88%,PDGFB;CASS4;CDK6;VIT;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.60357498194813,-1.0734964141053644,0.4166666666666667,1.0,1.0,2/10,7.91%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.6278236164765904,-1.0734962279590392,0.3050847457627119,1.0,1.0,4/13,11.44%,RPS19;GRN;SLAMF8;CR1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.6939504814857862,-1.0733798517709559,0.421875,1.0,1.0,4/7,29.18%,CD81;ZP3;C1S;C1QC
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5341248929443606,-1.073338072561783,0.37681159420289856,1.0,1.0,16/37,26.43%,UQCR10;ETFB;SURF1;NDUFS8;UQCRH;UQCRB;MDH2;ETFRF1;NDUFS7;COQ10B;UQCRC1;MTLN;UQCRFS1;NDUFA5;ETFA;NR4A3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4539892142467434,-1.0733160629620153,0.2948717948717949,1.0,1.0,28/95,25.80%,MCM2;DDX11;DHX16;MCM3;FTSJ3;DHX38;USP19;SNRNP200;EIF3D;CHAF1A;NEMP1;CHD4;MCM3AP;ILF3;NOL6;PRPF8;PDCD11;LSG1;TTF2;DHX37;DDX21;SSRP1;KPNB1;NOP14;EFTUD2;TOPBP1;DDB1;EIF3A
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.41954801527442986,-1.0732690872029282,0.3924050632911392,1.0,1.0,26/175,15.71%,CENPF;MCM2;BUB1;STMN1;CCNB2;H2AZ1;MT2A;CENPE;ORC6;KIF20B;MCM3;TPX2;TGFB1;SNRPD1;CDK4;SMC4;GINS2;CHAF1A;KPNA2;SMC2;HMGN2;NCL;ILF3;KIF4A;CBX1;PLK4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.6584949081614373,-1.073205945210291,0.4444444444444444,1.0,1.0,3/7,22.91%,TMSB4X;PSMD10;CCDC22
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.503628229248775,-1.0729951864496468,0.3235294117647059,1.0,1.0,18/56,30.45%,TRMO;BUD23;TRMT112;TRMT10A;FTSJ3;DIMT1;METTL3;TRMT5;WDR6;RBM15B;METTL5;CMTR1;NSUN4;THUMPD2;HENMT1;NSUN3;TRMT61A;THUMPD3
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5246538467089157,1.0729341125391014,0.3888888888888889,0.8596287358153193,1.0,4/20,9.90%,CHRNA4;SNCA;SYT3;GDNF
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6429711966714664,-1.072857164476,0.38333333333333336,1.0,1.0,3/9,11.10%,XBP1;BHLHE41;BDNF
prerank,MSigDB_Hallmark_2020__Coagulation,0.4302941084575147,1.0727284148240714,0.34782608695652173,0.8593624094218375,1.0,5/86,3.21%,F2;PDGFB;SH2B2;CTSK;DUSP6
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.39211632048918277,1.072578300359532,0.3333333333333333,0.8589724938301128,1.0,20/121,9.90%,BICDL1;ETV1;RUNX1;PBX3;ALK;CNTNAP2;TMEM108;AGER;L1CAM;NLGN1;ASCL1;PBX1;NPY;FRYL;GLI2;DOCK7;NTRK2;TGFB2;TBCD;GDNF
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.6510636482654497,1.0723168718380456,0.5128205128205128,0.8587568405543615,1.0,2/5,7.77%,SRC;NTRK2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.5759370499848562,-1.0723135469203275,0.35294117647058826,1.0,1.0,7/17,26.18%,FTSJ3;EXOSC4;EXOSC10;WDR12;NSA2;PES1;LAS1L
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.5573008515802503,1.072266217378414,0.4375,0.8581452610658984,1.0,8/17,24.66%,HAP1;MARK1;TRAK1;MARK2;MTM1;MFN1;TLE6;TRAK2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.5312885471840028,-1.0721768556849007,0.3611111111111111,1.0,1.0,11/33,20.72%,GAPDH;SLC25A11;G6PC3;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5926736528585659,1.0716876906729216,0.425,0.8591805012309921,1.0,6/9,26.58%,RAPGEF1;RAPGEF3;RAP1A;RAP2C;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.6222449309029973,1.0714045931254406,0.43243243243243246,0.8590394229431856,1.0,4/6,24.59%,RFWD3;FEM1B;CRY1;WDR76
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3381847943476602,1.0712277367735936,0.2222222222222222,0.8587256858371474,1.0,48/431,9.17%,CREB3L1;VDR;PDGFB;ZNF423;TP63;RIDA;DACH1;SPINDOC;PASK;ATXN1;IFNA2;GMNN;HDAC4;ATOH8;RELA;RFX3;HDAC10;CPEB3;HIC2;ID1;SAMD13;FOXK1;ZNF706;ASCL1;LEF1;YAF2;ZBTB16;IGF2BP2;SIRT1;EIF4E2;SAMD4A;SFMBT2;SMARCA2;HMX1;SYNCRIP;FOXN3;DHFR;ZNF93;NANOS3;HMBOX1;ZHX2;PHF10;ARID5A;PHC3;PUS7;MLXIPL;NPAS1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5426161456544342,1.071178761584593,0.4375,0.858079343011244,1.0,1/14,1.07%,IGF1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4252356731815128,1.07078028513516,0.35714285714285715,0.8583095118252462,1.0,15/67,21.06%,KAT2A;CHD5;SUPT3H;LEF1;TRIM16;CPA4;TAF12;KAT2B;CREBBP;JADE2;JADE3;TAF5L;ZZZ3;PER1;DR1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5655168557346604,-1.070759612966104,0.36486486486486486,1.0,1.0,3/20,10.45%,PRDX5;AR;BRF2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.580166527024605,1.07066456606808,0.36363636363636365,0.8578618018641544,1.0,6/11,26.69%,TCOF1;CDH2;KBTBD8;NRG1;NOLC1;TAPT1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6464041098437103,-1.0704620087258754,0.4166666666666667,1.0,1.0,2/10,14.31%,STAT1;CANX
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4967451755071249,-1.0704551247900767,0.3142857142857143,1.0,1.0,6/34,9.42%,PIGH;PGAP4;PIGC;PGAP2;DPM3;ST3GAL5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.49350940847559205,-1.0704132465516567,0.3287671232876712,1.0,1.0,20/66,23.36%,CSTF2T;POLR1G;POLR2L;POLR3K;POLR1F;FIP1L1;POLR1H;LSM10;TTF1;TAF1D;CPSF3;POLR2A;GTF2H2;NCBP1;CLP1;POLR1E;SMN1;TTF2;POLR1B;SSU72
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.607547222591751,-1.0702469778907993,0.4393939393939394,1.0,1.0,3/9,19.46%,VIL1;CFL2;WDR1
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6609137709176591,-1.0700715701126087,0.3559322033898305,1.0,1.0,3/6,9.15%,LIMA1;VIL1;PLEKHH2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6510968610376212,1.0700301792531581,0.42857142857142855,0.8589039641218349,1.0,2/6,9.12%,ADARB2;ADARB1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6235906869802563,-1.0700257338912762,0.4090909090909091,1.0,1.0,1/10,1.13%,HR
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.4802160393862078,-1.0695979191505693,0.35064935064935066,1.0,1.0,6/49,12.58%,TRPM1;COPS9;PCNA;TRIAP1;OPN4;PARP1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.550448455793373,1.0693185315921623,0.4,0.8602024321832794,1.0,2/15,4.20%,DACT2;GRHL2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6183090747877773,-1.0693020375212785,0.4098360655737705,1.0,1.0,2/10,10.69%,RHOG;SEMA3A
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6075132628081017,1.069294187672255,0.5,0.858730004262737,1.0,2/8,5.94%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6075132628081017,1.069294187672255,0.5,0.858730004262737,1.0,2/8,5.94%,PDE4B;SNCA
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.5021306422861038,-1.0692510136540936,0.36231884057971014,1.0,1.0,4/36,9.20%,SLC8A3;LCK;HTR2B;SLC24A1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.46067593704519255,1.0690626896161646,0.36363636363636365,0.8585046506459448,1.0,17/54,17.83%,ZNF423;DLX1;CHRD;SMAD4;SMURF2;LEMD3;BMPR2;GDF5;HIPK2;ACVR2B;CRIM1;ACVR2A;TRIM33;SMAD9;UBE2D3;SMAD2;BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.6424276745104075,1.0690428192194175,0.38461538461538464,0.8577529271023712,1.0,1/8,3.98%,ESPL1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.40988789354971206,1.068824139977482,0.2631578947368421,0.857394227976454,1.0,11/70,8.80%,PDGFB;RUNX1;FLT1;YJEFN3;TAL1;PRKX;ZBTB16;NOTCH4;DLL1;MEIS1;TGFB2
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.6300458631576854,1.0684081274097306,0.4791666666666667,0.8577332022482634,1.0,2/5,14.48%,SIRT1;STARD4
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5116981497080617,-1.0682251552138275,0.37681159420289856,1.0,1.0,11/34,27.16%,IFITM3;FAM111A;ILF3;IFIT5;ISG20;BTBD17;INPP5K;RNASEL;MORC2;IFIT1;SETDB1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4364613875110445,-1.0679978562706605,0.32,1.0,1.0,39/180,19.14%,GPX4;COX6A1;UQCR10;TST;RETSAT;HSPB8;PFKL;ETFB;UQCRQ;CYC1;COX7B;DHRS7;TALDO1;NDUFB7;JAGN1;SPARCL1;COQ3;STAT5A;NDUFAB1;RMDN3;MGST3;IDH3G;ESYT1;ARAF;DECR1;OMD;NMT1;MDH2;SLC25A1;SSPN;APOE;LAMA4;UCK1;UQCRC1;GRPEL1;NDUFS3;REEP5;ANGPT1;SOD1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5261150622075234,1.0679900198206507,0.40625,0.8578394327352636,1.0,4/14,8.21%,JCAD;SPRY2;ROBO1;DLL1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5816952164379363,-1.0677935413247739,0.3939393939393939,1.0,1.0,8/20,20.72%,GAPDH;PFKL;GCK;TPI1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5816952164379363,-1.0677935413247739,0.3939393939393939,1.0,1.0,8/20,20.72%,GAPDH;PFKL;GCK;TPI1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5978848852966278,-1.0675785896795134,0.31343283582089554,1.0,1.0,3/11,24.67%,CCT7;CCT2;CCT6A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5978848852966278,-1.0675785896795134,0.31343283582089554,1.0,1.0,3/11,24.67%,CCT7;CCT2;CCT6A
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.6253353691854334,1.0672526833116855,0.3888888888888889,0.8589341976392901,1.0,4/8,14.30%,TMEM108;NLGN1;NRXN1;PTEN
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.6560687193217313,1.0668276632383535,0.47619047619047616,0.8591733064400887,1.0,5/5,34.41%,PHF8;KDM6A;KDM7A;KDM6B;UTY
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.554841300186161,-1.0663163702342648,0.3484848484848485,1.0,1.0,2/18,10.69%,SEMA3E;SEMA3A
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.6184238790379712,1.0662997744593143,0.4117647058823529,0.8595460151018528,1.0,2/6,16.83%,JADE2;JADE3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.6908593686897759,-1.0662236484101724,0.47619047619047616,1.0,1.0,3/5,21.70%,HYOU1;ENO1;NOL3
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.5021436563059976,1.0661787400524616,0.3888888888888889,0.8590537291329535,1.0,4/10,14.09%,ALK;CCDC3;ASXL3;GPER1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.6452234614855348,-1.0661456381383883,0.40625,1.0,1.0,5/8,31.68%,XRCC3;BLM;TERF1;RECQL4;SLX4
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5150421247989146,1.0660919700099798,0.3,0.8584407003585511,1.0,2/29,3.00%,PDGFB;HSPB1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.39144825932271754,1.0660129426697593,0.2727272727272727,0.8578773782033919,1.0,31/155,10.02%,PDGFB;ADAMTSL3;COL5A3;TNC;ADAMTSL2;ICAM1;ITGA11;COL7A1;SLC39A8;COL22A1;FBLN5;VIT;JAM2;ADAM19;POSTN;VCAN;ADAMTS9;ADAMTS18;AGRN;ADAMTS2;ITGA10;COL9A1;ITGAX;COL14A1;LOX;COL6A1;COL5A1;NCAN;NPNT;COL23A1;ADAMTS10
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.5767662923641675,1.0660019516820107,0.375,0.8571329526059459,1.0,5/10,26.58%,TJP2;AFDN;TJP1;RAP2C;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4298365563283508,1.065990159754333,0.25,0.8563777299140221,1.0,16/54,17.61%,PDGFB;NPAS2;EGFR;EYA4;SIRT1;PPP1R10;RNF168;ATRX;HMGB1;RAD51;DHX9;UIMC1;FGF2;CEBPG;RGCC;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6245995485878608,-1.0658947149138405,0.42857142857142855,1.0,1.0,2/8,7.91%,CD9;CEACAM1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.5064834701978862,-1.0658445860544021,0.4057971014492754,1.0,1.0,1/33,0.32%,BMP5
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.5905120193099557,-1.0653175854685668,0.4696969696969697,1.0,1.0,4/13,10.52%,HLA-E;HLA-A;WFDC3;RPL39
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.6430147056474174,1.0652192832287652,0.5217391304347826,0.8575144450921953,1.0,4/5,34.46%,ZFP36;LGALS9;MAPK14;ZFP36L1
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.5170776418282843,-1.0651837253321281,0.3787878787878788,1.0,1.0,3/30,10.69%,SEMA3E;HTR2B;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.693827060585952,1.0650875003163391,0.45454545454545453,0.8569902893008141,1.0,2/6,3.07%,TMEM98;JAM2
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5310749654394824,1.0650284385979167,0.3333333333333333,0.8564065819763512,1.0,3/13,4.03%,PDIA5;PPARGC1A;CYB561
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5755937779904846,1.0649065006109757,0.38095238095238093,0.8559206097638092,1.0,1/12,0.67%,NUPR1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.6553618329796649,-1.064884936432466,0.45161290322580644,1.0,1.0,1/8,3.81%,CPTP
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.4834290971406158,-1.0648710484631438,0.4166666666666667,1.0,1.0,3/58,8.56%,GPAT3;RRAGA;LAMTOR5
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3856310904995469,1.064847601797308,0.2608695652173913,0.8553388962844319,1.0,23/125,10.24%,CREB3L1;ZNF423;COL5A3;ADAM33;FBLN5;C6;EGFR;POSTN;PPARGC1A;ARNT;PDGFRA;LTBP2;ZBTB16;ADAMTS2;COL14A1;LOX;HTRA1;COL6A1;EPSTI1;CYTH3;AQP1;NMB;C3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.3978933196110203,1.0647366057556433,0.2692307692307692,0.8548547403052981,1.0,21/90,12.28%,IGF1;NOS2;MYOM1;ABCC8;RFX3;ENSA;SYTL4;STX1A;BMP6;STXBP5;LLGL2;ADAM8;DRD4;TGFB2;KCNC2;HMGCR;ARFIP1;ITPR1;ATP13A2;SLC12A2;RAPGEF3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5829542819679301,-1.0647342558992086,0.45714285714285713,1.0,1.0,4/11,24.55%,CHMP2A;CHMP7;CHMP4B;UBE2S
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.6887264341196561,-1.0646597669736484,0.4827586206896552,1.0,1.0,1/5,1.25%,XBP1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.41708664829056585,1.0644745516947334,0.22727272727272727,0.8547210249649865,1.0,16/59,19.39%,CPNE1;CPNE7;NLGN1;SYT3;ACER1;GPLD1;CPNE2;ADCY8;RASGRP2;PKD2;CAMK2D;SYT5;WNT5A;CPNE6;CPNE5;CPNE9
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5978329491955049,-1.064319434122822,0.45454545454545453,1.0,1.0,6/11,24.78%,VIL1;DSTN;CFL1;CFL2;WDR1;TWF1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5642524061083231,1.0641561634564742,0.425,0.8548284221093121,1.0,5/9,13.16%,HSPA1A;HSPA1B;SACS;DNAJA4;DNAJB6
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5671661410501709,1.0641169955756085,0.3235294117647059,0.8542256789941607,1.0,4/13,16.39%,CAMSAP3;BAG3;ARHGAP21;BORCS5
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5667523371798868,1.0639499419200869,0.4117647058823529,0.8538524304620083,1.0,5/10,13.16%,HSPA1A;HSPA1B;SACS;DNAJA4;DNAJB6
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.46695728085200605,1.0632638635305645,0.25,0.8546930261457015,1.0,10/19,31.85%,MOV10L1;TNRC6B;CELF1;WTIP;HELZ;CNOT7;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.6546368337022487,-1.063064357411211,0.43636363636363634,1.0,1.0,5/13,22.77%,CHMP2A;CHMP3;CHMP7;CHMP4B;VPS4B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.5122575986356409,-1.063056638262669,0.40540540540540543,1.0,1.0,6/30,15.79%,POLR2G;LSM2;LSM7;EXOSC4;EDC4;NT5C3B
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.39345287831346226,1.0629194960743915,0.22727272727272727,0.8547400622462789,1.0,31/156,10.02%,PDGFB;ADAMTSL3;COL5A3;TNC;ADAMTSL2;ICAM1;ITGA11;COL7A1;SLC39A8;COL22A1;FBLN5;VIT;JAM2;ADAM19;POSTN;VCAN;ADAMTS9;ADAMTS18;AGRN;ADAMTS2;ITGA10;COL9A1;ITGAX;COL14A1;LOX;COL6A1;COL5A1;NCAN;NPNT;COL23A1;ADAMTS10
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5391690446974818,-1.0628676620889828,0.35526315789473684,1.0,1.0,4/24,9.64%,JUP;HYAL2;RBM22;TGFB1
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.6479376658592051,1.06275608059005,0.574468085106383,0.8543313780903776,1.0,2/5,6.15%,MAPKBP1;CYBA
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.48018267483117677,1.0627453454002458,0.3,0.8536119406359923,1.0,5/30,6.82%,IGF1;IRS1;PIK3R5;IGF1R;PLEKHA1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.617802692329292,-1.0625774729692812,0.43103448275862066,1.0,1.0,2/9,11.23%,CYB5R3;RGN
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5303038562439106,-1.062554649092184,0.425,1.0,1.0,6/35,9.88%,BTN3A1;ZFPM1;HLA-DPA1;HLA-A;RASGRP1;FADD
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.587692656337364,-1.0624879570596486,0.3333333333333333,1.0,1.0,1/10,1.63%,TAX1BP3
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6784113179522556,-1.062443153916802,0.5094339622641509,1.0,1.0,1/5,4.00%,PPIB
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.5516620935516081,-1.061979254223146,0.4,1.0,1.0,4/25,8.17%,RPS27A;LACC1;UBA52;IRGM
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5493504081035447,1.0618375318176723,0.3333333333333333,0.8555150428716102,1.0,2/15,3.54%,CBARP;HAMP
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5280766033244724,-1.0617652956173211,0.42424242424242425,1.0,1.0,1/26,0.46%,GATA1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.707390999050429,-1.0617451312964126,0.56,1.0,1.0,1/5,5.48%,HYAL2
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.6357055001789915,-1.0617176015610768,0.4153846153846154,1.0,1.0,2/6,19.01%,TSR3;RPUSD2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.6508036909809798,-1.061659694848926,0.4716981132075472,1.0,1.0,3/6,20.57%,UXT;UBB;MAP1S
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.4121315257853509,1.0613498297113604,0.3103448275862069,0.8559917005476839,1.0,34/114,19.27%,LIFR;PTPRD;CELF3;PLD1;LRP4;DPYSL3;STX1A;NPY;ADGRB3;PLPPR4;ASXL3;SNAP91;CACNA2D1;MAPK10;SHC3;UNC13A;CADPS;NRXN1;SEMA6D;SLC12A2;KCTD16;SLC8A2;P2RY1;RIMBP2;NFASC;RAPGEF4;KIF1B;NCS1;GRIA2;GUCY1A2;ADGRA1;MAP2;ADCYAP1R1;KCNIP1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5668636290209753,1.06082515406294,0.36363636363636365,0.8563599841788779,1.0,2/14,8.07%,CHST7;CHST3
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.4739288025504119,-1.060795520986184,0.3972602739726027,1.0,1.0,15/92,16.97%,SLC8A3;PKMYT1;CCNB2;CNPPD1;SERTAD1;CDC37;CCNJL;IRGM;CAMK1;MTCP1;CCNE2;SYAP1;SNF8;ACTB;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.6490898818176148,-1.0606724775417438,0.4406779661016949,1.0,1.0,1/8,0.45%,B2M
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.6460999313738038,-1.0606339542183774,0.4166666666666667,1.0,1.0,2/7,28.78%,TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.4731296465248924,1.060433416067255,0.45,0.856584367337839,1.0,11/24,21.65%,PRKX;RASIP1;PKD1;GLI2;ACVR1;MEGF8;SLIT2;PKD2;SCRIB;CSF1R;RYR2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4859267398416432,-1.0604232345991647,0.38235294117647056,1.0,1.0,6/49,12.38%,ATG16L2;ATG14;EMC6;IRGM;GABARAPL2;TP53INP2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5452816896639872,-1.060343330521816,0.3709677419354839,1.0,1.0,5/29,19.04%,RIMS1;PNKD;SYT11;SNAPIN;MCTP2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6285553882623658,-1.060228087613256,0.43283582089552236,1.0,1.0,4/9,27.05%,AP2S1;CLTA;AP2A2;AP2A1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6285553882623658,-1.060228087613256,0.43283582089552236,1.0,1.0,4/9,27.05%,AP2S1;CLTA;AP2A2;AP2A1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.6058992953915918,-1.060159140411893,0.36764705882352944,1.0,1.0,1/10,7.03%,METAP2
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.6320948855925087,-1.060123870642708,0.44776119402985076,1.0,1.0,1/8,4.37%,GBA3
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.46783570347583936,1.0600962637353892,0.22857142857142856,0.8567845012205929,1.0,1/23,0.07%,F2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5647732359972187,-1.0600272592412903,0.4745762711864407,1.0,1.0,7/20,20.48%,PTK6;HYAL2;VPS25;SH3BP5;CBLC;CAV1;SNX6
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5198270725999128,-1.0599742141748927,0.3880597014925373,1.0,1.0,2/33,1.48%,BMP5;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.5730795008786406,-1.059658797562253,0.37142857142857144,1.0,1.0,2/11,10.46%,GSTP1;GPS2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5256547632181918,1.058720444442087,0.30303030303030304,0.8593318587272862,1.0,6/13,25.66%,CASP7;RAD51;SLC8A1;RYR3;RYR2;CASQ2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4033372710172768,1.0584785589191381,0.4090909090909091,0.8591482295674976,1.0,25/120,12.16%,SPOCK1;ATXN1;GFAP;CELF3;MMD2;SCRT1;PSD2;NPY;ADGRB3;PLPPR4;ABHD2;AMER2;OLFM3;NXPH1;SNAP91;GRM3;PRSS12;NCAN;ZNF536;GABRB1;KCNC2;LRRC4C;NEGR1;NRXN1;SLC8A2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6370889448094373,-1.0582242195050444,0.43548387096774194,1.0,1.0,4/7,34.94%,MCRS1;GLUL;NVL;NMD3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.6171512807394062,1.0581058950395037,0.4722222222222222,0.8594288552643073,1.0,3/5,28.60%,STK39;CAB39;SLC12A6
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5360375985899702,1.0580572537553596,0.3333333333333333,0.8587700524490006,1.0,3/12,16.31%,IWS1;CPSF6;DHX9
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.6108378278729836,1.0577944474364125,0.3333333333333333,0.8584805248161322,1.0,2/6,12.67%,P2RX7;PLSCR4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.60393165519998,-1.0575542997396332,0.37681159420289856,1.0,1.0,5/15,13.05%,PDXDC1;ASAH2B;SMPD2;SGPL1;ASAH2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4304807463438174,1.0574491119915237,0.3125,0.8588203202645139,1.0,12/64,9.92%,TP63;TNC;TRIM29;EGFR;POSTN;LTBP2;EHD2;MYOF;RND3;FBLIM1;AHNAK2;ALDH1A3
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.6614729149906733,-1.0572167903088858,0.4339622641509434,1.0,1.0,1/6,6.31%,VAMP8
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.6320885686516426,-1.0570138135291578,0.41818181818181815,1.0,1.0,7/15,26.62%,CHMP2A;CHMP3;CHMP7;CHMP4B;RHOA;VPS4B;CNTROB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.5841408228618761,-1.0566809418382657,0.41935483870967744,1.0,1.0,3/13,11.71%,IRF4;HLA-E;CEBPB
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.4822914378793614,1.05667723523075,0.3,0.8597877870275283,1.0,10/36,11.74%,CLDN15;CLDN9;CLDN12;GRHL2;FRMPD2;TBCD;DLG1;PARD6B;AFDN;ESAM
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5183687078275527,1.0564537740641091,0.38235294117647056,0.8595691912851153,1.0,5/14,18.52%,SEC23B;SEC24B;SEC31A;SEC31B;MIA3
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5623399202879273,-1.056132997809019,0.41818181818181815,1.0,1.0,7/17,27.88%,CHMP2A;SNF8;CHMP3;VPS4B;SMPD3;SDC4;HGS
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6403788666006913,1.056090972439856,0.41025641025641024,0.8597888119648662,1.0,2/7,12.34%,SRC;UBR5
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.6371199472431047,-1.055991357505094,0.5,1.0,1.0,3/7,22.14%,CXCL17;SERPINE1;CREB3
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.4625338792568761,1.055864640389047,0.3125,0.8595824198631813,1.0,4/23,5.21%,FGFR1;POSTN;VCAN;OLR1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6455896601622159,-1.0556610078762998,0.4262295081967213,1.0,1.0,2/9,16.82%,IFT122;C12ORF57
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.5805148021930074,1.0556597485611565,0.4117647058823529,0.8592582603045961,1.0,4/9,8.02%,RUNX1;LEF1;HCLS1;TESC
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5900738699454049,1.0556425461808239,0.35294117647058826,0.8585451848314913,1.0,3/7,32.19%,SMC5;SMC6;RAD18
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.5498571167629294,-1.055565810988058,0.4,1.0,1.0,5/21,14.10%,PTK6;IL31RA;STAT5A;STAT1;NMI
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4730819137587786,-1.0555151103309264,0.375,1.0,1.0,3/32,3.35%,DUOX1;AQP9;CFTR
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4859917262324426,-1.055504673112158,0.3698630136986301,1.0,1.0,11/64,15.74%,GAPDH;POLR3H;POLR2L;POLR3K;IRF1;FLOT1;POLR3GL;STAT1;DDX41;RNF135;PQBP1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5353613423599745,-1.0553366712836136,0.373134328358209,1.0,1.0,1/18,0.62%,RIMS1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4769503618348239,-1.0545277436373228,0.4117647058823529,1.0,1.0,6/42,14.62%,B2M;HES6;BHLHE41;SERPINF1;OPRM1;APPL2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.5265555378564136,-1.0543819175602966,0.4603174603174603,1.0,1.0,8/24,24.51%,EEF1AKMT2;TRMT112;ANTKMT;METTL18;METTL21A;SETD7;CSKMT;ETFBKMT
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.4725336246708681,1.0541943377376808,0.4,0.8614063787110192,1.0,4/22,12.28%,ICAM1;COL22A1;RAPGEF1;RAPGEF3
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.53397438939908,1.0540920521901598,0.375,0.8607869307843097,1.0,4/12,13.47%,TICAM1;PTPN22;PRKCE;HCK
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.4860316186270486,-1.0540746884165568,0.3287671232876712,1.0,1.0,18/67,11.90%,PRB3;GBP2;NLRP1;RPL30;HLA-E;HLA-A;ROMO1;IL6R;COLEC12;RPS19;IRGM;WFDC3;RPL39;DEFB109B;SELP;SLAMF8;CEBPB;PPP1R11
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.486331292493947,1.0539940501327676,0.3333333333333333,0.8602274176312644,1.0,7/18,23.48%,CAMSAP3;CYTH3;CLASP1;GOLPH3;PARD3;FBF1;RAP2A
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.6106472049376823,-1.0532204457510932,0.42857142857142855,1.0,1.0,1/11,0.45%,B2M
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5335725478526381,-1.0532102346835919,0.4155844155844156,1.0,1.0,7/25,20.28%,JUP;HYAL2;RBM22;TGFB1;ECT2;RAN;PDCD5
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.7254728575680682,-1.0530379414944733,0.43137254901960786,1.0,1.0,1/5,17.50%,HMGCL
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.660332003135371,-1.0525729323534334,0.44594594594594594,1.0,1.0,4/7,24.55%,BRCA1;UBE2D4;RNF4;UBE2S
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.5256111991555968,-1.0525371245610606,0.41379310344827586,1.0,1.0,3/27,6.89%,RPS27A;UBA52;TNIP2
prerank,PanglaoDB_Augmented_2021__Platelets,-0.44109910930256785,-1.052075535910817,0.35,1.0,1.0,15/110,12.40%,DPEP2;AQP9;PPDPF;CD9;OST4;HLA-E;HLA-A;F5;SPARC;CYP2U1;GMFG;SELP;ILK;LGALS8;ADGRE5
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5947849168928019,1.0517758872589296,0.43902439024390244,0.8652673323881807,1.0,4/6,36.53%,RPGRIP1L;RP1;RPGRIP1;BBS4
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.45321931711855606,-1.0516202768657739,0.35526315789473684,1.0,1.0,5/66,3.12%,ADH4;ACTG1;CLU;CD9;ANXA5
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5990870571012883,-1.0513154344305782,0.4406779661016949,1.0,1.0,3/12,6.91%,ERVFRD-1;CD9;CD81
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.46223922306075577,-1.0506671809025543,0.36486486486486486,1.0,1.0,21/71,23.84%,FTH1;FTL;MT1E;MT2A;ISCU;ARF1;LCK;SLC39A7;SLC39A6;SLC22A17;MT1G;MT1M;CP;SOD1;HJV;ATP6AP1;NUBP1;HEPHL1;CCDC22;ATOX1;HEPH
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.6466744453120724,1.050613039630242,0.42857142857142855,0.8676544708068056,1.0,3/6,17.57%,GLS;PYCR1;ALDH18A1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.603572735595884,-1.0506025968574406,0.42857142857142855,1.0,1.0,2/8,8.41%,CCDC39;SRP54
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5459860611832118,-1.0501655813841766,0.40625,1.0,1.0,1/22,0.70%,TINF2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.513102419619977,-1.0501019795719235,0.44776119402985076,1.0,1.0,6/30,12.08%,SEMA3E;PHPT1;HRAS;HAX1;BAIAP2L2;CDK5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.5384340276404838,-1.0498995684327603,0.4153846153846154,1.0,1.0,4/19,14.62%,IRF1;FLOT1;GPS2;APPL2
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.3775765843529764,1.0498129091523423,0.22727272727272727,0.869133408950038,1.0,29/113,15.16%,KCNQ2;EFNB3;EGFR;CELF3;MYT1;CASKIN1;SCRT1;ASCL1;PBX1;SIRT1;CNR1;PCDH8;SEMA5B;ADGRB2;NCAM1;CAMKV;ADGRL3;SNAP91;NCAN;UNC13A;IGDCC3;B4GALNT4;SLC8A2;KIF5C;LRP8;NTNG1;DCX;PHF1;PPM1E
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.45520222514773173,-1.0495463876275652,0.36486486486486486,1.0,1.0,11/77,13.48%,CACNA2D4;SLC8A3;TRPM1;SLC24A5;PHB2;SLC24A1;AFG3L2;TMCO1;PMPCA;ORAI1;STOML2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.49459890903713855,-1.0491960604130652,0.43902439024390244,1.0,1.0,6/43,12.91%,IL26;GSTP1;COPS5;RASGRP1;MAPK8IP1;PPIA
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5032415407844227,-1.0491861807411809,0.35135135135135137,1.0,1.0,14/32,22.85%,CLU;HRK;PRELID1;PINK1;TRIAP1;PPIF;CIDEB;DNM1L;BAX;MOAP1;PDCD5;NOL3;PSMD10;BNIP3
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.48562267275921017,1.049149247731645,0.43478260869565216,0.8699645858887146,1.0,14/34,21.93%,ST8SIA6;ST6GAL2;ST8SIA1;ST8SIA4;FUT8;MAN2C1;ST3GAL6;ST3GAL2;FUT9;NEU4;NAGA;ST8SIA3;FUT2;ST8SIA5
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.6167174550721471,-1.0489416113801913,0.42105263157894735,1.0,1.0,2/10,11.11%,PSMC5;PSMC3
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.3815540155556994,1.048893468389032,0.3333333333333333,0.8696691312498371,1.0,24/120,10.70%,CHRNA4;GFAP;VCAN;PDGFRA;CSPG4;MMD2;SCRT1;ASCL1;PSD2;CTNND2;ADGRB3;PLPPR4;ETV5;PCDH15;NXPH1;ADGRL3;SNAP91;SHC3;SLCO1C1;NCAN;MEGF10;ZNF536;CORO2B;LRRC4C
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.668478220364806,-1.048852034153135,0.46875,1.0,1.0,5/9,22.85%,VPS35;DNM1L;BAX;FIS1;BNIP3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5102508867699461,-1.0488281969045061,0.375,1.0,1.0,8/33,19.43%,POLR1G;POLR2L;POLR1F;POLR1H;TTF1;TAF1D;GTF2H2;POLR1E
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5466923335622406,-1.048631313777449,0.5074626865671642,1.0,1.0,9/26,25.08%,ELOVL2;SCD;ACSBG2;SLC25A1;ELOVL1;FASN;PPT1;HSD17B8;HSD17B12
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.667713928934436,-1.0485942947629292,0.4666666666666667,1.0,1.0,1/8,8.14%,PARP14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5860104762338492,-1.0485588341828784,0.4,1.0,1.0,5/18,17.99%,RPA3;RBX1;PARP1;XPA;GTF2H2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5860104762338492,-1.0485588341828784,0.4,1.0,1.0,5/18,17.99%,RPA3;RBX1;PARP1;XPA;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6126963942764723,-1.048465554119881,0.4626865671641791,1.0,1.0,3/9,7.91%,HLA-F;HLA-E;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.6701359784763434,-1.0483995404013564,0.42,1.0,1.0,2/5,22.48%,NOP53;MAF1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5682495955731356,-1.0483104934332916,0.42424242424242425,1.0,1.0,5/23,13.74%,TTN;NCAPD3;NCAPH;SMC4;SMC2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.557107638763374,-1.0482929459944421,0.42028985507246375,1.0,1.0,8/21,23.57%,TMEM50A;CHMP2A;TMEM50B;CHMP3;CHMP7;CHMP4B;VPS4B;LAPTM4B
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.482818993380784,1.0481956545344737,0.36,0.8706623572844502,1.0,5/36,2.49%,ZAP70;LCP2;GNLY;PSTPIP1;PIK3R5
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.614285292959891,-1.048138075418404,0.4603174603174603,1.0,1.0,1/7,4.29%,DGAT2L6
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5437224494311306,1.0480414399727476,0.45454545454545453,0.8703083077485501,1.0,7/21,19.15%,CERS3;ACER1;SCEL;TXNIP;CDSN;WNT5A;BCR
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.6876107992023558,-1.0480032776567727,0.4666666666666667,1.0,1.0,3/5,25.34%,AIF1L;INPP5K;ARF6
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.5117503500159848,1.0478696575049924,0.3888888888888889,0.8700133213081684,1.0,8/18,20.49%,SLC7A1;SLC47A1;SLC7A5;SLC22A2;SLC6A13;SFXN1;SLC16A2;SLC6A1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.6315967461177129,-1.0476129659041558,0.46875,1.0,1.0,2/7,9.64%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6414894156193938,-1.0475492583814627,0.423728813559322,1.0,1.0,2/7,6.99%,SLC25A45;SLC22A4
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.5675575353038431,1.047427668031225,0.4166666666666667,0.8703729430519102,1.0,1/8,1.46%,CBARP
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4707168374601103,-1.0472864842170684,0.391304347826087,1.0,1.0,10/48,22.15%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP3;CHMP7;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4707168374601103,-1.0472864842170684,0.391304347826087,1.0,1.0,10/48,22.15%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP3;CHMP7;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.548999899324059,1.0468713917290753,0.5151515151515151,0.8710820539673292,1.0,6/13,21.70%,TSPOAP1;RIMBP2;KIF1B;ERC2;ERC1;DTNA
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5279710579790011,-1.0468282162766098,0.3709677419354839,1.0,1.0,3/22,11.71%,XBP1;CCDC39;CEBPB
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.625871398463556,1.0466694187247163,0.4166666666666667,0.8709504066777891,1.0,1/5,2.22%,SLC39A8
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.5918962050714283,1.0465696406401384,0.4411764705882353,0.8704461787445006,1.0,1/9,5.48%,SIRT1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.4248132266948867,-1.0464995464834985,0.34523809523809523,1.0,1.0,47/196,22.32%,POLR2G;XBP1;PTMA;POLR2J;GTF2F1;POLR3H;POLR2L;ELOB;IRF9;POLR3K;POLR2I;DRAP1;PAX8;TEFM;POLR3GL;BRF2;CEBPD;RTF1;TAF11;PAF1;THAP1;PARP1;NFIC;BTF3;TTF1;GTF2A2;HOXD3;TCEA2;POLR2A;SUPT5H;SNAPC2;GTF3C6;GTF2H2;DDX5;TFDP1;RRAGC;NCBP1;NFE2L3;SMN1;TTF2;DDX21;SMARCA5;NELFE;NAT14;SSRP1;RO60;NELFCD
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4896545913097625,-1.0464400200759414,0.4492753623188406,1.0,1.0,3/47,1.38%,B2M;FTH1;FTL
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.46412235843461674,-1.0460339308418034,0.410958904109589,1.0,1.0,18/71,15.99%,RPL5;CLU;GSAP;EFNA1;RPS4X;RBM3;LRRTM3;RACK1;LARP6;SMPD2;EIF3D;EEF2;TNFRSF1A;RPS27L;PYM1;EIF4A3;CIRBP;METTL3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.5278380934887021,1.0457310707189307,0.43333333333333335,0.8717237694813764,1.0,4/17,4.44%,NLRP7;IGF1;CARD18;CX3CR1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5784491517254245,-1.0457212220922358,0.43333333333333335,1.0,1.0,3/13,12.09%,ENTPD2;NUDT15;ENTPD3
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.6181572981914467,-1.0454759219552405,0.40350877192982454,1.0,1.0,2/9,13.61%,CFTR;AHR
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.6181572981914467,-1.0454759219552405,0.40350877192982454,1.0,1.0,2/9,13.61%,CFTR;AHR
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.6333728197356159,1.0453850412155725,0.39473684210526316,0.8719873378322369,1.0,2/6,11.77%,ULK3;ATP13A2
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.7083920316593018,1.045049385720016,0.5405405405405406,0.8723085553185456,1.0,1/5,5.48%,SIRT1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.5827434320597014,-1.0450189214571073,0.5151515151515151,1.0,1.0,1/16,0.70%,TINF2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.6634027887583713,-1.0449526457111544,0.46551724137931033,1.0,1.0,2/6,16.92%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.6634027887583713,-1.0449526457111544,0.46551724137931033,1.0,1.0,2/6,16.92%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.6634027887583713,-1.0449526457111544,0.46551724137931033,1.0,1.0,2/6,16.92%,ELOVL2;ELOVL1
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.6634027887583713,-1.0449526457111544,0.46551724137931033,1.0,1.0,2/6,16.92%,ELOVL2;ELOVL1
prerank,PanglaoDB_Augmented_2021__T Cells,0.429050618133851,1.0448811545559542,0.3181818181818182,0.8719558256179402,1.0,15/70,11.86%,ZAP70;LCP2;GNLY;PSTPIP1;LEF1;BATF3;SYT3;NOTCH3;GDPD3;CD4;IL2RA;PTPN22;NABP1;SEMA6D;PXDC1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5581621846651201,1.044803338871699,0.39285714285714285,0.8714412950433842,1.0,1/11,2.40%,SRC
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4689315707210922,-1.0442843672751987,0.40540540540540543,1.0,1.0,7/44,11.92%,ARHGEF16;RHBDF1;OVOL2;TMEM54;TEAD3;TOM1L1;ABCA12
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.5903003117294416,-1.0441930084894457,0.4057971014492754,1.0,1.0,3/14,16.44%,ARF1;DCTN1;MAP1A
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5422844813502755,-1.044095083035589,0.4067796610169492,1.0,1.0,2/22,5.49%,RPS27A;UBA52
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5345071272768902,-1.043589368201788,0.4305555555555556,1.0,1.0,3/25,6.37%,PLAAT4;PLAAT5;CHKB
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.6823402770765327,-1.0434299317067377,0.48484848484848486,1.0,1.0,3/6,17.09%,EDN1;APOE;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6110672024253688,-1.0431393584649917,0.4444444444444444,1.0,1.0,3/9,13.61%,HLA-F;CEACAM1;AHR
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.6352754433824096,-1.0431379495055042,0.4444444444444444,1.0,1.0,4/6,36.25%,G6PD;XYLB;DCXR;RPE
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5687638784625455,1.0430014894370163,0.4117647058823529,0.8753320059036813,1.0,2/11,5.09%,EPS8L2;NLGN1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.392876919471678,1.042864261348794,0.391304347826087,0.874908113386115,1.0,23/93,12.66%,ZNF423;LIFR;FRZB;PCDH18;POSTN;PDGFRA;ADAMTS9;LRP4;SLC47A1;DPYSL3;OBSL1;TMEM47;CDH11;COL14A1;GFRA1;HTRA1;CACNA2D1;COL6A1;CHRD;SEMA6D;PTH1R;FBXL7;SLIT2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6067067220184619,-1.0428531619740036,0.4153846153846154,1.0,1.0,1/8,0.46%,GATA1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5774378403116264,1.042786927256288,0.41935483870967744,0.874311385428013,1.0,5/11,20.41%,FUT8;CSGALNACT1;GFPT2;GFPT1;EXTL2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.398995145577731,-1.0427797838917048,0.4,1.0,1.0,57/294,20.76%,PSMB8;DDIT3;RPS27A;SELENOS;PSME1;SEC61B;PSMB6;PSMC5;RAD23A;PSMD8;PSMD7;KCTD2;UBA52;TRIM13;UBXN1;TRIM25;USP19;RBX1;PSMD3;PSMC3;RNF5;HSPA5;FAM8A1;RMND5B;SEL1L2;FBXO48;KAT5;PRAME;ANAPC15;KCTD5;UBB;PSMA4;NHLRC1;CDC34;ZFAND2B;MAN1B1;UBXN8;HECTD3;PSMA7;FBXL16;PSMD2;HSP90B1;FBXL13;SPSB3;ZFAND2A;PSMD6;PSMB2;ERCC8;PSMB4;CDC23;PSMA3;PSMB3;PSMC1;RNF175;RNF187;FOXRED2;SGTB
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6295797803530276,1.0425770079701682,0.42857142857142855,0.8740046946704972,1.0,3/7,2.14%,FGFR1;PLIN5;FGFR3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.5419333771905499,-1.0421386615827897,0.43243243243243246,1.0,1.0,5/21,14.83%,RNASE1;LACTB2;NHP2;POP7;CPSF3
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.5589648729811929,1.0420358852517344,0.375,0.8748420659321381,1.0,4/10,25.12%,BCL2L1;DFFA;TP53;FZD3
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.6580668200476716,1.0419813426332944,0.46875,0.8742353780299147,1.0,1/8,3.11%,GMNN
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.43367164726464424,1.0418453916022652,0.34615384615384615,0.8738834100441122,1.0,17/42,22.53%,BAG2;MAPK12;PLK1;CLN6;ADAM8;OGT;GPLD1;TANK;RCN3;BTRC;ASPH;TBC1D10A;SH3D19;RHBDD1;FBXW11;TNIP1;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5067161622954971,-1.0417911163867093,0.35135135135135137,1.0,1.0,8/32,16.44%,RPL11;NOP53;UBXN1;AQP11;GABARAPL2;GIPC1;CAMLG;MAP1A
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5772168066080985,-1.0416570281963071,0.45901639344262296,1.0,1.0,5/18,14.20%,QPRT;NMNAT3;NUDT12;HAAO;PARP9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6003898976910154,-1.0415065650861837,0.5076923076923077,1.0,1.0,2/14,7.58%,RPL23;GRWD1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3635360979075814,1.041360368519859,0.29411764705882354,0.8745574482195847,1.0,23/120,16.85%,PFKFB3;IGF1;IRS1;PLIN5;ARNT;TICAM1;AKT2;SNCA;TRIM65;P2RX7;OPTN;ADAM8;MLXIPL;SLC4A4;PRKD1;GPLD1;FOXO3;HMGB1;ITCH;GSK3B;PNPT1;PHKG2;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.40437919719706683,1.0413536386292206,0.35714285714285715,0.8738144087563565,1.0,15/75,13.75%,EPB41L4B;SRC;NRP2;ATOH8;SASH1;DOCK1;MAPRE2;TGFB2;FGF1;PRKD1;PRKCE;MAP4K4;GPLD1;CLASP1;BMPR2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.44551431327434393,-1.0413386301467074,0.4155844155844156,1.0,1.0,19/84,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PRKACA;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.44551431327434393,-1.0413386301467074,0.4155844155844156,1.0,1.0,19/84,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PRKACA;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.44551431327434393,-1.0413386301467074,0.4155844155844156,1.0,1.0,19/84,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;HRAS;PSMD3;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PRKACA;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.6700089912049405,-1.0412194480968007,0.5,1.0,1.0,1/7,2.74%,TGFBR2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5885724970810873,-1.0411611982180975,0.5,1.0,1.0,3/14,12.81%,EXOSC4;EXOSC10;SSB
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.5920329781189945,1.0408651616489493,0.4444444444444444,0.8742918292981964,1.0,2/8,13.00%,SOAT1;MTTP
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5365934722552564,-1.0408256092973298,0.4305555555555556,1.0,1.0,3/22,8.05%,CFTR;PDZK1;COX17
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.387711822312508,-1.0405393085322987,0.391304347826087,1.0,1.0,52/347,16.74%,CD44;APIP;GATA1;IL7;RPS27A;XBP1;BEX3;SFRP1;RPL10;PRDX5;ANXA5;PTMA;IL31RA;GSTP1;NRBP2;BCL2L2;RPS3A;PTRH2;PRELID1;UBA52;IFIT3;COPS5;MYDGF;HTR2B;ZNF830;PHB2;LAMTOR5;NAA38;HAX1;PINK1;DDAH2;TRIAP1;GRN;BDNF;IFI6;HSPA5;MAG;PPIF;CD27;ASAH2;ARAF;PRAME;UBB;CFL1;FSTL1;FIGNL1;AVEN;ANKLE2;GREM1;RNF213;TPT1;APOE
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.41175075688684,1.0401248140411488,0.38461538461538464,0.8753775221576257,1.0,26/91,21.83%,ZBTB1;KAT2A;HDAC4;ARID1B;SIRT1;SMARCA2;KDM4C;BAHD1;ARID1A;SMARCD2;SMARCD3;SMARCAD1;KAT2B;ATRX;MBD3;HDAC1;RSF1;SMARCC1;SATB2;BAZ2B;ACTR5;PBRM1;HNRNPC;DR1;SMARCE1;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.700598264061135,-1.0400182806547087,0.42857142857142855,1.0,1.0,3/5,19.05%,LARP6;EIF3D;NCBP1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.5851905253935514,1.0397868531081476,0.41025641025641024,0.8754853727522254,1.0,3/9,24.45%,ZDHHC3;MIA3;ZDHHC17
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.3883657320213384,1.039747658433761,0.3333333333333333,0.8748129001540956,1.0,40/108,18.93%,LIFR;ETV1;FRZB;ABCC8;PTPRD;PPARGC1A;LONRF2;CXXC4;SOWAHA;LIMCH1;PBX1;PLPPR4;NFIB;NTRK2;MEIS1;ASXL3;TOX3;SNAP91;MAPK10;RCAN2;PXK;NRXN1;SEMA6D;ESRRG;ARX;EGR3;PCDH19;SERTM1;RIMBP2;UNC5C;NFASC;RAPGEF4;NOL4;ADCYAP1;GRIA2;GUCY1A2;ERBB4;ADGRA1;FGF14;MAP2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5350432128551682,-1.0397207354224354,0.4084507042253521,1.0,1.0,6/24,20.74%,HLA-E;RPS19;FADD;NMI;IFI35;RIOK3
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5956258364058682,-1.0394403820499742,0.42105263157894735,1.0,1.0,2/9,18.89%,GABARAPL2;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5956258364058682,-1.0394403820499742,0.42105263157894735,1.0,1.0,2/9,18.89%,GABARAPL2;MAP1LC3B
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3928948047508299,1.0393737740038682,0.3225806451612903,0.8749898236380143,1.0,19/64,18.79%,IL1RAPL1;TIAM2;PTPRD;CX3CR1;OBSL1;PLXNA1;NTRK2;ROBO1;PLXNB2;SLIT2;SS18L1;ROBO2;SMARCD3;GPER1;CHODL;CUL7;PLXNA4;CUX1;LIG4
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.6082572378867932,-1.0392421142860055,0.47058823529411764,1.0,1.0,5/13,19.01%,NOP10;NHP2;PUSL1;GAR1;RPUSD2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.6395721086472874,-1.0391197889412436,0.4576271186440678,1.0,1.0,1/7,11.71%,CEBPB
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.6734646269631677,-1.0388474506505212,0.46774193548387094,1.0,1.0,3/5,26.97%,OSGEP;LAGE3;TPRKB
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.4537509876999205,1.0386927663413843,0.4,0.8758192837909621,1.0,2/30,4.12%,GSTT2;HPGDS
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.4301415949784067,1.0386347633852744,0.35714285714285715,0.875182563831292,1.0,13/27,31.85%,PRKRA;PUS10;DICER1;SMAD2;PUM2;PUM1;SMAD1;DROSHA;SMAD3;LIN28B;AGO3;SRRT;AGO2
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.6692504994274695,1.038583396657777,0.5294117647058824,0.8745583524333486,1.0,4/6,20.76%,DENND1A;DENND4B;DENND4A;DENND4C
prerank,PanglaoDB_Augmented_2021__Interneurons,0.3642751973246248,1.0385583419308684,0.21428571428571427,0.8738666479396503,1.0,61/271,13.86%,RELN;ETV1;CLDN9;KCNQ2;VEGFD;KCNIP2;CELF3;CTNNA2;DLX1;NRIP3;MMD2;SCRT1;VGF;L1CAM;LYPD1;CACNA1I;PSD2;NPY;CTNND2;FRYL;ELMO1;NCALD;ADGRB3;SPOCK3;AMER2;PCDH8;AGAP1;HAP1;CDH4;HIVEP2;OLFM3;CAMKV;NXPH1;SNAP91;CASK;GRM3;ADARB1;NCAN;NBEA;FAM81A;GRM1;UNC13A;NMB;PCF11;KCNC2;DNAJC6;ACSL4;PNOC;NRXN1;DCAF7;PTPN4;SLC8A2;RAB3B;ARHGAP21;ARX;ADCY8;CADM2;FBXO11;NTNG1;CDK17;KCNMA1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.49808135690038613,-1.0384048432412036,0.46153846153846156,1.0,1.0,2/51,0.55%,PLAAT4;GPX4
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4560865363783822,1.0382694242129251,0.35714285714285715,0.873792500748594,1.0,6/39,8.05%,RIDA;HSPA1A;EXOSC7;DNA2;ZC3H12D;HSPA1B
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.6136685537212413,-1.0376222053406545,0.5,1.0,1.0,5/9,31.76%,CAV1;BCAP31;SVIP;HERPUD1;UBQLN2
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.6531567246749731,1.0375243325894217,0.4146341463414634,0.87485898391702,1.0,3/6,18.25%,SULT2A1;SULT2B1;HS3ST5
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4340542593813548,1.037409384919634,0.34615384615384615,0.8743966811024925,1.0,2/37,0.96%,SPIRE2;PPP4R2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6318828477243346,-1.0373955951622527,0.5161290322580645,1.0,1.0,2/8,7.25%,KIF20B;CHAMP1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.47759042946347496,-1.0373416033557705,0.40789473684210525,1.0,1.0,10/51,12.31%,ARHGEF16;TMC4;CD9;TMEM125;OVOL2;ITGB4;BTG1;AR;CEBPD;UXT
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.6087605861334493,-1.037228007015614,0.38461538461538464,1.0,1.0,3/11,9.50%,UBXN1;AQP11;USP19
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.4651641562609992,-1.0370710749950471,0.36363636363636365,1.0,1.0,14/87,10.26%,SFRP1;TAX1BP3;RSPO4;KREMEN1;ATP6AP2;SHISA2;SFRP4;RSPO2;GPC3;RACK1;TRABD2B;NFATC1;DEPDC1B;PPP1CA
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.7106568066555168,-1.037033882536804,0.5333333333333333,1.0,1.0,1/5,8.80%,BEX4
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5426598051385465,-1.0368686346034448,0.5,1.0,1.0,7/21,16.07%,MT1E;MT2A;LCK;SLC39A7;SLC39A6;MT1G;MT1M
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.5584245928705059,1.0365930978086006,0.4074074074074074,0.8759504572957612,1.0,4/13,16.31%,CPEB3;CPEB2;CPEB4;DHX9
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.6181152035690701,-1.0365783632588874,0.45161290322580644,1.0,1.0,1/9,1.25%,XBP1
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.5415155333098403,1.0365276801267733,0.32432432432432434,0.8753514984472526,1.0,2/11,8.25%,SRC;CD4
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6116910301766034,-1.0365117329533065,0.5357142857142857,1.0,1.0,1/7,1.25%,XBP1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5616428948201637,1.0360723144160822,0.3902439024390244,0.8756287868795011,1.0,3/11,8.14%,BACE2;SOAT1;NECAB2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6141186875910439,1.035841145737088,0.42857142857142855,0.8746954159376266,1.0,5/7,16.95%,NRP2;ALCAM;SLIT2;SLIT3;SLIT1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6141186875910439,1.035841145737088,0.42857142857142855,0.8746954159376266,1.0,5/7,16.95%,NRP2;ALCAM;SLIT2;SLIT3;SLIT1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.6300644949885519,1.035836630485328,0.44680851063829785,0.8739747914939355,1.0,2/8,5.49%,ADGRB1;EHD2
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.5954515901769931,1.0355133037029343,0.41935483870967744,0.8739577556823102,1.0,4/9,11.44%,KAT2A;CLEC7A;CD4;CRTAM
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.6139230203303288,-1.0351978891792084,0.5245901639344263,1.0,1.0,1/12,1.00%,QPRT
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5658667777492516,-1.0351750589246471,0.43636363636363634,1.0,1.0,3/9,21.01%,HTR2B;DGKD;GAP43
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.5654526905582212,-1.0350374640163786,0.5151515151515151,1.0,1.0,2/15,9.64%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.6176305876845808,-1.034857088490175,0.46551724137931033,1.0,1.0,1/8,4.54%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.490315682730628,1.0348439890031647,0.3125,0.8748576118802892,1.0,2/13,3.56%,KCNN4;RELA
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.48462836488529404,1.0344434122753843,0.5,0.8750999942514299,1.0,5/33,5.00%,SPRY2;SPRED3;PLK1;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5206934309774566,-1.0343693016259086,0.36486486486486486,1.0,1.0,3/18,9.88%,SFRP1;HYAL2;FADD
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.6427281700935333,-1.0342941732028714,0.48333333333333334,1.0,1.0,1/9,0.45%,B2M
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.4620338594754685,-1.0342670990241847,0.4533333333333333,1.0,1.0,11/61,19.05%,POLR2G;EIF1B;MIF4GD;EIF5B;EIF1;CEBPB;ATF3;EIF2B2;IMPACT;DDX1;NCBP1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6442094883577214,-1.0337575903024334,0.5555555555555556,1.0,1.0,2/5,9.30%,BRK1;NEB
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.6623559242332993,-1.0336854017191524,0.421875,1.0,1.0,1/6,4.17%,TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.6623559242332993,-1.0336854017191524,0.421875,1.0,1.0,1/6,4.17%,TMED9
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.6623559242332993,-1.0336854017191524,0.421875,1.0,1.0,1/6,4.17%,TMED9
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.5111887376436888,-1.033256492390529,0.5084745762711864,1.0,1.0,13/33,19.95%,DDIT3;RPS7;RPS3;RACK1;LCK;EIF5A;UBB;SEPTIN4;DNM1L;BAX;SOD1;CAV1;FIS1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.47521231171991435,1.0332349061018387,0.358974358974359,0.8774664516116462,1.0,8/17,20.45%,MTCL1;ERBIN;DLG2;DLG1;DLG3;PARD3;SCRIB;MARK2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.4815901187935792,1.0332093719990494,0.375,0.8768142666020429,1.0,4/16,12.73%,ST8SIA6;CLN6;ST8SIA4;HEXB
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.47748191475031204,1.0331088460200357,0.48484848484848486,0.8763323917139398,1.0,10/44,16.52%,CLN6;SULT2A1;SOAT1;OSBPL1A;DHCR7;SULT2B1;HMGCR;LCAT;SC5D;FDX1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.41690424295983675,1.0330226440178032,0.38461538461538464,0.8757160520014226,1.0,34/93,19.15%,LIFR;PPFIBP1;PCDH18;TACC2;ADAMTS9;LIMCH1;DPYSL3;GLI2;OBSL1;TMEM47;CDH11;CHST3;CACNA2D1;PYGO1;SEMA6D;APBB2;CSRP2;FBXL7;NAV1;SLIT2;FIGN;ABI2;MPDZ;AMOTL1;SLIT3;PDE10A;NFASC;COL4A2;FGF2;GUCY1A2;TJP1;RNF150;PTPN14;NTM
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.5106626005004393,-1.0327022994537525,0.42857142857142855,1.0,1.0,11/36,20.72%,GAPDH;SLC25A11;G6PC3;TPI1;MDH2;MDH1;SLC25A1;GAPDHS;ALDOB;PGAM1;ENO1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.49321031027309264,1.032526321705231,0.3870967741935484,0.8761707074871377,1.0,5/18,13.47%,FBLN5;TNXB;LTBP3;GPM6B;NTNG1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5199346209764288,-1.032365266982734,0.43478260869565216,1.0,1.0,2/18,8.20%,XBP1;GPIHBP1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.47821649609552047,1.0321962355131586,0.3548387096774194,0.8763882843754819,1.0,5/19,16.83%,MSL2;OGT;KANSL2;JADE2;JADE3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5509612219617825,1.0320347491606001,0.3888888888888889,0.8761107573586334,1.0,3/7,11.63%,AGER;SH3RF1;CD55
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),-0.6810116710214735,-1.0318004424727651,0.47368421052631576,1.0,1.0,1/5,1.30%,DUOX1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.6133647001194474,-1.0317467774322417,0.46153846153846156,1.0,1.0,2/7,8.77%,AQP9;AQP11
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4781811463745582,-1.0315493886585494,0.45,1.0,1.0,6/35,18.21%,NARS1;AIMP1;WARS1;SARS1;AARS1;GARS1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5815556813850736,-1.0310007835131705,0.4782608695652174,1.0,1.0,4/16,11.35%,TGFBR2;ZFPM1;EFNA1;OLFM1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.5667155050311425,1.0306829699556894,0.4666666666666667,0.878822155530317,1.0,3/10,25.42%,MGAT5;CRLF2;HES1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.5212636522552772,1.0306665563677149,0.4,0.8781277275780801,1.0,3/9,17.26%,AKAP6;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.629674144644599,1.0305387043379097,0.5151515151515151,0.8776924226288412,1.0,1/6,3.67%,ARNT
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.6911356009564802,-1.0305009947705634,0.48484848484848486,1.0,1.0,5/7,24.31%,HAX1;PINK1;ATP5IF1;SREBF1;DNAJA1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.6546094747517249,1.0303100575004096,0.5434782608695652,0.8768575643393517,1.0,2/5,11.48%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.6546094747517249,1.0303100575004096,0.5434782608695652,0.8768575643393517,1.0,2/5,11.48%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.604051880427852,-1.0301585085125429,0.4461538461538462,1.0,1.0,2/11,4.04%,HLA-F;HLA-E
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.5841739177968133,1.0299381797079512,0.5106382978723404,0.8772187661487348,1.0,2/7,11.11%,OXTR;GPAT4
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.555978021209832,-1.0299038976813721,0.47368421052631576,1.0,1.0,1/14,1.40%,SIGIRR
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5305510719567935,-1.0297862437056782,0.46153846153846156,1.0,1.0,5/20,13.58%,RPS21;NOP9;FTSJ3;EXOSC10;WDR12
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.6636943260824416,-1.0294374550142096,0.5,1.0,1.0,1/5,8.17%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.4375731786319793,1.0293864579068528,0.42424242424242425,0.8779818235707803,1.0,3/22,4.44%,RFX3;CLEC7A;CX3CR1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6041526473737364,-1.02937032157818,0.4915254237288136,1.0,1.0,1/9,4.54%,DDX11
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.640515717901895,-1.029192738376683,0.46296296296296297,1.0,1.0,2/6,17.00%,PRPS1;PAICS
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.6876179685052778,-1.0291097642045606,0.5081967213114754,1.0,1.0,2/5,15.46%,TIMP1;TIMP2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6399875845018107,-1.028746966882103,0.55,1.0,1.0,4/8,19.32%,FLG;KRT10;F13A1;TGM1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.6803938783311942,-1.028738352443056,0.4426229508196721,1.0,1.0,1/8,1.80%,LOXL4
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.6248090534195705,-1.028672560169512,0.509090909090909,1.0,1.0,4/7,31.76%,CAV1;BCAP31;HERPUD1;UBQLN2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.5723912272853233,-1.0283996521013739,0.45,1.0,1.0,2/8,27.98%,MBD4;OGG1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.6525945557192769,-1.0283970292822795,0.5,1.0,1.0,2/5,23.55%,SDK2;PROM1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5676256366558546,1.0283735543072905,0.42857142857142855,0.8798494525114671,1.0,2/12,8.07%,CHST7;CHST3
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.6413963511899192,-1.028094648122982,0.5094339622641509,1.0,1.0,1/5,1.25%,XBP1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.5086762867524443,-1.0277201354673213,0.3076923076923077,1.0,1.0,3/26,10.69%,SEMA3E;CORO1B;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4852675171702357,1.0271678167086067,0.35294117647058826,0.8815912358830628,1.0,4/19,7.77%,IGF1;PICALM;HAP1;NTRK2
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.5775451951174718,1.0270878239197163,0.43478260869565216,0.881088678581543,1.0,1/9,5.49%,EHD2
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.6923197027821271,-1.0270374906830362,0.5319148936170213,1.0,1.0,4/5,24.74%,TMEM9;ALDOB;VMA21;PIP4P1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5768903059184914,-1.0264351684609057,0.4307692307692308,1.0,1.0,5/12,19.28%,HLA-E;HLA-A;GLI3;HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.43338984020038396,-1.0263868767365545,0.4050632911392405,1.0,1.0,20/94,18.17%,RHOC;CLU;RPS3;PSMC5;HRK;RACK1;TRABD2B;IL5;RPA3;BRK1;TGFB1;RBX1;PSMC3;TPPP3;PARP1;WARS1;XPA;LCP1;GTF2H2;BAX
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.608176588659869,1.0262816058026683,0.425,0.8824143078374267,1.0,1/8,5.48%,SIRT1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.7140083074035329,-1.0262092459687329,0.5344827586206896,1.0,1.0,2/5,24.31%,CTU2;URM1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.657745321528608,1.026097516275652,0.4722222222222222,0.8813880690869706,1.0,1/6,5.86%,IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.657745321528608,1.026097516275652,0.4722222222222222,0.8813880690869706,1.0,1/6,5.86%,IWS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6215650023839959,-1.0257834996804511,0.4745762711864407,1.0,1.0,1/8,3.70%,UQCC3
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6215650023839959,-1.0257834996804511,0.4745762711864407,1.0,1.0,1/8,3.70%,UQCC3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.42255985183541694,1.025775570853182,0.47619047619047616,0.8812874681448996,1.0,20/61,17.02%,ADGRB1;TBXA2R;LPAR2;ADGRB3;CNR1;ADGRB2;ADGRL3;ADRA1A;PTHLH;PTH1R;ADGRE2;GPR26;LGR5;ADCY8;ADGRE1;GPER1;LGR4;PTH;ADCYAP1;GNAQ
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.5592149692224269,1.025771704985925,0.38235294117647056,0.8805651013677317,1.0,5/10,16.43%,VASH1;NEK4;NUAK1;PNPT1;MARCHF5
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.5945586187128035,-1.0254524298083998,0.4307692307692308,1.0,1.0,2/9,12.03%,RPS21;EXOSC10
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.44495532056512904,-1.0253580041019308,0.4520547945205479,1.0,1.0,16/84,20.76%,SELENOS;SEC61B;TRIM13;TRIM25;USP19;RNF5;HSPA5;FAM8A1;SEL1L2;MAN1B1;UBXN8;CCDC47;HSP90B1;RNF175;FOXRED2;SGTB
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.45198005345144665,-1.0252988927820836,0.49122807017543857,1.0,1.0,9/48,21.07%,RIMS1;RHBDF1;VAMP8;RAB8A;SEPTIN4;SCG5;MCTP2;LGI3;SEPTIN2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.5012654585189531,-1.0252304767833311,0.38571428571428573,1.0,1.0,2/31,2.92%,RIMS1;STX19
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5349489134872334,1.0251641425900797,0.4444444444444444,0.8812310191519132,1.0,2/15,4.46%,HDAC4;GNL3L
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.37556694253515355,1.0249828215119865,0.43333333333333335,0.8811197059733726,1.0,26/111,13.25%,RAB27A;ZNF423;FRZB;PCDH18;PTPRD;CELF3;PDGFRA;ADGRB3;PLPPR4;OLFM3;CDH11;ASXL3;COL14A1;SNAP91;CACNA2D1;MAPK10;CADPS;ZNF536;CPEB4;SGCD;NRXN1;SEMA6D;KCTD16;ROBO2;MAGI2;CADM2
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.5600327756059101,1.0249238390066546,0.43243243243243246,0.8804878776330957,1.0,3/10,10.87%,KCNIP2;KCNMB4;STIM1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5339150242992777,1.024907131211171,0.4634146341463415,0.8798128032419797,1.0,4/13,12.10%,DOCK7;CLMN;SYNE2;PCM1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.4804047171990035,1.0246341439139013,0.36585365853658536,0.8798356473076577,1.0,6/21,9.67%,PPFIBP1;LRP4;AGRN;PPFIBP2;CACNB4;UNC13A
prerank,PanglaoDB_Augmented_2021__Microglia,0.39775028910396143,1.024557542395686,0.48,0.8793390310492799,1.0,18/81,11.11%,LCP2;C1ORF162;SLCO2B1;PIK3R5;HPGDS;CLEC7A;CX3CR1;CSF3R;P2RX7;ITGAX;LTC4S;CD4;AEBP1;MAFB;APBB1IP;SLC2A5;OTULINL;LAIR1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3930224814316833,-1.0244748738535001,0.4166666666666667,1.0,1.0,47/305,14.59%,GBP3;IL26;GBP2;IL7;RPS27A;XBP1;DUOX1;SIGIRR;GAPDH;SFRP1;NDN;IRF4;IFNGR2;MT2A;TIMP1;NPR2;HLA-DPA1;IL31RA;PTAFR;RPL13A;RPS3;IL6R;HYAL2;UBA52;IRF1;IRGM;DOCK8;LCK;IL5;HAX1;TGFB1;PTPN7;TNFRSF21;STAT5A;PIK3CB;STAT1;CEBPD;YBX3;BRCA1;ASAH2;IL3RA;IFNLR1;TNFRSF1A;OSMR;NLRP12;UBB;OPRM1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.42642082210422355,-1.0241346624976306,0.4025974025974026,1.0,1.0,8/88,5.39%,XBP1;SFRP1;AQP9;JUP;NEURL1;CFTR;TSHR;RRAGA
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.40086533495055976,1.024039078610594,0.34615384615384615,0.879848096089727,1.0,18/72,19.65%,NOS2;KYAT1;DAO;ACAD8;IDO1;KYNU;GLS;CBS;ARG1;BCKDHB;HDC;CARNMT1;QDPR;GAD1;MTRR;ABAT;ALDH4A1;GLDC
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5702107494171685,1.0240060045079686,0.5294117647058824,0.8791867751878902,1.0,5/7,23.87%,SIRT1;TDP1;LIG4;APLF;ERCC6
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.38010837569580563,1.0238565123084218,0.3333333333333333,0.8788241940715928,1.0,35/132,20.04%,PTPN6;PPP4R2;PPM1M;PLPP4;DUSP6;PTPRD;MTMR2;ACP6;PPM1L;DUSP1;DUSP10;PLPPR4;PSPH;PTPN22;PTPRK;PTPRE;PTPN4;DUSP18;PTEN;PPP2R2A;PPM1E;PTPRN2;CDC14B;BTRC;PTPRO;MTMR3;PPM1D;FBP1;PTPN14;PPP3CA;PTPRR;SSH2;PTPRU;SSH1;PPP2R5C
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.614303499643185,-1.0235920063009936,0.47619047619047616,1.0,1.0,3/10,19.10%,ATG10;APOE;WDR45B
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5094432602943793,1.0234163551052229,0.41025641025641024,0.8793104048278143,1.0,8/13,27.84%,PTPRN2;RAB11FIP2;ADCYAP1;CAMK2G;RIMS2;SNX19;SLC30A8;PTPRN
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.6413570997289675,1.0228682913150557,0.5384615384615384,0.8797187789783493,1.0,2/5,14.10%,ZNF304;ATRX
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.4019262358055418,1.0226578286422385,0.4,0.8795985990516207,1.0,24/75,20.00%,ATP6V0A4;ZBTB7C;TACC2;ALDH1L1;PDZD2;FRK;PROM2;DNAAF1;SCIN;BPIFB1;SCNN1B;CCDC30;ESRRG;ATP6V0D2;ITGB8;ERBB4;MUC20;NWD1;VWA3B;HYDIN;DNAH7;SLC22A6;CCDC60;WFDC2
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.6483829955758729,-1.0225173539124304,0.5294117647058824,1.0,1.0,1/5,11.59%,EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5000262851553421,1.0223656965376624,0.47619047619047616,0.8796544350628341,1.0,5/11,14.02%,CDK10;EVI5L;CCP110;CEP97;TESK1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.5562940458646128,1.022303684123093,0.53125,0.8790843258565019,1.0,4/16,10.48%,TSPOAP1;HSD17B7;DHCR7;HSD17B6
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4758227304290749,-1.0222999812157236,0.43243243243243246,1.0,1.0,7/32,15.99%,SERPING1;RPS19;GRN;SLAMF8;CR1;NMI;METTL3
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5779708394870836,1.022177348844473,0.42105263157894735,0.8786248500717735,1.0,2/7,9.12%,ADARB2;ADARB1
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.6034152067196739,1.021936569905316,0.41025641025641024,0.8785278684137077,1.0,1/8,1.12%,ACSM1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.6088618193963244,-1.0219028379122226,0.5454545454545454,1.0,1.0,1/8,17.32%,ECT2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.5768749276362627,1.021873614059049,0.42424242424242425,0.8780038656885195,1.0,1/6,5.94%,SNCA
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6386760088999106,-1.021813955236588,0.45454545454545453,1.0,1.0,2/7,8.12%,RPS15;NOP9
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.40848288487582346,-1.0217287247764713,0.3670886075949367,1.0,1.0,15/149,11.01%,CD44;GATA1;GPX4;XBP1;IRF4;PTRH2;LCLAT1;IFITM3;CDKN1C;CD81;ETV4;TNFRSF21;SYT11;HOPX;SELP
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.6221651644627957,1.0216210643507666,0.45454545454545453,0.8780279310504007,1.0,2/7,11.30%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.6259693578717442,-1.0215926037586496,0.48333333333333334,1.0,1.0,1/7,2.74%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.3908755596168341,1.0215915426219722,0.38095238095238093,0.8773958216953057,1.0,12/74,10.33%,PTPN6;IGF1;HSPB1;CLEC7A;CX3CR1;AGER;IRAK3;CYBA;TMEM106A;OAS3;PTPN22;DICER1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.6096575833644035,1.0214455728754441,0.425,0.8771799494662831,1.0,3/7,22.10%,KIF1C;PPFIA2;TANC2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.3981028921347407,1.0213208972441523,0.3125,0.8767460656578256,1.0,29/112,17.56%,NUPR1;NPAS2;BAG2;HSPA1A;VASH1;AIFM2;SIRT1;NEK4;HSPA1B;NUAK1;BAG3;AMFR;HSPH1;CORO2B;CHORDC1;NDC1;SLC38A2;NUP42;DYRK3;ADCY8;DNAJB6;SMG1;PTGES3;CREBBP;GSK3B;PNPT1;CAMK2D;ABL1;FKBP4
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.6669111795626781,-1.021191519691982,0.5081967213114754,1.0,1.0,1/6,7.22%,RACK1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.44305328883213857,-1.0211689784484708,0.4024390243902439,1.0,1.0,22/98,21.21%,PSMB8;PSME1;PSMB6;PSMC5;VAV3;PSMD8;PSMD7;NFATC1;PSMD3;PIK3CB;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;SHC1;CALM1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.5048718599770994,-1.0209652567570597,0.42857142857142855,1.0,1.0,10/29,29.00%,ZNF830;CLSPN;FBXO6;RAD9A;HUS1;E2F1;H2AX;DONSON;NBN;STK33
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5556972276043055,1.0209523951310528,0.48717948717948717,0.8769456131696364,1.0,4/12,19.83%,AFF2;DYRK3;HIPK2;SRPK2
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6628513977240797,-1.0209054722501276,0.5230769230769231,1.0,1.0,2/7,15.99%,ABCA12;METTL3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.4429066255856691,-1.0206586202355286,0.4583333333333333,1.0,1.0,26/86,22.77%,TTN;MIS12;CENPE;CHMP2A;RAB11A;NCAPD3;NCAPH;CENPK;DCTN2;ANKRD53;SPDL1;SMC4;KIF18A;SMC2;CHMP3;CHMP7;WRAP73;CDC23;RAN;ZW10;CHMP4B;KIF22;KPNB1;SMC1A;SET;VPS4B
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.4773661423876387,1.0205698482316958,0.4594594594594595,0.8771666404211332,1.0,6/19,15.95%,RFX3;DNAH3;TEKT5;CFAP54;DNAH8;DNAI3
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5035208830222023,1.0197898748930774,0.40425531914893614,0.8783022104592462,1.0,6/14,19.65%,IRS1;PID1;FOXO3;PDK4;LPL;GLDC
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.5625806744451146,-1.0197383888083429,0.4444444444444444,1.0,1.0,4/12,22.40%,IL6R;PTN;ZNF580;ADAM17
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.5979563625351051,1.0195170799745594,0.4666666666666667,0.8783150179833517,1.0,1/6,1.19%,ZBTB1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.47285842712461723,1.019331679973386,0.34375,0.8780668250640444,1.0,4/18,11.16%,QRICH2;RHOJ;SCIN;RHOQ
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.48341440981577427,-1.0193244846713339,0.463768115942029,1.0,1.0,6/43,10.12%,GATA1;RPS14;ZFPM1;SLC25A5;RPS19;ATP5IF1
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.44961233119571853,1.0193112455674316,0.4375,0.8774170088680302,1.0,3/39,1.53%,VDR;GALNT3;TRIM29
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.6138105546773676,-1.0189964141839507,0.48333333333333334,1.0,1.0,5/10,19.01%,NOP10;NHP2;TSR3;GAR1;RPUSD2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.43321366340416007,1.0188354097736825,0.3333333333333333,0.8777670536970641,1.0,10/47,12.28%,NOS2;PASK;ABCC8;RFX3;ENSA;STX1A;CHD7;KCNC2;ITPR1;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.4882554349094066,-1.0186624361246386,0.453125,1.0,1.0,7/38,13.94%,BUB1;BTG3;CDKN1C;BTG1;TGFB1;TOM1L1;ZWILCH
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.48218195127950203,1.018355183343117,0.4230769230769231,0.878398587124368,1.0,11/24,26.56%,PAXIP1;OGT;ASH2L;KMT2D;CXXC1;KMT2C;TET2;KDM6A;WDR5;KMT2A;TET3
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.6395657165424171,1.0183407293503728,0.4411764705882353,0.8777392257129942,1.0,3/5,15.02%,ROBO1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5153965877676492,1.0181085252851332,0.47619047619047616,0.8776441148376859,1.0,3/15,15.02%,HNRNPU;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.6243570995566212,-1.017823760080231,0.46875,1.0,1.0,1/6,0.32%,BMP5
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.6331994645247658,1.0178100896635176,0.5098039215686274,0.8774625795022627,1.0,5/5,36.70%,RPS6KA4;RPS6KA5;MST1;HMGA2;VRK1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.624261341821011,-1.0176503678707622,0.5161290322580645,1.0,1.0,1/7,11.09%,ARL13B
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.5270063838650221,-1.0174844027621663,0.4714285714285714,1.0,1.0,6/24,12.63%,ACOT2;DBI;ACSM6;OXSM;ACOT1;ACSM3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.5270063838650221,-1.0174844027621663,0.4714285714285714,1.0,1.0,6/24,12.63%,ACOT2;DBI;ACSM6;OXSM;ACOT1;ACSM3
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4509678421001973,1.017172411807924,0.25,0.8784599958786469,1.0,5/29,10.25%,LGALS4;ANXA4;DMBT1;GPR39;GCNT3
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.39631271335577195,-1.0171660984296769,0.45555555555555555,1.0,1.0,23/184,13.67%,NLRP1;MCM2;GAPDH;IFIT2;TGFBR2;MAGEH1;TCHP;KREMEN1;IFI27L1;IRF1;BCL2L14;ADAM15;IFI27L2;FADD;TNFRSF21;PAK5;IFI6;CDK5;PARP1;CIDEB;PPIA;AHR;DDX41
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6225231668668934,-1.017122844904318,0.5454545454545454,1.0,1.0,2/8,16.44%,DCTN1;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.5404694107571251,-1.016981724110833,0.4225352112676056,1.0,1.0,2/18,10.15%,RAB11A;CDK4
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.4187902532103275,1.0166019999910303,0.38461538461538464,0.879272140061962,1.0,8/38,14.07%,SRC;EGFR;ERBIN;SHC3;GAB1;REPS2;PIK3CA;FAM83A
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.616259750576615,1.0158281896905754,0.59375,0.8808711111215255,1.0,2/5,15.75%,TENT4B;TENT4A
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.5608630929567049,1.0157809595161982,0.4864864864864865,0.8802237185399273,1.0,1/12,0.30%,GRM2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.5097022219776028,1.0156793228658072,0.42857142857142855,0.8797605990550029,1.0,3/13,19.35%,NDC1;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.4863911171667646,1.0156086475929647,0.4358974358974359,0.8793305271504844,1.0,3/17,6.13%,ICAM1;OLR1;NT5E
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6281593400104359,-1.0152912188755638,0.559322033898305,1.0,1.0,1/7,7.22%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5763511079669419,-1.015092532723414,0.5,1.0,1.0,5/13,16.14%,HLA-F;HLA-E;RASGRP1;LAMP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5763511079669419,-1.015092532723414,0.5,1.0,1.0,5/13,16.14%,HLA-F;HLA-E;RASGRP1;LAMP1;CD160
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.6622842599745251,1.014788935423603,0.4883720930232558,0.879999405281635,1.0,2/6,11.30%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.6622842599745251,1.014788935423603,0.4883720930232558,0.879999405281635,1.0,2/6,11.30%,UGT8;B4GALT3
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4794530972052758,-1.0143259970575549,0.38666666666666666,1.0,1.0,12/40,25.32%,TINF2;APEX1;PCNA;RPA3;PARP1;RAD50;POLD2;POLD4;TERF2IP;BLM;TERF1;HUS1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.4843531251311257,1.0142156297404628,0.46875,0.8807198618642357,1.0,2/18,5.36%,PDGFB;AKT2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.40638991899732874,1.0139946712492167,0.4230769230769231,0.8804407011364085,1.0,3/61,1.08%,GSTT2;BACE2;TRHDE
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6007351167434687,-1.0139594791107092,0.4915254237288136,1.0,1.0,3/8,14.58%,TGFBR2;MTHFD1;EIF4A3
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6367562612139162,1.0138903567527298,0.5227272727272727,0.88001179333121,1.0,1/5,11.77%,ATP13A2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6663708347675289,1.0138182223596375,0.6,0.8795621255609455,1.0,3/5,28.39%,C9ORF72;VPS41;VPS39
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5331131011749114,1.0137133220431573,0.4594594594594595,0.8791131687278673,1.0,3/9,19.35%,NDC1;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6089877703171915,-1.0136480614169379,0.4745762711864407,1.0,1.0,2/10,10.07%,RACK1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.4025598775068153,1.0132968103177435,0.38235294117647056,0.879499706334251,1.0,8/61,11.12%,DACT2;SPOCK1;ACER2;DUSP1;PLXNA1;TBCD;CORO2B;PLXNB2
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5306758724333264,1.0131249161568752,0.42105263157894735,0.8792546920755235,1.0,2/14,1.47%,F2;GNLY
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.6086758692401366,1.013022746142149,0.45454545454545453,0.8787749834181584,1.0,2/8,23.10%,NR1H3;PPARA
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4477686013858798,-1.012808872468057,0.43661971830985913,1.0,1.0,11/69,12.08%,HLA-F;PM20D1;CLU;VPS35;PSMC5;CHMP2A;HTR2B;PINK1;LRPAP1;TM7SF3;CDK5
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5580636850058441,-1.0125460066700032,0.509090909090909,1.0,1.0,6/13,27.88%,CHMP2A;SNF8;VPS4B;SMPD3;SDC4;HGS
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.4878345080919216,-1.0123211033185053,0.3888888888888889,1.0,1.0,2/27,1.28%,TRPM1;JPH3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4074814219181821,1.0121835124834158,0.3333333333333333,0.8800577478594861,1.0,13/102,7.85%,F2;VDR;EPB41L4B;LEPR;NOS2;C6;HAMP;CYP2C8;GRB14;RND3;ZHX2;KIF13B;SERPINC1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3655733487282461,1.012015059935914,0.5384615384615384,0.8797701983081161,1.0,25/91,18.83%,CDK10;IQCJ-SCHIP1;EPHA3;RND3;CAMSAP3;ARHGAP44;P2RX7;DIAPH1;ARHGAP35;SPEF1;RICTOR;CELSR1;CORO2B;RHOQ;GPM6B;CLASP1;RHOF;TESK1;TRIM36;GSK3B;RHOBTB1;ABL1;TJP1;MAPT;ARHGAP17
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.6475346106048235,-1.011904552168278,0.5151515151515151,1.0,1.0,2/7,7.88%,IL7;TPP1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5187399333556966,1.0117664079927455,0.43333333333333335,0.8788768988323438,1.0,5/19,2.86%,TNNC2;TCAP;TPM2;MYH4;MYH3
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5187399333556966,1.0117664079927455,0.43333333333333335,0.8788768988323438,1.0,5/19,2.86%,TNNC2;TCAP;TPM2;MYH4;MYH3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4813080099032784,-1.0114548756878265,0.42028985507246375,1.0,1.0,7/38,11.67%,CLU;RPL13A;CPTP;NOP53;ANKRD27;TFIP11;HSPA5
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.47904395405765837,-1.0108617437718799,0.4794520547945205,1.0,1.0,4/39,9.87%,GPAT3;LCLAT1;DDHD2;PLA2G12A
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.5092101020697565,1.0108254439814188,0.4666666666666667,0.880464214721353,1.0,8/26,21.29%,ATP11C;ATP10A;P2RX7;PLSCR4;ATP8A1;ATP10D;ABCC1;ATP11A
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.394021372789959,1.010661552423309,0.37037037037037035,0.880326141317172,1.0,9/63,6.54%,PTPN6;NOS2;AFAP1L2;CD200R1;CLEC7A;AGER;IRAK3;CYBA;TMEM106A
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.43956063753702024,-1.010604125475922,0.3835616438356164,1.0,1.0,4/70,4.09%,HLA-F;PM20D1;CLU;VPS35
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5375019703271597,1.0101213568219274,0.45454545454545453,0.8810703112244697,1.0,2/13,4.93%,CHKA;LPIN3
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6484376419246591,1.0099889230158459,0.5675675675675675,0.8807196092433051,1.0,3/5,21.91%,NAA16;NAA30;NAA25
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.600992434876573,-1.0099343551541204,0.5396825396825397,1.0,1.0,4/9,21.21%,SRI;CALM3;TRDN;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.600992434876573,-1.0099343551541204,0.5396825396825397,1.0,1.0,4/9,21.21%,SRI;CALM3;TRDN;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3923682182455074,1.0098862558027966,0.3333333333333333,0.8802951852291527,1.0,21/76,20.43%,BAG2;HSPA1A;SIRT1;HSPA1B;BAG3;HSPH1;CHORDC1;NDC1;NUP42;DNAJB6;PTGES3;CREBBP;GSK3B;CAMK2D;FKBP4;RPTOR;MAPT;NUP98;DNAJB1;MAPKAPK2;CAMK2G
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.6132101805417612,-1.009709485081594,0.46296296296296297,1.0,1.0,3/8,20.98%,CEACAM1;NLRP12;CCR7
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.6321297093650305,-1.0096878231927313,0.5,1.0,1.0,1/6,6.48%,LIMA1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.4883341612111085,1.0096333934417723,0.40625,0.8803061025943649,1.0,5/13,20.10%,SERPINF2;TGFB2;SMAD4;ITGB8;LILRB1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6208134273371801,-1.009501703983391,0.5,1.0,1.0,4/7,31.68%,BLM;TERF1;RECQL4;SLX4
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.4791668676521914,-1.009210594906404,0.4520547945205479,1.0,1.0,4/38,9.87%,GPAT3;LCLAT1;DDHD2;PLA2G12A
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5894363431202332,-1.0084382664013734,0.5714285714285714,1.0,1.0,4/10,16.24%,COLEC12;TNIP2;FADD;SCARA3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.48396625848015057,-1.0082599851432725,0.5,1.0,1.0,10/30,22.40%,IL6R;CXCL17;CALR;C1QBP;SERPINE1;PTN;CCR7;ZNF580;CREB3;ADAM17
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.44050139331430255,-1.0080036995955375,0.41975308641975306,1.0,1.0,22/98,21.21%,PSMB8;PSME1;PSMB6;PSMC5;VAV3;PSMD8;PSMD7;NFATC1;PSMD3;PIK3CB;PSMC3;PSMA4;PSMA7;PSMD2;PSMD6;PSMB2;PSMB4;PSMA3;PSMB3;PSMC1;SHC1;CALM1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7111426750528019,-1.0078435952295846,0.5714285714285714,1.0,1.0,2/6,9.20%,GALK1;GALE
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.6128268613639559,-1.0074019113226809,0.5079365079365079,1.0,1.0,2/7,3.01%,QPRT;NMNAT3
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.5802510053165324,-1.0070616045842025,0.5,1.0,1.0,3/10,12.25%,DNPH1;NUDT15;NT5C
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6189971982688453,1.0070602660352381,0.5789473684210527,0.885942200887032,1.0,2/7,5.19%,NRP2;ASCL1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.538206828722575,-1.0070555276942172,0.4696969696969697,1.0,1.0,3/13,20.36%,FADD;CIDEB;CYFIP2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4584791301538142,1.0069470431077165,0.36363636363636365,0.8855464474178634,1.0,10/25,13.63%,CHST7;VCAN;CSPG4;CHST3;NCAN;CHSY3;CHST11;CSGALNACT1;UGDH;CHST15
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6334815661423683,-1.0066533687903463,0.5084745762711864,1.0,1.0,1/8,1.73%,SELENOS
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4386629496066157,-1.0064355341647389,0.45,1.0,1.0,5/70,7.95%,CD44;CD63;MADCAM1;ITGB4;ADAM15
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.5708445216822199,-1.006170879270092,0.4838709677419355,1.0,1.0,1/9,2.51%,GRIN3B
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.39512483543460525,1.0061405862784216,0.5161290322580645,0.8868542174685677,1.0,7/67,7.32%,B3GNT6;IGF1;ST8SIA6;GAL3ST2;ST8SIA1;TMEM106A;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5034981031334842,1.0061403042055368,0.5142857142857142,0.8861624435079838,1.0,3/16,7.94%,MFHAS1;RAB23;OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.5548878599875262,-1.0061226740191078,0.4067796610169492,1.0,1.0,5/14,24.81%,SRSF7;C1QBP;SAP18;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.6384854618304061,1.0059440785582288,0.5882352941176471,0.885925852239664,1.0,2/6,22.02%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5782057842292838,-1.0056638264517967,0.3793103448275862,1.0,1.0,1/8,12.44%,CAMLG
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.6567365998503425,-1.0053946648473209,0.5172413793103449,1.0,1.0,1/5,2.82%,ALKBH2
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.6733374645531769,-1.005379005175509,0.5606060606060606,1.0,1.0,2/6,6.99%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.4453235343331444,1.0050711924713833,0.3783783783783784,0.8873780040389679,1.0,8/25,15.94%,NUPR1;USP36;UBQLN4;PIK3CA;CLEC16A;SMG1;SCFD1;TMEM39A
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.45678427994881204,-1.005038225277415,0.4805194805194805,1.0,1.0,6/48,11.29%,ID3;IFNGR2;CDKN1C;TGFB1;PPP1CA;FNTA
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.48471481505628233,-1.004866150245255,0.46153846153846156,1.0,1.0,7/45,8.94%,XYLT2;HYAL2;B3GALT6;GPC3;SGSH;B4GALT7;FUCA1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.5996563618937523,-1.0047817768559226,0.5161290322580645,1.0,1.0,2/6,25.58%,BAX;PTPN1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6046504428119989,-1.0046734465477891,0.48484848484848486,1.0,1.0,5/9,31.21%,GPATCH3;C1QBP;RIOK3;DHX58;TKFC
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.4841745040797391,1.0045471355595081,0.38461538461538464,0.8879843653622057,1.0,1/23,0.35%,PPP1R36
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.43792406391956445,-1.004447031634909,0.42028985507246375,1.0,1.0,7/58,4.91%,POLR2G;POLR2J;GTF2F1;RAD23A;POLR2L;PPIE;POLR2I
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6521704910981986,-1.004234183730999,0.5,1.0,1.0,5/7,21.21%,SRI;CALM3;TRDN;CAV1;CALM1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.6136908483786618,-1.0041307739361711,0.48333333333333334,1.0,1.0,1/9,2.30%,ROGDI
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3409811652465676,1.0041036064623816,0.36363636363636365,0.8883579932106096,1.0,36/196,12.60%,KCNN4;KCNJ14;KCNH4;ATP6V0A4;KCNJ2;KCNQ2;SLC39A8;ABCC8;SCN9A;KCNH3;ATP12A;SLC24A3;SLC40A1;SLC39A11;PKD1;PKD2L1;P2RX7;SCNN1D;SLC9C2;ATP1B3;TRPC5;KCNN2;SCN7A;KCND2;SLC9A2;KCNH7;KCNC2;SLC4A4;SCNN1B;KCNN1;SLC12A2;CACNA1G;SLC8A2;ATP2C1;SLC6A13;LRRC38
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5834699215480142,1.0040713229050788,0.46511627906976744,0.8877835435367826,1.0,3/10,13.18%,SULT2A1;SULT2B1;ENPP1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.4796787397098232,-1.0036414775236633,0.5211267605633803,1.0,1.0,11/36,28.32%,GRWD1;CHAF1A;ASF1B;NAP1L2;CHAF1B;H2BC11;SMARCA5;SART3;PADI4;H2AX;ASF1A
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.6259579018086221,1.0030234453265432,0.5135135135135135,0.8894085759252646,1.0,1/5,1.97%,CARD18
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5166236976896234,1.0029199736988827,0.48484848484848486,0.88893931661133,1.0,7/15,17.28%,PBX1;MAML2;NOTCH4;NOTCH3;KAT2B;CREBBP;WWC1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.4373161204031231,1.0028675238461382,0.4166666666666667,0.8884182685299484,1.0,3/32,2.76%,F2;CD59;C6
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.4800866771516638,1.002861790212227,0.40625,0.8877825812798356,1.0,2/32,1.29%,REP15;ATP6V0A4
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5298500962041959,1.002554892705667,0.375,0.887976351171301,1.0,1/17,0.24%,RAB27A
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5274975305795158,-1.0023139555471663,0.4444444444444444,1.0,1.0,2/12,8.12%,RPS21;NOP9
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5062120958985734,1.002248790013667,0.4594594594594595,0.8881174268876569,1.0,3/17,7.72%,HNRNPU;RANGAP1;TAF3
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.6295185447128957,-1.0021964728775337,0.5272727272727272,1.0,1.0,1/8,9.88%,FADD
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4338481289510499,-1.0018078060555193,0.4383561643835616,1.0,1.0,13/92,14.51%,HSPE1;NLRP1;BEX3;RPS3;KHDC1;RACK1;PRR7;LCK;FADD;PDCD2;RPS27L;NLRP12;MTCH1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3632624427981293,1.0017630205194912,0.4,0.8884258172409497,1.0,10/91,8.25%,RELN;LCP2;HSPB1;MMD2;SPRED1;SIRT1;SNCA;CEP85;GSKIP;CD4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.6322118619292778,-1.0017096214613774,0.515625,1.0,1.0,1/6,0.32%,BMP5
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.4047566402829683,-1.0016020029061878,0.41975308641975306,1.0,1.0,29/137,20.09%,PSMB8;RPS27A;PSME1;DND1;APEX1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;PSMD3;PSMC3;EXOSC4;UBB;PSMA4;CIRBP;METTL3;HSPA8;PSMA7;PSMD2;MEX3D;PSMD6;PSMB2;VIP;PSMB4;PSMA3;PSMB3;PSMC1;YWHAB
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.5145866371581144,1.0014398026992972,0.4117647058823529,0.8884303128090806,1.0,3/13,7.32%,ST8SIA6;ST8SIA1;ST8SIA4
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.6030340943709984,-1.001418702457137,0.5223880597014925,1.0,1.0,2/9,5.45%,ADH4;ADH5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.42940596871689946,1.0013546562055167,0.4318181818181818,0.8879434336393279,1.0,9/23,17.31%,VASH1;ADGRB1;ADAMTS9;DUSP10;SLIT2;DNAJA4;PTEN;CORO1C;PTPN23
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6171814503418047,-1.0007710042136395,0.4576271186440678,1.0,1.0,3/7,16.47%,PHB2;PPIF;ANTKMT
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5281636291539157,-1.0007227770673277,0.5142857142857142,1.0,1.0,7/20,22.77%,CHMP2A;CEP131;GEN1;XRCC3;CHMP3;CHMP4B;VPS4B
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6448712559893964,-1.000581713863043,0.5873015873015873,1.0,1.0,5/6,34.92%,SSB;HSD17B10;TRNT1;TRMT10C;ELAC2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.5338710981314782,-1.0005784720554922,0.5230769230769231,1.0,1.0,4/16,21.21%,DEGS2;ASAH2;PTS;CALM1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.6278855910856498,-1.0003253362439333,0.45,1.0,1.0,3/6,14.81%,CHRM2;OPRM1;CHRM5
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.4405283258900878,0.9999912445780703,0.4864864864864865,0.890183860909854,1.0,3/23,8.99%,SH2B2;PLEKHA1;LAT2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.5876140340798119,-0.9999243128646118,0.48333333333333334,1.0,1.0,3/8,27.16%,INPP5K;MORC2;SETDB1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5549040549231165,-0.9997135432196758,0.5245901639344263,1.0,1.0,3/14,15.99%,PRELID1;SLAMF8;METTL3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.5303615570794771,-0.9996528437297814,0.5079365079365079,1.0,1.0,1/12,0.43%,CYP1A2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.6442789299484021,-0.9993393254546782,0.43333333333333335,1.0,1.0,3/5,26.60%,KCNQ1;KCNE1;KCND3
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.5841193367467143,0.9991353507116396,0.5128205128205128,0.891637946667242,1.0,1/6,3.59%,HDAC10
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.5132174744144047,-0.9989972020716457,0.47761194029850745,1.0,1.0,2/22,10.69%,SEMA3E;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4961844663287619,0.9989816511004077,0.5142857142857142,0.8913896238757558,1.0,2/16,8.90%,IGF1;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5341342731164542,0.9989705399574024,0.5,0.8907352069475287,1.0,3/14,14.30%,TAFA5;GPER1;PTEN
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.5591960906558775,-0.9987265885857564,0.5441176470588235,1.0,1.0,5/15,22.94%,SCD;SLC25A1;FASN;PPT1;HSD17B8
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3847902824378742,0.9984262373142127,0.37037037037037035,0.8914148462582641,1.0,16/73,16.53%,ARAP1;EPS8L2;AGRN;NLGN1;DPYSL3;P2RX7;CCP110;ARHGAP35;CDC42EP4;RHOQ;AUTS2;PIK3CA;ABI2;ANLN;CYFIP1;GPM6A
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.4557334749712173,0.9983661301560743,0.36363636363636365,0.8908654797668588,1.0,3/29,2.76%,F2;CD59;C6
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.43473934199631853,-0.9983593532170753,0.52,1.0,1.0,8/60,13.04%,XBP1;SFRP1;ZFPM1;BBS12;TGFB1;GPS2;CEBPB;SYAP1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.5719326717172318,0.9982111162608973,0.48484848484848486,0.8906081136540677,1.0,2/6,15.75%,TENT4B;TENT4A
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.35634045873809217,0.9980616289057272,0.3333333333333333,0.8902576278178748,1.0,32/129,12.27%,CLDN15;CLDN9;ICAM1;IL1RAPL1;CLDN12;IGSF11;PTPRD;HMCN1;L1CAM;NLGN1;PKD1;OBSL1;CDH4;ALCAM;CDH20;ROBO1;DSCAML1;CDH11;CDH8;CDH26;ADGRL3;TGFB2;ACVR1;CADM1;CELSR2;LRRC4C;PLXNB2;CRTAM;CDH2;CDH9;CDH10;ATP2C1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.5232116101126533,-0.9980477204095265,0.5147058823529411,1.0,1.0,1/24,1.13%,HR
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5377321795637083,0.9979950383959348,0.5666666666666667,0.8897415585947418,1.0,7/12,18.76%,PKD1;CPSF6;CPSF7;GRIN1;PKD2;CBR4;GRIN2B
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.4986458744568638,0.9977490557253261,0.5,0.889630888423517,1.0,5/14,20.02%,FOXK1;SIRT1;PDK4;PDK1;MLYCD
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.500127590246652,-0.9977397438886884,0.5303030303030303,1.0,1.0,5/32,10.80%,DDIT3;HYAL2;NOP53;RACK1;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4409368259899952,-0.9975444530007422,0.5121951219512195,1.0,1.0,13/55,11.37%,IL26;B2M;TINF2;SFRP1;AIMP1;CDKN1C;SPARC;CEACAM1;AQP11;TGFB1;PTPRM;ATP5IF1;STAT1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4135770404707488,0.9974744239509014,0.35714285714285715,0.8896551539942904,1.0,12/43,9.95%,NOS2;HSPA1A;AFAP1L2;ANXA4;MAPKBP1;RELA;CLEC7A;SSC5D;OTUD7B;HSPA1B;ARRB1;PTPN22
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4928230554480695,-0.9972774434251999,0.463768115942029,1.0,1.0,7/21,28.65%,EEF1AKMT2;BHMT;METTL21A;CSKMT;ETFBKMT;FAM98A;PRMT2
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.6052260364841809,-0.9970132496236355,0.5294117647058824,1.0,1.0,1/7,6.48%,LIMA1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.45146523757415585,-0.9968970874731689,0.47297297297297297,1.0,1.0,11/47,17.95%,IFITM3;TRIM13;FAM111A;STAT1;PPIA;ILF3;IFIT5;ISG20;HEXIM1;BTBD17;CHMP3
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.48101418843326793,-0.9968042422223848,0.5217391304347826,1.0,1.0,11/35,26.04%,CLU;LIMA1;APOE;OSBP;ABCA5;STARD5;CAV1;NPC2;ABCG5;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.4984087715341103,-0.9967615811599755,0.4383561643835616,1.0,1.0,9/26,26.91%,LSM10;EXOSC4;EXOSC10;SSB;CPSF3;NCBP1;SNRPG;NCBP2;SNRPE
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5752381266399408,0.9967311213201875,0.5128205128205128,0.8905495149396142,1.0,1/7,3.37%,ACER2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3822315253976534,0.9967265810726587,0.3684210526315789,0.8898898884281656,1.0,17/65,18.20%,KCTD8;GUCA1B;KLK14;RNF157;ZDHHC3;RGS5;GRK5;C3;PDE6B;MGLL;GNG7;RIC8B;GPER1;ADCYAP1;PPP1R9B;GRK4;GUCA1C
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.4259297342149425,-0.9965389985790647,0.49295774647887325,1.0,1.0,21/115,19.34%,POLR2G;DDX24;RNASE1;POLR2J;RBMS2;GTF2F1;POLR2L;POLR2I;RBM3;PCBP3;TFIP11;WDR74;PRPF4;ISG20;LAGE3;POLR2A;METTL3;HNRNPH2;FASTKD2;NCBP1;CLP1
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.6452994265859193,0.9965327311975236,0.5116279069767442,0.8895932706598179,1.0,2/5,21.34%,ST3GAL2;ST8SIA3
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.5320538872168635,-0.9965105851322076,0.47619047619047616,1.0,1.0,4/13,12.49%,CPS1;CYB5R3;DDAH2;ARG2
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3700304469621303,0.9963500037872528,0.4117647058823529,0.8893591154924599,1.0,29/148,13.75%,PDGFB;RELN;FGFR1;SRC;ALK;ARHGEF7;CPEB3;DLX1;NLGN1;ZBTB16;SIRT1;SCX;SERPINF2;COBL;PLD6;PAXIP1;SPIRE1;SOX5;LLPH;ACVR1;GDNF;SMURF2;NRXN1;RAPGEF3;ESRRB;CLASP1;LRP8;RPS6KA1;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6907215484952944,-0.9958685655097189,0.582089552238806,1.0,1.0,3/7,16.23%,SFRP1;ATRAID;GREM1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.5928898216631274,0.9957940072906403,0.5348837209302325,0.8900031240424153,1.0,1/5,1.53%,KLRD1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.542921573170142,-0.9957849864168353,0.5147058823529411,1.0,1.0,5/14,27.63%,FGF7;ANGPT1;SCG2;LGALS3;PLXNB3
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.4807533549057499,-0.995665653907656,0.463768115942029,1.0,1.0,7/31,18.01%,TPP1;GRN;GNPTAB;SNAPIN;LAMTOR1;TPCN2;NAGPA
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.3937328954734757,0.9955448272079854,0.4,0.889841248309208,1.0,6/34,8.80%,GCM1;CDK6;SPOCK1;ASCL1;HAP1;TGFB2
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.41734771184611474,-0.9955102333326525,0.5063291139240507,1.0,1.0,18/79,16.88%,NLRP1;IFIT2;RNASE1;IFIT3;IRF1;IFITM3;PHB2;FADD;STAT1;IFI6;EXOSC4;IFNLR1;IFIT5;AGBL5;ISG20;RNF135;PQBP1;NLRP9
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.40871042186899414,-0.9954574098995846,0.4588235294117647,1.0,1.0,24/149,16.37%,PARP2;DTX3L;RMI1;AP5S1;EME1;ABRAXAS1;UBXN1;RNF8;ATP23;RPA3;RAD51AP1;CYREN;PARP1;BRCA1;KPNA2;KDM4D;SFR1;MEIOB;KAT5;GEN1;PARP9;RAD50;XRCC2;XRCC3
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.5752236862138957,0.9950206234282646,0.4666666666666667,0.8905767124920589,1.0,1/6,0.30%,LEPR
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.46962587390210175,0.994945147366902,0.46153846153846156,0.8900746286782673,1.0,2/19,3.56%,KCNN4;RELA
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.6630491986484254,0.9947245004039389,0.5405405405405406,0.8900572081143148,1.0,3/5,21.47%,CHD7;ADCYAP1;DRD2
prerank,PanglaoDB_Augmented_2021__NK Cells,0.4072869013434277,0.9946472312533293,0.56,0.8895665691583304,1.0,9/62,7.16%,ZAP70;LCP2;GNLY;KLRD1;PSTPIP1;ZBTB16;PCDH15;HMBOX1;ITGAX
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.47895690274705893,-0.9945563666994952,0.4861111111111111,1.0,1.0,8/55,12.55%,SEMA3E;ACTG1;SFRP1;JUP;PLET1;ADAM15;PIK3CB;PLEKHA2
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.5522277819288952,0.994253779527979,0.4722222222222222,0.8898374040276095,1.0,2/9,6.83%,RUNX1;SERPINF2
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.6565402068899877,-0.9940529742086367,0.5636363636363636,1.0,1.0,2/5,19.83%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5136211048772126,0.9935876393040346,0.4411764705882353,0.8906419894867722,1.0,5/16,9.95%,PTPN6;CD200R1;IRAK3;ARRB1;PTPN22
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.4914559424483129,-0.9935378013191065,0.4444444444444444,1.0,1.0,3/22,5.80%,TGFBR2;MESP1;CCDC39
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.5808521696583762,0.9934343057415344,0.4864864864864865,0.8902854617504423,1.0,2/6,2.63%,DENND1B;IFNA2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.43486558725660834,-0.9933357399491519,0.47297297297297297,1.0,1.0,17/79,15.71%,CENPF;BUB1;ERCC6L;MCM4;MCM3;CENPH;WDHD1;ATAD5;DEPDC1B;ZGRF1;CHAF1A;PARP1;DNMT3B;NCL;RFC4;FANCD2;PLK4
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.43354921381848316,0.9930549958797384,0.40625,0.8905448805690577,1.0,17/40,21.83%,DLX1;CHRD;SMAD4;SMURF2;LEMD3;BMPR2;HIPK2;ACVR2B;CRIM1;ACVR2A;TRIM33;SMAD9;UBE2D3;BMPR1B;SMAD5;VWC2L;FBN1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.6288259685090509,-0.9929294523770602,0.47692307692307695,1.0,1.0,2/6,25.68%,MOCS1;MOCOS
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.5009274073083171,0.9928507177917008,0.5384615384615384,0.890240210769963,1.0,3/19,11.57%,NUPR1;OGT;PELI1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5604209320496003,-0.9928225513052372,0.43103448275862066,1.0,1.0,5/10,34.05%,CD81;BCAP31;SAR1A;SAR1B;TMEM30A
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.5853049558421625,0.9925815505166808,0.5517241379310345,0.890304687415134,1.0,3/7,26.48%,ATP1B3;WNK1;WNK2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.5609294360225459,-0.9922521005303967,0.48148148148148145,1.0,1.0,4/7,34.48%,GOLGA2;CDK1;PLK3;STX5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.4938260919192056,-0.9922115990919528,0.4520547945205479,1.0,1.0,5/29,19.19%,MAGEF1;TFIP11;CYREN;CGAS;POLQ
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.34015638968600664,0.9921838113397893,0.29411764705882354,0.8905430368277266,1.0,16/104,10.24%,IGF1;DACH1;CGNL1;FRZB;POSTN;PDGFRA;KCNT1;SASH1;TMEM47;DOCK1;ARID5A;CDH11;HTRA1;RGS5;AQP1;C3
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.48286064584294036,-0.9920803197119805,0.4810126582278481,1.0,1.0,12/30,20.67%,ENTPD2;CLCA2;ITGB4;FLG;DUOXA1;KRT10;IL13RA1;CBLC;KLF5;TGM1;DMKN;C6ORF132
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.5205688950654693,0.9918777467212141,0.4722222222222222,0.8906480908642633,1.0,3/10,16.66%,PSPH;CBS;SRR
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.4391378704182314,-0.9917304893667553,0.5342465753424658,1.0,1.0,10/78,13.29%,SLC8A3;PTK6;GSTP1;HYAL2;CDKN1C;CEACAM1;SH3BP5;DUSP26;PPIA;WARS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.47066265450675165,0.9913428243170922,0.5,0.8912025830183772,1.0,1/22,1.07%,IGF1
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.5639513192370985,-0.9912365356892001,0.56,1.0,1.0,3/9,16.40%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.5639513192370985,-0.9912365356892001,0.56,1.0,1.0,3/9,16.40%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.33639067304723186,0.9908522723754631,0.3125,0.8917868706757858,1.0,31/273,8.91%,F2;PDGFB;LEPR;RELN;PDGFC;IGF1;SPRY2;LCP2;VEGFD;SRC;PLK1;FGF17;EGFR;CSPG4;MMD2;CX3CR1;AGER;LIMCH1;PROM2;AKT2;SIRT1;SNCA;BMP6;FNIP2;DOCK7;TNIK;HCLS1;NTRK2;CD4;TGFB2;WDFY2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.4304125207614283,-0.9903898205715278,0.47058823529411764,1.0,1.0,7/102,5.48%,CD44;BMP5;MEPE;PRDX1;PPIB;RPL13;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6186459798232342,-0.9901458734212872,0.5223880597014925,1.0,1.0,1/8,1.48%,SFRP1
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.5937710012319959,0.9901414875090595,0.5161290322580645,0.8927681842729772,1.0,2/10,8.85%,TTLL11;TTLL9
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.4929885135530873,-0.9897552298401893,0.5,1.0,1.0,4/26,8.56%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,PanglaoDB_Augmented_2021__Pericytes,0.3744207208758843,0.9897209385479256,0.42857142857142855,0.8931872940009662,1.0,24/104,12.67%,COLEC11;ADAM33;ICAM1;FRZB;PCDH18;POSTN;PDGFRA;CSPG4;ADGRA2;PDZD2;ADAMTS2;NT5E;NOTCH3;CDH11;COL14A1;EMID1;HTRA1;RGS5;COL6A1;AQP1;SGCD;ECM1;PTH1R;PLSCR4
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.5681721224683561,-0.9890696258184553,0.5,1.0,1.0,4/12,20.17%,RPS15;NOP9;RAN;LSG1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.4954164421688623,-0.9889501439046101,0.4927536231884058,1.0,1.0,6/33,17.32%,TRPM1;RAD51AP1;OPN4;KDM4D;FIGNL1;ECT2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5708163661452378,-0.9888994482577376,0.5588235294117647,1.0,1.0,4/14,18.39%,RAD51AP1;PARP1;MRNIP;OOEP
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.389196495047781,-0.988876845013839,0.55,1.0,1.0,30/203,18.22%,EPN1;RIMS1;RPS27A;ACTG1;GRIN3B;CFTR;CPTP;CHMP2A;UBA52;VAMP8;CHRM2;BAIAP2L2;TIMM50;CR1;REEP4;NEMP1;AP2S1;MYADM;CLTA;UBB;MTCH1;CLTCL1;ARPC5;DNM1L;ACTB;HSPA8;CHMP3;TRDN;CHRNB1;CHMP7
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.5423641768037921,0.9886924625556835,0.425,0.8948282582159952,1.0,3/8,17.02%,GNGT1;PDE6B;GNAQ
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.34083539410166425,0.9886006507389756,0.47619047619047616,0.8944308129090143,1.0,7/75,5.83%,PDGFB;BAG2;CARD18;CPNE1;GNL3L;LEF1;TMC8
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.39996851642977105,0.988445491627939,0.375,0.8940644805958731,1.0,7/68,5.48%,PDGFB;VASH1;VEGFD;NRP2;ATOH8;ARNT;SIRT1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5166349787326108,-0.9884041184448983,0.4918032786885246,1.0,1.0,1/14,2.09%,DND1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.47201799772452385,-0.9884039641189942,0.4931506849315068,1.0,1.0,6/49,10.07%,SLC25A4;SLC25A5;HSPB8;TRIM13;IRGM;PINK1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3842922903431189,0.9883777366625648,0.391304347826087,0.8936275468007652,1.0,14/73,12.78%,NOS2;ACER2;LOC400499;RXRG;ASCL1;SNCA;IRAK3;TRIM16;ERBIN;RARG;PTPN22;PELI1;MAPKAPK3;FOXO3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5615950133412905,-0.9883396482281753,0.5087719298245614,1.0,1.0,5/13,24.81%,SRSF7;C1QBP;SAP18;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5811986958997715,0.9881270167908873,0.5135135135135135,0.8935569138105717,1.0,1/7,2.45%,STARD13
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.47656108422501386,-0.9879031393860679,0.5,1.0,1.0,8/34,17.09%,GAPDH;SERPING1;TIMP1;SERPINB8;CR1;SERPINF1;TIMP2;SERPINE1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.41836620563759574,-0.9878083617323009,0.48717948717948717,1.0,1.0,13/84,12.91%,NOX4;SELENOS;PRDX1;PRDX5;GSTP1;CHCHD2;TXNRD2;PINK1;BRF2;GPX7;RBM11;PARP1;PPIA
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5954981055851909,0.9877466995476845,0.5277777777777778,0.8937604155174604,1.0,4/10,19.54%,HSPA1A;BAG3;VHL;DNAJB1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.39273645353550773,-0.9874397808245174,0.5119047619047619,1.0,1.0,36/187,19.91%,PSMB8;DDIT3;PSME1;PSMB6;PSMC5;RAD23A;PSMD8;PSMD7;KCTD2;TRIM13;UBXN1;RBX1;PSMD3;PSMC3;RNF5;RMND5B;KAT5;PRAME;KCTD5;PSMA4;NHLRC1;CDC34;ZFAND2B;HECTD3;CCDC47;PSMA7;PSMD2;SPSB3;ZFAND2A;PSMD6;PSMB2;ERCC8;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3499520366558975,0.9874143371899996,0.35294117647058826,0.8940447455494996,1.0,32/175,10.29%,PDGFB;PDGFC;FGFR1;JCAD;IGF1;SPRY2;ICAM1;FLT1;FGFR3;PIK3R5;EGFR;PDGFRA;MFHAS1;AGER;TMEM106A;TPD52L1;IGF1R;SERPINF2;MTURN;ADAM8;NTRK2;ROBO1;ARRB2;NECAB2;CD4;DIRAS2;TGFB2;ADRA1A;NPNT;ARRB1;PTPN22;FBXW7
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.37489349857979315,0.9871830294379828,0.4444444444444444,0.8939840930424391,1.0,15/75,9.84%,COL20A1;COL5A3;COL7A1;COL22A1;COLGALT1;ADAMTS2;SCX;SERPINF2;COL9A1;COL14A1;LOX;TGFB2;COL6A1;COL5A1;COL23A1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.5588681034913483,0.9870814367159464,0.5294117647058824,0.8935994844230883,1.0,3/10,9.90%,NRP2;ASCL1;GDNF
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.35414599853648815,0.986996181404579,0.4375,0.8932053313761886,1.0,36/187,13.78%,FGFR1;TP63;IGF1;SNAI1;FRZB;MAPK12;MAPK11;CTNNA2;CPNE1;DLX1;MMD2;PLA2G10;ASCL1;LEF1;ZBTB16;BMP6;SERPINF2;LRRC8A;SOX5;TGFB2;WDFY2;NFKB1;NPNT;ACVR1;GDNF;BRINP3;SMAD4;CDS1;PRKD1;CDH2;XKR8;LOXL2;TCF4;RPS6KA1;BMPR2;GDF5
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5628595325842767,-0.9869329741228189,0.5151515151515151,1.0,1.0,3/13,4.59%,CLU;RPS3;DDIAS
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.632778010958305,-0.9869009461073284,0.5245901639344263,1.0,1.0,1/6,8.17%,IRGM
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.6150980003622856,0.9868038686690125,0.5365853658536586,0.8928926573978773,1.0,4/5,13.95%,CRACR2A;ORAI2;STIM1;STIM2
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.48941569287994247,-0.9867893740905977,0.46774193548387094,1.0,1.0,6/32,11.35%,TTN;ZFPM1;MESP1;SYNPO2L;HTR2B;OLFM1
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5779046358800417,-0.9867744834938144,0.5428571428571428,1.0,1.0,2/10,25.79%,BCKDK;ACOT8
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.39606428212267825,-0.9865750302820238,0.5529411764705883,1.0,1.0,30/166,14.91%,RPS12;DDIT3;H1-2;TAX1BP3;TCN2;RPL18;CLCA2;PCNA;RETSAT;ITGB4;RPL36;VAMP8;HINT1;ISCU;CD81;BTG1;RACK1;HRAS;FUCA1;TGFB1;PROCR;PMM1;TRIAP1;TM7SF3;NUDT15;VWA5A;RPS27L;ATF3;H2AJ;HEXIM1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.5720200052120055,0.9864378767072224,0.5,0.89290377158602,1.0,3/6,19.57%,PTPRD;TRIO;PTPRU
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4320967337331293,-0.9863713054707384,0.4342105263157895,1.0,1.0,15/83,18.37%,DDIT3;SELENOK;BCL2L2;HINT1;ZNF622;IFI6;CEBPB;BRCA1;CIDEB;C1QBP;MYBBP1A;PDK2;BAX;MOAP1;DDX5
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.5909318643600728,-0.986284686385597,0.5373134328358209,1.0,1.0,2/10,15.36%,IL31RA;MT1G
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.49432401352405364,-0.9862325994476784,0.4426229508196721,1.0,1.0,4/26,14.53%,IGSF10;KIF20B;SEMA3A;NTNG2
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3719968432256734,0.9859133971625946,0.47619047619047616,0.893631704982977,1.0,17/111,14.42%,FHDC1;BET1;ARHGEF7;TRAPPC12;OBSL1;OPTN;ZFP69B;VAMP4;NSFL1C;PRKD1;CLASP1;ARHGAP21;TRIP11;VTI1A;RAB30;GOLPH3;SPTBN5
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5989423675045367,0.9856558407308874,0.5897435897435898,0.893733051170807,1.0,2/6,15.54%,KYAT1;QDPR
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5390382536514077,0.9856541961920057,0.4864864864864865,0.8930680712220191,1.0,3/8,18.01%,AUP1;CDS1;PLA2G4C
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.5413579714653323,-0.9855783640710961,0.5161290322580645,1.0,1.0,1/12,1.63%,ZDHHC12
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.6688713955755509,-0.9855193466078287,0.5636363636363636,1.0,1.0,1/5,9.88%,FADD
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.48000859647708277,-0.9855157033433112,0.4788732394366197,1.0,1.0,4/40,8.94%,RHOC;SFRP1;SYNPO2L;VIL1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4557118665540978,-0.9854406477534429,0.5454545454545454,1.0,1.0,9/43,14.32%,RPS27A;PCNA;UBA52;TRIM25;RPA3;RFC2;SPRTN;RFC4;UBB
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.6483269882781753,-0.9851756542069748,0.5172413793103449,1.0,1.0,1/5,15.71%,PLK4
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.44629234814368157,0.9851709652405382,0.39473684210526316,0.8934517510170882,1.0,1/27,0.11%,TNFSF13B
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.43838543589580825,-0.9851578804007087,0.4794520547945205,1.0,1.0,13/76,15.93%,GAPDH;POLR3H;POLR2L;POLR3K;IRF1;TRIM25;POLR3GL;NLRX1;GPATCH3;DDX41;RNF135;PQBP1;RNF26
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.6910557476316301,-0.9850502298990308,0.5892857142857143,1.0,1.0,2/5,19.66%,PFKL;ALDOB
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.3476736632115155,0.9849687563439442,0.3870967741935484,0.8932912818754273,1.0,41/147,20.45%,RELN;IL1RAPL1;SPOCK1;CTNNA2;EPHA3;DPYSL3;ZNF804A;ARHGAP44;PDLIM5;NTRK2;KIF13B;ARHGAP35;RAPGEF1;LRRC4C;PLXNB2;PRKD1;CDH2;MAGI2;ABI2;NTNG1;KANK1;PTEN;RUFY3;MARK1;ROR1;GSK3B;LTK;CAMSAP2;NCS1;RAP1A;FKBP4;WNT5A;PTPRO;FUT9;ADCY6;MINAR1;CBFA2T2;SRCIN1;ABL2;CAMK2G;MARK2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.49513108982809095,0.9848767370843495,0.4883720930232558,0.8928091693447722,1.0,6/14,21.47%,OR3A2;UBR3;SLC24A4;MKKS;C5AR1;DRD2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4099203208442422,0.9847915455519636,0.41935483870967744,0.8923780288124071,1.0,8/32,8.95%,HSPA1A;MAPK11;TAL1;ARNT;MTURN;TESC;HSPA1B;SCIN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6220242533263659,0.9847896482211825,0.5135135135135135,0.8917165180423462,1.0,3/5,23.31%,MTMR2;MTMR3;MTMR9
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.45630910406492026,-0.9841498608736834,0.5333333333333333,1.0,1.0,6/48,4.12%,ARHGEF16;SERPING1;SLC3A1;CFTR;EFNA1;TMEM125
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5343539887024424,0.98408341432474,0.5333333333333333,0.8928725845005042,1.0,2/14,1.58%,CREB3L1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4753991285322219,-0.9839628737844698,0.5138888888888888,1.0,1.0,6/27,16.44%,RPL11;NOP53;UBXN1;GIPC1;CAMLG;MAP1A
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.36598748050332547,0.9838507962135475,0.48148148148148145,0.8928535442207234,1.0,9/75,8.25%,TNFSF13B;LCP2;PSTPIP1;PIK3R5;GRM8;ITGAX;HCLS1;CD83;CD4
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5627797578983357,-0.9836605034066785,0.5492957746478874,1.0,1.0,1/10,4.29%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.5052259776744128,0.983451711524552,0.5384615384615384,0.893125158561237,1.0,4/19,10.59%,PPARGC1A;PAXIP1;ARRB1;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.48685253596230427,-0.9833727002584262,0.44285714285714284,1.0,1.0,3/35,6.43%,RHOC;SFRP1;SYNPO2L
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5316643037458407,-0.983277393126896,0.5072463768115942,1.0,1.0,1/19,1.76%,RPS23
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.4010820966531574,0.9831515037932197,0.48,0.8932061016988748,1.0,8/58,5.00%,CREB3L1;STAB1;SPRY2;VASH1;ADGRB1;YJEFN3;ADAMTS9;SPRED1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.5743811375120028,-0.9830983629296838,0.5238095238095238,1.0,1.0,1/12,4.17%,TMED9
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4548985944161425,-0.9829362145237031,0.4864864864864865,1.0,1.0,9/41,19.75%,RPL10;ATG14;RBM3;PARP9;RBM4B;EIF2B4;MEX3D;EIF2A;METTL18
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.550147417979814,0.9829072028497837,0.5405405405405406,0.8931568368891537,1.0,2/12,8.80%,SNAI1;TGFB2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.514471155233913,0.9827459118936133,0.5151515151515151,0.892797662966582,1.0,2/11,10.62%,NOS2;KCNC2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5414918436635582,-0.9824956719588872,0.53125,1.0,1.0,3/16,12.91%,TRIM25;KPNA2;PPIA
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.452410247429653,-0.9824468002126726,0.4782608695652174,1.0,1.0,12/40,24.02%,VPS35;ARF1;FLOT1;PINK1;LAMTOR1;TBC1D16;PDK2;FASN;FOXM1;AGPAT1;NPC2;ARF4
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.4897019494060364,-0.9822337928603749,0.48484848484848486,1.0,1.0,6/28,11.37%,SERPING1;LPA;CYB5R3;F5;PLN;STAT1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.5855232739399516,0.9820926967449085,0.5128205128205128,0.8937479759894822,1.0,4/7,27.92%,PLOD1;PLOD3;P3H4;JMJD6
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.3790823427246824,-0.9820870225907297,0.43902439024390244,1.0,1.0,20/168,15.57%,H4C3;GATA1;SLC10A3;MARCHF2;RAD23A;CROCCP2;BLVRB;NFE2L1;HEBP1;SLC22A4;EIF2AK1;CTNS;LRP10;ARL2BP;MGST3;UROD;GYPE;GLRX5;EPOR;TMEM9B
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.431764399943637,-0.9818424299942445,0.5285714285714286,1.0,1.0,8/53,19.97%,COX7A1;COX7A2;PINK1;ATP5IF1;GCK;NUP50;FIS1;PGAM1
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.5394481306289954,-0.9817690374695766,0.4827586206896552,1.0,1.0,2/11,7.59%,MT2A;ARF1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.5243225688532582,0.9816496535513725,0.5142857142857142,0.8940878231499046,1.0,3/9,18.74%,HDAC4;UBA2;PIAS1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.6385723734672937,0.9813873933180928,0.5348837209302325,0.8940979181134888,1.0,2/7,5.49%,ADGRB1;EHD2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.638794582216515,0.9813531573426533,0.5882352941176471,0.8935197692744169,1.0,2/5,22.02%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.4436128522003077,-0.9810268673535263,0.42857142857142855,1.0,1.0,7/37,12.98%,ADH4;RBP1;RDH12;GPC3;GPIHBP1;RBP2;LRAT
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.6217539125147428,-0.9810062060843229,0.5849056603773585,1.0,1.0,2/5,12.91%,GPS2;PPIA
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.6064805342781097,-0.980760493434071,0.5079365079365079,1.0,1.0,2/7,23.97%,TGFB1;ESR1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.6248167942506699,-0.9805782475331981,0.55,1.0,1.0,1/6,3.91%,TST
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.6475863265244296,-0.9805755255446008,0.6101694915254238,1.0,1.0,1/5,7.22%,RACK1
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.6557591629684713,0.9805375122047728,0.5142857142857142,0.8946958972776976,1.0,2/5,21.65%,DRD2;RYR2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.5166759026000334,-0.9804353735477346,0.4838709677419355,1.0,1.0,1/15,1.48%,SFRP1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.645053401792451,0.9800712227130866,0.6,0.8938897119352218,1.0,3/5,23.08%,NSMCE2;SLF2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.645053401792451,0.9800712227130866,0.6,0.8938897119352218,1.0,3/5,23.08%,NSMCE2;SLF2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.645053401792451,0.9800712227130866,0.6,0.8938897119352218,1.0,3/5,23.08%,NSMCE2;SLF2;SMC5
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5953880523145718,-0.9800605609971729,0.5,1.0,1.0,2/7,22.40%,APH1A;ADAM17
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.4895459062493078,0.9798287237833139,0.42857142857142855,0.8938005733827981,1.0,2/15,7.44%,NFATC4;ADGRB2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.42917049992288103,0.979531029916194,0.4827586206896552,0.8939597193873525,1.0,13/33,20.59%,IP6K2;PIP4K2A;EFR3B;SOCS7;PIK3CA;PI4KA;SLA2;SMG1;SOCS4;ITPKC;PIK3R3;SOCS3;PIK3R1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3813749722453662,-0.9794511881599637,0.5714285714285714,1.0,1.0,46/283,20.48%,PSMB8;RPS27A;FBXW10;DTX3L;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;UBA52;RNF8;DDA1;ANAPC13;ARIH2;RBX1;PSMD3;PSMC3;RNF5;BRCA1;PRAME;UBB;PSMA4;FBXW8;NHLRC1;CDC34;UBE2D4;RNF135;RNF26;RNF167;RNF213;PSMA7;FBXL16;PSMD2;FBXL13;DCAF15;PSMD6;PSMB2;ERCC8;ZNF738;PSMB4;CDC23;PSMA3;PSMB3;PSMC1;DZIP3;RNF187
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3963045354737534,0.9794009011760029,0.45,0.8936623633747452,1.0,9/64,9.71%,VDR;LCP2;C1ORF162;CLEC7A;SLC40A1;CSF3R;ITGAX;CD4;CLEC5A
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),-0.6058321042251316,-0.9792959813970183,0.5901639344262295,1.0,1.0,2/6,18.69%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),-0.6058321042251316,-0.9792959813970183,0.5901639344262295,1.0,1.0,2/6,18.69%,ATP6AP2;CTSZ
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6073903504502359,0.9792741984207864,0.5581395348837209,0.8933753540466677,1.0,3/5,22.18%,SRSF12;PRPF39;SFSWAP
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5240933421684237,-0.9792631359117686,0.5079365079365079,1.0,1.0,1/21,1.48%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4116480655861965,0.979236631239313,0.4074074074074074,0.8927916326183352,1.0,10/42,15.56%,HAMP;MTMR2;EPHA3;SNCA;DYSF;PXK;PRKD1;PTEN;LRSAM1;NR1H3
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5628520251440413,-0.9791753121122188,0.5522388059701493,1.0,1.0,2/7,25.15%,MTIF3;MTIF2
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.6166734816886318,-0.9791365231360759,0.5849056603773585,1.0,1.0,2/6,7.67%,HCCS;SURF1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.36922345099812515,0.9791231403033396,0.4583333333333333,0.8924166042236914,1.0,5/85,4.62%,F2;RELA;GUCA1B;PDGFRA;ADGRA2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4369935221193814,-0.9790942546290667,0.5064935064935064,1.0,1.0,9/57,11.35%,BMP5;SFRP1;TGFBR2;EFNA1;IL17RD;OVOL2;BAMBI;TGFB1;OLFM1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5321849840500693,-0.9788369865778208,0.5342465753424658,1.0,1.0,3/17,8.07%,HLA-F;HLA-E;RASGRP1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5038122763293004,0.978721061695271,0.42424242424242425,0.8927245285676904,1.0,5/18,8.53%,ODAD3;CFAP53;DNAH11;DLL1;DNAI2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.6108313999713935,-0.9786922430499201,0.5967741935483871,1.0,1.0,3/9,23.72%,RAN;KPNB1;SREBF1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4332633147708124,0.9784206393703287,0.45714285714285713,0.8927355221892292,1.0,1/46,0.04%,MFNG
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.5449968630426572,-0.9783287829333164,0.532258064516129,1.0,1.0,5/17,20.99%,G6PC3;TALDO1;GCK;RBKS;G6PD
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.4437907163846525,-0.9783189993358272,0.4868421052631579,1.0,1.0,9/57,18.19%,COPS9;TIMP1;PCNA;HYAL2;TRIAP1;PARP1;METTL3;XPA;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.47561548699500317,0.9782559834735778,0.3611111111111111,0.8925489894975175,1.0,3/22,3.58%,MAPK12;MAPK11;CTNNA2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5027385297705983,-0.9782108936215377,0.5245901639344263,1.0,1.0,4/18,7.46%,TTN;JUP;PKDREJ;LHFPL5
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5606552332091317,-0.9780169146828056,0.5409836065573771,1.0,1.0,2/10,28.78%,TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.6500711194652447,-0.9779645927028094,0.532258064516129,1.0,1.0,2/5,30.03%,CAV1;MAPK3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.35997676121297073,0.9777125034183596,0.47619047619047616,0.8932903507633477,1.0,21/116,12.22%,EPB41L4B;PLIN5;CLDN12;SLC7A2;CHKA;EGFR;ERRFI1;RND3;OBSL1;TMEM47;EPB41L1;CHST3;DHCR7;COL6A1;CD276;TEAD1;CDC42EP4;KCTD3;EPDR1;FKBP5;GALNT18
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),-0.6018397683962823,-0.9773881032779165,0.5428571428571428,1.0,1.0,1/5,14.47%,EDN1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5142143805063015,-0.9773566348529448,0.5211267605633803,1.0,1.0,6/19,12.86%,DNPH1;MTHFD1;PRPS1;NUDT15;NT5C;PRPSAP1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5984560292023025,-0.9770045712297787,0.5757575757575758,1.0,1.0,2/10,7.30%,JUP;SERPINB8
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.5739833952925821,0.9769596032325921,0.5294117647058824,0.89424757797056,1.0,5/8,25.66%,P2RY1;SLC8A1;RYR3;RYR2;CASQ2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3349787783542758,0.9768628174775689,0.3125,0.8938731271941095,1.0,24/126,12.67%,BACE2;PCOLCE2;STAB1;PDIA5;POSTN;NXN;LTBP2;EHD2;TMEM47;DOCK1;BMP6;COL14A1;LOX;HTRA1;COL6A1;COL5A1;AQP1;TMTC1;TMEM184B;ACKR3;TMTC2;PXDC1;GXYLT2;PLSCR4
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.46620958892580266,-0.976832781927373,0.5714285714285714,1.0,1.0,4/45,5.48%,GBP3;GBP2;SFRP1;HYAL2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5128318638895987,-0.9766216162534552,0.5806451612903226,1.0,1.0,6/29,11.01%,PCDHB11;PCDHB4;CDH12;PCDHB2;CDH17;SELP
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.550849909748911,-0.9764253393236019,0.5714285714285714,1.0,1.0,1/15,1.05%,POLR2G
prerank,PanglaoDB_Augmented_2021__Myocytes,0.37791717439319467,0.9763700133368999,0.375,0.8942968120029975,1.0,16/83,11.07%,TNNC2;TCAP;IL4R;TPM2;MYH4;ALPK3;PLD1;MYH14;CKM;DOCK1;NOTCH3;MRC1;DLL1;SGCG;ENO3;SGCD
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5337065122452611,-0.9763592126373948,0.53125,1.0,1.0,3/13,12.25%,DNPH1;NUDT15;NT5C
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.5148750452817515,0.9762181921645395,0.42424242424242425,0.8939917469256089,1.0,1/12,1.21%,MAIP1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5547772333461782,-0.9761798302675567,0.5074626865671642,1.0,1.0,2/10,17.09%,ROMO1;SERPINE1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.5122666300847698,-0.976132540163115,0.47761194029850745,1.0,1.0,6/18,22.94%,SCD;SLC25A1;FASN;FAR2;PPT1;HSD17B8
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.4768977210860646,0.9761220888215854,0.4117647058823529,0.8935003068274258,1.0,6/31,12.57%,BACE2;ADAM19;RELA;NFKB1;SPPL3;NAPSA
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.46308940159750467,0.9760769827562883,0.5142857142857142,0.892930976398845,1.0,1/17,0.21%,SRPRB
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5867814618971876,-0.976014956751964,0.5166666666666667,1.0,1.0,2/9,17.82%,MESP1;MEOX1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.371248826236211,0.9759582653631397,0.4375,0.8925588363872163,1.0,8/53,10.16%,NFATC4;PPARGC1A;CX3CR1;ADAM8;NTRK2;TOX3;GDNF;CPEB4
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5061468977187444,-0.9757968665361896,0.4931506849315068,1.0,1.0,4/17,9.63%,CORO1B;ARF1;BRK1;GMFG
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.37197375777154523,0.9757523458609879,0.5,0.8923049691842372,1.0,11/49,9.80%,SPRY2;BAG2;HSPA1A;ADGRB1;NXN;LIMK1;GNL3L;ARRB2;HSPA1B;OGT;ARRB1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.4025203940846459,-0.9755705363137809,0.48717948717948717,1.0,1.0,17/99,11.54%,SLC28A2;CPS1;TMC4;PDZK1;GBA3;DEGS2;CBR1;TREH;CEACAM1;AQP11;VIL1;FABP6;RBP2;CDH17;TMEM45B;ART3;SLC51A
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.41264007975512473,0.9755268632414577,0.5161290322580645,0.8921495099347128,1.0,11/43,10.68%,ACER2;RXRG;EPHA3;ASCL1;TRIM16;TESC;WNT3;AQP1;RARG;BRINP3;STRA8
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.3712998684526817,0.9755159298923874,0.4,0.8915534119728178,1.0,25/152,9.57%,APOLD1;PDGFB;PALMD;STAB1;LIFR;FLI1;ICAM1;FLT1;TDRD10;NRP2;POSTN;PDGFRA;ACKR1;ID1;PLAC8;RASIP1;LTC4S;SGK1;NOTCH4;RHOJ;SLC7A5;LOX;RGS5;SLCO1C1;AQP1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.5745852986635364,0.9753868761937498,0.6285714285714286,0.8912225024144982,1.0,1/7,1.70%,ITGA11
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.5854077533455067,-0.9752580370930373,0.5370370370370371,1.0,1.0,4/7,25.33%,STAT1;TBC1D20;IFIT1;DDB1
prerank,GO_Biological_Process_2021__negative regulation of protein sumoylation (GO:0033234),0.6604162076764749,0.9752055830840292,0.5151515151515151,0.8910290301841873,1.0,1/5,4.46%,GNL3L
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.42562253639918424,-0.9750807498664203,0.524390243902439,1.0,1.0,1/72,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.6201676218144132,-0.9748437703893943,0.5357142857142857,1.0,1.0,2/7,19.16%,HMGCL;BCAT2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.4881571001518438,-0.974796647010511,0.5689655172413793,1.0,1.0,4/19,24.07%,CARTPT;CEBPB;LILRB3;TCTA
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5331903191187642,-0.974672510679264,0.5573770491803278,1.0,1.0,4/11,34.48%,GOLGA2;CDK1;PLK3;STX5
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4525086347821221,0.9745795039268942,0.5,0.8916961041648588,1.0,7/13,23.37%,DUSP1;PPP2R2C;PPP2R2A;PPP3CA;PPP1R15B;PPP2CB;NCK1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.5819155463825512,0.974100471931416,0.509090909090909,0.8922645291150835,1.0,6/6,41.83%,ATP11A;MAPK14;RBM24;MAML1;PIEZO1;SMYD1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.3997375302768466,-0.9738707296539101,0.5125,1.0,1.0,20/142,14.91%,RPL23;RPL5;RPS15;RMI1;RPL11;RPL37;RPS20;RPF2;NOP53;TPX2;RPA3;RFC2;CDK5;TAF11;BRCA1;CHD4;KAT5;SETD9;RFC4;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5115526809250686,0.9737948318116786,0.4857142857142857,0.892187864419868,1.0,1/9,1.43%,SPRY2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.5687665670614599,-0.9736054618386114,0.5384615384615384,1.0,1.0,6/11,30.40%,HIRIP3;CHAF1A;CHAF1B;SUPT16H;CDAN1;MTA2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.30621397577346604,0.9730050051928828,0.5,0.8935647526279553,1.0,85/538,12.78%,VDR;PDGFB;NFATC4;DACH1;ZBTB1;RUNX1;SNAI1;HSPA1A;ATXN1;PLK1;ZGLP1;TBX6;ZNF366;HDAC4;HAMP;RELA;HDAC10;BACH1;CPEB3;CNOT2;DLX1;SCRT1;ID1;HNRNPU;ZNF202;FRK;ASCL1;BATF3;ZBTB16;WWOX;SIRT1;TBL1XR1;SNCA;SMARCA2;GLI2;ETV5;ZBTB2;BMP6;NFIB;FNIP2;HMBOX1;ZHX2;ZNF451;PHF21A;ZNF778;ARID5A;ZFP69B;NOTCH4;TAF3;NRIP1;OTUD7B;ZEB2;JAZF1;ZNF785;DMRT1;AEBP1;SMYD2;NFKB1;BAG3;TRPS1;RARG;PURA;ZNF536;MITF;DICER1;DNMT3A;KLF11;SOX30;SMAD4;MNT;LCOR;DLG1;THRB;HDAC9;SMURF2;UHRF1;MEIS2;LOXL2;SLA2;ZNF281;MYPOP;ZFPM2;MCPH1;EED;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.49006984212553917,-0.9729255214360611,0.5362318840579711,1.0,1.0,4/27,10.46%,ZFPM1;BBS12;TGFB1;GPS2
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.5542963573884584,0.972773313990999,0.5714285714285714,0.8935847391292475,1.0,2/11,5.23%,SPRY2;PROM2
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.5750475151447825,-0.9727347593942941,0.5223880597014925,1.0,1.0,4/8,14.20%,DTX3L;DDX11;KDM4D;PARP9
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4697337614125407,-0.9724510986972018,0.5294117647058824,1.0,1.0,13/44,21.02%,XBP1;CD81;FADD;GRN;NMI;IFI35;ZP3;HLA-DRA;HLA-DRB1;CD226;RIOK3;CCR7;CD46
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.4979556152821062,-0.9724433894135271,0.49206349206349204,1.0,1.0,4/25,8.94%,HYAL2;GPC3;SGSH;FUCA1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.5062651464362236,0.9724243548216169,0.4864864864864865,0.893828731208336,1.0,5/15,16.33%,ROBO1;ROBO2;BMPR2;ACVR2B;PKD2
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),0.5888240426558405,0.972102119986401,0.5238095238095238,0.8937608967303723,1.0,2/5,14.65%,ACP6;GPAT2
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.6302595396721336,-0.9720788694835025,0.5573770491803278,1.0,1.0,2/5,8.65%,COL9A3;FSHR
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.4764522769263638,-0.9719832586617208,0.4927536231884058,1.0,1.0,3/28,11.78%,SEMA3E;SEMA3A;MAG
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.6742779891800588,-0.9719064813302405,0.5967741935483871,1.0,1.0,2/5,6.99%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.4024146582542142,-0.9718181534197659,0.5147058823529411,1.0,1.0,14/81,20.69%,FTH1;FTL;CHMP2A;GOLGB1;VAMP8;ARF1;BLOC1S4;CLTA;RP2;HSPA8;GOPC;SCAMP3;AP1S1;NAPA
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5281885719526744,-0.9717820052777827,0.5194805194805194,1.0,1.0,5/16,21.38%,SFRP1;TXNDC15;TEDC1;PDCL;EVC
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5111834235149324,-0.9715385438001424,0.532258064516129,1.0,1.0,3/21,12.92%,TCN2;AMN;SLC2A2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.3629783656691071,0.9715363474085139,0.5217391304347826,0.8943934775297144,1.0,12/79,8.25%,FGFR1;FLT1;FGFR3;ALK;EGFR;PDGFRA;EPHA3;HNRNPU;IGF1R;DRD4;NTRK2;CD4
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.458704361796882,0.9715153789252384,0.41935483870967744,0.8937810343013434,1.0,3/23,6.74%,MTMR2;CTNND2;IGF1R
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.49799883236696896,-0.9713661289178963,0.5394736842105263,1.0,1.0,10/26,19.87%,HLA-F;HLA-E;HLA-A;RASGRP1;FADD;LAMP1;CD160;HLA-DRA;HLA-DRB1;CD226
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4195042150915163,-0.9712635733087853,0.5072463768115942,1.0,1.0,6/74,6.23%,RPS27A;SFRP1;VPS35;UBA52;FZD8;SFRP4
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.4975337874761805,0.9711882563905437,0.45454545454545453,0.8940436114327368,1.0,3/9,24.84%,PLA2G4C;CHPT1;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.31604981423555545,0.9711776440182787,0.36363636363636365,0.8934128847810849,1.0,61/401,11.57%,PDGFB;RELN;PTPN6;PDGFC;NUPR1;FGFR1;JCAD;IGF1;SPRY2;CASS4;FLT1;IRS1;FGFR3;SRC;PIK3R5;FGF17;EGFR;RELA;IQCJ-SCHIP1;MAP3K14;CPNE1;PDGFRA;CHD5;TICAM1;MFHAS1;CLEC7A;CX3CR1;AGER;NLGN1;PTP4A3;AKT2;SIRT1;TRAF2;NRG2;MIB2;SASH1;CASP10;TMEM106A;C18ORF32;IGF1R;HCLS1;ADAM8;NTRK2;WDR59;CD4;TGFB2;ADRA1A;MALT1;RICTOR;TNFRSF19;EEF1D;GAB1;USP15;RRAGD;NOS1AP;FGF1;RUNDC3A;ECM1;PRKD1;PIK3CA;PELI1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.4239481666051454,-0.9708699019614195,0.5,1.0,1.0,12/87,9.64%,CD44;GATA1;NOX4;PTK6;IL31RA;EFNA1;IL6R;CD81;PARP14;IL5;HAX1;TGFB1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4407671008950053,0.9708104788751298,0.43478260869565216,0.89368504831261,1.0,9/46,9.46%,ZAP70;LCP2;GNLY;PSTPIP1;PIK3R5;TMC8;HCLS1;CD4;IL2RA
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5006550114514658,0.97068944268738,0.43243243243243246,0.8932880848611494,1.0,2/13,8.82%,RUNX1;AEBP1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.3644170624742537,0.9706749518891203,0.47058823529411764,0.8926786206240654,1.0,19/112,9.30%,VDR;FGFR1;TNC;PCDH18;POSTN;PDGFRA;LRP4;HMCN1;LTBP2;ADAMTS2;EHD2;SSC5D;CDH11;COL14A1;LOX;HTRA1;COL6A1;COL5A1;NPNT
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.41011218269115285,-0.970559275220595,0.5375,1.0,1.0,21/73,22.82%,TMEM208;SEC11C;METAP2;KLK6;FAM111A;APH1A;ATP23;PCSK1;AFG3L2;MYRF;SPCS2;PRSS3;SPRTN;STOML2;CTSS;HJV;SPCS1;BACE1;FURIN;ADAM17;CTSL
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5073443198136276,-0.9698423571593258,0.5147058823529411,1.0,1.0,1/15,1.87%,BUB1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.5287726195909213,-0.9698260502598897,0.5352112676056338,1.0,1.0,1/14,0.69%,PPP1R17
prerank,"GO_Biological_Process_2021__complement activation, classical pathway (GO:0006958)",-0.6337761119473622,-0.96977897873184,0.5645161290322581,1.0,1.0,2/5,29.18%,C1S;C1QC
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.35834525394749434,-0.9697746373328862,0.5376344086021505,1.0,1.0,78/562,16.51%,CD44;ARHGEF16;APIP;GATA1;IL7;RPS27A;XBP1;SFRP1;IFIT2;RPL10;CLU;NEURL1;PRDX5;ANXA5;PTMA;RPS6;IL31RA;GSTP1;RPS3;APEX1;BCL2L2;VAV3;RPS3A;RASGRF2;HRK;PRELID1;UBA52;TMEM219;IFIT3;SFRP4;BCL2L14;NOP53;COPS5;RACK1;CALR;PAX8;PRR7;MYDGF;HTR2B;ZNF830;APH1A;PHB2;NAA38;ZNF622;HAX1;LANCL1;FADD;PINK1;DDAH2;TRIAP1;BEX2;OLFM1;STAT1;IFI6;HSPA5;CDK5;PPIF;CD27;PDCD2;CIDEB;PPIA;C1QBP;ARAF;PRAME;LGALS1;UBB;MTCH1;CFL1;FSTL1;FIGNL1;AVEN;RABGGTB;SEPTIN4;ANKLE2;UTP11;GREM1;TPT1;DNM1L
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.41009339746404644,0.9697160972437524,0.55,0.894479850068734,1.0,24/100,11.95%,ZNF423;NOS2;FRZB;GFAP;PTPRD;RXRG;ACKR1;L1CAM;NDRG2;ALDH1A1;CCDC3;PLPPR4;SORBS1;NTRK2;ADGRL3;SLCO1C1;MEGF10;AQP1;ALDH1A3;ZNF536;RCAN2;INTS6;NRXN1;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.5021836059071035,0.9696421156062662,0.53125,0.8939864583741114,1.0,2/11,10.87%,NOS2;STIM1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.6172809525532749,-0.9695469602966957,0.6428571428571429,1.0,1.0,2/5,21.86%,CD81;LGALS3
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.48901034435247653,0.9694554407603752,0.46875,0.8939093310372939,1.0,6/15,21.73%,ST8SIA6;FUT8;ST3GAL6;ST3GAL2;FUT9;FUT2
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.6288297548406103,0.9693629924585506,0.5853658536585366,0.8928289645504434,1.0,4/5,36.71%,KMT5B;KMT5C;BEND3;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.6288297548406103,0.9693629924585506,0.5853658536585366,0.8928289645504434,1.0,4/5,36.71%,KMT5B;KMT5C;BEND3;SMYD5
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.45847689922344115,-0.9692305015867066,0.5416666666666666,1.0,1.0,2/29,4.51%,IL7;IL6R
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.3524289252236599,0.969083342460213,0.3333333333333333,0.8927528257373512,1.0,31/162,15.77%,F2;LEPR;VEGFD;FGF17;EGFR;AGER;LIMCH1;PROM2;AKT2;SIRT1;NSMF;TNIK;NTRK2;CD4;WDFY2;ARRB1;C3;NOS1AP;FGF1;CAMTA1;SPPL3;RAPGEF3;P2RY1;TESK1;GPER1;FXR1;DYRK1A;NIBAN1;ACVR2A;PELI2;ASPSCR1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.4534847422688152,0.9689310731775311,0.4838709677419355,0.8924262409276223,1.0,8/15,21.08%,RUNX1;CD22;PTPN22;CBFB;NFAM1;ELF1;ELF2;SLC39A10
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.3897164442371602,-0.9687399507560365,0.47435897435897434,1.0,1.0,7/116,6.82%,TYRP1;TRPM1;PMP22;RHBDF1;HSPB8;FILIP1L;TNS2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.43890296776149956,0.9685902539493013,0.4,0.8924853145391388,1.0,7/25,18.28%,ICAM1;RAPGEF1;TJP2;AFDN;RAPGEF3;RAP1A;TJP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.6269326142651108,-0.9684725646342127,0.6140350877192983,1.0,1.0,1/5,2.74%,TGFBR2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.40550003760855974,0.9682533341807714,0.46875,0.8926116653472924,1.0,9/40,11.74%,CLDN15;CLDN9;GRHL2;FRMPD2;TBCD;DLG1;PARD6B;AFDN;ESAM
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5354329868668027,-0.9681148683455362,0.4915254237288136,1.0,1.0,1/11,3.35%,CFTR
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.4296615677360238,0.9680885865834696,0.5,0.8922666437053177,1.0,9/36,13.39%,SLC26A7;ANO4;CLIC5;SLC26A6;SLC13A4;ANO8;SLC26A9;ENPP1;CLCN4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.41394276095009175,0.967889738102879,0.6521739130434783,0.892210392428654,1.0,6/52,5.00%,STAB1;SPRY2;VASH1;ADGRB1;YJEFN3;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.5857152006748224,0.9678321044942184,0.5161290322580645,0.8916836956678932,1.0,2/7,25.42%,SERPINE2;HES1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.5933686353787104,0.9675435406572434,0.6,0.891714298712853,1.0,3/7,13.13%,DNMT3A;PCGF5;KDM1B
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.46861541673359025,0.9674744494056872,0.42105263157894735,0.891294177146878,1.0,1/27,0.07%,F2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.4698400660996054,0.9674397314215657,0.5428571428571428,0.8907309170782364,1.0,2/18,2.63%,HELLS;IFNA2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4850038438564642,-0.9671244446601978,0.4852941176470588,1.0,1.0,2/17,3.38%,JUP;MADCAM1
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.6372427314184839,-0.9667631100819237,0.5333333333333333,1.0,1.0,1/5,0.32%,BMP5
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4374379938647267,0.966627094313051,0.5806451612903226,0.8917483958541629,1.0,4/32,4.59%,TNNC2;TCAP;MYH3;MYH14
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4376022284941964,-0.9663323649293365,0.5571428571428572,1.0,1.0,10/51,22.15%,CCNB2;CHMP2A;REEP4;ANKLE2;CHMP3;CHMP7;EMD;RAN;CHMP4B;KPNB1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5965048024184648,0.9662065896671638,0.46153846153846156,0.8920754948490982,1.0,1/5,1.49%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.6017218228830885,0.9661006744416233,0.5365853658536586,0.8910370468533428,1.0,3/6,20.59%,MAPRE2;MAP4K4;PIK3R1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.6017218228830885,0.9661006744416233,0.5365853658536586,0.8910370468533428,1.0,3/6,20.59%,MAPRE2;MAP4K4;PIK3R1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.6060406935855691,-0.9654335598814591,0.5714285714285714,1.0,1.0,5/9,20.52%,XYLT2;B3GALT6;B4GALT7;CHST9;B3GAT2
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.6048605208492319,0.9652480633907999,0.5384615384615384,0.8916426954611066,1.0,2/5,8.05%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.6048605208492319,0.9652480633907999,0.5384615384615384,0.8916426954611066,1.0,2/5,8.05%,HSPA1A;HSPA1B
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.4617455513304868,0.9646652673665108,0.5555555555555556,0.8922166273584458,1.0,5/14,28.43%,PANK1;PANK3;PANK4;PPCDC;ACOT7
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5208318506589229,0.964636819677098,0.5277777777777778,0.8903845319557482,1.0,2/11,11.25%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.5208318506589229,0.964636819677098,0.5277777777777778,0.8903845319557482,1.0,2/11,11.25%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5208318506589229,0.964636819677098,0.5277777777777778,0.8903845319557482,1.0,2/11,11.25%,ESPL1;NSMCE2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.4698390760855362,-0.9645184438903345,0.5211267605633803,1.0,1.0,7/25,22.82%,FADD;CIDEB;PRSS3;F11;CYFIP2;FURIN;CTSL
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.44325688839355837,0.964408543589965,0.5151515151515151,0.8902446196470553,1.0,5/23,9.50%,KYAT1;DAO;IDO1;KYNU;CBS
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5252998806181596,-0.964306526224229,0.5833333333333334,1.0,1.0,2/12,16.14%,SFRP4;CD160
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.4184411012459718,-0.9641983254696674,0.5,1.0,1.0,17/75,20.98%,CLU;RPS3;SYNPO2L;VIL1;BAIAP2L2;ANKRD53;STMN2;LMOD1;KATNB1;EDN1;DCTN1;CFL2;APOE;WDR1;PFN2;CDC42EP1;CCR7
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.5808169142386234,-0.9641013906653565,0.5344827586206896,1.0,1.0,3/9,21.62%,PPP1R3D;PPP1R3E;INPP5K
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5905540112436741,-0.9639312265880956,0.5689655172413793,1.0,1.0,3/10,8.94%,CORO1B;ARF1;VIL1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.4418812134338837,-0.9638027097245166,0.5641025641025641,1.0,1.0,15/51,16.78%,HSPE1;DDX18;NOP16;MCM4;GRWD1;CDK4;NOC4L;WDR74;MYBBP1A;IMP4;MRTO4;PLK4;RABEPK;MCM5;NIP7
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3342609293495402,0.963589629773094,0.47058823529411764,0.8914351201198301,1.0,16/148,6.15%,ZAP70;ZDHHC11;COLEC11;NOS2;KLRD1;SRC;DMBT1;RELA;TRIM35;MFHAS1;CLEC7A;CX3CR1;AGER;FRK;SNCA;CYBA
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5449327379763463,-0.9635838789166106,0.55,1.0,1.0,3/13,14.59%,PTK6;NLRP12;OPRM1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.6175121371494583,-0.963554877256083,0.5846153846153846,1.0,1.0,1/6,4.90%,MESP1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.4402402542798959,0.9632273040381514,0.5,0.891598504110865,1.0,6/16,19.35%,P2RX7;PLEKHA7;NDC1;AFDN;AHCTF1;NUP98
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.40055367111516926,0.9630733067424341,0.47619047619047616,0.8913916179399052,1.0,19/102,9.29%,PDGFB;IGF1;IRS1;PASK;EGFR;PIWIL2;CPEB3;PLD1;DNA2;AKT2;SIRT1;SAMD4A;GLI2;SORBS1;TMEM106A;STN1;PRR16;TGFB2;NFKB1
prerank,PanglaoDB_Augmented_2021__Neurons,0.3320042263346003,0.9629037483555913,0.5,0.891147094924603,1.0,51/264,13.86%,IGF1;LUZP2;CBARP;KCNQ2;CELF3;CTNNA2;CNTNAP2;MMD2;SCRT1;GNL3L;VGF;TMEM191C;PSD2;STX1A;NPY;NCALD;CACNB4;ADGRB3;RIN1;SPOCK3;SAFB2;AMER2;HAP1;MATK;OLFM3;PNCK;TESC;NECAB2;NXPH1;SNAP91;CACNA2D1;GRM3;NCAN;NBEA;AQP1;NWD2;CTTNBP2;UNC13A;CADPS;RNF220;FBXW7;UNC79;ACSL4;NRXN1;SLC8A2;SLC32A1;SACS;TRIP11;CADM2;PNISR;KCNMA1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.49759031188572733,0.9628912662341395,0.6216216216216216,0.8905428650760221,1.0,4/10,20.76%,SLC7A9;SLC6A13;PDPN;SLC5A6
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4419331974708667,-0.962534803088057,0.4675324675324675,1.0,1.0,4/51,10.07%,SLC8A3;SFRP1;NOP53;PINK1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6294822547247418,-0.9623589193526277,0.5806451612903226,1.0,1.0,1/6,7.51%,MTHFD1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.5925657964653563,-0.9623266609318356,0.546875,1.0,1.0,3/8,15.72%,TRIM25;PHB2;RNF135
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.4257243369733196,-0.9620504722386539,0.5189873417721519,1.0,1.0,1/70,0.05%,SLC28A2
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.4789905339807274,-0.9620086974595115,0.5789473684210527,1.0,1.0,5/20,20.98%,TGFBR2;TGFB1;SOD1;ADH6;CCR7
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.4630313081109193,-0.961912319179339,0.4931506849315068,1.0,1.0,12/36,27.89%,CEP131;IFT122;DYNLRB1;IFT81;DYNLRB2;DYNLL1;DYNC2H1;DYNC2I1;IFT22;WDR35;KIF3A;DYNC2I2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.41325650896179256,-0.961860443368249,0.5405405405405406,1.0,1.0,6/86,8.14%,ARHGEF16;PDZK1;RHOG;CD81;CEMIP;HRAS
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.5581368682164054,0.9618399084262348,0.5365853658536586,0.8926095537981342,1.0,3/6,18.81%,SNCA;CHRM3;BCL2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5445143038027225,0.9615736995669945,0.5853658536585366,0.8924782333679644,1.0,6/15,17.44%,ISYNA1;IP6K2;IPMK;ACER3;FGF2;ITPKC
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.5915074439840794,-0.9615604424282924,0.5370370370370371,1.0,1.0,3/7,35.88%,CAV1;GLA;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.5915074439840794,-0.9615604424282924,0.5370370370370371,1.0,1.0,3/7,35.88%,CAV1;GLA;PTGIS
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.46099048559233724,0.9614911080807513,0.5,0.8920350768260535,1.0,3/15,18.66%,ADAMTS9;FBXO2;NEU4
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.570372419251494,-0.9613835642866344,0.5846153846153846,1.0,1.0,2/11,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.6145456142698841,-0.961230743628436,0.5714285714285714,1.0,1.0,1/5,27.72%,MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.551331172079523,0.9610810584031679,0.5555555555555556,0.8921688992676995,1.0,5/8,24.39%,PRKCE;CAMK2D;NEDD4L;STK39;HECW2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.4244249123016072,0.9609614087946247,0.3333333333333333,0.8918587633023457,1.0,10/28,21.62%,PTCH2;PKD2L1;GLI2;ULK3;HIPK2;TTBK2;PTCHD1;MAP3K10;KIAA0586;SMO
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.41307494894423885,-0.9608489728525795,0.52,1.0,1.0,23/73,17.96%,SLC8A3;MT1E;MT2A;SLC24A5;CALR;LCK;HTR2B;SLC24A1;RGN;TMCO1;RMDN3;SLC39A7;STOML2;EDN1;SLC39A6;MT1G;SLC41A1;MT1M;TPT1;TPCN2;HTR2A;ATP2C2;TRDN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.41500541123971774,0.9607542525083711,0.48484848484848486,0.8916434130815598,1.0,1/29,0.84%,TP63
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.57227622527696,0.9606967584217091,0.5151515151515151,0.8911549269765453,1.0,1/8,6.23%,PKD2L1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.4623600968981123,-0.960422817715444,0.5733333333333334,1.0,1.0,4/32,8.56%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5623598123191991,0.9602805017058171,0.4358974358974359,0.8916281904934681,1.0,1/5,4.97%,AFG1L
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5994648555455138,-0.9600187418795068,0.5625,1.0,1.0,1/8,7.03%,METAP2
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.6054406547738606,0.9596954328526686,0.4883720930232558,0.8924020989417496,1.0,5/6,37.51%,ST3GAL2;ST8SIA3;ST3GAL1;ST6GAL1;ST6GALNAC2
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.4387501670485304,-0.9594124609339634,0.5616438356164384,1.0,1.0,2/49,1.48%,BMP5;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5843706496879589,-0.9593189652853273,0.5932203389830508,1.0,1.0,2/7,16.90%,PIP;ORMDL3
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.48469119235412045,-0.9589300657688828,0.5441176470588235,1.0,1.0,2/22,5.49%,RPS27A;UBA52
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.5773177390921128,0.9588281483294097,0.5,0.8937018460732293,1.0,1/7,7.34%,AK4
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5901326094662129,0.9586210512527935,0.5789473684210527,0.8935423798931749,1.0,3/7,24.06%,TGFB2;NRG1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5383492916568836,0.9585657595667202,0.4642857142857143,0.8930448745495932,1.0,4/9,22.34%,RELA;NFAT5;FUT9;MDK
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5368779990005199,-0.9585119393651943,0.5538461538461539,1.0,1.0,4/9,28.17%,CADM4;PTPN1;HGS;NEDD4
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.35198486815236213,0.9583392114107577,0.4166666666666667,0.8929236431074395,1.0,17/108,9.91%,RUNX1;IL1RAPL1;PBX3;SPOCK1;ALK;CTF1;ATOH8;PTPRD;NLGN4X;ASCL1;PBX1;GLI2;NTRK2;VAX2;TGFB2;WNT3;SNPH
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.34375822662060934,0.9577709853101053,0.5714285714285714,0.8934969294538382,1.0,22/124,14.74%,ADGRB1;CTNNA2;CPNE1;CNTNAP2;LRP4;NLGN1;CTNND2;PLPPR4;DOCK7;ALCAM;TNIK;SGK1;DSCAML1;DICER1;CELSR2;PARD6B;MAP4K4;DCDC2;NTNG1;TRIO;PTEN;RYK
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4671037227346977,-0.9573997022110916,0.47761194029850745,1.0,1.0,3/22,10.13%,TPP1;TGFB1;USE1
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.3867631011071892,0.9573826626114473,0.45161290322580644,0.8937037344188947,1.0,4/48,7.82%,REP15;SNCA;PICALM;ARRB2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.5594164143986298,-0.9570923747973331,0.5454545454545454,1.0,1.0,3/8,21.25%,GPR183;CCR7;ALOX5
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.5379075047068685,-0.9570741109057055,0.6029411764705882,1.0,1.0,3/15,2.77%,DUOX1;PRDX1;PRDX5
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.5760339854033507,0.9567372581836968,0.5,0.8944537207962793,1.0,2/6,16.66%,PSPH;SRR
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.5930673635735654,-0.9567108497849075,0.5737704918032787,1.0,1.0,1/6,3.45%,PDZK1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.6370433423798607,-0.9564469867317152,0.576271186440678,1.0,1.0,1/5,1.62%,DTX3L
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.4877991491953119,0.9562589600499684,0.47619047619047616,0.8949498519370505,1.0,4/11,11.11%,OXTR;GUCA1B;SLC22A2;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.36142169038659466,-0.9560167312157899,0.6046511627906976,1.0,1.0,29/251,14.51%,ARHGEF16;DDIT3;RPS27A;SFRP1;IFIT2;CLU;NEURL1;RPS6;RPS3;VAV3;RASGRF2;HRK;PTRH2;UBA52;SFRP4;BTG1;RACK1;PRR7;APH1A;ZNF622;FADD;GRN;OLFM1;CDK5;PDCD2;C1QBP;MYBBP1A;UBB;MTCH1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.4821810467437552,-0.9556632372133896,0.5294117647058824,1.0,1.0,3/21,5.30%,DDX4;BTBD18;ZSCAN21
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.29255509526098794,0.9553226373259436,0.6666666666666666,0.8962968017648798,1.0,97/744,11.53%,CREB3L1;VDR;PDGFB;ZNF423;TP63;DACH1;ZBTB1;RUNX1;SNAI1;SPINDOC;ATXN1;PLK1;ZGLP1;IFNA2;TBX6;ZNF366;GMNN;HDAC4;ATOH8;HAMP;RELA;RFX3;HDAC10;BACH1;CPEB3;CNOT2;HIC2;DLX1;SCRT1;ID1;HNRNPU;SAMD13;ZNF202;FOXK1;FRK;ZNF706;ASCL1;LEF1;BATF3;YAF2;ZBTB16;WWOX;SIRT1;TBL1XR1;SNCA;SFMBT2;SMARCA2;HMX1;GLI2;FOXN3;ETV5;ZBTB2;BMP6;FNIP2;ZNF93;HMBOX1;ZHX2;PHF10;PHF21A;ZNF778;ARID5A;ZFP69B;NOTCH4;TAF3;NRIP1;OTUD7B;ZEB2;JAZF1;PHC3;ZNF785;DMRT1;AEBP1;SMYD2;MLXIPL;NPAS1;CDKN2A;NFKB1;TRPS1;BAHD1;RARG;PURA;ZNF536;MITF;DICER1;DNMT3A;KLF11;SOX30;SMAD4;MNT;PTPRK;LCOR;DLG1;THRB;HDAC9;SMURF2;UHRF1;ZNF318
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.48088651089893875,-0.9551795192219081,0.5217391304347826,1.0,1.0,2/34,2.51%,SFRP1;JUP
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3777556098889227,-0.9549394934337153,0.5375,1.0,1.0,10/142,8.21%,ARHGEF16;SFRP1;TAX1BP3;ARHGAP42;USP6;RHOG;RACK1;RASGRP1;HRAS;DOCK8
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.47930859772973067,-0.9547682771818281,0.582089552238806,1.0,1.0,1/27,0.32%,BMP5
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.643184442448866,-0.9545853004202408,0.5294117647058824,1.0,1.0,1/5,11.11%,PSMC3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.36017132698875387,0.9545493706264864,0.4375,0.8973987735053705,1.0,4/64,7.39%,VAPB;SPTSSB;STX1A;REEP1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.45788628725559993,0.9545336072781909,0.45161290322580644,0.896798566359128,1.0,4/25,5.20%,ARAP1;AGRN;NLGN1;DPYSL3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.4417486294518161,0.9542368339618473,0.47368421052631576,0.8968248217890329,1.0,6/21,21.29%,ATP11C;ATP10A;ATP8A1;ATP10D;ABCC1;ATP11A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.5321994399131824,0.9540360856593663,0.5510204081632653,0.8966644128763781,1.0,2/7,10.49%,MFHAS1;BPIFB1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5908910208305589,0.9539279042355457,0.6176470588235294,0.8963084000391274,1.0,3/6,27.35%,CD274;TWSG1;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.3760344891946675,0.9538056232301252,0.5,0.8959342397563617,1.0,10/62,10.87%,NUPR1;CDK6;PLK1;GMNN;TRIM35;DUSP1;CDKN2A;HECA;BRINP3;PTPRK
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.39419742998835017,-0.9537391338656593,0.5581395348837209,1.0,1.0,11/88,16.74%,CLU;C4BPB;GPC3;C4BPA;RASGRP1;VPS28;TGFB1;SNF8;MAPK7;DACT1;APOE
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.39759042716944853,0.9537309349813651,0.45454545454545453,0.8953743504055744,1.0,11/54,12.45%,HSD17B7;CLN6;SULT2A1;SOAT1;OSBPL1A;DHCR7;SULT2B1;HMGCR;HMGCS1;MVD;LCAT
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.3935364231730749,-0.9527314870112638,0.4927536231884058,1.0,1.0,15/78,18.68%,SIGIRR;SELENOS;VPS35;CXCL17;GPS2;C1QBP;TNFRSF1A;NMI;NLRP12;MAPK7;RNF26;APOE;SERPINE1;TEK;MMP26
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3041715214200419,0.9526332239939751,0.5,0.8971975080635571,1.0,71/363,15.24%,IL1RAPL2;RELN;PDGFC;NPAS2;ADGRB1;KCNQ2;EFNB3;SPOCK1;ATXN1;FGF17;TBX6;HDAC4;VCAN;LIMK1;GRHL2;GLRB;ADGRA2;L1CAM;NLGN1;ASCL1;ZBTB16;IGF2BP2;MBNL1;PKD1;ADORA1;OBSL1;HAP1;CHD7;DPYSL4;ST8SIA4;ADGRB2;UGT8;ROBO1;TRPC5;DSCAML1;ZEB2;NHEJ1;VAX2;GFRA1;ADGRL3;SCIN;NPAS1;NCAN;FBXL17;CELSR1;GDNF;CHRM3;TEAD1;HMGCR;NRXN1;CDH2;GPM6B;NLGN3;MERTK;NAV1;CHST8;ROBO2;FGF13;TMOD2;SHANK2;JRKL;PTEN;RPS6KA6;DCX;DYRK1A;RYK;ATXN10;NAV2;PSPN;CRIM1;ACVR1C
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5236192617611201,-0.952452635705709,0.5070422535211268,1.0,1.0,3/17,19.19%,MAGEF1;CGAS;POLQ
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.5104995273463714,0.9524094008647285,0.5357142857142857,0.8971396870858949,1.0,1/12,2.66%,AIFM2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.5730223611816255,-0.9519651400585388,0.5909090909090909,1.0,1.0,1/8,4.37%,GBA3
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.45534356491262284,0.9517586209799394,0.4411764705882353,0.8978532650912793,1.0,4/14,19.35%,XPO1;ANP32A;HMGA1;NUP98
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.45221485521148785,0.9516421251879301,0.5,0.8974607549283954,1.0,2/21,1.41%,CGNL1;ARAP1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.6369236076474154,-0.9516000658884153,0.5932203389830508,1.0,1.0,2/5,26.34%,TMLHE;ALDH9A1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.6369236076474154,-0.9516000658884153,0.5932203389830508,1.0,1.0,2/5,26.34%,TMLHE;ALDH9A1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3840156552509286,-0.95155089272624,0.5697674418604651,1.0,1.0,28/164,15.99%,GAPDH;TYMS;RPL5;RPL10;EIF1B;RPL13A;RPS3;RPS4X;MIF4GD;RBM3;RACK1;CALR;EIF5B;EIF1;LARP6;EIF3D;EEF2;RPS27L;PATL2;EIF2B2;NCL;RBM4B;PYM1;EIF4A3;ILF3;CIRBP;EIF2B4;METTL3
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.4938366014419024,-0.9513590134130832,0.5,1.0,1.0,7/21,13.89%,STMN1;STMN2;KIF18A;TPPP3;STMN3;KATNB1;MAP7D3
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5256850868497163,-0.9513447439157818,0.509090909090909,1.0,1.0,4/13,11.01%,MADCAM1;GCNT1;SELE;SELP
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.36238607536734063,0.9512842140233808,0.5185185185185185,0.8975049555117354,1.0,24/100,15.92%,FRZB;TMEM98;ABCC8;PTPRD;CELF3;SOWAHA;ALDH1A1;PLPPR4;TMEM47;ASXL3;GLS;TOX3;CACNA2D1;MAPK10;MAFB;CADPS;RCAN2;SEMA6D;ARX;RIMBP2;GPC6;NFASC;RAPGEF4;NOL4
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.5974251154228908,0.9512780632157374,0.5641025641025641,0.8968999207754007,1.0,4/6,25.10%,NLGN1;GPER1;BAIAP3;STX1B
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.5946990290550136,-0.9512098193887446,0.5087719298245614,1.0,1.0,2/6,12.06%,IRF1;MAPK8IP1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.37490797162994616,0.9506766010550938,0.5357142857142857,0.8975839076980959,1.0,8/104,7.92%,F2;VAPB;MAIP1;MCUB;SLC24A3;ATP13A1;DRD4;TRPC5
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.5015420302003664,0.950449027494661,0.5263157894736842,0.8974241860117776,1.0,2/9,10.70%,RFWD3;FEM1B
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.47069427141162756,0.9503863842223488,0.5454545454545454,0.8969592701003142,1.0,6/16,25.11%,MYO5B;MYO1D;MYO1B;MYO7A;MYO5A;WASL
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3558192216439291,0.9503233262771184,0.47368421052631576,0.8965042374909324,1.0,15/114,8.90%,PTPN6;LIFR;IL1RAPL1;SRC;IRAK2;HDAC4;PTPN20;RELA;LEF1;DPYSL3;SNCA;IRAK3;HCLS1;KYNU;AKAP6
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.44971877274758465,0.95012206921283,0.48484848484848486,0.8957161012906455,1.0,4/15,16.83%,OGT;KANSL2;JADE2;JADE3
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.44971877274758465,0.95012206921283,0.48484848484848486,0.8957161012906455,1.0,4/15,16.83%,OGT;KANSL2;JADE2;JADE3
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.554620941211372,0.9499958476998155,0.525,0.8953736018797377,1.0,1/7,4.03%,MTMR2
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.5347804412651276,0.9499257456386454,0.5641025641025641,0.8949577814021226,1.0,2/6,19.62%,SLC25A33;ABCC11
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.41892414657262544,0.9498806458899773,0.5925925925925926,0.8944227037588658,1.0,10/41,10.79%,ZNF423;PLCL2;ID1;PLCL1;ALDH1A1;NPR3;CCDC3;DOCK7;TLE3;ARRDC3
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.39585955589750804,-0.9498595860238591,0.5466666666666666,1.0,1.0,26/88,19.91%,PSMB8;PSME1;PSMB6;PSMC5;PSMD8;PSMD7;TMSB4X;PSMD3;PSMC3;TXNDC17;STAT1;ILK;CD27;TNFRSF1A;EIF5A;PSMA4;TNFSF9;PSMA7;PSMD2;PSMD6;PSMB2;PLVAP;PSMB4;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.6141183027012845,-0.9495795846547981,0.6031746031746031,1.0,1.0,3/6,14.41%,ADH4;CYP3A4;LDHD
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.4674618951245129,-0.9495169975508466,0.5692307692307692,1.0,1.0,8/35,22.29%,GSAP;VPS35;SNF8;MAPK7;CENATAC;APOE;TMEM9;FURIN
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.5763477875760211,0.9494862241447096,0.5,0.8949476049149779,1.0,3/6,16.72%,TGFB2;ZFPM2;SOX4
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5617930288201751,-0.9491526392813789,0.5714285714285714,1.0,1.0,1/7,2.91%,TIMP1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.6360456656935033,0.9490998285325876,0.6274509803921569,0.8953429281617913,1.0,1/5,4.06%,PLD1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.37002251186421387,0.9490864550743232,0.55,0.8947810836950376,1.0,21/108,8.96%,ZNF423;LIFR;FRZB;PCDH18;EFNB3;TMEM98;LRP4;DPYSL3;PBX1;GLI2;OBSL1;TMEM47;EPB41L1;AGAP1;CDH11;CHST3;MEIS3;GFRA1;ADGRL3;NUAK1;CACNA2D1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.40496462467361716,0.9490080446452741,0.5,0.8943394993119902,1.0,1/41,0.11%,B3GNT6
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.4685127340257691,0.9489295257351458,0.47058823529411764,0.8938985136874281,1.0,4/14,12.30%,SNAI1;SIRT1;BAHD1;LOXL2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4304651958699939,-0.9488705753247103,0.5333333333333333,1.0,1.0,5/62,6.43%,RHOC;ACTG1;SFRP1;STMN1;SYNPO2L
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.4125887445763399,0.9488292677996185,0.5652173913043478,0.8935499223911297,1.0,3/32,2.76%,F2;CD59;C6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.49459808922236526,-0.9487443979306468,0.5645161290322581,1.0,1.0,5/19,13.48%,SLC8A3;PHB2;AFG3L2;PMPCA;STOML2
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.48970299179408533,0.948730722944246,0.4722222222222222,0.8931467623394026,1.0,8/20,17.06%,ERRFI1;DNAAF1;PKD1;GLI2;FGF1;CHI3L1;RCN3;FGF2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.4954617862029943,0.9481435603156843,0.5476190476190477,0.8938717204368657,1.0,3/13,12.84%,SLC2A9;SLC2A5;SORT1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.3625342916871879,-0.9479039516271629,0.6436781609195402,1.0,1.0,54/316,19.91%,PSMB8;DDIT3;XBP1;DTX3L;PSME1;PSMB6;PSMC5;RAD23A;PSMD8;PSMD7;ADRM1;KCTD2;TRIM13;UBXN1;RNF8;TRIM25;ARIH2;VPS28;RBX1;PINK1;TOM1L1;PSMD3;WDR91;PSMC3;RNF5;PPP1R11;RMND5B;KAT5;PRAME;ANAPC15;KCTD5;PSMA4;NHLRC1;CDC34;UBE2D4;RNF167;UBL7;ZFAND2B;RNF213;HECTD3;RNF111;PSMA7;PSMD2;SPSB3;ZFAND2A;PSMD6;PSMB2;CBLC;ERCC8;PSMB4;CDC23;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.4470799848206063,0.9476143061417152,0.5789473684210527,0.8944124770260589,1.0,2/24,1.41%,CGNL1;ARAP1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.3777267021070354,-0.9473762298264091,0.5517241379310345,1.0,1.0,33/170,19.97%,CD44;STMN1;LDHA;XYLT2;GALK1;POLR3K;B3GALT6;GPC3;TALDO1;B4GALT7;GALE;HAX1;PRPS1;HSPA5;AKR1A1;PPIA;TPI1;PYGL;MDH2;KDELR3;ISG20;MDH1;GLRX;CHPF;TXN;TPBG;IL13RA1;LDHC;SOD1;AGL;GAPDHS;ALDOB;PGAM1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.418171242738999,-0.9473608531990952,0.5362318840579711,1.0,1.0,1/36,0.32%,BMP5
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5610315142084792,-0.9472075797934285,0.6,1.0,1.0,1/10,2.92%,STX19
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.4246502715094937,-0.9471268893434762,0.6410256410256411,1.0,1.0,14/89,19.89%,GBP2;RPL11;RPF2;NOP53;CALR;PHB2;ARL2BP;PTTG1IP;PAF1;APPL2;XPA;CSE1L;RAN;NUP50
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.40273352962405706,-0.9470782890261016,0.5774647887323944,1.0,1.0,12/97,12.63%,GPX4;XBP1;ACOT2;ACSM6;OXSM;ACOT1;SLC27A5;NDUFAB1;SGPL1;ACBD5;ACSBG2;ACSM3
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.3369511501424322,0.9470405773116648,0.5,0.8951813745814626,1.0,29/118,12.95%,KCNQ2;EFNB3;GFAP;CELF3;DLX1;SCRT1;NPAS3;ASCL1;CTNND2;RND3;P2RX7;IGF1R;PCDH8;SEMA5B;CAMKV;NXPH1;MEIS3;ADGRL3;CACNG4;TOX3;SNAP91;NCAN;MEGF10;ZNF536;MGAT5;GPM6B;SLC8A2;SRRM3;ARX
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3588316239419769,0.9468680201514457,0.5416666666666666,0.8949611755712975,1.0,13/50,13.11%,IGSF11;HMCN1;L1CAM;PKD1;OBSL1;CDH4;ROBO1;DSCAML1;CADM1;CELSR2;PLXNB2;CDH2;ROBO2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4182736320570215,0.9468372227935942,0.4,0.8944212857362885,1.0,28/60,25.32%,GALNT3;CDK10;NLK;TNKS;ACVR1;PRKD1;GALNT2;DYRK3;GALNT16;HIPK2;DYRK1A;HIPK3;GSK3B;SBK1;CAMK2D;MAPK8;GALNTL6;WNK1;GALNT11;MAP3K10;MARK2;PRKCA;STK39;PDPK1;CSNK2A1;OXSR1;DYRK2;CAD
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.37451817576671986,0.9463345597139137,0.42105263157894735,0.8949053951063195,1.0,33/118,21.83%,ZBTB1;KAT2A;SNAI1;HDAC4;HDAC10;SIRT1;SMARCA2;BRWD1;KDM4C;FAM47E;ARID1A;SMARCD2;LOXL2;SMARCD3;SMARCAD1;KAT2B;ATRX;PHF1;EHMT1;HDAC1;SETDB2;RSF1;SMARCC1;SATB2;HDAC3;BAZ2B;PBRM1;PHF19;HP1BP3;CHD1;DR1;SMARCE1;ZBTB7A
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6189405025893797,-0.9461991456877833,0.6461538461538462,1.0,1.0,2/7,9.20%,ARF1;SLC24A1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5351753891174602,0.9461930705566123,0.5675675675675675,0.8946493064422448,1.0,4/11,13.09%,CORO2B;SLC38A2;DYRK3;ADCY8
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.4941895934484438,0.9460879101894566,0.48717948717948717,0.8943023222361228,1.0,5/11,26.56%,OGT;KMT2D;TET2;KMT2A;TET3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.483472581701107,-0.9460444085724635,0.5,1.0,1.0,3/21,8.14%,PDZK1;CEMIP;HRAS
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.4100966521452756,-0.9458338679826959,0.5466666666666666,1.0,1.0,15/82,13.80%,GBP3;HLA-C;TNFAIP2;DTX3L;ANXA5;MARCKSL1;LRP10;GRN;PARP12;CEBPD;TBC1D2;NFIC;TNFRSF1A;AHR;HELZ2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.45444548312445915,0.9457729614793198,0.5142857142857142,0.8943387570131363,1.0,3/15,8.80%,SRC;ABHD2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5269757251122141,-0.9456728259405829,0.5873015873015873,1.0,1.0,2/11,17.09%,CORO1B;SERPINE1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.5832941383645287,0.9455720074050895,0.5897435897435898,0.8941655720179428,1.0,2/6,18.76%,GRIN1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.4146085718231969,0.945518047248347,0.5135135135135135,0.8936466051359022,1.0,13/29,20.02%,IRS1;FOXK1;AKT2;SIRT1;OGT;GPLD1;RUBCNL;PDK4;SLC45A3;FBP1;ZNF692;PDK1;MLYCD
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5752949513532248,-0.9454716486314088,0.5862068965517241,1.0,1.0,5/10,21.21%,SRI;CALM3;TRDN;CAV1;CALM1
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.6080662442745264,-0.9451798886725339,0.6111111111111112,1.0,1.0,1/5,3.45%,PDZK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.40717812972419976,0.9451229898020919,0.4838709677419355,0.893883596621283,1.0,8/29,11.43%,HSPB1;CLEC7A;AGER;TMEM106A;P2RX7;TRIM16;MALT1;STMP1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5768650904955465,0.9450447673721512,0.6538461538461539,0.8934382629976153,1.0,5/9,17.68%,ACVR1;ACVR2B;ACVR1C;ACVR2A;SMAD2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.4633155159803475,0.944772050149849,0.5116279069767442,0.8934024564865927,1.0,5/21,6.44%,IGF1;IRS1;PASK;AKT2;SORBS1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4251381911613453,0.9441907802999029,0.45714285714285713,0.8941204406514074,1.0,3/24,5.48%,ACADVL;FOXK1;SIRT1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5682214900085014,-0.9441754921226537,0.5757575757575758,1.0,1.0,3/10,20.84%,DCK;DCTD;ERH
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5910926169971711,0.9441182947216074,0.6571428571428571,0.8936939935436768,1.0,3/7,5.40%,RFX3;CFAP53;DNAAF1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.4133398812928077,-0.9436598895942786,0.5316455696202531,1.0,1.0,21/88,19.81%,DCTN3;SSNA1;TUBB4B;RAB11A;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;SCLT1;CEP72;DYNLL1;DCTN1;PLK4;CEP135;CC2D2A;PRKACA;CEP41;TUBB;NPHP1;TUBA4A
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5021568988483565,-0.9434681649760011,0.5223880597014925,1.0,1.0,2/15,11.37%,DUOX1;STAT1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4517944322824833,-0.9433813496791225,0.547945205479452,1.0,1.0,11/44,17.38%,SFRP1;GPC3;RACK1;FUZ;GLIS2;TXNDC15;IFT122;IFT81;INTU;TEDC1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.3776174639228309,0.9429923113248805,0.4838709677419355,0.8958890814756171,1.0,5/35,6.11%,ADGRB1;EGFR;BANP;SNCA;IRAK3
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5591734800715343,-0.9426673356504387,0.5573770491803278,1.0,1.0,2/8,14.47%,VAMP8;EDN1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.3959134345617911,-0.9425023889977541,0.5616438356164384,1.0,1.0,28/103,26.00%,GAPDH;NRBP2;VPS35;RRAGA;TRIM13;LAMTOR5;PINK1;CDK5;CAPNS1;SUPT5H;LAMTOR1;ATP6V1E1;ATP6V1E2;RRAGC;ATP6V1D;PRKACA;ATP6V1C2;SNX6;LAMTOR2;BNIP3;EXOC7;UCHL1;SNX32;SMCR8;ATP6V1G1;DCN;SCOC;LAMTOR4
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5155760660231039,-0.9424519206080522,0.5409836065573771,1.0,1.0,2/12,12.79%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.5029383578292171,-0.9422636384517007,0.5972222222222222,1.0,1.0,1/17,0.46%,GATA1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6095416655519482,-0.9422452125114559,0.5882352941176471,1.0,1.0,2/5,35.65%,GNPAT;DHRS7B
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6095416655519482,-0.9422452125114559,0.5882352941176471,1.0,1.0,2/5,35.65%,GNPAT;DHRS7B
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4666283894166039,0.9416561288091919,0.5294117647058824,0.898054043793481,1.0,2/14,6.58%,SRC;ABHD2
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.486097423700488,0.9413996621563494,0.5,0.8967620500613862,1.0,5/11,28.43%,PANK1;PANK3;PANK4;PPCDC;ACOT7
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.486097423700488,0.9413996621563494,0.5,0.8967620500613862,1.0,5/11,28.43%,PANK1;PANK3;PANK4;PPCDC;ACOT7
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.486097423700488,0.9413996621563494,0.5,0.8967620500613862,1.0,5/11,28.43%,PANK1;PANK3;PANK4;PPCDC;ACOT7
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.5410830240604466,-0.9413310018539494,0.5625,1.0,1.0,1/12,6.20%,WWC2
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.4985916994505927,-0.94130939096822,0.5714285714285714,1.0,1.0,2/14,7.59%,MT2A;ARF1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.641059958837259,-0.9412030472121571,0.7049180327868853,1.0,1.0,3/5,32.49%,BAX;APAF1;CYCS
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.5361186814656586,-0.9411310386595779,0.576271186440678,1.0,1.0,3/11,10.12%,IRF4;HLA-E;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.4179081394562686,0.9410373843316653,0.45161290322580644,0.8968507609254138,1.0,12/36,19.05%,NPAS2;NEK4;SMYD2;RFWD3;FEM1B;SMG1;FXR1;BCLAF1;POLH;ABL1;MAPT;ANKLE1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.5295432298565215,-0.9409489306004792,0.6031746031746031,1.0,1.0,1/14,3.93%,FABP3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.321978151503194,0.9408060606964705,0.6521739130434783,0.896740631824296,1.0,45/196,14.35%,RELN;TP63;JCAD;IGF1;IRS1;SRC;HOMER1;ARNT;TMEM108;KLK14;NLGN1;MAML2;SIRT1;SASH1;SORBS1;BMP6;TPD52L1;TRIM16;HAP1;MN1;NOTCH4;ROBO1;CRADD;NECAB2;DLL1;TGFB2;C3;FGF1;ULK3;RAB34;MGAT5;NRXN1;GRIN1;TRIM44;NLGN3;CD80;DCDC2;KANK1;ZRANB1;TSPAN14;KAT2B;GPER1;PRKCZ;PTEN;GKAP1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.39843816010561056,-0.9407095549646055,0.5609756097560976,1.0,1.0,15/104,12.91%,NOX4;SELENOS;PRDX1;PRDX5;GSTP1;RPS3;ROMO1;CHCHD2;TXNRD2;PINK1;BRF2;GPX7;RBM11;PARP1;PPIA
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.3682359729867974,-0.9406033534311584,0.6263736263736264,1.0,1.0,66/356,22.00%,CENPF;TMEM107;TTC36;RPS23;ATG16L2;RPS3;FLII;ATG14;MIS12;CENPE;CHMP2A;RAB11A;EMC6;VPS25;CCDC28B;IRGM;RAB32;CEP131;VPS28;GORASP2;NEK6;HAUS6;FUZ;GABARAPL2;ABLIM3;ARL13B;TXNDC15;IFT122;IFT81;SCLT1;TP53INP2;DNAH5;RAB8A;MYH6;FAM149B1;LMOD1;GOLGA8B;PATL2;SNF8;DYNLL1;CIRBP;CFAP410;DYNC2H1;RP2;PLK4;INTU;GOLGA2;CHMP3;CHMP7;CC2D2A;MAP1LC3B;ATP6V1D;WDR45B;SMIM22;TUBGCP4;CEP41;EIF2A;GOLGA8M;CHMP4B;SEPTIN2;LSM3;DYNC2I1;DHX37;TUBGCP2;VPS36;DHX29
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),-0.6271858793901244,-0.9405327436179634,0.5892857142857143,1.0,1.0,2/7,18.02%,ARF1;CHRNB1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.5109766174623851,-0.9404230454066257,0.5161290322580645,1.0,1.0,2/16,7.51%,NIT2;MTHFD1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5706376230220499,-0.9397726043579718,0.5555555555555556,1.0,1.0,2/8,14.21%,GSTP1;OSMR
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.40652255607334875,0.9397412687987543,0.5483870967741935,0.8984901673720311,1.0,9/38,7.16%,IL4R;LCP2;ICAM1;C1ORF162;PSTPIP1;PIK3R5;CLEC7A;CSF3R;ITGAX
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.38688208166279797,0.9397370734188373,0.4074074074074074,0.8979100130738166,1.0,19/74,18.92%,RELN;HOMER1;NLGN1;CACNB4;CACNG5;CACNG4;DLG2;DLG1;GRIN1;DMD;FGF13;SLMAP;DLG3;CAMK2D;GRIA2;SHISA9;FGF14;GRIN2B;JPH1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.32750172993593824,0.939690695808577,0.631578947368421,0.8974388080619082,1.0,31/199,11.75%,PDGFB;PDGFC;IGF1;SPRY2;SNAI1;CASS4;FLT1;SRC;ARHGEF7;EGFR;PDGFRA;CLEC7A;LEF1;AKT2;TMSB15B;NSMF;DOCK1;IGF1R;SEMA5B;ITGAX;TGFB2;GAB1;SYNE2;ACVR1;ZNF304;FGF1;MGAT5;SMURF2;PRKCE;MAP4K4;SEMA6D
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.40609732595204306,0.9393294631464492,0.42857142857142855,0.8976168618414597,1.0,3/31,7.24%,RAB27A;SYT3;UNC13D
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4435303760216145,-0.9392817368048388,0.6031746031746031,1.0,1.0,8/29,20.79%,B2M;MAG;GORASP1;APPL2;OMG;PTN;GDI1;RHOA
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.47466199455073727,0.9391186102489356,0.48148148148148145,0.8975516035531149,1.0,2/16,5.56%,SLC39A8;SLC39A11
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32189849983084934,0.9389669988314491,0.6,0.8973964637636471,1.0,5/154,2.15%,F2;VAPB;BET1;CD59;COL7A1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4603250523764226,-0.9389024736100997,0.4838709677419355,1.0,1.0,4/22,21.54%,CFTR;ABCA12;HLA-DRB1;NR1D1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4297292044707176,-0.9387620245646295,0.5211267605633803,1.0,1.0,4/56,7.91%,EPN1;PTK6;RHBDF1;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.5576195901558479,0.9386731166720793,0.6410256410256411,0.8975112552624234,1.0,1/8,0.53%,BACE2
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.4991667252329048,0.9386629923161693,0.5121951219512195,0.8969340584163961,1.0,1/9,6.89%,SMS
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.40167705038556506,0.9386228299452772,0.6129032258064516,0.8964025212273117,1.0,3/27,5.48%,YJEFN3;PLA2G10;SIRT1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.4297535036997391,-0.9385931871372987,0.4864864864864865,1.0,1.0,3/57,1.48%,GATA1;XBP1;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5218401921464363,-0.937908277390459,0.578125,1.0,1.0,1/14,1.48%,SFRP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.39337657630151496,0.9378122536413847,0.5555555555555556,0.8975137441192784,1.0,6/46,16.08%,NOS2;OGT;NDC1;NUP42;RUBCNL;PNPT1
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),-0.6010205692896458,-0.9376941209204106,0.6595744680851063,1.0,1.0,3/5,19.83%,COLEC12;FLOT1;CAV1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.381897688373366,-0.937660106803787,0.6029411764705882,1.0,1.0,23/99,17.96%,SLC25A4;TTN;COX7A1;FABP3;NPPC;HSPB8;SYNPO2L;GPIHBP1;PLN;PDLIM3;ART3;BDNF;SGPL1;DUSP26;COL21A1;MYH6;LMOD1;CKB;SRL;MYOM2;PDE1A;FLNC;TRDN
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.3562334884554675,0.9375577644624266,0.5714285714285714,0.897565384799763,1.0,22/97,13.86%,VDR;ONECUT1;STAB1;CTSK;NRP2;GRM8;CX3CR1;AGER;FCGRT;IRAK3;DYSF;MRC1;MAFB;CA2;CLEC5A;SMAD4;PTH1R;PID1;RAB3B;HCK;CHI3L1;KCNMA1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.5943111032796836,-0.9374240016697856,0.6363636363636364,1.0,1.0,2/5,37.05%,MYOCD;OLFM2
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5228870160848,0.9373728352306122,0.5476190476190477,0.897500462678786,1.0,2/7,5.17%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6071108790889227,-0.9373451161541043,0.5660377358490566,1.0,1.0,3/7,28.43%,PDZD11;CAV1;AP4M1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5930850474817281,-0.937192993395761,0.6060606060606061,1.0,1.0,3/6,34.71%,EZH2;EZH1;RIF1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3417372301914438,0.9365694476031594,0.44,0.8983669663607384,1.0,24/87,19.39%,HOMER1;KCNIP2;CPNE1;CPNE7;NLGN1;KCNMB4;SYT3;ACER1;STIM1;GPLD1;CPNE2;ADCY8;KCNMA1;RASGRP2;SEC31A;PKD2;CAMK2D;SYT5;WNT5A;KCNMB2;CPNE6;PPP3CA;CPNE5;CPNE9
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.46465022284747726,-0.9361791121720784,0.5466666666666666,1.0,1.0,6/29,12.63%,ACOT2;DBI;ACSM6;OXSM;ACOT1;ACSM3
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.44351477321925004,-0.9360358620644268,0.5507246376811594,1.0,1.0,10/44,21.60%,FTH1;FTL;ISCU;SLC22A17;CP;SOD1;HJV;ATP6AP1;NUBP1;HEPHL1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3828129517972683,0.9360187294456819,0.5454545454545454,0.8989548977937506,1.0,5/52,8.92%,PDGFB;GRHL2;NAF1;HMBOX1;TNKS
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.4569111506994926,-0.9358656462506877,0.5970149253731343,1.0,1.0,8/28,11.54%,AQP9;SLC10A6;SLC10A3;SLC16A1;CEACAM1;SLC27A5;SLC16A8;SLC51A
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.6168527519996505,-0.935805838855875,0.6190476190476191,1.0,1.0,2/6,4.17%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.5745158467526006,-0.9357938727137335,0.6575342465753424,1.0,1.0,5/9,30.84%,ATP6AP1;CAV1;ATP6V1G1;ATP6V0D1;FAS
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.6442965387272795,-0.9356993326435233,0.7,1.0,1.0,1/5,6.20%,WWC2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.6052704688224971,0.9355878503182508,0.5652173913043478,0.8993810724175555,1.0,2/5,10.80%,SNCA;SLC22A2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.525381232091582,-0.9353861343717391,0.6065573770491803,1.0,1.0,6/17,31.53%,POLR2L;RASL11A;MAF1;POLR2K;EIF2AK3;HEATR1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.4889935744059116,-0.9352911376430234,0.546875,1.0,1.0,4/23,14.47%,RIMS1;CARTPT;ILK;EDN1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.4430043916654275,-0.9350561555822141,0.5866666666666667,1.0,1.0,9/46,19.32%,TINF2;APEX1;PCNA;RPA3;PARP1;RAD50;XRCC3;POLD2;POLD4
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.521862916314737,-0.9349208223860619,0.5522388059701493,1.0,1.0,4/15,11.86%,GRIN3B;PLN;SRI;ORAI1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.5390105013032955,-0.9341716812381358,0.6031746031746031,1.0,1.0,3/22,17.15%,DDX11;NCL;RASL11A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5703215305357509,0.9339515714280134,0.6111111111111112,0.9023806763949742,1.0,2/8,5.19%,NRP2;ASCL1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.47050199594549946,-0.9339173646116316,0.5882352941176471,1.0,1.0,6/30,13.57%,VAV3;PEX11A;LAMTOR5;NEB;PPP1CA;PEX11G
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.40498126338426094,-0.9338202039460803,0.6296296296296297,1.0,1.0,16/73,25.33%,VPS35;C4BPB;GPC3;C4BPA;VPS28;PTTG1IP;SNF8;DACT1;APOE;VIP;OAZ3;MSN;FURIN;APC2;PLK2;DDB1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6010617671350913,-0.9337583093418633,0.6101694915254238,1.0,1.0,1/7,17.99%,GTF2H2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.45749949162780007,-0.9335677565291054,0.5866666666666667,1.0,1.0,7/31,19.86%,JUP;HYAL2;RBM22;TGFB1;APOD;ECT2;RAN
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.4841500017285916,0.9335085276840019,0.5277777777777778,0.9026789887854079,1.0,1/5,7.66%,LRRC8A
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4862147343611275,0.9333238155641179,0.5666666666666667,0.9025306233687781,1.0,3/14,16.47%,TTLL12;OAS3;USP18
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.5018275287286547,-0.9330984958440889,0.6031746031746031,1.0,1.0,5/17,22.29%,SNF8;CENATAC;HPGD;TMEM9;FURIN
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.5444832717776367,0.9326338599594511,0.625,0.9034349919920421,1.0,1/9,1.24%,NOS2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.3948919120641831,0.9324113290640346,0.4838709677419355,0.9033665499827598,1.0,9/37,14.07%,GRM2;HOMER1;GRM8;GRM3;GRM1;CPEB4;GRIN1;GRIK2;GRIN3A
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.41448442912276656,-0.9322037803976106,0.5362318840579711,1.0,1.0,15/64,17.94%,HLA-F;HLA-C;SIGIRR;HLA-E;IRF1;VAMP8;LRP10;PARP12;CEBPB;ADGRE5;HELZ2;ISG20;CTDSP1;IFI35;PRKD2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.5081653644463322,-0.9321497797802204,0.5166666666666667,1.0,1.0,1/11,2.71%,EEF1AKMT2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.48053728354628855,0.9320544698846628,0.5862068965517241,0.9036812458632026,1.0,2/16,5.56%,SLC39A8;SLC39A11
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3326955229648132,0.9319723256197722,0.48148148148148145,0.9032922514386649,1.0,19/104,11.34%,PDGFB;TCAP;KAT2A;PDLIM7;SGCZ;ALPK3;TBX19;PKD1;GLI2;CHD7;PDLIM5;SMG9;TGFB2;SGCG;ACVR1;RBM20;MEGF8;SGCD;HDAC9
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.5266156287733004,-0.931889381142376,0.5555555555555556,1.0,1.0,4/11,14.65%,SSB;RPP25;POP7;RPP38
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.504188947426996,-0.9317896928532337,0.5857142857142857,1.0,1.0,1/19,3.93%,FABP3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.4096754340153917,0.9316298029259186,0.5357142857142857,0.9034642405660901,1.0,12/31,21.00%,SPRY2;RASIP1;ARHGAP44;ARHGAP35;TGFB2;SYNGAP1;KANK1;ARHGAP24;SPRY4;FBP1;ABL2;KCTD10
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5447986512128689,0.9316274492273913,0.625,0.9028714162612568,1.0,6/8,30.63%,RELB;LILRB1;NLRC3;YY1;PTPRS;CACTIN
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.43877424595911796,-0.9315209751498492,0.5675675675675675,1.0,1.0,5/36,7.08%,SLC6A12;SLC3A1;SLC25A45;SLC7A14;SLC7A7
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3610336541078395,-0.931469317770905,0.6385542168674698,1.0,1.0,22/215,12.11%,RIMS1;TINF2;ACTG1;SYCE2;SPAG17;RHOG;RSPH6A;CORO1B;ELOB;STAG3;LRRTM3;LIMA1;CLDN14;VIL1;NIFK;BAIAP2L2;TGFB1;GORASP2;AFG3L2;ILK;CHAF1A;AIF1L
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.609259269769783,-0.9313808972246076,0.6296296296296297,1.0,1.0,2/5,14.57%,SFRP4;KRT10
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.5473400211615086,-0.9313719850908887,0.5555555555555556,1.0,1.0,6/13,28.14%,FUCA2;TRIM25;CAV1;EXOC7;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.550033248695259,-0.9311988343841968,0.6060606060606061,1.0,1.0,2/9,9.64%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5578833169239577,-0.9311371439261025,0.5932203389830508,1.0,1.0,2/11,14.20%,NUDT12;PARP9
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5006632224313335,-0.9311061549329185,0.5692307692307692,1.0,1.0,1/18,0.32%,BMP5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.46529855510089374,0.9308520921382801,0.5294117647058824,0.9040296602690756,1.0,7/17,14.30%,RELN;NLGN1;NRXN1;GRIN1;NLGN3;PRKCZ;PTEN
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5335537196797917,-0.9306344603969087,0.5970149253731343,1.0,1.0,2/11,6.96%,MESP1;GPC3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3797011956904277,-0.9305727627421065,0.547945205479452,1.0,1.0,24/96,22.20%,RHOC;CLU;RPS3;HRK;NOP53;RACK1;IRGM;TRABD2B;BRK1;TGFB1;PINK1;TFIP11;SELP;HSPA5;WARS1;APOE;HSPA8;BAX;IMPACT;NAPA;RIOK3;MTLN;LGALS3;SVIP
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.3876275981173427,0.9304173361805226,0.5135135135135135,0.9046270153851472,1.0,8/35,10.64%,PIEZO2;MAP3K14;MAP2K4;CRADD;MAP3K1;NFKB1;AQP1;TNFRSF10A
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5010173266382804,-0.9300204802751906,0.6142857142857143,1.0,1.0,1/15,2.92%,STX19
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.43026485301368667,-0.9299349581442616,0.5362318840579711,1.0,1.0,3/41,7.85%,CENPF;HYAL2;PAX8
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.34109711453519004,0.9299207623719675,0.5454545454545454,0.9049751416403264,1.0,30/121,15.23%,RELN;PCDH18;PBX3;ATXN1;KLHL17;AFF2;CTNNA2;CNTNAP2;GRHL2;CX3CR1;PBX1;NFIB;HAP1;DSCAML1;MEIS1;SMG9;MEIS3;ADGRL3;PLXNB2;PITPNM1;CDH2;GRIN1;MEIS2;POMK;ROBO2;PTEN;JHY;SYNJ2;SLC23A1;TBC1D23
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.5156425190364075,-0.9298350414811251,0.5238095238095238,1.0,1.0,1/11,3.91%,LACC1
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.6072326461498333,-0.9293793485096261,0.6101694915254238,1.0,1.0,2/5,8.65%,PAX8;FSHR
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.5510832656422064,-0.9291963566211283,0.6142857142857143,1.0,1.0,4/7,26.33%,HTR2B;HTR2A;HTR1E;HTR1F
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.5820541908773964,-0.9291244504741183,0.6101694915254238,1.0,1.0,1/5,3.72%,LPA
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3981633061643098,0.9290616204922668,0.56,0.9061829385126468,1.0,7/58,11.04%,PTPN6;CDK6;EGFR;PKD1;CDKN2A;UBE2E2;DLG1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.614498478078426,-0.9290147740547993,0.6333333333333333,1.0,1.0,2/5,26.14%,PINK1;PARK7
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.46495060427153667,0.9288326862015461,0.46875,0.9059801799210624,1.0,1/9,5.35%,DLAT
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.4969712141683648,-0.928642285074852,0.5507246376811594,1.0,1.0,8/17,32.20%,FLII;VIL1;SVIL;TWF1;TWF2;VILL;GSN;EPS8
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.4969712141683648,-0.928642285074852,0.5507246376811594,1.0,1.0,8/17,32.20%,FLII;VIL1;SVIL;TWF1;TWF2;VILL;GSN;EPS8
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.505625785696504,0.9284622934868073,0.5,0.9063267391544759,1.0,4/10,17.47%,SESN2;RRAGD;SESN1;GCN1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.41091453997375826,0.9279948096945506,0.6451612903225806,0.9066728456651808,1.0,4/47,4.85%,VAPB;SRPRB;PDIA5;ACADVL
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5202377644031512,-0.9279008649633756,0.5396825396825397,1.0,1.0,3/13,11.42%,CD81;LAMTOR5;GLMP
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3548335737465284,0.9277360370609282,0.4482758620689655,0.9066824234352585,1.0,17/61,14.17%,ZBTB7C;MORN5;TACC2;MYO5B;ATP12A;GRHL2;MYH14;DNAH3;TMCO5A;BPIFB1;CDS1;SLC12A2;DNAH12;SHANK2;SHROOM3;KCNMA1;ARFGEF3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.42816759459674536,-0.9274829612024236,0.547945205479452,1.0,1.0,3/43,4.62%,ARHGEF16;RHOG;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.39020082857060795,0.9274778520993893,0.42857142857142855,0.9067008270697762,1.0,2/59,2.48%,F2;PLK1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.36920123178948716,0.9274620909458483,0.5217391304347826,0.9061450878232559,1.0,17/66,14.38%,SPRY2;HSPA1A;SRC;MTMR2;EPHA3;TMC8;IRAK3;BMP6;TMEFF2;HSPA1B;PRKD1;RAPGEF3;SACS;DNAJA4;DNAJB6;PRKCZ;LRSAM1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.45282953871482007,0.9272881922873001,0.45161290322580644,0.9059872806524358,1.0,1/16,0.19%,VDR
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.5503128432075767,-0.9272187471962426,0.603448275862069,1.0,1.0,2/7,22.44%,DDX5;MYOCD
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.5562035889319836,0.9268836311904237,0.5714285714285714,0.9063677659058852,1.0,3/7,24.79%,DUSP10;PTPRO;PTPRB
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5828173271627681,-0.9267188283683945,0.7049180327868853,1.0,1.0,4/8,24.89%,BUB1;ZWILCH;ZW10;PLK2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.46990266585446744,0.9267111102656003,0.575,0.9061042349013224,1.0,4/9,22.31%,ADGRB3;C3;ANKS1A;APP
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.5290230229216705,0.9264036798619341,0.575,0.9060700968817442,1.0,3/10,12.36%,KLRD1;CD55;SLA2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.5318561468744359,-0.926251124107549,0.6065573770491803,1.0,1.0,2/11,8.07%,CR2;RASGRP1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.4683280524071554,-0.9261501270032481,0.5423728813559322,1.0,1.0,5/28,20.69%,COPE;GABARAPL2;TRAPPC3;COPZ1;NAPA
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4406837956867001,0.9260781051613906,0.48484848484848486,0.9061592578590567,1.0,3/20,6.81%,ARAP1;AFAP1L2;HAP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.506746967084862,-0.925859141685666,0.5571428571428572,1.0,1.0,3/15,14.47%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.4097307797916494,-0.9257524120372362,0.5405405405405406,1.0,1.0,15/58,21.54%,SELENOS;VPS35;CXCL17;GPS2;C1QBP;TNFRSF1A;NMI;NLRP12;MAPK7;RNF26;APOE;TEK;MMP26;ALOX5;NR1D1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.5388463912102202,0.9257261747479936,0.5882352941176471,0.9062131103007444,1.0,3/7,6.13%,SNAI1;TBX19;SCX
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.5807558510367788,0.9257032684411053,0.6486486486486487,0.9056426270438678,1.0,1/6,1.10%,DACH1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.4629706804365031,0.9256305003334512,0.5526315789473685,0.9051343911323876,1.0,5/17,7.30%,TCAP;ALPK3;PDGFRA;OBSL1;PDLIM5
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),-0.6457464212484347,-0.925176770109712,0.6964285714285714,1.0,1.0,1/5,14.47%,EDN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.3806590462449659,0.9251495814954132,0.5151515151515151,0.9056717624492386,1.0,12/33,18.20%,HSPB1;CLEC7A;AGER;TMEM106A;P2RX7;TRIM16;MALT1;STMP1;HMGB1;WNT5A;S100A13;LPL
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.4958951589877766,-0.9249483866796623,0.578125,1.0,1.0,3/11,13.12%,TGFB1;HOPX;MYH6
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.46974937755344887,0.9249142000343741,0.5294117647058824,0.9055502832659955,1.0,4/18,10.80%,CPEB3;CPSF6;CPSF7;ZC3H14
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5535659560113952,-0.9248256245398673,0.6119402985074627,1.0,1.0,2/12,10.12%,SFRP1;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.5865712554929738,-0.9243034277250752,0.6181818181818182,1.0,1.0,2/6,19.32%,FGF7;TGM1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4047830783686389,-0.9241926197010374,0.6125,1.0,1.0,9/67,10.00%,MAGEF1;CLU;RAD23A;ELOB;NOP53;RACK1;DDA1;ARIH2;RBX1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.49236516242653555,0.9241770571988658,0.4883720930232558,0.9065339451053717,1.0,8/16,23.28%,ROBO1;GPLD1;SLIT2;EGR3;FGF2;MIA3;PIK3R3;KDR
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.39535212513327966,-0.9238916732122248,0.6,1.0,1.0,11/88,9.99%,AQP9;PRDX5;RBP1;RETSAT;NUDT12;PEX11A;LCK;SLC35B2;GSTK1;AR;SLC27A5
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.44158230614135885,-0.923886709761554,0.6172839506172839,1.0,1.0,13/57,14.21%,CD44;IL7;IFNGR2;CD9;IRF9;IRF1;HAX1;TGFB1;TNFRSF21;STAT1;IL3RA;TNFRSF1A;OSMR
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.43983851696835424,0.9238394627456343,0.5217391304347826,0.9066399304270496,1.0,4/25,11.16%,QRICH2;RHOJ;SCIN;RHOQ
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.4543631490447194,0.9236937609705358,0.48484848484848486,0.9064304772375384,1.0,6/13,22.24%,IWS1;SAFB2;SLTM;DHX9;SRPK2;PTCD2
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.46360843404300256,-0.9234246045638288,0.5833333333333334,1.0,1.0,6/25,15.83%,NLRP1;STAT5A;STAT1;EIF2B1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.6084056444765983,-0.9233668113265713,0.6779661016949152,1.0,1.0,1/5,7.91%,CEACAM1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.4762748399313107,-0.9233348083864724,0.5352112676056338,1.0,1.0,5/16,20.31%,SURF1;COX17;SMIM20;COA5;TIMM21
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.6137886299724895,-0.9232560211678295,0.6296296296296297,1.0,1.0,3/5,31.48%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.6137886299724895,-0.9232560211678295,0.6296296296296297,1.0,1.0,3/5,31.48%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.6137886299724895,-0.9232560211678295,0.6296296296296297,1.0,1.0,3/5,31.48%,AKR1A1;XYLB;DCXR
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.43674965893401396,0.9232401690726317,0.5483870967741935,0.9069652755939961,1.0,6/20,21.65%,PDE4B;SNCA;ABL1;ADCY6;GABPA;RYR2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5495587338054024,-0.9231219373512694,0.6363636363636364,1.0,1.0,2/13,7.24%,BUB1;IHO1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.5637275008916234,-0.923097284951551,0.5147058823529411,1.0,1.0,3/9,22.77%,CHMP2A;CHMP7;VPS4B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.5637275008916234,-0.923097284951551,0.5147058823529411,1.0,1.0,3/9,22.77%,CHMP2A;CHMP7;VPS4B
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.4848542007281277,-0.9229491841006697,0.6,1.0,1.0,5/16,19.34%,TRPT1;TSEN34;C2ORF49;DDX1;CLP1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4347532251600703,0.9228750465955754,0.5,0.9071495007898429,1.0,9/29,19.15%,CERS3;ACER1;SCEL;TXNIP;ERCC2;CDSN;HDAC1;WNT5A;BCR
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.5466718829320762,0.922546666620507,0.6176470588235294,0.9073509711218587,1.0,2/8,5.20%,IFNA2;LEF1
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),-0.5697942320780662,-0.9224752691321564,0.5714285714285714,1.0,1.0,2/6,14.47%,HTR2B;EDN1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.5404571946525488,-0.9224216970033808,0.6507936507936508,1.0,1.0,2/8,9.87%,LCLAT1;PLA2G12A
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.39323066764865056,-0.9223509955786221,0.6285714285714286,1.0,1.0,16/94,20.07%,APIP;B2M;ALDH1A2;CHMP2A;AQP11;APPL2;RNF135;RNF213;GOLGA2;ECT2;MCOLN1;NINJ1;POLQ;ATL3;HSD17B10;USP16
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.46360933190487774,0.9222296063079817,0.5333333333333333,0.9074822953633016,1.0,8/16,21.87%,DUSP6;DUSP1;DUSP10;DUSP18;PPM1E;PPM1D;PPP2CB;DUSP16
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.40236060158845166,-0.9220775596572759,0.5915492957746479,1.0,1.0,7/53,15.70%,DTX3L;RNF8;ARIH2;RBX1;RNF5;CDC34;UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.4394609294558229,-0.9220722738179391,0.6,1.0,1.0,9/41,19.86%,JUP;HYAL2;RBM22;CAMK1;TGFB1;ECT2;GTSE1;EMD;RAN
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.6371365407061381,-0.9219275466501506,0.6923076923076923,1.0,1.0,1/6,6.91%,CD81
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5002397414998689,-0.9218597785294786,0.6666666666666666,1.0,1.0,8/15,37.73%,CR1;KAT5;NAV3;SFTPD;TNFAIP3;HOMER3;LAPTM5;PRNP
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.45421889581879277,-0.9217910687215356,0.6307692307692307,1.0,1.0,3/21,14.47%,CPS1;HTR2B;EDN1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.47751435568814043,-0.9215027601523121,0.6111111111111112,1.0,1.0,5/21,25.08%,ELOVL2;ACSBG2;ELOVL1;FAR2;HSD17B12
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5216257631659323,0.9214719960113545,0.625,0.9086959900052881,1.0,1/11,0.13%,CREB3L1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3843809043578964,0.9213701404909054,0.6296296296296297,0.9083377049820378,1.0,7/34,9.33%,HSPA1A;CDK6;MAPK11;TAL1;ARNT;HSPA1B;MAFB
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3714927536666365,0.9211682133290778,0.48,0.908154259524156,1.0,10/41,10.76%,ODAD3;CFAP53;DNAH11;DNAAF1;CAMSAP3;TEKT5;ADCY10;DNAI2;SPEF1;CFAP54
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.35552846016871076,0.9211106682590532,0.5185185185185185,0.9076747972792673,1.0,20/64,14.46%,RELN;NFATC4;AGER;NLGN1;HAP1;CACNG5;CACNG4;ZDHHC3;ADRA1A;CRHR2;NRXN1;SLC8A2;NLGN3;CLSTN2;ADCY8;GRIK2;SHANK2;GPER1;PRKCZ;NMU
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.4501592334079822,0.9210532409398439,0.6129032258064516,0.90720465902552,1.0,4/27,10.87%,SRC;ARHGEF7;SORBS1;PTPRK
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.4347284072233304,-0.920997655653403,0.5652173913043478,1.0,1.0,11/42,19.75%,RPL10;VPS35;RBM3;TGFB1;WDR91;RBM4B;EDN1;EIF2B4;APOE;EIF2A;METTL18
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.6277121811120224,-0.9209104099566158,0.6491228070175439,1.0,1.0,1/5,13.65%,MMP24
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.567584087458829,-0.9206768814008716,0.631578947368421,1.0,1.0,2/6,8.77%,AQP9;AQP11
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.3594386462034763,0.9206564807106533,0.7391304347826086,0.9072833584322081,1.0,24/90,19.14%,LIFR;EGFR;ERRFI1;LRP4;RND3;GLI2;OBSL1;DOCK1;CHST3;NUAK1;CACNA2D1;CD276;TEAD1;SLIT2;FIGN;MPDZ;COL12A1;COL4A2;MYO1B;KIF7;WNT5A;TJP1;RAI14;ADCY6
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.5099481328666615,-0.9206161345474703,0.6060606060606061,1.0,1.0,2/16,6.20%,NEK8;WWC2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5717407938504407,-0.920573801754431,0.6440677966101694,1.0,1.0,2/7,21.27%,APH1A;BACE1
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.5714209637131956,-0.9205368524712855,0.5961538461538461,1.0,1.0,1/5,8.17%,IRGM
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.47911272597653387,0.9202623984577256,0.4883720930232558,0.9076663356319806,1.0,3/10,10.34%,SOX5;TGFB2;LTBP3
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3567774838238609,0.9202415297767186,0.45454545454545453,0.9071188888630745,1.0,24/92,17.31%,PDGFB;PTPN6;IL1RAPL1;PTPN20;LEF1;DPYSL3;HCLS1;AKAP6;ACVR1;PTPN4;PID1;NFAT5;SLIT2;ROBO2;BMPR2;ACVR2B;SLIT3;ACVR1C;ACVR2A;FLT3;NCOA2;GHR;MAPK8;PTPN23
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.5251246189571851,-0.9199508399955648,0.6,1.0,1.0,6/15,17.16%,TRPT1;DTD1;SSB;SARS1;POP7;AARS1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.4136303228240779,0.9198124617998567,0.5483870967741935,0.9074493681659296,1.0,10/23,25.52%,EGFR;EIF4E2;FXR1;TNRC6B;DHX9;PUM2;PUM1;WTIP;TP53;ZFP36
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.4662090548114666,0.9196851228114965,0.5897435897435898,0.907067678456481,1.0,7/19,16.44%,KAT2A;SUPT3H;USP36;USP15;USP49;USP3;UIMC1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5387382178726935,0.9194843258656156,0.6585365853658537,0.9069727282914656,1.0,4/6,31.18%,PTPRN2;RAB11FIP2;PTPRN;RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.49281820510491176,-0.9193775034061641,0.6129032258064516,1.0,1.0,1/17,0.45%,B2M
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5013160042957673,-0.9193663342707066,0.6271186440677966,1.0,1.0,2/13,10.69%,KIF20B;SEMA3A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.42245772098241624,-0.9193100303753144,0.6056338028169014,1.0,1.0,2/42,2.08%,RHOC;STMN1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.502968735484687,0.919102804617444,0.5625,0.9066965604702081,1.0,3/14,15.60%,SRC;PTEN;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.502968735484687,0.919102804617444,0.5625,0.9066965604702081,1.0,3/14,15.60%,SRC;PTEN;CORO1C
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.6079466989812469,-0.918769572774778,0.6538461538461539,1.0,1.0,2/5,21.73%,CRB2;USH1C
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.6079466989812469,-0.918769572774778,0.6538461538461539,1.0,1.0,2/5,21.73%,CRB2;USH1C
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5957988421093466,-0.9187018935035978,0.6911764705882353,1.0,1.0,4/7,22.25%,SFRP1;UFL1;MEOX1;SP7
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3973948594250822,0.9186470626622557,0.5,0.9070608843448112,1.0,5/39,8.92%,SRC;GRHL2;NAF1;HMBOX1;TNKS
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.49013988026707717,-0.9185036789215617,0.5735294117647058,1.0,1.0,5/14,21.62%,CORO1B;LIMA1;AIF1L;CCR7;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.559214512193974,-0.9184219063939718,0.6031746031746031,1.0,1.0,3/10,18.51%,MADCAM1;PIK3CB;ZP3
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.5026237861380454,-0.918356409908223,0.6056338028169014,1.0,1.0,1/14,1.48%,SFRP1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.5570182370563617,0.9182778589565356,0.6410256410256411,0.9073901344833631,1.0,3/6,18.69%,GRK5;TACR3;TAC1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6141911649752492,-0.9179135237175917,0.6388888888888888,1.0,1.0,3/5,30.36%,ATP6AP1;ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.38932967793867557,-0.9178396955651338,0.6538461538461539,1.0,1.0,20/110,13.53%,TOMM7;ZDHHC12;SRP14;NACA;SLC25A6;RPL11;DNAJC19;YIF1B;TIMM8B;TIMM10;CDC37;TSPO;SRP54;AQP11;TOMM20;SRPRA;GIPC1;NACAD;SPCS2;KATNB1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.37816104418009233,0.9178120488674186,0.5925925925925926,0.9078140768763615,1.0,10/56,12.16%,KCNJ14;KCNJ2;SLC39A8;ATP12A;SLC9C2;ATP1B3;CACNA2D1;SLC9A2;SLC12A2;SLC8A2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.34710145075398946,0.9177188907213921,0.6086956521739131,0.907459781769232,1.0,22/90,13.38%,PRNT;GCNA;MORN5;EGFR;PIWIL2;DNAH6;CREB5;DMC1;DNAAF1;SPATA20;EFCAB10;DNAH3;TMCO5A;DMRT1;TEX15;STRA8;TSSK6;OSBP2;MYO1D;CCDC30;GALNTL5;SLFNL1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2602828187860992,0.917549788913799,1.0,0.9073131919059892,1.0,308/1673,17.09%,CREB3L1;VDR;PDGFB;ZNF423;GCM1;NFATC4;ZNF697;ONECUT1;CRX;TP63;NPAS2;IGF1;DACH1;ZBTB1;FLI1;ETV1;KAT2A;MYRFL;RUNX1;ZNF521;SNAI1;HES4;ZBTB7C;BNC2;DACH2;MXD3;SPINDOC;SLC39A8;PBX3;ATXN1;DUXA;ZNF717;ZGLP1;IFNA2;TBX6;AFAP1L2;ANXA4;AEBP2;ZNF415;ZNF366;TAL1;GMNN;HDAC4;ATOH8;EGFR;PPARGC1A;RELA;RFX3;HDAC10;ARNT;HNF4G;BACH1;CNOT2;RXRG;HIC2;DLX1;CHD5;MYT1;ZXDC;GRHL2;SCRT1;SUPT3H;ID1;ATF1;SAMD13;ZNF347;ZNF516;ZNF202;CREB5;FOXK1;ZNF615;ARID1B;ZNF264;NPAS3;ZNF706;ASCL1;LEF1;PBX1;PTP4A3;BATF3;YAF2;TBX19;ZNF98;ZBTB16;HIVEP3;SIRT1;MLLT3;MLLT6;TBL1XR1;NEK4;NSD2;ZNF283;SFMBT2;SMARCA2;CCNH;BRWD1;SCX;ZNF668;HMX1;GLI2;SAFB2;FOXN3;ETV5;DHFR;ZBTB2;NFIB;ZNF93;RYBP;PICALM;TRIM16;MAMSTR;CHD7;ZNF613;NFIA;HMBOX1;HIVEP2;ZHX2;PHF10;HCLS1;ZNF397;ZNF778;NRF1;ZFHX4;ARID5A;ZFP69B;NOTCH4;PHF14;NLK;ZNF488;TESC;SOX5;ZEB2;TCF12;CD4;BACH2;MEIS1;MEIS3;PHC3;ST18;VAX2;ZNF785;DMRT1;KDM4C;TOX3;MLXIPL;NCOA7;NPAS1;CDKN2A;NFKB1;MAFB;ZNF334;TRPS1;ZFP2;BAHD1;FAM47E;ZBTB37;IKZF2;OGT;ACVR1;ARRB1;PURA;RNF14;ZNF771;ZNF536;ZNF304;TEAD1;ZNF460;WAC;MITF;ZNF704;SOX12;CELSR2;KLF11;SOX30;SMAD4;STRA8;PCGF5;ARID1A;PRRX2;MNT;ZNF157;PTPRK;ZNF761;LCOR;ZNF483;KLF15;HDAC9;SMURF2;SMARCD2;ZNF318;CAMTA1;ZNF561;HBP1;JMY;ZNF473;TRIM44;MEIS2;APBB2;TEAD2;LOXL2;MGA;STAT6;RGMB;CD80;ESRRB;EPC2;NFAT5;ZNF281;ESRRG;MYPOP;ZFPM2;EED;FOXO3;TCF4;ZNF160;ARX;VEZF1;ZNF624;SS18L1;ZNF316;RELB;EGR3;ZNF143;RPS6KA1;PLAGL1;JMJD1C;ZNF644;SMARCD3;CBFB;CDK17;ZNF556;TFDP2;ZNF254;ATRX;EBF4;HMGB1;ZNF24;GPBP1L1;HNRNPD;CEP290;ZNF212;SSBP2;TFEC;PHC1;HIPK2;BCLAF1;ACVR2B;MED13;TRIB3;DYRK1A;MED13L;BRIP1;ZNF69;PRDM15;ZNF41;ZNF341;PHF1;EHMT1;ZNF587;SFPQ;BBX;CREBBP;NR4A2;CSRNP1;NR1H3;ZBTB34;VHL;CCAR1;RAI1;TRIM33;KMT2D;CXXC1;JDP2;CTBP2;SOHLH1;TIMELESS;SMAD9;ZNF280D;ZNF121;MTERF3;SLTM;HIVEP1;DHX9;CAMTA2;ZNF467;UIMC1;CDK18;ZNF169;HMGA1;FOXO6;NCOA2;E2F5;IKZF1;SOX4;CAMK2D;GLIS1;ELP3;ZBTB20;ZNF568;ELF1;MYNN;PKNOX2;ZNF182;ZNF268;MDM4;ABL1;FGF2;NR6A1
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.5478832337855901,0.9175278573457122,0.5652173913043478,0.906795695885723,1.0,2/5,7.42%,SLC26A6;SLC22A16
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3143674321809157,0.9174890451068962,0.7,0.9063219815463444,1.0,18/86,15.28%,EGFR;MFHAS1;PHLPP1;AGER;TRAF2;DUSP10;TPD52L1;IGF1R;SERPINF2;MTURN;SH3RF1;TNFRSF19;MAP4K2;MAP4K4;TRAF3;HMGB1;HIPK2;ITCH
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.3302077755511801,0.917293937120289,0.45454545454545453,0.9061246807005645,1.0,42/260,11.78%,VDR;PDGFB;RAB27A;EPB41L4B;IGF1;SPRY2;MYOM1;HSPA1A;FGF17;MAPK11;ADAM19;PPARGC1A;TICAM1;CLEC7A;SLC24A3;LEF1;ZNF804A;SNCA;SCX;P2RX7;BMP6;ITGAX;NTRK2;ROBO1;ARRB2;TESC;HSPA1B;FUBP1;TBC1D5;WNT3;ARRB1;PTPN22;ZNF304;MITF;SLC22A2;NOS1AP;FGF1;SERPINB9;SLC38A2;AFDN;ATP13A2;AMH
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.44875892166336906,0.9167597231418342,0.5925925925925926,0.9067545371030152,1.0,3/11,7.33%,SIRT1;SNCA;ZNF451
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4683894080327209,0.9164004381648221,0.5714285714285714,0.9068498887609502,1.0,2/14,5.17%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.5596520415695718,0.9161405730223104,0.625,0.9067644632610569,1.0,3/8,27.85%,ROBO1;ZNF703;RTN4
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.4485913835400952,0.9160191011139732,0.6060606060606061,0.9064900075105353,1.0,3/17,7.77%,IGF1;HAP1;NTRK2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.41070875608697915,-0.9159697786330872,0.5942028985507246,1.0,1.0,17/47,19.66%,ADH4;SLC3A1;PDZK1;SLC22A9;TSHR;C4BPB;TMEM45B;SMLR1;TTF1;CYP3A5;SLC2A2;CYP3A4;SLC28A1;F11;BHMT;FMO5;ALDOB
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5063994604094904,-0.9158519099224358,0.6111111111111112,1.0,1.0,4/16,24.15%,PPP1CA;CAV1;WNT8B;DVL3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3650697874791481,-0.9155930756859102,0.6666666666666666,1.0,1.0,27/280,10.16%,IL26;BMP5;B2M;TINF2;NOX4;FTH1;SFRP1;NEURL1;GSTP1;FABP3;INCA1;ALDH1A2;IFIT3;IRF1;BTG3;SFRP4;CDKN1C;TNS2;BTG1;FBLN1;HRAS;B4GALT7;AQP11;AR;TGFB1;FABP6;FUZ
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.3581464257982994,-0.9154171882642984,0.6666666666666666,1.0,1.0,32/248,16.04%,CENPF;RPL23;SFRP1;CCNB2;PTK6;RAD23A;DDIAS;IRF1;USP51;KIF20B;NOP53;RACK1;ANKK1;CALR;HRAS;DYNLT3;SPATA22;TGFB1;NEK6;GADD45GIP1;CDK4;BEX2;CDK5;THAP1;BRCA1;ASAH2;WDR12;MYBBP1A;FIGNL1;PRR11;METTL3;RNF167
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.42227459181606586,-0.9153513343536993,0.569620253164557,1.0,1.0,5/35,8.94%,ARHGEF16;CFTR;OVOL2;EFNA2;VIL1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.46907085198525594,0.9152687199242929,0.4864864864864865,0.9076335402548947,1.0,4/13,19.42%,DRD4;TESC;DMD;WNK1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5374527921430459,-0.9152295420965941,0.5833333333333334,1.0,1.0,1/10,2.74%,TGFBR2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.43901808044048607,0.9151463081018567,0.5862068965517241,0.9073331226649095,1.0,8/27,17.70%,LEF1;TLE3;PYGO1;ASH2L;CREBBP;KMT2D;TLE4;HDAC1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4277893290756,-0.9151418079725332,0.5797101449275363,1.0,1.0,6/29,10.72%,CD63;SFRP4;ARF1;FLOT1;SELE;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.49596792435133225,-0.9148488317112121,0.6290322580645161,1.0,1.0,7/18,21.70%,CD63;SFRP4;SELE;APLN;GREM1;ANGPT1;ATAD1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.33605098603492894,0.9147164484192832,0.625,0.9076165852678341,1.0,25/119,15.86%,VDR;PPARGC1A;HDAC10;HNF4G;RXRG;MAML2;TBL1XR1;CCNH;NOTCH4;TAF3;NOTCH3;TAF4;RARG;TEAD1;THRB;HDAC9;TAF12;TEAD2;ESRRB;ESRRG;KAT2B;CREBBP;NR4A2;NR1H3;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.41103084661684003,-0.9143356654203723,0.569620253164557,1.0,1.0,11/52,25.33%,C4BPB;GPC3;C4BPA;VPS28;SNF8;DACT1;VIP;OAZ3;APC2;PLK2;DDB1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4129833831289676,-0.9142493778716737,0.6363636363636364,1.0,1.0,20/52,29.00%,EME1;NOP53;ABRAXAS1;ZNF830;CLSPN;BRCA1;RPS27L;MUS81;FANCD2;MRNIP;MDC1;BLM;RAD9A;TOPBP1;HUS1;BRSK1;DONSON;NBN;RPA2;STK33
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.3697947811231797,0.9142436908097171,0.5909090909090909,0.9081054997772384,1.0,18/89,17.11%,PDGFB;IGF1;PRR5;TRAF2;TNIK;TGFB2;MALT1;RICTOR;TNFRSF10A;FGF1;MAP4K4;ADCY8;CHI3L1;KIF14;PRRC1;GHR;ABL1;PRKACB
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5218972542511588,0.9142248396365918,0.5806451612903226,0.9075568230646535,1.0,4/8,32.26%,RPS6KB1;SLC27A2;ACSL1;SPX
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.45941514063490846,0.9140208902209211,0.5526315789473685,0.9073685534278914,1.0,6/20,25.12%,CX3CR1;SMARCD3;DRD2;KDM1A;MDK;FZD3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.529238210551624,-0.9140171748814984,0.6666666666666666,1.0,1.0,1/14,3.47%,FGL1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.49629735340012515,-0.9139343045292104,0.6307692307692307,1.0,1.0,4/19,21.17%,ANKRD27;WDR91;SNF8;EEA1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.5051371628586928,-0.9137575150788806,0.546875,1.0,1.0,2/12,16.92%,ELOVL2;ELOVL1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.37065226840190213,0.9137012544959865,0.5925925925925926,0.9076512773819374,1.0,5/52,7.47%,NFKBIZ;NUPR1;FEM1A;SNCA;ADAM8
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.33710027540429965,0.9135921559094355,0.6818181818181818,0.9072835562077342,1.0,17/115,14.23%,B3GNT6;ST8SIA6;EOGT;SLC39A8;ST8SIA1;ST8SIA4;OGT;GCNT3;FUT8;MGAT5;GALNT2;GALNT18;GFPT2;POMK;GALNTL5;GFPT1;TMEM165
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.5082308355958453,0.9134679373631933,0.5625,0.9070188797723762,1.0,2/11,4.82%,MFHAS1;PLA2G10
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.5736246416176035,-0.913051002329556,0.6071428571428571,1.0,1.0,3/8,21.35%,TST;TXN2;MPST
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.5226228419904824,0.913037171436508,0.5789473684210527,0.9073610904489199,1.0,2/5,9.17%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5587590505283084,0.9125932798281906,0.6129032258064516,0.9077797084538745,1.0,2/7,17.96%,ARHGAP21;RIPOR1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.4475314595681765,-0.9122492345600762,0.578125,1.0,1.0,8/30,23.88%,SFRP1;SOX21;HTR2B;UFL1;MEOX1;EPCAM;SP7;METTL5
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.5338369693524159,-0.9121512705384571,0.5692307692307692,1.0,1.0,4/9,22.29%,SEC11C;SPCS2;SPCS1;FURIN
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5330862305044982,-0.9120544670975586,0.5396825396825397,1.0,1.0,2/8,11.40%,MESP1;IFT122
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.4764900694317576,-0.9117460637027118,0.6,1.0,1.0,3/18,7.91%,ZFPM1;CARTPT;CEACAM1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.3675739059947725,-0.9114620711413229,0.6385542168674698,1.0,1.0,21/129,19.71%,XBP1;SFRP1;ATP6V1F;ATG14;RRAGA;CARTPT;LAMTOR5;GABARAPL2;HSPA5;CEBPB;MYBBP1A;LAMTOR1;ATP6V1E1;HSPA8;IMPACT;ATP6V1E2;MAP1LC3B;RRAGC;ATP6V1D;WDR45B;ATP6V1C2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.503435846394808,0.9111804071881063,0.5238095238095238,0.9100748932245043,1.0,4/10,21.58%,P2RX7;P2RY1;SSH1;RYR3
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.37302230812186454,0.911045579435915,0.6190476190476191,0.9098005995223104,1.0,9/58,9.79%,ZAP70;LCP2;GNLY;PSTPIP1;LEF1;TMC8;CD4;EPSTI1;APBB1IP
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.5453157501870984,-0.9109262895004439,0.6438356164383562,1.0,1.0,3/8,19.54%,HYAL2;MT1G;FER1L5
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.6120132719297731,-0.9107536232138843,0.711864406779661,1.0,1.0,2/5,23.41%,ATP23;TMEM70
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.47516645785947886,0.9107383747341925,0.5151515151515151,0.910046463138822,1.0,2/11,5.17%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.5652892820858038,-0.9105822394239299,0.6779661016949152,1.0,1.0,2/6,20.98%,GPR183;CCR7
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.44674965638388253,-0.9104875972187637,0.5454545454545454,1.0,1.0,10/20,27.51%,RBM3;PAF1;NCL;CIRBP;SNW1;NCBP1;SF3B4;NCBP2;LEO1;DHX36
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.5089549478708324,-0.9098103499479036,0.6515151515151515,1.0,1.0,3/14,13.36%,SFRP1;AR;SFR1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5143471357177208,-0.9097861198638507,0.6086956521739131,1.0,1.0,7/14,30.51%,SCNM1;PQBP1;DDX5;SRSF9;PUF60;RSRC1;SLU7
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5591166847301502,-0.9095513568831239,0.543859649122807,1.0,1.0,3/7,20.06%,CHAF1A;ASF1B;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5591166847301502,-0.9095513568831239,0.543859649122807,1.0,1.0,3/7,20.06%,CHAF1A;ASF1B;CHAF1B
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.6082010399004075,0.9094739022376069,0.6285714285714286,0.9121655722189844,1.0,2/5,18.64%,BAG3;MAPT
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4367808645852825,0.9094237934620493,0.6071428571428571,0.9117032443937517,1.0,8/26,16.24%,EFNB3;LRP4;DIP2B;FGF13;PTEN;RUFY3;MCF2;TRIM46
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.48918949960195446,0.909233067566018,0.5957446808510638,0.9114796500374468,1.0,6/12,26.52%,DLL1;FGF1;FGF2;TJP1;PDPK1;SMAD1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.5371838996448205,0.9088171834993335,0.5405405405405406,0.911859845389622,1.0,3/7,10.49%,NOS2;OTUD7B;BPIFB1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.5224532201367174,-0.908780168105707,0.6,1.0,1.0,3/12,14.91%,IFITM3;TRIM13;HEXIM1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4113693693650087,0.9085985854857344,0.5625,0.9118997720146639,1.0,6/27,20.46%,AEBP2;DNMT3A;EED;PHF1;PPM1D;PHF19
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5864781502076284,-0.9085583855833985,0.6896551724137931,1.0,1.0,1/5,14.62%,APPL2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.4690889364415293,-0.9084176862563662,0.59375,1.0,1.0,8/26,21.73%,CORO1B;LIMA1;BAIAP2L2;AIF1L;LCP1;HSP90B1;CALD1;USH1C
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.4307333403232493,-0.9082972582280897,0.5909090909090909,1.0,1.0,3/26,5.80%,TGFBR2;MESP1;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.4722349771047846,0.908273318373333,0.5714285714285714,0.9120754802427001,1.0,1/11,1.46%,CBARP
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.3669930056294375,0.9080608800704917,0.6774193548387096,0.9119879594200243,1.0,4/41,7.08%,RIDA;CPEB3;FTO;NANOS3
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.5826948569600049,0.907952446141615,0.6829268292682927,0.911671619127399,1.0,1/5,16.65%,GHR
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.3933082762028011,-0.9078376714949341,0.64,1.0,1.0,9/69,14.04%,XBP1;SELENOS;CELA2A;USF1;CEACAM1;PARP1;RAB8A;SYAP1;GCK
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.36658719074222057,-0.9078249819679551,0.6666666666666666,1.0,1.0,20/140,14.97%,TYRP1;RPL5;CLU;FABP3;PCNA;RPS4X;RBM3;ATAD5;DDAH2;LARP6;GIPC1;EIF3D;EEF2;DUOXA1;RPS27L;GCK;PYM1;EDN1;EIF4A3;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.5610517553887304,-0.9076163448096308,0.5967741935483871,1.0,1.0,3/5,40.05%,HIF1A;RBPJ;VEGFA
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.3948913712387177,0.9076085914283938,0.5151515151515151,0.9118301932821079,1.0,10/25,21.78%,TEAD1;NPHP4;TJP2;TEAD2;AMOTL1;MOB1A;WWC1;TJP1;LATS2;DVL2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.4288599508958553,-0.9074880107285691,0.6666666666666666,1.0,1.0,10/51,19.03%,TNFAIP2;AQP9;PTAFR;PLET1;TRIM25;SLAMF8;CLEC12A;LILRB3;IGSF6;CTSS
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.4265116375099421,-0.9074410194914991,0.6410256410256411,1.0,1.0,4/30,8.56%,XBP1;NEURL1;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.48695218216889435,-0.9073022643443862,0.609375,1.0,1.0,1/18,2.71%,EEF1AKMT2
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.47353845856547017,-0.9070561700104072,0.6323529411764706,1.0,1.0,1/16,2.08%,STMN1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3870413310134599,-0.9067487016630552,0.7058823529411765,1.0,1.0,13/119,12.92%,BMP5;RIMS1;JPH3;TCEAL2;TCEAL5;STMN2;HOPX;PCSK1;PAK5;SCG3;DUSP26;CHGB;SLC2A2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.453268853703758,-0.9065639699359958,0.6197183098591549,1.0,1.0,1/28,0.62%,RIMS1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.522981555450155,0.9062451350938091,0.5952380952380952,0.9140209500781475,1.0,2/9,15.13%,PGAP1;SCFD1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.5259358792823676,0.9062170178030563,0.65,0.9135008215861318,1.0,2/7,11.52%,CKM;CKMT1A
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.6166901742320844,-0.9061721667374839,0.7241379310344828,1.0,1.0,2/5,8.17%,LACC1;IRGM
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.5398226577640941,-0.9061495867845589,0.6081081081081081,1.0,1.0,4/12,20.79%,SFRP1;ATRAID;GREM1;RHOA
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.47399237048939846,0.9059203561114912,0.575,0.9136833300056708,1.0,4/11,19.39%,NT5E;NT5M;UPP1;DPYD
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4447027561055917,0.905749302979098,0.42857142857142855,0.9134514428559934,1.0,2/22,1.29%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.5018433670015182,-0.9056341626931936,0.6666666666666666,1.0,1.0,2/11,10.39%,IL7;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.5018433670015182,-0.9056341626931936,0.6666666666666666,1.0,1.0,2/11,10.39%,IL7;STAT5A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.515140002188827,0.9056097600752193,0.5714285714285714,0.9131438206207539,1.0,1/10,4.03%,MTMR2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.4604212248396182,0.9054854127971292,0.5909090909090909,0.9128787910790376,1.0,3/10,17.93%,KLF15;MAGI2;PTPRO
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.4627273531649595,0.9053881154247793,0.5555555555555556,0.9125128521913443,1.0,2/18,9.60%,PLK1;FAM47E
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.5166794229032747,0.9053066995144493,0.6176470588235294,0.9121642314674525,1.0,2/8,17.08%,PCGF5;RNF2
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.4072773662330928,-0.9051049263613589,0.6056338028169014,1.0,1.0,21/62,25.34%,SYNPO2L;HRAS;VIL1;HAX1;BAIAP2L2;CDK5;LMOD1;EDN1;PFDN2;PLK4;CFL2;TEK;WDR1;KATNBL1;PFN2;CDC42EP1;CCR7;PFN1;DYNC1H1;NES;ARF6
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.4496021695399962,0.9048161095331819,0.6129032258064516,0.9126249521560134,1.0,2/11,14.92%,PHYH;IDH2
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.40464812169842346,-0.9046475539158814,0.6388888888888888,1.0,1.0,3/59,4.50%,APIP;B2M;ALDH1A2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.43669427597634425,-0.9046267713735751,0.65,1.0,1.0,2/35,1.63%,SELENOK;ZDHHC12
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.4008731407692188,0.9045474911922465,0.5853658536585366,0.9125124799105768,1.0,4/26,12.72%,PLK1;ESPL1;NSFL1C;CLASP1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.49139102782300337,-0.9043484041637263,0.6190476190476191,1.0,1.0,5/13,19.77%,SSB;RPP25;POP7;RPP38;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.4552801418121811,-0.904113352238076,0.6323529411764706,1.0,1.0,5/26,21.46%,IRF1;FLOT1;RNF135;RIOK3;TOMM70
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.5290167097671198,0.9040876468961394,0.5555555555555556,0.9129724119719197,1.0,2/6,17.83%,BMPR2;BMPR1B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.5178792584928258,-0.9039540572084739,0.5909090909090909,1.0,1.0,2/11,9.92%,CCNB2;NEK6
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.4855535258363384,-0.9035909944009308,0.6031746031746031,1.0,1.0,5/15,19.34%,TRPT1;TSEN34;C2ORF49;DDX1;CLP1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.5578435707438705,-0.9033910881305139,0.6721311475409836,1.0,1.0,2/9,9.20%,GALK1;GALE
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.45331307925129644,0.9032858839138955,0.6666666666666666,0.9143064579572028,1.0,1/12,1.07%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.5544966702928498,-0.9031775990491534,0.6610169491525424,1.0,1.0,1/8,0.27%,IGSF1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.4336687775037146,-0.9028721424828633,0.6493506493506493,1.0,1.0,5/29,16.52%,GSTP1;PINK1;GPS2;MAPK8IP1;DACT1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.4180940544554304,-0.9026251389238533,0.6447368421052632,1.0,1.0,11/61,20.88%,TRMO;TRMT112;TRMT10A;QTRT2;SSB;PUSL1;OSGEP;AARS1;TRMT5;WDR6;AARS2
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4459712794419205,-0.9024210680973387,0.625,1.0,1.0,6/36,7.54%,GAPDH;SERPING1;CSTB;TIMP1;SERPINB8;UBXN1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3731819618476375,0.9023619521043453,0.5714285714285714,0.9157817374445859,1.0,1/32,0.21%,PDGFB
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.43470737425375106,0.90229982672395,0.6216216216216216,0.9153987869105162,1.0,5/12,17.43%,INPP1;NUDT3;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5763806695149937,-0.9020819877811808,0.6617647058823529,1.0,1.0,2/6,23.82%,RNF26;SQSTM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.4081525951084013,0.9020011870034793,0.5833333333333334,0.9154444456658742,1.0,6/19,9.23%,RUNX1;PDE4B;CLEC7A;TRAF2;CD4;MALT1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.5093421861020813,0.9018668513457827,0.5483870967741935,0.9150873470265584,1.0,6/11,29.09%,ADRA1A;DRD2;ADRB1;RAPGEF2;ADCY9;LMBRD2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.4488236444755439,-0.9017163267622706,0.6101694915254238,1.0,1.0,4/32,7.95%,SEMA3E;PLET1;FBLN1;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.5341572033567118,0.9013235686087538,0.58,0.9155859001084151,1.0,1/7,10.59%,SMAD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5653269993516096,-0.9012188789425642,0.6666666666666666,1.0,1.0,2/7,12.91%,HYAL2;PPIA
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5653269993516096,-0.9012188789425642,0.6666666666666666,1.0,1.0,2/7,12.91%,HYAL2;PPIA
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5169707399245874,-0.9010150271315968,0.6,1.0,1.0,2/8,19.77%,TRMT5;HSD17B10
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.5784266469511425,0.9010083244990303,0.6363636363636364,0.9159162520642975,1.0,3/8,20.23%,CX3CR1;CD274;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3973488254583037,-0.9009338329052743,0.5942028985507246,1.0,1.0,9/75,12.08%,HLA-F;PM20D1;NRBP2;VPS35;PINK1;GRN;BDNF;MAG;CDK5
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.4380171328388396,-0.9007513773002765,0.6285714285714286,1.0,1.0,5/38,10.22%,NOX4;CPS1;PYCR3;MTHFD1;DDAH2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.46316517010521946,0.9006799008590887,0.5384615384615384,0.9159614781248624,1.0,3/10,11.35%,GAS2;DPYSL3;BAIAP2L1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.567786099464482,-0.9006511548331192,0.647887323943662,1.0,1.0,1/7,1.30%,DUOX1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5455165111552671,0.9005868113136095,0.675,0.915064845287888,1.0,2/5,16.31%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5455165111552671,0.9005868113136095,0.675,0.915064845287888,1.0,2/5,16.31%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4187411978755393,0.9005717690651028,0.6,0.9145003389058475,1.0,4/22,10.29%,ARAP1;AFAP1L2;HAP1;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5174819412266605,0.9005642758089877,0.5,0.9139615887691487,1.0,2/9,3.45%,NOS2;PPARGC1A
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.36546109898804274,-0.9004707853385253,0.6588235294117647,1.0,1.0,33/126,19.91%,PSMB8;BTN3A1;PSME1;HLA-DPA1;HLA-A;PSMB6;PSMC5;PSMD8;PSMD7;HHLA2;LCK;TNFRSF21;PSMD3;PIK3CB;BTN2A1;PSMC3;BTN3A3;EIF2B1;STOML2;EIF2B2;PSMA4;EIF2B4;PSMA7;PSMD2;PRKD2;PSMD6;PSMB2;PSMB4;HLA-DRA;HLA-DRB1;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.3999090623075624,0.9003619440994937,0.5,0.9138158701601359,1.0,7/34,15.60%,CPNE1;SGMS1;CPNE7;HDHD5;MVD;GPAT2;LPCAT1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5159777407724131,-0.9001005857661449,0.6833333333333333,1.0,1.0,6/19,21.21%,JPH3;SRI;CALM3;TRDN;PRKACA;CALM1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5185539882460254,-0.900099198840741,0.6142857142857143,1.0,1.0,1/12,2.74%,TGFBR2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.5262499270805066,0.9000712620631388,0.5813953488372093,0.9138789086819042,1.0,3/8,22.32%,CLASP1;PTEN;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4251368730785893,0.8997186510047133,0.6071428571428571,0.9139835594815744,1.0,3/23,3.86%,VASH1;STARD13;TBXA2R
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3466689903335447,0.8997037552292356,0.6521739130434783,0.9134214539714383,1.0,18/138,12.84%,NFKBIZ;IGF1;CDK6;AFF2;MTMR2;ASCL1;IGF2BP2;TRIM11;ZNF451;MKLN1;FUBP1;CIAO3;GDNF;PTHLH;MEGF8;TRIM44;SLC8A2;SORT1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.607415337199875,-0.899573066881381,0.6666666666666666,1.0,1.0,3/5,15.72%,TRIM25;PHB2;RNF135
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5250379898209991,-0.8995700497569051,0.5517241379310345,1.0,1.0,5/12,26.43%,RACK1;TXN;GPR37L1;PARK7;NR4A3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.5060719624104116,-0.8989591545867075,0.5555555555555556,1.0,1.0,2/11,16.92%,ELOVL2;ELOVL1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.5193889007954946,-0.8988490975826764,0.703125,1.0,1.0,7/11,28.57%,BLOC1S4;AP3B2;SNAPIN;BLOC1S2;DTNBP1;AP3M1;AP3M2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.5193889007954946,-0.8988490975826764,0.703125,1.0,1.0,7/11,28.57%,BLOC1S4;AP3B2;SNAPIN;BLOC1S2;DTNBP1;AP3M1;AP3M2
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.5001670980434324,-0.8987249466104819,0.6571428571428571,1.0,1.0,3/13,15.15%,CCNB2;NEK6;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),0.5448467786320665,0.8987012381460249,0.6222222222222222,0.9151335078801366,1.0,2/5,15.56%,PROM2;NR1H3
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.3363863157852062,0.8985103886583713,0.6521739130434783,0.9150624204292783,1.0,15/59,13.39%,ACSM1;AK3;ADSS2;RAB23;HPRT1;SULT2A1;AMPD1;AK4;SULT2B1;PTHLH;GPAT4;RHOQ;ACOT6;ENPP1;AMPD3
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.44523814184373517,0.8985080292159364,0.5217391304347826,0.9145006878200522,1.0,8/24,16.87%,SRC;RELA;ST18;NFKB1;SMAD4;PID1;ST3GAL6;FER
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4242806582099301,-0.8983519317493587,0.676056338028169,1.0,1.0,3/54,2.84%,TTN;AQP9;MT2A
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.5635500851543591,-0.8983488720569943,0.6333333333333333,1.0,1.0,1/7,4.92%,PNKP
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.5571446502870816,-0.8981528632974654,0.7333333333333333,1.0,1.0,1/6,0.95%,TTN
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4938129633278905,-0.8980655338355039,0.6349206349206349,1.0,1.0,5/15,18.48%,HRAS;HAX1;BAIAP2L2;CDK5;TEK
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.533560148064836,0.8979453312342272,0.6363636363636364,0.9150036311606743,1.0,3/7,26.55%,KMT2D;KMT2C;KMT2A
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.47193525163201194,-0.897631897445049,0.6470588235294118,1.0,1.0,4/16,29.72%,HRAS;TMEM109;CRYAB;XRCC6
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5058363626704119,0.8975955114499498,0.5428571428571428,0.915223509583213,1.0,7/8,38.49%,TBC1D8B;ITGA3;TMEM63C;SULF2;SULF1;XPNPEP3;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.5070370913873229,0.8971945826242838,0.5757575757575758,0.9155012340126409,1.0,2/9,14.38%,PIP4K2A;LRSAM1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5263792307834501,-0.897183400155927,0.6567164179104478,1.0,1.0,2/13,7.91%,GSTP1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5742449791220849,-0.8966577571450328,0.6119402985074627,1.0,1.0,1/5,5.17%,CHMP2A
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.47645836103137046,-0.8966517231595704,0.6060606060606061,1.0,1.0,4/16,34.17%,BRD8;MSL3;YEATS4;NAA40
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5084086916580794,-0.8966154222558865,0.6142857142857143,1.0,1.0,3/12,17.86%,ABHD1;OXSM;GLYATL2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5102153736722259,-0.8965105491479608,0.59375,1.0,1.0,3/16,16.92%,ELOVL2;ACSBG2;ELOVL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.45233340344416123,0.8964052457905302,0.5555555555555556,0.9167742733461475,1.0,5/26,10.33%,PTPN6;IGF1;IRAK3;PTPN22;DICER1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3781786540698943,0.8961929088487969,0.6206896551724138,0.9166361064053408,1.0,5/34,7.32%,CERS3;ST8SIA6;SGMS1;SPTSSB;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3884758325621959,-0.896049536509617,0.6666666666666666,1.0,1.0,19/65,23.71%,STMN1;CLU;LIMA1;TPX2;PLEKHH2;STMN2;VBP1;MYADM;KATNB1;PFDN2;APOE;PFDN6;HSPA8;PFN2;TUBB4A;PFDN1;APC2;PFN1;NAV3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.43254329430013366,-0.895993899373831,0.6338028169014085,1.0,1.0,2/38,1.48%,XBP1;SFRP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.40273104145190086,-0.895295906568152,0.6075949367088608,1.0,1.0,10/66,9.64%,CD44;GATA1;SFRP1;EFNA1;IL6R;CD81;IL5;HAX1;PDCL3;TGFB1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.4729878280697405,0.8952130837159096,0.631578947368421,0.9180643469362479,1.0,5/14,22.48%,P2RX7;P2RY1;SSH1;RYR3;TRPC3
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.49800653897168645,0.8950135618915852,0.6129032258064516,0.9179918156348705,1.0,3/11,7.34%,NMNAT2;AK3;AK4
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3899665570991857,-0.8948252114774944,0.6891891891891891,1.0,1.0,4/87,1.23%,CACNA2D4;SLC8A3;TRPM1;SELENOK
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.4067514856929523,-0.8945445790729224,0.7164179104477612,1.0,1.0,7/70,8.63%,ACTG1;EFNA1;VAV3;EPHA10;HRAS;APH1A;EFNA2
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.5896138415979709,-0.8940572507206331,0.6481481481481481,1.0,1.0,1/6,0.95%,TTN
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.5855781412403749,-0.8933117030101179,0.671875,1.0,1.0,2/5,29.83%,TOE1;TRIR
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5571796730413545,-0.8932614978827519,0.6774193548387096,1.0,1.0,2/8,12.49%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.4274531085424935,0.8931160594274985,0.6,0.9215115264520303,1.0,4/23,10.33%,TMEM98;JAM2;ITGAX;DICER1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.3662015610588111,0.893041286691899,0.5217391304347826,0.9211226508682765,1.0,26/64,22.52%,SYCP2L;SORBS1;COL9A1;GREB1;ADRA1A;ACACB;ZNF483;ESRRB;LRP1B;CADM2;FGF13;TFDP2;GALNT16;ACVR2B;PTCHD1;CMYA5;MAPT;ADCYAP1R1;MYH7B;ATP1A2;GARNL3;LRRC2;RYR2;DTNA;ADCY2;SLC35F1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.38455588302022325,0.8930252788017775,0.6774193548387096,0.9205854482851844,1.0,4/28,10.29%,PTPN6;PKD1;MN1;FBXW7
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.39663978065506167,-0.8930169118616005,0.6233766233766234,1.0,1.0,9/72,9.63%,DPEP2;P2RY10;PSG2;CR2;P2RY14;STAG3;DOCK8;MAP4K1;GMFG
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.4392215558336367,-0.8928982304955158,0.5942028985507246,1.0,1.0,10/27,22.30%,CENPX;CENPH;CENPQ;CENPK;MIS18BP1;ITGB3BP;CENPU;CENPN;SMARCA5;MIS18A
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.40096615082374065,0.8926080666932521,0.5862068965517241,0.9208089782216257,1.0,5/39,6.47%,ARAP1;AGRN;NLGN1;DPYSL3;ARHGAP44
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.33482498295552826,0.8926050217205168,0.6956521739130435,0.9202478514829164,1.0,24/127,13.85%,SPIRE2;TCAP;CGNL1;TPM2;CASS4;MYO5B;GAS2;DPYSL3;KASH5;RND3;ELMO1;COBL;SPIRE1;CORO6;SCIN;ELMO2;DLG1;BAIAP2L1;MYO1D;ABI2;TMOD2;RHOF;ELMO3;SHROOM3
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5281702004491247,-0.8925622794557623,0.6716417910447762,1.0,1.0,3/11,14.20%,PARP14;PARP12;PARP9
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4223098078360011,-0.8923448377149531,0.6724137931034483,1.0,1.0,8/39,22.61%,NARS1;AIMP1;WARS1;SARS1;AARS1;GARS1;AARS2;TARS3
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.5897105551464649,0.892159651449205,0.6571428571428571,0.9207436191330692,1.0,2/5,10.49%,NOS2;BPIFB1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.384498033172308,-0.891952411416342,0.6144578313253012,1.0,1.0,13/67,19.83%,RPS2;CENPX;FANCM;RBX1;PINK1;PTTG1IP;BRCA1;SPRTN;UBB;SEPTIN4;FANCI;ANGPT1;CAV1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5212242537623616,-0.8916747814152904,0.5483870967741935,1.0,1.0,3/11,20.62%,CEACAM1;ANGPT1;PDE2A
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.46009451149908553,0.8916639259921632,0.5517241379310345,0.9213047562966209,1.0,7/19,19.05%,MBNL1;PKD1;CHD7;FUT8;ZNF568;LIG4;PTPRR
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4565267049897487,-0.8916627811748603,0.6285714285714286,1.0,1.0,8/20,22.28%,ROMO1;TIMM8B;TIMM10;TIMM13;BAX;MOAP1;TOMM70;TOMM22
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.41956166169546,-0.8915518750668645,0.5915492957746479,1.0,1.0,5/29,10.22%,CPS1;NIT2;PYCR3;GLYATL1;DDAH2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.4219632113827951,-0.8911173646409514,0.5753424657534246,1.0,1.0,16/42,26.91%,SF3A1;SNRPD1;SNRNP200;PRPF6;SNRPD2;CRNKL1;DDX1;NCBP1;SMN1;NOL3;SRSF9;SRSF10;SRSF5;SNRPG;KHDC4;SNRPE
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.43145850171174094,-0.8911167193245316,0.6811594202898551,1.0,1.0,3/36,10.69%,SEMA3E;HTR2B;SEMA3A
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.37718154490583505,-0.8908683412203032,0.6708860759493671,1.0,1.0,11/102,17.40%,ARHGAP4;RHOC;ZMYM6;RHOG;CNN2;PAK5;DIAPH3;CFL1;CFAP410;APOE;FGD5
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.5620591756845793,-0.8908165690896186,0.6507936507936508,1.0,1.0,4/5,12.98%,RBP1;ALDH1A2;RBP2;LRAT
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.48576021172317346,0.8907400316925745,0.6428571428571429,0.9228129958836871,1.0,1/7,10.33%,DICER1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5302758490366213,-0.8906461010811659,0.696969696969697,1.0,1.0,4/11,18.71%,CALR;PRAME;SNW1;EZH2
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.4173480505337448,-0.8906319053392794,0.631578947368421,1.0,1.0,3/51,3.46%,HLA-F;HLA-DPA1;PTAFR
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.5057180316167833,-0.8906014768160218,0.6140350877192983,1.0,1.0,1/11,8.16%,RAG2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.41253474775079446,0.8905253681229583,0.5625,0.922721501494961,1.0,5/24,7.68%,DACH1;SRC;GNL3L;HNRNPU;STN1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5082699493123142,-0.8904580491875304,0.6285714285714286,1.0,1.0,2/11,7.51%,SEPHS2;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),-0.5774643643878513,-0.8903620843556421,0.6071428571428571,1.0,1.0,2/5,32.30%,TCIM;RAMP3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.44274074302752237,-0.8900374691587576,0.6060606060606061,1.0,1.0,7/24,26.76%,ANAPC13;UBE2D4;RNF26;CDC23;RNF4;UBE2S;ANAPC11
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.571510416300303,-0.8900260682996389,0.6612903225806451,1.0,1.0,2/6,21.70%,TRDN;NOL3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.4232243442356899,-0.8899086690654061,0.5921052631578947,1.0,1.0,10/50,19.14%,PRDX5;GSTP1;RPS3;ROMO1;HYAL2;TXNRD2;APOD;APOE;PDK2;SOD1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.337308038516793,-0.8898123481573207,0.7362637362637363,1.0,1.0,43/308,19.19%,DDIT3;PARP2;DTX3L;NUDT1;RPS3;APEX1;BCL2L2;VAV3;DDX11;PNKP;POLE3;NOP53;RNF8;WDHD1;FAM111A;RAD51AP1;RFC2;BOD1L1;PARP1;BRCA1;CIDEB;SPRTN;MBD4;MUS81;RFC4;CBX1;UFL1;METTL3;RAD50;XRCC2;KIN;FANCF;XRCC3;REXO4;MRNIP;XPA;RBBP5;BAX;MOAP1;CGAS;ERCC8;RECQL;POLQ
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.47187350083613777,0.889787367572314,0.5483870967741935,0.923716688846647,1.0,1/22,0.13%,CREB3L1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5593153763198782,-0.8894907523047181,0.6949152542372882,1.0,1.0,1/6,3.42%,MSRB1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3702092685305872,-0.8886109519871234,0.6835443037974683,1.0,1.0,27/118,21.54%,NLRP1;SELENOS;LACC1;VPS35;CXCL17;HYAL2;TMSB4X;SELE;GPS2;GRN;TNFRSF1A;NMI;NLRP12;MAPK7;UFL1;APOE;IFI35;SERPINE1;NINJ1;TEK;ZP3;MMP26;SNX6;DAGLA;PDE2A;ALOX5;NR1D1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.4517077313321129,-0.8884973125070352,0.582089552238806,1.0,1.0,7/26,21.73%,CORO1B;LIMA1;BAIAP2L2;AIF1L;LCP1;CALD1;USH1C
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.36738091200709644,0.8881629315532455,0.55,0.9266521446724242,1.0,13/84,7.12%,TNNC2;TCAP;TPM2;MYOM1;OXTR;MYH4;KCNIP2;MYH3;GNAO1;MYOF;DYSF;SORBS1;SMTN
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.26975067932575797,0.8880929703918008,0.875,0.9262296230417708,1.0,194/905,17.06%,VDR;PDGFB;ZNF423;GCM1;ONECUT1;CRX;TP63;NPAS2;IGF1;FLI1;ETV1;KAT2A;MYRFL;RUNX1;SNAI1;CCDC62;ZGLP1;IFNA2;AFAP1L2;TAL1;HDAC4;ATOH8;EGFR;PPARGC1A;RELA;RFX3;ARNT;HNF4G;RXRG;DLX1;LMO7;ZXDC;GRHL2;SUPT3H;PLAC8;HNRNPU;ATF1;ZNF516;CREB5;FOXK1;LPIN3;ARID1B;AGRN;NPAS3;ASCL1;LEF1;PBX1;MAML2;YAF2;LMO2;ZBTB16;WWOX;HIVEP3;SIRT1;MLLT3;MLLT6;TBL1XR1;PKD1;NEK4;SMARCA2;SCX;GLI2;ETV5;BMP6;NFIB;RYBP;PICALM;TRIM16;SERPINF2;NFIA;PHF10;ZNF451;HCLS1;NRF1;NOTCH4;NRIP1;TESC;ZEB2;TCF12;DLL1;CD4;MEIS1;ASXL3;MEIS3;ST18;DMRT1;GABPB1;TOX3;TNKS;MLXIPL;NCOA7;NFKB1;MAFB;CRTC1;OGT;EAF2;ACVR1;ARRB1;RARG;GDNF;RNF14;ZNF304;TEAD1;WAC;MITF;SOX12;SOX30;SMAD4;PCGF5;ARID1A;FGF1;KLF15;RHOQ;THRB;AUTS2;PRKD1;UHRF1;SMARCD2;ZNF318;GRIN1;SCAF8;TRIM44;MEIS2;TEAD2;ELL;STAT6;RGMB;CD80;ESRRB;PID1;NFAT5;ZNF281;ESRRG;ZFPM2;FOXO3;TCF4;VEZF1;SS18L1;KDM1B;ZNF143;RPS6KA1;PLAGL1;MLLT10;SMARCD3;BMPR2;TFDP2;THAP3;KAT2B;GPER1;ATRX;HMGB1;PPRC1;ZNF24;HNRNPD;CEP290;SSBP2;TFEC;HIPK2;BCLAF1;MED13;DYRK1A;SSBP4;PRDM15;SFPQ;PRDM10;ACVR2A;CREBBP;NR4A2;CSRNP1;NR1H3;VHL;SS18;RAI1;KMT2D;CXXC1;CTBP2;RPRD1B;HIVEP1;PTH;DHX9;CAMTA2;PKD2;MRTFA;HMGA1;NCOA2;E2F5;SOX4;KMT2C;GLIS1;ELF1;ADCYAP1;ZNF268;ABL1;FGF2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.5334057930511715,-0.887969970080688,0.6666666666666666,1.0,1.0,4/10,26.14%,ART3;ART4;PADI4;PARK7
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.39528042253986473,-0.887796290217808,0.6811594202898551,1.0,1.0,10/65,19.83%,PPP1R17;VAV3;ARHGAP15;ATP5IF1;STMN3;PLXNC1;FGD5;PLXND1;SOD1;CAV1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4728246457156995,-0.887565636192513,0.6551724137931034,1.0,1.0,2/16,7.22%,KIF20B;RACK1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.5761293253565513,0.8875445172984162,0.6571428571428571,0.926801824841201,1.0,1/6,0.53%,BACE2
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.5610120493481303,-0.8875182118657692,0.6964285714285714,1.0,1.0,2/5,16.74%,GPIHBP1;APOE
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5366399837776381,-0.8872057481485421,0.6065573770491803,1.0,1.0,1/8,1.73%,SELENOS
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.61738521702232,-0.8869164711933961,0.7301587301587301,1.0,1.0,2/5,14.60%,MYADM;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.61738521702232,-0.8869164711933961,0.7301587301587301,1.0,1.0,2/5,14.60%,MYADM;MAPK7
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.3636958736384429,0.8866650745273573,0.7692307692307693,0.9280466875291166,1.0,14/52,11.44%,ZAP70;LEPR;IFNA2;CLEC7A;CHD7;KIF13B;CD4;NHEJ1;ADA;CD276;GPR89B;PTPN22;LFNG;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.45876724878588454,-0.8860917581317309,0.6619718309859155,1.0,1.0,6/26,14.47%,IL7;PARP14;IRGM;FADD;PARP9;EDN1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.48589939639942903,-0.8855972713674635,0.5970149253731343,1.0,1.0,3/16,11.52%,RHBDF1;CEACAM1;IFI6
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4887231268281028,0.8851741830689741,0.5555555555555556,0.9306277287803858,1.0,2/12,9.79%,SNAI1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4449910481706533,0.8851170571445441,0.6296296296296297,0.9301956219782361,1.0,5/27,10.33%,PTPN6;IGF1;IRAK3;PTPN22;DICER1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.5236038528180597,0.8846868227703476,0.6222222222222222,0.929955551225238,1.0,1/5,7.47%,ADAM8
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.5236038528180597,0.8846868227703476,0.6222222222222222,0.929955551225238,1.0,1/5,7.47%,ADAM8
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.4709140223222485,-0.8846588364652169,0.5571428571428572,1.0,1.0,4/18,14.10%,IL31RA;STAT5A;STAT1;NMI
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5183548190279836,0.88461905741801,0.6470588235294118,0.9295328206790934,1.0,1/7,1.43%,SPRY2
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.5729293363098426,-0.8844979425438939,0.704225352112676,1.0,1.0,2/6,9.33%,ABHD1;OXSM
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.4021745608046948,0.8844237389199754,0.5142857142857142,0.9293724210776051,1.0,5/19,9.90%,FGFR1;HSPA1A;EYA4;HSPA1B;GDNF
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.5611057437049801,0.8843699852542771,0.7142857142857143,0.9289341987872158,1.0,1/5,28.23%,ASS1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.36605680612090064,-0.8843071745652493,0.6962025316455697,1.0,1.0,5/109,4.04%,CD44;SERPING1;RNASE1;TGFBR2;HLA-E
prerank,PanglaoDB_Augmented_2021__Podocytes,0.3163764144149815,0.8842955547968688,0.631578947368421,0.928553709237881,1.0,49/163,19.23%,DACH1;LIFR;STARD13;EGFR;CLIC5;LIMCH1;RND3;NPR3;TMEM47;DOCK1;NFIB;EPB41L1;OPTN;BCAM;CHST3;GOLIM4;HTRA1;NUAK1;MAFB;TEAD1;CORO2B;RHPN1;MYO1D;PTH1R;APBB2;LOXL2;CD80;MERTK;RASAL2;PLSCR4;RAB3B;MAGI2;MPDZ;KANK1;COL12A1;NAV2;DOCK5;ARHGAP24;LGR4;COL4A2;MYO1B;PTPRO;QKI;TJP1;RAI14;MAPT;NEBL;ADCY6;TRIB2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.4049891248033688,0.8841322812369031,0.6,0.9282798505827882,1.0,2/17,4.64%,ATP6V0A4;CLN6
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5740310013631121,0.8839609252574787,0.6428571428571429,0.9280716192548789,1.0,2/5,24.11%,STMP1;DDX3X
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.5371541231877028,-0.8838706738625084,0.6716417910447762,1.0,1.0,3/8,27.55%,ZNF830;BLM;DONSON
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.45016835224757223,0.8838538225072555,0.5897435897435898,0.9272401384858833,1.0,6/11,31.85%,NOTCH4;ZFP36;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.45016835224757223,0.8838538225072555,0.5897435897435898,0.9272401384858833,1.0,6/11,31.85%,NOTCH4;ZFP36;TNRC6A;AGO3;TNRC6C;AGO2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.5866149304180255,0.8836100108504781,0.6829268292682927,0.9271306773773382,1.0,2/5,15.23%,TRIP11;TBC1D23
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.37953732271710666,0.8834149713231546,0.6428571428571429,0.9270132052811071,1.0,7/37,13.95%,CRACR2A;P2RX7;DRD4;GDNF;DLG1;RAB3B;STIM2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4433408548894985,-0.8834078217637756,0.578125,1.0,1.0,1/24,0.62%,RIMS1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3101044153782873,0.8833925411901996,0.8,0.9264808535765421,1.0,15/98,11.00%,SPRY2;BAG2;HSPA1A;ADGRB1;NXN;GNL3L;SASH1;PAXIP1;ARRB2;HSPA1B;MALT1;OGT;ARRB1;FBXW7;DCUN1D1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3238543036735729,0.8831941526375618,0.76,0.9263232486708025,1.0,13/71,10.96%,SLC26A7;CA12;SLCO2B1;SLC39A8;SLC26A6;LRRC8A;SLC52A1;SLC25A41;SLCO1C1;CA2;AQP1;SLC4A4;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.5709712787031049,-0.8831447057235262,0.7049180327868853,1.0,1.0,1/6,0.68%,SLC8A3
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.3692249006580027,-0.8820631058113604,0.735632183908046,1.0,1.0,21/153,10.22%,CYP1A2;SLC6A12;AQP9;JUP;HES6;MT2A;GSTM4;BLVRB;RETSAT;ADH5;PGRMC1;SERTAD1;CBR1;MTHFD1;FBLN1;DHRS7;BPHL;SPINT2;PMM1;PINK1;DDAH2
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.5061998403097633,-0.8820537057046436,0.6666666666666666,1.0,1.0,6/12,30.12%,IFT122;DYNC2H1;DYNC2I1;WDR35;DYNC2I2;TTC21A
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.4854044419688932,-0.8818400320996111,0.5873015873015873,1.0,1.0,6/15,26.04%,OSBP;CAV1;NPC2;ABCG5;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.2837531031769357,0.8817059535474472,1.0,0.9290593644900552,1.0,168/686,17.84%,VDR;PDGFB;GCM1;ONECUT1;CRX;TP63;NPAS2;IGF1;ETV1;KAT2A;RUNX1;CCDC62;ZGLP1;TAL1;HDAC4;ATOH8;EGFR;PPARGC1A;RELA;RFX3;ARNT;HNF4G;RXRG;DLX1;LMO7;GRHL2;PLAC8;HNRNPU;ATF1;LPIN3;CDK12;AGRN;ASCL1;LEF1;PBX1;MAML2;LMO2;WWOX;SIRT1;MLLT6;TBL1XR1;PKD1;SMARCA2;SCX;GLI2;ETV5;BMP6;NFIB;SERPINF2;NFIA;PHF10;PAXIP1;ZNF451;HCLS1;NRF1;NOTCH4;NOTCH3;NRIP1;ZEB2;TCF12;DLL1;MEIS1;ASXL3;MEIS3;ST18;DMRT1;TGFB2;GABPB1;TOX3;TNKS;MLXIPL;NCOA7;NFKB1;CRTC1;OGT;EAF2;ACVR1;ARRB1;RARG;GDNF;ZNF304;TEAD1;MITF;SOX12;SOX30;SMAD4;PCGF5;FGF1;KLF15;RHOQ;THRB;AUTS2;PRKD1;UHRF1;SMARCD2;GRIN1;MEIS2;ELL;STAT6;ESRRB;PID1;NFAT5;ZFPM2;FOXO3;TCF4;VEZF1;SS18L1;KDM1B;ZNF143;RPS6KA1;PLAGL1;MLLT10;SMARCD3;BMPR2;TFDP2;THAP3;KAT2B;GPER1;ATRX;HMGB1;PPRC1;ZNF24;SSBP2;TFEC;HIPK2;BCLAF1;MED13;SSBP4;PRDM15;SFPQ;PRDM10;ACVR2A;CREBBP;NR4A2;CSRNP1;NR1H3;SS18;KMT2D;CTBP2;SMAD9;RPRD1B;HIVEP1;PTH;DHX9;CAMTA2;PKD2;MRTFA;HMGA1;NCOA2;E2F5;SOX4;KMT2C;GLIS1;ELF1;ADCYAP1;ZNF268;ABL1;FGF2;WWC1;CEBPG;GCN1;RGCC;SMAD2;HDAC1;RSF1;MAFF;BMPR1B;WNT5A
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5810251996318264,-0.881662969183883,0.6901408450704225,1.0,1.0,1/5,3.65%,EFNA1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.48825004866602756,-0.8815627668114555,0.7121212121212122,1.0,1.0,4/14,21.86%,PHPT1;CEACAM1;CD160;LGALS3
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.5569508549254524,-0.8811387676732451,0.6984126984126984,1.0,1.0,2/5,37.80%,SLC6A17;SLC36A1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3659315370668598,0.8810553463176866,0.6551724137931034,0.9297208282157949,1.0,10/36,17.08%,YAF2;RYBP;PHC3;MGA;EED;TFDP2;PHC1;RAD51;EHMT1;RNF2
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.5535737823239153,-0.8810399545805637,0.6851851851851852,1.0,1.0,1/6,5.55%,ORC6
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3617709301507135,0.8809851063710317,0.68,0.9293099024368058,1.0,4/37,2.63%,IGF1;FGFR3;CTF1;IFNA2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.4043247745791229,-0.8808610439558361,0.6029411764705882,1.0,1.0,10/38,22.82%,RPS27A;LACC1;UBA52;UBB;CNPY3;HSP90B1;CTSS;S100A1;UBC;CTSL
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.40670619785396567,-0.8804059043249891,0.6027397260273972,1.0,1.0,8/43,11.54%,SLC6A12;SLC10A6;SLC10A3;SLC16A1;CEACAM1;SLC27A5;SLC16A8;SLC51A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4128090080903444,0.8803464388986714,0.5,0.9300109904519083,1.0,1/28,0.24%,RAB27A
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.383291022672691,0.880024260380752,0.6666666666666666,0.9300706724655451,1.0,17/78,12.66%,TNC;PCDH18;NRP2;NXN;DPYSL3;RND3;FBLIM1;GLI2;TMEM47;NOTCH3;CDH11;CHST3;CD276;CSRP2;GFPT2;FBXL7;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.53367533230276,0.8799302978218527,0.6666666666666666,0.9297251034921192,1.0,3/7,29.00%,CDKN2A;E2F3;PDCD4
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3988316580498121,-0.8798652139558241,0.6081081081081081,1.0,1.0,13/51,25.33%,CELA2A;TPP1;CEACAM1;USE1;RNF5;APOE;HSPA8;NR1D1;FBXO6;PPT1;DENND3;HTRA2;DDB1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.49381293052146513,0.8797235785477904,0.4838709677419355,0.9296391075738071,1.0,4/12,16.72%,ASCL1;GDNF;ARX;SOX4
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3776111154017005,0.8797111523107848,0.7142857142857143,0.9291242371562805,1.0,11/28,21.73%,P2RX7;BMP6;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B;SLC8A1;WNT4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.4214881992969193,-0.8796494129127926,0.696969696969697,1.0,1.0,2/25,0.68%,RIMS1;SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5207760944942217,-0.879472108887039,0.6440677966101694,1.0,1.0,3/9,21.40%,STOML2;WIZ;DBF4
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.46111993696773884,0.8794406519168282,0.6,0.9292085732847956,1.0,2/10,7.14%,IFNA2;TRIM11
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.4270529207249583,-0.8792516466639692,0.6619718309859155,1.0,1.0,4/31,5.87%,CLU;GSAP;EFNA1;LRRTM3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3088589847932729,0.8788920192739915,0.7368421052631579,0.9299152961488172,1.0,16/157,7.16%,PDGFB;PDGFC;IGF1;SPRY2;SNAI1;CASS4;FLT1;EGFR;PDGFRA;CLEC7A;LEF1;AKT2;TMSB15B;IGF1R;SEMA5B;ITGAX
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.6212506951797162,-0.8788788727776458,0.7636363636363637,1.0,1.0,3/6,18.39%,RAD51AP1;MEIOSIN;OOEP
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.45378731581773585,-0.8786090737835701,0.6865671641791045,1.0,1.0,1/19,1.46%,ACTG1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.4985953421212596,-0.8785868027171734,0.6307692307692307,1.0,1.0,7/12,29.05%,SLC25A11;LRRC8D;SLC1A6;SLC1A1;SLC25A30;SLC25A10;SLC25A12
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.4719734811844243,-0.8785096825314154,0.6612903225806451,1.0,1.0,4/19,15.56%,GFRA3;PMP22;BDNF;GSTM3
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.42271434623159443,-0.8782756087569021,0.6805555555555556,1.0,1.0,5/38,5.46%,DUOX1;TMC4;CFTR;TMEM125;CXCL17
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.39939316076938586,0.8782521006054738,0.7391304347826086,0.9306858116187341,1.0,7/27,11.53%,SRC;EGFR;NRG2;MATK;ERBIN;GAB1;PIK3CA
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.4960828638070719,0.8782407323702982,0.5789473684210527,0.9301473209154177,1.0,4/6,25.43%,ALDH1A1;GAD1;BCAT1;GAD2
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.4662603815536684,0.878025006299775,0.625,0.9300210318044031,1.0,4/12,19.39%,NT5E;NT5M;UPP1;DPYD
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.3130147328948989,0.8778391360677178,0.6923076923076923,0.929806178000071,1.0,21/206,11.12%,F2;LEPR;VEGFD;FGF17;HSPB1;EGFR;AGER;LIMCH1;PROM2;AKT2;SIRT1;FNIP2;SESN2;TNIK;NTRK2;CD4;WDFY2;ARRB1;C3;FGF1;PLXNB2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.46243668401850796,0.8776987647444703,0.5806451612903226,0.9295754594105844,1.0,5/14,13.86%,KCNJ2;ATP12A;ATP1B3;SLC12A2;KCNMA1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5494563786188448,-0.877646344849155,0.66,1.0,1.0,1/6,7.63%,DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5494563786188448,-0.877646344849155,0.66,1.0,1.0,1/6,7.63%,DOLK
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.49327784666860897,0.8774399114685825,0.627906976744186,0.9296511208774585,1.0,2/8,11.90%,HMGCR;MVD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.47999491283631535,0.8774393772068256,0.6571428571428571,0.9290987435031997,1.0,2/8,9.17%,SIRT1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.3451144115905415,0.8773425815145077,0.6923076923076923,0.9287883975580105,1.0,2/71,1.07%,PDGFB;IGF1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.4344197289493965,-0.8773402088434934,0.6615384615384615,1.0,1.0,4/22,15.93%,SIGIRR;C1QBP;NMI;RNF26
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.4157408195644061,-0.8772130867209971,0.6621621621621622,1.0,1.0,1/42,0.08%,C1GALT1C1L
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5577983979775878,0.8768026334145212,0.6285714285714286,0.9293548967855897,1.0,4/9,20.41%,CSGALNACT1;GFPT2;GFPT1;EXTL2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.40738497279265246,-0.8767803783719162,0.6447368421052632,1.0,1.0,6/41,13.12%,BMP5;ALDH1A2;LMX1B;TGFB1;BRCA1;MYH6
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3986613844351508,-0.876577496139871,0.6721311475409836,1.0,1.0,13/41,19.95%,DDIT3;BCL2L2;RACK1;LCK;PINK1;PPIF;RTKN2;SEPTIN4;DNM1L;BAX;NDUFS3;CAV1;FIS1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.37540602035683185,-0.8763002696412381,0.654320987654321,1.0,1.0,10/107,7.08%,CENPF;SLC6A12;AQP9;TCN2;SLC3A1;SLC25A45;CHMP2A;SLC7A14;SLC22A4;SLC7A7
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.39337521625662586,-0.8762944184814486,0.6,1.0,1.0,7/54,8.52%,GBP2;APOL6;PTAFR;HLA-E;IL6R;IRF1;GPR183
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.5343121101524179,-0.8761460500061339,0.609375,1.0,1.0,2/7,9.88%,CD81;FADD
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.4612196810991894,-0.8759757404388214,0.5892857142857143,1.0,1.0,4/16,22.64%,TGFB1;ASPN;GREM1;HEY2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.3877290753985751,0.8751371199118668,0.6060606060606061,0.9323637599173802,1.0,4/29,9.80%,PPARGC1A;PAXIP1;FAM47E;ARRB1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.33107415057386486,0.8745005413209213,0.7083333333333334,0.9331121935675452,1.0,12/69,14.74%,ADGRB1;CTNNA2;LRP4;PLPPR4;DOCK7;DSCAML1;TBCD;CELSR2;PARD6B;DCDC2;NTNG1;RYK
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.5362632487995488,0.8743821713390875,0.6428571428571429,0.9328644196481446,1.0,1/7,2.85%,KCNIP2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.4304733943145786,-0.8743210505099616,0.7384615384615385,1.0,1.0,4/34,13.88%,XBP1;ATG14;HSPA5;MYBBP1A
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.36232631922038755,0.874202968401029,0.6363636363636364,0.9327372695497869,1.0,10/32,15.22%,STARD13;PRKX;ADGRA2;PTP4A3;ZEB2;PIK3CA;LOXL2;KANK1;TESK1;ANLN
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.367417701709226,0.8739073478222839,0.7,0.9326984600213649,1.0,6/45,8.95%,SPIRE2;PSTPIP1;DIAPH1;COBL;SPIRE1;SCIN
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.6212905130447002,-0.8736906764913807,0.7931034482758621,1.0,1.0,1/5,19.73%,ATL3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.37861237684381327,0.8736647267662759,0.5757575757575758,0.9327077716363008,1.0,5/27,16.33%,CDK6;CDKN2A;DLG1;PTEN;PKD2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4173292406771734,-0.8736496319121111,0.6438356164383562,1.0,1.0,8/36,25.85%,EEF1AKMT2;TRMT112;BHMT;EZH2;METTL21A;CSKMT;ETFBKMT;FAM98A
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.4469512597815646,0.8733546631066332,0.5833333333333334,0.9327571112686152,1.0,7/27,13.18%,IGF1;IRS1;AKT2;SORBS1;RHOQ;PID1;ENPP1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.4776663349425186,0.873338107167487,0.7096774193548387,0.9322221681500004,1.0,2/14,3.48%,AIFM2;COQ2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.43062271934757423,-0.8733054449694128,0.6712328767123288,1.0,1.0,4/25,19.32%,PCNA;RPA3;POLD2;POLD4
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.39861934888374845,-0.8732519333907236,0.6533333333333333,1.0,1.0,11/51,19.03%,DPEP2;AQP9;PTAFR;CEACAM1;DOCK8;CR1;ARG2;CLEC12A;LILRB3;IGSF6;CTSS
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.41988492722559595,0.8730293764019893,0.5581395348837209,0.9323277246443625,1.0,3/11,15.59%,MTMR2;NECAB2;ANKRD13D
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3792018617076531,-0.8730091198237234,0.7051282051282052,1.0,1.0,10/76,12.29%,ZDHHC12;SRP14;NACA;YIF1B;SEC62;GET3;AQP11;SRPRA;NACAD;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.543178512434363,-0.8729879666898381,0.65625,1.0,1.0,1/8,7.91%,CEACAM1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4634269900891109,-0.8728632291745303,0.6142857142857143,1.0,1.0,6/16,25.70%,TYMS;PPIA;POLD2;POLD4;CDKN2D;POLL
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.4530582948452159,-0.8726539152040362,0.6923076923076923,1.0,1.0,6/19,25.81%,VPS35;PINK1;DNM1L;FIS1;BNIP3;DCN
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.44224801568062894,0.8725607746154168,0.6538461538461539,0.9327768827512705,1.0,8/27,16.85%,SORBS1;ASXL3;MLXIPL;C3;ADIPOR2;GPER1;PDK4;ZBTB20
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.37213427973224555,-0.8724093637116119,0.675,1.0,1.0,32/119,27.37%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;PLK4;CEP135;PRKACA;CEP41;TUBB;TUBA4A;FOXM1;TUBB4A;USH1C;DYNC1H1;OFD1;NES;BORA;YWHAE;BRSK1;FBXL15;TUBG1;MAPRE1;CEP76
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3484850085505006,-0.872274491008091,0.7317073170731707,1.0,1.0,15/136,13.68%,BMP5;SFRP1;ZFPM1;BBS12;EFNA1;IL17RD;OVOL2;BAMBI;CALR;TGFB1;GPS2;HOPX;PAF1;WNT9A;PRAME
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5711095822918907,-0.8720727487697365,0.6923076923076923,1.0,1.0,1/7,2.82%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3676479187663363,0.871999347618697,0.5925925925925926,0.9334012673969617,1.0,4/31,2.63%,IGF1;FGFR3;CTF1;IFNA2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.4531604247796764,-0.871937661608207,0.696969696969697,1.0,1.0,3/19,8.03%,CHMP2A;TRIM13;TRIM25
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.4562489935849086,-0.8718920435848063,0.7272727272727273,1.0,1.0,5/19,21.21%,JUP;CALM3;RANGRF;CAV1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.44610940132092586,-0.8717210350933895,0.6833333333333333,1.0,1.0,4/19,21.86%,PPP1R11;BOD1L1;PTPA;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.3247466743557463,0.8713519483880955,0.7391304347826086,0.9343043635518735,1.0,24/130,16.09%,PTPN6;SPRY2;SAMSN1;SPRED3;SPRED2;HSPB1;ERRFI1;SPRED1;SNCA;CEP85;GSKIP;MLXIPL;PID1;SLIT2;DMD;ENPP1;TESK1;PRKCZ;PTEN;TRIB3;PPM1E;NIBAN1;CORO1C;IBTK
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5171010239207442,0.8713431496157741,0.6774193548387096,0.933786043445487,1.0,5/8,29.83%,CAMK2D;NEDD4L;WNK1;WNK2;COMMD1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.47404792020715747,0.871289163726507,0.5833333333333334,0.9334198549159234,1.0,3/15,6.46%,DPYSL3;SARM1;DHFR
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.4011195466035261,0.871149789177804,0.8148148148148148,0.9331098880435051,1.0,8/26,17.64%,CHKA;LPIN3;GPAT4;LCAT;SLC44A5;LPCAT1;SLC44A1;ABHD3
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.39392175218758096,-0.8710737218706118,0.7313432835820896,1.0,1.0,20/50,26.14%,XBP1;ALDH1A2;ACMSD;ACSM6;OXSM;SLC27A5;NDUFAB1;ACSM3;OSBP;LIPH;HSD17B10;LIPI;AKR1D1;ALOX5;HSD17B8;SDS;OSBPL2;CYP27A1;ACOT8;PARK7
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.4239775787451521,-0.8709363654520615,0.726027397260274,1.0,1.0,3/40,4.70%,SLC8A3;NPR2;NPPC
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.34247201874169164,0.8708934952191657,0.6756756756756757,0.9330472141230423,1.0,12/36,22.73%,SRC;ADAM8;ADA;MEGF10;CELSR2;AFDN;ZDHHC2;FUT9;PTPRR;MDGA1;EPHB3;EFNA5
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.37976236242166106,-0.8708469923503483,0.7215189873417721,1.0,1.0,15/80,23.09%,CLU;GPIHBP1;PHB2;PTTG1IP;ACBD5;APPL2;APOE;CSE1L;RAN;NUP50;FIS1;ATAD1;KPNB1;TOMM22;PXMP4
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3096934893224514,0.8705546504104262,0.8461538461538461,0.9330801429150138,1.0,16/111,12.96%,COLEC11;STAB1;PDLIM7;AP1G2;TMEM108;SNCA;PICALM;ARRB2;MRC1;DLL1;SNAP91;HSPH1;DNAJC6;ACKR3;NLGN3;LRP1B
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.33594656354894864,-0.8705163869001363,0.7790697674418605,1.0,1.0,17/233,9.88%,ARHGEF16;RPS27A;SFRP1;IFIT2;CLU;NEURL1;RPS6;VAV3;RASGRF2;HRK;UBA52;SFRP4;RACK1;PRR7;APH1A;ZNF622;FADD
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5077340070949492,0.8703148173492921,0.7037037037037037,0.9330812087119814,1.0,4/11,13.75%,PRKX;DLG1;LOXL2;BMPR2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.4278110098562582,0.870154449038945,0.7222222222222222,0.9329630020808408,1.0,8/18,28.51%,AGMO;ACER1;ST3GAL6;FUT2;CERK;CYP1B1;TECR;ARV1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.4752727541566533,0.8700549943788802,0.6333333333333333,0.9326303719063797,1.0,3/10,21.39%,CEP290;DCX;MYO7A
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4029869862333278,0.8693930722887506,0.65,0.9334894452016563,1.0,7/32,11.77%,ABCC8;SLC7A2;SLC7A1;PKD2L1;SLC7A5;SLC25A29;ATP13A2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.49031462298467854,-0.8691599965237463,0.6865671641791045,1.0,1.0,5/16,24.06%,FSHR;AKAP7;TCIM;AKAP5;PRKAR1B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4848748035769934,-0.8689338797614494,0.7230769230769231,1.0,1.0,1/20,1.25%,XBP1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5244557136133615,0.8688890861784079,0.6,0.9333720994253076,1.0,5/7,24.94%,CXCL13;WNT5A;WNK1;STK39;OXSR1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5244557136133615,0.8688890861784079,0.6,0.9333720994253076,1.0,5/7,24.94%,CXCL13;WNT5A;WNK1;STK39;OXSR1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.38238415580568796,-0.8688496407465846,0.7317073170731707,1.0,1.0,14/99,10.72%,B2M;DTX3L;IFIT2;ZFPM1;RPL11;GTF2F1;DDX11;BAMBI;RACK1;CAMK1;FLOT1;PPP1CA;TFIP11;LRPAP1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.5033482322132509,-0.8687625973961155,0.7166666666666667,1.0,1.0,1/10,0.98%,NOX4
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3744627421132359,0.868568372404591,0.5,0.9334681284273249,1.0,2/38,1.91%,PPP1R36;PLIN5
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5432375096593979,-0.8683705519342148,0.6610169491525424,1.0,1.0,1/7,7.73%,RNF8
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3507699417610505,0.8683617929719456,0.5,0.9332946457026078,1.0,6/50,5.63%,IRAK2;RELA;MAP3K14;TICAM1;TBKBP1;TRAF2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.3985908002870292,-0.8683168361198589,0.7466666666666667,1.0,1.0,7/66,9.63%,DPEP2;P2RY10;IL7;CR2;ZBTB32;MAP4K1;GMFG
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.49228675836964025,-0.8682935126169437,0.640625,1.0,1.0,2/19,7.77%,XYLT2;SGSH
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.35092509404765015,-0.8682039446445496,0.7051282051282052,1.0,1.0,10/125,10.31%,CD44;SFRP1;TGFBR2;CORO1B;HYAL2;OVOL2;RACK1;VIL1;TGFB1;STMN2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.3585203285859968,-0.8678000377361468,0.7341772151898734,1.0,1.0,21/114,19.73%,GBP2;SEC61B;RPL11;VPS35;ARL1;RAB11A;CALR;GABARAPL2;IFT122;SCG3;PAF1;SSB;FSIP2;FAM149B1;LAMP1;XPA;CCDC47;DDX1;ATP6V1D;EMD;TRAM1L1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.4431677425268856,-0.8673665848365911,0.7121212121212122,1.0,1.0,3/24,12.37%,DTX3L;ATXN7L3;PAF1
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.5334003873235192,0.8670646944394746,0.6595744680851063,0.9354811923595643,1.0,1/6,3.51%,CPT1C
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.48076390850094963,-0.8668790132372132,0.7205882352941176,1.0,1.0,5/21,21.21%,JPH3;PLN;PRKACA;HPCA;CALM1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.40481517096276487,-0.8667273296833605,0.6216216216216216,1.0,1.0,3/44,4.20%,ARHGAP4;TAX1BP3;RHOG
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.5523002786887486,-0.8667045832804389,0.6290322580645161,1.0,1.0,3/5,25.11%,EIF5A;USP16;EIF5A2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.5128130594253701,-0.8664305463157308,0.7101449275362319,1.0,1.0,4/11,14.20%,DTX3L;DDX11;KDM4D;PARP9
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4021293925152964,-0.8651662261748586,0.7432432432432432,1.0,1.0,5/47,10.90%,TOMM7;UBL5;ARIH2;PINK1;ABLIM3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.384569515335906,0.8649052475714413,0.6785714285714286,0.9392322072645334,1.0,5/25,8.05%,HSPA1A;MAPK11;TAL1;ARNT;HSPA1B
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.5138015625276484,-0.8648628274791138,0.6545454545454545,1.0,1.0,1/8,5.35%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4261865632975685,-0.8644768430750417,0.6716417910447762,1.0,1.0,6/25,12.02%,SFRP1;PTK6;HYAL2;PARP14;SH3BP5;CADM4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.3264420905053705,0.8643593259928003,0.6,0.9397912595672138,1.0,26/137,11.42%,STAB1;RUNX1;SPRY2;FLT1;VASH1;ADGRB1;YJEFN3;VEGFD;HSPB1;ADGRA2;SPRED1;SIRT1;SASH1;ITGAX;RHOJ;CEMIP2;TGFB2;CXCL13;AQP1;GAB1;ZNF304;STIM1;FGF1;VASH2;ECM1;PRKD1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.3891587006089261,-0.864333671276182,0.7096774193548387,1.0,1.0,6/44,9.88%,DDIT3;RPS3;HYAL2;RACK1;LCK;FADD
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.34399491806281723,-0.8643249337898441,0.788235294117647,1.0,1.0,13/123,10.30%,PLAAT4;MUSK;DTX3L;RPS2;DBI;PCNA;EPHA10;PNKP;DSCC1;ZNF622;TGFB1;PINK1;RFC2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.3923511343708925,-0.8643010842119758,0.6883116883116883,1.0,1.0,11/61,10.72%,B2M;IFIT2;ZFPM1;GTF2F1;DDX11;RACK1;ADAM15;CAMK1;PPP1CA;TFIP11;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.5386325103436003,0.8642487671027027,0.6842105263157895,0.9394405821364106,1.0,5/7,19.57%,ADAM19;SERPINF2;AFDN;TJP1;PTPRU
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.40190897993845554,-0.864168442818544,0.6619718309859155,1.0,1.0,2/27,3.35%,AQP9;CFTR
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.5249355653976925,0.8641637222094328,0.6363636363636364,0.9385588498464056,1.0,2/5,13.18%,SLC52A1;ENPP1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.5249355653976925,0.8641637222094328,0.6363636363636364,0.9385588498464056,1.0,2/5,13.18%,SLC52A1;ENPP1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.45046073527867314,-0.8641262068615426,0.671875,1.0,1.0,2/22,2.82%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4492721618762522,-0.8640178116264841,0.6764705882352942,1.0,1.0,8/22,17.88%,MTHFD1;PRPS1;GMPR2;PRPSAP1;DCK;APRT;PAICS;PRPS2
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5269395394656655,-0.8639708899804246,0.703125,1.0,1.0,2/9,16.08%,SLAMF8;ECSIT
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.38616760517235243,0.8639191162724913,0.6590909090909091,0.9385646073018695,1.0,6/27,19.07%,PLK1;LLGL2;NSFL1C;CLASP1;NDE1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.3607560824665613,0.8631188428514588,0.6296296296296297,0.9394930920886068,1.0,15/60,17.18%,TP63;PLK1;TAL1;MLLT3;AURKC;DLL1;FSD1;CCP110;FGF1;ESRRB;PRDM15;AHCTF1;TXNIP;BCL2L1;CSPP1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.4647442378800364,-0.8629596444944431,0.6712328767123288,1.0,1.0,2/21,7.22%,XBP1;RACK1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.4290533795662095,-0.862909807423109,0.5967741935483871,1.0,1.0,5/24,13.53%,LIMA1;TPX2;PLEKHH2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4059199823802999,-0.8628900070709713,0.7213114754098361,1.0,1.0,16/36,29.84%,ATG14;PHB2;PINK1;GABARAPL2;CISD2;MAP1LC3B;WDR45B;FIS1;BNIP3;SQSTM1;FUNDC1;ULK2;WIPI2;MAP1LC3A;FBXO7;FUNDC2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.5189800542332785,0.8623856670422451,0.6326530612244898,0.9406490754189768,1.0,1/6,1.27%,KAT2A
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3454253461995737,-0.8622507049811025,0.75,1.0,1.0,13/158,8.65%,CD44;APIP;IL26;PDGFD;GSTP1;FBLN1;CEACAM1;RASGRP1;HRAS;HTR2B;PHB2;GPR183;FSHR
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.562133438580301,-0.8619048863813312,0.7291666666666666,1.0,1.0,1/5,7.85%,PAX8
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.43928375245415907,-0.8618448706361113,0.609375,1.0,1.0,3/27,7.95%,SEMA3E;PLET1;ADAM15
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.44528067973065244,0.8614631755692278,0.5588235294117647,0.9421897093969943,1.0,2/14,4.73%,KAT2A;C10ORF90
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.5030280838985948,-0.8610795824016781,0.65,1.0,1.0,2/8,11.06%,EFNA1;GRN
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5355981883201163,-0.8610645401859848,0.671875,1.0,1.0,2/6,23.41%,ATP23;TMEM70
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.5290567245144461,-0.8607937719939297,0.7288135593220338,1.0,1.0,1/6,9.64%,TGFB1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.39872492498572354,-0.8606616301711074,0.6857142857142857,1.0,1.0,4/34,10.46%,CR2;SLC25A5;RAG2;GPS2
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.50250053168638,-0.8606033445993782,0.676923076923077,1.0,1.0,2/10,6.99%,RIMS1;SLC22A4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.48500323981035975,-0.8605049923326675,0.6865671641791045,1.0,1.0,4/18,13.84%,CXCL17;TGFB1;BRCA1;SARS1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.5395439103148488,-0.8604695781424853,0.7,1.0,1.0,1/9,6.31%,VAMP8
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.32780663882967775,0.8593054625951316,0.7777777777777778,0.9460195575519731,1.0,17/67,17.54%,ACER2;CNOT2;SESN2;PAXIP1;CRADD;CNOT11;PIDD1;CNOT4;CNOT6L;PLAGL1;TFDP2;ATRX;RPS6KA6;HIPK2;SOX4;MDM4;RGCC
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.45571304115801897,-0.8592688163269266,0.6956521739130435,1.0,1.0,3/19,1.73%,DDIT3;XBP1;SELENOS
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.5391647838571708,-0.859220814316102,0.711864406779661,1.0,1.0,2/6,14.88%,TGFBR2;DOCK2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.35501131173577716,-0.8591981281538776,0.7619047619047619,1.0,1.0,16/89,19.46%,SLC10A6;CPTP;FABP3;SLC10A3;PRELID1;CEACAM1;SLC27A5;TRIAP1;SLC51A;ABCA12;APOE;OSBP;APOL2;ATP8B1;ABCA5;STARD5
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.441788595604291,-0.8591224178926602,0.7121212121212122,1.0,1.0,9/27,19.83%,SFRP1;TRIM25;AR;CITED4;BRCA1;SFR1;GSTM3;RBBP5;CAV1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4348353090703929,-0.8588902976112451,0.6567164179104478,1.0,1.0,11/31,26.91%,CSTF2T;FIP1L1;LSM10;CPSF3;NCBP1;CLP1;TTF2;SSU72;SNRPG;NCBP2;SNRPE
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.45701121726265703,-0.8585628132826143,0.6818181818181818,1.0,1.0,7/16,28.89%,EIF2B1;MYRF;EIF2B2;EIF2B4;PLP1;PRDM8;EIF2B5
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5506018372587931,-0.858559013951938,0.7540983606557377,1.0,1.0,2/6,11.37%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5506018372587931,-0.858559013951938,0.7540983606557377,1.0,1.0,2/6,11.37%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.35837851223312284,0.8581929712322672,0.7419354838709677,0.9479644348213413,1.0,3/26,3.13%,FLT1;VASH1;ATOH8
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3280700946041041,0.858109668698462,0.7916666666666666,0.9475636631869758,1.0,22/91,14.53%,EGFR;MTCL1;NXN;LRP4;CSPG4;EHD2;RND3;GLI2;OBSL1;CHST3;MEIS3;LOX;HTRA1;NUAK1;CD276;TEAD1;AMH;TEAD2;FIGN;MPDZ;AMOTL1;COL12A1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.3286668473791957,0.8580174382398951,0.6428571428571429,0.947179074821011,1.0,16/69,12.28%,RUNX1;FLT1;VEGFD;HSPB1;SIRT1;SASH1;ITGAX;AQP1;GAB1;ZNF304;STIM1;FGF1;VASH2;ECM1;PRKD1;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.4789674928968526,-0.8578124724997348,0.6615384615384615,1.0,1.0,2/15,8.56%,RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.40126551736987426,-0.8577908994533323,0.7066666666666667,1.0,1.0,10/43,13.05%,ASAH2B;DEGS1;ORMDL2;DEGS2;SGMS2;ORMDL1;SMPD2;SGPL1;ABCA12;ASAH2
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.43214158984774315,0.8577877439479189,0.5945945945945946,0.9470384253270827,1.0,1/15,0.94%,TNNC2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4741750678799879,-0.8575928802789872,0.7313432835820896,1.0,1.0,5/18,19.83%,IGSF8;MYL6;CAV2;SVIL;CAV1
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.5231336213909776,-0.8575620457654841,0.6981132075471698,1.0,1.0,4/5,23.92%,EDN1;SCG5;SNX6;VAMP3
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.33642171775079366,0.8575551547399646,0.6086956521739131,0.9469528892393398,1.0,17/69,14.23%,VAPB;KCNJ2;ATP12A;LETM2;SLC24A3;ATP13A1;DRD4;ATP1B3;STIM1;ATP13A2;SLC12A2;PTH1R;SLC8A2;ATP2C1;KCNMA1;STIM2;TMEM165
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.5547054078666853,-0.8572375921875203,0.7547169811320755,1.0,1.0,1/6,6.70%,NOP53
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.40575417265745917,-0.8569166368012837,0.6619718309859155,1.0,1.0,5/26,11.11%,MAGEF1;CLU;PSMC5;ATP5IF1;PSMC3
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.37785225228006936,0.8569087886516383,0.6071428571428571,0.94760493069097,1.0,6/41,6.48%,F2;EPB41L4B;MYO5B;HNF4G;MAP2K4;RNF128
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.4877550829495767,0.8562359064245082,0.5428571428571428,0.9486561072173482,1.0,3/8,15.02%,ROBO1;SLIT2;SLIT3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.4155554530815796,0.8560040828085086,0.6333333333333333,0.9486011296890502,1.0,4/21,8.80%,ACER2;TESC;ADA;TGFB2
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.49649433790273756,0.8553952971552813,0.6136363636363636,0.9492745834252906,1.0,2/6,21.69%,ERC2;ERC1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.5941683941831795,-0.8552558704075224,0.7868852459016393,1.0,1.0,1/6,1.43%,GAPDH
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.4441900573155657,-0.8551298406200774,0.6142857142857143,1.0,1.0,5/18,20.31%,SURF1;COX17;SMIM20;COA5;TIMM21
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.4464393176223458,0.8550734925130643,0.6857142857142857,0.9493288955324775,1.0,1/14,1.48%,SGO1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.5218233152736047,0.8545319385735689,0.675,0.9498916312817134,1.0,1/6,5.09%,NLGN1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.34287264523659655,0.8544874875918863,0.7692307692307693,0.9493982399423055,1.0,13/35,20.91%,LIMK1;L1CAM;DIP2B;RUFY3;GSK3B;TRIM46;ABL1;NRCAM;MAPT;ZFYVE27;MAP2;DNM2;MACF1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.34521564839727914,0.8544616071398468,0.7241379310344828,0.9489054176817207,1.0,1/48,0.18%,VAPB
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.3251792889537714,0.8541715116817309,0.6296296296296297,0.9489520080088426,1.0,17/79,12.28%,RUNX1;FLT1;VEGFD;HSPB1;SIRT1;SASH1;ITGAX;DLL1;AQP1;GAB1;ZNF304;STIM1;FGF1;VASH2;ECM1;PRKD1;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.47096699482976456,-0.8540564869718815,0.7205882352941176,1.0,1.0,1/10,0.69%,SLC25A4
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3128525024269644,0.8540295030478485,1.0,0.9486863509801313,1.0,123/791,12.84%,CREB3L1;VDR;PDGFB;RAB27A;EPB41L4B;ZNF423;NFKBIZ;GCM1;ONECUT1;CRX;ABCC2;IGF1;NOS2;RUNX1;SPRY2;MYOM1;HSPA1A;CDK6;BNC2;SLC39A8;ATXN1;FGF17;IFNA2;MAPK11;HDAC4;ATOH8;ADAM19;AFF2;PPARGC1A;RELA;RFX3;HDAC10;BACH1;CPNE1;MYT1;TICAM1;CLEC7A;SCRT1;SUPT3H;ZNF516;SLC24A3;ASCL1;LEF1;PTP4A3;YAF2;ZNF98;IGF2BP2;SIRT1;MLLT6;ZNF804A;MBNL1;USP36;NSD2;SFMBT2;SMARCA2;SCX;CCDC3;FOXN3;P2RX7;BMP6;RYBP;PICALM;CHD7;NFIA;TRIM11;ITGAX;ZNF451;HCLS1;NTRK2;ROBO1;TCEAL1;NLK;ZNF488;TESC;HSPA1B;CLK1;AHNAK2;SLC7A5;TGFB2;MLXIPL;FUBP1;WNT3;NFKB1;MAFB;CD276;CIAO3;GDNF;PTPN22;RNF14;ZNF536;RBM20;MBNL2;ZNF460;MITF;SOX12;FBXW7;DICER1;CELSR2;RBM12B;PTHLH;SLC22A2;PRRX2;NOS1AP;MEGF8;FGF1;SERPINB9;PTBP2;SLC38A2;AFDN;ATP13A2;AMH;TRIM44;SLC8A2;APBB2;TEAD2;UBR5;ESRRB;PID1;ZNF281;ESRRG;SLC26A9;TRAF3;SORT1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.25319252903260553,0.8539544658233985,1.0,0.9482883939034644,1.0,323/1642,17.09%,CREB3L1;VDR;GCM1;NFATC4;ZNF697;ONECUT1;CRX;TP63;NPAS2;IGF1;DACH1;ZBTB1;FLI1;ETV1;KAT2A;RUNX1;ZNF521;SNAI1;CCDC62;HES4;ZBTB7C;DACH2;MXD3;PBX3;ATXN1;PLK1;DUXA;ZNF717;ZGLP1;TBX6;ANXA4;AEBP2;ZNF415;ZNF366;TAL1;HDAC4;ATOH8;EGFR;PPARGC1A;HAMP;RELA;RFX3;HDAC10;ARNT;HNF4G;BACH1;CPEB3;CNOT2;RXRG;HIC2;DLX1;CHD5;MYT1;LMO7;ZXDC;GRHL2;SCRT1;SUPT3H;ID1;PLAC8;HNRNPU;ATF1;ZNF347;ZNF202;CREB5;FOXK1;LPIN3;ZNF615;ARID1B;CDK12;ZNF264;AGRN;FRK;NPAS3;ASCL1;LEF1;PBX1;MAML2;BATF3;TBX19;LMO2;ZBTB16;WWOX;HIVEP3;SIRT1;MLLT6;TBL1XR1;PKD1;ZNF283;SNCA;SMARCA2;CCNH;BRWD1;SCX;ZNF668;HMX1;GLI2;SAFB2;ETV5;ZBTB2;BMP6;NFIB;FNIP2;ZNF93;SERPINF2;MAMSTR;ZNF613;NFIA;HMBOX1;HIVEP2;ZHX2;PHF10;ZNF451;HCLS1;ZNF397;PHF21A;ZNF778;NRF1;ZFHX4;ARID5A;ZFP69B;NOTCH4;TAF3;PHF14;NRIP1;OTUD7B;SOX5;ZEB2;TCF12;DLL1;JAZF1;BACH2;MEIS1;ASXL3;MEIS3;ST18;VAX2;ZNF785;DMRT1;KDM4C;GABPB1;AEBP1;SMYD2;TOX3;TNKS;MLXIPL;NCOA7;NPAS1;CDKN2A;NFKB1;MAFB;ZNF334;TRPS1;ZFP2;CRTC1;ZBTB37;IKZF2;OGT;EAF2;ACVR1;ARRB1;RARG;GDNF;PURA;RNF14;ZNF771;ZNF536;ZNF304;TEAD1;MITF;ZNF704;SOX12;DICER1;DNMT3A;KLF11;SOX30;SMAD4;STRA8;PCGF5;ARID1A;PRRX2;MNT;ZNF157;ZNF761;LCOR;ZNF483;FGF1;KLF15;DLG1;RHOQ;THRB;HDAC9;AUTS2;SMURF2;PRKD1;UHRF1;SMARCD2;CAMTA1;ZNF561;HBP1;JMY;GRIN1;ZNF473;MEIS2;TEAD2;LOXL2;SLA2;MGA;STAT6;ESRRB;EPC2;PID1;NFAT5;ZNF281;ESRRG;MYPOP;ZFPM2;MCPH1;EED;FOXO3;TCF4;ZNF160;ARX;VEZF1;ZNF624;SS18L1;ZNF316;KDM1B;RELB;EGR3;ZNF143;RPS6KA1;PLAGL1;JMJD1C;ZNF644;MLLT10;SMARCD3;CBFB;BMPR2;ZNF556;TFDP2;THAP3;ZNF254;KAT2B;GPER1;ATRX;EBF4;HMGB1;PPRC1;ZNF24;PTEN;ZNF212;SSBP2;TFEC;HIPK2;BCLAF1;ACVR2B;MED13;TRIB3;MED13L;SSBP4;BRIP1;ZNF69;PRDM15;ZNF41;ZNF587;MIER2;SFPQ;BBX;PRDM10;ACVR2A;CREBBP;NR4A2;CSRNP1;TNRC6B;NR1H3;ZBTB34;VHL;SS18;KCNIP3;RAI1;TRIM33;KMT2D;JDP2;CTBP2;SOHLH1;SMAD9;RPRD1B;ZNF121;SLTM;HIVEP1;PTH;DHX9;CAMTA2;ZNF467;PKD2;ZNF169;MRTFA;HMGA1;FOXO6;UBE2D3;NCOA2;E2F5;IKZF1;SOX4;KMT2C;CAMK2D;GLIS1;ELP3;ZBTB20;ZNF568;ELF1;MYNN;ADCYAP1;PKNOX2;ZNF182;NEDD4L;ZNF268;MDM4;ABL1;FGF2;RNF2;NR6A1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5236882931624713,-0.8538645360639744,0.640625,1.0,1.0,1/8,10.07%,PINK1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.4642166105065341,-0.8538302357468402,0.6578947368421053,1.0,1.0,4/16,19.75%,BUD23;TRMT112;DIMT1;METTL18
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.40194708821814057,-0.8538181960115575,0.6753246753246753,1.0,1.0,17/37,37.44%,PHAX;SSB;NOL6;RAN;NUP50;NCBP2;NUP155;NUP58;NUP93;NUP88;POM121;NUP107;POM121C;AAAS;SEC13;NPM1;XPOT
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.4596256317823475,0.8531462208802241,0.6,0.9493721082895422,1.0,5/13,15.04%,SLC26A6;P2RX7;CA2;C3;C2CD5
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.3754440853657998,-0.8528243683552593,0.7638888888888888,1.0,1.0,15/70,19.19%,RMI1;AP5S1;RPA3;RAD51AP1;PARP1;BRCA1;KDM4D;SFR1;MEIOB;GEN1;RAD50;XRCC2;XRCC3;RECQL;POLQ
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.4495143699320175,0.8526473851592168,0.6333333333333333,0.9499325540083001,1.0,4/8,26.47%,ADAM8;SYK;PRKCA;TNFRSF11A
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.5801384108013623,-0.8524291677930118,0.7796610169491526,1.0,1.0,2/6,17.11%,DCTN1;HSPA8
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.5225316284438191,0.8523842976427456,0.6585365853658537,0.9499316987478802,1.0,3/5,36.70%,PRKCA;DCAF1;VRK1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.44703336221320056,-0.852196062868097,0.7428571428571429,1.0,1.0,5/19,17.82%,SFRP1;SBDS;TGFB1;UFL1;MEOX1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.39568242986307145,-0.8521794099985048,0.6527777777777778,1.0,1.0,6/38,18.59%,RIMS1;PDZD11;CDK5;SNAPIN;HSPA8;NRXN2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.43116432926824516,0.8521166025295013,0.5555555555555556,0.9498452377709331,1.0,4/13,14.75%,TCOF1;FBXL17;CDH2;KBTBD8
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5003468950987857,0.8520364206172589,0.7380952380952381,0.9494088678756428,1.0,2/7,9.80%,ARRB2;ARRB1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.3591246983425357,0.8520045508637754,0.6428571428571429,0.9489341312053422,1.0,5/70,7.56%,CRX;KCNJ14;ZNF385C;GNGT1;DRD4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4535351427598139,-0.8519408862978112,0.6363636363636364,1.0,1.0,1/16,0.46%,GATA1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4535351427598139,-0.8519408862978112,0.6363636363636364,1.0,1.0,1/16,0.46%,GATA1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.37106163519748275,-0.8517555184348359,0.7402597402597403,1.0,1.0,3/67,1.46%,SLC8A3;SEMA3E;ACTG1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.503605693364962,0.8515385342146091,0.631578947368421,0.9491824596760595,1.0,5/8,24.94%,CXCL13;WNT5A;WNK1;STK39;OXSR1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4494208621756867,0.8515049653913257,0.7352941176470589,0.9487239260389931,1.0,8/25,19.37%,JAM2;FAM9B;PLD6;SOX30;GALNTL5;SYCP3;ACRBP;MKKS
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.445430708594181,-0.8514713576094559,0.7246376811594203,1.0,1.0,3/14,20.98%,C1QBP;DNM1L;CCR7
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.445430708594181,-0.8514713576094559,0.7246376811594203,1.0,1.0,3/14,20.98%,C1QBP;DNM1L;CCR7
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.529560595050615,-0.8509487789614532,0.7142857142857143,1.0,1.0,4/6,22.88%,ATP6AP2;GRN;TMEM9;PPT1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.3951161145207686,-0.8507261058794795,0.7761194029850746,1.0,1.0,4/38,10.31%,STMN1;RPS3;ANKRD53;STMN2
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.5725080235670694,-0.8505779878098193,0.75,1.0,1.0,2/5,30.84%,GLI3;FAS
prerank,PanglaoDB_Augmented_2021__B Cells,0.31911354721022583,0.8505032417605317,0.8,0.950314594795487,1.0,15/91,12.46%,BTLA;FLI1;LCP2;PSTPIP1;CD22;TMC8;CD72;HCLS1;BACH2;EAF2;LAIR1;PXK;CD55;SEMA6D;CD80
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.37124582646611765,-0.8503542119365721,0.76,1.0,1.0,9/49,21.24%,EHHADH;ETFB;DECR2;DECR1;ECHDC1;HSD17B10;ACOXL;ECHS1;MTLN
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.34589006032171454,0.8501662025176491,0.7692307692307693,0.9504143483619043,1.0,10/52,11.11%,LCP2;C1ORF162;PSTPIP1;PIK3R5;CSF3R;ITGAX;LTC4S;HCLS1;IKZF2;LAIR1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.503134215863666,-0.8500861871984329,0.7096774193548387,1.0,1.0,1/8,4.37%,GBA3
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.4633643311956659,0.849869302919518,0.6666666666666666,0.9504209726515169,1.0,2/13,5.89%,RAB23;RANGAP1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.36815663514436636,0.8497570292231296,0.6666666666666666,0.950140956654982,1.0,3/29,6.52%,CASS4;ARHGEF7;DOCK1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.4279599073448552,-0.8496325277829999,0.7058823529411765,1.0,1.0,11/30,22.94%,SCD;SLC27A5;AWAT1;SLC25A1;HMGCL;HPGD;FASN;ALOX5;FAR2;PPT1;HSD17B8
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.4540123842849375,-0.8496205499447465,0.6984126984126984,1.0,1.0,2/18,8.07%,PRDX1;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.39879760495782723,-0.8495400835776845,0.8194444444444444,1.0,1.0,4/39,10.46%,SIGIRR;GSTP1;PARP14;GPS2
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.5305386433935376,0.8493175420399433,0.5909090909090909,0.9504574257287094,1.0,1/5,11.90%,MVD
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.49381746970813056,-0.8490491407907572,0.65,1.0,1.0,3/11,20.99%,TALDO1;RBKS;G6PD
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.3906483232366187,0.8484098894352764,0.675,0.9519110166206526,1.0,1/12,1.07%,IGF1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.4735737100064763,-0.848405206061991,0.6949152542372882,1.0,1.0,4/10,22.85%,BAX;MOAP1;BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.5135628937227806,0.8481351692264046,0.7272727272727273,0.9518239687446607,1.0,1/12,4.10%,ADAMTS9
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.4054546763712174,-0.8479241894633842,0.7027027027027027,1.0,1.0,13/47,16.74%,PSME1;PSMC5;RAD23A;RHBDF1;USP19;PINK1;GABARAPL2;PSMC3;NUDT15;ARAF;UBB;UFL1;APOE
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4206911310403892,0.8478552181132293,0.7083333333333334,0.9513875293738305,1.0,7/22,16.07%,ZDHHC11;ZDHHC23;ZDHHC3;GOLGA7B;ZDHHC11B;ZDHHC2;ZDHHC20
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4206911310403892,0.8478552181132293,0.7083333333333334,0.9513875293738305,1.0,7/22,16.07%,ZDHHC11;ZDHHC23;ZDHHC3;GOLGA7B;ZDHHC11B;ZDHHC2;ZDHHC20
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.5063068013608054,0.84783051504848,0.5897435897435898,0.9509149113237837,1.0,2/5,18.66%,HEXB;NEU4
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4728847171704951,-0.8477535517678356,0.7230769230769231,1.0,1.0,4/14,12.30%,CLU;PRELID1;TRIAP1;PPIF
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.31554813926952213,0.8477410911644608,0.8095238095238095,0.9505354229461865,1.0,11/123,9.34%,PDGFB;RELN;LCP2;CASS4;SRC;MMD2;SNCA;TNIK;CD4;TGFB2;PARP16
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.3848746224911899,-0.8475948134133564,0.7162162162162162,1.0,1.0,10/57,8.83%,CCDC181;ARMC3;ATP5MK;DCDC2B;TUBB4B;CXCL17;TMEM212;CCDC39;DNAH9;ANKUB1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.4147817846037086,0.8475450061148183,0.6153846153846154,0.9503954248100731,1.0,2/18,5.09%,EPS8L2;NLGN1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.394969964663701,0.8475196299909155,0.6756756756756757,0.9498856417600717,1.0,5/24,12.00%,ADGRB1;ELMO1;DOCK1;MEGF10;XKR8
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.46263647547861697,0.8474654884702935,0.6363636363636364,0.9494765745944072,1.0,2/6,19.83%,BNIPL;PRUNE2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.4504512100183526,-0.847461493868664,0.6417910447761194,1.0,1.0,5/14,22.14%,CXCL17;SLAMF8;GREM1;SERPINE1;CREB3
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5722357041507832,-0.8469106448535144,0.6938775510204082,1.0,1.0,1/5,11.37%,STAT1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.3782953946398071,-0.8468896558044909,0.7083333333333334,1.0,1.0,8/68,11.01%,DPEP2;GATA1;AQP9;CD9;GMFG;TGFB1;NFATC1;SELP
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.5845257433189943,-0.8467522889086041,0.75,1.0,1.0,2/5,15.68%,PMP22;EMP3
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.44890793093956427,-0.8466844137571524,0.6825396825396826,1.0,1.0,1/11,0.95%,TTN
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3526696935650583,-0.8466651796696294,0.7375,1.0,1.0,12/87,14.62%,RPS27A;SFRP1;TGFBR2;HYAL2;UBA52;OVOL2;BAMBI;TGFB1;FNTA;UBB;MAPK7;APPL2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.5520215634048072,-0.8466301314675709,0.6785714285714286,1.0,1.0,3/7,21.44%,PRELP;OMD;OGN
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.501413316505724,-0.8466150252121729,0.6949152542372882,1.0,1.0,1/8,3.54%,GSTP1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4780788911117732,0.8462431064799972,0.675,0.9514852737540578,1.0,4/8,17.49%,ELL;SNAPC4;SNAPC3;ICE2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.36903441025133127,0.8462308850974044,0.7419354838709677,0.9509603521968173,1.0,10/44,11.72%,GPR35;IGF1;MMD2;ERBIN;MAPRE2;ROBO1;RAPGEF1;ARRB1;AUTS2;MAP4K4
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.36629352482703015,0.8461409157349581,0.6551724137931034,0.9505667509236123,1.0,6/19,10.92%,PDGFRA;DSCAML1;ACVR1;RARG;ALDH1A3;MEGF8
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5209858558936629,0.8455143697882865,0.6571428571428571,0.9513648195824576,1.0,2/6,15.79%,DCX;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.49456676104940867,-0.8452682106237699,0.6666666666666666,1.0,1.0,3/8,28.66%,HSPA5;PTPN1;PPP1R15A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.40930488841465623,0.8449218128923286,0.7096774193548387,0.9520390881115144,1.0,4/12,17.06%,EGFR;IGF1R;DYRK1A;ABL1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.48337245518956967,0.8448134244156674,0.6756756756756757,0.9518221065548091,1.0,1/8,2.00%,TSPOAP1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.42970274602230374,-0.8446903589369293,0.7536231884057971,1.0,1.0,2/32,7.88%,TINF2;TPP1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.33251199748775684,0.8445599420529792,0.8,0.951751143611877,1.0,7/53,9.80%,GPR35;EPS8L2;STARD13;RASIP1;ROBO1;ARHGAP35;ARRB1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.5035953795356274,-0.8443641679193383,0.7014925373134329,1.0,1.0,2/9,17.72%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.4428515696377731,0.8442010133102054,0.717948717948718,0.9519793096724716,1.0,2/9,2.23%,MTHFD2L;MTHFS
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.2987621001189307,0.8440815239676288,0.8888888888888888,0.951693757907377,1.0,17/147,9.27%,KCTD8;KCNQ2;CHRNA4;CSDC2;GALNT14;CELF3;MMD2;SCRT1;IGLON5;PSD2;ADGRB3;PCDH8;OLFM3;CAMKV;NXPH1;SNAP91;NCAN
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.38499217444599515,-0.8439449236616019,0.704225352112676,1.0,1.0,3/43,4.54%,RPL23;XBP1;DDX11
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.44415728422782264,0.843658447489004,0.75,0.951990631658828,1.0,4/11,11.99%,HSD3B7;ADAM8;CXCL13;SLC12A2
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.4455184230360938,-0.8431681941283004,0.7205882352941176,1.0,1.0,5/16,17.99%,TYMS;GMPR2;DCK;APRT;POLD2
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.4250666374672543,0.8429581746342517,0.6571428571428571,0.9528995634388908,1.0,5/25,9.28%,IL1RAPL1;HOMER1;ARHGAP44;PDLIM5;ABHD17C
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.35233169764791766,-0.8429126715235447,0.7272727272727273,1.0,1.0,10/108,9.64%,CD44;IL26;PDGFD;RASGRP1;HRAS;HTR2B;PHB2;GPR183;FSHR;TGFB1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.42843816967978415,-0.8427407932542936,0.7121212121212122,1.0,1.0,4/25,18.34%,TYMS;DCTD;GLRX;NME3
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.4463246935470081,-0.8423585490858964,0.7164179104477612,1.0,1.0,8/25,21.46%,ARF1;IRGM;IFI6;LGALS8;EIF5A;BAX;RIOK3;TOMM70
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.30357114266001034,0.8423498787427939,0.8461538461538461,0.9534861437203164,1.0,41/212,15.20%,RELN;PDLIM7;DOK4;ADGRB1;EFNB3;SRC;NRP2;CTNNA2;EPHA3;PLA2G10;L1CAM;PLPPR4;GLI2;DOCK7;SEMA5B;NCAM1;NOTCH3;ROBO1;DSCAML1;ARHGAP35;GFRA1;SHC3;DOK5;GAB1;GDNF;PARD6B;AUTS2;NRXN1;PIK3CA;SEMA6D;NLGN3;KIF5C;SLIT2;ROBO2;NTNG1;PTEN;SPTBN5;RYK;SLIT3;PSPN;UNC5C
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.3901624239439876,-0.842180149026782,0.6666666666666666,1.0,1.0,6/39,18.59%,RIMS1;PDZD11;CDK5;SNAPIN;HSPA8;NRXN2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.40260864981827005,-0.8419895546265496,0.6933333333333334,1.0,1.0,11/49,13.83%,PDXDC1;TST;ERAP1;ERAP2;TPP1;USE1;SMPD2;SGPL1;CYP3A5;TXN2;CYP3A4
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.5613286159859594,-0.8417178632789318,0.8059701492537313,1.0,1.0,1/5,14.60%,MAPK7
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.33138527022138703,0.8416822366064465,0.75,0.9542249875197858,1.0,7/52,9.16%,SYTL4;EHD2;MYOF;DYSF;P2RX7;AHNAK2;COL5A1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.4588146734792277,0.8412896291814129,0.6410256410256411,0.95428286290567,1.0,3/10,8.48%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.39331268379924067,-0.8408149634018082,0.7866666666666666,1.0,1.0,4/50,8.77%,AQP9;RBP1;USF1;AQP11
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4128257978102074,-0.8405969789469008,0.65625,1.0,1.0,3/19,11.71%,SGMS2;TGFB1;CEBPB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.3756416460094819,-0.8404034619320889,0.7297297297297297,1.0,1.0,15/49,26.14%,VPS35;HRK;PINK1;PPIF;CIDEB;DNM1L;BAX;MOAP1;FIS1;PDCD5;BNIP3;HTRA2;PLAUR;DCN;PARK7
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4470786618710067,0.8403597972860992,0.5833333333333334,0.955639074944761,1.0,1/9,4.16%,CD200R1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.4756599594537764,0.839949005345833,0.6111111111111112,0.9558563889120912,1.0,2/8,6.98%,PKD1;COBL
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4128426180621084,0.8398863895574229,0.6904761904761905,0.9554402464023598,1.0,1/12,9.91%,ALG13
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.36393689591551437,-0.8397808825844807,0.7352941176470589,1.0,1.0,21/72,19.94%,NOX4;TTC36;PDZK1;GBA3;C3P1;HAAO;SLC22A8;SMLR1;SLC2A2;CYP3A4;CYP2E1;SLC28A1;APOE;F11;GSTZ1;BHMT;GJB1;ADH6;SLC22A1;ALDOB;SLC5A2
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.37312277770829677,0.8397594794241353,0.6944444444444444,0.955116069426529,1.0,7/22,14.92%,SIRT1;PAXIP1;FAM47E;OGT;SMAD4;AUTS2;PHF1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.5404597500742632,-0.8395628134841157,0.7407407407407407,1.0,1.0,1/7,0.95%,TTN
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5100269920347248,-0.8393872329328481,0.7241379310344828,1.0,1.0,2/10,8.50%,DNAJC19;PHB2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.37985982378419686,-0.8390572719801305,0.7468354430379747,1.0,1.0,15/79,16.90%,GAPDH;TYMS;CLU;RPL13A;RPS3;ORMDL2;RACK1;CALR;ORMDL1;PATL2;NCL;EIF4A3;ILF3;APOE;ORMDL3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.45856498779579746,-0.8389927806773195,0.6825396825396826,1.0,1.0,2/14,8.58%,SFRP1;LMX1B
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.40980271865289,-0.8388778908315819,0.6712328767123288,1.0,1.0,2/45,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.5187488162881468,0.8387509421785722,0.6904761904761905,0.9564687617498285,1.0,3/5,15.48%,KCNMA1;DOCK5;DOCK4
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.3858734718440197,0.8383687996012444,0.6551724137931034,0.9565708778371268,1.0,3/13,8.80%,SIRT1;IRAK3;TGFB2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.33546507007180526,0.838093672676113,0.75,0.9565891481406219,1.0,15/76,9.78%,KCNQ2;EFNB3;CELF3;GRM8;MYT1;CASKIN1;VGF;PCDH8;CAMKV;CACNG4;SNAP91;MEX3A;NCAN;UNC13A;IGDCC3
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.34304763555739876,0.8380928195003856,0.8333333333333334,0.9560520402528393,1.0,9/71,6.55%,SPRY2;SPRED3;SPRED2;DUSP6;SPRED1;DUSP1;IRAK3;DUSP10;P2RX7
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3503802754580247,0.8380883308894262,0.6206896551724138,0.955538345290397,1.0,9/29,20.45%,MTCL1;CAMSAP3;ERBIN;DLG2;DLG1;DLG3;PARD3;SCRIB;MARK2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.49927818151698056,0.8377916390394922,0.6216216216216216,0.9556255559041432,1.0,2/10,6.04%,IGF1;SOAT1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.3995265808641498,-0.8377836048254577,0.7575757575757576,1.0,1.0,1/43,0.30%,PSMB8
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.3829101288297738,-0.8370753803881699,0.6666666666666666,1.0,1.0,16/60,24.55%,TRMT10A;TRPT1;QTRT2;TRMT10B;TSEN34;SSB;SARS1;POP7;AARS1;C2ORF49;DDX1;CLP1;AARS2;CTU2;URM1;TRNT1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.33118260909633435,0.8370018044865528,0.6538461538461539,0.9568139214557606,1.0,21/85,14.30%,DACH1;SRGAP2B;LIMCH1;DPYSL3;SPOCK3;DUSP10;ROBO1;TMEFF2;FRMD5;ADARB1;MITF;CHRD;RECK;PTPRK;ZMYND8;AFDN;SLIT2;FOXO3;MAGI2;KANK1;PTEN
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.4735168228415819,-0.8369421962942237,0.7377049180327869,1.0,1.0,3/14,13.05%,ASAH2B;GBA3;ASAH2
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.4375809918811308,0.8361050911450237,0.5945945945945946,0.9580237272796902,1.0,1/11,5.49%,EHD2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.35911507536129805,0.8358924197658896,0.6666666666666666,0.9578893959114048,1.0,3/37,5.20%,IGF1;CPNE1;LEF1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.38663057382866384,-0.8358914386619313,0.6716417910447762,1.0,1.0,2/30,1.63%,SELENOK;ZDHHC12
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.4743924173641349,-0.8358566392104058,0.7368421052631579,1.0,1.0,3/14,21.45%,GABARAPL2;HSPA5;BCAP31
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3142067025784663,-0.8358443877070487,0.9,1.0,1.0,66/447,20.48%,PSMB8;RPS27A;FBXW10;DTX3L;SELENOS;PSME1;MAGEF1;NEURL1;HLA-A;PSMB6;PSMC5;MARCHF2;PCNA;ELOB;RNF181;PSMD8;PSMD7;RRAGA;UBA52;PEX10;RACK1;TRIM13;RNF8;TRIM25;DDA1;ARIH2;TRIM17;RBX1;PINK1;PSMD3;PSMC3;TRIM61;RTF1;PAF1;BRCA1;PRAME;UBB;PSMA4;FBXW8;NHLRC1;CDC34;UBE2D4;RNF135;RNF26;RNF167;RNF213;RNF111;PSMA7;FBXL16;PSMD2;FBXL13;DCAF15;PSMD6;PSMB2;CBLC;ERCC8;ZNF738;PSMB4;CDC23;PSMA3;PSMB3;PSMC1;UVSSA;FBXO25;DZIP3;RNF187
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.45985906091753653,-0.8355725639388087,0.7014925373134329,1.0,1.0,2/16,6.89%,IL31RA;TNIP2
prerank,PanglaoDB_Augmented_2021__Basophils,-0.37556411540437207,-0.8355163459364184,0.7922077922077922,1.0,1.0,3/80,3.46%,CD44;AQP9;PTAFR
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3482503487903473,0.8353012064996209,0.6,0.9585058423996903,1.0,4/29,8.92%,GRHL2;NAF1;HMBOX1;TNKS
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.48920117820802245,-0.8351759199615871,0.6984126984126984,1.0,1.0,1/7,3.65%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3530680297379042,0.8349687861532958,0.7419354838709677,0.9586820837285056,1.0,2/42,3.79%,TNFSF13B;SLC7A1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.355699949534082,0.8346608943159943,0.7777777777777778,0.9588354071703239,1.0,6/56,5.00%,FGFR1;GALNT3;FGFR3;FGF17;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.52432441807379,0.8341740529730569,0.7446808510638298,0.9593064736253506,1.0,1/5,8.48%,KYNU
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.4344925539431781,0.8337351264265973,0.71875,0.9596559714457934,1.0,4/19,16.33%,ADAMTS9;TGFB2;BMPR2;PKD2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.38355951804346144,-0.8336728409359231,0.7692307692307693,1.0,1.0,10/68,23.06%,RPL23;PHB2;PTTG1IP;KPNA2;APPL2;CSE1L;RAN;NUP50;KPNB1;RGPD1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.33263857689863957,-0.8334463924217922,0.782051282051282,1.0,1.0,11/124,9.28%,CD44;TSPAN11;CLU;PCDHB4;DBI;GNAI2;HSPB8;SPARC;TCEAL7;SPARCL1;ITM2B
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5412302875382392,-0.8333155381248902,0.7142857142857143,1.0,1.0,3/6,29.65%,DDR1;AAMP;PLAT
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.3529673570100902,-0.8330668612777787,0.7837837837837838,1.0,1.0,14/92,9.64%,RHOC;CLU;NEURL1;RPS3;TMED9;HRK;GPC3;RACK1;TRABD2B;BRK1;CAMK1;AR;FLOT1;TGFB1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.3436829049015061,-0.8330387919338416,0.8375,1.0,1.0,16/188,13.48%,PDE4A;FAM131C;CLGN;TMEM107;CNPPD1;CARTPT;CCDC28B;SPEF2;SEZ6L2;LARP6;SGPL1;CADM4;MAPK8IP1;SPA17;LRRC49;LRRC73
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.36084589074959417,0.8328906401556964,0.8461538461538461,0.9609199530258933,1.0,4/39,6.49%,PDGFB;IGF1;DUSP1;OBSL1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3156276322061242,0.8328287757233643,0.6153846153846154,0.9604973752974363,1.0,50/303,11.75%,PDGFB;PDGFC;IGF1;DACH1;SPRY2;SNAI1;CASS4;FLT1;SRC;FGF17;SRGAP2B;EGFR;CTNNA2;OSGIN1;PDGFRA;PRKX;CLEC7A;LIMCH1;LEF1;DPYSL3;AKT2;TMSB15B;CAMSAP3;SASH1;DUSP10;IGF1R;SEMA5B;ITGAX;PLXNA1;SGK1;ROBO1;TMEFF2;FRMD5;ADARB1;SYNE2;ACVR1;ZNF304;MITF;SGK3;CHRD;RECK;PTPRK;ZMYND8;FGF1;PARD6B;PLXNB2;MGAT5;AFDN;MAP4K4;SEMA6D
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.5496598313412779,0.8327464380599754,0.6774193548387096,0.9601054787163394,1.0,1/5,4.16%,CD200R1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.5432843207244518,-0.8326304849325161,0.6724137931034483,1.0,1.0,1/6,7.73%,RNF8
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.34234093067970983,-0.8325101827592906,0.7954545454545454,1.0,1.0,48/186,26.57%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CHMP2A;CCNJL;CETN2;DCTN2;CEP131;HAUS6;CDK4;TUBA1A;CEP72;CCNE2;DYNLL1;DCTN1;CDC34;PLK4;CEP135;MAX;CHMP7;PRKACA;CEP41;TUBB;CDC23;TUBA4A;FOXM1;CHMP4B;SPDYA;TUBB4A;DBF4;USH1C;CCNG1;CDKN2D;DYNC1H1;OFD1;CRLF3;UBE2S;NES;PLK2;BORA;E2F1;YWHAE;BRSK1;FBXL15;TUBG1;CCNJ
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.5009432846915992,0.832098633685302,0.6976744186046512,0.9608311677846757,1.0,1/5,11.56%,SLC25A29
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.5265056048468733,-0.8319412969258656,0.7068965517241379,1.0,1.0,1/6,10.39%,STAT5A
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.5018106167819718,0.8318767982690228,0.7446808510638298,0.9607714622128526,1.0,2/7,11.67%,ARHGEF7;PRKCE
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.5173423266030384,-0.8318129736299584,0.8103448275862069,1.0,1.0,3/9,12.92%,AQP9;AQP11;SLC2A2
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.3570050588270569,-0.831527168455609,0.7763157894736842,1.0,1.0,7/104,8.45%,ARHGEF16;JUP;TMEM125;NFE2L1;RHBDF1;VWA1;TMEM54
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.4537439655755932,-0.8313834251570046,0.6714285714285714,1.0,1.0,8/15,33.27%,RBM22;SNRNP200;NCBP2;WBP11;CWC15;DDX23;WBP4;SNRPC
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3593800934346255,-0.8313774428247295,0.821917808219178,1.0,1.0,10/106,11.92%,CENPF;AQP9;TCN2;SLC22A9;CHMP2A;SLC22A4;SLC48A1;AMN;SLC22A25;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.5153195309992011,-0.831168159741247,0.6610169491525424,1.0,1.0,2/7,21.22%,CARTPT;NENF
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.38959273633738667,0.831113566915059,0.5757575757575758,0.9616467710657761,1.0,2/29,1.29%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.5182645640044632,0.831101514016996,0.65,0.961111928590211,1.0,2/5,9.29%,RELA;NFKB1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.5108812395117172,-0.831031803252573,0.6521739130434783,1.0,1.0,2/5,21.25%,GRN;ALOX5
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.4913345823804594,0.8309904360551347,0.7105263157894737,0.9607810317731095,1.0,2/5,19.83%,BNIPL;PRUNE2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.37749428699309573,-0.8305396435664123,0.6986301369863014,1.0,1.0,1/44,0.32%,BMP5
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.4393403371672391,-0.8305370064095392,0.7424242424242424,1.0,1.0,4/25,15.72%,IRF1;ERAP1;APPL2;RNF135
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.3999215683063765,0.8303705173158332,0.5862068965517241,0.9615043297312245,1.0,8/28,10.92%,ODAD3;RFX3;CFAP53;DNAH11;DNAAF1;DLL1;DNAI2;MEGF8
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.4239887665887866,0.830114809695583,0.6486486486486487,0.9614519393018995,1.0,2/13,7.32%,ST8SIA6;ST8SIA4
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.385384779924132,-0.829904449465823,0.7027027027027027,1.0,1.0,8/63,15.87%,FAM131C;TMEM198;EFNA2;SEZ6L2;RCOR2;HOXD3;CKB;NKAIN1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.33646754409957047,0.8298584362268082,0.7391304347826086,0.9615123917509102,1.0,30/118,19.34%,SPOCK1;PTCH2;GFAP;STON2;HNRNPU;CD22;MLLT3;TRAF2;TMC8;CAMSAP3;IRAK3;PICALM;SGK1;RAPGEF1;SGK3;RASGRP2;ITCH;KIF14;CAMSAP2;CAMK2D;ABL1;RAP1A;ARHGEF11;WNT5A;NRG3;TJP1;RPTOR;ANKRA2;MARK4;TFRC
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.38128874938699864,0.8296175584302133,0.7,0.9614525401530396,1.0,3/21,9.31%,CDK10;EGFR;UBE2E2
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.3213253941592035,0.8294992333774888,0.8260869565217391,0.9611449035852191,1.0,7/55,11.60%,CDK6;CCNH;EIF4EBP1;EIF4E;CDKN2A;ACVR1;RCC1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.47592853465709595,0.8293530038728715,0.6666666666666666,0.9608901532851122,1.0,6/7,38.49%,TBC1D8B;TMEM63C;SULF2;SULF1;XPNPEP3;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.37997976621058654,-0.8290513461928773,0.7183098591549296,1.0,1.0,16/57,28.96%,RPS3;BAIAP2L2;ANKRD53;PINK1;TPPP3;LMOD1;DCTN1;PFN2;CDC42EP1;CCR7;PFN1;NAV3;ARF6;MAPRE1;EVL;FES
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.36168057347119786,0.8286862015680159,0.8333333333333334,0.9617610344133689,1.0,9/28,18.93%,FGFR3;DUSP10;DIP2B;FGF13;PTEN;TRIM46;WWC1;BBS2;MAP2
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.43767899681055034,0.8286742623006915,0.7631578947368421,0.9612512870878389,1.0,1/10,1.27%,KAT2A
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.4093704674445917,0.8284099354637368,0.64,0.9612367096033606,1.0,4/20,14.29%,LHFPL2;PLA2G10;SMURF2;TACR3
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3543682277427734,-0.8283310549799316,0.7848101265822784,1.0,1.0,22/118,21.73%,PKMYT1;CCNB2;DCTN3;SSNA1;TUBB4B;CETN2;DCTN2;CEP131;HAUS6;TUBA1A;CEP72;DYNLL1;DCTN1;PLK4;CEP135;PRKACA;CEP41;TUBB;TUBA4A;FOXM1;TUBB4A;USH1C
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.5375152694992746,-0.8281214687427164,0.7321428571428571,1.0,1.0,1/5,23.53%,TMBIM1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.5018299833083313,0.8280705230688165,0.6923076923076923,0.9613494763158557,1.0,3/6,26.58%,ROBO2;WNT5A;RAPGEF2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.5414971831791199,-0.8280308623948642,0.6825396825396826,1.0,1.0,1/6,21.21%,CALM1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.43479036858690684,-0.8279966299475066,0.6666666666666666,1.0,1.0,4/14,15.18%,CHRM2;OPRM1;CHRM5;GNA11
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3775345924414029,0.827972405367903,0.78125,0.9609456017418447,1.0,8/22,18.71%,IGF1;CHST11;CSGALNACT1;CHST8;BMPR2;HS3ST4;BMPR1B;XYLT1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.40025922242890494,-0.8278231229448678,0.7142857142857143,1.0,1.0,5/41,13.10%,CPTP;GBA3;ST3GAL5;SMPD2;ESYT1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.3772857691834799,0.8278200143411498,0.696969696969697,0.9606469158090948,1.0,7/22,16.22%,ACADVL;MLXIPL;ADIPOR2;TRIB3;PDK4;NR1H3;SLC45A3
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.483352316963032,0.8276601322254374,0.7297297297297297,0.9603859469847882,1.0,1/6,8.21%,RHOJ
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.3444680282933053,0.8275423666706697,0.6428571428571429,0.9600953725977357,1.0,9/41,18.66%,ADAMTS9;EXOSC7;SIAH2;FBXO2;HNRNPD;PNPT1;MTREX;UBE2G2;NEU4
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.36168819580657535,0.827494945875921,0.6875,0.9596632029736183,1.0,5/30,16.33%,CDK6;CDKN2A;DLG1;PTEN;PKD2
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.4278501020761882,0.8272273406048866,0.5853658536585366,0.9597167428324166,1.0,1/7,6.12%,XPO1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.29376435654652955,0.8271323028718759,0.8571428571428571,0.9594195559572509,1.0,20/139,10.81%,PTPN6;TP63;ALK;AIFM2;ACER2;OSGIN1;PHLPP1;TNFRSF25;SIRT1;TRAF2;USP36;CASP10;SGK1;CRADD;TOX3;ANP32A;MALT1;RARG;TNFRSF10A;PIDD1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.436903212513916,-0.8270403101143984,0.7714285714285715,1.0,1.0,10/21,29.54%,GPR62;CDC34;GPR61;CGAS;PDE2A;SCTR;PRKAR1B;PDE4D;RASD2;PDE11A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.4366253510518628,-0.8269488236659436,0.6956521739130435,1.0,1.0,1/16,2.48%,IRF4
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.37778173500467616,-0.8267123090108516,0.75,1.0,1.0,9/38,18.39%,DTX3L;DDX11;PNKP;RAD51AP1;PARP1;KDM4D;PARP9;MRNIP;OOEP
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.49295414899431217,-0.8267019562203787,0.6612903225806451,1.0,1.0,1/9,5.99%,DDX60
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.47163502212881214,-0.8264222498503933,0.7301587301587301,1.0,1.0,7/17,28.12%,TPX2;ANKRD53;DCTN1;DYNC1H1;RNF4;BORA;TACC3
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.4712640699350239,0.8263786288338659,0.7647058823529411,0.960442569295293,1.0,2/8,7.28%,CYP2C8;LTC4S
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.5879950462350783,-0.8261728523536982,0.8032786885245902,1.0,1.0,1/5,10.26%,PPP1CA
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.48220122140236943,-0.8259246115344934,0.7258064516129032,1.0,1.0,3/12,18.42%,TGFB1;DDR1;CST3
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.42074393149975015,-0.8256624113529591,0.7301587301587301,1.0,1.0,3/25,8.14%,PDZK1;CEMIP;HRAS
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.3526944764630428,-0.8253700012231674,0.7857142857142857,1.0,1.0,14/94,17.41%,DDIT3;VAV3;CALR;ARF1;HRAS;LCK;PLA2G12A;CDK4;PPP1CA;TNFRSF1A;FGF22;CFL1;ECSIT;HSP90B1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.31850111110294355,0.8252816148585798,0.7368421052631579,0.9620830403058604,1.0,37/156,12.91%,COL5A3;ADAM33;IGF1;FLI1;RUNX1;ARAP1;CTSK;FRZB;PCDH18;COL7A1;FBLN5;POSTN;PDGFRA;LTBP2;TNXB;PBX1;ADAMTS2;SSC5D;NT5E;PIP4K2A;CDH11;ZEB2;COL14A1;LOX;HTRA1;COL6A1;COL5A1;NFKB1;ADAMTS10;ENO3;SGCD;CD55;ACKR3;SLC6A13;NFAT5;PLSCR4;TCF4
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.4610903794423641,0.8252802638731446,0.6666666666666666,0.9615541326421407,1.0,1/8,2.74%,BDH2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.3341086095437244,0.8252761472502254,0.7,0.9610332508141654,1.0,4/53,5.97%,VDR;HSD17B7;CYP2C8;SULT2A1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4564957662064447,-0.8252042372977783,0.7101449275362319,1.0,1.0,4/14,19.40%,RBM22;CAMK1;GTSE1;EMD
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3476360963713491,-0.8241595144876164,0.7763157894736842,1.0,1.0,12/118,11.45%,GATA1;SERPING1;CLU;RHBDF1;HSPB8;TNS2;VWA1;FSHR;AR;LURAP1L;ABLIM3;S100A16
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.32508977948907325,-0.8240068246972597,0.8481012658227848,1.0,1.0,17/144,11.90%,BMP5;DDIT3;SFRP1;TIMP1;EFNA1;IL17RD;OVOL2;WWC2;RPS19;CALR;TGFB1;PROCR;SYT11;LRPAP1;GRN;SLAMF8;PPP1R11
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5089287549417905,-0.8239228937291405,0.7962962962962963,1.0,1.0,3/9,27.88%,PSMC3;INPP5K;JUN
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3394098683346406,-0.8238554943058698,0.8072289156626506,1.0,1.0,23/134,19.28%,RHOC;GAPDH;APOL3;TNIP2;TRIM13;TMED4;TRIM25;HTR2B;LAMTOR5;SLC35B2;FADD;NEK6;PINK1;TNFRSF1A;LGALS1;IFIT5;TMEM9B;GPR89A;S100B;ECT2;SHISA5;DDX1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.545264110735891,0.823227029330383,0.6875,0.9645308274464549,1.0,1/5,4.38%,CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3236976614224219,-0.8229468683079988,0.8941176470588236,1.0,1.0,38/312,11.44%,BMP5;RPL23;GLP2R;IL7;PDGFD;COPS9;XBP1;SFRP1;TGFBR2;TIMP1;RPS6;IL31RA;SLC25A5;RHOG;ROMO1;IL6R;GNAI2;TSHR;RPS9;RPS4X;SERTAD1;KIF20B;CD81;BAMBI;CALR;COX17;HRAS;HTR2B;AQP11;CEP131;AR;TGFB1;SOX15;CDK4;CLEC11A;GRN;STAT1;CR1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.4506613170286699,-0.8228300044944797,0.7884615384615384,1.0,1.0,3/11,7.17%,MESP1;SFRP4;BTG1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.4301889555956905,-0.8228060705997915,0.7361111111111112,1.0,1.0,4/15,16.52%,ALDH1A2;TGFB1;ARL13B;DACT1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.511017900610767,-0.8227765265828927,0.7333333333333333,1.0,1.0,1/11,3.45%,PDZK1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.36855056804795266,0.8227296610949626,0.6818181818181818,0.96492356656977,1.0,4/27,9.29%,PLIN5;MTMR2;OPTN;NFKB1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.45906723541182054,0.8226920237311551,0.65625,0.9644685849409702,1.0,1/9,2.74%,BDH2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.43866590066440503,-0.8226137632807149,0.6896551724137931,1.0,1.0,4/16,16.75%,VAMP8;AR;CDK5;ACTB
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.3987808580477219,-0.8224674949253663,0.7272727272727273,1.0,1.0,1/29,0.45%,B2M
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.4354391114203988,0.8223632278375609,0.6470588235294118,0.9645712241415402,1.0,4/14,7.68%,EGFR;DNA2;GLI2;STN1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.31633472638326043,0.8223191145488673,0.9,0.9641540552986694,1.0,17/102,16.34%,KAT2A;HDAC4;HDAC10;EYA4;SUPT3H;SIRT1;TBL1XR1;USP36;AURKC;CPA4;HDAC9;UHRF1;PHC1;EHMT1;MIER2;CREBBP;USP3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.503704121483657,-0.8221617212981864,0.7936507936507936,1.0,1.0,1/6,13.27%,TNFRSF1A
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.31056063532167766,0.8221606479415364,0.631578947368421,0.963863486036873,1.0,27/94,17.11%,ADGRB1;VIPR1;VIPR2;GRM8;TBXA2R;LPAR2;GNAO1;ADGRB3;CNR1;NPY1R;ADGRB2;ADGRL3;GRK5;PTHLH;CRHR2;PTH1R;ADGRE2;GPR26;LGR5;ADCY8;ADGRE1;GPER1;LGR4;PTH;ADCYAP1;GNAQ;PRKACB
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4728562060058868,-0.8219897695316284,0.7536231884057971,1.0,1.0,1/14,0.52%,PLAAT4
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.39318248713384835,0.8217956540231934,0.7407407407407407,0.9640478649442284,1.0,4/32,10.98%,HSPA1A;HSPA1B;BAG3;FGF1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.34174753974576927,0.8216956343988383,0.68,0.9636835513014748,1.0,7/48,7.71%,HSPB1;CLEC7A;AGER;CYBA;TMEM106A;ADAM8;OAS3
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.39971902638906015,-0.8216597396996682,0.7777777777777778,1.0,1.0,6/43,14.62%,PTK6;CLU;AQP11;NLRP12;MAPK7;APPL2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.34663019445240806,-0.8216255564169485,0.8552631578947368,1.0,1.0,23/111,22.59%,AFP;GLP2R;GFRA3;TCEAL5;STMN2;PCSK1;PAK5;SCG3;DUSP26;CCK;CHGB;MLN;NPSR1;INA;SCG5;CALY;GDAP1L1;HPCA;GAP43;SCG2;USH1C;CHGA;SST
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.4783549574705327,0.8215740508865609,0.6666666666666666,0.9633714919328452,1.0,2/6,23.28%,ADIPOR2;KDR
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.36606122950404385,-0.8212280319159533,0.7848101265822784,1.0,1.0,11/66,22.15%,RAB11A;PHB2;PINK1;PTTG1IP;LAMP1;APPL2;CSE1L;ZDHHC15;RAN;NUP50;KPNB1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.34104289176910757,0.8212084832456285,0.6896551724137931,0.9635706453040451,1.0,5/33,14.09%,SRC;RNF14;ARID1A;UBR5;GPER1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.39953037463580954,0.8211826970870257,0.625,0.9630813910076662,1.0,5/18,18.33%,RGPD4;RGPD3;RGPD2;KPNA3;CBLB
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3774045664506866,-0.8211197601702918,0.746268656716418,1.0,1.0,5/66,6.46%,SLC8A3;GSTP1;INCA1;HYAL2;CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.40264316164241887,0.820985449548082,0.6470588235294118,0.9629328801457996,1.0,1/10,1.24%,NOS2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.4742399093715395,-0.8209738999834062,0.75,1.0,1.0,2/10,17.86%,DGKG;PGP
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5235876847467388,0.8208764208692605,0.7948717948717948,0.9625701685505156,1.0,3/5,23.68%,HMGB1;LPL;TIRAP
prerank,MSigDB_Hallmark_2020__Complement,0.3269176997378343,0.8207197296236065,0.8571428571428571,0.9623186693375069,1.0,9/151,3.21%,F2;PDGFB;LCP2;HSPA1A;CD59;SRC;PIK3R5;KCNIP2;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.48739269638409205,0.8206313494384008,0.75,0.9619640715513378,1.0,1/10,0.19%,VDR
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.36079462508101395,-0.8204877793733529,0.7831325301204819,1.0,1.0,8/99,4.05%,P2RY10;HLA-C;FTL;AQP9;CR2;HLA-DPA1;PTAFR;HLA-A
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.3718622698765758,-0.8203558122883642,0.7352941176470589,1.0,1.0,1/41,0.14%,VAMP5
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.4669301498754671,0.8202678741333264,0.6944444444444444,0.9621781001467252,1.0,3/9,16.56%,PHKA1;GSK3B;PHKG2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.33507647312432615,0.8202302563890896,0.7037037037037037,0.9617354562506164,1.0,6/60,6.11%,PTPN6;LIFR;RUNX1;IRAK2;TRAF2;IRAK3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.5298494049439888,-0.820112715710178,0.7540983606557377,1.0,1.0,2/6,17.72%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.44157546165265293,-0.8200231116162164,0.7580645161290323,1.0,1.0,3/19,9.51%,JUP;PLN;SRI
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.45734581570718913,0.8199719765015991,0.6888888888888889,0.9616323927414644,1.0,5/11,21.51%,KCNJ2;PIK3CA;CAMK2D;ATP1A2;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.513102413421811,-0.8199320427546756,0.7692307692307693,1.0,1.0,3/6,27.80%,LAMTOR1;APOE;AGT
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3624003502958614,-0.8199000702352719,0.7428571428571429,1.0,1.0,8/72,7.32%,PKMYT1;CCNB2;INCA1;CNPPD1;SERTAD1;CDKN1C;CDC37;CCNJL
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.34527862690805466,0.8198380845885967,0.7083333333333334,0.9613747195568121,1.0,34/127,16.14%,ADAM33;TPM2;PCDH18;FBLN5;NRP2;POSTN;PDGFRA;LMO7;PDE4DIP;AKT2;EHD2;OBSCN;TMEM47;SMTN;NOTCH3;CDH11;COL14A1;LOX;MSRB3;HTRA1;RGS5;COL5A1;AQP1;SGCD;ACKR3;FBXL7;PLSCR4;KAT2B;COL12A1;KIF1C;SLIT3;ZBTB44;OTUD1;COL4A2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.35780420734964025,0.8196376555260294,0.8695652173913043,0.9612277819331769,1.0,4/42,8.05%,RIDA;HSPA1A;ZC3H12D;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.41763977401839397,-0.8195896677291583,0.7230769230769231,1.0,1.0,5/24,19.83%,GPS2;ABCA12;APOE;ABCA5;CAV1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3520947695348676,-0.8194332527545629,0.7733333333333333,1.0,1.0,13/106,13.83%,CYP1A2;PDHX;LDHA;ACOT2;ALDH1A2;SLC16A1;PDZD11;ACOT1;SLC16A8;SGPL1;ACSBG2;CYP3A5;CYP3A4
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.5174593826038298,-0.8191705390306896,0.7931034482758621,1.0,1.0,1/8,4.62%,CORO1B
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.2953448380370815,0.8190087681382153,0.9565217391304348,0.9619126499164828,1.0,23/104,17.11%,SAMSN1;SRC;VIPR1;MAPKBP1;ADORA2B;VIPR2;IRAK3;CYSLTR1;GPR39;GPR27;PTHLH;CRHR2;HTR4;PTH1R;ADCY8;HCK;PCBP2;ITCH;SYK;PTH;FER;ADCYAP1;PRKACB
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.43982498123031544,-0.8190031018864843,0.6610169491525424,1.0,1.0,3/18,10.43%,OVOL2;TGFB1;FAM89B
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.46061235116917787,0.8189854194746691,0.7142857142857143,0.9609055531876719,1.0,3/9,8.48%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.46061235116917787,0.8189854194746691,0.7142857142857143,0.9609055531876719,1.0,3/9,8.48%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.38638338060303956,0.8186375732202856,0.6666666666666666,0.9610677931981962,1.0,2/20,5.17%,PLA2G10;LPCAT4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.4836997680021375,0.818594323547218,0.631578947368421,0.9606570453893639,1.0,1/7,8.73%,PUS7
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.41917507847097024,-0.8184385589762033,0.7313432835820896,1.0,1.0,2/26,2.82%,TGFBR2;ZFPM1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.33811711905499303,-0.8183931084189353,0.8076923076923077,1.0,1.0,17/152,11.10%,CD44;SFRP1;TIMP1;PPIB;PMP22;ACTA2;FZD8;SFRP4;SGCB;SPARC;FBLN1;FUCA1;MGP;TGFB1;MEST;GPX7;BDNF
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.4774062227497425,-0.8179749299308773,0.7903225806451613,1.0,1.0,2/9,12.93%,RAB11A;RAB8A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4509918968440596,0.8179390714518355,0.6666666666666666,0.9612082517765403,1.0,1/10,10.59%,SMAD4
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.5056511004745496,0.8179203504927631,0.7435897435897436,0.9607245147851258,1.0,2/5,11.48%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.4823433009483138,0.817775299960917,0.625,0.9604832514208587,1.0,2/5,12.85%,NOS1AP;DMD
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.47566602892822396,-0.8175114006671409,0.7580645161290323,1.0,1.0,1/12,0.95%,TTN
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4337856706917431,-0.8174932471760731,0.6875,1.0,1.0,4/15,12.22%,SPAG17;CCDC39;SPEF2;SPA17
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.44520840317077404,0.8174690394369948,0.6829268292682927,0.960498723982588,1.0,1/10,2.95%,IRAK2
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),-0.583406568780962,-0.8174662084649506,0.75,1.0,1.0,1/5,18.48%,TEK
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.37642908295127386,-0.8171194800850354,0.782051282051282,1.0,1.0,26/67,34.37%,PHB2;SNRPD1;PTTG1IP;SNRPD2;APPL2;CSE1L;RAN;NUP50;GEMIN6;DDX20;SMN1;KPNB1;NXT1;SNUPN;SNRPG;SNRPE;GEMIN2;NUP155;NXT2;SNRPB;NUP93;NUP88;POM121;NUP107;POM121C;EIF4ENIF1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.3893331329897308,-0.8170948795199294,0.75,1.0,1.0,7/39,15.83%,XBP1;CELA2A;STAT5A;STAT1;EIF2B1;EIF2B2;EIF2B4
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.4526080216247037,-0.8166330304740838,0.7808219178082192,1.0,1.0,5/14,24.55%,SSB;INTS5;INTS12;TOE1;TRNT1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3862524021172551,0.8158333387355069,0.6285714285714286,0.9631214864327643,1.0,2/15,5.48%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5051519935062416,-0.8157468012481986,0.734375,1.0,1.0,1/7,5.99%,DDX60
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.36172363229780163,0.8156347206044486,0.7272727272727273,0.9630110780234014,1.0,10/36,16.34%,PIWIL4;PIWIL2;PRKRA;PLD6;XPO5;DICER1;TENT4B;MOV10L1;TDRD12;TDRD9
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.3733625694822697,0.8150311866243689,0.7037037037037037,0.9635519115829946,1.0,6/29,12.28%,PPARGC1A;IWS1;SNCA;PAXIP1;ARRB1;RAPGEF3
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.3181478865638403,0.8148276086483446,0.7692307692307693,0.9633975178294913,1.0,6/47,7.73%,SPIRE2;PSTPIP1;ZNF207;DIAPH1;COBL;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.424345323155651,-0.8147053159531851,0.7419354838709677,1.0,1.0,5/19,19.28%,CHMP2A;KPNA2;LGALS1;CHMP3;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.40749681499856416,0.8145571161198787,0.6285714285714286,0.9633821444084133,1.0,5/10,20.10%,AGER;DLL1;CD274;TRIB2;LILRB1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.4864837887782807,-0.8141062535782431,0.6779661016949152,1.0,1.0,2/7,11.63%,MTHFD1;HAAO
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.44182034511699686,0.8140998199799585,0.6363636363636364,0.9637392994180147,1.0,2/10,10.48%,HSD17B7;HSD17B6
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37119935791280656,-0.8140751556632478,0.8028169014084507,1.0,1.0,8/49,9.37%,COPS9;RPL5;SVBP;RPL11;RPS3;UBXN1;PRR7;VPS28
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.3459027573296177,-0.8135457677678618,0.8051948051948052,1.0,1.0,5/114,2.58%,SLC8A3;SEMA3E;MUSK;PCDHB11;PCDHB4
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.42781804305953497,0.8135217785718359,0.6756756756756757,0.9642785750273747,1.0,4/13,18.73%,HAP1;NTRK2;SORT1;ZFYVE27
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.5250825074856683,-0.8133488577793522,0.72,1.0,1.0,1/6,3.35%,CFTR
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.4249485864229563,0.8132890935503883,0.5625,0.9641751965413229,1.0,2/8,13.17%,LRRC8A;UGDH
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.4814389773915438,-0.8130785723009413,0.7647058823529411,1.0,1.0,2/10,10.94%,SGMS2;SMPD2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.5378011338798521,-0.8127891442065047,0.796875,1.0,1.0,2/5,28.32%,GREM1;SMAD7
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.3537487882558724,0.8127150636568549,0.7692307692307693,0.9648813813451794,1.0,3/22,5.34%,IGF1;AGER;IDO1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.37852472029545425,-0.8124082243788867,0.7142857142857143,1.0,1.0,9/33,23.84%,FTH1;COX17;ATP2C2;CP;HEPHL1;CUTC;TRPC6;ATOX1;HEPH
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.2998774638511534,0.8123067250788848,0.9411764705882353,0.9650110198219639,1.0,41/177,16.95%,RELN;PDLIM7;DOK4;EFNB3;SRC;NRP2;EPHA3;PLA2G10;L1CAM;GLI2;NFIB;SEMA5B;ALCAM;PLXNA1;NCAM1;NOTCH3;ROBO1;DSCAML1;ARHGAP35;GFRA1;SHC3;DOK5;GAB1;GDNF;PLXNB2;NRXN1;PIK3CA;SEMA6D;KIF5C;SLIT2;ROBO2;SPTBN5;RYK;SLIT3;PSPN;UNC5C;SH3KBP1;CYFIP1;SEMA3C;SEMA4A;SLIT1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.48879940127183713,-0.8122428370435356,0.7377049180327869,1.0,1.0,4/10,14.58%,TGFBR2;FUZ;HOXD3;EIF4A3
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.42120701572438374,0.8121958064886714,0.6666666666666666,0.9647471548653065,1.0,5/9,21.04%,NLGN4X;NLGN1;NLGN3;WNT5A;C5AR1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3094978250404106,-0.8118867323827182,0.9,1.0,1.0,24/383,8.58%,IGSF1;GATA1;ZNF100;DDIT3;ZNF492;PLAG1;SPIN2A;RPL10;EDF1;HES6;ZNF664;PPIE;DRAP1;ZSCAN21;RBM3;SOX21;WWC2;HINT1;BTG1;ZNF92;CALR;RPL6;DSCC1;LMX1B
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.48034814416508337,-0.8117795587613564,0.7384615384615385,1.0,1.0,3/9,28.20%,PDZD11;BTD;PCCB
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.43244267570611783,-0.8116889841476584,0.7166666666666667,1.0,1.0,5/15,19.05%,RBM3;NCL;CIRBP;SNW1;NCBP1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.40070656493678236,0.8116278817927463,0.6122448979591837,0.965328123650844,1.0,7/19,17.06%,DNAAF1;GLI2;HECA;FGF1;CHI3L1;PCSK5;FGF2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.3863728494828282,-0.8116203047508619,0.7638888888888888,1.0,1.0,1/32,0.74%,SEMA3E
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3522522813408341,-0.8116058431579423,0.7341772151898734,1.0,1.0,5/74,9.30%,SEMA3E;RHOC;RHOG;PHPT1;NEB
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.4183282802947036,-0.8115991087056084,0.7894736842105263,1.0,1.0,11/27,27.37%,CHMP2A;CEP131;GEN1;XRCC3;CENATAC;CHMP3;CHMP4B;VPS4B;PLK2;RAB6C;CEP76
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.4741177157011107,-0.8115065510256286,0.6515151515151515,1.0,1.0,2/10,8.45%,FBLN1;SPINT2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.45988584273442984,-0.8114075929140265,0.7222222222222222,1.0,1.0,5/15,17.88%,NMNAT3;MTHFD1;PRPS1;PRPSAP1;PRPS2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.46613467684247745,-0.8112916733106179,0.6935483870967742,1.0,1.0,3/8,28.70%,TSFM;MTRES1;NSUN3
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.45151597913574865,0.8112505928691788,0.7659574468085106,0.9655082501954866,1.0,4/11,17.06%,HSPB1;FGF1;PRKD1;FGF2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.4329924027540882,-0.8110920386354116,0.6774193548387096,1.0,1.0,1/12,1.46%,ACTG1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.4030834072977365,-0.8109373447755608,0.746268656716418,1.0,1.0,12/28,31.29%,CD81;LAMTOR5;GLMP;NAGPA;AP3M1;M6PR;LAMTOR4;HGS;NEDD4;AP4M1;NCOA4;ZFYVE16
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3833381691339356,0.8102060226030732,0.6052631578947368,0.9670554676813821,1.0,2/13,9.28%,DCTPP1;NT5M
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.4502942001226681,-0.8101180749788915,0.7142857142857143,1.0,1.0,3/10,27.16%,INPP5K;MORC2;SETDB1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.3380162598199544,0.8099672260720806,0.7931034482758621,0.9670164076547132,1.0,8/52,8.21%,SRC;STON2;MTMR2;EPHA3;CD22;SNCA;PICALM;DLL1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.41558887012747836,-0.8099420094308274,0.7162162162162162,1.0,1.0,2/18,9.87%,DBI;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.40578278277381097,-0.8097657252687867,0.7377049180327869,1.0,1.0,1/24,0.15%,EPN1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.4753468813711694,-0.8094088709118785,0.75,1.0,1.0,2/10,15.15%,TPP1;DCTN1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3667082568889336,-0.8093216388844486,0.7857142857142857,1.0,1.0,9/63,12.13%,ZDHHC12;NACA;GRIN3B;YIF1B;RAB11A;AQP11;GORASP2;NECTIN3;NACAD
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.4370401409722468,-0.8093084503226321,0.6721311475409836,1.0,1.0,5/17,15.17%,RNF212;RNF212B;IHO1;MEIOB;FANCD2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.4746528675180922,0.8087684560384918,0.75,0.9690043216322469,1.0,2/6,29.15%,SETD2;RB1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.39594540531867295,-0.8083454366782536,0.6764705882352942,1.0,1.0,6/36,8.52%,IL7;XBP1;VAV3;TNIP2;CD81;GPR183
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.45681170899535045,-0.8078190510558497,0.7457627118644068,1.0,1.0,3/11,17.17%,PAX8;HOXD3;DKK3
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.3891206267160172,0.8077337594737861,0.6451612903225806,0.9704600449098807,1.0,4/30,3.98%,SGO1;ZNF207;PLK1;ESPL1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.4025476519819856,-0.8075226615851814,0.7058823529411765,1.0,1.0,6/27,12.30%,CLU;SLC25A5;PRELID1;PINK1;TRIAP1;PPIF
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.39344288865322335,0.8073196990641526,0.7058823529411765,0.9707240267918236,1.0,1/18,1.04%,BCL2A1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.4126073181367611,-0.8069966707410683,0.7014925373134329,1.0,1.0,4/31,14.47%,RIMS1;CARTPT;ILK;EDN1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.47210369689738296,-0.8069628065423166,0.734375,1.0,1.0,2/16,2.15%,SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.359481317303132,0.8069139080772746,0.72,0.9709514594273007,1.0,7/54,6.64%,CREB3L1;SNAI1;HSPA1A;SRC;HSPB1;SIRT1;TXNDC12
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4259749006941207,-0.8068573569232939,0.7777777777777778,1.0,1.0,4/15,21.45%,SELP;PRKACA;FIS1;BCAP31
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.3479811942478931,0.8063882877945227,0.8260869565217391,0.9714106308096947,1.0,2/33,1.95%,SLC38A1;SLC7A9
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3350593639775255,-0.8061378738767613,0.88,1.0,1.0,8/83,10.43%,IGSF1;RPS27A;TGFBR2;IL17RD;UBA52;BAMBI;TGFB1;FAM89B
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.4925397641642474,0.806088809784363,0.7027027027027027,0.9714925417425915,1.0,2/5,11.37%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.3661111505808199,-0.8060292486132294,0.7941176470588235,1.0,1.0,3/65,4.73%,SLC8A3;SLC6A12;SLC5A10
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.42937089874445555,-0.8058585384659323,0.7580645161290323,1.0,1.0,2/20,11.11%,PSMC5;PSMC3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.37743429945209106,0.805843582209488,0.7222222222222222,0.9714078062010988,1.0,3/15,13.39%,ADSS2;AMPD1;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5172896227510112,-0.8056238883104855,0.8095238095238095,1.0,1.0,2/6,9.63%,CORO1B;GMFG
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.5172896227510112,-0.8056238883104855,0.8095238095238095,1.0,1.0,2/6,9.63%,CORO1B;GMFG
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.5374378932866153,0.8050672042658659,0.813953488372093,0.972090370487665,1.0,3/5,24.02%,ADRA1A;TPM1;ADRB1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.42411192018145605,-0.8049434429298887,0.7666666666666667,1.0,1.0,1/19,0.68%,SLC8A3
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.4810620464978441,0.804732910369511,0.725,0.9715879481199008,1.0,2/6,15.74%,NAPSA;RCN3
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.4810620464978441,0.804732910369511,0.725,0.9715879481199008,1.0,2/6,15.74%,NAPSA;RCN3
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.4307937523444942,-0.8046689449921324,0.7230769230769231,1.0,1.0,1/13,4.92%,PNKP
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.4175485111634142,0.8046577744861247,0.7560975609756098,0.9712142927419896,1.0,3/10,17.29%,DICER1;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.4973590244294766,-0.8043814695852175,0.7605633802816901,1.0,1.0,2/9,9.64%,GSTP1;TGFB1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.306528258273784,-0.8043733871424211,0.945054945054945,1.0,1.0,39/303,19.71%,VAMP5;CENPF;ATP6V1F;CLU;STX19;SVBP;USP6;SNX17;VPS35;TMED9;ARL1;CHMP2A;ARF5;ARF1;TMED4;GPIHBP1;RAB32;AMN;ARCN1;ABCA12;TBC1D2;RAB8A;STX16;CANX;ARL17A;GRTP1;APOE;ATP6V1E1;TBC1D16;HSP90B1;COPZ1;MCOLN1;CHMP3;ATP6V1E2;SCG5;ATP6V1D;ATP6AP1;SCAMP3;ATP6V1C2
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.41298041155774634,0.8041589767712366,0.6363636363636364,0.9716066091752722,1.0,2/11,7.14%,TRIM35;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.5149979719267012,-0.8037846134656504,0.7377049180327869,1.0,1.0,1/6,4.76%,ATP6AP2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5056730743585574,0.8036851171160844,0.7222222222222222,0.9719696334104867,1.0,4/6,12.60%,KCNIP2;AKAP6;NOS1AP;LRRC38
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4525229184868398,-0.8035712323746088,0.7571428571428571,1.0,1.0,3/17,12.62%,CXCL17;TGFB1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.46530803053261177,0.8033319225611688,0.6666666666666666,0.9716201045532369,1.0,5/7,33.66%,ABL1;GABPA;ATF4;LRRK2;PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.46530803053261177,0.8033319225611688,0.6666666666666666,0.9716201045532369,1.0,5/7,33.66%,ABL1;GABPA;ATF4;LRRK2;PRKN
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3785767990733818,-0.8029102112218542,0.6944444444444444,1.0,1.0,2/49,1.48%,ACTG1;SFRP1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.40941297727249554,-0.802904352574696,0.7096774193548387,1.0,1.0,4/19,14.47%,PPIB;SRP54;PPIA;EDN1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.49871955932439016,-0.8026695349995184,0.7368421052631579,1.0,1.0,1/6,9.85%,PRPS1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.31232462885245316,0.8023374196726616,0.8125,0.9728978344050595,1.0,10/71,10.16%,NUPR1;NFATC4;PPARGC1A;NSMF;ADAM8;NTRK2;TGFB2;TOX3;GDNF;CPEB4
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.32621437925898866,-0.8020743487482843,0.8214285714285714,1.0,1.0,20/91,21.92%,SNRNP25;SCNM1;PRPF3;DHX16;RNPC3;SNRPN;SNRPD1;SRSF7;PRPF6;PRPF4;SNRPD2;PRPF18;ZCRB1;MAGOHB;PRPF8;RRAGC;NCBP1;NOL3;PDCD7;WDR83
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.5238238389514481,-0.8019636704562785,0.7916666666666666,1.0,1.0,1/5,1.73%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.5238238389514481,-0.8019636704562785,0.7916666666666666,1.0,1.0,1/5,1.73%,SELENOS
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.35309100030752294,-0.8019547448241794,0.7142857142857143,1.0,1.0,7/52,13.00%,TNFAIP2;RNASE1;CXCL17;SCD;SLAMF8;CEBPD;DUOXA1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.3221418245024321,0.8018282103827663,0.696969696969697,0.9734034640588631,1.0,9/57,11.32%,KCNJ14;KCNJ2;CHRNA4;SNCA;SYT3;P2RX7;CA2;GDNF;PXK
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.29200221467630266,0.8013790994485874,0.85,0.9737501703410948,1.0,21/124,14.29%,IGF1;EPS8L2;RRAS2;MAPK11;CNKSR1;LIMK1;PLD1;ELMO1;SHC3;RAPGEF1;CDKN2A;MRAS;CELSR1;ZNF304;CDC42EP4;PRKD1;RAPGEF3;ABI2;G3BP1;ARHGAP5;RASGRP2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2805237592601485,0.8009936217531338,1.0,0.9738806421122438,1.0,21/136,12.28%,ARAP1;ARHGEF7;EVI5L;EPHA3;AGRN;PROM2;RASIP1;ARHGAP44;PICALM;CPEB2;MAPRE2;PLXNA1;NTRK2;RAPGEF1;SGSM2;PKP4;DOCK9;PLXNB2;AFDN;MAP4K4;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3625921607909566,-0.8009682033863368,0.7571428571428571,1.0,1.0,3/42,5.48%,XBP1;IL6R;HYAL2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.3921950605691833,-0.8008753862208834,0.7384615384615385,1.0,1.0,6/30,15.54%,RPS3;BCL2L14;BDNF;PPIA;ASAH2;BCL2L12
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.30977880872844027,0.8005682673744142,0.95,0.9741476181112416,1.0,12/55,14.64%,MFHAS1;AGER;TRAF2;TPD52L1;SERPINF2;MTURN;SH3RF1;TNFRSF19;MAP4K2;TRAF3;HMGB1;HIPK2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.31868932468469136,0.8004601753177228,0.875,0.9738249024276942,1.0,5/45,9.37%,MTHFD2L;MTHFS;ALDH1L1;DHFR;PHYH
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.4505400335901214,0.8001984470680443,0.6829268292682927,0.9736964995681081,1.0,5/8,17.06%,NPNT;GDNF;FGF1;PKD2;FGF2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.42790141502796425,0.8001809987570188,0.7446808510638298,0.9731948577620062,1.0,1/12,1.36%,KCNJ2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3511526689390541,-0.8001143330297642,0.782051282051282,1.0,1.0,8/67,10.00%,CLU;RAD23A;ELOB;NOP53;RACK1;DDA1;ARIH2;RBX1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.38545327752875197,0.7996782088220306,0.7058823529411765,0.973468807853208,1.0,7/27,16.85%,PLIN5;SORBS1;MLXIPL;GPLD1;NR1H3;SLC45A3;ZBTB20
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.34482871959457784,-0.7995612424315691,0.8076923076923077,1.0,1.0,13/59,24.03%,XBP1;SCD;ACSM6;OXSM;NDUFAB1;ACSM3;LIPH;LIPI;ALOX5;FDXR;HSD17B8;SREBF1;MBOAT1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.5079444328577044,-0.7994936560389172,0.8035714285714286,1.0,1.0,1/6,1.63%,ZDHHC12
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.3278455061463128,0.7993717744229096,0.7272727272727273,0.973434042356037,1.0,13/58,14.57%,CDK6;VASH1;FGFR3;ZNF706;NFIB;NOTCH4;DLL1;RAPGEF3;LOXL2;IL17D;KANK1;GRIN3A;RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.42510833920746405,-0.7993122030667991,0.75,1.0,1.0,8/17,22.40%,MADCAM1;IL6R;PTN;ZP3;PLVAP;ZNF580;LGALS3;ADAM17
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.4138294236629543,0.7993104503403546,0.7674418604651163,0.9730480379437232,1.0,3/14,6.13%,SNAI1;TBX19;SCX
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.4769051980216703,0.7990639158931682,0.7105263157894737,0.9730063666269739,1.0,2/6,14.46%,GPER1;NMU
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.4792253247258024,-0.798966478426676,0.7837837837837838,1.0,1.0,1/10,5.11%,NEFL
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.4324481572521669,-0.7988878710793343,0.8181818181818182,1.0,1.0,2/18,4.90%,TTN;MESP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.4330842731781208,-0.7988877119701393,0.75,1.0,1.0,3/16,14.47%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.45152976965087727,-0.7985163970906903,0.8,1.0,1.0,6/17,26.78%,TIMP1;TIMP2;APOE;FURIN;TIMP4;PACSIN3
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3211268078647199,-0.7985034145948164,0.8552631578947368,1.0,1.0,16/139,13.65%,XBP1;SFRP1;SELENOS;H2AZ1;PTK6;CFTR;GSTP1;TNIP2;ADAM15;IRGM;MAP4K1;AR;PAF1;WNT9A;AHR;KAT5
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.39460233921242843,-0.7984313820459518,0.8153846153846154,1.0,1.0,5/30,11.32%,HES6;BHLHE41;RPS19;GRN;SLAMF8
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.37387002101788636,-0.7983271701724269,0.8028169014084507,1.0,1.0,2/36,4.20%,RHOC;RHOG
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.4625628423403214,0.7980846183253117,0.6829268292682927,0.9744256473772996,1.0,3/6,16.08%,RELA;NFKB1;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5128049096951508,-0.7980133802176118,0.71875,1.0,1.0,1/5,8.07%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5128049096951508,-0.7980133802176118,0.71875,1.0,1.0,1/5,8.07%,RASGRP1
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.5107346270467479,0.7978172871118516,0.7941176470588235,0.9744763402484258,1.0,2/6,13.13%,DNMT3A;KDM1B
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.4661885511001287,0.7978152498974418,0.7073170731707317,0.9739761407084074,1.0,6/9,31.61%,SNCA;SCRIB;RAB29;INPP5F;ANXA2;NSF
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4719545429756764,0.7975320306357315,0.7142857142857143,0.973413243076987,1.0,3/8,23.49%,SLC1A2;PNPT1;MLKL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4719545429756764,0.7975320306357315,0.7142857142857143,0.973413243076987,1.0,3/8,23.49%,SLC1A2;PNPT1;MLKL
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3241691378809672,-0.7973869617653453,0.8837209302325582,1.0,1.0,35/142,19.91%,PSMB8;BTN3A1;PSME1;HLA-DPA1;HLA-A;PSMB6;PSMC5;VAV3;PSMD8;PSMD7;HHLA2;LCK;TNFRSF21;PSMD3;PIK3CB;BTN2A1;PSMC3;BTN3A3;EIF2B1;STOML2;EIF2B2;PSMA4;EIF2B4;PSMA7;PSMD2;PRKD2;PSMD6;PSMB2;BMX;PSMB4;HLA-DRA;HLA-DRB1;PSMA3;PSMB3;PSMC1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.4723223416006933,0.7971483625080618,0.675,0.9735643568827423,1.0,1/5,10.41%,MGLL
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4400504631020288,-0.7970488314376863,0.6567164179104478,1.0,1.0,2/11,13.05%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4400504631020288,-0.7970488314376863,0.6567164179104478,1.0,1.0,2/11,13.05%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.5534651833743294,-0.7969959091432431,0.7777777777777778,1.0,1.0,2/5,17.74%,DDR1;COL4A6
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.4964366735586839,-0.7966620222952011,0.8113207547169812,1.0,1.0,1/7,3.65%,EFNA1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.3277840750338924,0.7963635863603793,0.9583333333333334,0.9745077044124525,1.0,10/34,23.06%,IWS1;SAFB2;PAPOLA;SLTM;DHX9;KHDRBS3;QKI;SRPK2;PTCD2;CPSF4
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.5304812010892888,-0.7961483073738419,0.8524590163934426,1.0,1.0,1/5,15.01%,CCT2
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.5304812010892888,-0.7961483073738419,0.8524590163934426,1.0,1.0,1/5,15.01%,CCT2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.38342651736949673,0.796032110645237,0.7317073170731707,0.9746366779832804,1.0,4/19,18.20%,PLA2G10;NFKB1;NR1H3;LPL
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.46193174285886496,0.7957163969090676,0.775,0.9747084665051836,1.0,3/9,15.54%,DHFR;PRKG2;QDPR
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3353256739783172,0.7956369474956573,0.7931034482758621,0.9743596623311763,1.0,8/53,7.33%,ADAMTSL2;SPRY2;HSPA1A;SPRED3;SPRED2;SPRED1;SIRT1;ZNF451
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.37893393151429244,-0.7952495255305182,0.7741935483870968,1.0,1.0,3/28,9.64%,KIF20B;CEP131;TGFB1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.4024732064822938,0.7949994429553515,0.782608695652174,0.974901682722995,1.0,2/13,9.60%,TTLL12;FAM47E
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4108916857265372,-0.7949446996979529,0.7432432432432432,1.0,1.0,2/27,7.22%,XBP1;RACK1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.3631977342935609,-0.7948947521115818,0.7714285714285715,1.0,1.0,2/35,2.49%,DDIT3;CLU
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.43230559610679203,-0.7948649937637536,0.7580645161290323,1.0,1.0,2/11,11.45%,HLA-A;BTN3A3
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.48866051903584107,0.7948193768248684,0.74,0.974802340762634,1.0,2/5,24.69%,SETD2;SETD5
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.4474788032334944,-0.7948153750580872,0.835820895522388,1.0,1.0,3/21,8.25%,HLA-DPA1;TNIP2;LCK
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.4552874082556867,-0.7947658223531286,0.7910447761194029,1.0,1.0,5/19,19.28%,TNFRSF21;CR1;CEBPB;PDCD1LG2;HLA-DRB1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3362035503340494,-0.7944520259283429,0.8205128205128205,1.0,1.0,13/74,11.54%,SLC6A12;SLC3A1;SLC25A45;SLC10A6;SLC25A11;SLC10A3;SLC7A14;SLC16A1;SLC7A7;CEACAM1;SLC27A5;SLC16A8;SLC51A
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.47546251713794313,-0.7943730180182369,0.7457627118644068,1.0,1.0,1/9,3.65%,EFNA1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.5226669451956146,-0.7940657998336424,0.78125,1.0,1.0,3/8,22.44%,MESP1;CBY1;MYOCD
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.46753930135651567,-0.7937390057257621,0.7333333333333333,1.0,1.0,4/8,22.88%,ATP6AP2;GRN;TMEM9;PPT1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.44920067000737707,-0.7936747717443059,0.7183098591549296,1.0,1.0,3/12,7.57%,TIMP1;NPPC;CALR
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.5047571300290462,0.793430061228153,0.717948717948718,0.976759679022322,1.0,1/7,3.07%,JAM2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.30367464185532334,0.793327892298564,0.96,0.9764389802693573,1.0,19/101,11.12%,CDK6;FGF17;EGFR;MEMO1;OSGIN1;PRKX;AKT2;NRG2;TMSB15B;CAMSAP3;SPOCK3;DIAPH1;PLXNA1;SGK1;FRMD5;SGK3;FGF1;PARD6B;PLXNB2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.4155930771760958,-0.7932156171342015,0.7301587301587301,1.0,1.0,5/21,19.51%,CCDC186;TUBA1A;MYO10;TUBA1B;TUBB
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3913958562769386,-0.7931230949462942,0.7857142857142857,1.0,1.0,2/27,4.46%,TYMS;PCNA
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.36666723043591215,0.7928470087381253,0.7333333333333333,0.9767441847175816,1.0,5/25,7.39%,MAIP1;EGFR;STX1A;RTP5;REEP1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.33646387395604804,-0.7927735598658344,0.8181818181818182,1.0,1.0,12/80,24.10%,VPS35;TMED9;ARL1;STX16;CLTCL1;DCTN1;RAB7B;SNX6;TBC1D14;SNX32;VAMP3;SURF4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.450573829294364,-0.7925868425492086,0.7258064516129032,1.0,1.0,4/10,23.14%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.450573829294364,-0.7925868425492086,0.7258064516129032,1.0,1.0,4/10,23.14%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.4360918148727109,0.7924981114332259,0.7407407407407407,0.9768856544302982,1.0,3/10,8.50%,PATL1;DCP1B;DCP1A
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.348126737429287,0.7920052566132662,0.76,0.9772187098952154,1.0,5/33,8.48%,GLRB;IRAK3;DHFR;DRD4;KYNU
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.37193903027846426,0.7919857302966471,0.7333333333333333,0.976770686920698,1.0,3/22,8.21%,CDK6;ZNF488;DLL1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.41827266012517983,0.7918707156831826,0.6666666666666666,0.9764933848798941,1.0,3/15,6.20%,IGF1;JAM2;ADGRB3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.3799644716131994,0.7918294543655654,0.7307692307692307,0.976060390572262,1.0,5/32,8.28%,HSPA1A;PLK1;HNRNPU;HSPA1B;FSD1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.37785917818150777,0.7918005351445025,0.7631578947368421,0.9756349355922148,1.0,2/9,10.62%,AQP1;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.46406714191347054,-0.7914839441815583,0.7692307692307693,1.0,1.0,4/11,24.53%,IRGM;JMJD4;BNIP3;SMCR8
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.4755526473099211,0.7914624614581253,0.75,0.975649052836435,1.0,2/6,5.40%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.42286239737697573,0.791402833053054,0.775,0.9752454943375143,1.0,6/12,23.10%,PTP4A3;CORO2B;CEP290;SCFD1;KIAA0586;GAPVD1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.43444277304070406,0.7912571066304936,0.7391304347826086,0.9750333904974041,1.0,1/8,3.80%,KYAT1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.39099980573446136,0.7912086353668054,0.6774193548387096,0.9746517894079395,1.0,1/9,5.86%,CAMSAP3
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3028117883559579,-0.7912015915621515,0.9310344827586207,1.0,1.0,51/247,20.45%,PSMB8;GFRA3;RPS27A;PSME1;IL31RA;PSMB6;PSMC5;PSMD8;RASGRF2;PSMD7;NEFL;IL17RD;UBA52;PEBP1;TNIP2;RASGRP1;HRAS;HTR2B;IL5;TGFB1;PTPN7;RBX1;PSMD3;PIK3CB;PSMC3;FNTA;LRRC7;IL3RA;ARAF;FGF22;UBB;PSMA4;FRS3;PSMA7;PSMD2;FGF7;NRG4;PSMD6;PSMB2;TEK;PLVAP;ANGPT1;PSMB4;PSMA3;PSMB3;ZDHHC9;PSMC1;YWHAB;ITGAV;SHC1;RASGRP4
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.3533397795677267,-0.7911944974314371,0.8169014084507042,1.0,1.0,9/64,19.05%,TGFBR2;TST;DHX38;FLOT1;SRSF7;EIF4A3;SRSF3;MAGOHB;NCBP1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.44987715732663813,-0.7911268385468085,0.8125,1.0,1.0,5/10,16.77%,ATP23;AFG3L2;PMPCA;STOML2;IMMP1L
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4075847386881335,-0.7910054797041552,0.7432432432432432,1.0,1.0,4/18,11.47%,P2RY10;SYNPO2L;PRAG1;GPR17
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.506091790322852,-0.7908781391608533,0.7846153846153846,1.0,1.0,1/6,15.98%,GTF3C6
prerank,MSigDB_Hallmark_2020__Apical Junction,0.2802873603640722,0.7908061762881653,1.0,0.9748218843272755,1.0,27/162,13.65%,CLDN15;CLDN9;ICAM1;IRS1;SRC;MAPK11;EGFR;VCAN;ARHGEF6;AKT2;PKD1;ITGA10;COL9A1;CDH4;CDH11;CDH8;CD276;MAP4K2;DLG1;NEGR1;AMH;MVD;PPP2R2C;NLGN3;SLIT2;CADM2;RHOF
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.315587603616323,-0.7906965096157758,0.9523809523809523,1.0,1.0,14/166,7.17%,DDIT3;GAPDH;MT1E;LDHA;PRDX5;MT2A;EFNA1;GALK1;PFKL;CDKN1C;PHKG1;B3GALT6;GPC3;BTG1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3023709293679455,0.790680057438021,0.85,0.9745396907396485,1.0,10/78,9.34%,NPAS2;HSPA1A;RRAS2;ACER2;SARM1;SNCA;TXNDC12;HSPA1B;SPEF1;PARP16
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.2935280961559542,0.7902235229425644,0.8333333333333334,0.9749285440156086,1.0,16/82,10.20%,TPM2;EGFR;POSTN;CSPG4;STK40;ZBTB16;EHD2;RND3;TMEM47;CHST3;HTRA1;CACNA2D1;COL6A1;COL5A1;TEAD1;ENO3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.4958900577251908,-0.7898743057473059,0.78125,1.0,1.0,1/7,0.15%,EPN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5426772234189887,-0.7894128682930197,0.8387096774193549,1.0,1.0,2/5,19.14%,APOE;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5426772234189887,-0.7894128682930197,0.8387096774193549,1.0,1.0,2/5,19.14%,APOE;SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5426772234189887,-0.7894128682930197,0.8387096774193549,1.0,1.0,2/5,19.14%,APOE;SOD1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.4042901700257687,-0.7888414613783709,0.75,1.0,1.0,8/21,27.85%,VAV3;LAMTOR5;EDN1;RHOA;MSN;LAMTOR4;VAV2;LARS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.423747084704022,-0.788740545092358,0.7971014492753623,1.0,1.0,5/17,22.40%,CDKN1C;GIPC1;RNF111;SNW1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.423747084704022,-0.788740545092358,0.7971014492753623,1.0,1.0,5/17,22.40%,CDKN1C;GIPC1;RNF111;SNW1;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4247364808673004,-0.788737921374385,0.7878787878787878,1.0,1.0,4/17,16.14%,PHPT1;CEACAM1;GPS2;CD160
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.34206084238374146,-0.7886932405299131,0.8214285714285714,1.0,1.0,14/81,20.13%,COPS9;USP1;PCNA;USF1;TRIAP1;PARP1;SPRTN;CIRBP;METTL3;SCARA3;XPA;GTF2H2;ERCC8;UVSSA
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4240885873462985,0.7886906028705661,0.7272727272727273,0.9770459273418397,1.0,2/8,13.18%,ECM1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.4405962792176219,-0.7884051728741251,0.734375,1.0,1.0,1/11,4.17%,BTBD18
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.33861203589657557,0.7882688084224517,0.7692307692307693,0.9772637942145733,1.0,11/44,15.60%,SRC;SASH1;DUSP10;DOCK1;RHOJ;TGFB2;PRKCE;CLASP1;BMPR2;DOCK5;CORO1C
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.36389490773190863,-0.7882351494937679,0.8378378378378378,1.0,1.0,8/50,15.36%,TGFBR2;IL31RA;SRP54;GPR183;EFNA2;CDK4;PARP1;MT1G
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.33487947257711137,0.7882241117591283,0.75,0.97683992671952,1.0,3/27,9.57%,CX3CR1;LEF1;AQP1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.40963990505742454,-0.7881556974380262,0.8181818181818182,1.0,1.0,3/16,11.67%,PINK1;ARL2BP;HSPA5
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.32972517242886307,-0.7881103709487451,0.8205128205128205,1.0,1.0,6/94,9.01%,B2M;TMEM50A;DBI;ADRM1;MYL12A;SCD
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.4201078281692089,-0.787967090558073,0.7246376811594203,1.0,1.0,2/17,13.05%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.44889873630748256,-0.7879377176989754,0.7142857142857143,1.0,1.0,2/9,15.93%,C1QBP;RNF26
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.35350000751453836,0.7878787325246914,0.8205128205128205,0.9770506282574383,1.0,2/21,6.98%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.3685002272227909,-0.7871671765556864,0.782608695652174,1.0,1.0,7/41,8.25%,IL7;XBP1;HLA-DPA1;HLA-A;CD81;DOCK8;LCK
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.34987229513990803,-0.7871233593310373,0.8170731707317073,1.0,1.0,8/74,14.41%,IL26;RASGRP1;HRAS;ZNF622;SEMA3A;MAPK8IP1;CD27;ANKRD6
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.32558670455498384,0.7869364748828859,0.8518518518518519,0.9780568801301046,1.0,16/47,25.36%,CELF3;HNRNPU;MBNL1;MBNL2;RBM5;CELF2;FXR1;KHDRBS3;NSRP1;CELF1;SRSF12;ZBTB7A;WTAP;RBFOX2;RBFOX1;RBM15
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.47786938190093997,-0.7869288972624757,0.7777777777777778,1.0,1.0,2/8,7.25%,KIF20B;CHAMP1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.49791990628948535,-0.78656976930121,0.7966101694915254,1.0,1.0,2/8,14.22%,GNPTG;GNPTAB
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.41130086051280523,-0.7860939809993068,0.7096774193548387,1.0,1.0,4/17,14.47%,PPIB;SRP54;PPIA;EDN1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.40373289028245046,0.7856308209269851,0.7567567567567568,0.9796462860659302,1.0,1/13,0.37%,GPR35
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.37611490247311474,-0.785422156192,0.75,1.0,1.0,5/28,15.79%,LSM2;LSM7;EXOSC4;EDC4;NT5C3B
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.3586461529747357,-0.7850767050682299,0.8823529411764706,1.0,1.0,15/61,22.02%,SLC8A3;NPR2;NPPC;PLN;SRI;APLN;MYH6;FXYD4;CALM3;KCNQ1;TRDN;PRKACA;S100A1;CALM1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.4885257553465714,-0.7850601513761392,0.7333333333333333,1.0,1.0,2/5,22.44%,LRPAP1;MYOCD
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.36190458707451917,-0.7847190460977009,0.7916666666666666,1.0,1.0,4/43,10.68%,SLC6A12;AQP9;SLC16A1;SLC16A8
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.44062025538700667,-0.7846214017104038,0.7246376811594203,1.0,1.0,3/11,16.40%,CA6;TAS2R39;PIP
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.2958638812761074,-0.7844547914795076,0.9777777777777777,1.0,1.0,69/535,14.59%,BMP5;RPL23;GLP2R;NOX4;IL7;PDGFD;FTH1;COPS9;XBP1;SFRP1;CLU;JUP;NEURL1;TGFBR2;TIMP1;RPS6;IL31RA;FABP3;INCA1;SLC25A5;RHOG;ROMO1;ALDH1A2;IL6R;GNAI2;TSHR;RPS9;RPS4X;IFIT3;IRF1;BTG3;SERTAD1;SFRP4;KIF20B;TNS2;CD81;TSPO;BTG1;BAMBI;CALR;COX17;HRAS;HTR2B;AQP11;BEX4;CEP131;AR;TGFB1;FABP6;CDK4;FUZ;STAT5A;CLEC11A;STAT1;CR1;CADM4;CAPNS1;ESM1;IFNLR1;WARS1;CCKBR;WNT9A;PRAME;FGF22;NMI;OSMR;EDN1;RTKN2;OPRM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3466031706088401,-0.7843518218148354,0.7794117647058824,1.0,1.0,12/65,14.54%,CLU;GSTP1;SLC25A5;BCL2L2;PRELID1;AR;PINK1;TRIAP1;BDNF;PPIF;ASAH2;RTKN2
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.34726473165255933,-0.7840572866290371,0.8055555555555556,1.0,1.0,6/69,6.09%,ARHGEF16;TMC4;EFNA1;TMEM125;OVOL2;ITGB4
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.45888085922986366,0.783918416044617,0.6739130434782609,0.9825143922252298,1.0,3/6,13.11%,ALCAM;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5034898767679853,-0.7838778902287087,0.7592592592592593,1.0,1.0,1/7,6.20%,ACMSD
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.486910240244932,-0.7838673925690313,0.7457627118644068,1.0,1.0,2/8,14.70%,AGBL3;AGBL5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.38705194456760805,0.7838411255198753,0.75,0.9821099935193021,1.0,1/17,1.91%,PLIN5
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.5188498960720391,0.7837301348747217,0.7906976744186046,0.9818254834517393,1.0,1/5,7.07%,CHD7
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.32542329041209384,-0.7832364698862584,0.8452380952380952,1.0,1.0,7/119,4.84%,ARHGEF16;ARHGAP4;RHOC;RHOG;VAV3;ARHGAP15;RASGRF2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.34420795773759494,-0.783220040438019,0.7916666666666666,1.0,1.0,10/61,19.34%,CSTF2T;FIP1L1;DHX38;SRSF7;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;CLP1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.4852720653750891,0.783198223489797,0.717391304347826,0.9822436636863112,1.0,1/5,24.18%,CRKL
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4458415856449058,0.7826209691058612,0.6285714285714286,0.9828649996750849,1.0,1/11,3.51%,CPT1C
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.4768952318038805,-0.7826051050265639,0.8225806451612904,1.0,1.0,4/11,30.36%,PARG;MYOCD;PARK7;AKAP8
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3900919723608657,-0.7825494977257964,0.7464788732394366,1.0,1.0,6/25,25.81%,VPS35;PINK1;DNM1L;FIS1;BNIP3;DCN
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4200733927281586,0.7817976657221896,0.6739130434782609,0.9837102258302387,1.0,4/10,23.86%,CACNG5;NPTX2;DLGAP4;DLGAP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.4659862454698822,0.7809225660778308,0.8095238095238095,0.9846247074745015,1.0,2/7,2.88%,SRC;ARHGEF7
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.43254372862927254,-0.7806643576081492,0.7704918032786885,1.0,1.0,3/11,19.43%,TAF11;GTF2A2;POLR1E
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3396208666846639,-0.7804174403050239,0.8666666666666667,1.0,1.0,16/86,20.79%,ACTG1;PCDHB11;TLN1;PCDHB4;CDH12;PCDHB2;BDNF;ILK;CDK5;SDK2;ACTB;FLNC;NRXN2;PLXND1;PCDHB9;RHOA
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.4977469097876318,-0.7798970182586301,0.7857142857142857,1.0,1.0,1/8,5.62%,PFKL
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.3550816972340531,0.779600004835068,0.7878787878787878,0.9865686274418657,1.0,3/23,15.12%,CDK6;CHRD;CRIM1
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.30741938500958144,-0.7795018947255562,0.8641975308641975,1.0,1.0,14/189,14.94%,CENPF;ARHGAP4;BUB1;CCNB2;CENPE;KIF20B;TPX2;CEP131;SMC4;CEP72;UXT;KATNB1;DOCK2;KIF4A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4403233286232662,-0.7794232131985042,0.7397260273972602,1.0,1.0,1/17,2.85%,XYLT2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.38439433328845707,0.7794080116123959,0.7297297297297297,0.9864017931363708,1.0,2/11,7.14%,IFNA2;TRIM11
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.3863584053266971,-0.7793876799037538,0.7848101265822784,1.0,1.0,1/28,3.93%,FABP3
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.46411918670641583,0.7793010025823086,0.75,0.9860880856258872,1.0,2/7,5.40%,DNAH11;DNAAF1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2945674015474912,0.7792733833634206,0.8148148148148148,0.9856137353898379,1.0,10/57,12.61%,EGFR;RELA;CPNE1;AGER;PTP4A3;SASH1;PTPN22;DLG1;TRIM44;NFAT5
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.34190863361682267,0.779158163695159,0.7647058823529411,0.9853007586345262,1.0,8/43,14.65%,HSD3B7;OSBPL1A;DHCR7;OSBPL6;HMGCR;OSBPL7;SC5D;DHRS11
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.399892088070349,0.7791223265737661,0.7222222222222222,0.984855269518379,1.0,6/19,18.64%,TMEM108;NTRK2;RAPGEF1;MAGI2;RAP1A;MAPT
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.4502622566466098,-0.779088119142453,0.7878787878787878,1.0,1.0,3/12,14.62%,CEACAM1;BRCA1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.3656821934173512,0.778907006136522,0.8378378378378378,0.9846687858638745,1.0,2/20,4.19%,ENSA;MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.3440734059228095,0.7788781323466961,0.8148148148148148,0.9842380500273442,1.0,9/44,12.89%,IL1RAPL1;PTPRD;CNTNAP2;NLGN1;NPHP4;NRXN1;MAP4K4;NLGN3;CLSTN2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.3812955989769032,-0.7788699419837679,0.8529411764705882,1.0,1.0,4/48,4.04%,HLA-F;P2RY10;GBP2;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.46041530391811936,0.7788292282617311,0.6744186046511628,0.9838147385480523,1.0,2/6,9.25%,ARNT;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3621080041640898,0.778630983134969,0.7435897435897436,0.9837128019845137,1.0,9/20,23.72%,DLX1;SMAD4;SMURF2;TRIM33;SMAD2;TGFBR3L;LATS2;ZNF703;ITGA3
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.500940970004876,0.7786040219321674,0.6923076923076923,0.9832274364750933,1.0,1/5,10.98%,FGF1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.4857521686106521,0.7782521989055381,0.7619047619047619,0.983341969331684,1.0,2/5,24.62%,LIG4;POLB
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.5018590151761538,-0.7781235769570862,0.7714285714285715,1.0,1.0,2/8,9.64%,GSTP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.34850820428590223,0.777933599839618,0.75,0.9833588580001572,1.0,2/18,6.75%,MTMR2;PICALM
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.3460505837695709,-0.7776653347619574,0.8860759493670886,1.0,1.0,13/59,22.70%,PCDHB11;PCDHB4;LRRTM3;PCDHB2;BDNF;CDK5;SDK2;NRXN2;PLXND1;PCDHB9;LRRC4;PCDHB3;FLRT3
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.35016807910642395,0.7776346806717706,0.75,0.9834523178328946,1.0,2/28,3.56%,KCNN4;RELA
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.46569892593210416,-0.7773677889720273,0.7241379310344828,1.0,1.0,3/9,20.43%,RPS27L;KAT5;FOXM1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.5297513161289192,-0.7772665747105563,0.8571428571428571,1.0,1.0,2/6,19.87%,CEACAM1;CD226
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3763148012296707,-0.7767747199443583,0.8194444444444444,1.0,1.0,14/35,36.28%,TOMM20;SSB;NOL6;RAN;NUP50;NUP155;NUP58;NUP93;NUP88;POM121;NUP107;POM121C;AAAS;SEC13
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.30218595179286817,0.7767090333282723,0.8620689655172413,0.9845338620485513,1.0,13/64,13.75%,VASH1;ADGRB1;NRP2;ATOH8;ADAMTS9;SASH1;RHOJ;FGF1;PRKD1;GPLD1;SLIT2;DNAJA4;BMPR2
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.4471088513131415,-0.7762753252137637,0.7666666666666667,1.0,1.0,1/9,9.64%,TGFB1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.41827995580932964,-0.7761684007226848,0.7580645161290323,1.0,1.0,3/13,14.47%,CBR1;PTGES2;EDN1
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),-0.5337068188710266,-0.7760228586158503,0.7884615384615384,1.0,1.0,2/5,11.89%,NUDT1;NUDT15
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.534078380751343,-0.7758816497404736,0.875,1.0,1.0,3/5,43.75%,ENG;VEGFA;PROX1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.4518299941183251,-0.7755202243929223,0.78125,1.0,1.0,3/10,19.28%,IL31RA;PARP1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.37944962672912913,-0.7751540174285003,0.7763157894736842,1.0,1.0,10/42,20.03%,MAGEF1;USP51;RAD51AP1;PARP1;FIGNL1;MRNIP;OOEP;CGAS;POLQ;PPP4C
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.3255332048082311,-0.7749393434389666,0.84,1.0,1.0,18/104,15.15%,XBP1;RPS14;FKBP14;CALR;NHP2;SRPRA;IMP3;EXOSC4;HSPA5;CEBPB;EXOSC10;EEF2;EDC4;ATF3;YIF1A;EIF4A3;KDELR3;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.40906924475239,-0.7748159869655402,0.803030303030303,1.0,1.0,7/16,22.14%,CXCL17;CALR;C1QBP;SERPINE1;CCR7;LGALS3;CREB3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.4098900101011233,0.7739193311820958,0.6976744186046512,0.988090434062113,1.0,5/10,24.64%,PLD6;PID1;TFRC;ADCK1;HUWE1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.5004129681905473,-0.773802489320934,0.7666666666666667,1.0,1.0,1/5,10.20%,NCEH1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.4418242302460019,-0.773707169575289,0.7733333333333333,1.0,1.0,3/12,19.54%,RACK1;SYT11;FER1L5
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.3385054569194549,-0.7736941665243863,0.8194444444444444,1.0,1.0,3/51,5.45%,ADH4;EHHADH;ADH5
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5028672258995639,-0.7736831543779934,0.8253968253968254,1.0,1.0,5/6,49.31%,NAGK;GNPDA2;RENBP;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.3414927103128922,-0.7736629072001614,0.8533333333333334,1.0,1.0,5/62,8.17%,XBP1;SELENOS;GSTP1;TNIP2;IRGM
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.4193504200624744,-0.7735412299959185,0.8125,1.0,1.0,4/19,19.83%,GPS2;ABCA12;APOE;CAV1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.32580172356949083,0.7731999212371462,0.78125,0.9887444242736665,1.0,5/63,3.98%,KIFC2;SGO1;ZNF207;PLK1;ESPL1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4650844776032324,-0.7731943300498048,0.7966101694915254,1.0,1.0,3/10,20.43%,RPS27L;KAT5;FOXM1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.35746474788914073,0.7729610580859182,0.7931034482758621,0.9885639464505317,1.0,2/29,1.29%,RAB39A;ATP6V0A4
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.419765021676722,-0.7729427387161726,0.8166666666666667,1.0,1.0,1/14,0.81%,BEST1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.34014792544863237,-0.7729369574628169,0.8717948717948718,1.0,1.0,13/87,13.42%,CLU;RPL11;RAD23A;ELOB;NOP53;RACK1;UBXN1;DDA1;ARIH2;RBX1;GIPC1;CAMLG;ARAF
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4932299561832214,-0.7728182630947582,0.765625,1.0,1.0,2/8,7.17%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.45380511573124155,0.7727323611949963,0.8421052631578947,0.9883905983871987,1.0,3/8,11.23%,SLC26A6;SLC2A5;TJP2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.4693723589119178,0.7724361774588707,0.7096774193548387,0.9883909577210466,1.0,4/7,25.66%,NEDD4L;STK39;CAB39;CASQ2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.4255722854315168,-0.7723657396992506,0.8194444444444444,1.0,1.0,2/17,8.91%,RHOG;BRK1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4184059195605153,-0.7721864347337839,0.8305084745762712,1.0,1.0,4/14,11.01%,MADCAM1;GCNT1;SELE;SELP
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.5030239806176318,-0.7718827732398978,0.75,1.0,1.0,1/5,6.91%,CD81
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.30942146263636194,0.7711558566498464,0.8620689655172413,0.9899939109126669,1.0,10/38,17.08%,YAF2;RYBP;PHC3;MGA;EED;TFDP2;PHC1;RAD51;EHMT1;RNF2
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.5009241782249358,0.7709920110496641,0.8064516129032258,0.9897368881364401,1.0,2/6,9.11%,PUS7;PUS10
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.31573264021388675,0.7709050083095619,0.9090909090909091,0.9893553785788681,1.0,6/41,6.92%,SPRED3;SPRED2;HSPB1;SPRED1;FNIP2;SESN2
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.45285410782293567,-0.7708623191154089,0.7538461538461538,1.0,1.0,4/12,19.54%,NMI;DOCK2;IFI35;FER1L5
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.31947224958677806,-0.7706961958698201,0.9253731343283582,1.0,1.0,8/106,8.85%,DDIT3;ID3;SIGIRR;HES6;SFRP4;TCEAL7;PHB2;TMSB4X
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3623889158963754,0.7699494654454482,0.8076923076923077,0.9904912714105034,1.0,8/39,14.57%,HSD3B7;OSBPL1A;DHCR7;OSBPL6;HMGCR;PNPO;OSBPL7;SC5D
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.44480400004152654,0.7695354383535956,0.7222222222222222,0.990649795926786,1.0,1/6,6.12%,XPO1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.41974278448639923,0.7693552980499059,0.7142857142857143,0.9904206429304359,1.0,4/9,21.47%,UBR3;SLC24A4;MKKS;DRD2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4017732628458174,0.7692313159330763,0.7380952380952381,0.9901640583276972,1.0,4/11,17.67%,PLK1;PTEN;CDC14B;BTRC
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.33294476325724887,-0.7684567895949811,0.8571428571428571,1.0,1.0,10/108,13.27%,CD44;NOX4;PRDX5;APOL3;TGFB1;SELE;ABCF1;CEBPB;ADGRE5;TNFRSF1A
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.43859354781261845,0.7684231382548303,0.7586206896551724,0.9911935275180176,1.0,5/11,13.39%,HPRT1;AMPD1;ADA;GMPR;AMPD3
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4375435727198457,-0.7684105462346749,0.7704918032786885,1.0,1.0,5/13,22.32%,RNF8;HEXIM1;SUPT5H;NELFE;NELFCD
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.36725894786973123,0.7684023421849857,0.8888888888888888,0.9907018930886121,1.0,7/43,5.73%,LEPR;TRIM29;TMC5;GRHL2;ALS2CL;PROM2;ALDH1A1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.26524962600520846,0.7683189526789119,1.0,0.9903005353887211,1.0,33/167,18.55%,VAPB;ARHGEF7;SPTSSB;ALS2CL;TRAPPC12;MYOF;DYSF;OBSL1;OPTN;ZFP69B;NSFL1C;PRKD1;CLASP1;ARHGAP21;TRIP11;RAB30;LEMD3;SUN3;GOLPH3;SPTBN5;SEC31A;AP3D1;ATL2;TOR1AIP2;SEC31B;DYM;CUL7;DMPK;HACE1;TRAPPC8;DNAJC28;MIA3;RNF112
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.3153716638843836,-0.7678673440498658,0.8518518518518519,1.0,1.0,3/102,2.84%,B2M;MT1E;MT2A
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3242512031112207,0.7678387561936894,0.7931034482758621,0.9903965518751423,1.0,23/54,25.32%,CDK10;NLK;TNKS;ACVR1;PRKD1;DYRK3;HIPK2;DYRK1A;HIPK3;GSK3B;SBK1;CAMK2D;MAPK8;WNK1;MAP3K10;MARK2;PRKCA;STK39;PDPK1;CSNK2A1;OXSR1;DYRK2;CAD
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.32949139540369204,0.7677973920105237,0.9090909090909091,0.9899336693305832,1.0,12/41,17.83%,ANKH;P2RX7;BMP6;ACVR1;ECM1;GPM6B;ENPP1;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4769067420241706,-0.7675847000583333,0.8275862068965517,1.0,1.0,1/7,7.85%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4769067420241706,-0.7675847000583333,0.8275862068965517,1.0,1.0,1/7,7.85%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.48250769424355816,-0.767473463146441,0.6984126984126984,1.0,1.0,2/5,26.43%,CD226;NR4A3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.3629968416101213,0.7674719528174234,0.8888888888888888,0.989995298440135,1.0,6/19,16.25%,ADGRB1;MEGF10;XKR8;HMGB1;NR1H3;RHOBTB1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.35600612375503204,0.7674458958199389,0.875,0.9895606579308919,1.0,1/28,0.42%,ZNF423
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.4950223085327213,-0.7670952088873616,0.7796610169491526,1.0,1.0,3/5,24.69%,NOP9;NOP14;ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.4950223085327213,-0.7670952088873616,0.7796610169491526,1.0,1.0,3/5,24.69%,NOP9;NOP14;ABT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.4950223085327213,-0.7670952088873616,0.7796610169491526,1.0,1.0,3/5,24.69%,NOP9;NOP14;ABT1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4152098089870164,0.7670432330387765,0.8108108108108109,0.9895879727163696,1.0,1/15,2.94%,GDAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.2908409722990491,-0.7668514512636937,0.9587628865979382,1.0,1.0,59/421,14.99%,BMP5;RPL23;GLP2R;IL7;PDGFD;COPS9;XBP1;SFRP1;PTK6;TGFBR2;TIMP1;RPS6;IL31RA;SLC25A5;RHOG;RAD23A;ROMO1;IL6R;DNPH1;GNAI2;TSHR;RPS9;RPS4X;SERTAD1;KIF20B;COLEC12;RPS19;CD81;BAMBI;TRIM13;CALR;PRR7;COX17;HRAS;HTR2B;AQP11;CEP131;AR;FLOT1;TGFB1;CDK4;CLEC11A;GRN;CR1;EXOSC4;MYRF;DUSP26;CAPNS1;CIDEB;ESM1;C1QBP;CCKBR;PRAME;FGF22;OSMR;EDN1;RTKN2;DOCK2;ZFHX3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.37647818621637963,-0.766824116781908,0.8235294117647058,1.0,1.0,12/51,25.82%,NOP10;FTSJ3;QTRT2;TSR3;SSB;METTL3;AARS1;AARS2;RBM15B;CTU2;URM1;NSUN4
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.32787710173781,0.7661596564422545,0.8387096774193549,0.9906961669071019,1.0,9/37,17.50%,FLT1;ID1;RASIP1;SERPINF2;LOX;CDH2;SYK;CUL7;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.37350531866606956,0.7661007445793558,0.7878787878787878,0.990275595196495,1.0,3/11,19.42%,ATP1B3;DMD;WNK1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.34113036925013585,-0.7659700726798773,0.78125,1.0,1.0,12/66,19.98%,RPS27A;UBA52;COLEC12;TNIP2;FADD;NMI;UBB;CNPY3;SCARA3;HSP90B1;CTSS;S100A1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.39419113434394953,-0.7659606078013272,0.890625,1.0,1.0,4/29,8.25%,HLA-DPA1;FGL1;PRELID1;LCK
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.36712815283062317,-0.765777131555192,0.7164179104477612,1.0,1.0,4/24,9.65%,JUP;SVBP;TGFB1;PTPRM
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.37223705635486204,0.7653362304234899,0.8421052631578947,0.991045304569219,1.0,6/22,11.23%,EGFR;NOTCH3;DLL1;ARRB1;FBXW7;LFNG
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.3564164934559048,-0.7652828041751694,0.7741935483870968,1.0,1.0,8/42,23.92%,EFNA1;ILK;NTNG2;TEK;ITGAV;RHOA;PXN;VAMP3
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.47993990479919946,-0.7652226611709999,0.7321428571428571,1.0,1.0,1/6,10.00%,RBX1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.38777954293087263,-0.7649817044568121,0.8208955223880597,1.0,1.0,7/29,19.97%,RPL10;RBM3;RBM4B;EIF2B4;EIF2A;METTL18;PGAM1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.481919006260972,-0.7648896979374471,0.7843137254901961,1.0,1.0,2/5,18.90%,ZFHX2;VIP
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4189254994092999,0.7648114557858396,0.775,0.9914842674713022,1.0,2/10,17.34%,YOD1;UBE2G2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.4829500080333892,0.7646834682993819,0.8108108108108109,0.991215093397895,1.0,1/5,3.58%,CTNNA2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.4233739525771506,-0.7646101021871458,0.7352941176470589,1.0,1.0,5/11,27.51%,PAF1;NCBP1;NCBP2;LEO1;DHX36
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.4940364720509707,-0.7645472374874578,0.8,1.0,1.0,2/6,4.05%,HLA-E;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.44819433217054483,0.7644703553007306,0.7857142857142857,0.991021732609405,1.0,2/7,15.81%,EHD2;ZDHHC2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.4050197140822465,-0.7641394621575566,0.8142857142857143,1.0,1.0,5/17,24.88%,GSTP1;EDN1;HPGD;PTGR1;PRXL2B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.35968748591786814,-0.7638916229973411,0.7857142857142857,1.0,1.0,4/31,14.60%,SPINT2;TGFB1;MYADM;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3079584625645049,-0.7637639976934636,0.8947368421052632,1.0,1.0,7/108,10.16%,ARHGAP4;SFRP1;TIMP1;HYAL2;CALR;ADAM15;FUZ
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4280173801736723,-0.7634238572361499,0.8225806451612904,1.0,1.0,1/12,1.63%,ZDHHC12
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.38641214277606745,0.7633942547997942,0.8108108108108109,0.9922356534296164,1.0,3/13,16.08%,MYH14;PID1;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.45239853130201296,-0.763371006156181,0.8181818181818182,1.0,1.0,3/12,12.30%,PLN;ATP5IF1;PPIF
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.30075241206694203,0.7632815873882478,0.9,0.9919184852783225,1.0,31/106,18.64%,VASH1;ADGRA2;SARM1;NSMF;ADGRB3;ARHGAP44;TNIK;PDLIM5;STRIP1;KIF13B;DLL1;ARHGAP35;CXCL13;FMNL2;GDNF;LRRC4C;LFNG;VASH2;CDH2;PID1;CLASP1;ABI2;ZRANB1;RUFY3;GSK3B;MARCHF5;NEDD4L;FGF2;CYRIB;LZTS1;MAPT
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.4249812276393604,-0.7632313272690119,0.7857142857142857,1.0,1.0,5/13,27.73%,DDX11;RAD50;GNL3;DHX36;NBN
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.4200183202712253,-0.763033692105934,0.8333333333333334,1.0,1.0,3/26,6.46%,DTX3L;PHPT1;CDKN1C
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.34322000451790247,-0.7630117227376767,0.9090909090909091,1.0,1.0,3/63,3.54%,BMP5;GATA1;GSTP1
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.45111285697577913,0.762997342685162,0.7027027027027027,0.9919239117654212,1.0,1/9,2.14%,FGFR3
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.3183604665802888,0.7622935392250526,0.6666666666666666,0.992594114227496,1.0,3/31,5.94%,PLK1;SIRT1;SNCA
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.407508695213603,0.7622129721776352,0.7222222222222222,0.9922224462773354,1.0,3/14,12.72%,ESPL1;LLGL2;CLASP1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.33124995218234343,-0.762185228028863,0.8933333333333333,1.0,1.0,6/64,9.64%,XBP1;SELENOS;GSTP1;TNIP2;IRGM;TGFB1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.48488087948357894,-0.7621567991436189,0.7674418604651163,1.0,1.0,4/5,47.51%,TMEM167B;RAB3A;TRAPPC11;TMEM167A
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.3329981572284415,0.7620070034573897,0.8,0.9920291627055464,1.0,12/28,19.88%,IQCJ-SCHIP1;KANK4;SMAD4;PIK3CA;SLIT2;CLASP1;KANK1;FKBP4;CYRIB;TJP1;SSH2;SSH1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.34769452242747806,0.7619324709800598,0.8,0.9916444694402183,1.0,5/33,4.38%,NOS2;HSPA1A;AFAP1L2;RELA;CLEC7A
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.2995715528636119,0.7618002128310655,0.9523809523809523,0.9913490790830072,1.0,9/57,11.53%,SRC;EGFR;NRG2;MATK;ERBIN;SHC3;GAB1;REPS2;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.33805963277756024,0.761617186433384,0.8571428571428571,0.9911702009750747,1.0,8/40,14.49%,CNOT2;PIP4K2A;CCP110;ARHGAP35;CNOT6L;G3BP1;LRSAM1;ASAP1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.2870127709378398,-0.7614197309039615,0.945054945054945,1.0,1.0,37/275,15.62%,B2M;RPS27A;RHOC;COL9A3;LOXL4;STMN1;COL4A4;PPIB;FLII;RHOG;CORO1B;NEFL;UBA52;ITGB4;ADAMTS14;P4HA3;APH1A;B4GALT7;MARCKSL1;ITM2B;FAT1;COL10A1;STMN2;BFSP1;KIF18A;TPPP3;STMN3;COL21A1;MYH6;LMOD1;KATNB1;MAP7D3;UBB;FIGNL1;DCTN1;MYO1H;TLL2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.35975874746170167,-0.7610469716590863,0.8571428571428571,1.0,1.0,2/53,4.58%,SFRP1;DNPH1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.32076607184208017,0.7606117151308972,0.9375,0.9922828799213965,1.0,7/48,9.55%,GPR35;HOMER1;CX3CR1;NMBR;GRPR;ADRA1A;GRM1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.4684599517359805,-0.7605929271955948,0.8148148148148148,1.0,1.0,1/7,17.00%,PAICS
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.44955953616848465,-0.7603496330269341,0.7666666666666667,1.0,1.0,1/5,9.49%,FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.3220868569556042,-0.7602536022505861,0.875,1.0,1.0,17/89,16.52%,RPL5;VPS35;RPS4X;RBM3;ATG10;TGFB1;FADD;LARP6;EIF3D;PTTG1IP;EEF2;RPS27L;PYM1;EIF4A3;CIRBP;METTL3;DACT1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.49251016726814645,-0.7601752379000688,0.8524590163934426,1.0,1.0,2/8,2.77%,PRDX1;PRDX5
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.46314558312134935,0.760041310403158,0.8055555555555556,0.9926432211722326,1.0,4/8,32.52%,PIK3CA;MAP3K7;AKT1;MTOR
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3296817749680666,-0.7596787699546403,0.8552631578947368,1.0,1.0,11/63,22.82%,RPS27A;UBA52;CTSO;UBB;CTSZ;CTSS;CHMP4B;NR1D1;UBC;VPS4B;CTSL
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.3041503383950383,-0.7596018579963375,0.9770114942528736,1.0,1.0,35/162,22.18%,RBMS2;SNRNP25;SCNM1;RBM3;PRPF3;DHX16;RNPC3;SF3A1;SNRPN;SNRPD1;TFIP11;TSEN34;SRSF7;PRPF6;PRPF4;SNRPD2;PRPF18;PRMT9;METTL3;KIN;ZCRB1;MAGOHB;PRPF8;RRAGC;AURKAIP1;FASTKD2;NCBP1;PRKACA;CLP1;DDX20;LSM3;NOL3;PDCD7;RNASEL;SRSF9
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.4542990144018515,-0.7595661259683476,0.8125,1.0,1.0,2/13,4.17%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.4517715053991894,-0.7594096367911473,0.7543859649122807,1.0,1.0,2/11,8.20%,RHOC;GPIHBP1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.3133873821470714,-0.7591607296132408,0.9142857142857143,1.0,1.0,12/115,14.35%,JUP;PDZK1;RAB11A;CD81;FLOT1;GORASP2;NECTIN3;ABCA12;RAB8A;MYADM;TNFRSF1A;GORASP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4205388077196668,-0.7585536759818444,0.7833333333333333,1.0,1.0,4/13,23.14%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.41035453912669767,0.7584692993941025,0.7804878048780488,0.9943751844223585,1.0,5/12,18.81%,SRC;ZNF304;PIK3CA;PDK4;BCL2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.33409885102481224,-0.7580901733586525,0.9027777777777778,1.0,1.0,12/73,22.40%,MAGEF1;METAP2;APH1A;PCSK1;AFG3L2;NDUFAB1;CIAO2B;CTSS;NNAT;BACE1;FURIN;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.37782078489295773,-0.7580183067133899,0.7910447761194029,1.0,1.0,6/29,20.60%,CFTR;TM7SF3;MYRIP;GCK;HLA-DRB1;NNAT
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.3773215616322877,-0.7580164167441444,0.8354430379746836,1.0,1.0,2/29,5.25%,SFRP1;RHBDF1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.43452193243084514,0.7578312769284432,0.7021276595744681,0.9948023328586254,1.0,2/7,9.95%,SASH1;PTPN22
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.3502876923840973,-0.757750737255545,0.8857142857142857,1.0,1.0,12/68,13.00%,RHOC;MT1E;TAX1BP3;CD9;CLCA2;DNPH1;MT1L;ITGB4;TMEM54;S100A16;ILK;DUOXA1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.500595328426718,-0.7577421451264525,0.8208955223880597,1.0,1.0,1/7,2.82%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.4306709389235527,0.7576409081153296,0.7380952380952381,0.9945744344671883,1.0,3/8,19.75%,PTPN22;HMGB1;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.37821460079491676,0.7575831869054587,0.8055555555555556,0.9941627469621489,1.0,1/12,3.11%,GMNN
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.33759687211170814,-0.75723782320724,0.84375,1.0,1.0,9/40,20.89%,XBP1;PAX8;SRP54;FADD;HOXD3;DKK3;SOD1;CAV1;MSN
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.4024029724563633,0.7571624132880453,0.8055555555555556,0.9943100630994472,1.0,3/11,6.46%,MTHFD2L;MTHFS;DHFR
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.27257426083783687,0.7568821954923856,1.0,0.9942461631514158,1.0,47/149,19.29%,TAFA5;NMNAT2;TAFA1;CELF3;CYB561;SCRT1;HIVEP3;ADGRB3;PLPPR4;AHDC1;STXBP5;OLFM3;NTRK2;ASXL3;SCN7A;ADGRL3;SNAP91;AKAP6;CACNA2D1;MAPK10;SHC3;NCAN;CYTH3;ZNF536;GOLGA7B;LRRC4C;NRXN1;PIK3CA;KCTD16;RGMB;CADM2;NMU;RIMBP2;NFASC;ZDHHC2;KIF1B;TTBK2;PLEKHA5;GRIA2;GUCY1A2;CA10;ADGRA1;TAC1;MAP2;ADCYAP1R1;KCNIP1;TSHZ1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.2497834746902198,0.7567648881857078,1.0,0.9939373392424252,1.0,46/280,13.97%,VDR;GCM1;ZBTB1;PPARGC1A;HDAC10;HNF4G;RXRG;CDK12;MAML2;MLLT3;TBL1XR1;IWS1;CCNH;NOTCH4;TAF3;NOTCH3;ARRB2;PAPOLA;SOX5;TAF4;NFKB1;WDR33;EAF2;PCF11;RARG;TEAD1;NABP1;INTS6;CPSF7;MNT;PIR;THRB;HDAC9;TAF12;SCAF8;ZNF473;TEAD2;ELL;ESRRB;ESRRG;TRIP11;SNAPC4;ZNF143;CBFB;ELL2;KAT2B
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.4425368650456391,0.756731148178188,0.8,0.9934927891955236,1.0,4/10,13.11%,ROBO1;TGFB2;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.4399887324147227,-0.7567230760124409,0.8135593220338984,1.0,1.0,3/7,21.86%,PRELID1;PIP;LGALS3
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.5133976326724644,-0.7566913977261038,0.8076923076923077,1.0,1.0,1/5,8.76%,AGBL3
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.35658012503446757,-0.7564295900549055,0.9104477611940298,1.0,1.0,6/43,11.40%,RPL10;TGFBR2;ZFPM1;TGFB1;TEAD3;IFT122
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.44960126252624494,-0.7563607899023755,0.7457627118644068,1.0,1.0,3/9,23.50%,SUPT5H;NELFE;CTR9
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),-0.4808445382289743,-0.7562299172513728,0.8103448275862069,1.0,1.0,1/5,12.92%,SLC2A2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.385003715300171,-0.7561427396121141,0.7678571428571429,1.0,1.0,3/18,12.08%,DDIT3;GRN;CDK5
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.423774941978916,-0.7555942126710938,0.7534246575342466,1.0,1.0,3/12,23.72%,RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.4856468175193841,-0.7554420267173094,0.8615384615384616,1.0,1.0,1/7,4.23%,SLC22A9
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.35150354328894845,-0.754875121616153,0.8289473684210527,1.0,1.0,4/39,13.29%,NPR2;NPPC;SLC35B2;IMPDH2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.3930768686278446,-0.7546429484622456,0.8688524590163934,1.0,1.0,8/29,21.86%,FGL1;CEACAM1;TNFRSF21;CR1;CEBPB;PDCD1LG2;HLA-DRB1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.4195210824910978,-0.7544017470416055,0.8059701492537313,1.0,1.0,1/17,0.70%,TINF2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.3697407302800985,0.7543812666211464,0.8,0.9964410854897062,1.0,2/17,5.87%,LPIN3;CYP4F11
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.3169206995556142,0.7541986309793997,0.7931034482758621,0.9962131653009315,1.0,9/65,9.54%,ATP6V0A4;EPS8L2;PIEZO2;CLIC5;GRXCR2;MYH14;PCDH15;MYO3A;PJVK
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.4187158664375405,-0.7540838235975048,0.7857142857142857,1.0,1.0,3/10,20.26%,MYADM;DGKG;DGKD
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.3271045032418978,0.7538676252854721,0.8518518518518519,0.9962028042217488,1.0,6/33,9.23%,RUNX1;PDE4B;CLEC7A;TRAF2;CD4;MALT1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.4987349955644298,-0.7537677829305286,0.7884615384615384,1.0,1.0,1/6,7.24%,CARTPT
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3145149823301231,0.7536925561348709,0.782608695652174,0.9958937736386473,1.0,3/71,2.22%,KCNN4;CHRNA4;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4470660419455601,0.7534387860558905,0.6888888888888889,0.9957275329310739,1.0,5/5,55.31%,IL18;IL12RB1;SLC11A1;IL1R1;IL23A
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3924226806693311,0.7533028341562692,0.7804878048780488,0.9955072075566338,1.0,3/11,16.08%,MYH14;PID1;PNPT1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.36362967861964174,-0.7530729657339151,0.8059701492537313,1.0,1.0,8/40,23.73%,CHMP2A;RPS19;REEP4;CHMP3;CHMP7;CHMP4B;VPS4B;SYNE1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.45014552310952827,0.7530701435970889,0.8,0.9953413265526608,1.0,1/8,9.95%,PTPN22
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.35433649148604673,-0.7530687407709907,0.8387096774193549,1.0,1.0,6/30,21.21%,PPP1R11;BOD1L1;CALM3;HSP90B1;PTPA;CALM1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3925898967730381,-0.7527616249057224,0.8695652173913043,1.0,1.0,6/24,8.77%,XBP1;SELENOS;CLU;RACK1;UBXN1;AQP11
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.31697743637656667,0.7523372946222826,0.7878787878787878,0.9960834082133891,1.0,8/59,10.64%,BCL2A1;FGFR3;TRAF2;P2RX7;CRADD;TGFB2;BAG3;TNFRSF10A
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.3781970834204251,0.7523281977118671,0.7941176470588235,0.9956059290574506,1.0,3/14,11.62%,CHRNA4;CHRNA5;CHRNB3
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.3821156479237232,0.7522407154750068,0.8064516129032258,0.9953387297895459,1.0,1/20,0.35%,PPP1R36
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.38703369349399913,-0.7520836287774787,0.7796610169491526,1.0,1.0,4/20,20.98%,LCK;HTR2B;HTR2A;CCR7
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.4542232426669607,-0.7515437772641289,0.7678571428571429,1.0,1.0,2/6,8.52%,ZFPM1;GPR183
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3332867403700314,0.7514114990252551,0.7741935483870968,0.995984998904895,1.0,2/36,2.29%,KIFC2;ZNF207
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.4352895235970098,0.7510983957820863,0.6666666666666666,0.9960626922621182,1.0,7/7,56.49%,SLC27A2;ABCD2;ACOX1;ABCD3;ABCD1;SLC27A4;ABCD4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.2958311550458069,-0.7510527791400984,0.9285714285714286,1.0,1.0,26/191,14.25%,BMP5;SIGIRR;SFRP1;TAX1BP3;PTK6;NEURL1;SHISA2;SFRP4;TNS2;GPC3;RACK1;CALR;TRABD2B;NFATC1;GPS2;LRPAP1;PIK3CB;BDNF;GLIS2;IFT122;APLN;CADM4;ASAH2;APOD;PRAME;NLRP12
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.34560412239218097,0.75090832401411,0.9166666666666666,0.9958632420674638,1.0,5/40,7.68%,GMNN;EGFR;DNA2;GLI2;STN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.37596056140876266,0.7508412738608712,0.7272727272727273,0.9954883778905025,1.0,3/15,13.59%,NT5E;NT5M;UPP1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.2856040771809864,-0.7507314407110262,0.9782608695652174,1.0,1.0,20/346,8.58%,IGSF1;ZNF100;DDIT3;ZNF492;PLAG1;SPIN2A;EDF1;HES6;ZNF664;PPIE;DRAP1;ZSCAN21;SOX21;WWC2;HINT1;BTG1;ZNF92;CALR;RPL6;LMX1B
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.4486255331372485,-0.7506708508097214,0.8166666666666667,1.0,1.0,2/8,18.68%,APOE;ABCA5
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.27505751665750494,0.7505225619455292,1.0,0.9955459496352506,1.0,40/171,19.34%,HSPA1A;FRZB;SPOCK1;PTCH2;EGFR;OSGIN1;IP6K2;SIRT1;TMC8;SMARCA2;SESN2;SGK1;HSPA1B;TGFB2;AKAP6;CDKN2A;SGK3;SMAD4;APBB2;SLIT2;ENPP1;RPS6KA1;BMPR2;RASGRP2;SLIT3;ST7L;ITCH;SIPA1;KIF14;CAMK2D;ARHGEF11;PPP1R9B;NRG3;RPTOR;SLC25A33;FBP1;BCL2;KLHL22;MINAR1;TFRC
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2902257124889956,-0.7504449051268833,0.9883720930232558,1.0,1.0,36/377,14.25%,ARHGEF16;GPAT3;ARHGAP4;RHOC;RPL5;RMI1;RPL11;RHOG;VAV3;ARHGAP15;NEK8;ATP6AP2;RASGRF2;RPF2;WWC2;NOP53;CEACAM1;TPX2;FSHR;RPA3;TMSB4X;DEPDC7;ARHGDIG;DEPDC1B;RFC2;PAK5;RGN;CDK5;TAF11;BRCA1;CHD4;ARAF;KAT5;SETD9;RFC4;NLRP12
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.31366139078575184,-0.7504171942950584,0.92,1.0,1.0,23/106,30.11%,VPS35;ARL1;ANKRD27;WDR91;STX16;LAMP1;SNF8;CLTCL1;DCTN1;SNX6;EEA1;DOP1B;SNX32;VAMP3;CCDC91;KLHL20;ANKFY1;AP2A1;RAB6C;AP4M1;HEATR5B;YKT6;RAB14
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.48097133625490335,-0.7501748548433345,0.7681159420289855,1.0,1.0,4/7,22.85%,PRELID1;BAX;ARL6IP5;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.351676406086079,-0.7496810306191163,0.8888888888888888,1.0,1.0,2/44,4.00%,RIMS1;PPIB
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.4041051601701173,0.7490023079559466,0.8125,0.9972633766914077,1.0,3/13,8.12%,HELLS;SIRT1;AURKC
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.4701724564616959,-0.7489275343453289,0.7796610169491526,1.0,1.0,2/6,20.89%,TGFB1;MSN
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.31810103765276415,-0.7487444205874562,0.8961038961038961,1.0,1.0,11/70,19.34%,CSTF2T;FIP1L1;DHX38;SRSF7;PAF1;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;CLP1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.44622663433257437,0.7486787639767521,0.8048780487804879,0.9973469846136656,1.0,2/6,8.78%,MLLT3;SPEF1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4534301835606154,-0.7481540983008723,0.7903225806451613,1.0,1.0,2/10,12.06%,GSTP1;MAPK8IP1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3385440563426168,-0.7480099350052591,0.8933333333333333,1.0,1.0,17/66,26.00%,TRIM13;ABRAXAS1;RNF8;RAD51AP1;BRCA1;KDM4D;KAT5;FIGNL1;FANCD2;MRNIP;ECT2;IKBIP;BLM;RAD9A;TOPBP1;HUS1;BRSK1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.33631669170982414,-0.747969646455791,0.8428571428571429,1.0,1.0,12/51,23.60%,XBP1;FABP3;LIMA1;GPIHBP1;ACSM3;LAMTOR1;APOE;ABCA5;CAV1;NR1D1;NPC2;ABCG5
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.3349302677847317,-0.747885178453274,0.7945205479452054,1.0,1.0,4/46,9.88%,CLU;HLA-E;RASGRP1;FADD
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.37122868406703846,-0.7477664391438763,0.8888888888888888,1.0,1.0,2/25,3.45%,CD63;PDZK1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.4724665975292104,-0.747760247521788,0.803030303030303,1.0,1.0,1/6,16.90%,ORMDL3
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.32803348867786614,0.7474019870081869,0.8235294117647058,0.998792170815015,1.0,1/18,0.67%,ZDHHC11
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3515615239198854,0.7473656648240762,0.8214285714285714,0.9983089814766951,1.0,9/23,28.90%,AUP1;FBXL17;UGGT1;ZER1;KLHL15;RNF185;LONP1;DERL1;CUL3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.32613876339901854,-0.747271587755082,0.9,1.0,1.0,9/96,9.64%,SFRP1;MT1E;MT2A;TCHP;HYAL2;BTG1;RACK1;ADAM15;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.47227136610946485,-0.7470976601900767,0.7936507936507936,1.0,1.0,2/5,10.09%,TGFB1;CUEDC2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.45687716528228084,-0.7470599342619217,0.8305084745762712,1.0,1.0,2/7,8.28%,TTN;HTR2B
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.33644280554011924,-0.7469322460769836,0.8142857142857143,1.0,1.0,12/50,23.60%,XBP1;FABP3;LIMA1;GPIHBP1;ACSM3;LAMTOR1;APOE;ABCA5;CAV1;NR1D1;NPC2;ABCG5
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3185656071613736,0.7469096349729556,0.9230769230769231,0.9985064264112807,1.0,5/45,8.05%,HSPA1A;CPNE1;TRAF2;CCDC3;HSPA1B
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.4190570521595315,0.7468537432496876,0.8048780487804879,0.9981517452855243,1.0,2/9,17.34%,YOD1;UBE2G2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.45750277462417255,-0.7468320950395387,0.8059701492537313,1.0,1.0,2/6,20.35%,ORAI1;AKAP5
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.35330077422754314,-0.7467642248256575,0.8076923076923077,1.0,1.0,5/33,16.52%,GSTP1;PINK1;GPS2;PPIA;DACT1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.39041399008739025,-0.7465802598117836,0.8088235294117647,1.0,1.0,3/14,21.24%,GPIHBP1;APOE;MTLN
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.30196948958524433,0.7462363938037039,0.9259259259259259,0.9986719927132628,1.0,14/88,10.65%,ADAM33;TPM2;FRZB;TMEM98;POSTN;PDGFRA;TMEM47;CDH11;COL14A1;HTRA1;COL6A1;AQP1;ALDH1A3;INTS6
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.3206135994614258,0.7461938275048994,0.85,0.9982167188877777,1.0,7/42,11.63%,NOS2;SNCA;IRAK3;ERBIN;PTPN22;PELI1;MAPKAPK3
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.4467389480250581,0.7456257065707101,0.7222222222222222,0.9985011887019761,1.0,4/6,35.80%,KMT2D;KMT2A;SETD1B;SETD1A
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.4410942988326697,0.745434297807971,0.725,0.998214388597281,1.0,1/6,5.09%,NLGN1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.4623358774795441,-0.7453179291645445,0.7846153846153846,1.0,1.0,4/10,17.88%,MTHFD1;PRPS1;PRPSAP1;PRPS2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.3692919702284393,0.7450483647816973,0.7692307692307693,0.9982770098493768,1.0,4/10,14.14%,RUNX1;SH3RF1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.47742356580583395,0.7450316454754159,0.8,0.996315580755438,1.0,1/5,4.47%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.47742356580583395,0.7450316454754159,0.8,0.996315580755438,1.0,1/5,4.47%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.47742356580583395,0.7450316454754159,0.8,0.996315580755438,1.0,1/5,4.47%,EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.47742356580583395,0.7450316454754159,0.8,0.996315580755438,1.0,1/5,4.47%,EXOSC7
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.4445403143562754,-0.7447023561678514,0.875,1.0,1.0,1/10,22.17%,GNE
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.430491722107717,0.7444293011134067,0.6842105263157895,0.9967004697171084,1.0,3/9,10.91%,PDE4B;CACNA2D1;NOS1AP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.370371450940965,-0.7443556733644786,0.7922077922077922,1.0,1.0,7/31,18.80%,HINT1;RPS27L;MYBBP1A;PDK2;SNW1;DDX5;TMEM109
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.47685969580340704,-0.7442557833441437,0.7857142857142857,1.0,1.0,2/6,13.27%,FADD;TNFRSF1A
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.26662872171072965,0.7437789970719763,0.9642857142857143,0.9970916726253218,1.0,19/113,12.66%,KCNQ2;FGFR3;CPEB3;ZBTB16;CKM;NGB;MAGIX;SGK1;TGFB2;GDNF;CPA2;PDE6B;CELSR2;TEX15;THRB;LFNG;KCNN1;CD80;GP1BA
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.2933496467266539,0.7437446484854485,1.0,0.9966327365048323,1.0,11/76,12.28%,NOS2;IRS1;ABCC8;RFX3;ENSA;STX1A;LRRC8A;KCNC2;ACSL4;ITPR1;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.37776771905910733,0.7437281374735689,0.8055555555555556,0.9961675657676173,1.0,6/18,22.59%,TAFA1;SLC16A2;KDM2B;KDM1A;MDK;PTPRZ1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3342092092161425,0.7437228745306613,0.9090909090909091,0.9956828009131325,1.0,5/29,5.25%,STARD13;PRKX;ID1;ADGRA2;PTP4A3
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.36368794375970576,0.7433790962419725,0.8947368421052632,0.9957530427672452,1.0,1/11,5.48%,SIRT1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3449525531653154,0.7432709178329373,0.8235294117647058,0.995462615526751,1.0,4/30,9.98%,RUNX1;SAFB2;KDM4C;RNF14
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.4207096350102802,0.7432589272729921,0.7333333333333333,0.9949722398540778,1.0,1/9,6.23%,PKD2L1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.43100996689101306,0.7429497889485649,0.8095238095238095,0.9949960294164173,1.0,1/12,0.19%,VDR
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.47086968747864977,-0.7426968853010489,0.8,1.0,1.0,2/7,28.32%,MAPK7;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.35377484859675906,0.7426274864276848,0.8235294117647058,0.9949064409883627,1.0,2/17,5.48%,HSPB1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.3916777894675466,-0.7421894792862398,0.7936507936507936,1.0,1.0,5/23,11.40%,GPC3;RACK1;RFX4;GLIS2;IFT122
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.4276899006534357,-0.7420520520980023,0.7846153846153846,1.0,1.0,1/12,10.20%,NCEH1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.38338850432282795,0.7417512941949749,0.8108108108108109,0.9956300263308586,1.0,2/16,5.26%,SAMSN1;CD22
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.3651098107374605,0.7416854138566646,0.8888888888888888,0.9952337917457282,1.0,6/18,19.34%,ACER2;PDE4B;GPLD1;PPM1E;FBP1;TFRC
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.47396852635591835,0.7413435641026156,0.78125,0.9953306449704039,1.0,1/6,8.96%,CACNA2D1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.33914207524841866,0.7413167877107066,0.7714285714285715,0.9948550888635683,1.0,7/22,18.93%,CAMSAP3;AEBP1;PIK3CA;CAMSAP2;ABL1;MAPT;MAP2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.31904399734967404,-0.7411080582811299,0.9066666666666666,1.0,1.0,7/97,11.29%,BMP5;RPS27A;TGFBR2;UBA52;BAMBI;TGFB1;FNTA
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.39035816957192415,-0.7408661023232955,0.8888888888888888,1.0,1.0,1/21,0.95%,TTN
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.40805559635988947,0.7406084188129988,0.631578947368421,0.9953511258585153,1.0,2/5,20.10%,CD274;LILRB1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.3249456637371392,-0.740607535949029,0.8333333333333334,1.0,1.0,2/65,1.36%,SLC8A3;SLC6A12
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.34680412370101815,-0.7405338893797699,0.8133333333333334,1.0,1.0,5/41,7.73%,RPS3;USP1;PCNA;ABRAXAS1;RNF8
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3909720384429295,0.7402854156853013,0.8275862068965517,0.995500965222557,1.0,3/9,11.02%,SIRT1;SNCA;KLF15
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.4205019640086187,-0.7400732183492773,0.8064516129032258,1.0,1.0,5/17,23.72%,APOE;SOD1;RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.46566947659388597,-0.7399422523295064,0.84375,1.0,1.0,3/6,26.00%,FUZ;NPHP1;BRSK1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.333936570865167,-0.7397518433138438,0.8648648648648649,1.0,1.0,3/54,3.98%,SLC25A4;SLC25A5;SLC25A11
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.4175022211797319,0.7395409198295895,0.7555555555555555,0.9961158093546956,1.0,3/7,22.88%,ACADS;PCCA;MMAA
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.37896268822329604,-0.7394592307765674,0.8333333333333334,1.0,1.0,4/26,14.47%,GSTP1;RPS3;MAPK8IP1;EDN1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.419109748078599,0.7387682398272742,0.8095238095238095,0.9967898266060877,1.0,2/8,7.47%,GLI2;ADAM8
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.45371490053755126,-0.7387522569037642,0.9016393442622951,1.0,1.0,4/12,9.50%,CLU;MANF;AQP11;USP19
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.43776573088110526,-0.7384196020887809,0.7777777777777778,1.0,1.0,2/8,14.43%,TEFM;MGME1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.3990505839215477,-0.7383409588946344,0.85,1.0,1.0,5/16,22.40%,KLK6;APH1A;APOE;BACE1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4932557858397495,-0.7380073530760267,0.8461538461538461,1.0,1.0,2/7,7.17%,SFRP1;BTG1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3917739851614556,-0.7379663206585158,0.8289473684210527,1.0,1.0,3/24,12.62%,SFRP1;CALR;BRCA1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.3701505037847498,0.73792378603264,0.7586206896551724,0.9974963759467163,1.0,1/20,0.32%,RELN
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.3192579379095283,0.737902531750055,0.90625,0.9970410623584144,1.0,2/24,2.14%,IGF1;FGFR3
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.4809508083560529,-0.7378273345980276,0.8064516129032258,1.0,1.0,1/6,8.14%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.4809508083560529,-0.7378273345980276,0.8064516129032258,1.0,1.0,1/6,8.14%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.45970560332323424,-0.7376451905200491,0.8070175438596491,1.0,1.0,3/8,23.50%,SUPT5H;NELFE;CTR9
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.4774080907009258,-0.7375362667257261,0.873015873015873,1.0,1.0,2/5,19.92%,YBX3;RCSD1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.27428751490949405,0.7374815752043832,1.0,0.9971764437954986,1.0,19/107,15.37%,SH2B2;ATP6V0A4;IRS1;GRB14;LPIN3;AKT2;SORBS1;IGF1R;CPEB2;GAB1;RHOQ;HDAC9;GPLD1;ENPP1;KAT2B;ATP6V0D2;TRIB3;C2CD5;PDK4
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.31186416513905624,-0.7374655950517277,0.9436619718309859,1.0,1.0,3/83,1.28%,P2RY10;TRPM1;JPH3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.4636148535410725,-0.7374253871187646,0.8305084745762712,1.0,1.0,2/8,19.22%,APOE;PRKACA
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.4511692551053046,-0.7373791870949838,0.7796610169491526,1.0,1.0,2/7,24.16%,TFIP11;DHX8
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.33562435068969043,0.7372390604985805,0.8620689655172413,0.9969073377999946,1.0,2/44,1.29%,REP15;ATP6V0A4
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.47734706569413515,-0.7371322388956302,0.8524590163934426,1.0,1.0,2/5,19.92%,YBX3;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3114727611498368,-0.7370554977319053,0.925,1.0,1.0,13/98,14.54%,RHOC;SFRP1;RPS3;GBA3;RACK1;RASGRP1;HRAS;DOCK8;PINK1;FNTA;TBC1D2;ZC3H15;CAV2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4085217938864948,-0.7368240691061206,0.8421052631578947,1.0,1.0,4/12,29.72%,IKBIP;BLM;NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.4204896635950221,-0.7366636320323063,0.8225806451612904,1.0,1.0,4/11,25.93%,SLC25A11;SLC25A3;SLC25A30;SLC25A10
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.4204896635950221,-0.7366636320323063,0.8225806451612904,1.0,1.0,4/11,25.93%,SLC25A11;SLC25A3;SLC25A30;SLC25A10
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.4778817403300385,-0.7365655802080711,0.8771929824561403,1.0,1.0,1/6,5.35%,RAB11A
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.42657912947421883,0.7365577439140772,0.8918918918918919,0.9972944223076431,1.0,4/6,16.87%,PLEKHA7;AFDN;CDH2;FER
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.46835548917282716,-0.7363134455009573,0.7903225806451613,1.0,1.0,1/8,3.54%,GSTP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.45496150259328483,-0.7362882130807884,0.7966101694915254,1.0,1.0,2/6,9.51%,PLN;SRI
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.4039517280871605,0.7360693302959809,0.8,0.9974427259867572,1.0,3/8,19.36%,CRTAM;CD274;SCRIB
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.293065762868442,-0.7360692533542591,0.9764705882352941,1.0,1.0,34/176,21.66%,RHOC;GAPDH;GSTP1;APOL3;TNIP2;TRIM13;TMED4;TRIM25;HTR2B;LAMTOR5;SLC35B2;FADD;NEK6;PINK1;NLRX1;STAT1;TNFRSF1A;PPM1N;LGALS1;NLRP12;IFIT5;TMEM9B;UFL1;GPR89A;S100B;ECT2;SHISA5;DDX1;HLA-DRB1;RIOK3;RHOA;CCR7;NR1D1;DDX21
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.39703528559217116,0.736026006628311,0.7435897435897436,0.996995169811073,1.0,6/14,21.51%,SLC9C2;SLC9A2;SLC12A2;SLC9A9;SLC6A1;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.4763365116727919,0.7357283882159329,0.8378378378378378,0.9969913108502562,1.0,1/5,1.58%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.2719822122818514,0.7351755769633798,1.0,0.9972784098054484,1.0,33/137,18.62%,LIFR;CD59;DPPA2;PIWIL4;PIWIL2;NXN;LRP4;LEF1;RND3;FBLIM1;GLI2;DOCK1;CD276;TEAD1;SMAD4;TEAD2;ESRRB;SHROOM3;PAWR;NAV2;KCNIP3;ROR1;LGR4;SMAD9;COL4A2;SPRY4;MYO1B;NR6A1;PARD3;SMAD2;TJP1;RAI14;PTPN14
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.42414175561239564,0.7349911646580782,0.78125,0.9970298698036727,1.0,3/7,16.49%,SERPINB9;SFPQ;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.42788270414959273,0.7347985215996717,0.8666666666666667,0.9967881783078605,1.0,1/9,0.67%,NUPR1
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.4592167806335783,0.7347662606790808,0.8125,0.9963354287222496,1.0,1/6,10.51%,SOX30
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4624955203331305,0.7343149074674133,0.7857142857142857,0.9965298918304525,1.0,3/10,12.28%,ADGRB1;EHD2;RAPGEF3
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.3542615664758352,0.7340788267821764,0.8235294117647058,0.9963745512240801,1.0,3/19,6.11%,IFNA2;TICAM1;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.3620439382475758,-0.7338293532563935,0.8142857142857143,1.0,1.0,7/27,16.74%,RHBDF1;VAMP8;PNKD;SYT11;TNFRSF1A;GRM7;APOE
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.37425677646703037,0.733783626130225,0.85,0.9963116678251958,1.0,4/11,16.33%,PKD1;GDNF;ROBO2;PKD2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3342058221368223,-0.7335950216287372,0.88,1.0,1.0,13/57,21.10%,F8;TRAPPC1;TRAPPC4;F5;MCFD2;TRAPPC2L;GORASP1;TRAPPC3;GOLGA2;CTSZ;NAPA;TBC1D20;TMED2
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3342058221368223,-0.7335950216287372,0.88,1.0,1.0,13/57,21.10%,F8;TRAPPC1;TRAPPC4;F5;MCFD2;TRAPPC2L;GORASP1;TRAPPC3;GOLGA2;CTSZ;NAPA;TBC1D20;TMED2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3342058221368223,-0.7335950216287372,0.88,1.0,1.0,13/57,21.10%,F8;TRAPPC1;TRAPPC4;F5;MCFD2;TRAPPC2L;GORASP1;TRAPPC3;GOLGA2;CTSZ;NAPA;TBC1D20;TMED2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.47675889919368075,0.7335047216261888,0.8048780487804879,0.9962224852745073,1.0,3/5,28.66%,GOLPH3;VPS13D;SORL1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.4395495076228759,-0.7334793817259029,0.7868852459016393,1.0,1.0,5/8,27.51%,TGFB1;GREM1;MYOCD;EFNB2;DHX36
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.44941402446118917,-0.7334304984578331,0.7758620689655172,1.0,1.0,2/7,22.60%,MYRF;PLP1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.36074312010177245,0.7333558133272382,0.8048780487804879,0.9959753043901568,1.0,2/11,7.51%,SLC15A2;SGK1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3393592520110932,0.7327197536631476,0.7894736842105263,0.9963933150219281,1.0,6/25,12.85%,CLDN12;JAM2;TJP2;ESAM;SLC12A2;DMD
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.37427109517719426,-0.732354873244201,0.8169014084507042,1.0,1.0,3/17,21.10%,HRAS;FICD;TMED2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3369654273464735,-0.7323169781893857,0.8227848101265823,1.0,1.0,5/46,15.01%,TINF2;PNKP;CCT7;EXOSC10;CCT2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.46701572105963474,0.7321633213428904,0.7567567567567568,0.9967977586635501,1.0,1/5,4.82%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.42381667007728463,0.7320396577575685,0.6842105263157895,0.9965243493551009,1.0,2/8,7.11%,CPEB3;CPEB2
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),-0.48749075027295685,-0.731713627673532,0.8333333333333334,1.0,1.0,1/5,1.87%,BUB1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.4263638644618474,-0.7315773560354173,0.8307692307692308,1.0,1.0,4/10,22.04%,BRCA1;LRIF1;METTL3;RBM15B
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.33129803724596374,0.7309400419644573,0.9354838709677419,0.997677783550455,1.0,5/20,13.39%,HPRT1;NT5E;NUDT3;PRTFDC1;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.47669736097453863,-0.7308935434632093,0.7857142857142857,1.0,1.0,3/6,20.79%,PRELID1;BAX;ARL6IP5
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4226290394104542,0.7308516216959685,0.7567567567567568,0.9973319326953206,1.0,3/12,11.12%,NRP2;PLXNA1;PLXNB2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.38889691926844167,0.7308392450448186,0.7647058823529411,0.9968550627355687,1.0,1/9,2.52%,DENND1B
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.3214215927989067,-0.7307450651479068,0.8888888888888888,1.0,1.0,10/54,19.32%,PTK6;TMC4;VAMP8;TRIM25;LRP10;TMCO4;PRICKLE3;PRKD2;TGM1;POLD4
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.45659449797508267,0.7306492867622242,0.775,0.9966412363654448,1.0,1/6,10.29%,FBXW7
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.42156337412320505,-0.7305388612018613,0.8484848484848485,1.0,1.0,3/11,20.62%,HTR2B;APOE;PDE2A
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.4522312713534335,0.730472612210898,0.7,0.996335758069202,1.0,1/6,4.82%,PLA2G10
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4104462679119416,-0.7302324036934289,0.7941176470588235,1.0,1.0,5/14,30.94%,AR;DDX5;ESR1;SAFB;NCOA4
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.36981043078816256,0.7301064698700623,0.84,0.996469973742122,1.0,3/13,15.04%,C3;TRIB3;C2CD5
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.34795048756423785,-0.7297733786410621,0.8636363636363636,1.0,1.0,5/32,19.03%,PDZK1;PHB2;PPIF;FXYD4;RANGRF
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.4208536880849675,-0.729411197805405,0.7543859649122807,1.0,1.0,8/10,24.30%,KLK6;FAM111A;AFG3L2;MYRF;SPRTN;HJV;CTSL;HTRA2
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.4645357576887992,-0.72922142153757,0.8421052631578947,1.0,1.0,3/6,26.48%,USH1C;LRTOMT;PDZD7
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.36412205401413433,-0.7290601807067337,0.8548387096774194,1.0,1.0,5/37,17.40%,CPS1;MOCS1;TPI1;ITPKA;PPIP5K1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.3637432201399138,-0.7285616541143978,0.835820895522388,1.0,1.0,2/25,5.33%,SFRP1;SGMS2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.36075577353250504,-0.7284873391663015,0.92,1.0,1.0,8/29,21.21%,NOSTRIN;HTR2B;DDAH2;PIK3CB;APOE;CAV1;S100A1;CALM1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.443945064918636,0.7283002329893268,0.72,0.9985836725781554,1.0,4/5,28.95%,FGF13;DCC;ULK1;PTPRS
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.3856264971062832,-0.7282568083740469,0.8732394366197183,1.0,1.0,1/18,0.68%,SLC8A3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.3769101881291001,0.7282459440474053,0.7407407407407407,0.9981466613438758,1.0,1/11,6.75%,PICALM
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.43364618484549344,-0.7281974717005147,0.7903225806451613,1.0,1.0,2/8,13.97%,TAF11;GTF2A2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.3919805689518594,-0.7280564515008143,0.859375,1.0,1.0,4/20,10.33%,PNKD;ARF1;SLC24A1;SYT11
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.44371769484870505,-0.7271604967160821,0.8,1.0,1.0,2/6,19.28%,AHR;HLA-DRB1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.4458722839288995,0.72691388499073,0.8918918918918919,0.9994454710569513,1.0,1/5,6.12%,XPO1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3722537132976247,-0.7263899163237624,0.8405797101449275,1.0,1.0,11/31,24.70%,NEFL;BLOC1S4;AP3B2;KIF4A;DCTN1;SNAPIN;SOD1;BLOC1S2;DYNC1H1;DTNBP1;AP3M1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.30363985115911374,0.7263353366567117,0.9629629629629629,0.9996695622392896,1.0,9/31,17.83%,P2RX7;BMP6;ACVR1;GPM6B;BMPR2;ACVR2B;ACVR2A;PTH;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2951522089101247,-0.7261817997369219,0.9647058823529412,1.0,1.0,14/183,9.49%,DDIT3;RPS27A;CLU;BEX1;JUP;RPS3;UBA52;COPS5;TRIM13;TRIM25;PHB2;LAMTOR5;AR;FLOT1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3659345710144192,-0.7261271416652699,0.7833333333333333,1.0,1.0,4/25,17.17%,SFRP4;TGFB1;FSTL1;DKK3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.34358737802245504,-0.7256448906830307,0.9130434782608695,1.0,1.0,5/30,12.08%,ACTG1;USP6;RAB11A;PINK1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3147633846726924,0.7256222467722703,0.9130434782608695,1.0,1.0,11/51,14.39%,IGF1;MYOM1;SYTL4;BMP6;ADAM8;LRRC8A;TGFB2;ACSL4;ATP13A2;GPER1;GOLPH3
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.280894651232097,0.7254835258123887,0.9523809523809523,0.9999536158924485,1.0,21/80,18.71%,DSE;CHST7;VCAN;CSPG4;AGRN;CHST3;HS2ST1;NCAN;CHSY3;CHST11;CSGALNACT1;B4GALT3;UGDH;CHST15;GPC6;EXT2;GPC4;ST3GAL6;ST3GAL2;HS3ST5;XYLT1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.35352093355918074,-0.7241349698365658,0.8823529411764706,1.0,1.0,5/31,18.90%,DND1;PHAX;CIRBP;ZCCHC17;VIP
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.4096537389549926,0.7240789064826886,0.8085106382978723,1.0,1.0,5/11,21.76%,CTNNA2;PTEN;BBS2;MKKS;FBXW11
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.4493247014844983,-0.7236855729086902,0.7727272727272727,1.0,1.0,2/7,17.21%,IL5;LCP1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3551520354710089,-0.7235378524784345,0.8208955223880597,1.0,1.0,10/28,27.73%,NOP53;ABRAXAS1;CLSPN;BRCA1;MRNIP;BLM;TOPBP1;BRSK1;DONSON;NBN
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.4329544105862431,0.7235234234496704,0.7619047619047619,1.0,1.0,1/7,12.16%,SLC8A2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.25402509878410506,0.7235191802957439,1.0,1.0,1.0,21/100,16.24%,HSPA1A;FRZB;OSGIN1;IP6K2;SIRT1;SMARCA2;SESN2;DIP2B;HSPA1B;TGFB2;CDKN2A;SMAD4;APBB2;SLIT2;ENPP1;FGF13;BMPR2;SLIT3;ST7L;SIPA1;TRIM46
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.351074778295506,-0.7234510713570387,0.8405797101449275,1.0,1.0,2/20,9.64%,TGFBR2;TGFB1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.34508699144882005,-0.7234155802672265,0.8955223880597015,1.0,1.0,12/37,27.73%,NOP53;ABRAXAS1;ZNF830;CLSPN;BRCA1;MRNIP;BLM;TOPBP1;HUS1;BRSK1;DONSON;NBN
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.2867477771120696,-0.723065053978444,1.0,1.0,1.0,17/226,8.56%,XBP1;SFRP1;SELENOS;AQP9;H2AZ1;PTK6;NEURL1;PRDX5;CFTR;GSTP1;RPS3;ROMO1;TSHR;RRAGA;TNIP2;IRGM;LAMTOR5
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.3488674130420035,-0.7228127760577948,0.9402985074626866,1.0,1.0,4/53,9.87%,PLAAT4;DBI;CHKB;PLA2G12A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.437490381111341,-0.7227354730605563,0.896551724137931,1.0,1.0,2/12,19.83%,PARP14;CAV1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.39018649018885676,0.7226727694621949,0.8125,1.0,1.0,1/12,2.00%,TSPOAP1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.2890350168331321,-0.7224753015664269,0.9753086419753086,1.0,1.0,22/178,16.84%,RPS27A;XBP1;DTX3L;ADRM1;UBA52;RNF8;TRIM25;ARIH2;RBX1;PINK1;PSMD3;WDR91;RNF5;PPP1R11;ANAPC15;UBB;CDC34;UBE2D4;RNF167;UBL7;RNF213;RNF111
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.39477075134277884,-0.7222879393679695,0.890625,1.0,1.0,6/19,20.66%,CHMP2A;NEMP1;DCTN1;CHMP7;EMD;CHMP4B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.2593439543347448,0.722183088550876,1.0,1.0,1.0,22/148,12.67%,VDR;PPARGC1A;HDAC10;HNF4G;RXRG;MAML2;TBL1XR1;CCNH;NOTCH4;TAF3;NOTCH3;TAF4;RARG;TEAD1;THRB;HDAC9;TAF12;TBPL2;TEAD2;TFB1M;ESRRB;ESRRG
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.40457686883223454,0.7221696761722705,0.717948717948718,1.0,1.0,2/7,8.50%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.44059421357413997,-0.7221428266953276,0.75,1.0,1.0,1/8,15.10%,MAP3K12
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.39661486776692206,0.7218739479425694,0.8,1.0,1.0,1/8,3.37%,EGFR
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.3100917086900358,-0.7217674250714726,0.9342105263157895,1.0,1.0,10/87,8.61%,TMEM107;SPAG17;ENKUR;ARMC3;CXCL17;TMEM212;HSPA2;RGS22;SPEF2;DNAH9
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.3179966304875875,-0.7216763360175786,0.9090909090909091,1.0,1.0,9/55,16.51%,TTN;KIF20B;RACK1;CEP131;VPS28;TGFB1;PPIA;MYH10;DNM1L
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.30857287727540716,0.7214098488419374,0.8529411764705882,1.0,1.0,9/42,17.06%,CASS4;ARHGEF7;DOCK1;KANK1;TESK1;DOCK5;CORO1C;SPRY4;ABL1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.39921165947925136,0.7213271102797987,0.7209302325581395,1.0,1.0,3/6,20.23%,RAB34;MAPKAPK3;MAPKAPK2
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.42774291381534224,0.7213208243185933,0.825,1.0,1.0,3/6,32.70%,DLEC1;RBMS3;PLK5
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.34904134142321913,-0.7210860137833531,0.8714285714285714,1.0,1.0,2/37,3.46%,AQP9;PTAFR
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.46840440717608645,-0.7209470861465842,0.8363636363636363,1.0,1.0,3/5,31.22%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.46840440717608645,-0.7209470861465842,0.8363636363636363,1.0,1.0,3/5,31.22%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.3119415999442007,-0.7209254292900263,0.891566265060241,1.0,1.0,14/98,13.10%,PDXDC1;CPTP;DEGS1;ORMDL2;GBA3;DEGS2;SGMS2;ELOVL2;ORMDL1;SMPD2;SGPL1;ABCA12;ASAH2;ESYT1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4137201459452995,-0.7205377152067308,0.84375,1.0,1.0,1/11,7.76%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4137201459452995,-0.7205377152067308,0.84375,1.0,1.0,1/11,7.76%,FBLN1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.31836451582706277,0.7204360801114147,0.8285714285714286,1.0,1.0,8/31,21.47%,P2RX7;DLG1;SLMAP;NKAIN2;SCN3B;WNK1;PER1;DRD2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3043516008029123,-0.7202811428091291,0.9367088607594937,1.0,1.0,15/79,22.18%,MBNL3;RBM3;RBM11;SRSF7;C1QBP;C9ORF78;NCL;CIRBP;SRSF3;SNW1;DDX5;NCBP1;SAP18;RBM15B;SRSF9
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.4722648506929175,0.7197919996091787,0.7608695652173914,1.0,1.0,2/5,26.24%,KDR;IL33
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.3536481497736058,0.719474091421468,0.8108108108108109,1.0,1.0,5/22,21.45%,OTUD7B;YOD1;OTUD4;OTUD7A;USP25
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.3988246285320558,-0.7194590233121665,0.8615384615384616,1.0,1.0,2/17,6.99%,PDZK1;SLC22A4
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.36761089243676665,0.7192385104655196,0.8571428571428571,1.0,1.0,4/12,24.86%,SPEF1;PPP1R9B;DNM3;FGD3
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.34951584078905595,-0.718927897725875,0.8529411764705882,1.0,1.0,11/37,21.86%,HLA-DPA1;TNFRSF21;CR1;CEBPB;TNFSF9;ZP3;PDCD1LG2;HLA-DRB1;CD46;HLA-DPB1;LGALS3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.318431513435846,0.7187259730533897,0.9032258064516129,1.0,1.0,6/34,12.07%,ENSA;MFHAS1;NSMF;CAMTA1;PPP6R3;SPPL3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.4074130870627788,0.718719791890429,0.7209302325581395,1.0,1.0,2/7,8.25%,TRIM11;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.4074130870627788,0.718719791890429,0.7209302325581395,1.0,1.0,2/7,8.25%,TRIM11;CD4
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.36948287284163334,-0.7182101803866148,0.8266666666666667,1.0,1.0,5/17,23.16%,CDKN1C;DYNLL1;ANKLE2;INPP5K;CDKN2D
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.3415337465003695,-0.7181603949775964,0.8382352941176471,1.0,1.0,5/28,13.34%,TTN;FLII;SYNPO2L;MYH6;LMOD1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3268744688410514,0.7180361589381496,0.8888888888888888,1.0,1.0,7/26,11.73%,VIPR1;NPY;CNR1;NPY1R;DRD4;CHRM3;HTR4
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),-0.4496189802644146,-0.7178982696635213,0.8392857142857143,1.0,1.0,1/5,5.48%,HYAL2
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.44880198656159476,0.7178314123046409,0.8,1.0,1.0,1/5,21.62%,SMO
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),-0.4802462254279142,-0.7172348959269618,0.7966101694915254,1.0,1.0,2/5,11.92%,ITGB4;ABCA12
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.38327486596209825,0.7168778580262857,0.7567567567567568,1.0,1.0,3/17,10.60%,YJEFN3;NFKB1;OSBPL6
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3548091197335404,0.7168243147810368,0.9583333333333334,1.0,1.0,3/23,5.24%,PLK1;ESPL1;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2979174393877646,0.7165331186613237,0.9310344827586207,1.0,1.0,11/44,18.88%,CLEC7A;SIRT1;MALT1;GRIN1;GPER1;HMGB1;ACVR1C;SYK;ASPH;GRIN2B;TBC1D10A
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.28876751711293647,-0.7163783792115181,0.9733333333333334,1.0,1.0,21/160,15.35%,DDIT3;GSTP1;BCL2L2;HYAL2;PEBP1;WWC2;NOP53;RACK1;TMSB4X;PINK1;PIK3CB;NLRX1;STAT1;PPIF;PIK3IP1;MYADM;PPM1N;NMI;NLRP12;RTKN2;CDC34
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.3488779135353649,0.716248686007769,0.7777777777777778,1.0,1.0,6/18,17.98%,ABHD2;TGFB2;SLIT2;SLIT3;NR1H3;CATSPERD
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.4909530217715439,-0.7161353089448694,0.9333333333333333,1.0,1.0,1/5,12.33%,YBX3
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.4522231182605537,-0.7160222708679616,0.8095238095238095,1.0,1.0,2/7,17.39%,APPL2;PTN
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.32671970554111307,-0.7159238749336593,0.8533333333333334,1.0,1.0,11/45,27.20%,HRAS;RAD51AP1;KDM4D;FIGNL1;ECT2;TMEM109;BLM;RAD9A;HUS1;NUCKS1;CRYAB
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.37764267363145787,0.7157798500013082,0.925,1.0,1.0,1/14,1.58%,HSPA1A
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.4702798703343172,-0.7156256342883897,0.7903225806451613,1.0,1.0,2/6,28.12%,CDC23;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.4702798703343172,-0.7156256342883897,0.7903225806451613,1.0,1.0,2/6,28.12%,CDC23;TACC3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.3186267612575217,0.7156221275637883,0.8387096774193549,1.0,1.0,11/26,27.32%,OGT;ATPSCKMT;KMT2D;TET2;KMT5B;SETD2;SETD5;KMT5C;KMT2A;TET3;VCPKMT
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.4990602304688544,-0.7153984777772925,0.9354838709677419,1.0,1.0,2/5,20.79%,GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.3675489310816612,0.7153144483477168,0.8,1.0,1.0,2/10,5.48%,ACADVL;SIRT1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.3281847907832954,0.7152861712116848,0.8421052631578947,1.0,1.0,8/29,16.52%,CLN6;SULT2A1;SOAT1;OSBPL1A;SULT2B1;LCAT;IDH2;FDX1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.43449133794807426,-0.7151789808421479,0.835820895522388,1.0,1.0,3/9,31.44%,ABHD12B;GGACT;CHAC2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.3058667512832469,-0.7148525154886014,0.918918918918919,1.0,1.0,15/74,22.48%,POLR1G;POLR2L;POLR1F;POLR1H;DNMT3B;CGGBP1;MYBBP1A;TAF1D;ACTB;ZFP57;EZH2;POLR1E;DDX21;SMARCA5;POLR1B
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.4016372332807291,0.7145307041399419,0.782608695652174,1.0,1.0,2/8,10.33%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.2865981519609549,0.7144574249914575,0.9259259259259259,1.0,1.0,13/79,13.15%,RELN;ALK;EPHA3;DPYSL3;ZNF804A;COBL;NTRK2;ARHGAP35;RAPGEF1;PLXNB2;PRKD1;LRP8;MAGI2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.36395859654575924,0.7144249438308521,0.8823529411764706,1.0,1.0,2/22,3.39%,ATP6V0A4;ATP12A
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.4639019247409593,-0.7142654372956763,0.8032786885245902,1.0,1.0,2/7,27.73%,RAD50;NBN
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.30020573472696266,0.7141774445850327,0.9393939393939394,1.0,1.0,9/34,19.22%,TVP23B;LTBP2;RAB3B;MTTP;TANGO6;GOLPH3;RCN3;MIA3;ARFGAP3
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.3128694957698542,-0.7140235140811936,0.95,1.0,1.0,9/70,17.68%,RPS13;MBNL3;RBM22;RPS26;C9ORF78;POLR2A;PQBP1;SRSF3;HNRNPH2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.40476959207590074,-0.713605056140204,0.8852459016393442,1.0,1.0,2/18,4.17%,DDX4;BTBD18
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3238249285999784,-0.7133593105486041,0.8666666666666667,1.0,1.0,10/72,11.11%,CLU;PSMC5;RAD23A;ELOB;NOP53;RACK1;DDA1;ARIH2;RBX1;PSMC3
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.3604400171343529,0.7132812232425272,0.7941176470588235,1.0,1.0,3/11,10.96%,SLCO2B1;SLCO1C1;SLCO1A2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.32572380941184503,-0.7129568609791149,0.8571428571428571,1.0,1.0,5/50,13.57%,SFRP1;FZD8;SFRP4;PPP1CA;WNT9A
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.4585955061148131,-0.7126565895879744,0.8450704225352113,1.0,1.0,1/8,5.48%,HYAL2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.3957288098641481,0.7124934637749619,0.8235294117647058,1.0,1.0,2/7,21.65%,BMPR2;RYR2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.36748717644850776,-0.7123854436089486,0.8253968253968254,1.0,1.0,6/19,21.86%,PPIB;SRP54;PPIA;EDN1;SCG2;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.4136751731757343,0.7120241419788443,0.7169811320754716,1.0,1.0,2/5,14.14%,AGER;HMGB1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.4273754359968531,-0.7118927316050103,0.8166666666666667,1.0,1.0,3/8,32.05%,GSTZ1;TYR;FAH
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.31203320959442293,-0.7118053272534741,0.9295774647887324,1.0,1.0,12/62,21.07%,RHOC;STMN1;DCTN3;SEPTIN12;KIF4A;SEPTIN4;MYH10;ECT2;USP8;CHMP4B;RHOA;SEPTIN2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.3182885207398932,0.7114380407972907,0.9142857142857143,1.0,1.0,7/29,16.20%,SRC;ARHGEF7;AUTS2;PIK3CA;ABI2;CORO1C;CYFIP1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.30614662866932774,-0.7112650045883769,0.975609756097561,1.0,1.0,9/91,12.37%,XBP1;CPS1;SELENOS;GSTP1;TNIP2;IRGM;SELE;SELP;PAF1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.36799239325777133,-0.7111174376989957,0.8484848484848485,1.0,1.0,3/18,9.78%,EFNA1;TGFB1;NFATC1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.43442258698747366,-0.7109737303825897,0.8656716417910447,1.0,1.0,1/8,12.58%,PARP1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.27411459053802983,0.7109373541147896,1.0,1.0,1.0,48/140,21.30%,LUZP2;FGFR3;GFAP;MMD2;ALDH1L1;PSD2;ADGRB3;PLPPR4;SORBS1;AMER2;CDH20;NTRK2;HTRA1;WNT3;SLCO1C1;NCAN;SNPH;RCAN2;TEAD1;SLC4A4;FGF1;NRXN1;GPM6B;LCAT;SLC1A2;ADCY8;CADM2;SLC6A11;NFASC;RAPGEF4;SLC25A46;SRR;SLIT1;GRIA2;CA10;FABP7;ADGRA1;SPHKAP;NTM;ADCYAP1R1;KCNIP1;SLC16A2;SOCS3;SLC6A1;NFATC3;ATP1A2;GABRG1;GRM5
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.3799847309581925,-0.7107336325633982,0.8732394366197183,1.0,1.0,2/25,2.15%,SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.3747397852091799,-0.7105569888798653,0.8552631578947368,1.0,1.0,3/19,7.88%,ERAP1;ERAP2;TPP1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.4548632712342106,-0.7104966394952893,0.8333333333333334,1.0,1.0,1/5,4.15%,DNAJC19
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.4358874794945813,-0.7104689637546948,0.8679245283018868,1.0,1.0,3/7,29.87%,FIS1;BCAP31;MICU1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.384315837123674,0.7094485651948588,0.8780487804878049,1.0,1.0,1/8,1.34%,RUNX1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.4624718055096411,-0.7093682658256804,0.8412698412698413,1.0,1.0,4/6,43.67%,SLC6A17;SLC36A1;SLC1A4;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.301803575639855,-0.7093613913391235,0.9493670886075949,1.0,1.0,32/127,24.89%,GLP2R;SELENOS;GSTP1;VPS35;TSHR;CXCL17;RPS19;FSHR;GPS2;GRN;SLAMF8;TNFRSF1A;NLRP12;MAPK7;APOE;NPSR1;TEK;MMP26;VIP;PRKACA;HLA-DRB1;ALOX5;NR1D1;GPHB5;FURIN;ADAM17;SCTR;PTH2R;NLRP3;PRKAR1B;GPR83;PLK2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.41493572767519665,0.7092772532524317,0.825,1.0,1.0,1/5,2.52%,DENND1B
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3462032680607338,0.7091783121972222,0.8125,1.0,1.0,1/12,5.86%,CAMSAP3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3766976743859104,-0.7084991472126732,0.9264705882352942,1.0,1.0,2/25,2.30%,DTX3L;RPS2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.3065544697840257,0.7084092297518771,0.90625,1.0,1.0,9/56,10.35%,IRAK2;MAPK11;ADORA2B;ARHGEF6;MAP2K4;MAPK10;NFKB1;TNFRSF19;MAP4K2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.346895857634811,0.7079878981654886,0.8536585365853658,1.0,1.0,2/18,3.87%,RELA;CPNE1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.3764600042413471,-0.7078779441197561,0.9402985074626866,1.0,1.0,4/21,17.86%,SELENOS;GCK;PDK2;PGP
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.29380774852567937,0.7078046628625706,0.8787878787878788,1.0,1.0,9/42,18.93%,TRIM67;UNC13D;PARD6B;ADGRE2;TRIM46;CAMK2D;FER;WWC1;MAP2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.37140325048779615,-0.7077041618199335,0.8571428571428571,1.0,1.0,4/21,20.98%,LCK;HTR2B;HTR2A;CCR7
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3811051495385134,-0.707346579216798,0.875,1.0,1.0,2/18,6.46%,INCA1;CDKN1C
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.4082990554989103,0.7066394890267381,0.7428571428571429,1.0,1.0,1/9,1.29%,ATP6V0A4
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.41985660587782936,0.7064367027433338,0.85,1.0,1.0,1/7,4.47%,EXOSC7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.41985660587782936,0.7064367027433338,0.85,1.0,1.0,1/7,4.47%,EXOSC7
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.37005568193725846,0.7063230945623162,0.8378378378378378,1.0,1.0,2/14,5.48%,SAMSN1;SIRT1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.3638903065085737,-0.7062957001667297,0.8450704225352113,1.0,1.0,1/21,1.46%,ACTG1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.31549945927406875,-0.7060907155127664,0.927710843373494,1.0,1.0,11/83,15.99%,GAPDH;TYMS;RPL13A;RPS3;RACK1;CALR;PATL2;NCL;EIF4A3;ILF3;METTL3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.39592348150246875,-0.7060759285047293,0.8813559322033898,1.0,1.0,4/14,26.04%,OSBP;NPC2;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.4682203950073379,-0.7055546479440726,0.8333333333333334,1.0,1.0,1/6,16.90%,ORMDL3
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.4382945202530254,-0.705362536438755,0.8421052631578947,1.0,1.0,1/7,10.80%,PIK3CB
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.3800640286495083,-0.7053469932823074,0.8387096774193549,1.0,1.0,2/23,3.38%,MUSK;MADCAM1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.45531847453805496,-0.7053437933650574,0.8688524590163934,1.0,1.0,1/7,7.51%,MTHFD1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.44843852841317844,-0.7052683363101375,0.8813559322033898,1.0,1.0,1/6,13.15%,MYADM
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.43906810479351077,0.7051774456312445,0.9090909090909091,1.0,1.0,3/6,21.58%,SNCA;FBP1;RYR3
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.4764971817829685,-0.7051288573966823,0.9180327868852459,1.0,1.0,1/6,15.15%,DCTN1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.33256598036509155,0.7048031011160486,0.96,1.0,1.0,4/24,6.54%,AGER;SNCA;DYSF;TMEM106A
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.3732266437226412,0.7046096976273175,0.8055555555555556,1.0,1.0,3/13,8.48%,KYAT1;IDO1;KYNU
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.4381972333779563,0.7042818665588867,0.8409090909090909,1.0,1.0,5/5,56.19%,GNAI1;EPB41;EPB41L2;GPSM2;NUMA1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.3282775546028194,0.704199448954114,0.925,1.0,1.0,6/25,12.85%,TCAP;SGCZ;SGCG;SGCD;PIK3CA;DMD
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.41143631733518815,-0.7041700205953856,0.8615384615384616,1.0,1.0,2/8,16.74%,OLFM1;APOE
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.2883017137728064,0.7039924963781143,1.0,1.0,1.0,13/40,21.43%,ARID1B;SMARCA2;ARID1A;SMARCD2;SMARCAD1;MBD3;NASP;HDAC1;SMARCC1;ACTR5;PBRM1;HNRNPC;SMARCE1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.3718737491870282,-0.703986080153597,0.8493150684931506,1.0,1.0,2/26,9.46%,SFRP1;AR
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.30664713824561796,-0.7037649719884621,0.9375,1.0,1.0,3/85,4.58%,RIMS1;SFRP1;DNPH1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.2862437409704852,0.7036983175438801,0.9090909090909091,1.0,1.0,6/55,7.19%,HSPB1;HNRNPU;SPRED1;SNCA;CEP85;GSKIP
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.3396198265994403,0.7034559196354072,0.9,1.0,1.0,8/19,16.34%,PIWIL4;PIWIL2;PLD6;TEX15;MOV10L1;GPAT2;TDRD12;TDRD9
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.3769998931078477,-0.7034177377699533,0.8701298701298701,1.0,1.0,1/17,9.99%,SLC27A5
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.4166812061474157,0.703192653854166,0.8,1.0,1.0,1/5,9.88%,SGSM2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3093240132809715,0.7029099557044344,0.9736842105263158,1.0,1.0,10/26,17.67%,PLK1;ARRDC4;FBXW7;ARRDC3;DCUN1D1;DCUN1D4;PTEN;TRIB3;CDC14B;BTRC
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.29122613692589344,-0.7028484335466118,0.9866666666666667,1.0,1.0,12/130,13.60%,LRTM1;CACNA2D4;GPR179;TCEAL6;RNPC3;TCEAL5;PCBP3;STMN2;PAK5;SCG3;DUSP26;AP3B2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.27012108411116387,-0.7024929950334765,1.0,1.0,1.0,39/426,10.72%,BMP5;NOX4;FTH1;SFRP1;CLU;NEURL1;CD9;DDX4;FABP3;INCA1;TCHP;VPS35;BTBD18;ALDH1A2;CHMP2A;HYAL2;ORC6;IFIT3;IRF1;BTG3;SFRP4;VAMP8;TNS2;BTG1;RACK1;FBLN1;ADAM15;HRAS;HTR2B;AQP11;AR;TGFB1;FABP6;ARHGDIG;TNFRSF21;FUZ;SYT11;HOPX;LRPAP1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.38589931069890254,-0.7020485926035023,0.864406779661017,1.0,1.0,2/12,17.12%,ACTA2;TPCN2
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.37337751723366136,0.7020042508706573,0.8064516129032258,1.0,1.0,6/13,18.42%,MTERF1;TFB1M;FOXO3;FASTKD1;PNPT1;SLC25A33
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.26670616623200594,-0.7017547511028766,0.989010989010989,1.0,1.0,52/271,24.50%,GRIN3B;STX19;CD63;USP6;SNX17;VPS35;TMED9;CORO1B;ARL1;RRAGA;ARF5;ARF1;TMED4;GPIHBP1;RAB32;RIC3;ARCN1;SEPTIN12;ABCA12;TBC1D2;DUOXA1;STX16;LAMTOR1;SEPTIN4;ARL17A;GRTP1;TBC1D16;FGF7;COPZ1;SCG5;ANGPT1;RRAGC;WDR45B;ZDHHC15;NPHP1;ARMCX3;SNX6;NAPA;LAMTOR2;SEPTIN2;TMED2;TMED1;HEY2;RAB31;TBC1D14;DNAJC27;IFT22;ABHD17A;ARF4;TBC1D9B;USP4;MESD
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.31181912444772486,0.7016892758047322,0.8148148148148148,1.0,1.0,7/41,10.87%,HOMER1;PLPP4;CRACR2A;CD4;CACNA2D1;GRAMD2A;STIM1
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4503047686002919,-0.7011761067104529,0.8823529411764706,1.0,1.0,1/7,4.54%,DDX11
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.4304219679123154,-0.7009910962919185,0.8615384615384616,1.0,1.0,1/8,9.64%,TGFB1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3160621629518953,0.7009095959117682,0.9523809523809523,1.0,1.0,2/22,10.43%,PLK1;NSFL1C
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.3340387425861423,0.7007842763447265,0.9,1.0,1.0,4/16,15.37%,SRC;ZNF304;PIK3CA;PDK4
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.35001581854962627,-0.7005124418649311,0.8421052631578947,1.0,1.0,7/22,21.62%,TNIP2;MAPK7;CD160;SERPINE1;TEK;ANGPT1;SCG2
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.41345127040472096,0.7004620339136611,0.813953488372093,1.0,1.0,3/5,21.83%,FBXW7;LILRB1;FBN1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3633094036281842,0.6997403900646998,0.8857142857142857,1.0,1.0,4/11,17.43%,INPP1;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.3633094036281842,0.6997403900646998,0.8857142857142857,1.0,1.0,4/11,17.43%,INPP1;PTEN;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3219313478704452,-0.6997201555130723,0.9420289855072463,1.0,1.0,5/37,15.72%,RNF8;ARIH2;RNF5;UBE2D4;RNF135
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3519167047315478,-0.6996895235780712,0.8548387096774194,1.0,1.0,6/26,18.17%,HSPB8;HSPA2;TM7SF3;HSPA5;HSPA8;BAX
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.3085846200944016,-0.699651469070104,0.9863013698630136,1.0,1.0,9/85,11.06%,BMP5;XBP1;SFRP1;HRAS;MYDGF;HTR2B;PDCL3;STAT5A;GRN
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.40395087349209285,0.6995813631703176,0.8823529411764706,1.0,1.0,5/9,31.34%,CSRP2;SMO;NF1;SRPK3;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3774856088036322,0.6994635400327723,0.8518518518518519,1.0,1.0,4/17,8.34%,KLK14;SNCA;RNF157;ADA
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.34164055525804116,-0.6991930944073488,0.9014084507042254,1.0,1.0,4/28,11.40%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.34164055525804116,-0.6991930944073488,0.9014084507042254,1.0,1.0,4/28,11.40%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.4075158869584231,0.6990691460815048,0.8260869565217391,1.0,1.0,1/8,4.06%,PLD1
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.4794721026390609,-0.6987493270727784,0.85,1.0,1.0,1/5,11.25%,BFSP1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.3905828174625897,-0.6985377026909941,0.847457627118644,1.0,1.0,4/12,26.04%,OSBP;NPC2;OSBPL2;NPC1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.3083925726301355,-0.6984393907545159,0.9565217391304348,1.0,1.0,7/63,13.15%,TLN1;JUP;CDH12;TGFB1;NECTIN3;CDH17;MYADM
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.24699939236406301,0.6983543632507218,1.0,1.0,1.0,39/239,18.36%,FHDC1;ARHGEF7;EXOC6;RAB3IP;RFX3;ARHGEF6;DNAAF1;EHD2;RAB23;PKD1;P2RX7;TEKT5;TRAPPC14;TNIK;DNAI2;SPEF1;TMEM216;IFT88;CFAP54;MAP4K4;PCM1;DCDC2;IFT140;GOLPH3;CEP290;ASAP1;RABL2B;INPP5E;CDC14B;CYFIP1;TTBK2;DYNLL2;ARL6;RAP1A;PTPN23;PPP1R9B;PTPRO;WHAMM;BBS2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.2704223588174324,0.697853099620506,1.0,1.0,1.0,21/115,14.90%,PDGFB;CCDC62;EGFR;SLC26A6;P2RX7;DIAPH1;NRIP1;AKAP6;RAPGEF1;AQP1;CASP7;GABRB1;LCOR;SLC26A3;RAPGEF3;ADCY8;P2RY1;GPER1;GOLPH3;LARP1;RAD51
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3543729415273213,-0.6977858533557288,0.8656716417910447,1.0,1.0,1/24,0.45%,B2M
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.4624663792762351,-0.6977317959547383,0.8548387096774194,1.0,1.0,1/5,6.76%,CBR1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.37371141741343045,-0.697637268024121,0.8840579710144928,1.0,1.0,5/23,19.28%,TNFRSF21;CR1;CEBPB;PDCD1LG2;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.33005841049966167,-0.6976023042117884,0.8873239436619719,1.0,1.0,2/54,2.82%,GATA1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.42474802452231053,-0.6975739300204263,0.873015873015873,1.0,1.0,1/10,7.91%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.4575582625640416,-0.6972278959914511,0.7878787878787878,1.0,1.0,1/5,19.87%,CD226
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.44532351532606046,-0.6971717202638293,0.8333333333333334,1.0,1.0,2/5,44.91%,SLC25A37;PRMT1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.365178067430892,0.6971196926910553,0.8333333333333334,1.0,1.0,2/12,10.34%,HNRNPU;LTBP3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.43585201279028063,-0.6971163245846125,0.8656716417910447,1.0,1.0,1/7,9.64%,TGFB1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.44906724629275174,-0.6970889742294487,0.8620689655172413,1.0,1.0,3/6,29.34%,FANCB;RAD21L1;REC8
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.33826575860913327,0.696976477895338,0.8484848484848485,1.0,1.0,2/18,6.98%,GDAP1;PLD6
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.3547373405511878,0.6968229792104402,0.75,1.0,1.0,2/11,10.20%,RFWD3;WAC
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.39644914505741746,-0.6968223985376696,0.8450704225352113,1.0,1.0,3/14,13.18%,PRELID1;NOP53;IFNLR1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.35441466640809804,-0.6964914553461341,0.875,1.0,1.0,2/23,10.34%,PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.398299545942657,-0.6964907037320336,0.8852459016393442,1.0,1.0,1/9,2.74%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.2907673749272966,0.6963382922792524,0.9714285714285714,1.0,1.0,1/35,1.15%,UBA7
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.40757676560856426,-0.6961667469691345,0.8360655737704918,1.0,1.0,3/8,30.08%,MYOCD;HEY2;HEY1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.3575379402882046,-0.6960175788033305,0.9206349206349206,1.0,1.0,7/27,21.21%,TGFB1;DUSP26;PPIA;ANKLE2;CALM3;PTPA;CALM1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3466965991242963,0.6959985147472391,0.9285714285714286,1.0,1.0,3/19,5.23%,KCNIP2;AGER;KCNMB4
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.40797135957948805,0.695930265084471,0.717948717948718,1.0,1.0,4/11,17.44%,IP6K2;IPMK;FGF2;ITPKC
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.4030536107722419,-0.6957849762666277,0.8360655737704918,1.0,1.0,4/8,30.86%,PDK2;GSTZ1;PDPR;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.4030536107722419,-0.6957849762666277,0.8360655737704918,1.0,1.0,4/8,30.86%,PDK2;GSTZ1;PDPR;PDK3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.2561853434486083,0.6956740201734892,0.9615384615384616,1.0,1.0,12/77,16.09%,NUPR1;HDAC4;HNRNPU;SIRT1;CDKN2A;PID1;SLIT2;TESK1;PTEN;NIBAN1;CORO1C;IBTK
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3675224354953856,0.6954752317947349,0.7714285714285715,1.0,1.0,3/12,17.26%,CACNA2D1;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3350495385888422,-0.6954665102072018,0.9305555555555556,1.0,1.0,9/34,23.93%,ENDOG;TSN;GEN1;RAD50;XRCC2;XRCC3;RECQL;RAD54B;BLM
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.4531452546448195,-0.695386880272366,0.8472222222222222,1.0,1.0,2/6,17.94%,FNTA;PRKD2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.37904474175423974,-0.6953390115647727,0.8870967741935484,1.0,1.0,2/20,6.46%,INCA1;CDKN1C
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.3811781769496819,0.6951689169997672,0.7567567567567568,1.0,1.0,7/7,61.90%,NTN1;NRP1;SHTN1;SDCBP;CD2AP;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.350709385433559,0.6950740815216657,0.8214285714285714,1.0,1.0,1/11,3.37%,EGFR
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.40114525044770377,-0.6950279625846073,0.8805970149253731,1.0,1.0,3/13,16.37%,ANAPC15;GEN1;XRCC3
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3566995081614795,-0.6949075646387425,0.875,1.0,1.0,3/26,14.47%,CLU;DDAH2;EDN1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3845313944672389,-0.6947572730078366,0.8695652173913043,1.0,1.0,5/20,21.21%,CEMIP;IRGM;TGFB1;CALM3;CALM1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.39403182949794024,-0.6945358197495403,0.8360655737704918,1.0,1.0,3/9,30.80%,TMC2;PDZD7;HPN
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3007413469994424,0.6944398549583775,0.9142857142857143,1.0,1.0,8/28,20.59%,AUTS2;PIK3CA;SLIT2;ABI2;CYFIP1;FER;AKIRIN1;PIK3R1
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.45541549828462446,-0.6942871316940451,0.864406779661017,1.0,1.0,2/6,11.28%,TBCC;VBP1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.3895146273749348,0.6937674989206358,0.8648648648648649,1.0,1.0,2/8,24.45%,MIA3;ZDHHC17
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.4038014956751297,0.6936142744969626,0.8571428571428571,1.0,1.0,2/6,9.25%,PRR5;RICTOR
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.32834455874119906,-0.6932399922181262,0.9178082191780822,1.0,1.0,4/29,20.09%,APH1A;SOD1;CAV1;YWHAB
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.29076793587268807,-0.6930897033285316,0.9746835443037974,1.0,1.0,4/92,5.72%,LOXL4;EEF1AKMT2;RNF212;RNF212B
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.4211781952128376,0.6929936533599261,0.76,1.0,1.0,1/6,4.42%,SLC2A9
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.3590017145110723,0.6928930118291329,0.7954545454545454,1.0,1.0,3/15,10.17%,LYPD1;AGRN;CHRM3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.354837634826292,-0.6928346859342108,0.9154929577464789,1.0,1.0,6/27,22.40%,PHB2;LSM10;PAF1;EZH2;TFDP1;ADAM17
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.30267303660451794,-0.6927599787778219,0.9473684210526315,1.0,1.0,8/68,14.62%,RPS27A;TGFBR2;UBA52;BAMBI;TGFB1;FNTA;UBB;APPL2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.313676387570585,0.6924690806785118,0.9142857142857143,1.0,1.0,1/22,1.07%,IGF1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.33263270076654994,-0.692257025581266,0.921875,1.0,1.0,7/22,26.82%,BRK1;HAX1;WDR1;PFN2;PFN1;COTL1;ARHGAP18
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.4156003533665592,-0.6918166201173218,0.8548387096774194,1.0,1.0,2/11,9.30%,TTN;NEB
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.3017375860011126,-0.6915729512134986,0.9583333333333334,1.0,1.0,15/62,17.96%,SLC8A3;SLC24A5;CALR;HTR2B;SLC24A1;RGN;TMCO1;RMDN3;STOML2;EDN1;TPT1;TPCN2;HTR2A;ATP2C2;TRDN
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.2511731768008809,0.6912181083479455,1.0,1.0,1.0,15/195,9.42%,FHDC1;EXOC6;RAB3IP;RFX3;FAM161B;DNAAF1;EHD2;RAB23;PKD1;TEKT5;TRAPPC14;DNAI2;CCP110;TMEM216;IFT88
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.3716353471162479,-0.691007174095429,0.9365079365079365,1.0,1.0,3/14,15.93%,C1QBP;IFNLR1;RNF26
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.33495825879988456,-0.6909961563235157,0.9166666666666666,1.0,1.0,5/35,15.10%,RPS27A;UBA52;GPS2;UBB;MAP3K12
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.3238647278929243,0.6909538367722227,0.9032258064516129,1.0,1.0,4/16,16.49%,PICALM;RHOQ;PID1;BCL2L1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.3341093001366199,0.6901828180522853,0.9354838709677419,1.0,1.0,10/42,13.33%,YJEFN3;VEGFD;ADGRA2;ROBO1;DLL1;RECK;GPLD1;LOXL2;SLIT2;EGR3
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.4156100654225433,-0.69016650396424,0.8636363636363636,1.0,1.0,6/9,28.53%,BHMT;SMOX;COMT;LRTOMT;HNMT;DMGDH
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.3381871236860694,0.6899439864218773,0.8787878787878788,1.0,1.0,7/15,26.89%,ADCY8;PRRC1;PRKACB;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.35059724135388437,0.6899101862999095,0.868421052631579,1.0,1.0,5/16,15.96%,ADCY10;AQP1;KCNC2;ATRX;TIMELESS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.34836417316847457,-0.6896648995481023,0.890625,1.0,1.0,7/23,22.27%,PLN;SRI;CALM3;KCNQ1;PRKACA;CALM1;CHGA
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.41876740380469624,-0.6892125380403129,0.864406779661017,1.0,1.0,4/6,36.97%,FURIN;LAPTM4B;FN1;HSP90AB1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2781463704788219,0.6886781094414328,1.0,1.0,1.0,13/59,17.54%,CNOT2;CRADD;RFWD3;CNOT11;WAC;PIDD1;CNOT4;CNOT6L;PLAGL1;TFDP2;SOX4;MDM4;RGCC
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.33647330804507253,0.6886104203835981,0.8611111111111112,1.0,1.0,6/13,24.05%,TICAM1;IPMK;PGAM5;TRPM7;MLKL;CYLD
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.2805980381853138,0.688451002511186,0.9615384615384616,1.0,1.0,14/38,22.32%,CHRNA4;CHD7;SOBP;SLC8A2;LINS1;CYFIP1;PTCHD1;DGCR2;HRH3;MGAT3;C5AR1;GRM5;APP;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.4299209366767144,-0.6884210358021956,0.8852459016393442,1.0,1.0,1/6,10.46%,GPS2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.38468884376062007,-0.6884063033143599,0.8529411764705882,1.0,1.0,2/12,9.92%,CENPE;NEK6
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.3968444147781648,-0.6883939370322193,0.8548387096774194,1.0,1.0,3/11,12.95%,STMN1;ABCA12;FLG
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.3968444147781648,-0.6883939370322193,0.8548387096774194,1.0,1.0,3/11,12.95%,STMN1;ABCA12;FLG
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.33579522567118086,0.6879347285856274,0.8292682926829268,1.0,1.0,5/18,15.56%,MFHAS1;CYBA;PTPN22;HMGB1;NR1H3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.28017499755165715,0.6877993726840919,1.0,1.0,1.0,11/105,6.82%,BICDL1;FAM161B;CNTNAP2;TMEM108;AGER;L1CAM;NLGN1;NPY;FRYL;DOCK7;PLEKHA1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.3871167148684914,-0.687638768427915,0.875,1.0,1.0,4/11,28.43%,LAMP1;CCDC91;ANKFY1;AP4M1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.30070984297501463,0.6876013214482609,0.8974358974358975,1.0,1.0,6/21,19.14%,MYO5B;AQP1;ADCY8;RAB11FIP2;PRKACB;ADCY6
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.24898469979993512,0.6873681619377887,1.0,1.0,1.0,7/73,9.23%,U2AF1;ATXN1;PKD1;XPO1;XPO5;EIF4E;MALT1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.38810302049613454,-0.6871532143090074,0.8615384615384616,1.0,1.0,2/10,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.3212361089584289,0.6871439914015608,0.8461538461538461,1.0,1.0,2/21,5.89%,RAB23;RANGAP1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.2670111732070271,0.6870452398918124,1.0,1.0,1.0,15/72,16.44%,CDK6;BACH1;CCNH;DHFR;EIF4EBP1;EIF4E;CDKN2A;ACVR1;KLF11;RCC1;CDK17;TFDP2;POLE;NASP;CDK18
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4007362391121201,0.6869374088559288,0.9473684210526315,1.0,1.0,3/13,23.10%,NR1H3;LPL;PPARA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2749590595599545,0.6865059016830237,0.96,1.0,1.0,3/43,6.64%,BCL2A1;SIRT1;FNIP2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.3667706279639985,-0.6862862029777982,0.8888888888888888,1.0,1.0,3/15,22.44%,CHRM2;CAV1;MYOCD
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.25434735508748435,0.685698766151266,1.0,1.0,1.0,16/75,18.80%,ZBTB1;HOMER1;SNCA;LRRC8A;TMEM120B;CPSF6;KCNC2;CPSF7;ADCY8;UGDH;PNPT1;PKD2;ATL2;GLRA3;RNF112;PRMT8
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.2847193856293261,0.6855910610070238,1.0,1.0,1.0,5/51,10.42%,CTSK;AFG1L;MALT1;CPA2;SIAH2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3616773168844345,0.6855013026061334,0.8285714285714286,1.0,1.0,2/14,7.23%,SNCA;OPTN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.32552497817544396,0.6853529326233448,0.9444444444444444,1.0,1.0,4/16,16.49%,PICALM;RHOQ;PID1;BCL2L1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.35004190311773453,-0.6853348838533345,0.9375,1.0,1.0,2/25,9.64%,BTG1;TGFB1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.4329751528920922,-0.6847493904004087,0.8305084745762712,1.0,1.0,2/6,13.17%,GSTP1;APOD
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.39013199796905884,-0.6846705049307205,0.8688524590163934,1.0,1.0,5/12,25.32%,ZNF830;CLSPN;RAD9A;TOPBP1;HUS1
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.41674371572491486,0.6841291512961944,0.7959183673469388,1.0,1.0,3/5,19.75%,CDH26;HMGB1;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3735101302075756,-0.6839701359136245,0.8529411764705882,1.0,1.0,6/14,21.62%,TNIP2;MAPK7;SERPINE1;TEK;ANGPT1;SCG2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.4152701852103037,0.6833859992591722,0.7954545454545454,1.0,1.0,1/5,17.53%,ATP8A1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.4288817191947194,0.6831801360190194,0.7777777777777778,1.0,1.0,3/5,25.10%,GPER1;BAIAP3;STX1B
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),0.38897022844398926,0.6830662448085111,0.8292682926829268,1.0,1.0,1/5,3.86%,TBXA2R
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.31711111132184544,-0.6829677584410283,0.9166666666666666,1.0,1.0,16/45,23.34%,TMC4;TMEM125;CXCL17;OVOL2;CEACAM1;GGH;ATP2C2;CBLC;LIPH;KLF5;SMIM22;C9ORF152;C6ORF132;MUC16;EPCAM;GPX2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.3905811923486929,0.682852844073704,0.90625,1.0,1.0,1/13,2.08%,YJEFN3
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.3365260943865508,-0.6828389876704988,0.9305555555555556,1.0,1.0,4/26,14.04%,AIMP1;TM7SF3;MYRIP;GCK
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.3482992927637885,-0.6828261514482471,0.8970588235294118,1.0,1.0,4/22,13.27%,EFNA1;TGFB1;NFATC1;TNFRSF1A
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.3185906210497528,0.6823005576466454,0.9629629629629629,1.0,1.0,3/35,6.33%,PLPP4;CYP2C8;PLPPR4
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.3871813465722094,0.6822085040702601,0.8648648648648649,1.0,1.0,6/6,61.29%,AXIN2;TCF7L2;MSH2;RMI2;MSH6;MSH3
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.3323855177374137,-0.6819878446838384,0.9014084507042254,1.0,1.0,2/23,8.14%,CALR;HRAS
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.2823836028262765,0.6819850593314265,1.0,1.0,1.0,8/26,17.04%,ACER2;SESN2;PAXIP1;FHIT;JMY;ATRX;PPP1R13B;MDM4
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.3469873937239025,-0.6816970011255259,0.8666666666666667,1.0,1.0,2/18,9.64%,APH1A;TGFB1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.46054184886031013,-0.6814738967175493,0.8571428571428571,1.0,1.0,1/5,14.62%,APPL2
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.45293392533815124,-0.6814575798487814,0.8507462686567164,1.0,1.0,2/5,13.04%,CORO1B;SYAP1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.41306583467292257,0.6812939656470567,0.8620689655172413,1.0,1.0,1/6,5.24%,DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.41306583467292257,0.6812939656470567,0.8620689655172413,1.0,1.0,1/6,5.24%,DUSP1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.25140070123449576,-0.680915418107061,1.0,1.0,1.0,126/852,19.43%,PSMB8;AFP;GLYCTK;PARP2;FBXW10;BTBD6;PSME1;MEPE;UBL5;B3GNT9;PTK6;TGFBR2;TIMP1;PIGH;USP6;NRBP2;PSMB6;PSMC5;PP2D1;ASB18;ELOB;PSMD8;COPS6;COPS7A;F5;ALG10B;PSMD7;RAB11A;UBA52;PHPT1;GPC3;FUCA2;METAP2;COPS5;VWA1;PARP14;LCK;DAD1;DDA1;ATG10;MAP4K1;B4GALT7;SPARCL1;CAMK1;PRAG1;ST3GAL5;GMFG;TGFB1;PTPRM;PTPN7;NEK6;RBX1;PINK1;CDK4;PPP1CA;PSMD3;STRADB;ART3;PAK5;PSMC3;PPM1G;JMJD4;TIMM50;ILK;DDOST;CDK5;SCG3;DUSP26;PARP1;CHGB;NUCB1;RAB8A;FLG;ARAF;LGALS1;PARP9;ASB13;KRT10;ILF3;PSMA4;FSTL1;FBXW8;MAP3K12;CDC34;B3GALT9;RABGGTB;MAN2A2;PLK4;PRSS23;UFL1;PPP2R5D;CTDSP1;AGA;CKAP4;GLRX;APOE;RCN1;MFGE8;GOLGA2;PSMA7;FBXL16;GGCX;PSMD2;B3GALT5;HSP90B1;PDK2;FBXL13;SPSB3;PRKD2;NAGPA;RBBP5;SHISA5;CP;PSMD6;PSMB2;CST3;NEK3;BMX;ERCC8;WDR45B;PSMB4;F13A1;PRKACA;IGFBP7;TGM1;ASB6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.26698425374638135,0.6808527216332808,1.0,1.0,1.0,11/51,17.54%,CNOT2;CRADD;CNOT11;PIDD1;CNOT4;CNOT6L;PLAGL1;TFDP2;SOX4;MDM4;RGCC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.4246177984462193,-0.680845748700524,0.8421052631578947,1.0,1.0,2/6,19.83%,FLOT1;CAV1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.4381411785172451,-0.6808436305648176,0.8245614035087719,1.0,1.0,1/5,11.09%,ARL13B
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.2883342759843829,-0.6807200856604507,1.0,1.0,1.0,10/119,13.27%,JUP;PDZK1;RAB11A;CD81;PDZD11;FLOT1;ABCA12;RAB8A;MYADM;TNFRSF1A
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.2951444164576617,-0.6806805860234305,0.9605263157894737,1.0,1.0,9/84,14.04%,XBP1;SELENOS;TSHR;USF1;CEACAM1;PARP1;RAB8A;SYAP1;GCK
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.3023173070117209,-0.6800195188111646,0.9324324324324325,1.0,1.0,8/40,23.82%,PI4K2A;CAV2;LAMTOR1;RNF26;CAV1;USP8;LAPTM4B;SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.31492004407096774,0.6798655422584311,0.8484848484848485,1.0,1.0,1/24,2.01%,TAFA5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.329241885928587,-0.6798059042608626,0.921875,1.0,1.0,4/31,13.53%,STMN1;TPX2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.3771672279206896,0.6797855369829291,0.8484848484848485,1.0,1.0,3/8,13.56%,DCUN1D1;DCUN1D4;UBA3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.3796466095090144,-0.6797767149189591,0.84375,1.0,1.0,5/14,27.73%,PARP1;RAD50;TERF2IP;TERF1;NBN
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.293642629527556,0.6792866394204912,0.9696969696969697,1.0,1.0,5/39,9.57%,RELA;SIRT1;PLEKHA1;CAT;AQP1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3408941644946448,-0.6792068457128042,0.8676470588235294,1.0,1.0,3/18,20.98%,C1QBP;DNM1L;CCR7
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.4302345160789458,0.6790500570596365,0.8409090909090909,1.0,1.0,2/5,8.50%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.43382155801901334,-0.6789515186432603,0.8888888888888888,1.0,1.0,1/8,8.91%,BRK1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.38372244062154115,0.6787968871071038,0.8780487804878049,1.0,1.0,3/12,16.33%,PKD1;NFKBIE;PKD2
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.37980195896221647,0.6782840907425585,0.8947368421052632,1.0,1.0,3/9,14.02%,ERRFI1;ENPP1;TESK1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.2655189922827582,0.6782454175433461,1.0,1.0,1.0,10/71,11.26%,ADGRB1;CTNNA2;L1CAM;PLPPR4;DHFR;DOCK7;DSCAML1;ARHGAP35;PARD6B;VASH2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4104831634531615,-0.6779074966797654,0.835820895522388,1.0,1.0,3/9,20.79%,DOCK8;APOD;RHOA
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.2883825991649541,-0.6776491082474216,0.972972972972973,1.0,1.0,20/96,21.85%,GBP2;HSPB8;TNS2;AR;LURAP1L;S100A16;OSMR;CAV2;FSTL1;SCARA3;RASL11A;FLNC;C2;FAM114A1;CALB2;CAV1;MATN2;PKHD1L1;SLCO2A1;MUC16
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.3465660395710288,-0.6770837068636639,0.9104477611940298,1.0,1.0,3/17,18.99%,LAMTOR1;APOE;FMO5
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.41949934568235236,0.6769825302730798,0.8837209302325582,1.0,1.0,1/5,4.44%,CX3CR1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.4508016173489068,-0.6769666865682965,0.864406779661017,1.0,1.0,1/5,14.83%,CPSF3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.4316865421123695,0.6766207048833117,0.7555555555555555,1.0,1.0,1/5,3.07%,JAM2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.25984656404728246,-0.676384428584998,1.0,1.0,1.0,36/230,21.83%,RIMS1;F8;TRAPPC1;TRAPPC4;ELOB;F5;WDCP;CLDN14;VIL1;NIFK;PDZD11;FADD;RBX1;MCFD2;AFG3L2;TRAPPC2L;TNFRSF1A;STOML2;KAT5;GORASP1;TRAPPC3;NDUFAF1;DNM1L;GOLGA2;RBBP5;CTSZ;TUBGCP4;ZW10;RSPH4A;NAPA;TBC1D20;TMED2;NOL3;USH1C;TUBGCP2;HGSNAT
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.3047042208393242,-0.676293643577879,0.9726027397260274,1.0,1.0,8/73,12.92%,AFP;TPH1;CFTR;TREH;PCSK1;RGN;SMLR1;SLC2A2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.31201183034271796,0.6762880822260594,0.9117647058823529,1.0,1.0,1/12,5.86%,CAMSAP3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.3326658986103146,-0.6760445621662774,0.95,1.0,1.0,6/30,18.17%,HSPB8;HSPA2;TM7SF3;HSPA5;HSPA8;BAX
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.4313074659002608,-0.6760228105254275,0.8852459016393442,1.0,1.0,1/6,16.74%,APOE
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.4137428157393123,0.6758824751095512,0.7959183673469388,1.0,1.0,1/5,7.07%,CHD7
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.36311739818674205,-0.675831570720149,0.8695652173913043,1.0,1.0,1/10,10.39%,STAT5A
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.3393608090949861,-0.6758036631786947,0.9384615384615385,1.0,1.0,7/25,23.71%,TPX2;STMN2;KATNB1;MAP1A;MAP1S;APC2;NAV3
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.36006727182330767,0.6757489022996344,0.8666666666666667,1.0,1.0,2/16,7.65%,SRC;GLO1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.3892352692107502,0.6754966674891366,0.8,1.0,1.0,4/7,17.06%,NPNT;GDNF;PKD2;FGF2
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.3545697582559319,-0.6754623330693317,0.875,1.0,1.0,3/13,19.94%,SLC5A10;SLC2A2;SLC5A2
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.30179843957328806,0.6752908975162946,0.9166666666666666,1.0,1.0,6/34,14.73%,SNAI1;ACADVL;NFKB1;FBXW7;PRMT3;TRIB3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.363338379421574,-0.6752505956198235,0.90625,1.0,1.0,3/12,12.49%,CYB5R3;DDAH2;ARG2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.43024531468599203,-0.6751879518381934,0.9,1.0,1.0,1/6,9.64%,TGFB1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2562030333107911,-0.6749050508876501,1.0,1.0,1.0,36/341,16.84%,RPS27A;DTX3L;SELENOS;MAGEF1;UFC1;HLA-A;MARCHF2;RNF212;PCNA;ELOB;RNF181;RRAGA;UBA52;RNF212B;PEX10;RACK1;TRIM13;RNF8;ATG10;ARIH2;TRIM17;RBX1;PINK1;TRIM61;RTF1;PAF1;BRCA1;UBB;FBXW8;CDC34;UBE2D4;RNF135;UFL1;RNF26;RNF213;RNF111
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.43090877154205437,-0.6745502391906276,0.9344262295081968,1.0,1.0,1/5,13.02%,C1QBP
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.39811535337044535,-0.674063983249848,0.8333333333333334,1.0,1.0,3/9,19.82%,TMSB4X;ANTKMT;GCLM
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.42567415631957195,-0.6739862859369831,0.9104477611940298,1.0,1.0,1/10,2.85%,XYLT2
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3077899896534302,-0.6738434365241691,0.9615384615384616,1.0,1.0,9/58,19.19%,ABRAXAS1;RNF8;ATP23;CYREN;BRCA1;KAT5;RAD50;ERCC8;POLQ
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.37109216169769277,-0.6731037165846175,0.921875,1.0,1.0,3/9,19.24%,ACTB;ATP8B1;GOPC
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4053643586873603,-0.6730133582313601,0.9310344827586207,1.0,1.0,1/9,8.25%,LCK
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.25827188621086505,0.6729542281610856,1.0,1.0,1.0,30/146,16.97%,BICDL1;CNTNAP2;TMEM108;AGER;L1CAM;NLGN1;NPY;CTNND2;FRYL;DOCK7;TNIK;SGK1;IFT88;GDNF;DICER1;VASH2;MAP4K4;GPM6B;TRIO;HMGB1;PTEN;UHMK1;RYK;ATXN10;TBC1D23;GSK3B;CNTNAP1;CAMSAP2;GPM6A;ADCYAP1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.4204494436079247,-0.6729261535304908,0.8888888888888888,1.0,1.0,2/6,9.92%,CENPE;NEK6
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2514484271820208,0.6728249850617543,1.0,1.0,1.0,20/76,19.25%,SRC;VIPR1;ADORA2B;VIPR2;CYSLTR1;GPR39;GPR27;PTHLH;CRHR2;HTR4;PTH1R;ADCY8;HCK;SYK;PTH;ADCYAP1;PRKACB;CD247;ADCY6;ADCYAP1R1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.35296132868091107,-0.6727681149601508,0.9142857142857143,1.0,1.0,5/19,26.48%,TPX2;GOLGA2;TUBGCP4;TUBGCP2;TUBG1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.28718652070631934,-0.6726920866925045,1.0,1.0,1.0,14/78,17.78%,RPS27A;TGFBR2;IL17RD;UBA52;CDKN1C;BAMBI;TGFB1;FAM89B;GIPC1;ASPN;UBB;RNF111;DKK3;SNW1
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),-0.4506856973617411,-0.6723079888588807,0.9365079365079365,1.0,1.0,1/5,8.77%,AQP11
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.40255485357555254,-0.672256630336527,0.8305084745762712,1.0,1.0,1/8,7.94%,PRR7
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.42176983245001054,-0.6721150022429061,0.8676470588235294,1.0,1.0,1/8,9.88%,FADD
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.35061431261155696,-0.6720960339380884,0.9,1.0,1.0,2/19,16.03%,PNKP;RAD50
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.4332840254031834,-0.672030163836273,0.875,1.0,1.0,1/6,5.38%,POLE3
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.28295206481932444,-0.6719378652403621,1.0,1.0,1.0,12/112,14.33%,PIGH;PGAP4;CDIPT;PIGC;PGAP2;ARF1;DPM3;PIK3CB;IMPA1;PLEKHA2;PI4K2A;PLEKHA4
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.44293956697322856,-0.6712600578654768,0.9090909090909091,1.0,1.0,1/5,32.21%,CCDC66
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.36209080939569815,-0.6710453740223795,0.821917808219178,1.0,1.0,4/12,24.67%,CCT7;CCT2;GNL3;CCT6A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3728929488671932,-0.6708328390375805,0.8787878787878788,1.0,1.0,3/12,21.21%,CALM3;PTPA;CALM1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.34397419972622745,-0.6703066948729418,0.8387096774193549,1.0,1.0,1/25,2.09%,DND1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.38699173839145995,0.6702704074891331,0.875,1.0,1.0,2/6,10.64%,ZDHHC3;TNFRSF10A
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.33300750387765443,0.6701258731083566,0.967741935483871,1.0,1.0,6/14,18.71%,PDGFRA;DSCAML1;MEGF8;PCSK5;WNT5A;XYLT1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3320292572620802,-0.6699932668302677,0.9154929577464789,1.0,1.0,5/22,20.79%,KIF20B;GIPC1;ECT2;SVIL;RHOA
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.41020296006996787,0.6698713777359069,0.7954545454545454,1.0,1.0,1/5,5.94%,SNCA
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.40252776646979077,-0.669846902745479,0.9047619047619048,1.0,1.0,2/8,9.91%,TMSB4X;TMSB10
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.38494488623729295,-0.6696966135452531,0.9,1.0,1.0,4/12,20.62%,TGFB1;FGFBP3;ANGPT1;PDE2A
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.4295998551802165,-0.669226618844649,0.8771929824561403,1.0,1.0,2/7,13.67%,CBR1;PTGES2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3328347756845984,-0.6691295447258854,0.967741935483871,1.0,1.0,10/31,25.31%,GSTP1;NLRX1;STAT1;PPM1N;NLRP12;RIOK3;NR1D1;CCDC22;ESR1;RHOH
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.36196363848486235,0.6691087465485817,0.8863636363636364,1.0,1.0,3/8,20.10%,AGER;HMGB1;LILRB1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3623048282871479,-0.6689355163975493,0.90625,1.0,1.0,3/22,12.58%,TINF2;EXOSC10;PARP1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.3517186563786192,-0.6687267801431656,0.859375,1.0,1.0,5/20,11.54%,SLC10A6;SLC10A3;CEACAM1;SLC27A5;SLC51A
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.31258877751324354,0.6686669990551861,0.8611111111111112,1.0,1.0,7/22,25.66%,ATP1B3;DLG1;NEDD4L;FHL1;STK39;CAB39;CASQ2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.37307344946294785,0.6684829281589011,0.8780487804878049,1.0,1.0,2/9,6.98%,CXXC4;COBL
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.43151694234005267,-0.6682788940050307,0.8518518518518519,1.0,1.0,2/6,25.02%,CAV1;KCNE1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.378976760570615,-0.6679390809461317,0.8888888888888888,1.0,1.0,3/16,13.84%,SEPHS2;MTHFD1;SARS1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.3621755896086801,-0.6678690856162739,0.8970588235294118,1.0,1.0,5/15,26.04%,APOE;ABCA5;NPC2;ABCG5;NPC1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.40511054728880813,-0.6677619534250188,0.8571428571428571,1.0,1.0,2/10,8.50%,NLRP1;PHB2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.31369221465958674,0.6673188832820707,0.926829268292683,1.0,1.0,4/21,16.14%,COL7A1;COL6A1;COL12A1;COL4A2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.30393843584791236,-0.6671858950795023,0.9315068493150684,1.0,1.0,9/56,18.97%,FBXO43;CHMP2A;TOM1L1;UXT;BRCA1;MAX;EZH2;TFDP1;AURKAIP1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.31094091406767493,-0.66714398244603,0.9436619718309859,1.0,1.0,8/46,20.93%,CPTP;GBA3;FUCA1;SMPD2;ESYT1;ST6GALNAC4;ESYT3;B3GNT5
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.3189156888335576,-0.6668534465673134,0.9315068493150684,1.0,1.0,4/31,11.40%,MTHFD1;TGFB1;FUZ;IFT122
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.38613904298727586,-0.6665442760747271,0.9047619047619048,1.0,1.0,3/13,9.88%,RPS3;HHLA2;FADD
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2820073270397443,0.6662711928195837,1.0,1.0,1.0,9/59,9.80%,ANXA4;IRAK2;SIRT1;IRAK3;MTURN;ERBIN;ARRB2;CDKN2A;ARRB1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.3881099982203623,-0.6657580813293985,0.9354838709677419,1.0,1.0,2/9,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.37914942420221354,-0.6656937422488884,0.8787878787878788,1.0,1.0,4/14,12.30%,COX7A1;COX7A2;PINK1;PPIF
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3227470666076693,-0.6652323053600004,0.9210526315789473,1.0,1.0,2/33,9.64%,SFRP1;TGFB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.28280276181441144,-0.664682042827911,0.9733333333333334,1.0,1.0,15/97,16.24%,SEMA3E;COL4A4;RHBDF1;HSPB8;ITGB4;FBLN1;TMEM54;TEAD3;HOPX;S100A16;THSD4;OSMR;RTKN2;DDR1;SCARA3
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.28453982099734293,0.6646637867428339,1.0,1.0,1.0,7/46,17.06%,ACER2;SESN2;PAXIP1;ATRX;BRIP1;MDM4;ABL1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.40596450921197647,-0.6645173288384757,0.847457627118644,1.0,1.0,5/9,40.92%,GCLM;CHAC2;GSS;GGCT;MGST2
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.43077065165231315,-0.6644493319091468,0.7868852459016393,1.0,1.0,2/5,17.86%,ABHD1;GLYATL2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.4302638661772841,-0.664217071961411,0.9137931034482759,1.0,1.0,2/5,28.49%,KCNQ1;GJA1
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.4040693712888108,-0.6635125067288263,0.8545454545454545,1.0,1.0,2/6,33.80%,NUP155;NUP107
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.3363529757083364,0.6633765074533541,0.7878787878787878,1.0,1.0,2/11,12.73%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.362599558999948,-0.6627354366785644,0.8771929824561403,1.0,1.0,1/16,7.63%,DOLK
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.39382151653097974,-0.6626810367318579,0.90625,1.0,1.0,3/8,17.86%,COQ3;TPI1;PGP
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3092684610782242,0.6624384369178189,0.8611111111111112,1.0,1.0,1/20,2.94%,GDAP1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.2994811859052491,-0.6620535040258132,1.0,1.0,1.0,24/91,23.92%,COPE;CD63;ARF1;TOM1L1;ARCN1;AP2S1;CLTA;STX16;CAV2;SSPN;DNM1L;SOD1;SCAMP3;GNAS;ZW10;NAPA;TMED2;ATP1A1;VPS4B;BNIP3;PPT1;GOLGA4;RAB2A;VAMP3
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.3410059106699032,-0.6620511067672527,0.9420289855072463,1.0,1.0,8/29,21.95%,BRF2;TTF1;TCEA2;POLR2A;SMN1;TTF2;SMARCA5;NAT14
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.2684564924269716,0.6618338161981776,1.0,1.0,1.0,8/68,9.54%,ATP6V0A4;EPS8L2;CLIC5;GRXCR2;MYH14;PCDH15;MYO3A;PJVK
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.34436144985499373,0.6617101562295192,0.8048780487804879,1.0,1.0,2/11,14.47%,IGF2BP2;PCBP2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.3448793342179965,-0.6612645050297379,0.9016393442622951,1.0,1.0,3/19,14.62%,HYAL2;TGFB1;APPL2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.27269913174262733,0.6612169448824701,0.96875,1.0,1.0,5/27,14.37%,NAF1;PPP1R10;TNKS;ATRX;HNRNPD
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.30552403519287685,0.6609613408999298,0.9655172413793104,1.0,1.0,5/29,10.05%,CYBA;SASH1;BMP6;ADAM8;USP15
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.33247839501382137,-0.6606689351874422,0.9113924050632911,1.0,1.0,3/35,7.24%,XBP1;RACK1;CARTPT
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3633824548975376,0.6605806178094942,0.8387096774193549,1.0,1.0,5/13,13.75%,ROBO1;TGFB2;SLIT2;ROBO2;BMPR2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.35566439316244003,-0.660522516004455,0.9076923076923077,1.0,1.0,4/24,16.44%,STMN1;STMN2;STMN3;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2898812989531822,-0.6604078905938352,0.9625,1.0,1.0,10/65,19.83%,CENPX;PINK1;PTTG1IP;BRCA1;SPRTN;UBB;SEPTIN4;FANCI;ANGPT1;CAV1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.3165153945218552,-0.660345998574296,0.9850746268656716,1.0,1.0,5/29,20.62%,HTR2B;AHR;MAPK7;APOE;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.3755445719931278,-0.6602125914317659,0.9344262295081968,1.0,1.0,2/12,13.65%,CAMK1;KAT5
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.29075655792972027,-0.6599037645723181,0.9710144927536232,1.0,1.0,6/53,12.36%,MED8;MED10;CDK4;CEBPB;CCNC;MED31
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3378306888755547,0.6597755584080093,0.85,1.0,1.0,3/14,17.26%,CACNA2D1;NOS1AP;KCNE4
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.38791357467082554,0.6596259320657892,0.8333333333333334,1.0,1.0,4/8,36.53%,RPGRIP1L;RP1;RPGRIP1;BBS4
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.300693945307809,0.6595634316407769,0.8571428571428571,1.0,1.0,4/25,10.77%,PICALM;DLL1;SNAP91;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3097745261338828,0.6594274989392712,0.9333333333333333,1.0,1.0,4/22,12.07%,SRC;NSMF;CAMTA1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3236565007760823,-0.6591723134195299,0.927536231884058,1.0,1.0,6/33,19.80%,DNAJC9;GABARAPL2;RGN;DYNLL1;ALDOB;PFN2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.3915531331282822,-0.6588060588561017,0.9607843137254902,1.0,1.0,1/11,9.64%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3149779114348301,-0.6587890966703724,0.8955223880597015,1.0,1.0,4/33,11.35%,TGFBR2;BAMBI;TGFB1;OLFM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.3539916476331364,0.6587423998461782,0.9361702127659575,1.0,1.0,3/13,18.73%,REEP1;ATL2;ZFYVE27
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.32205772116214,0.6587140217082033,0.9782608695652174,1.0,1.0,1/20,1.07%,IGF1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.3257531818724869,-0.6586846610712814,0.9142857142857143,1.0,1.0,9/25,29.92%,PEX10;ACBD5;FIS1;PEX1;ATAD1;PXMP4;PEX16;PXMP2;PEX12
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3148044895146821,-0.6585313663626415,0.9682539682539683,1.0,1.0,14/33,29.84%,PINK1;GABARAPL2;CISD2;MAP1LC3B;WDR45B;FIS1;BNIP3;SQSTM1;FUNDC1;ULK2;WIPI2;MAP1LC3A;FBXO7;FUNDC2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.33995753477571866,-0.6577815028037881,0.9523809523809523,1.0,1.0,6/16,21.54%,FLOT1;APPL2;IFI35;NINJ1;RAB7B;NR1D1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.34976201894716685,0.6577433258940911,0.8611111111111112,1.0,1.0,3/10,17.96%,CYP2C8;UGDH;SLC35D1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.3777405024572426,-0.657642468385259,0.9710144927536232,1.0,1.0,2/13,11.06%,CLU;GRN
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.31685677431893855,-0.6575486890480428,0.9365079365079365,1.0,1.0,2/31,5.72%,HES6;BHLHE41
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.32628203883412676,-0.6573499699659989,0.8805970149253731,1.0,1.0,3/38,7.91%,CD9;CD81;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.30204093009573574,-0.6571220089508307,0.9315068493150684,1.0,1.0,8/38,16.76%,CLU;AZIN1;EIF2AK1;VBP1;EDN1;PFDN2;APOE;PFDN6
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.26347892558832264,0.6570086704045489,1.0,1.0,1.0,7/82,7.20%,SRC;STON2;PLD1;CD22;PICALM;HAP1;STXBP5
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.2326148424027844,0.6568554713057244,1.0,1.0,1.0,26/97,21.51%,SLCO2B1;GFAP;MMD2;NDRG2;P2RX7;MTURN;CDH20;NTRK2;SLCO1C1;NRXN1;SLC1A2;PID1;CHI3L1;PDK4;GRIA2;CA10;CPNE6;TNS1;TDRD6;RTN1;CSF1R;SLC6A1;ATP1A2;SSTR1;GRM5;SLC8A1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.30157660498471583,-0.656482856478833,0.9444444444444444,1.0,1.0,4/41,10.39%,JUP;CDH12;NECTIN3;CDH17
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.2939040805750951,-0.6564419712310186,1.0,1.0,1.0,3/57,6.96%,RHOC;RHOG;CNN2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.3841600370161815,-0.6562573263011663,0.95,1.0,1.0,2/13,14.81%,RACK1;CFL1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.31344959051938764,-0.655989057270665,0.92,1.0,1.0,14/33,37.44%,SSB;NOL6;RAN;NUP50;NUP155;NUP58;NUP93;NUP88;POM121;NUP107;POM121C;AAAS;SEC13;XPOT
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.31344959051938764,-0.655989057270665,0.92,1.0,1.0,14/33,37.44%,SSB;NOL6;RAN;NUP50;NUP155;NUP58;NUP93;NUP88;POM121;NUP107;POM121C;AAAS;SEC13;XPOT
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.35784393158549815,-0.6557082343397709,0.8888888888888888,1.0,1.0,2/13,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.30504173826288683,-0.6556578917282286,0.9733333333333334,1.0,1.0,4/58,11.13%,BMP5;CDKN1C;TGFB1;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3875302841204944,-0.6553478401345366,0.8421052631578947,1.0,1.0,4/12,22.32%,RNF8;HEXIM1;NELFE;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.36298790789874535,-0.6551946268005353,0.8636363636363636,1.0,1.0,4/12,26.66%,THAP7;BRCA1;SET;TAF7
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.3731851228230356,-0.654942648403747,0.9090909090909091,1.0,1.0,2/11,10.31%,STMN1;STMN2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.2961198158613411,-0.6549000263583891,0.9863013698630136,1.0,1.0,15/79,19.13%,APOL6;AQP9;HLA-DPA1;GSAP;HSPA2;ANKUB1;RASSF4;OMG;TMEM220;LDHC;C2;CP;FMO5;CTSS;HLA-DRA
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.3743302184063046,-0.6546510743989761,0.8904109589041096,1.0,1.0,3/9,23.91%,APOE;PPT1;ABHD17A
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),0.40266622043730466,0.6545553050821606,0.8048780487804879,1.0,1.0,5/5,59.74%,RRM1;SAMHD1;RRM2;RRM2B;DERA
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.40063460199285034,0.6545451255718143,0.9459459459459459,1.0,1.0,2/9,15.56%,PROM2;NR1H3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.4062857364204417,0.6545139547086786,0.8913043478260869,1.0,1.0,2/5,26.50%,TRPC3;MLIP
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3048167144042087,-0.654376353627949,0.9436619718309859,1.0,1.0,3/37,12.80%,USP1;TOM1L1;KPNA2
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.35741216380109947,0.654356412329522,0.8974358974358975,1.0,1.0,5/12,26.52%,SMAD4;CACNA1G;SMAD5;BMPR1A;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.40046355835647995,0.654324034360689,0.9,1.0,1.0,1/7,5.36%,AKT2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.42577887078007415,-0.6540485158687922,0.85,1.0,1.0,2/5,14.43%,PARP1;MGME1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.3685662129045837,-0.6529413049552624,0.9206349206349206,1.0,1.0,2/8,20.42%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.3685662129045837,-0.6529413049552624,0.9206349206349206,1.0,1.0,2/8,20.42%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.347534087648851,0.6526408321552547,0.8947368421052632,1.0,1.0,3/10,22.32%,CAMK2D;PRMT6;NIPBL
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.28664930545884343,-0.6525690490840261,0.9733333333333334,1.0,1.0,11/62,21.21%,RAB11A;KIF20B;CETN2;ANKRD53;GIPC1;PLK4;CALM3;ECT2;SVIL;RHOA;CALM1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.3415160833703609,0.6522365270073263,0.8611111111111112,1.0,1.0,2/15,4.85%,PPARGC1A;ACADVL
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.39538514189736274,0.6518408154463653,0.9210526315789473,1.0,1.0,1/8,2.63%,IFNA2
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.377201453932691,0.6516899693581267,0.775,1.0,1.0,2/7,18.28%,TJP2;TJP1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.262268019036455,-0.6512513603492562,0.9882352941176471,1.0,1.0,12/155,14.33%,GPAT3;LCLAT1;CHKB;CDIPT;DDHD2;ARF1;PLA2G12A;PIK3CB;IMPA1;PLEKHA2;PI4K2A;PLEKHA4
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.3893537916510268,0.6511649655852452,0.925,1.0,1.0,4/10,21.76%,CLMN;SYNE2;SUN2;FBXW11
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.3561961298320847,-0.65107513130228,0.8923076923076924,1.0,1.0,2/16,6.43%,TTN;SYNPO2L
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3455413466620243,0.6510475080504802,0.9375,1.0,1.0,3/15,13.18%,SULT2A1;SULT2B1;ENPP1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.3168229811728044,0.6509925397218638,0.9354838709677419,1.0,1.0,4/21,13.73%,HSD3B7;OSBPL1A;OSBPL6;OSBPL7
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.3669876324930774,0.6507895102568215,0.9142857142857143,1.0,1.0,4/11,16.25%,ADGRB1;MEGF10;XKR8;RHOBTB1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.2917582400758538,-0.6505842625594668,0.9855072463768116,1.0,1.0,8/62,14.64%,TCN2;CYB5R3;MTHFD1;PDZD11;AMN;DHFR2;PRSS3;MMACHC
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.2531670513986184,-0.6501881600823421,1.0,1.0,1.0,29/283,14.62%,STX19;RPL11;USP6;SNX17;VPS35;TMED9;ARL1;VPS25;ARF5;CDC37;CALR;ARF1;TMED4;GPIHBP1;PHB2;RAB32;VPS28;TGFB1;SRPRA;STRADB;GIPC1;ARCN1;ABCA12;PTTG1IP;TBC1D2;KATNB1;STX16;SNF8;APPL2
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),-0.4535074454783675,-0.6501776162203402,0.8787878787878788,1.0,1.0,1/5,6.72%,RPS19
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.39364935590993727,0.6497412886171292,0.8780487804878049,1.0,1.0,1/6,2.63%,IFNA2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4327978846982723,-0.649529525385453,0.9076923076923077,1.0,1.0,2/7,15.95%,PHAX;ZCCHC17
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.39838879752582645,0.6487347484860599,0.8648648648648649,1.0,1.0,2/6,11.37%,ARRB1;AUTS2
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.3455558883353527,0.6486188415170208,0.9230769230769231,1.0,1.0,2/11,10.59%,BMP6;SMAD4
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.32203976059036177,0.6486135303999618,0.975609756097561,1.0,1.0,6/17,17.06%,CASK;SLC12A2;CLASP1;PTEN;SERPINE2;FGF2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.35970536144649445,0.6485190454891195,0.9,1.0,1.0,1/10,6.23%,PKD2L1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.333381945455382,-0.6482359373897951,0.8709677419354839,1.0,1.0,3/20,15.12%,NMNAT3;DCK;DCTD
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.304993220874356,-0.6482016954752119,0.9117647058823529,1.0,1.0,11/26,29.49%,STMN1;STMN2;MYADM;PFN2;TUBB4A;PFN1;TWF1;MAPRE1;CLIP3;HIP1R;TWF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.3634747669483386,0.6481522121014948,0.8863636363636364,1.0,1.0,2/8,14.14%,AGER;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.4304626966344808,-0.6481333685511764,0.8947368421052632,1.0,1.0,2/5,22.44%,ENO1;MYOCD
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.3016923390894941,0.6480901703305921,0.9642857142857143,1.0,1.0,4/19,17.96%,GFPT2;UGDH;GFPT1;SLC35D1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3465148216976272,-0.647719681088513,0.8923076923076924,1.0,1.0,5/13,28.34%,IMPDH2;PAICS;RFK;PFAS;GART
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.304336498960078,-0.6476081434730989,0.9428571428571428,1.0,1.0,10/39,20.79%,RPS3;PHB2;ILK;CD27;NMI;NLRP12;RTKN2;IFI35;TCIM;RHOA
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3077860976519535,0.6474529401902785,0.875,1.0,1.0,7/21,16.52%,PIWIL2;DMC1;NANOS3;STRA8;FMN2;KMT2D;M1AP
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.3482668877580931,0.6472175210219332,0.9310344827586207,1.0,1.0,7/16,24.36%,ADGRB3;C3;PICK1;ANKS1A;APP;B4GALT5;B4GALT6
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.330483612348861,-0.6469691194054553,0.9666666666666667,1.0,1.0,7/21,17.38%,KREMEN1;RSPO2;IFT122;GREM1;INTU;IQCE;GLI3
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3514014747517964,-0.6468115970476297,0.90625,1.0,1.0,1/20,2.30%,ROGDI
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.2562438277560641,-0.6463550354815868,1.0,1.0,1.0,13/166,13.27%,JUP;MADCAM1;PDZK1;RAB11A;CD81;RAB32;PDZD11;FLOT1;ABCA12;LRRC7;RAB8A;MYADM;TNFRSF1A
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.3478043868183892,0.6461377222967977,0.78125,1.0,1.0,5/10,27.75%,PUS10;SMAD2;SMAD1;DROSHA;SMAD3
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3265434150193198,0.6459126174156388,0.9459459459459459,1.0,1.0,2/12,17.74%,ZNF304;SETDB2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.2681367629327624,0.6458576346773606,1.0,1.0,1.0,11/42,16.13%,CLEC7A;SLC40A1;CSF3R;ITGAX;CLEC5A;MERTK;ADGRE1;HCK;TFEC;NR1H3;NFAM1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.26096935598367155,-0.6455101112368477,0.987012987012987,1.0,1.0,13/135,12.59%,CLGN;TCEAL2;HSPB8;TCEAL6;LRRTM3;TCEAL7;TCEAL5;TMEM35A;STMN2;PAK5;NACAD;DUSP26;VWA5A
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.4147769410235608,-0.645451678864428,0.847457627118644,1.0,1.0,2/6,21.40%,WIZ;DBF4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2572992270081199,-0.645340375161035,1.0,1.0,1.0,43/274,19.81%,TMEM107;TTC36;DCTN3;SSNA1;RSPH6A;TUBB4B;RAB11A;CCDC39;CCDC28B;CETN2;DCTN2;CEP131;HAUS6;FUZ;BBOF1;ABLIM3;ARL13B;TXNDC15;IFT122;TUBA1A;DYNLRB1;IFT81;SCLT1;CEP72;DNAH5;RAB8A;DYNLRB2;FAM149B1;DYNLL1;DCTN1;CFAP410;DYNC2H1;RP2;PLK4;INTU;CEP135;CC2D2A;ATP6V1D;PRKACA;CEP41;TUBB;NPHP1;TUBA4A
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.29709930809890417,-0.6451789158051275,0.9315068493150684,1.0,1.0,4/41,19.97%,LACC1;GCK;NUP50;PGAM1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.3601468641931681,0.644768314027395,0.84375,1.0,1.0,1/8,9.28%,ABHD17C
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.3601468641931681,0.644768314027395,0.84375,1.0,1.0,1/8,9.28%,ABHD17C
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.2895754142876941,-0.6442657218991621,0.9523809523809523,1.0,1.0,10/32,27.31%,LAMP1;ANTKMT;LCP1;NEFH;REEP5;REEP6;DYNC1H1;PTPN1;CRYAB;DNAJC30
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.33012752508788223,0.6441079977221948,0.9210526315789473,1.0,1.0,3/10,23.68%,CORO2B;MAPT;NDFIP2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3534312310998393,0.6439984208104873,0.8648648648648649,1.0,1.0,5/9,24.99%,SNCA;CBLB;CBL;PTPRJ;NDRG4
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.3861680075905405,-0.6437218366381401,0.9,1.0,1.0,2/7,20.66%,DNM1L;CHMP4B
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.3981014897767643,-0.6436271528835893,0.95,1.0,1.0,1/6,11.44%,CR1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.3392838552969574,0.6436193026848268,0.8717948717948718,1.0,1.0,5/12,15.86%,PIWIL2;NANOS3;STRA8;FMN2;KMT2D
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.33840486086199895,-0.6434997209879063,0.8939393939393939,1.0,1.0,5/19,23.72%,APOE;FMO5;RAN;KPNB1;SREBF1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.2975257198579059,0.6434447960041058,0.9375,1.0,1.0,4/24,13.73%,HSD3B7;OSBPL1A;OSBPL6;OSBPL7
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.3315984659389807,-0.6429870664989481,0.9571428571428572,1.0,1.0,9/35,21.24%,PRELID1;PINK1;ATP5IF1;STOML2;UBB;BAX;SOD1;ARL6IP5;MTLN
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.3026070610484191,-0.6427295669703726,0.9324324324324325,1.0,1.0,7/41,15.06%,BUD23;TRMT112;RBM22;HRAS;TGFB1;DIMT1;POLR2A
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.32145172650904374,-0.6424675785475686,0.9523809523809523,1.0,1.0,7/27,25.58%,SRI;MTCH1;TRDN;SCG5;IGFBP7;GRK6;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3222143498173582,-0.6423165762717699,0.9428571428571428,1.0,1.0,3/29,15.01%,PNKP;CCT7;CCT2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.3803795075846488,-0.64217776979494,0.9122807017543859,1.0,1.0,2/9,20.42%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.3803795075846488,-0.64217776979494,0.9122807017543859,1.0,1.0,2/9,20.42%,STAT5A;SHC1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.39622407227507395,0.6420337965722929,0.8095238095238095,1.0,1.0,2/5,18.28%,TJP2;TJP1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.2586757214151297,-0.6413792990742402,0.9875,1.0,1.0,18/161,17.86%,PLAAT4;GPX4;PNKP;PFKL;G6PC3;HTR2B;TGFB1;PPP1CA;PIK3CB;CDK5;IMPA1;NT5C;GCK;DUSP28;DUSP23;ITPKA;PPIP5K1;PGP
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.38500583595530435,-0.6411733949483459,0.8813559322033898,1.0,1.0,1/6,8.91%,BRK1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.2833581871769851,-0.6411636682287579,0.9861111111111112,1.0,1.0,21/68,26.02%,UBL5;PIGH;USP6;UBA52;B4GALT7;PARP1;ARAF;CDC34;RABGGTB;GGCX;NAGPA;TGM1;SERP1;UBL4A;MCRS1;FBXL2;UBE2S;PADI4;RPN1;UBE2M;PARP4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.39226786046318407,0.6407403064011984,0.9215686274509803,1.0,1.0,2/7,20.61%,CLASP1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.3772657799686942,-0.6406021453073603,0.8787878787878788,1.0,1.0,1/7,5.41%,PRELID1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.38817081288845146,-0.6405876304817328,0.8813559322033898,1.0,1.0,1/6,4.09%,VPS35
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.398915419816107,-0.6404473564710562,0.8852459016393442,1.0,1.0,2/7,21.40%,WIZ;DBF4
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.43678950028456537,-0.6404166880854554,0.9538461538461539,1.0,1.0,3/5,32.83%,DNM1L;ARMC1;CLUH
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.28500716765455053,-0.6401693719757688,0.9861111111111112,1.0,1.0,15/64,22.24%,RPS3;RAB11A;ABRAXAS1;TPX2;NEK6;HAUS6;GOLGA8B;GOLGA2;WRAP73;TUBGCP4;GOLGA8M;RHOA;TUBGCP2;KPNB1;SMC1A
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3516416616682794,0.6399625808328353,0.7272727272727273,1.0,1.0,3/9,17.33%,PLXNA1;PLXNB2;PLXNA4
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.3797445276989117,-0.6396418471919492,0.9016393442622951,1.0,1.0,2/8,11.25%,NEFL;BFSP1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.3537760670532869,-0.6396171699523959,0.9855072463768116,1.0,1.0,3/17,19.40%,REEP4;NEMP1;EMD
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.3513870623385251,0.639255307906229,0.84375,1.0,1.0,2/7,16.77%,PRKD1;CAMK2D
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.37902675467260366,0.6382497491022958,0.9024390243902439,1.0,1.0,1/8,8.18%,VPS8
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.32923812399734964,-0.6381135107692502,0.9402985074626866,1.0,1.0,8/22,29.96%,DDX11;RAD50;DDX1;RECQL;BLM;DHX36;NBN;RECQL4
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.27151539440090705,-0.6380454668886685,0.9875,1.0,1.0,9/114,9.49%,RPS27A;CLU;RPS3;UBA52;TRIM13;TRIM25;LAMTOR5;AR;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.39770724613621034,-0.6380175625466222,0.8301886792452831,1.0,1.0,1/5,18.19%,IMPACT
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.28747403968835483,0.6377387086312404,0.9393939393939394,1.0,1.0,2/17,11.55%,ADAMTS9;FBXO2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.3588642195693405,0.6370099702226212,0.9772727272727273,1.0,1.0,7/7,64.13%,TP53;BOK;SIRT2;FAP;TP53BP2;DLC1;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.2848734976935219,-0.636524563348832,0.927536231884058,1.0,1.0,7/44,16.74%,ITM2C;PRAG1;STMN2;SEMA3A;MAG;GORASP1;APOE
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3241493348886744,-0.6358890230159032,0.9122807017543859,1.0,1.0,6/15,30.90%,DOP1B;KLHL20;AP2A1;AP4M1;RAB14;VPS13A
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.340399419837108,0.6356763694540233,0.8604651162790697,1.0,1.0,7/7,65.97%,NUFIP1;PIH1D1;RUVBL2;ZNHIT3;RUVBL1;PIH1D2;ZNHIT6
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3517535431322969,-0.635563811928846,0.8805970149253731,1.0,1.0,4/13,19.98%,HTR2B;PIK3CB;APOE;S100A1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.32146753564278835,0.6353967228773142,1.0,1.0,1.0,3/15,9.20%,TMEM108;HAP1;DLG2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.38565567718007737,0.6350612709824981,0.9411764705882353,1.0,1.0,4/9,22.53%,ITGAX;DICER1;PARD3;TNFRSF1B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.31935356444638063,0.6348263372563507,0.925,1.0,1.0,1/13,3.02%,PIEZO2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.3543618643859392,0.6347510326850571,0.875,1.0,1.0,1/10,3.73%,CPEB3
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.33655142881731703,0.6345174200066229,0.9459459459459459,1.0,1.0,2/9,16.31%,DICER1;DHX9
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.35934993338772525,-0.6343411961068884,0.9322033898305084,1.0,1.0,5/12,24.50%,MESP1;MEST;BMX;GDF11;MESD
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.33282748843322907,-0.6343122885454003,0.8923076923076924,1.0,1.0,2/17,14.47%,RPS3;EDN1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.346070173481341,0.6342782261941824,0.8837209302325582,1.0,1.0,6/6,65.40%,SENP1;SENP6;SENP2;SENP5;USPL1;SENP7
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.2585365055058263,0.6341542181541624,1.0,1.0,1.0,15/47,22.78%,TVP23B;LTBP2;RAB3B;MTTP;TANGO6;GOLPH3;RCN3;PCSK5;ADCYAP1;MIA3;ARFGAP3;CAMK2G;RIMS2;SNX19;RAB3C
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3443038145294971,-0.6335784980550427,0.8955223880597015,1.0,1.0,4/15,19.83%,IGSF8;MYL6;SVIL;CAV1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.41603039331071456,-0.6335641640734517,0.9152542372881356,1.0,1.0,1/5,12.62%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.30132297072583014,-0.6333545293733945,0.9285714285714286,1.0,1.0,4/25,21.62%,VIL1;SYAP1;EEF1A1;INPP5K
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.36596977209679943,-0.6332518181432779,0.9384615384615385,1.0,1.0,3/9,29.58%,EDN1;PRXL2B;CD74
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.31662380892049957,-0.633045504067738,0.9692307692307692,1.0,1.0,2/25,8.65%,TSHR;FSHR
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.2865486170777161,0.6326145055323183,0.9705882352941176,1.0,1.0,6/21,20.59%,AUTS2;PIK3CA;ABI2;CYFIP1;AKIRIN1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.39585574984909533,-0.6325959678730542,0.9122807017543859,1.0,1.0,1/5,27.60%,SDC4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3738957460608756,-0.6324123162381611,0.9242424242424242,1.0,1.0,1/9,6.38%,ETFB
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.29757610950429125,0.6320761142793998,1.0,1.0,1.0,1/20,4.93%,LPIN3
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.3482185548577018,-0.6320476642582302,0.9253731343283582,1.0,1.0,4/13,25.68%,PYCR3;MOCS1;ALOX5;MOCOS
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.30923197516118356,-0.631863138737974,0.9295774647887324,1.0,1.0,9/27,29.92%,PEX10;ACBD5;FIS1;PEX1;ATAD1;PXMP4;PEX16;PXMP2;PEX12
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.42895131430566236,-0.6318106925442779,0.9298245614035088,1.0,1.0,3/5,21.21%,CALM3;TRDN;CALM1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.3173850746364244,-0.6316062965053357,0.921875,1.0,1.0,4/25,15.08%,LACC1;ATP5F1B;SLC9C1;SLC9B1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.36399465557114974,0.6312745333419261,0.9024390243902439,1.0,1.0,1/8,7.56%,DRD4
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.29254350744599494,-0.6309912285429927,0.9620253164556962,1.0,1.0,7/58,11.54%,MADCAM1;ITGB4;FBLN1;CEACAM1;ADAM15;CDH17;ILK
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.3113636331027302,-0.6309515597477215,0.9253731343283582,1.0,1.0,9/34,21.04%,HLA-DPA1;RPS3;HHLA2;FADD;TNFSF9;ZP3;PDCD1LG2;CD46;HLA-DPB1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.24331574019588176,0.630827219190052,1.0,1.0,1.0,20/203,11.77%,LEPR;NUPR1;DAPL1;GFAP;HSPB1;ACER2;TICAM1;FOXK1;RASIP1;USP36;TRIM65;OPTN;PIP4K2A;EIF4E;PTPN22;RRAGD;FBXW7;ITPR1;PRKD1;ATP13A2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.2919616617884573,-0.6306799857724928,0.9402985074626866,1.0,1.0,9/40,21.63%,GNAI2;CHRM2;OPRM1;CHRM5;GRM7;GPR37L1;AKAP5;PDE2A;HTR1E
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.33437291540047137,-0.6301915764207986,0.927536231884058,1.0,1.0,4/17,31.10%,SDS;HYKK;CRYM;DLST
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.30109329864835854,0.6297750175970604,0.9393939393939394,1.0,1.0,3/13,10.73%,ARID1B;FAM47E;ARID1A
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.38745232033631927,-0.6296650413921692,0.9433962264150944,1.0,1.0,1/8,7.85%,PAX8
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.38089770508145626,-0.629619937927415,0.9365079365079365,1.0,1.0,1/8,6.31%,VAMP8
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.2793338756212128,0.6295944410288616,1.0,1.0,1.0,4/37,6.23%,SPRY2;DUSP1;IRAK3;DUSP10
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.28244257117518373,0.6292695978006194,0.9743589743589743,1.0,1.0,4/15,18.12%,PRKRA;DICER1;DHX9;CELF1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.2686334776680623,0.629116724294087,1.0,1.0,1.0,12/53,16.97%,TRIM67;MMD2;PICALM;FBXW7;DLG1;AFDN;DNAJB6;TESK1;CEP290;TRIM46;MAPK8;ADCYAP1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.31944922025903566,-0.6287783688912136,0.9,1.0,1.0,6/24,18.45%,DTX3L;STAT1;IFNLR1;PARP9;PQBP1;CGAS
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.30765504022126244,-0.6287348148421309,1.0,1.0,1.0,5/31,20.26%,DGAT2L6;APOE;DGKG;CAV1;DGKD
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2811079953215154,-0.6280580988678924,0.9871794871794872,1.0,1.0,4/75,8.65%,GLP2R;SELENOS;TSHR;FSHR
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.40403404723975267,-0.6275997635382572,0.8983050847457628,1.0,1.0,1/5,23.50%,CTR9
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3086571704348908,-0.6274768634481962,0.9726027397260274,1.0,1.0,3/31,15.01%,PNKP;CCT7;CCT2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.332756896627929,0.6274619700357855,0.9459459459459459,1.0,1.0,2/11,17.74%,ZNF304;SETDB2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.30393664669302095,-0.6274482016581348,0.9315068493150684,1.0,1.0,3/23,14.43%,PPP1CA;PER3;RBM4B
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.362464759339711,-0.6272104958014332,0.9041095890410958,1.0,1.0,1/11,11.72%,ARCN1
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.3688785867089177,0.6269731005700537,0.8571428571428571,1.0,1.0,1/5,11.24%,CSGALNACT1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.2416852078903863,-0.6268796055051356,1.0,1.0,1.0,54/357,21.10%,ARHGAP4;ZMYM6;TMED9;ARL1;CHMP2A;PEX11A;GOLGB1;CHCHD2;CNN2;PEX10;TMED4;MNS1;PHB2;RAB32;HAX1;ATP5F1B;GORASP2;PINK1;PAK5;PARP1;PPIA;STOML2;GOLGA8B;PI4K2A;DIAPH3;GORASP1;CAV2;CFL1;KIF4A;FBXW8;CFAP410;DYNC2H1;DNM1L;APOE;GOLGA2;FGD5;LMAN2;MCOLN1;CHMP3;CHMP7;ATP8B1;ZNF501;REEP5;RHOU;ATL3;HSD17B10;GOLGA8M;CAV1;PEX1;ZW10;CHMP4B;TBC1D20;BNIP1;TMED2
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.383976067836437,0.6268505766922727,0.8043478260869565,1.0,1.0,1/5,3.37%,EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.383976067836437,0.6268505766922727,0.8043478260869565,1.0,1.0,1/5,3.37%,EGFR
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.2903270442698724,0.6265254023604404,0.9473684210526315,1.0,1.0,2/17,10.33%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.27518485023539563,-0.6261537412713809,1.0,1.0,1.0,12/66,21.07%,ATP6V1F;RRAGA;LAMTOR5;CEBPB;LAMTOR1;ATP6V1E1;IMPACT;ATP6V1E2;RRAGC;ATP6V1D;ATP6V1C2;LAMTOR2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.3683362317953486,0.6254603443899648,0.8888888888888888,1.0,1.0,2/8,14.04%,EXOSC7;ERI1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.3683362317953486,0.6254603443899648,0.8888888888888888,1.0,1.0,2/8,14.04%,EXOSC7;ERI1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.26088427832616623,-0.6251541102510543,1.0,1.0,1.0,31/169,22.87%,GJC3;TMEM125;ARSG;TCEAL6;LRRTM3;ITGB4;KLK6;CLDN14;TCEAL5;SPARCL1;OPALIN;GPR62;MAG;MYRF;OLIG1;OMG;TMEM151A;HEPN1;ERMN;GJB1;ZDHHC9;LGI3;FASN;NFE2L3;HPCA;BACE1;PLEKHH1;SP7;BRINP2;PLP1;MOG
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.3706610316787043,-0.6251454247323478,0.9056603773584906,1.0,1.0,4/10,19.22%,ALDH1A2;CYP3A5;CYP3A4;ADH6
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.34602521778128553,-0.625046128743534,0.9264705882352942,1.0,1.0,2/15,17.39%,TGFB1;PTN
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.39140246237286735,-0.6250044367945529,0.9272727272727272,1.0,1.0,2/9,20.38%,ABCA5;ITGAV
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.35714928093481735,-0.6248735774787257,0.9545454545454546,1.0,1.0,3/9,21.01%,OMG;PTN;GAP43
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.3787858941521009,0.6243328312346067,0.8636363636363636,1.0,1.0,1/6,5.36%,AKT2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.3449825140659747,-0.6242603496508422,0.95,1.0,1.0,1/14,3.47%,FGL1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.30334299740554244,-0.6238760281497079,0.9714285714285714,1.0,1.0,5/37,21.46%,IRF1;FLOT1;RNF135;RIOK3;TOMM70
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3474536228072892,-0.6230910081664844,0.8939393939393939,1.0,1.0,5/18,21.21%,SRI;CALM3;TRDN;PRKACA;CALM1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.26185377632004553,0.6230530290516774,0.967741935483871,1.0,1.0,11/46,20.60%,CNTNAP2;TNIK;SGK1;DICER1;MAP4K4;TRIO;CNTNAP1;GPM6A;SNX1;DNM2;NYAP2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.3703391475323015,0.6230174136239061,0.9090909090909091,1.0,1.0,1/6,6.81%,HAP1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.23450013233397993,0.6229361910050462,1.0,1.0,1.0,17/88,17.84%,ADGRB1;GFAP;EGFR;BANP;IRAK3;HMGCR;SMURF2;ATP13A2;FMN2;ITCH;ZDHHC2;GSK3B;NEDD4L;MDM4;AGAP2;HACE1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.2912021523764342,0.6227283682817715,0.9354838709677419,1.0,1.0,9/27,17.18%,TAL1;AURKC;PKP4;FGF1;PRKCE;CDC25B;CDC14B;KIF14;CSPP1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.26161199689945414,-0.6225848530720123,0.9878048780487805,1.0,1.0,19/85,19.22%,NUDT12;LSM2;PRPF3;SF3A1;PCBP3;LSM10;SRSF7;SSB;CPSF3;PRPF18;RNH1;PRMT9;METTL3;KIN;PRPF8;DDX5;AURKAIP1;NCBP1;PRKACA
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.34411444268289165,0.6221354226848096,0.896551724137931,1.0,1.0,1/10,4.92%,DNA2
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.34411444268289165,0.6221354226848096,0.896551724137931,1.0,1.0,1/10,4.92%,DNA2
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.34411444268289165,0.6221354226848096,0.896551724137931,1.0,1.0,1/10,4.92%,DNA2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.2912807889055071,-0.6221313087907673,1.0,1.0,1.0,6/61,12.62%,DTX3L;RNF181;TRIM13;RNF8;TRIM17;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.3351779996420239,-0.6220691303462271,0.9333333333333333,1.0,1.0,4/12,22.27%,APLN;EDN1;KCNQ1;CHGA
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.3191867854721003,0.6220089236377994,0.9259259259259259,1.0,1.0,6/19,22.32%,COL5A1;RARG;ALDH1A3;AGTPBP1;FBN1;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.37414504599562765,-0.6219594445498433,0.873015873015873,1.0,1.0,4/9,21.02%,CR1;HLA-DRA;HLA-DRB1;CD46
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.26922519773436243,0.6214064826157176,0.9393939393939394,1.0,1.0,5/21,18.46%,DLG1;SLMAP;CAMK2D;NEDD4L;SCN3B
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.378037407270142,-0.6212256296690107,0.90625,1.0,1.0,2/11,14.11%,LACTB2;POP7
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.30325762766297903,0.6205004591149352,0.9024390243902439,1.0,1.0,1/16,2.36%,TMEM98
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.25891428579631326,0.6204417173257053,1.0,1.0,1.0,27/95,21.47%,PIK3R5;MTMR2;PLA2G10;PGAP1;PLEKHA1;PIP4K2A;MTMR11;CDS1;PITPNM1;PIK3CA;PI4KA;PTEN;SYNJ2;INPP5E;FGF2;INPP5B;INPP5D;MTMR3;PLA2G4C;MTMR12;PIKFYVE;PIK3R3;CSF1R;PIK3R1;PLEKHA8;MTM1;PIP4P2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.36046755028197575,0.6199927597578938,0.9285714285714286,1.0,1.0,1/9,8.25%,CD4
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.3316861279551094,-0.6195875867750698,0.9838709677419355,1.0,1.0,3/15,19.64%,AP2S1;CLTA;CALY
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.29884362961986854,-0.6194524478507458,0.918918918918919,1.0,1.0,3/24,14.43%,PPP1CA;PER3;RBM4B
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.37410345506735365,0.6192613830606594,0.8285714285714286,1.0,1.0,2/6,13.29%,SASH1;MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.36628182432669465,-0.6191499668896085,0.9206349206349206,1.0,1.0,1/13,11.37%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.3657148120123368,-0.6186152209054816,0.9393939393939394,1.0,1.0,3/11,30.36%,FNTA;SAP30BP;AKAP8
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.36293114783688407,-0.618538025124838,0.9298245614035088,1.0,1.0,2/11,12.62%,CAMK1;BRCA1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.3431645253117793,-0.6184568855272721,0.9365079365079365,1.0,1.0,6/14,33.04%,NTNG2;CTSS;NID2;LAMB1;HPN;COL4A1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.36182324163138385,0.6184366787728699,1.0,1.0,1.0,2/9,9.95%,CD22;PTPN22
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.388306200742502,-0.6184279863919905,0.9444444444444444,1.0,1.0,2/10,17.38%,INTU;GLI3
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.3895577695030104,-0.6181723609205902,0.8813559322033898,1.0,1.0,2/5,28.68%,GOPC;ABCB1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.37485634671106727,-0.61801234896209,0.9130434782608695,1.0,1.0,2/7,10.07%,TMSB4X;PINK1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.3858484582986438,-0.6177368441394367,0.8923076923076924,1.0,1.0,4/6,42.51%,ACAA2;STPG1;CAMK2A;THEM4
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.39467618772325413,-0.6176548152350047,0.9482758620689655,1.0,1.0,2/5,24.55%,HSD17B10;TRNT1
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.3774037191420719,0.6174858077740409,0.9,1.0,1.0,1/5,6.81%,HAP1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.3486227692136866,0.6172564265384097,0.9473684210526315,1.0,1.0,2/8,10.18%,MAN2A1;ENGASE
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.3356254770071522,-0.6169012094432765,0.9230769230769231,1.0,1.0,3/13,25.58%,STAT5A;PXN;PTPN1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.33985795407986047,0.616858171627397,0.972972972972973,1.0,1.0,3/10,12.06%,DMBT1;SSC5D;PGLYRP2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.31530519189140704,-0.6162565484900325,0.9459459459459459,1.0,1.0,1/30,1.63%,TAX1BP3
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2939862340118376,0.616196627389222,0.9629629629629629,1.0,1.0,13/31,26.48%,PRKCE;DMD;FGF13;SLMAP;CAMK2D;NEDD4L;SCN3B;FGF14;WNK1;STK39;HECW2;UTRN;WNK2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.3659304945970249,-0.6153394453717445,0.9166666666666666,1.0,1.0,3/8,21.24%,STOML2;GLRX;MTLN
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.3871453969903614,0.6150773547906024,0.8780487804878049,1.0,1.0,1/5,3.50%,PDE4B
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.3359901282415596,0.6149933951445604,0.9230769230769231,1.0,1.0,4/12,26.88%,GPLD1;AGTPBP1;FOLH1B;ATG7
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.27429472280177813,-0.6134623214333113,0.9859154929577465,1.0,1.0,6/48,18.64%,CPTP;PRELID1;TRIAP1;ABCA12;APOE;ATP8B1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.3418938991862913,-0.612217200221445,0.9538461538461539,1.0,1.0,7/16,29.05%,GIPC1;LRRC8D;ARL6IP5;SLC1A6;SLC1A1;GJA1;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.31378384900381906,0.6120665766194407,0.9705882352941176,1.0,1.0,2/13,17.74%,ZNF304;SETDB2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.2782131892320786,0.6120037712305192,0.9655172413793104,1.0,1.0,5/53,5.20%,EFNB3;SPOCK1;LRP4;NLGN1;DPYSL3
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.3958620786473475,-0.6117949911901609,0.9032258064516129,1.0,1.0,2/7,14.43%,PARP1;MGME1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.32363776721672594,-0.6111934017063816,0.9242424242424242,1.0,1.0,4/21,19.95%,PEX11A;PEX11G;DNM1L;FIS1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.38042932599418233,-0.6109829183903914,0.9814814814814815,1.0,1.0,2/7,17.38%,INTU;GLI3
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.3152851758246408,-0.6104931857882919,0.9583333333333334,1.0,1.0,4/17,23.45%,C1QBP;DNM1L;CCR7;CD99
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.39948636228497664,-0.6104774456009995,0.9245283018867925,1.0,1.0,1/5,28.32%,SMAD7
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.3424923939093044,0.60970852836044,0.8421052631578947,1.0,1.0,2/10,6.31%,CX3CR1;DYSF
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.26784704638219287,-0.609579158206949,1.0,1.0,1.0,12/67,21.07%,ATP6V1F;RRAGA;LAMTOR5;CEBPB;LAMTOR1;ATP6V1E1;IMPACT;ATP6V1E2;RRAGC;ATP6V1D;ATP6V1C2;LAMTOR2
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.36158702897103806,-0.6090414844095473,0.9076923076923077,1.0,1.0,3/8,26.14%,TXN;GPR37L1;PARK7
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.3643893558117654,0.6085122128823802,0.9024390243902439,1.0,1.0,3/7,17.18%,RAPGEF1;MAGI2;RAP1A
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3599044959581693,-0.6079492689470454,0.9230769230769231,1.0,1.0,1/7,14.57%,KRT10
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.37065601608259763,0.6079251407234093,0.9473684210526315,1.0,1.0,1/6,5.94%,SNCA
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.35616051166311924,-0.6076028274270417,0.8923076923076924,1.0,1.0,3/9,26.14%,TXN;GPR37L1;PARK7
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.38659355680384455,0.6072790974400079,0.8648648648648649,1.0,1.0,1/6,6.89%,SMS
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.33326524343192054,-0.6071659952529967,0.9692307692307692,1.0,1.0,8/18,29.63%,HAX1;PINK1;DNM1L;SREBF1;HTRA2;PARK7;VDAC1;FBXO7
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.32545240591939006,-0.6071120719340499,0.9672131147540983,1.0,1.0,6/21,27.84%,PRELP;OMD;OGN;CHST2;CHST6;SLC35D2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.36990071037657263,-0.6067301237359687,0.9298245614035088,1.0,1.0,1/9,6.96%,GPC3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2610809820803909,-0.6065007874453985,0.974025974025974,1.0,1.0,12/53,23.94%,RAB11A;STMN3;FIGNL1;DCTN1;TRDN;TUBGCP4;RHOA;TUBGCP2;KATNA1;KPNB1;VPS4B;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.33402948029034424,-0.6061402160191222,0.95,1.0,1.0,3/13,12.78%,PIK3CB;CADM4;STMN3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.28679266649234386,-0.6054218345086845,0.9295774647887324,1.0,1.0,9/49,17.07%,HLA-E;IRF1;CDC37;ERAP1;NMI;PARP9;APPL2;RNF135;IFI35
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3054120858723338,-0.6052168541671925,0.984375,1.0,1.0,1/22,4.17%,BTBD18
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.3461578614110566,-0.6049412922052403,0.9545454545454546,1.0,1.0,2/9,26.00%,MAP1A;BRSK1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.24676602826424288,-0.6046710234932275,1.0,1.0,1.0,6/98,11.26%,RIMS1;ELOB;CLDN14;VIL1;NIFK;AFG3L2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.35745585026079246,-0.6044162855667473,0.9152542372881356,1.0,1.0,2/10,20.79%,ZNF622;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.29829807764876193,0.6037660620352627,0.9411764705882353,1.0,1.0,4/13,18.16%,EIF4EBP1;LARP1;EIF3E;EIF4EBP2
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.3356104536120622,-0.6037425535477094,0.9076923076923077,1.0,1.0,1/19,3.44%,IL31RA
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.321897526254454,-0.6024388213705714,0.9487179487179487,1.0,1.0,5/27,16.55%,XYLT2;B3GALT6;B4GALT7;CHST10;CHST9
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.3360293726843776,0.6019266215472452,0.8611111111111112,1.0,1.0,1/10,6.65%,DIAPH1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.26528433549263036,-0.6015883982516931,0.9714285714285714,1.0,1.0,12/55,22.81%,HTR2B;DDAH2;SELE;GPR62;CXCR6;EDN1;APOE;TPCN2;MCTP2;DGKD;CCR7;CCR3
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),0.36338117321038776,0.6015435686930561,0.9574468085106383,1.0,1.0,2/5,22.35%,AGTPBP1;FOLH1B
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.28925314513725064,-0.60149074691468,0.9868421052631579,1.0,1.0,4/48,12.70%,CLU;TRIM13;PRR7;CIDEB
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.3546051930351912,0.6014072190236415,0.9534883720930233,1.0,1.0,1/7,4.83%,AGER
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.35710841972543017,0.6006035036605127,0.8636363636363636,1.0,1.0,2/7,9.90%,STX1A;GDNF
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.3640036735451785,0.600350882846423,0.9705882352941176,1.0,1.0,2/6,15.18%,SERPINB9;SFPQ
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.3865075980907285,-0.6001623358467433,0.9090909090909091,1.0,1.0,2/5,29.72%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.24677003408214482,-0.5998732899117069,1.0,1.0,1.0,11/102,15.91%,ATG14;CDKN1C;NOP53;AR;SLAMF8;ILK;CADM4;KDM4D;GCK;DYNLL1;ANKLE2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.28864423851614524,-0.5995422511201296,0.9850746268656716,1.0,1.0,4/23,13.15%,TMSB4X;VIL1;TMSB10;MYADM
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.36795715720182975,0.5994518395158628,0.9722222222222222,1.0,1.0,7/7,63.22%,LIG4;MSH2;TCF3;MSH6;XRCC4;MSH3;PRKDC
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.3003151627852681,-0.5992408882994091,0.9375,1.0,1.0,3/21,13.53%,TPX2;STMN2;KATNB1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.40617634627863397,-0.5991142007134392,0.9464285714285714,1.0,1.0,2/6,31.22%,HEY2;ENG
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.26828893842034596,-0.5988759050744344,1.0,1.0,1.0,2/50,5.72%,RNF212;RNF212B
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.34698556133880504,0.5987656860967201,0.9166666666666666,1.0,1.0,2/7,15.18%,SERPINB9;SFPQ
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.31307981269869734,0.5980185927069034,0.9310344827586207,1.0,1.0,1/16,3.67%,ARNT
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.38838644693412916,-0.5973657802140827,0.9107142857142857,1.0,1.0,1/5,16.34%,MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.38838644693412916,-0.5973657802140827,0.9107142857142857,1.0,1.0,1/5,16.34%,MAN1B1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.38838644693412916,-0.5973657802140827,0.9107142857142857,1.0,1.0,1/5,16.34%,MAN1B1
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.38197302365940966,-0.5973168347561837,0.9692307692307692,1.0,1.0,2/5,16.37%,FANCM;XRCC3
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.33237620907585663,-0.5970209259114739,0.9571428571428572,1.0,1.0,4/18,18.91%,SFRP1;WARS1;RNH1;PLXND1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.2846612173706681,0.5967876396256523,1.0,1.0,1.0,2/19,11.71%,ACAD8;BCKDHB
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.2846612173706681,0.5967876396256523,1.0,1.0,1.0,2/19,11.71%,ACAD8;BCKDHB
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.3360964367297322,-0.5965293629340207,0.9206349206349206,1.0,1.0,2/14,13.05%,ASAH2B;ASAH2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.3131870646324976,0.5961029760787008,0.9142857142857143,1.0,1.0,3/13,19.66%,IWS1;SARNP;THOC2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.3168960101039421,0.5953112743340399,0.8604651162790697,1.0,1.0,2/13,8.87%,PROM2;SNAP91
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.2515922061270695,-0.5947083705819541,0.9866666666666667,1.0,1.0,14/76,24.56%,EDF1;SCD;GPS2;C1QTNF2;HELZ2;CAV1;FASN;OPA3;NR1D1;NPC2;CERS2;LACTB;SREBF1;TM7SF2
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.32328907213823965,-0.5943132429549088,0.9420289855072463,1.0,1.0,2/12,16.23%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.3498633346349082,0.5942800794043613,0.9130434782608695,1.0,1.0,6/6,65.03%,FERMT2;ITGB1BP1;CX3CL1;COL16A1;FN1;FERMT3
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.3158717117080558,-0.5936858580969794,0.9714285714285714,1.0,1.0,1/19,1.51%,MUSK
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.2989349577734988,0.5933477884730501,0.9318181818181818,1.0,1.0,6/12,21.59%,HDAC9;SORT1;NR1H3;PCSK5;LPL;PCSK6
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.32050897037091985,-0.5932688033247479,0.9523809523809523,1.0,1.0,2/21,9.31%,NEURL1;CAMK1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.31601648338196825,0.5927093976529447,0.9393939393939394,1.0,1.0,2/7,18.40%,PJVK;PEX5
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.39563854601633697,-0.5925651456947105,0.9666666666666667,1.0,1.0,1/5,12.52%,CD27
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.330962225879596,0.5924617820862512,1.0,1.0,1.0,3/16,10.59%,SRC;ST18;SMAD4
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3240463503811399,-0.5924254159095237,0.9538461538461539,1.0,1.0,3/22,13.04%,RPS6;PINK1;SYAP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.31686381952511816,-0.5921875558260649,0.9558823529411765,1.0,1.0,3/16,18.06%,CCT7;CCT2;CEP135
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.26319480027438014,-0.5919949372143538,1.0,1.0,1.0,6/56,12.36%,MED8;MED10;CDK4;CEBPB;CCNC;MED31
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.35126273551661014,0.5912239564153563,0.8679245283018868,1.0,1.0,1/5,10.80%,SLC22A2
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.35126273551661014,0.5912239564153563,0.8679245283018868,1.0,1.0,1/5,10.80%,SLC22A2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.3327949854901144,-0.5910000814884169,0.9607843137254902,1.0,1.0,5/15,32.73%,WDR45B;ULK2;WIPI2;ATG2A;ATG12
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.30952343114362746,-0.5909897126610505,0.9705882352941176,1.0,1.0,3/33,12.78%,STMN1;STMN2;STMN3
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.3142750311306516,-0.59093356686281,0.9682539682539683,1.0,1.0,3/17,19.94%,SLC5A10;SLC2A2;SLC5A2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.32126026972282745,0.5906273730426266,1.0,1.0,1.0,4/11,22.53%,ADAM8;GPLD1;SH3D19;TNFRSF1B
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.3433002342965523,0.5898057879344445,0.9142857142857143,1.0,1.0,7/7,65.68%,THOC2;THOC1;THOC6;THOC3;THOC7;ALYREF;THOC5
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.3433002342965523,0.5898057879344445,0.9142857142857143,1.0,1.0,7/7,65.68%,THOC2;THOC1;THOC6;THOC3;THOC7;ALYREF;THOC5
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.38948914113106636,-0.5891924346777503,0.9122807017543859,1.0,1.0,4/5,25.81%,HPGD;ALOX5;PTGR1;ALOX12
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.3403804317509902,0.5891542189656535,0.9090909090909091,1.0,1.0,6/6,65.97%,FBL;PIH1D1;ZNHIT3;PRPF31;NOP58;ZNHIT6
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.3915927930693852,-0.5886245687444787,0.9661016949152542,1.0,1.0,2/6,22.78%,APPL2;RAB31
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.3662427487728694,0.5881260337552207,0.9473684210526315,1.0,1.0,5/5,63.39%,TET2;PON1;EPHX2;PON2;ACAA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3357801870850388,-0.5875243207604094,0.9206349206349206,1.0,1.0,4/11,21.25%,SELE;SELP;RHOA;ALOX5
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.3584688697535999,0.5871769003183007,0.9523809523809523,1.0,1.0,2/8,10.43%,CEP85;NSFL1C
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.35988240921613535,-0.5869680889233915,0.9491525423728814,1.0,1.0,2/7,22.85%,VAT1;BNIP3
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.24949056319500096,-0.5864234341596749,1.0,1.0,1.0,18/89,27.54%,FIP1L1;DHX38;UPF2;SRSF7;MCM3AP;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;NUP50;RBM15B;SRSF9;SRSF5;NXT1;NCBP2;GLE1;DDX39A
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2840096179143452,-0.5861695624040455,0.9861111111111112,1.0,1.0,5/26,22.32%,BTBD18;RNF8;HEXIM1;NELFE;NELFCD
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.38744161942164657,-0.5859466718172813,0.9285714285714286,1.0,1.0,1/5,19.66%,ALDOB
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.29761807291965076,-0.5857439223223433,0.958904109589041,1.0,1.0,8/28,24.53%,TMED9;IRGM;PFDN2;KATNBL1;ATL3;SURF4;HTRA2;SMCR8
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.2912862962831106,0.5851329853816721,0.9714285714285714,1.0,1.0,5/20,19.69%,MOGAT1;DGKI;DGKE;DGKB;DGKK
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.3329295032242366,-0.5847832332498238,0.9411764705882353,1.0,1.0,2/14,14.98%,SFRP4;FSTL1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.2594872179540757,0.584198126264842,1.0,1.0,1.0,6/64,9.37%,BDH2;ECHDC2;ACADVL;LPIN3;ABHD2;PHYH
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.34186639170855837,-0.5839196551483212,0.9264705882352942,1.0,1.0,4/12,22.04%,BRCA1;LRIF1;METTL3;RBM15B
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2608844697950462,-0.5836848477191321,0.987012987012987,1.0,1.0,7/61,16.75%,ACTG1;VAV3;BRK1;PIK3CB;ARPC5;MYO10;ACTB
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.3615632609827767,0.5833183892569854,0.9428571428571428,1.0,1.0,2/6,20.60%,ATP13A2;MGAT3
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.3752819706418439,-0.5826420736138186,0.96875,1.0,1.0,3/7,37.34%,P4HB;STAT3;STAT4
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.37774248681416306,-0.5825247574841251,0.9682539682539683,1.0,1.0,2/5,24.55%,UBE2D4;UBE2S
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.3373221554777949,-0.5823470406278353,0.90625,1.0,1.0,2/10,34.03%,ERH;TYMP
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.331000347674248,-0.5821590640089562,0.9855072463768116,1.0,1.0,3/15,14.52%,METAP2;FNTA;NMT1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.342854535671711,-0.5820345020783475,0.9090909090909091,1.0,1.0,1/10,7.22%,RACK1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.3384343958739903,-0.5816912141770048,0.9344262295081968,1.0,1.0,4/11,29.92%,PEX10;PEX1;PEX16;PEX12
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.2929690918749636,-0.5815978388426237,0.9571428571428572,1.0,1.0,5/21,25.68%,PYCR3;MOCS1;ALOX5;FDXR;MOCOS
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.3542811845569161,-0.5811242722441576,0.9193548387096774,1.0,1.0,4/9,36.42%,IFIT1;ISG15;SMPD1;SHMT2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.350244809123899,-0.5809894613851483,0.8888888888888888,1.0,1.0,1/9,9.46%,AR
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.2967871054622275,0.5806442532497927,1.0,1.0,1.0,1/8,7.58%,PIP4K2A
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.26495604103330295,-0.5804458955008774,1.0,1.0,1.0,9/59,19.53%,DDIT3;RRAGA;WDR91;RAB8A;CISD2;RMC1;TPCN2;RRAGC;DRAM1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.3361617901454039,0.5797575772650789,0.9210526315789473,1.0,1.0,1/5,14.26%,PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.3361617901454039,0.5797575772650789,0.9210526315789473,1.0,1.0,1/5,14.26%,PRKCZ
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.31538955071898356,-0.579678289319234,0.9848484848484849,1.0,1.0,5/13,25.05%,ETFB;ETFRF1;UQCRFS1;NDUFA5;ETFA
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.33281307484361844,-0.5791807531945758,0.9473684210526315,1.0,1.0,1/14,7.17%,BTG1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.26524834629437877,-0.5789584229701232,0.9861111111111112,1.0,1.0,7/60,16.75%,ACTG1;VAV3;BRK1;PIK3CB;ARPC5;MYO10;ACTB
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.26524834629437877,-0.5789584229701232,0.9861111111111112,1.0,1.0,7/60,16.75%,ACTG1;VAV3;BRK1;PIK3CB;ARPC5;MYO10;ACTB
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2687834421396553,-0.5788307325724477,1.0,1.0,1.0,8/49,22.77%,RAB11A;PHB2;CDK4;LSM10;TFDP1;CDC23;ADAM17;VPS4B
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.2480619166571796,-0.5785127623092351,1.0,1.0,1.0,9/68,20.89%,VPS35;TMED9;PINK1;SYT11;STMN3;DNM1L;FIS1;PDE2A;MSN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.27956013908415905,0.5776835882278626,1.0,1.0,1.0,6/26,18.46%,KCNJ2;CACNA2D1;CACNA1G;CAMK2D;KCNE4;SCN3B
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.293628848919998,0.5774396750768829,0.9772727272727273,1.0,1.0,5/22,13.82%,DNAAF1;GLI2;CHD7;FGF1;CHI3L1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.2543302335384793,-0.5772476255476982,1.0,1.0,1.0,17/87,21.44%,GSTM4;GSTP1;SLC35B2;GSTK1;AKR1A1;MGST3;PRELP;OMD;GSTM3;CHST9;CHPF;GSTZ1;ANGPT1;GCLM;MAT2B;MPST;OGN
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.29877937698807583,-0.5764194342892998,0.9545454545454546,1.0,1.0,6/24,21.54%,PHKG1;PYGL;NHLRC1;AGL;CALM1;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.337594757437435,0.5763861981582351,0.85,1.0,1.0,1/6,7.47%,ADAM8
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.24161383286306576,-0.576163042155257,1.0,1.0,1.0,19/92,27.54%,FIP1L1;DHX38;UPF2;SRSF7;MCM3AP;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;RAN;NUP50;RBM15B;SRSF9;SRSF5;NXT1;NCBP2;GLE1;DDX39A
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.3499176180312048,0.5759771873911579,0.9210526315789473,1.0,1.0,2/6,17.89%,SERPINB9;S100A13
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.33104640785363687,0.575933811132174,0.9782608695652174,1.0,1.0,5/5,66.90%,HES1;PRKCI;CHRM1;NOTCH1;PRKCH
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.3319753133492524,0.5758605446738266,0.9545454545454546,1.0,1.0,4/7,20.25%,SMS;MSRA;MTRR;MTR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.3244674099172025,-0.575055984486138,0.9571428571428572,1.0,1.0,1/10,6.89%,TNIP2
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.3780119957212269,-0.575054527225332,0.9661016949152542,1.0,1.0,1/5,15.40%,STPG4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.3780119957212269,-0.575054527225332,0.9661016949152542,1.0,1.0,1/5,15.40%,STPG4
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.270485711668881,0.5742157412204922,0.9375,1.0,1.0,5/23,18.71%,SGCZ;MEGF10;DMD;MRTFA;NEBL
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.3485620833742814,-0.5742133808416361,0.9508196721311475,1.0,1.0,2/8,17.00%,PRPS1;PAICS
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.297030047270237,0.5741492665268654,0.9285714285714286,1.0,1.0,5/13,25.99%,ELP3;ELP4;ALKBH1;MTO1;TRMT9B
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.3005048492775591,0.5740242463269033,1.0,1.0,1.0,6/15,19.94%,INTS6;INTS9;INTS11;MTREX;INTS1;ZCCHC8
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.3008631501074294,-0.5735257530422175,0.9852941176470589,1.0,1.0,6/29,21.44%,TST;PRELP;TXN2;OMD;MPST;OGN
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.2988205942629136,-0.5735138356091223,0.9552238805970149,1.0,1.0,4/21,11.10%,HTR2B;PHB2;SELE;BDNF
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3252297094348836,0.5732410715957822,0.8863636363636364,1.0,1.0,4/8,22.15%,RAB34;MAPKAPK3;MAPKAPK2;SNX5
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.2928775063364706,-0.5728787034699498,0.9861111111111112,1.0,1.0,5/26,19.86%,CALR;TGFB1;STRADB;CSE1L;RAN
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.2925415372934533,0.572735924853169,0.9666666666666667,1.0,1.0,1/12,5.83%,PATL1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.36521482272909056,-0.5727314892511632,0.9666666666666667,1.0,1.0,2/6,25.57%,DKK3;INSM1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.29953155479947624,-0.5725738370116931,0.9833333333333333,1.0,1.0,5/30,15.88%,CFTR;ATP5F1B;SLC9C1;SLC9B1;GPR89A
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.3406803779094181,-0.5724934543592305,0.9433962264150944,1.0,1.0,3/13,24.07%,CARTPT;LILRB3;TCTA
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.32093878224342176,0.5722682503758766,0.9285714285714286,1.0,1.0,2/10,12.54%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.38838022450584564,-0.572195075121394,0.9473684210526315,1.0,1.0,2/5,30.90%,DDX21;DDX23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.3549603332710473,0.5718605602336312,0.972972972972973,1.0,1.0,1/7,5.70%,RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.3549603332710473,0.5718605602336312,0.972972972972973,1.0,1.0,1/7,5.70%,RAB23
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.34023757928227316,-0.571750949194273,0.9642857142857143,1.0,1.0,2/9,12.79%,BRCA1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.2626990870183159,0.5713332221678911,1.0,1.0,1.0,3/24,8.25%,IFNA2;TRIM11;CD4
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.29996863209797986,-0.5712962988992133,0.9859154929577465,1.0,1.0,4/26,18.39%,RAD51AP1;PARP1;MRNIP;OOEP
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.32396995742791823,-0.5708732851369364,0.9552238805970149,1.0,1.0,2/11,16.23%,WNT9A;GREM1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.2992598325134594,-0.570850618056274,0.9672131147540983,1.0,1.0,3/18,14.00%,EXOSC4;INTS5;INTS12
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3430542893802318,-0.5701756783985304,0.9701492537313433,1.0,1.0,6/10,31.64%,PRR7;HTRA2;PLAUR;PARK7;FAS;GSN
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.2939021021072044,-0.5699745386912446,1.0,1.0,1.0,6/19,28.76%,RACK1;CAV1;INPP5K;PDE4D;SMAD7;DDIT4
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.35079331652157886,0.569919996764992,0.9473684210526315,1.0,1.0,1/12,3.18%,ADAM19
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.3684364139343125,-0.5694477566720118,0.9836065573770492,1.0,1.0,2/7,22.77%,CHMP3;VPS4B
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.2856706753135782,-0.569266792535884,0.958904109589041,1.0,1.0,5/26,21.02%,IRF4;TNFRSF21;PDCD1LG2;HLA-DRB1;CD46
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.3606703980751732,0.5692044868957162,0.975609756097561,1.0,1.0,3/5,25.10%,NAPB;UNC13B;STX1B
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.31893910096835393,-0.5691623261683406,0.9305555555555556,1.0,1.0,1/21,3.38%,ENO4
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.3247889533654414,-0.5689437768264621,0.9384615384615385,1.0,1.0,5/13,20.72%,TMSB4X;PINK1;PARP1;ANTKMT;ENO1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.3981076587482911,-0.5688463125585091,0.9649122807017544,1.0,1.0,2/5,22.78%,APPL2;RAB31
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.3981076587482911,-0.5688463125585091,0.9649122807017544,1.0,1.0,2/5,22.78%,APPL2;RAB31
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.33787197718674866,0.5685474847254467,0.9642857142857143,1.0,1.0,2/12,8.52%,CHD7;MYO3A
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),0.3371036452314729,0.5678143567894334,0.925,1.0,1.0,2/6,12.66%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.2718830595955385,-0.5666160945333361,1.0,1.0,1.0,7/28,19.05%,RBM3;RBM22;NCL;CIRBP;POLR2A;SNW1;NCBP1
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3062168082796881,0.5664450622534997,0.9047619047619048,1.0,1.0,3/9,19.19%,NSFL1C;GSK3B;MARK4
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.28292556962718957,-0.5661336629451506,0.9846153846153847,1.0,1.0,9/31,24.30%,PTK6;WNT9A;MEIOSIN;SNW1;PTK7;WNT8B;ZNF35;BRINP2;HTRA2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.35649367679444854,-0.5658773328487567,0.9649122807017544,1.0,1.0,2/10,11.52%,RACK1;IFI6
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.31327351671023956,-0.5654350494631045,0.984375,1.0,1.0,1/12,7.76%,FBLN1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.2537254215358332,0.5653268577052272,1.0,1.0,1.0,9/24,22.31%,PAPOLA;WDR33;PCF11;SCAF8;TENT4B;PNPT1;SYMPK;PAPOLG;APP
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.2537254215358332,0.5653268577052272,1.0,1.0,1.0,9/24,22.31%,PAPOLA;WDR33;PCF11;SCAF8;TENT4B;PNPT1;SYMPK;PAPOLG;APP
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.25740191622929276,0.5639306055000687,0.9696969696969697,1.0,1.0,3/36,9.13%,GFAP;TRAF2;RAPGEF1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.26217362634681035,-0.56391059761908,1.0,1.0,1.0,4/36,18.90%,DND1;YBX3;CIRBP;VIP
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.3437341121668812,0.5638519951600288,0.9761904761904762,1.0,1.0,2/6,26.24%,CSF1R;IL33
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.3261084318255105,0.563516325590683,0.9,1.0,1.0,3/8,21.47%,SLC2A5;BMPR2;DRD2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.3336821029254995,-0.5626592548034445,0.9508196721311475,1.0,1.0,3/11,22.40%,DOCK8;RHOA;ADAM17
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.2846943085412286,-0.5625577485690066,1.0,1.0,1.0,16/35,27.97%,PHAX;SNRPD1;SNRPD2;NCBP1;LSG1;GEMIN6;DDX20;SMN1;RBM15B;NXT1;SNUPN;SNRPG;NCBP2;SNRPE;RITA1;GEMIN2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.30456563468672004,0.5619296339855246,0.9736842105263158,1.0,1.0,4/11,18.15%,SCIN;ABI2;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.3626729138777332,0.5618484104734015,0.9069767441860465,1.0,1.0,5/5,63.74%,CSNK2A1;PLSCR1;TPR;NUMA1;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.28668547589752164,-0.5617483348138206,0.984375,1.0,1.0,1/25,3.17%,CD63
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.3532709708215672,0.5615909810372377,0.95,1.0,1.0,2/6,21.40%,MAPT;FYCO1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.294199322841119,-0.5612097869128423,0.9393939393939394,1.0,1.0,5/17,22.40%,VPS25;CBLC;SHC1;SNX6;ADAM17
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.37273323675373937,-0.561186006102287,0.9245283018867925,1.0,1.0,3/5,40.79%,BAD;GCKR;DUSP12
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.311825433009569,-0.5609875827066169,0.9365079365079365,1.0,1.0,1/9,7.88%,TPP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.28866402619709486,-0.5607683287989925,0.9428571428571428,1.0,1.0,6/20,25.02%,TGFB1;GDI1;MRAP;INPP5K;TMBIM1;KCNE1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.2724345211773184,-0.5601987148781402,1.0,1.0,1.0,6/29,21.03%,RPS3;PPIF;MAPK7;ECT2;IMPACT;ZNF580
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.2763686927461158,-0.5601899153547574,0.9565217391304348,1.0,1.0,4/22,19.40%,RBM22;CAMK1;GTSE1;EMD
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.25535051987347734,0.5601569408325747,1.0,1.0,1.0,7/30,18.93%,CAMSAP3;HCLS1;ESAM;CAMSAP2;ABL1;MAPT;MAP2
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.36574744401999065,-0.5596711703604065,0.9259259259259259,1.0,1.0,2/6,19.07%,AQP11;SLC14A2
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.30854209674719635,0.5593922807740666,0.9811320754716981,1.0,1.0,10/10,69.16%,NIPBL;ACD;LRWD1;PIH1D1;POT1;RUVBL2;MACROH2A1;BRCA2;MACROH2A2;NABP2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.3488413295936511,-0.559354765884781,0.9655172413793104,1.0,1.0,1/7,19.82%,GCLM
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.3488413295936511,-0.559354765884781,0.9655172413793104,1.0,1.0,1/7,19.82%,GCLM
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2342649637079427,-0.5592034765725066,1.0,1.0,1.0,18/93,27.54%,FIP1L1;DHX38;UPF2;SRSF7;MCM3AP;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;NUP50;RBM15B;SRSF9;SRSF5;NXT1;NCBP2;GLE1;DDX39A
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.2960375003754514,-0.5588501372519437,0.9857142857142858,1.0,1.0,3/18,19.92%,YBX3;LRRC8D;RCSD1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.3645199041426313,-0.5587394183261997,0.9642857142857143,1.0,1.0,1/5,19.16%,BCAT2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.2590530100763616,0.5583901447098452,1.0,1.0,1.0,9/30,23.19%,CLASP1;RPS6KA6;EHMT1;NIBAN2;PHLDB2;NIPBL;TLE6;PLCB1;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.33495614270026974,0.5583676598760228,0.9166666666666666,1.0,1.0,2/5,24.76%,KMT2D;LMO3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.2440011192059338,-0.5580958410865284,1.0,1.0,1.0,13/68,22.81%,IRGM;HTR2B;SELE;SELP;CXCR6;EDN1;TPCN2;MCTP2;PRKACA;FIS1;CCR7;BCAP31;CCR3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3086650863559466,-0.5580854353745053,0.9848484848484849,1.0,1.0,2/19,16.74%,RHBDF1;APOE
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3066521030813015,-0.5578379523919585,0.967741935483871,1.0,1.0,4/11,28.34%,IMPDH2;PAICS;PFAS;GART
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.35634795298670385,-0.5577135442994021,0.9090909090909091,1.0,1.0,2/5,24.57%,BLOC1S2;DTNBP1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.36558646739171413,-0.5576386653221441,0.9491525423728814,1.0,1.0,2/5,26.43%,CHGA;NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.36558646739171413,-0.5576386653221441,0.9491525423728814,1.0,1.0,2/5,26.43%,CHGA;NR4A3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.3550044218489233,-0.557231576906085,0.9830508474576272,1.0,1.0,1/5,26.79%,AGO4
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.33886789836277353,-0.5563774516334181,0.9354838709677419,1.0,1.0,2/8,20.98%,CDC42EP1;CCR7
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.33886789836277353,-0.5563774516334181,0.9354838709677419,1.0,1.0,2/8,20.98%,CDC42EP1;CCR7
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.2646189035665014,-0.5557712212892193,0.9852941176470589,1.0,1.0,8/54,18.19%,PRDX5;RPS3;ROMO1;PPIF;MAPK7;ECT2;PDK2;IMPACT
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.2576994756566872,0.5539673661000847,1.0,1.0,1.0,7/17,26.89%,ADCY8;PRKACB;ADCY6;ADCY2;CRY1;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.35387133719898967,-0.5536964978351293,0.9692307692307692,1.0,1.0,2/6,18.61%,SSB;DDX1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.32914006915373617,-0.5535028139074263,0.9166666666666666,1.0,1.0,3/10,20.48%,VPS25;CBLC;SNX6
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.3469069002063926,0.5528225399714444,0.8958333333333334,1.0,1.0,6/6,65.32%,NIPBL;LRWD1;PIH1D1;RUVBL2;MACROH2A1;MACROH2A2
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.2964182102209329,0.5527483111820428,0.975,1.0,1.0,9/9,70.37%,ATXN2;RBFOX1;HNRNPA2B1;SIDT1;YBX1;RTRAF;SIDT2;NXF5;CKAP5
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.3329924109085115,-0.5519878153037702,0.9411764705882353,1.0,1.0,2/7,18.90%,ZFHX2;VIP
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.32378952595672417,0.551339092905806,0.9743589743589743,1.0,1.0,2/9,18.46%,KCNN2;SCN3B
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.3110141349092747,0.55121195349444,1.0,1.0,1.0,4/9,20.91%,DUSP6;PTEN;WWC1;LATS2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.23933652335266034,-0.5510896647005477,1.0,1.0,1.0,9/75,16.90%,TRIM13;IRGM;PHB2;PINK1;PIK3CB;KAT5;SUPT5H;UFL1;ORMDL3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.3196371299662476,-0.5509198408135727,0.9473684210526315,1.0,1.0,2/8,22.85%,BLOC1S2;BNIP3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.27546292589712285,-0.5508465373182497,0.9420289855072463,1.0,1.0,2/19,13.12%,TGFB1;MYH6
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.32743950660051696,0.5496625548706058,0.8947368421052632,1.0,1.0,1/7,6.11%,IRAK3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.2852964412786736,-0.5492171414074027,0.9710144927536232,1.0,1.0,1/24,6.01%,TRMT112
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.256961544244446,0.5489302606458655,0.9696969696969697,1.0,1.0,5/24,17.96%,OBSL1;OPTN;GOLPH3;ARL5A;RIPOR1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.3063960602441411,-0.5479866915277566,0.9850746268656716,1.0,1.0,3/12,23.82%,ACBD5;MAP1LC3B;SQSTM1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.3685088677775766,-0.5471235311440852,0.96875,1.0,1.0,3/5,37.76%,HIP1R;LRP1;PTPN12
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.35002904039147026,-0.5468241755935521,0.9814814814814815,1.0,1.0,1/7,17.39%,PTN
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.2834376075500038,0.5465253813196069,1.0,1.0,1.0,5/14,21.73%,FUT8;ST3GAL6;ST3GAL2;FUT9;FUT2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.34720923676129445,-0.5463482279201978,1.0,1.0,1.0,1/8,11.10%,BDNF
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.34356459945390594,0.5457219552885667,0.9032258064516129,1.0,1.0,2/6,15.60%,ADARB1;CORO1C
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.23187106366122656,-0.5457072417504878,1.0,1.0,1.0,19/94,27.54%,FIP1L1;DHX38;UPF2;SRSF7;MCM3AP;EIF4A3;CPSF3;SRSF3;MAGOHB;NCBP1;NUP50;RBM15B;SRSF9;ENY2;SRSF5;NXT1;NCBP2;GLE1;DDX39A
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2536112585617927,0.5452754333738116,0.9722222222222222,1.0,1.0,11/29,25.49%,OTUD7B;YOD1;ZRANB1;OTUD1;UIMC1;OTUD4;OTUD7A;USP25;CYLD;USP7;USP27X
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.3183162961902005,-0.5451193326743425,0.9649122807017544,1.0,1.0,4/14,22.91%,GPR68;MCOLN1;IMPACT;HVCN1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.29769662110453915,0.5444903299900956,0.972972972972973,1.0,1.0,4/11,24.58%,PRKG2;QDPR;GCH1;MTHFD1L
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.26643767815838304,0.544334661657952,1.0,1.0,1.0,3/22,13.35%,PUS7;ZC3H13;METTL8
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.3072000172926005,0.5434540394865556,0.9459459459459459,1.0,1.0,2/10,13.12%,PCM1;NINL
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.3059485930253516,-0.5432513682964905,0.958904109589041,1.0,1.0,5/12,32.65%,VIP;CAV1;ACTN2;NOS1;CAV3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.3107589122199098,-0.5415442585592429,0.9850746268656716,1.0,1.0,1/9,14.60%,MAPK7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.3189739391967671,0.5411473097583938,0.972972972972973,1.0,1.0,2/9,12.66%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.2982158385107222,-0.5409907981621038,0.984375,1.0,1.0,1/16,11.37%,STAT1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.29190161191774433,0.5396080944705833,0.96,1.0,1.0,5/12,24.66%,HAP1;MAPT;TRAK1;MTM1;TRAK2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3253121362198731,-0.5395778089805703,0.9436619718309859,1.0,1.0,2/9,26.14%,SLC18A2;PARK7
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2626206473123013,-0.5392172252757995,0.9868421052631579,1.0,1.0,4/24,21.44%,TCEA2;SUPT5H;HTATSF1;TSFM
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.30462383070928234,-0.5389277341965246,0.9848484848484849,1.0,1.0,4/11,23.14%,DCK;TK2;UCK1;UCKL1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.29673772795437453,-0.5387229050379486,0.9848484848484849,1.0,1.0,3/18,16.03%,BRCA1;KAT5;RAD50
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.2689146379773545,-0.5385655594137008,1.0,1.0,1.0,8/32,20.05%,NEFL;BLOC1S4;AP3B2;KIF4A;SNAPIN;MAP1A;SOD1;BLOC1S2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.3433383052781151,0.5379091852842207,0.9512195121951219,1.0,1.0,3/5,34.06%,E2F3;PDCD4;PPARG
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.2957089814107338,0.5373907520679414,0.9629629629629629,1.0,1.0,6/11,25.61%,PAXIP1;TFRC;SHLD1;KMT5B;HMCES;KMT5C
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.2469487297127349,0.5367824165840291,1.0,1.0,1.0,6/29,17.74%,PAXIP1;SMYD2;ASH2L;KMT2D;CXXC1;SETDB2
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.2796595178557055,0.5362814434243042,0.9545454545454546,1.0,1.0,2/18,8.85%,TTLL11;TTLL9
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.28536283752559394,0.5361952153460535,0.95,1.0,1.0,2/8,21.78%,WNT5A;DVL2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),-0.28860202148974057,-0.5352766936616891,0.9583333333333334,1.0,1.0,1/13,8.17%,IRGM
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.285643843741697,-0.5330784749674887,0.9857142857142858,1.0,1.0,3/15,22.45%,INTS5;INTS12;TOE1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.29722191230614736,0.532935336264962,0.9523809523809523,1.0,1.0,7/7,70.29%,LIG4;TOP2A;MGMT;XRCC4;LIG1;LIG3;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.33680979301549047,0.5323166753354868,1.0,1.0,1.0,1/8,5.94%,SNCA
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.3039271894213559,0.5320304584010632,0.9722222222222222,1.0,1.0,1/8,6.46%,DHFR
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.2642474467258964,-0.5319782653538366,0.984375,1.0,1.0,3/33,11.92%,KIF20B;CEP131;ABCA12
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.31392558922837777,-0.5317395914371863,0.9166666666666666,1.0,1.0,4/13,21.21%,PHKG1;PYGL;AGL;CALM1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.2936681152940989,0.5300861607007117,0.9333333333333333,1.0,1.0,4/10,18.42%,MTERF1;TFB1M;FOXO3;SLC25A33
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.2879507748039369,-0.5293031250483982,0.984375,1.0,1.0,3/14,26.14%,EDN1;VIP;PARK7
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.3234785519049478,0.5291797918138353,0.9512195121951219,1.0,1.0,6/6,67.66%,CDS2;PLA2G6;PGS1;SLC27A1;TAMM41;GPAM
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.267617475372691,0.5288889850604896,1.0,1.0,1.0,2/13,17.34%,YOD1;UBE2G2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.25487640362075037,0.5283889413622063,1.0,1.0,1.0,6/15,26.89%,ADCY8;PRKACB;ADCY6;ADCY2;ADCY5;ADCY9
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.2855322069066023,0.5273330796475968,0.972972972972973,1.0,1.0,3/14,12.36%,BACH2;CD55;SLA2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.35062472110664883,0.5269336116679835,0.8888888888888888,1.0,1.0,5/5,64.95%,CAD;CTPS1;DHODH;UMPS;CTPS2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.3230709680860571,-0.5268171490663173,0.9848484848484849,1.0,1.0,2/8,17.63%,LAMP1;NEFH
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.28158279227466476,0.5265757892915954,0.8709677419354839,1.0,1.0,5/10,24.94%,DUSP1;SLC12A2;WNK1;STK39;OXSR1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.26433306059394074,0.526521132918066,0.9166666666666666,1.0,1.0,5/15,22.34%,ITGAX;GDNF;FGF2;SMO;MDK
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.3244759050714152,-0.5260408735585331,0.9672131147540983,1.0,1.0,1/7,16.51%,DNM1L
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.3244759050714152,-0.5260408735585331,0.9672131147540983,1.0,1.0,1/7,16.51%,DNM1L
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.324821655566536,-0.525917234851989,0.9464285714285714,1.0,1.0,3/5,29.23%,KCNQ1;CHGA;GSTO1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.2923096712817167,-0.5253881462014831,0.9850746268656716,1.0,1.0,4/16,23.50%,BRCA1;DNMT3B;SNW1;CTR9
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.27608934109277683,0.5251938795897311,1.0,1.0,1.0,5/24,12.84%,CRADD;ZDHHC3;BAG3;TNFRSF10A;SORT1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.24603791776753364,-0.5247662331993332,1.0,1.0,1.0,8/30,26.45%,SNAPIN;LAMTOR1;BLOC1S2;CHGA;PIP4P1;FAM98A;NR4A3;KXD1
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.34403852368510124,-0.5227580534540383,0.9830508474576272,1.0,1.0,1/6,19.96%,CDHR2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.2818661718532536,0.5225248325873748,1.0,1.0,1.0,4/12,24.96%,PCM1;NINL;BICD2;NIN
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.2870437422468699,0.5214464275668302,1.0,1.0,1.0,1/13,3.48%,COQ2
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.2870437422468699,0.5214464275668302,1.0,1.0,1.0,1/13,3.48%,COQ2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.2960856619013678,-0.5213255425613998,0.9726027397260274,1.0,1.0,2/11,18.37%,AR;DDX5
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.34378199963531125,-0.5202367103405375,0.9818181818181818,1.0,1.0,3/6,29.05%,LRRC8D;SLC1A6;SLC25A12
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.2535214544686529,-0.5192097658763258,1.0,1.0,1.0,3/27,15.15%,RPS3;ANKRD53;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.2986680143535246,-0.5187027291136591,0.953125,1.0,1.0,4/9,29.54%,CDC34;PDE2A;PDE4D;PDE11A
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3132647501432464,-0.5186370963749009,0.9705882352941176,1.0,1.0,4/12,23.50%,BRCA1;DNMT3B;SNW1;CTR9
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.24314979683771504,0.5183053542476391,1.0,1.0,1.0,2/19,12.73%,AUP1;UGGT1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.29164342296106205,0.517846173265416,0.9555555555555556,1.0,1.0,7/7,70.85%,TRNAU1AP;SEPSECS;DIO2;SECISBP2L;SELENOT;SECISBP2;EEFSEC
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.29164342296106205,0.517846173265416,0.9555555555555556,1.0,1.0,7/7,70.85%,TRNAU1AP;SEPSECS;DIO2;SECISBP2L;SELENOT;SECISBP2;EEFSEC
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.2406398043982001,-0.5168091301543118,1.0,1.0,1.0,6/44,17.21%,GPC3;BDNF;CEP72;PARP1;MAP1A;LCP1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.2704837970555519,-0.5167893336602044,0.984375,1.0,1.0,2/30,8.56%,RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.31239189788109545,0.5149422621004662,0.9285714285714286,1.0,1.0,1/5,14.29%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.31239189788109545,0.5149422621004662,0.9285714285714286,1.0,1.0,1/5,14.29%,TACR3
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.31239189788109545,0.5149422621004662,0.9285714285714286,1.0,1.0,1/5,14.29%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.31239189788109545,0.5149422621004662,0.9285714285714286,1.0,1.0,1/5,14.29%,TACR3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.30573698250869524,-0.5146703468592503,0.9821428571428571,1.0,1.0,1/5,21.45%,BCAP31
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.25004998879902146,0.5146186044012585,1.0,1.0,1.0,5/25,15.13%,STXBP5;LLGL2;ARFIP1;ATP13A2;SCFD1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.26518540021442394,-0.5141174453356842,0.9682539682539683,1.0,1.0,3/19,20.48%,VPS25;CBLC;SNX6
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.3130648220461899,0.5137265174451592,0.9705882352941176,1.0,1.0,7/7,68.71%,CAD;CTPS1;DHODH;CMPK1;UMPS;CTPS2;AK5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.30030683403068337,0.5136868183036503,0.9743589743589743,1.0,1.0,8/8,69.98%,CSF1R;MAPK1;CSF1;IL34;LYN;PTK2;IL12A;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3023709902370988,0.5134426998297283,0.8857142857142857,1.0,1.0,8/8,69.78%,GSK3B;DYRK2;HOMER2;FHL2;ATP2B4;PRNP;HOMER3;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.3023709902370988,0.5134426998297283,0.8857142857142857,1.0,1.0,8/8,69.78%,GSK3B;DYRK2;HOMER2;FHL2;ATP2B4;PRNP;HOMER3;CHP1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.31800162446495495,0.5122128188702161,0.975,1.0,1.0,2/6,15.21%,HDC;CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.31800162446495495,0.5122128188702161,0.975,1.0,1.0,2/6,15.21%,HDC;CARNMT1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.2680929953769505,-0.5121869710839447,1.0,1.0,1.0,2/18,16.82%,IFT122;C12ORF57
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.29370651384966173,-0.5115180040007391,0.9710144927536232,1.0,1.0,2/9,21.25%,MGST3;ALOX5
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.33435781070854376,-0.5095758613037489,0.9523809523809523,1.0,1.0,1/5,19.46%,STARD5
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.33435781070854376,-0.5095758613037489,0.9523809523809523,1.0,1.0,1/5,19.46%,STARD5
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.3322385526038352,0.5094769156113474,1.0,1.0,1.0,1/5,11.44%,CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.3322385526038352,0.5094769156113474,1.0,1.0,1.0,1/5,11.44%,CRTAM
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.30343251994057374,-0.5090994439983408,1.0,1.0,1.0,2/13,13.69%,PPIF;ATF3
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.3163097840776032,0.5087199087331838,0.9230769230769231,1.0,1.0,4/7,34.84%,SMO;NF1;PTCH1;EFEMP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.300256581883088,0.5080378042182667,0.9761904761904762,1.0,1.0,5/5,69.98%,CSF1R;MAPK1;IL34;PTK2;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3239933792541315,-0.5073463777124354,0.9322033898305084,1.0,1.0,2/6,17.97%,IFI35;NINJ1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.29843652031483303,-0.507264083906551,0.9682539682539683,1.0,1.0,2/10,29.24%,WDR45B;WIPI2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.26915268910195717,-0.506818732399604,1.0,1.0,1.0,8/24,26.14%,PINK1;PPIA;MAPK7;TXN;GPR37L1;NOL3;HTRA2;PARK7
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.28733357690671557,-0.5063588793293822,0.9855072463768116,1.0,1.0,4/11,27.80%,EDN1;RFK;PARK7;AGT
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.33078746626090416,-0.5061958100958587,0.9838709677419355,1.0,1.0,1/7,19.17%,CEND1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.3019632650920016,-0.5060591618383288,0.9841269841269841,1.0,1.0,3/8,29.92%,PEX1;PEX16;PEX12
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.3399848420359445,0.5055375190442098,0.9767441860465116,1.0,1.0,1/5,9.70%,CIAO3
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.319217902409513,-0.5040313941209827,0.9821428571428571,1.0,1.0,3/7,26.48%,SOD1;USH1C;PDZD7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.2588684882589848,0.5036138493302713,1.0,1.0,1.0,2/16,8.90%,HAP1;AKAP6
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.3033220864751677,0.5025616626858199,0.95,1.0,1.0,1/6,17.74%,SETDB2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.30432409527351273,-0.5025237773401592,0.95,1.0,1.0,2/8,30.36%,MAPK3;AKAP8
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.33439312806782684,0.5016899304523702,0.972972972972973,1.0,1.0,5/5,66.57%,SLC6A15;SLC6A7;SLC36A4;SLC1A4;SLC6A17
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.2986947791164659,0.5014297759471443,0.9821428571428571,1.0,1.0,5/5,70.14%,EFHD1;SLC25A23;CLN3;LETM1;MICU1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.28224243734889215,0.5014259144112678,0.9736842105263158,1.0,1.0,1/9,12.84%,SORT1
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.33623560050474705,-0.5005225732869459,1.0,1.0,1.0,2/5,23.31%,HAAO;AOX1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.29859855034168814,0.500497087995064,0.9512195121951219,1.0,1.0,2/7,17.71%,IFT88;SLC4A7
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.29308392751159557,-0.5001950224464287,1.0,1.0,1.0,4/11,26.14%,CAMK1;KAT5;TERF2IP;PARK7
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.3039941225543459,-0.4994029724486169,1.0,1.0,1.0,3/7,29.92%,PEX1;PEX16;PEX12
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.24788533080902547,-0.49871674627654605,1.0,1.0,1.0,9/39,24.30%,VPS35;HAX1;PINK1;DNM1L;FIS1;PDE2A;SREBF1;SQSTM1;HTRA2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.30922182714138846,-0.49868011243669896,0.9830508474576272,1.0,1.0,2/5,27.37%,PEX16;CLIP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.295597835183842,0.49765767206890554,1.0,1.0,1.0,10/10,70.46%,SCN3B;ANK3;WNK3;AHCYL1;SCN4B;CNKSR3;PKP2;GPD1L;NOS1;SCN1B
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.2601477580258412,0.49659326374264323,1.0,1.0,1.0,10/16,31.87%,CASK;SIGLEC10;FGF2;MDK;INPP5F;PTPRS;RTN4RL1;GIT1;CRK;RTN4R
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.24642764790946423,-0.4960234216361532,0.987012987012987,1.0,1.0,6/28,21.79%,TPX2;TPPP3;MAP7D3;GOLGA2;TUBGCP4;TUBGCP2
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.3331519794891853,-0.49597830884005345,0.9833333333333333,1.0,1.0,2/5,21.71%,SLC22A1;SLC18A2
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.3065667124635592,0.4955794759808532,1.0,1.0,1.0,2/6,18.88%,AKIRIN1;PPP3CA
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.2637449512953315,-0.4955241688742451,1.0,1.0,1.0,2/23,13.65%,DSCC1;KAT5
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.29499014544018837,0.49548529648105016,0.9761904761904762,1.0,1.0,1/5,12.17%,SLC32A1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2593893940860477,-0.4951159134835826,1.0,1.0,1.0,6/14,32.65%,PLN;GOPC;YWHAE;NEDD4;ACTN2;CAV3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.288488015122099,-0.49449312108810145,0.9833333333333333,1.0,1.0,1/12,12.33%,YBX3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.31311274844884973,-0.49383515438460157,0.9830508474576272,1.0,1.0,2/7,19.83%,RANGRF;CAV1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.31248954091593684,0.49374154159281775,0.9761904761904762,1.0,1.0,6/6,68.76%,NFKBIA;EIF2AK4;FOXO1;DNAJC3;SAXO1;EIF2AK3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.2886645098459084,-0.4904769254254152,1.0,1.0,1.0,1/11,9.46%,AR
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3042797332955848,0.4901909530821253,0.9743589743589743,1.0,1.0,7/9,34.72%,SLC22A2;RAB29;SLC22A3;ADAM10;ANTXR1;RAB40B;SLC29A4
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.272650660168011,-0.4894725636382629,1.0,1.0,1.0,6/13,34.82%,CAV1;BCAP31;USP13;HERPUD1;UBQLN2;BAG6
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.2929746005290647,0.4858387524684667,0.9787234042553191,1.0,1.0,1/5,14.64%,HIPK2
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.3086233824185631,0.48483426209036246,1.0,1.0,1.0,5/5,69.15%,FAM120B;PPARG;RXRA;ACTN4;PDK3
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.3002565818830879,0.4848337469636139,1.0,1.0,1.0,5/5,69.98%,RPS6KA4;RPS6KA5;FMR1;CDK9;MAPK3
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.2657217789185871,0.48296550011250894,0.9696969696969697,1.0,1.0,12/12,73.45%,DLD;PIPOX;OGDH;ALDH7A1;GCDH;PHYKPL;AADAT;SLC25A21;AASS;DLST;CRYM;HYKK
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.2657217789185871,0.48296550011250894,0.9696969696969697,1.0,1.0,12/12,73.45%,DLD;PIPOX;OGDH;ALDH7A1;GCDH;PHYKPL;AADAT;SLC25A21;AASS;DLST;CRYM;HYKK
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.26436833687474315,0.4820841917198567,0.967741935483871,1.0,1.0,2/11,14.38%,PIP4K2A;LRSAM1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.29296953398375486,-0.4812785975908271,0.984375,1.0,1.0,1/8,14.53%,NTNG2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.2555378213090541,-0.4796394049338539,0.9830508474576272,1.0,1.0,6/25,27.84%,PRELP;OMD;OGN;CHST2;CHST6;SLC35D2
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.32216244861811794,-0.47875934309097024,1.0,1.0,1.0,2/6,16.90%,SCARA3;XPA
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.2837792753202978,-0.47800198886994644,0.9354838709677419,1.0,1.0,4/11,27.25%,SERTAD1;SMARCD1;ELOF1;ZMIZ2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.3279968762202263,0.47515075956766634,1.0,1.0,1.0,6/6,67.21%,ERC1;MAP3K7;DAB2IP;CHUK;TLR2;PRDX4
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.28412635342127046,0.4747313849046029,1.0,1.0,1.0,4/7,28.58%,ATG2B;ATG13;ATG7;ULK1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.28412635342127046,0.4747313849046029,1.0,1.0,1.0,4/7,28.58%,ATG2B;ATG13;ATG7;ULK1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.2865384756000393,-0.47449768716733554,1.0,1.0,1.0,1/8,16.14%,CD160
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.28538985279380247,0.47186502010139375,0.9736842105263158,1.0,1.0,2/6,20.78%,MAPT;SIAH3
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.29391181080439915,-0.47035888425937133,1.0,1.0,1.0,1/6,23.18%,CERS2
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.32134091923248553,0.4699875859830873,0.9772727272727273,1.0,1.0,5/5,67.87%,SLF2;PARP3;IFFO1;XRCC4;SLF1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.2997965859839128,-0.46975760918429654,1.0,1.0,1.0,2/5,21.01%,ROBO3;GAP43
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.2911478482134993,0.4694928433133625,1.0,1.0,1.0,2/6,20.59%,GHR;PIK3R1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.2342292125316271,-0.46905502028737506,0.9857142857142858,1.0,1.0,8/32,27.73%,CLSPN;FBXO6;RAD9A;HUS1;E2F1;H2AX;DONSON;NBN
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.26073843089807935,-0.46869254891703044,1.0,1.0,1.0,3/14,21.21%,CALM3;PTPA;CALM1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.23955743129517426,0.4685288797611472,1.0,1.0,1.0,4/12,21.65%,NEDD4L;KCNE4;SCN3B;RYR2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.24484470229202276,-0.4684243018617835,1.0,1.0,1.0,7/23,25.34%,GPIHBP1;RIC3;FGF7;ANGPT1;USP4;MESD;ARF6
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.31617964784193053,0.4681651531459324,1.0,1.0,1.0,2/5,17.40%,CHDH;SLC44A1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.24849565774605764,-0.46771115326118573,1.0,1.0,1.0,9/20,32.65%,PLN;SYT11;VIP;INPP5K;PACSIN3;NEDD4;ACTN2;NOS1;CAV3
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.23876490981533438,0.4655412046829824,0.9705882352941176,1.0,1.0,1/9,10.80%,SLC22A2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.2127465298803154,-0.4640490618586656,1.0,1.0,1.0,17/60,29.72%,VIL1;HAX1;BAIAP2L2;MYADM;LMOD1;PFN2;CDC42EP1;CCR7;PFN1;TWF1;ARF6;COTL1;ARHGAP18;EVL;HIP1R;TWF2;RASA1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.26052415608684043,0.46382600945529695,0.975609756097561,1.0,1.0,2/10,17.04%,TMEM65;MDM4
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.2857723240393405,-0.46309316547981694,0.9642857142857143,1.0,1.0,2/7,25.65%,GLI3;HFE
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.2592393302288615,-0.4628110535938024,1.0,1.0,1.0,6/16,31.95%,TAF11;SNW1;NUCKS1;JUN;HPN;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.23512361538139148,-0.4609409152874222,1.0,1.0,1.0,9/35,27.85%,RRAGA;LAMTOR5;LAMTOR1;RRAGC;LAMTOR2;SMCR8;PIP4P1;LAMTOR4;LARS1
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.2725147933885831,0.46081818936415947,1.0,1.0,1.0,1/5,17.26%,KCNE4
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.28690825400359365,-0.46026221388598,0.9642857142857143,1.0,1.0,3/5,37.93%,PBLD;MUC4;SOX9
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.2778470563730052,-0.46018618867043604,0.9836065573770492,1.0,1.0,1/13,11.19%,JMJD4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.26322358930365897,-0.45990879524743905,1.0,1.0,1.0,3/13,22.91%,TMSB4X;PSMD10;CCDC22
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.2667906315229215,-0.4581832687665884,1.0,1.0,1.0,3/14,21.21%,CALM3;PRKACA;CALM1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.240251124987661,-0.4581238060202968,1.0,1.0,1.0,2/24,9.64%,AR;TGFB1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.24329479433430148,-0.45781776817347847,1.0,1.0,1.0,5/12,31.72%,SOD1;ADH6;GLRA2;SDF4;ADCY7
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.3054466115299411,-0.4576103758391083,1.0,1.0,1.0,1/5,21.71%,SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.2827178400089256,-0.4560125200929643,1.0,1.0,1.0,7/7,71.74%,CERS2;THY1;EPHA4;RTN4R;RTN4RL1;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.25653327216803257,0.4545489917696232,1.0,1.0,1.0,4/10,19.69%,DGKI;DGKE;DGKB;DGKK
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2402282174019206,-0.4539574380103308,1.0,1.0,1.0,3/19,18.80%,RPS27L;SNW1;TMEM109
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.24845494128519438,-0.4533556716555764,1.0,1.0,1.0,2/11,17.87%,EDN1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.2828694148491101,0.452271531270658,0.9302325581395349,1.0,1.0,6/6,71.72%,KDR;F3;NTRK3;VEGFA;CDH13;ANGPT2
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.27844712182061593,0.45091062144319727,0.9767441860465116,1.0,1.0,5/5,72.16%,TIRAP;CD14;CD36;TLR2;TLR1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.2840807675145023,0.4507979249645515,0.9791666666666666,1.0,1.0,5/5,71.60%,MAPK8;MAPK14;CAP2;MAPK3;CAP1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.26787905835099846,0.44886996468759266,0.9761904761904762,1.0,1.0,7/7,73.22%,DHX9;DDX3X;AGO3;AGO2;AGO1;DHX36;AGO4
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.2632181495463205,0.4484721487165344,1.0,1.0,1.0,2/6,22.38%,ATP13A2;TRPM7
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.25343084105899244,-0.44839707706078374,1.0,1.0,1.0,2/12,21.73%,CRB2;USH1C
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.2766580479867693,0.4479602619712971,1.0,1.0,1.0,2/6,18.49%,FGF2;AKIRIN1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.24940444350579938,-0.4477347966084374,1.0,1.0,1.0,1/12,19.97%,PGAM1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.2836791636916921,-0.44749114413569635,1.0,1.0,1.0,1/5,20.76%,TRPV3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.27508396331874446,-0.44694532185857405,0.9838709677419355,1.0,1.0,1/7,20.98%,CCR7
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.23231026785714284,0.44553529467680153,1.0,1.0,1.0,13/13,76.79%,ELP3;ELP4;MTO1;TRMT9B;DPH3;ELP1;MOCS3;GTPBP3;TRMU;CTU1;ALKBH8;URM1;CTU2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.2301639925306804,-0.4394816550310307,1.0,1.0,1.0,2/24,12.03%,EXOSC4;EXOSC10
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.24965515487093323,-0.4393759825883366,1.0,1.0,1.0,2/12,21.54%,NHLRC1;NR1D1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.24965515487093323,-0.4393759825883366,1.0,1.0,1.0,2/12,21.54%,NHLRC1;NR1D1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.26062157307907396,-0.4380229894540015,1.0,1.0,1.0,7/14,35.70%,ROBO3;ROBO4;VSTM2L;PALLD;BSG;MYPN;NEXN
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.2271617529848562,-0.43759047726648137,1.0,1.0,1.0,6/20,30.39%,AHR;MAPK7;PDE2A;PDE4D;CAP1;PDE7A
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.27220952133281345,0.43730112719564473,1.0,1.0,1.0,2/5,18.13%,HSPH1;CIITA
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.2658347882149002,-0.43517037944374326,1.0,1.0,1.0,2/10,16.37%,RAD50;XRCC3
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.20776754661904934,-0.4330038111614166,1.0,1.0,1.0,10/26,33.27%,SF3A1;NOL3;SRSF9;SRSF10;SRSF5;KHDC4;PUF60;SLU7;SF3A3;SNRPC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.2505665446971507,-0.4328620127128229,1.0,1.0,1.0,5/17,30.29%,CALM3;PRKACA;CALM1;GSTO1;ATP1B1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.23674983810997796,0.43224616033300833,1.0,1.0,1.0,6/13,29.15%,RPTOR;UCP1;RPS6KB1;ATF4;ULK1;FAM107A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.23716806255964307,-0.431792928836029,1.0,1.0,1.0,2/14,19.87%,C17ORF99;CD226
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.26992283520499266,-0.43125920203137796,0.96875,1.0,1.0,2/5,31.77%,SSU72;RPRD1A
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.2758589273395839,0.4299703599406211,0.9761904761904762,1.0,1.0,2/5,15.68%,RUNDC3A;PDE10A
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.23998825783983607,-0.42821201347613047,1.0,1.0,1.0,4/14,22.31%,GEN1;RAD50;XRCC3;RAD54B
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.2672263260904623,0.4229414345065029,0.9411764705882353,1.0,1.0,3/5,25.94%,POLH;MAP3K4;YY1
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.2558009817045963,0.42275864638547245,1.0,1.0,1.0,5/5,74.43%,PPP1R15B;NCK1;ABCA7;PPP1R15A;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.2815707273538599,0.41931236984060727,1.0,1.0,1.0,5/5,71.85%,LPL;SCARB1;SREBF2;MSR1;EHD1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.21914424060255847,0.4190357860277901,1.0,1.0,1.0,4/13,22.54%,CAMK2D;NEDD4L;SCN3B;FHL1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.23719808588542254,0.41783113428567464,1.0,1.0,1.0,1/8,10.16%,CPEB4
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.27764258125142294,-0.41749718945803,1.0,1.0,1.0,2/5,25.56%,TFDP1;E2F1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.2401435006805117,-0.41523615117304896,1.0,1.0,1.0,3/13,22.70%,GRWD1;SMARCD1;SET
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.2401435006805117,-0.41523615117304896,1.0,1.0,1.0,3/13,22.70%,GRWD1;SMARCD1;SET
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.24376949528599362,-0.4126798198266081,1.0,1.0,1.0,5/11,34.47%,ASF1B;ASF1A;SUPT16H;CABIN1;HAT1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.2579907402242428,0.41262690513474326,1.0,1.0,1.0,6/6,74.21%,ATG2B;ATG7;ULK1;ATG9A;ATG2A;ULK2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.2255101194666651,-0.409139807351447,1.0,1.0,1.0,3/11,30.36%,PRKD2;SAP30BP;AKAP8
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.2510841712815141,-0.40858748044948956,0.9838709677419355,1.0,1.0,2/7,31.07%,USH1C;SPINK5
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.2727576974564927,0.4053557315176565,1.0,1.0,1.0,5/5,72.73%,FYCO1;KIF13A;KIFAP3;KIF3B;KIF3A
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.22151816479331574,-0.40511075070428804,1.0,1.0,1.0,3/15,27.72%,NTNG2;DVL3;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.24977688531905395,0.40087066853430287,1.0,1.0,1.0,5/5,75.03%,PPARA;ABHD5;OSBPL8;PPARG;PNPLA2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.23253072668145852,0.39971402151846414,1.0,1.0,1.0,1/7,13.09%,ADCY8
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.23989620653692456,0.39884213787214723,1.0,1.0,1.0,1/5,14.30%,PTEN
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.24112929081060133,-0.3971605289199336,1.0,1.0,1.0,3/8,29.65%,DDR1;AAMP;PLAT
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.24039051603905162,-0.3953414225962855,1.0,1.0,1.0,8/8,75.98%,SREBF1;ERLIN2;SREBF2;INSIG1;INSIG2;ERLIN1;SCAP;ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.24039051603905162,-0.3953414225962855,1.0,1.0,1.0,8/8,75.98%,SREBF1;ERLIN2;SREBF2;INSIG1;INSIG2;ERLIN1;SCAP;ARHGEF10L
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.26348039200327605,-0.3893163782988073,1.0,1.0,1.0,1/5,20.38%,ITGAV
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.2166174119830127,0.3835905330348074,1.0,1.0,1.0,4/9,25.66%,NEDD4L;STK39;CAB39;CASQ2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.25111557340473,0.3824075288842662,0.9772727272727273,1.0,1.0,5/5,74.90%,PDPN;ANK3;DMTN;JAK1;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.20617526973184724,-0.37974610389049374,1.0,1.0,1.0,2/14,24.98%,ITGAV;PNPLA2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.23395968664356967,-0.3787429586481452,1.0,1.0,1.0,3/7,33.49%,MYOCD;ENG;SOD2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.21514248812443393,-0.377692330685335,1.0,1.0,1.0,3/9,28.78%,ACTB;SMAD7;VCL
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.25220664088542794,-0.3719236142360781,1.0,1.0,1.0,2/6,29.72%,ERCC8;XRCC6
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.20803231739295347,-0.3716297518283459,1.0,1.0,1.0,1/13,14.10%,NMI
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.2194879377180906,0.3701407438280511,1.0,1.0,1.0,2/7,23.10%,NR1H3;PPARA
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.19486428162016545,0.3663586838299912,1.0,1.0,1.0,2/11,18.15%,JMY;WHAMM
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.21605811835273162,-0.36118768715975536,1.0,1.0,1.0,3/10,30.46%,SDK2;PROM1;NKD1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2315900245942555,-0.3569562585531432,1.0,1.0,1.0,2/8,27.88%,CAV1;HGS
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.16212303160937477,-0.3552282179352448,1.0,1.0,1.0,16/41,38.27%,GCK;NUP50;PGAM1;NUP155;NUP58;JMJD8;NUP93;NUP88;POM121;NUP107;POM121C;AAAS;SEC13;HIF1A;SCARB2;GCKR
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.18541869415342002,0.34189985510468457,1.0,0.999989108355525,1.0,2/15,13.35%,ZC3H13;METTL8
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.21630208903667625,-0.33324454517013774,1.0,1.0,1.0,3/6,33.49%,GPR37L1;PRCP;SOD2
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.21150526484633675,-0.3161019530719958,1.0,1.0,1.0,1/5,19.54%,GPD1
